5329260316

Download as pdf or txt
Download as pdf or txt
You are on page 1of 181

Made in

India.
Made for
India.
Insights
Ideas
Impact

Annual Report 2015 16


This year’s report

Corporate Performance Governance Financial


Overview Statements
01-23 24-50 51-101 102-173

02 The World of 24 Financial Highlights 51 Corporate 102 Standalone Financial


Jyothy Laboratories Information Statements
26 Made to Deliver
06 Made in India. 52 Directors’ Report 140 Consolidated
28 M.R. Jyothy’s
Made for India. Financial Statements
Communiqué 88 Report on
Make in India Corporate
30 Segment Overview
is About Governance
36 Board of Directors
08 Pride & Excellence
38 Management
10 Digital India
Discussion &
12 Inclusive Growth Analysis
14 Domestic
Consumption
16 Self-Reliance
18 Youth Power
20 Chairman and
MD’s Statement
22 Q&A with Joint
Managing
Director and CFO

Stay informed.
This year’s report is complemented by a
range of online information and resources:
Investor
Centre Annual
Report
Main site
Visit the Investor Centre and Media Centre
Corporate
site on our corporate website to stay up-to-
annualreport2016/jyothylaboratorieslimited.com
date on Jyothy Laboratories’ results, latest
http://www.jyothylaboratories.com/ Visit our online annual report site. Each section
press releases, presentations, conference
Key sections include About Us, Our Brands, call transcripts, quarterly results and code of the annual report can be downloaded in pdf
Investor and Media Centre. format.
of conduct.
From a humble family-owned business in 1983 from Kerala to a national
corporate house in 2016, Jyothy Laboratories Limited has been driven
by one vision: giving Indians the best in the world.

With each offering made to the consumer, we hope to instil a sense of


pride and wellbeing. We understand this billion-strong population, and
everything we do creates a stronger connection with the country.

EVERY MOMENT, WE
ARE GRATEFUL FOR
THIS RELATIONSHIP
OF DEEP AND
COMPLETE TRUST.
2 Jyothy Laboratories Limited
Annual Report 2015-16

The World of
Jyothy Laboratories

WE HAVE OFFERINGS IN
FABRIC CARE, DISH WASH,
HOUSEHOLD INSECTICIDE AND
PERSONAL CARE. OUR BRANDS
ARE HOUSEHOLD NAMES SUCH
AS UJALA, HENKO, EXO, PRIL,
MAXO AND MARGO.
Corporate Overview Performance Governance Financial Statements 3

OUR BUSINESS OUR ORGANISATION OUR INSPIRATION


Jyothy Laboratories Limited is in the With a market capitalisation in excess We do not follow. We lead.
business of meeting the everyday needs of ` 5,200 crore as on March 31, 2016, Every product launched by the Company
of consumers by creating well-packaged and total sales of ` 1,644.73 crore, the is backed by cutting-edge ideas and
and technologically advanced products Company’s operations are spread across innovation in the industry. With that
in four segments of the fast-moving the length and breadth of the country, strategy and intent, all our brands
consumer goods industry. We have comprising 24 manufacturing facilities ÌɚsEsOŸŎsƼNjŸʩǼEĶsÞŘǼÌsǣÌŸNjǼsǣǼ
offerings in fabric care, dish wash, across 14 locations, two research possible time.
household insecticide and personal care. and development centres, and 5,500
Our brands are household names such committed employees. Our sustained success has come
as Ujala, Henko, Exo, Pril, Maxo and from never losing sight of the main
Margo. We are also in the business of purpose: to make life better, happier
laundry services. for the common man – or in our case,
the common woman, as she was the
OŸŘǣȖŎsNjŸ¯ŸȖNjʩNjǣǼƼNjŸ_ȖOǼʰȕĠĶʳ
4 Jyothy Laboratories Limited
Annual Report 2015-16

1
OUR BIG MOMENT OUR NETWORK OUR PEOPLE
A watershed moment came in 2011, with Jyothy Laboratories today covers about We are a company that puts the best
the acquisition of the controlling stake in 0.6 million direct sales outlets across people in the right jobs. Our highly
Henkel India Limited, the local arm of the the country through our sales team and experienced senior executives make
German FMCG giant. This was more than 1 million outlets through stockists. Our Jyothy Laboratories more competitive,
a business deal. It was a matter of great products like Ujala Fabric Whitener is drive new product developments and
pride that we had the reach and resources available in 2.9 million retail outlets. Our chart a growth path. At every level, there
ǼŸOOŸŎƼĶÞǣÌǼÌÞǣʳōŸNjsǣÞ¶ŘÞʩOŘǼĶɴʰ priority is deeper and wider penetration is top-down training and grooming
ɠsɠsNjsǼÌsʩNjǣǼŎĠŸNjÝŘ_ÞŘƼĶɴsNjǼŸ into the most promising markets. for higher roles. Employees receive
acquire a foreign company’s consumer Besides making the products available continuous guidance in technical,
business in this country. in more places, the sales network focus functional and leadership skills. Our sales
is on reaching the right stores. We force, affectionately called the ‘white
build relationships with outlets that are army’, has a thorough knowledge of
best placed to give us access to the territories. Passion, creativity, speed and
OUR STRATEGY
ǼNj¶sǼOŸŘǣȖŎsNjǣ¯ŸNjǣƼsOÞʩOENjŘ_ǣʳ hard work sum up our work culture. We
Jyothy Laboratories has a clear
This brings the maximal return on the have the industry’s best human resource
strategic intent: we want to focus
investment in distribution network. Also, practices, making every employee feel
on strengthening our position as
changes in logistics now allow for a like family.
manufacturer of superior products,
much shorter transit time, enabling us
with brands that are backed by
to quickly replenish stocks in these sales
strong investments. Brand innovation,
outlets whenever required.
targeted messaging, re-launching and OUR PROMISE
repackaging brands to keep in tune with Right price points for products,
the evolving consumer has helped us convenient packaging, extensive
grow. OUR REACH distribution, and strategic
We connect with sales outlets through OŸŎŎȖŘÞOǼÞŸŘNjsǼÌs¯ŸȖNj_sʩŘÞض
an aggressive ‘feet on street’ strategy, aspects of our business. We focus on
which pays off handsomely. Today, our simple, strong, sincere ways of serving
OUR PATH TO GROWTH
1,978-strong sales force has ensured that consumers.
Three elements have helped us on our
our products are available across more
journey. First, the voice of the consumer
than 1,400 stockists, 260 super-stockists
– we listen and gather genuine insights;
and 4,000 sub-stockists, and that we can
ǣsOŸŘ_ʰŸȖNjƼNjŸOsǣǣs¯ʩOÞsŘOɴ˛ɠs OUR USP
reach out to the smallest of urban and
_NjÞɚssŘ_˚ǼŸ˚sŘ_s¯ʩOÞsŘOÞsǣONjŸǣǣŸȖNj In a world of business rules, Jyothy
rural towns. In 2015-16, we added 42,200
value chain; and third, our organisation- Laboratories is an exception. We have
more rural outlets over the previous
building capabilities. All of this has the power of small’
proved ‘the small – small
ɴsNj˅ǣʩ¶ȖNjsʳÝŘONjsǣs_OŸɚsNj¶sŘ_
helped us strengthen our presence on g ideas
insights leading to big idea
ideass and
go-to-market strategy for rural centres
ground and in the market place. amazing impact.
are expected to help us sustain growth.

WE HAVE PROVED
‘THE POWER OF SMALL’
- SMALL INSIGHTS
LEADING TO BIG IDEAS
AND AMAZING IMPACT.
Corporate Overview Performance Governance Financial Statements 5

Our Story in
Numbers

1 million
Outlets reached through
0.6 million
Outlets reached through
stockists direct sales team

24
Manufacturing clusters
1,978
Sales team members ensuring
across India Jyothy Laboratories’ products
are available across India

263%
Growth in net revenues
from 2011 to 2016, CAGR
of 21.3% over 5 years
6 Jyothy Laboratories Limited
Annual Report 2015-16

Made in India.
Made for India.

Insights
Ideas
Impact
‘MAKE IN INDIA’ IS THE
BIGGEST BRAND THIS
COUNTRY HAS EVER
CREATED.
Corporate Overview Performance Governance Financial Statements 7

It has drawn the world’s attention to ŸŘʰŘ_ǼÌǼǼÌsɴɠÞĶĶEsŎ_sǼŸ¯ȖĶʩĶ close relationship we build with our
Indian manufacturing capabilities and its every Indian’s needs and desires. consumers, listening to them, seeing
R&D prowess; the power of exceptional things like they do; converting these
quality products and brilliant minds Driven by this ambitious goal, every day, insights into solutions that are useful,
ǼÌǼOŘɚÞǣȖĶÞǣsÞŘʩŘÞǼsƼŸǣǣÞEÞĶÞǼÞsǣʱ we put all our passion, capital, blood and unique and unparalleled; and ensuring
innovative ideas, solutions and skills that sweat into creating products that are that a positive impact comes from the
only need the fuel of good policy and best in their class and promise to make a unprecedented value we put into every
investment to rocket upwards. lasting difference to the lives of Indians, product, every day, every minute.
give them something no one has given
We at Jyothy Laboratories Limited began before. Jyothy Laboratories has been on a
our journey down that road more than ŎÞǣǣÞŸŘ¯NjŸŎǼÌsɚsNjɴʩNjǣǼ_ɴʳ
three decades ago. Since inception, Translating our vision into reality is
ŸȖNjƼÌÞĶŸǣŸƼÌɴɠǣʩNjŎĶɴNjŸŸǼs_ÞŘ our triple ‘I’ approach – Insights, Ideas, Our mission now mirrors a national
the belief that we can make the best Impact – to business: generating sharp, initiative.
products we set our hearts and minds incisive insights that come from the very
8 Jyothy Laboratories Limited
Annual Report 2015-16

Make in India
is About
Pride and
Excellence
Corporate Overview Performance Governance Financial Statements 9

Best-in-class manufacturing infrastructure


and world-class products. That is India’s
mantra in this century. The blueprint for
making this country a global manufacturing
destination has been created. Pride in our
capabilities and our products is rising.
Together, we must seize the day.

For Indian manufacturing to achieve Lean engineering, automation,


supremacy on the global landscape, capacity de-bottlenecking has helped
excellence is the only key. We must us to reinforce effectiveness in our
develop new technologies and operations. Through consolidation
augment our manufacturing prowess of our manufacturing units, we have
to international standards. The ǣÞŎƼĶÞʩs_ǼÌsƼNjŸOsǣǣŸ¯ǣŸȖNjOÞضŘ_
emphasis has to be upon zero defects procurement. Additionally, we have
in production and zero impact on the NjsƼs_s¯ʩOÞsŘOɴ¶ÞŘǣ_ȖsǼŸǼÌs
environment. EsŘsʩǼǣŸ¯ǣOĶÞضƼNjŸ_ȖOǼÞŸŘʳ

Jyothy Laboratories has invested The key to producing excellence, day


ÞŘǼÌÞǣ¯NjŸŎǼÌsɚsNjɴʩNjǣǼ_ɴʱǼÌÞǣ after day, year after year is through
is what makes us different. Always continual investments in research and
manufacturing in-house ensures strict development. The results of our R&D
quality control, and the deployment of efforts are manifested in our strong
the right processes makes our products product innovation pipeline.
environment-friendly. Our strong focus
on quality has led us to integrate Quality Manufacturing units in India should
Module in our ERP systems. Periodic become centres of excellence – they
audits at plants, quality control audits at should not only produce goods, but
third-party locations, and documentation produce world-class goods that are
of lab practices in the Quality Manual are unbeatable value for money. With
the other methods adopted to ensure strong conviction in our manufacturing
our products score high on the quality ǣǼNjsضǼÌǣʰɠsNjsOŸŘʩ_sŘǼŸ¯EÞ¶¶sNj
parameter. and brighter tomorrow.
10 Jyothy Laboratories Limited
Annual Report 2015-16

Make in India
is About
Digital
India
Corporate Overview Performance Governance Financial Statements 11

It used to be said that knowledge is


power. That remains true, but in this
century, digitisation is power. Digitisation
is, indeed, the channel through which
NQRZOHGJHÀRZVLQDEXQGDQFH,WLVWKH
lifeline of modern industry, the foundation
of skill-building, and the enabler of a level
playing ground.

The government’s digital policy aims performers, accelerating career


to empower Indians. Harnessing advancement. With the errors resulting
technology can give them access from human intervention minimised, the
to greater employment and skill employee satisfaction rate has spiralled
development opportunities. Digital tools upwards.
can connect trained tradespeople and
small entrepreneurs with the right clients The ultimate positive outcome of any
and markets. In governance, digitisation _Þ¶ÞǼĶÞŘÞǼÞǼÞɚsÞǣǼŸ¯ȖĶʩĶǼÌsÌȖŎŘ
removes bottlenecks, facilitating start- potential. Investment in technology
ups, letting business owners devote is really about investment in people.
their energies to productive work. The Just the reason why automation at the
overarching purpose is to turn India manufacturing units is meant to make
into a digitally empowered society and our products perfect, but never to
knowledge economy. downsize manpower.

Jyothy Laboratories has made optimal The digital world knows no limits, just
use of technology for a range of like human potential.
functions, in particular, human resource ɟsNjsOŸŘʩ_sŘǼǼÌǼǼÌNjŸȖ¶ÌŸŘsʰɠs
development and deeper market reach. can unleash the other.
Digitisation has helped us streamline
administrative functions, letting
employees speedily carry out procedures
through a self-servicing platform. Digital
records of employee appraisals have
increased the visibility of outstanding
12 Jyothy Laboratories Limited
Annual Report 2015-16

Make in India
is About
Inclusive
Growth
Corporate Overview Performance Governance Financial Statements 13

If India is to rise and rise some more, no


one can be left behind. There is a treasure
trove of talent waiting to be discovered
everywhere, in the remotest corners of
the country. Women, in particular, can
become the strongest growth drivers of
this economy. In our march forward,
everyone must walk to the same rhythm.

The cornerstone of the state policy is Corporate social responsibility


to take progress to every nook and programmes are undertaken to not only
cranny of the country, to help people in improve people’s life, but also to give
myriad little ways. Villagers are getting them a space from where they can step
more targeted subsidies and women out with a sense of pride and hope.
entrepreneurs are promised access to ŷȖNjEsŘsʩOÞNjÞsǣNjsƼNjÞŎNjÞĶɴ¶ÞNjĶǣŘ_
easier loans. Inclusive growth is about women. They are the ones most in need
raising the standard of living through of a helping hand; they are also the
ʩŘŘOÞĶÞŘOĶȖǣÞŸŘŘ_NjȖNjĶsŎƼĶŸɴŎsŘǼ ones who change society the most when
schemes. empowered.

The core belief of Jyothy Laboratories is As with our product innovations, our
that Indian corporate houses must go to social initiatives, too, are designed for
the rural areas and create jobs. Women’s the maximum impact.
inclusion is a fundamental of the
Company policy. At the manufacturing Progress is permanent only when
ȖŘÞǼǣ¯ŸNjŸȖNjʩNjǣǼENjŘ_ȕĠĶʰɠŸŎsŘ gether.
everyone walks together.
workers outnumber men. Within the
Company, we promote equality and
inclusion through our people-friendly
measures. No distinction is made
between higher and lower ranks of
employees in providing health care.
14 Jyothy Laboratories Limited
Annual Report 2015-16

Make in India
is About
Domestic
Consumption
Corporate Overview Performance Governance Financial Statements 15

India is about booming consumerism and


thriving aspirations. It is a land of exciting
opportunities and boundless possibilities,
with one of the most promising growth
potential globally, the nation is ready for a
consumption wave.

In a country on the go, wants and needs grow. We are in the household goods
evolve rapidly. Now exposed to the best space, directly related to people’s
in the world, consumers here expect ket
health and hygiene. Making this market
to see that same standard – or better grow has meant constantly renewing
– from home-grown manufacturers. ers
connections, reaching out to consumers
The expanding Indian middle class are ier.
not served by what was available earlier.
big spenders; they are also increasingly
conscious of the value proposition of Encouraging domestic consumption
brands backed by solid research and is, for us, both a business need and
development. The people here have a a valuable contribution to national
strong desire for competitive pricing progress, which we are optimistic will
combined with the best quality. make our economy future-proof.

At Jyothy Laboratories, the endeavour Today, for the global conglomerates,


¯NjŸŎǼÌsɚsNjɴʩNjǣǼ_ɴÌǣEssŘǼŸ w it
India is the land of promise. We knew
serve the domestic market, to introduce en
long ago, and that knowledge has been
people to the world-beating technology our best ally.
that an Indian company can offer.
Localised, affordable goods, created
by understanding the minute details of
people’s life, have helped this Company
16 Jyothy Laboratories Limited
Annual Report 2015-16

Make in India
is About
Self-Reliance
Corporate Overview Performance Governance Financial Statements 17

People make a nation. Their skills make


the economy. When citizens are highly
skilled and their entrepreneurial spirit
LV¿UHGXSDFRXQWU\WUDQVIRUPVLWVHOI
from ground up. Indians of today have
enormous potential to be job creators,
not just job-seekers. The possibilities are
endless. And exciting.

Skilling India and Make in India are two We motivate employees in order to
sides of the same coin. Skill leads to build an engaged workforce. Training
employment, or self-employment, and and guidance are given at every step,
that has a cascading effect on the entire Ř_Ķs_sNjǣÌÞƼLJȖĶÞǼÞsǣÞ_sŘǼÞʩs_Ř_
community. The desire for self-reliance encouraged. New growth avenues are
ǣƼNjs_ǣĶÞĨsɠÞĶ_ʩNjsʰ¶ÞɚÞضƼsŸƼĶsǼÌs always made available to the most
OŸŘʩ_sŘOsǼŸŎŸɚs¯ŸNjɠNj_¯ǣǼsNjʳ deserving. A ‘Skill Recognition Award’
Modern India has made the promotion puts the outstanding employees in
of entrepreneurship its priority. The aim the limelight, making them feel valued
is to develop and channel the energy and inspiring others. Besides technical
of our greatest resource: our young, knowledge, enthusiasm and innovation
energetic population. Skill training and are also rewarded.
industrial training are among the primary
objectives of the ‘Skill India’ mission. There is no doubt that the qualities
ɠsʩŘ_Ř_ŘȖNjǼȖNjsÞŘŸȖNjsŎƼĶŸɴssǣ
At Jyothy Laboratories, we embrace are present in most Indians. It is our
building skill sets with passion and responsibility to give them a chance
aggression. We have always believed to shine. Every Indian company must
that the answer to greater and sustained partner the nation in the Skill India
prosperity for a company and a nation programme. We shall leave no stone
lies in encouraging employability and unturned to create a workforce that will
development. With over three decades row.
contribute to an enriching tomorrow.
of enhancing the skills of its own
employees and of the communities that
Jyothy Laboratories sees as its own, the
Company is committed to the goal of
complete self-reliance.
18 Jyothy Laboratories Limited
Annual Report 2015-16

Make in India
is About
Youth
Power
Corporate Overview Performance Governance Financial Statements 19

The energy of the millennials is India’s


greatest strength. As much world citizens
are rooted in the country’s tradition, they
DUHWKHFRQVXPHUVRIWKHIXWXUH)XO¿OOLQJ
their unmet needs is the key to success.

The majority of the country’s population our loyal customer base built over three
ÞǣEsĶŸɠǼÌs¶sŸ¯ǼÌÞNjǼɴ˚ʩɚsʳǻÌÞǣ decades, our focus is on engaging
generation is proud of home-grown with the millennials through strategic
ingenuity, and wants to triumph against communication, earning their trust and
every international benchmark. Global admiration.
businesses woo them as consumers,
yet they remain supportive of national We are not thirty-three years old; we are
brands that deliver world-class quality. thirty-three years young and average
age of our employees is below thirty-
Today’s India is driven by their three. As a Company, we are among the
aspirations. This population is millennial. Like the youth, our optimism
demanding, and that compels businesses and ambition knows no bounds. Every
to innovate. The youth are the catalysts innovation that will happen in this
for the transformation of modern century can happen here. We shall make
industry. it so.

Jyothy Laboratories has always believed


that the future is here. We are certain
that as India grows, youth power shall
propel national brands to positions of
market leadership. Even as we retain
20 Jyothy Laboratories Limited
Annual Report 2015-16

Chairman and
MD’s Statement
DEAR SHAREHOLDERS, better for the people of this country to make a real impact, working in a
by manufacturing world-class products focussed manner. We have put all our
It pleases me to say that we have using local skills. We believe that money in one district in Kerala, where
ʩŘÞǣÌs_ɴsǼŘŸǼÌsNjɴsNjOĶÞŎEÞض indigenous skill should be much better the company started. In the Thrissur
a few more steps towards growth. than what is available abroad. district, we have installed 350 good
ŗŸɠɠsƼNjsǣsŘǼǼŸɴŸȖǼÌsǣÞ¶ŘÞʩOŘǼ toilets in all the government schools for
shareholder value that was created by At Jyothy Laboratories, we want to – girls. Then we built homes for people
the strong performance of our team. and we do – contribute something to who were displaced by a dam project
make the nation proud. ‘Make in India’ but were given land by the government.
The market is never without challenges, should spread across the country; we go We also gave pukka houses to 27
but we have continued on a growth to the rural areas and create jobs. We ɠÞ_ŸɠǣŸ¯ʩǣÌsNjŎsŘʳ
trajectory, reinforcing core strengths, believe that the manufacturing sector
which enabled us to ride out the can reduce the excessive dependence on OFFERING PRODUCTS DIFFERENTLY
macroeconomic uncertainties. I can agriculture and bring more people into The keystone for us is differentiation
ǼsĶĶɴŸȖɠÞǼÌOŸŎƼĶsǼsOŸŘʩ_sŘOs˛ the bracket of prosperity. – every one of our products has to
OŸŘʩ_sŘOsǼÌǼÞǣEǣs_ŸŘǼÌsÞŎŎsŘǣs have a USP, every single product must
power of the whole Jyothy Laboratories Our corporate social responsibility be different and better than other
team – that we are poised for larger initiatives are driven by the same products in its class. With each new
tasks. principle of making Indians proud. When launch, we have targeted a particular
we present underprivileged widows or segment, offering a solution that Jyothy
We shall do everything to retain this adivasis with the gift of housing, they ĵEŸNjǼŸNjÞsǣǼÌŸȖ¶ÌǼŸ¯ʩNjǣǼʳ
winning edge, and the national policy get more than a shelter; they develop a
environment in the country has become greater degree of self-esteem, as they The consumers always deserve better;
our tailwind. This environment is are now able to step out from a place it is possible to always give them
extremely encouraging for businesses they can call their own. something better. Society grows by
like your Company. We have always been always wanting more.
in India, for India, and we are proud of Business, for us, is so much more than
‘Make in India’. The initiative, launched numbers. It has a higher purpose, that In keeping with this, the technology used
in late 2014, gained momentum in 2015, of giving back to society. Our people in our manufacturing is of the highest
the year under review in this report. connect helps us to identify the most quality. Our plants are highly automated
We have walked this path from our relevant areas of corporate social for the purpose of making the output as
inception. The fundamental principle responsibility. CSR is very important perfect as possible. Simultaneously, we
of Jyothy Laboratories is making life to us, and we choose our programmes invest in manpower and strengthen the

“WHEN AN ORGANISATION HAS ALL


THE RIGHT SYSTEMS AND A TEAM
WITH ITS HEART AND BRAIN IN PLACE,
IT CAN FOCUS ON DELIVERING THE
GREATEST VALUE TO THE CUSTOMERS
AND INVESTORS.”
Corporate Overview Performance Governance Financial Statements 21

M. P. Ramachandran
Chairman
& Managing Director

people connect, so that we can think like recommended a dividend of 500 per sustainable, room for giving more value
a consumer and imagine what they want. cent, or ` 5 per share, inclusive of for money. In the years when external
Consumers have desires, but are not the interim dividend of 400 per cent factors make business easy, we do not
always able to articulate them. It is up to declared and paid earlier. take it easy – we set the bar still higher
us to draw out that desire, and create an and create something unique.
inspired offering. The external challenges during the year
under review, mainly the subdued rural This journey of three decades is that of
As a business, our success is based on demand caused by low rainfall, were the entire Jyothy Laboratories family,
the insight gained from reading the somewhat mitigated by the drop in oil as we have earned the loyalty of
consumer’s mind; crystallising that into a prices, which reduced our input costs. both employees and consumers. Our
viable product idea; and then developing Automation of our manufacturing units OŸŘǣÞǣǼsŘǼĶɴƼŸǣÞǼÞɚsʩŘŘOÞĶNjsǣȖĶǼǣŘ_
that product to make a meaningful cut operational expenses. The marketing solid reputation are the outcome of the
impact for the consumer. So, with pride, strategy continued to centre around efforts made by everyone at every level.
I can share that the three pillars of your people power. Our brand ambassadors
Company are: insights, ideas and impact. are celebrities, but our real connect with We thank all the people within and
consumers and sales outlets comes from outside the organisation who have
TRANSLATING OUR EFFORTS INTO a proprietary system of building on- placed their faith in Jyothy Laboratories
NUMBERS the-ground relationships. This is a very – our highly energised team; our supply
The strategy of launching unique cost-effective way to grow. The strategy chain stakeholders; and our valued
products, and reinventing brands with of developing people and developing shareholders, who always give us such
newer advantages, has led us to an technology further streamlined our excellent support.
overall 9.3 per cent growth during the operations. When an organisation has
year under review. The operating EBIDTA all the right systems and a team with Our ceaseless endeavour has been
jumped to ` 237.6 crore, a sharp increase its heart and brain in place, it can focus to build trust and value, and we shall
of 24 per cent over the previous year. on delivering the greatest value to the continue doing so, giving all we can to
Each of our six Powerbrands gained customers and investors. the dream of making India a better place
market share and the overall Powerbrand on the globe.
ǣĶsǣÞŘONjsǣs_ˠ˟ʳˢƼsNjOsŘǼʳNǣÌƼNjŸʩǼ GOING FORWARD
stood at ` 206.9 crore, an increase of The strategy of your Company is to
13.4 per cent over the previous year. consolidate and grow by presenting
products and experiences that capture M. P. Ramachandran
Our working capital cycle, which was the imagination of a new generation. Chairman & Managing Director
down to 17 days in FY14-15 from
27 days in FY13-14, has now come We see every year as an opportunity
down to 14 days in FY15-16. Based rather than a challenge; there is always
on our positive results, the Board has room to grow, room to become more
22 JYOTHY LABORATORIES LIMITED
ANNUAL REPORT 2015-16

Q&A with Joint Managing


Director and CFO
Ullas Kamath, Joint Managing Director, sheds light on the insights, ideas and
impact that have helped Jyothy Laboratories move steadily ahead in the industry,
powered by both business gains and customer trust

“WHEN A COUNTRY DOES WELL,


EVERYONE DOES WELL. ONCE THE
UPSWING COMES, THE COMPANIES THAT
ARE EXCEPTIONALLY WELL-POSITIONED
WILL DO EXCEPTIONALLY WELL – AND WE
ARE ONE OF THEM.”
HOW DO YOU SEE THE PAST YEAR WHAT ARE THE BIGGEST STRENGTHS Company, helping us adapt still faster
FOR JYOTHY LABORATORIES, IN OF JYOTHY LABORATORIES IN THE to changes in consumer needs and
RELATION TO THE INDUSTRY AND CONTEXT OF INDIAN COMPANIES spending patterns.
THE NATIONAL ECONOMY? COMPETING WITH INTERNATIONAL
To answer that, let me talk about the PLAYERS?
ğɴŸǼÌɴĵEŸNjǼŸNjÞsǣ^ŗʩNjǣǼʳDsOȖǣs Our portfolio has products that are WHAT IS THE BEST THING TO
our performance in the past year stands of world standard and offered at an HAVE HAPPENED AT JYOTHY
on the shoulders of our achievements affordable price. We are competing LABORATORIES IN THE PAST COUPLE
of more than three decades. During with the multinationals, and all our OF YEARS?
this time, we have positioned ourselves ENjŘ_ǣÌɚsEsOŸŎsƼNjŸʩǼEĶsÞŘǼÌs As we expanded across segments
as a company catering to the needs of shortest possible time. We have taken and launched new products within
every Indian household. Those needs ŸŘǼÌsʩsNjOsǣǼOŸŎƼsǼÞǼÞŸŘŘ_OŸŎs those segments, we also built a great
can only grow, and we have a long track out a winner, because of our ear-to- management team to deliver the desired
record of meeting them effectively. All the-ground insights, the agility of results. The major transformation,
our product innovation has been done our product idea development, and as I said, began from the point of
keeping in mind the smallest details of a the impact of our precisely targeted acquiring Henkel India. We were already
consumer’s life. communication. With every launch, the doing very well, taking leadership
Company has been able to disrupt that positions in extremely competitive
Against this backdrop, in the year under particular category, gaining market share product segments. Building on that,
review, compared to the rest of the at an exponential rate. we revamped our management
FMCG industry, we have done well. As policies and systems, and brought
for the national economy, it all comes new team members on board, making
down to job creation and consumption. ARE YOU ALSO ABLE TO REACH OUT the company culture even more
The ‘Make in India’ initiative is very TO EVERY CONSUMER SEGMENT performance-driven. As a result, we are
important in this context. Because of NOW? ŘŸɠŎȖOÌŎŸNjsǣǼNjsŎĶÞŘs_ʰs¯ʩOÞsŘǼʰ
this initiative, Indian manufacturing Yes, indeed. Following the acquisition of Ř_EsǼǼsNj¯ŸNjǼÞʩs_¶ÞŘǣǼsɮǼsNjŘĶ
is getting the attention it has never the Henkel India bouquet of products, factors.
got before. ‘Make in India’ is about our Company has a presence in every
OŸŘʩ_sŘOsÞŘɴŸȖNjŸɠŘǣǼNjsضǼÌǣʰÞǼÞǣ consumer segment. That acquisition All aspects of key functions were looked
about self-reliance in manufacturing was a turning point in other ways, at with a critical eye – this included
and quality – things we have always too – it infused an additional measure sales, marketing, manufacturing,
believed in. of modern business practices into the research and development, and human
Corporate Overview Performance Governance Financial Statements 23

Ullas Kamath
Joint Managing Director
and CFO

resource development. To help the new challenges. Our Company is about WHAT IS YOUR STRATEGY FOR
management team stay focussed on having the right direction at the right CREATING A NEW GENERATION OF
the new goals, we set annual KPI (key time in the right country. LOYAL CONSUMERS?
performance indicator) metrics and A growth strategy must always be
monthly reviews. around innovation. And innovation in
AND THE FACTORS DRIVING THE our industry has to be driven by insights.
JYOTHY LABORATORIES GROWTH? If a company has insights into the mind
HOW DO YOU SEE THE ROLE Well, let me say that we have delivered of the youth, it would do well. In this
OF CORPORATE INDIA IN on every front: excellent and relevant country, 65 per cent of the population
THE COUNTRY’S INCLUSIVE products; the most advanced research is under 35 years of age; they are the
GROWTH? AND THAT OF JYOTHY and development; strategic brand consumers of the future.
LABORATORIES PARTICULARLY? extensions; optimal advertising and
Inclusive growth means, when a country sales force to propagate our brands; For instance, our Powerbrand Ujala is not
does well, everyone does well. Once and an apt communication strategy. ŸŘĶɴɠÞǼÌǼÌsʩNjǣǼȕĠĶɠŸŎŘʰEȖǼĶǣŸ
that upswing comes, the companies that Jyothy Laboratories is family owned with her daughter or her granddaughter.
are exceptionally well-positioned will professionally managed and the most If they – the youth – stay with our
do exceptionally well – and we are one modern business practices which means brands, that makes a big difference.
of them. That is going to be the India a great culture.
¶NjŸɠǼÌǣǼŸNjɴʳɟsʩNjŎĶɴǣǼǼsǼÌǼɠs
are with the government initiative. Only SO YOU REACH OUT TO SOCIETY
companies with great differentiated PLEASE SAY MORE ABOUT THROUGH YOUR BUSINESS?
products can grow this country. We have YOUR ORGANISATION AND Absolutely, yes. A company making
to create jobs. We have to be everywhere. POWERBRANDS. ¶NjsǼƼNjŸ_ȖOǼǣŎĨsǣƼNjŸʩǼʰŸEɚÞŸȖǣĶɴʰ
We believe in India’s growth story. The organisation is nimble, with but it also makes the national economy
complete control on our manufacturing and society that much more vibrant.
and R&D, the essential drivers of From excellence in manufacturing to job
WHAT ARE THE SPECIFIC STEPS YOU success. Our reach is deep, covering creation, from promoting educational
HAVE TAKEN – OR WILL – IN THIS places even with small populations. The facilities to helping the marginalised, in
DIRECTION? insights we gather, the way we ideate, every way, we exemplify the key facets of
At present, the government has given and then make an impact, all of that the roadmap laid out by the government
impetus to skill development and has helped us replicate the success of ÞŘÞǼÞǼÞɚsʳ®NjŸŎǼÌsʩNjǣǼɴsNjŸ¯ŸȖNj
job creation. We, too, believe in this Ujala in our subsequent products, Maxo, journey, we have lived that agenda.
– Jyothy Laboratories has proactively Exo and in the reinvention of Margo,
invested in skill development and a 95-year-old highly trusted brand. In Our business philosophy is in sync with
employment generation programmes. the past year, we saw a drop in rural the thinking of the country. This, we
We have created jobs at every level of OŸŘǣȖŎƼǼÞŸŘEsOȖǣsŸ¯_sʩOÞsŘǼ are certain, will help us keep growing
the Company. Our consistent growth, rainfall, but we expect a turnaround this alongside India.
_sǣƼÞǼsǼÌsʪȖOǼȖǼÞŸŘǣÞŘǼÌssɮǼsNjŘĶ year based on the monsoon prediction.
sphere, has shown that we are agile,
innovative and prepared to face
24 Jyothy Laboratories Limited
Annual Report 2015-16

Financial Highlights
for 2015-16 (Consolidated)

NET SALES SHARE OF POWERBRANDS IN REVENUE

` 1,644.73
crore
86.9% (` 1,430 crore)

TOTAL SALES GROWTH YEAR-ON-YEAR

9.3%

POWERBRAND SALES GROWTH YEAR-ON-YEAR

10.3%
Corporate Overview Performance Governance Financial Statements 25

PROFIT AFTER TAX SHARE OF SALES GROWTH IN


SOUTH AND NON-SOUTH MARKETS

` 158 crore
2015-16
Non-south
60
` 121 crore

2014-15

Up 30.4% 40
South

OPERATING EBIDTA GROWTH BY VOLUME

` 237.6 crore (14.4%) 9.3%


2015-16

` 191.7 crore (12.7%)


2014-15

Up 24%
26 Jyothy Laboratories Limited
Annual Report 2015-16

Made to
Deliver

Featured - big numbers


on power brands’
performance, shining
products, presence
and penetration across
length and breadth
of the country,
manufacturing units,
HI¿FLHQF\
Corporate Overview Performance Governance Financial Statements 27

8.3%
Growth by value for Margo, the
premium category soap, which has
the twin advantage of an Indian
personal care heritage association
and a strong following among

36%
modern young women

77.6%
Market share captured by
Growth by volume for our
Powerbrand Henko Matic
LINTelligent, a superior
ȕĠĶʰŸȖNjʩNjǣǼƻŸɠsNjENjŘ_ laundry product that protects
that targeted the problem of the newness of garments
‘yellowed whites’ like nothing
else could

10.7%
Growth for Exo, our fastest
esst
41.6%
Growth for Maxo ‘Fits All
growing Powerbrand and da Machines’ Liquid Vapouriser, an
one
product offering three-in-one e
invention that helped grow Maxo
ǼsNj
EsŘsʩǼǣŸ¯¶sNjŎ˚ĨÞĶĶÞضʰɠǼsNj˚
saving, and easily achieved Liquid at a CAGR of 55% for the
shine past 3 years

15.5%
Growth for Pril, our liquid
15.5%
Growth for the Maxo brand as a
dish wash Powerbrand that is whole (including liquid vapouriser,
now available as a ‘superior coil, card), making it the fastest
degreaser’ bar with its own growing brand in the household
scrubber insecticide category in India
28 Jyothy Laboratories Limited
Annual Report 2015-16

M.R. Jyothy,
Director of Jyothy
Laboratories Limited
M.R. Jyothy, Director of Jyothy Laboratories Limited, the brain behind all the recent
revolutionary product innovations, says what it means to design every product
around the smallest needs of the consumer.

“OUR EFFORT IS TO ENSURE


THAT INNOVATION,
CONVENIENCE AND UNIQUE
VALUE SET THE PREMISE
FOR ANY NEW PRODUCT WE
LAUNCH”
When taking any new initiative, we in delivering unique value to our This makes the bar last longer, there
keep the consumer at the centre. consumers. is no breakage and the sink area looks
We want to make the consumer’s cleaner. This new product was an instant
life easier by offering innovative ǻÌsʩNjǣǼǣȖOÌsɮŎƼĶsÞǣǼÌǼŸ¯rɮŸʳ hit in the market.
products for everyday needs. Every When it came to the market many
Jyothy product is backed by intensive ɴsNjǣ¶ŸʰÞǼɠǣǼÌsʩNjǣǼŘǼÞ˚EOǼsNjÞĶ Our second example is in the detergent
research, which involves consumer dishwash bar in India. At that time, category, where we launched Henko
contact programmes, detailed market consumers faced two problems: utensils LINTelligent. Our expertise in the fabric
surveys, comprehensive evaluation of kept in the sink were vulnerable to care category helped us to identify
competition products, and the best bacterial infections; the other thing was a unique positioning for the brand
industrial design solution. ǼÌǼOŸŘǣȖŎsNjǣɠsNjs_ÞǣǣǼÞǣʩs_ɠÞǼÌǼÌs following the acquisition of Henkel
way the available dishwash bars broke India. The insight was to go beyond
Our effort is to ensure that innovation, off, or turned soggy by absorbing water stain removal and offer care through
convenience and unique value set the from the sink area, leading to wastage. lint reduction. The reduction in lint
premise for any new product we launch. meant lesser fraying of the garment,
And at the heart of every innovation, The anti-bacterial properties of Exo colour protection, better shine and
there’s a very simple idea that makes life took care of the germs. To address the texture, and longer fabric life. The
easier, happier and more convenient for wastage issue, we launched Exo Round, product is differentiated on all fronts:
the average consumer. ʩNjǣǼŸ¯ÞǼǣĨÞŘ_NjŸȖŘ_˚ǣÌƼs_ENjÞŘ the pink colour of the powder connotes
a plastic container along with a free care, innovative packaging gives the
Our major launches under three scrubber. The shape aids in easy use premium offering feel, and a delightful
different categories validate our success and the container ensures zero wastage. sensorial experience enhances trust in
Corporate Overview Performance Governance Financial Statements 29

the brand’s promise. The product has


been recognised for its insightful and
innovative mix by numerous awards.

The third segment that saw market-


leading innovations from Jyothy
Laboratories is that of household
insecticides. One example here is
the Maxo ‘Fits All Machines’ Liquid
Vapouriser bottle. The core idea was to
ǣŸĶɚsǼÌsOŸŘȖŘ_NjȖŎŸ¯ʩŘ_ÞضǼÌsNjÞ¶ÌǼ
ǣÞʊsŸ¯ĶÞLJȖÞ_EŸǼǼĶsǼŸʩǼǼÌsŎOÌÞŘs
at home – we made a bottle design
compatible with all machines, so that
consumers would not have to worry
EŸȖǼǼÌsʩǼʳ

The latest innovation in the mosquito


repellent category is the launch of
Maxo Magic Card. We entered this
category with a strong and a powerful
differentiator – we call it ‘the safety
stand’. The safety stand is a simple
innovative feature that lets consumers
burn the card without any risk of a
ʩNjsʱǼÌsǣǼŘ_ƼNjsɚsŘǼǣǼÌsĶÞ¶ÌǼɠsÞ¶ÌǼ
ONj_¯NjŸŎʪɴÞضŸ¯¯ɠÌÞĶsǣǼÞĶĶEȖNjŘÞض
Ř_ĶŘ_ÞضŸŘǣŸŎsʪŎŎEĶs
object. The stand also ensures it burns
completely till the very end. With the
safety stand, Maxo Magic Card offers a
complete solution for instant relief from
mosquitoes. MR Jyothy
MR Jyothy has been voted yet
Our efforts are directed at ensuring again among the
that we bring distinctive, innovative ˄ˤ˟ōŸǣǼÝŘʪȖsŘǼÞĶɟŸŎsŘ
and convenient products to delight our in Indian Media, Advertising
consumers, and we believe this approach and Marketing, 2016’ by
will keep us always one step ahead of exchange4media Group.
the competition.
30 Jyothy Laboratories Limited
Annual Report 2015-16

Segment Overview
Fabric
Care
Segment
Brands: Ujala,
Henko,
Mr. White, Chek

THE POWERBRAND STORY


UJALA SUPREME wash. It essentially revives fabrics from
Ujala Supreme entered the market the harsh effects of detergents and
in 1983 with a promise to solve the keeps them looking new. Its unique
problem of ‘yellowing whites’. White ƻŷĵɳ®ɭOǼÞŸŘOŸǼǣǼÌsʩENjsǼŸ¶Þɚs
clothes lose their brightness and become ǣŎŸŸǼÌʩŘÞǣÌŘ_ONjÞǣƼ¯ssĶʳǣ
yellowish over a period of time; some a result, the fabric looks fresher and
of the reasons are detergents, quality of retains its newness.
water, and pollution. Ujala Supreme has
a unique whitening action that prevents HENKO LINTELLIGENT
this ‘yellowing’ of white fabrics. This Henko, the premium detergent brand
fabric whitener is a market leader with that was part of the Henkel India
77.6 per cent market share. Brand sales portfolio, had to be differentiated in
have grown over 4 per cent in the past order to make inroads into the highly
ʩŘŘOÞĶɴsNjʰĶNj¶sĶɴǼǼNjÞEȖǼEĶsǼŸŸȖNj competitive detergent category. Our
efforts to expand the Ujala Supreme sheer in-depth understanding of the
consumer base with effective and highly fabric care category helped us to identify
targeted brand communication. a unique positioning. The insight was to
Contribution to total sales
go beyond stain removal and offer care
Ujala detergent powder, an extension through lesser lint removal from the
of the brand in the detergent category,
was relaunched with a new proposition
of ‘effortless cleaning’ in Kerala. The
fabric. This led to the launch of Henko
LINTelligent. Less lint removal from the
fabric means less fraying, protecting the
41.85%
market share grew by 160 BPS to reach garment’s colour, shine and texture, and Growth year-on-year
17.7 per cent within just 12 months of its extending fabric life.

6.4%
relaunch.
The brand was recognised for its
Our understanding of consumers’ insightful and innovative mix, and won
changing lifestyles and consequent numerous awards, including an award Overall market share
fabric care expectations helped us for consumer insights at the Indian
develop two very unique and leading- Marketing Awards by Exchange4Media, Ujala Fabric Whitener
edge products: and the Asia Star Packaging Award for
˒ ȕĠĶNNjÞǣƼŘ_ǢÌÞŘs
˒ ËsŘĨŸĵÝŗǻsĶĶÞ¶sŘǼ
excellence in packaging. After the new
launch, the brand was ranked No. 8
77.6% by value
among Economic Times Most Trusted
Henko Matic
UJALA CRISP AND SHINE Brands in the fabric care category for the
This is a post-wash product that
ŎÞŘǼÞŘǣǼÌs¯ŸNjŎŘ_ʩŘÞǣÌŸ¯OĶŸǼÌsǣ
while enhancing the shine with every
ʩNjǣǼǼÞŎssɚsNjʳōŸNjsŸɚsNjʰǼÌsENjŘ_ɠǣ
adjudged ‘Product of the Year’ in that
category.
5% by value
Corporate Overview Performance Governance Financial Statements 31

Dishwash
Segment
Brands: Pril, Exo Contribution to total sales

THE POWERBRAND STORY


28.33%
EXO PRIL
Growth year-on-year
Exo dishwash solves three household The brand positioning of Pril is to take
problems in one stroke – it kills germs the chore out of doing the dishes and
left on dishes by kitchen pests; it slices
through grease and requires minimal
infuse a bit of romance and fun in
the process. This premium brand has 11.8%
water for washing off; it stays intact superior grease-cutting properties and
in its box without loss from melting. also gives a great sensory experience Overall market share
Thus, it has made itself relevant to with its fragrance. Our slice-of-life brand
ƼsŸƼĶssɚsNjɴɠÌsNjsʳǻÌsʩNjǣǼŘǼÞ˚ campaign speaks to modern couples Exo Dishwash Bar
who are equals in everything, and who
bacterial dishwash (with cyclozan) and
ǼÌsʩNjǣǼENjǼŸOŸŎsÞŘÞǼǣŸɠŘNjŸȖŘ_˚
shaped container, Exo has captured the
can turn kitchen work into an occasion
for adding more ‘sparkle’ to their
10.43% by value

imagination of both health-conscious relationship. Pril Liquid


urban buyers and cost-conscious rural
consumers. The new anti-bacterial Exo
scrubber has added to its appeal. With
The Pril Powerbrand story has now been
extended in a premium new offering, “a 16.69% by value

sales growth in the high double-digits, superior degreasing dishwash bar”. The
this Powerbrand is storming markets ʩNjǣǼŸ¯ÞǼǣĨÞŘ_ÞŘÝŘ_ÞʰǼÌsŘsɠƻNjÞĶENj
across the nation. comes with some innovative features:
˒ 
 OǼÞɚsEŸŸǣǼsNjǣƼsOĨĶsǣǼŸOȖǼǼÌs
toughest grease with ease
˒ 
 ǼŎƼsNj˚ƼNjŸŸ¯ǢȖƼsNjǻȖEǼŸƼNjsɚsŘǼ
any wastage
˒ r
 ŘÌŘOs_Ř_Njs¯NjsǣÌÞضNjŸŎ¯ŸNj
delightful sensory experience

ɟÞǼÌǼÌÞǣÞŘŘŸɚǼÞŸŘʰɠsNjsOŸŘʩ_sŘǼŸ¯
growing our share substantially across
markets.
32 Jyothy Laboratories Limited
Annual Report 2015-16

Segment Overview
Household
Insecticides
Segment
Brand: Maxo

THE POWERBRAND STORY machine of its kind, which automatically


MAXO switches modes from attack (high mode)
to defend (low mode) after a certain
Maxo is a remarkable success story
time. This spares the consumer the effort
ÞŘǼÌsʩsNjOsĶɴOŸŎƼsǼÞǼÞɚsÌŸȖǣsÌŸĶ_
of manually changing modes, as one
insecticide category. Contribution to total sales
has to do with other mosquito repellent
machines. Maxo Genius thus offers
The launch of the Maxo ‘Fits All
Machines’ liquid bottle with a new brand
identity (new brand logo, packaging
consumers a combination of superior
performance and value through optimal
liquid consumption.
16.58%
and positioning) shook up the market Growth year-on-year
ɠÞǼÌ˄ŸŘsǣÞʊsʩǼǣĶĶ˅ǣŸĶȖǼÞŸŘʳŷȖNj The latest of all is the launch of Maxo
research showed that consumers, Magic Card. We entered the fast
when buying a liquid insecticide bottle,
ɠsNjsȖŘǣȖNjsÌŸɠÞǼɠŸȖĶ_ʩǼÞŘǼÌs
growing card segment of mosquito
repellents with a strong and a powerful
15.5%
vapouriser machines they already had differentiator, ‘the safety stand’. The
ǼÌŸŎsʳōɮŸɠǣ_sǣÞ¶Řs_ǼŸʩǼŘɴ Overall market share
safety stand is a simple innovative
vapouriser machine; thus it solved a feature that lets the consumers use the
bothersome problem for the consumer. Maxo Repellent Coil
product – a light paper card coated with
This innovation has helped the liquid
clock sales more than the overall market
growth rate.
insecticide, released when it burns –
ɠÞǼÌŸȖǼNjÞǣĨÞضʩNjsʰǣǼÌsǣǼŘ_ÌŸĶ_ǣ 18.43% by value
the burning card securely, preventing
ÞǼ¯NjŸŎʪɴÞضɠɴʳōɮŸō¶ÞONNj_ Maxo Repellent Liquid
In a continuing story of bringing relevant
innovations to the consumer, we
ÞŘǼNjŸ_ȖOs_ōɮŸµsŘÞȖǣʰǼÌsʩNjǣǼǣŎNjǼ
today is the fastest growing brand in
this category as per the latest quarterly
report from AC Nielsen.
6.69% by value
Corporate Overview Performance Governance Financial Statements 33

Personal
Care
Brands: Margo,
Fa, Neem

THE POWERBRAND STORY Margo Active Glycerine Soap, the brand


MARGO is well-positioned to leverage the soap’s
In India, neem (margosa) and skin care equity, which is known for original/ pure
have gone hand in hand for generations. neem. Margo Active Glycerine comes
Launched in 1920, Margo soap has been with a unique combination of ‘neem and
synonymous with neem. Infused with glycerine’, thereby giving the skin much-
100 per cent pure neem oil and Vitamin needed protection and moisturising
E, the Margo Original Neem soap is a effect. With 8 per cent brand growth,
highly valued and respected personal Margo has outpaced the overall category
care product. growth.

We restructured the brand with the NEEM ACTIVE TOOTHPASTE Contribution to total sales
key objective of targeting younger In the oral hygiene space, Neem Active
consumers. A series of brand Toothpaste offers complete care. At
OŸŎŎȖŘÞOǼÞŸŘʩĶŎǣɠsNjs_sɚsĶŸƼs_
to this effect, and they have contributed
the centre of this unique formulation
is neem, an ingredient that has been
9.02%
hugely to the overall growth the brand associated with oral hygiene in India
Growth year-on-year
has achieved over the past three years. for centuries. With the growing trend
towards products that are more natural
The Margo Powerbrand story perfectly
ʩǼǣÞŘǼŸOŸŘǣȖŎsNjŎs¶˚ǼNjsŘ_ʲŘǼȖNjĶ
and our efforts to build this brand, Neem
Active Toothpaste is poised to grow in 5.1%
skin care. With the successful relaunch of the years to come.
34 Jyothy Laboratories Limited
Annual Report 2015-16

Segment Overview
Laundry
Services
Segment
Brands: Fabric Spa,
Snoways, Busy Easy,
Wardrobe

THE BRAND STORY


Modern urban Indians are always on ˒ Jyothy Fabricare Services Limited (JFSL)
the move, hard-pressed for time. Their is a subsidiary of Jyothy Laboratories
needs, combined with those of the Ltd.
expanding hospitality sector, made it
natural for us to enter the professional ˒ Premium laundry service – biggest in
laundry service segment, given our India
market leading presence in the FMCG
industry. ˒ Highly sophisticated infrastructure

˒ 93 outlets in key cities of India

˒ Currently, country’s biggest laundry


chain

˒ Current operations in Bengaluru, Delhi,


Mumbai, Pune and Chennai Contribution to total sales

˒ Bagged prestigious Western Railways


at Ahmedabad BOOT contract for
10 years
2.62%
Growth year-on-year
˒ Bagged prestigious Delhi International
Airport Limited (DIAL) BOOT project
for 15 years
2.4%
Corporate Overview Performance Governance Financial Statements 35

Our Brand
Ambassadors
36 Jyothy Laboratories Limited
Annual Report 2015-16

Board of Directors

3 2 4 5

8 6 1 7
Corporate Overview Performance Governance Financial Statements 37

1 5

M.P. RAMACHANDRAN NILESH MEHTA


Chairman & Managing Director Independent Director
M.P. Ramachandran remains the driving force behind the Nilesh Mehta is the co-founder and Managing Partner of Access
Company’s progress. His vision and understanding of the India Fund which invests in mid market, unlisted opportunities
customers’ pulse has led to the Company emerging as a in India. He was the Managing Partner of Aureos Capital from
formidable player in the FMCG segment. ˡ˟˟ˤǼŸˡ˟ˠ˟ʳËsÞǣLJȖĶÞʩs_NÌNjǼsNjs_OOŸȖŘǼŘǼɠÞǼÌƼŸǣǼ
¶Nj_ȖǼs_s¶Njss¯NjŸŎÝÝōʳËÞǣsɮƼsNjÞsŘOsǣƼŘǣɚNjÞŸȖǣʩsĶ_ǣÞŘ
ʩŘŘOsʰNjضÞض¯NjŸŎÞŘɚsǣǼŎsŘǼEŘĨÞضʰƼNjÞɚǼssLJȖÞǼɴǼŸ¯ȖŘ_˚
NjsĶǼs_OǼÞɚÞǼÞsǣʳËsÞǣɚsǼsNjŘÞŘǼÌsʩsĶ_Ÿ¯ƼNjÞɚǼssLJȖÞǼɴŘ_
mergers and acquisitions of mid-cap Indian companies.

2 6

K. ULLAS KAMATH K. P. PADMAKUMAR


Joint Managing Director and CFO Independent Director
ħʳȕĶĶǣħŎǼÌÞǣLJȖĶÞʩs_NÌNjǼsNjs_OOŸȖŘǼŘǼŘ_NŸŎƼŘɴ K. P. Padmakumar brings to the table more than four decades
Secretary. He also has a degree in law and has attended the Ÿ¯sɮƼsNjÞsŘOsÞŘǼÌsʩsĶ_Ÿ¯NŸŎŎsNjOÞĶDŘĨÞضʰǻNjsǣȖNjɴ
Advanced Management Programme at Wharton Business School Management, Capital Markets and Mutual Funds. A graduate
and the Harvard Business School. He has completed Global ÞضNjÞOȖĶǼȖNjsŘ_NsNjǼÞʩs_ǣǣŸOÞǼsŸ¯ÝŘ_ÞŘÝŘǣǼÞǼȖǼsŸ¯
Management Programme at London School of Economics, Bankers – CAIIB, he has vast experience in the banking and capital
London, UK. It is under his leadership that the Company has markets arena.
_ÞɚsNjǣÞʩs_Ř_EsOŸŎsŎȖĶǼÞ˚ƼNjŸ_ȖOǼ®ōNµOŸŎƼŘɴʳËs
has spearheaded the successful setting up of Fabric Spa and
the Henkel (India) acquisition. He has also won the CA Business
Achiever Award in the SME category in the ICAI Awards, 2008.

3 7

S. RAGHUNANDAN BIPIN SHAH


Whole Time Director and CEO Independent Director
S. Raghunandan has a degree in Chemical Engineering from the Bipin R. Shah is a Chartered Accountant with a postgraduate
Birla Institute of Technology and Science (Pilani). He also has degree in Management. He has also attended the Senior
a post-graduate degree from IIM Kolkata. He has worked with Executive Programme conducted by Sloan School of Business,
leading FMCG players like Dabur, Paras and Reckitt Benckiser. Massachusetts Institute of Technology at Boston, USA. Currently,
Having joined in May 2012, he brings to the table his vast he serves on the Board of various companies and the Company
industry experience in areas of sales, marketing and general EsŘsʩǼǣ¯NjŸŎÌÞǣsɮƼsNjÞsŘOsɠÞǼÌĶs_Þض®ōNµƼĶɴsNjǣʳ
management. In last three years at Jyothy Laboratories, he has
created a sustainable business model by saving ` 100 crores,
increasing spends for brand building and above all created a
strong management team.

4 8

M. R. JYOTHY R. LAKSHMINARAYANAN
Director Independent Director
A postgraduate in management with an additional diploma An IIT and IIM alumnus, R. Lakshminarayanan has a string of
in Family Managed Business Administration, M. R. Jyothy successes in his career. He has worked with leading FMCG
OŸŘǼNjÞEȖǼsǣǣÞ¶ŘÞʩOŘǼĶɴǼŸǼÌsǣĶsǣʰŎNjĨsǼÞضŘ_ENjŘ_ conglomerates across product categories and held eminent
communication aspects of the Company. She has also completed positions with top notch advertising companies in India. He has
the Owner / President Management Programme from Harvard a keen interest in business strategy, brand strategy, media plural
Business School. In the year gone by, she was awarded with communications and brand portfolio management.
Emerging Kerala – Entrepreneurship Excellence Award for women.
ǢÌsɠǣĶǣŸŎŸŘ¶ǼÌs˄ˤ˟ōŸǣǼÝŘʪȖsŘǼÞĶɟŸŎsŘÞŘÝŘ_ÞŘ
Media, Marketing and Advertising’ list by IMPACT for two years
in a row.
38 Jyothy Laboratories Limited
Annual Report 2015-16

Management Discussion
& Analysis

JYOTHY LABORATORIES LIMITED


STARTED OFF AS A CONSUMER
PRODUCT COMPANY WITH
OPERATIONS CONCENTRATED IN THE
SOUTH INDIAN MARKET. OVER THE
YEARS, THE COMPANY HAS EVOLVED
AND TRANSITIONED FROM A REGIONAL
BRAND TO A NATIONAL BRAND.
Corporate Overview Performance Governance Financial Statements 39

7.3%
Growth rate in 2015

7.6%
Growth rate in 2016

ECONOMIC SCENARIO growth of -3.8% and -3.7% respectively. INDIAN ECONOMY


GLOBAL ECONOMY Advanced economies grew moderately The real GDP in India grew by 7.6% in
The global economy grew 3.1% in 2015 at 1.9% as unfavourable demographics, 2015-16 (from 7.3% in 2014-15), largely
compared to 3.5% in 2014 as slowdown ¯ǼsNj˚s¯¯sOǼǣ Ÿ¯ ǼÌs ¶ĶŸEĶ ʩŘŘOÞĶ driven by growth in private consumption
in investments, weakening commodity crisis and low productivity continued to due to low oil prices and higher real
ƼNjÞOsǣʰ _sONjsǣÞض OƼÞǼĶ ʪŸɠǣ ǼŸ impact growth. However, the Eurozone income. The agriculture sector witnessed
emerging economies and geopolitical showed signs of recovery as it grew 1.6% a growth of 1.1% despite poor rainfall.
ƼNjsǣǣȖNjsǣ OŸŘǼÞŘȖs_ ǼŸ ǣǼÞʪs NjsOŸɚsNjɴʳ in 2015 compared to 0.9% in 2014. The services sector continued to grow
Despite a fall in growth rate from 4.6% strongly despite a fall in growth rate
in 2014 to 4.0% in 2015, the emerging Global stresses related to macro- from 8.8% in 2014-15 to 8.4% in 2015-
nations continued to contribute a economic problems in various parts of 16. The industrial sector outperformed
majority share in the global growth. the world, falling growth rate in advanced expectations as rising manufacturing
A tough macro-economic scenario countries, asset market volatility and other activities led to a growth of 8.8% in
weakened China’s growth from 7.3% non-economic factors could continue 2015-16 compared to 6.5% in 2014-15.
in 2014 to 6.9% in 2015. The Indian to hinder global economic activity, as Manufacturing grew from 5.5% in 2014-
economy continued to perform strongly growth is expected to be around 3.2% 15 to 9.5% in 2015-16. The country’s
as it grew from 7.3% in 2015 to 7.6% in 2016 and then pick up momentum to foreign exchange reserves reached an
in 2016. Brazil and Russia continued to 3.5% in 2017. (Source: World Economic all-time high of USD 361.30 billion as in
show signs of distress with a negative Outlook, International Monetary Fund) April 2016.
40 Jyothy Laboratories Limited
Annual Report 2015-16

ǻÌs ʩǣOĶ _sʩOÞǼ _sONjsǣs_ ¯NjŸŎ ˣʳˤ̇ foreign companies (up to January 2016). Ìɚs ENjŸȖ¶ÌǼ _ŸɠŘ ÞŘʪǼÞŸŘ ǼŸ _sǣÞNjs_
in 2014-15 to 3.99% in 2015-16 and is These companies intended to set up levels. It is further expected to fall down
expected to be 3.5% in 2016-17. Factors units in sectors where foreign direct to targeted levels of 5% in 2016-17. In
that helped the Indian economy were investment is permitted. (Source: Rajya India, food and beverages is the most
the drop in oil prices; stabilisation of Sabha Q&A) important category in the consumer
the rupee against the dollar after a price index, with a weight of 45.86%,
ǣÌNjƼǣĶÞ_sʱŘ_ÞŘʪǼÞŸŘOŸŎÞضȖŘ_sNj ÝŘʪǼÞŸŘ Ř_ ɠÌŸĶsǣĶs ƼNjÞOs ÞŘ_sɮʲ ǻÌs followed by housing (10%), transport
control. A positive atmosphere for ÞŘʪǼÞŸŘ NjǼs ɚsNj¶s_ ˦ʳ˦˨̇ _ȖNjÞض and communication (8.6%), fuel and light
manufacturing was created by the ‘Make 2012-16, reaching an all-time high of (6.84%), clothing and footwear (6.5%),
in India’ initiative. During the period 11.16% in November 2013. However, medical care (5.9%) and education
under review, the country received 424 tight monetary policy, supply side ʹˣʳˤ̇ʺʳĵŸɠsNjÞŘʪǼÞŸŘĶsɚsĶǣNjsĶÞĨsĶɴǼŸ
proposals worth ` 48,902 crore from measure and low commodity prices boost consumer spending.

The wholesale price index continued to witness a declining trend due to moderation in raw material prices and weaker
demand.

ÝŘʪǼÞŸŘNjǼs_ȖNjÞضˡ˟ˠˤ˚ˠ˥ ɟÌŸĶsǣĶsƼNjÞOsÞŘ_sɮ_ȖNjÞضˡ˟ˠˤ˚ˠ˥

6 0
5.61 5.69 -0.73
5.4 5.41 -0.85 -1
5.26 5.5 -1.07 -0.91
5.01 5 -2
4.87 4.83 5 -2.2 -2.13 -2.04
-2.43 -3
4.41 4.5 -3.7
-4
-4.05
4 -4.59 -5
3.69 3.74
-5.06
3.5 -6
Apr 2015 Jul 2015 Oct 2015 Jan 2016 Apr 2015 Jul 2015 Oct 2015 Jan 2016

ǻÌsŸȖǼĶŸŸĨ¯ŸNjǼÌsÝŘ_ÞŘsOŸŘŸŎɴÞǣǣǼNjŸŘ¶ʰǣNjÞǣÞضÞŘ¯NjǣǼNjȖOǼȖNjsǣƼsŘ_ÞضʰOŸŎŎÞǼŎsŘǼǼŸʩǣOĶǼNj¶sǼǣʰ¯ŸNjsOǣǼŸ¯EŸɚs
normal rainfall and government’s focus on promoting manufacturing, skills and enterprise are likely to boost growth. Real GDP
growth for 2016-17 is estimated at 7.6%. (Source: RBI: Monetary Policy Report)

7.6%
Estimated Real GDP growth for 2016-17
Corporate Overview Performance Governance Financial Statements 41

INDUSTRY OVERVIEW
FMCG MARKET SEGMENT
The FMCG market in India is the fourth
largest sector in the economy and is
18% Food and Beverages
expected to grow at a CAGR of 11.9%
Food and beverages
during 2007 to 2016. The revenue from
(Health beverage, bakery
the sector grew from USD 17.8 billion Household product, snacks, ice cream,
in 2007 to USD 47.3 bn in 2015 and is and staples/ cereals, tea/ coffee/
Personal soft drinks, chocolates,
forecast to become worth USD 49 bn Care 50% processed fruits and
in 2016 and USD 103.7 bn by 2020. The vegetables, dairy products,
Household and ENjŘ_s_ʪŸȖNjʺ
market share of personal care products Personal Care (Oral
in the total FMCG market increased from care, skin care, hair
less than 30% in 2000 to about 48% in care, perfumes, 32%
deodorants/ Healthcare
2015. The size of personal care market is cosmetics, fabric wash,
estimated at USD 22.7 bn in 2015. feminine hygiene Healthcare (Over the counter
and paper products, products and ethical)
household cleaners)

Despite the economic recovery from economy. Growing brand awareness, consumer markets have immense
the slowdown of the past decade, the ease of access and aspirational lifestyles potential, accounting for almost 70%
Indian markets are still not entirely would be the key growth drivers for the of the country’s population. Nearly
ƼNjs_ÞOǼEĶsʰǣǼÌsŎŸŘǣŸŸŘÞŘʪȖsŘOsǣ sector. 50% of the rural spending is on FMCG
rural demand. However, increasing products. The FMCG market in India is
urbanisation and movement of ÝŘ_ÞŘ OŸŘǣȖŎsNj OŸŘʩ_sŘOs NjsŎÞŘs_ highly fragmented and about half of it
people to cities has seen a pick-up the highest in the world for four successive is dominated by the unorganised sector.
in demand from the urban market. quarters. In Q1 2016, the country’s ǻÌÞǣ ƼNjŸɚÞ_sǣ ǣÞ¶ŘÞʩOŘǼ ŸƼƼŸNjǼȖŘÞǼÞsǣ
A good monsoon should also see a OŸŘǣȖŎsNjOŸŘʩ_sŘOsɠǣǼÌsÌÞ¶ÌsǣǼÞŘ for branded retailers to create new
quick turnaround in rural demand. about 10 years, rising to a score of 134 consumer bases. Companies need to
Overall, the Indian consumer market is after three consecutive quarter scores strengthen their distribution networks
expected to witness steady recovery in of 131. This was much higher than the and use that effectively to reach
the next few years starting 2016. US (110 points), China (105), Germany consumers currently using unbranded
and the UK (97) and Japan (73). The and unpackaged goods. (Source: Forbes
A positive macro-economic scenario, score is based on perceptions of local India, Indian Brand Equity Foundation).
growth in employment levels, expanding ĠŸE ƼNjŸǣƼsOǼǣʰ ƼsNjǣŸŘĶ ʩŘŘOsǣʰ Ř_
ƼNjŸ_ȖOǼ _ÞǣǼNjÞEȖǼÞŸŘ Ř_ ǣÞ¶ŘÞʩOŘǼ immediate spending
increment in salaries and pensions upon intentions. (Source:
the implementation of the Seventh AC Nielsen)
Pay Commission (which is likely to put
additional funds of USD 15 billion in the The Indian
hands of consumers starting 2016) are consumer markets
expected to drive demand for consumer have shown changes
products. Government schemes like in trend, as FMCG
‘Jan Dhan Yojana’ and direct transfer of companies have
subsidies, coupled with low commodity increased focus
(especially oil) prices, are likely to bring on rural areas.
ǣÞ¶ŘÞʩOŘǼ ǣǼNjȖOǼȖNjĶ OÌضsǣ ÞŘ ǼÌs The Indian rural
42 Jyothy Laboratories Limited
Annual Report 2015-16

Advantage India

Rising demand Attractive opportunities

t )JHIFSJODPNFMFWFM t -PXQFOFUSBUJPOMFWFMTJOSVSBMNBSLFU
t 'BWPVSBCMFEFNPHSBQIJDTXJUIIVHFZPVUIQPQVMBUJPO t 3JTJOHEJTQPTBCMFJODPNFJOSVSBM*OEJB
t 3JTFJOTQFOEJOHPGöSTUUJNFNPEFSOUSBEFTIPQQFST t (SPXJOHEFNBOEGPSQSFNJVNBOEDVTUPNJTFEQSPEVDUT
t 5JFS*****DJUJFTBSFXJUOFTTJOHGBTUFSHSPXUIJONPEFSOUSBEF t &YQPSUNBSLFU

Higher investments Policy support

t .BSLFUQMBZFSTBSFTQSFBEJOHUPOFXHFPHSBQIJFTBOE t BOE'%*BQQSPWBMJOTJOHMFCSBOEBOENVMUJCSBOE
 DBUFHPSJFT  SFUBJMSFTQFDUJWFMZ
t 3JTJOHJOWFTUNFOUTGSPNWFOUVSFDBQJUBMJTUBOEQSJWBUF t 'PPETFDVSJUZCJMMBOEEJSFDUUSBOTGFSPGTVCTJEJFT
 FRVJUZQMBZFST t .JOJNVNDBQJUBMJTBUJPOGPSGPSFJHO'.$(DPNQBOJFT

THRUST ON SUSTAINABLE GROWTH

Jyothy Laboratories Limited started off as a consumer product company with operations concentrated in the south Indian market.
Over the years, the Company has evolved and transitioned from a regional brand to a national brand.

rɚŸĶȖǼÞŸŘÞŘǼÌsƼǣǼˠ˟ɴsNjǣ

2005-06 2015-16
`
`ˢ˟ˠʳ˨ˢONjNJsɚsŘȖsǣ `ˠʰ˥ˣˣʳ˦ˢONjNJsɚsŘȖsǣ

ˡʳˤŎÞĶĶÞŸŘŷȖǼĶsǼǣ ˡʳ˨ŎÞĶĶÞŸŘŷȖǼĶsǼǣ

ˡʰˤ˟˟^ÞǣǼNjÞEȖǼŸNjǣ ˠʰ˥˦˥^ÞǣǼNjÞEȖǼŸNjǣ
Corporate Overview Performance Governance Financial Statements 43

Over the years, the Company has introduction of products that aid brand number of online shoppers increasing
developed a robust pan-India extension, e.g. the Pril bar and the Ujala from 50 million in 2015 to 320 million
distribution network and undertaken detergent powder, are all part of the in 2020. (Source: The Economic Times,
substantial marketing and brand sustained growth plan. Assocham)
promotion activities. With this, it has
created a sustainable business model KEY TRENDS IN THE INDIAN FMCG
that is not dependent on a particular MARKET
region or product. This strategy has led ˒ƻNjŸ_ȖOǼ ÞŘŘŸɚǼÞŸŘʰ OȖǣǼŸŎÞǣǼÞŸŘ
to strong business growth in the non- and premiumisation: The FMCG
south regions of India; growth in the companies are constantly investing in
non-south markets has outpaced that in research to develop newer products
the Company’s primary southern market. that are unique, have better features
The Company’s revenue grew faster than Ř_ Njs OȖǣǼŸŎÞǣs_ ǼŸ ŎssǼ ǣƼsOÞʩO
industry across all product segment. consumer needs. Buyers are willing to
pay higher prices for premium products
Today, the proportion of revenues from in the convenience, health and wellness
a single region or a single product is not
more than 20% of the total revenues.
space.
ˠˤ˟million
The number of consumers
˒DNjŘ_ ƼNjs¯sNjsŘOsʲ Rising disposable
that are expected to be
The Company increased investments in income and customer engagement ÞŘʪȖsŘOs_EɴǼÌs_Þ¶ÞǼĶ
key business segments and reinforced by companies have drawn consumers revolution by 2020
on-ground relationships with key outlets towards the most appealing brands.
in the top cities and town of India, leading
to overall increase in throughputs. ˒®ŸOȖǣ ŸŘ NjȖNjĶ ŎNjĨsǼǣʲ Companies
Superior products, pan-India distribution,
greater penetration into rural markets,
are focussing on rural markets to
tap new consumers and increase the
ȕǢ^ˣ˟million
The expected spending of digital
differential positioning and high brand spending of existing consumers by
consumers in 2020
recall enabled Jyothy Laboratories to offering wider product range.
achieve sustainable growth.
˒rɮƼŘ_Þض_ÞǣǼNjÞEȖǼÞŸŘŘsǼɠŸNjĨʲ In a
The Company intends to enhance bid to capture market share in existing
its presence in the rural markets by markets as well as new markets, FMCG ˢˡ˟million
identifying key districts across the companies have focussed on enhancing The expected number of online
country. The growth strategy in the their distribution network to enhance shoppers by 2020
coming years is based on enhancing OÌŘŘsĶ s¯ʩOÞsŘOɴʰ Njs_ȖOs Ķs_ ǼÞŎs
shopper’s delight through: Ř_¶ÞŘʩNjǣǼ˚ŎŸɚsNj_ɚŘǼ¶sʳ
˒ Ý_sŘǼÞ¯ɴÞضƼNjŸǣƼsOǼÞɚsŸȖǼĶsǼǣÞŘǼÞsNjÝ
towns ˒ÝŘONjsǣs_ ÌÞNjÞض ÞŘ ǼÞsNj ÝÝˀ ÝÝÝ
˒ ^sɚsĶŸƼÞضOĶsNjǣÌsĶ¯ƼĶŘ ng
cities: FMCG companies are hiring
˒ NJsOŸŘʩ¶ȖNjÞض ǣɴǣǼsŎǣ ǼŸ sŘÌŘOs sĶĶ
ʩsĶ_ ǣǼ¯¯ ONjŸǣǣ ǣŎĶĶ ǼŸɠŘǣ ǼŸ ǣsĶĶ
service in the outlets nd
diverse products and enhance brand
˒ DȖÞĶ_ÞضǣǼNjŸŘ¶NjsĶǼÞŸŘǣÌÞƼǣɠÞǼÌŸȖNj awareness.
customers
˒r˚OŸŎŎsNjOsʲ The e-commerce industry
ry
The Company continues to drive te
in India is growing at an astounding rate
category growth across all markets, from USD 3.8 billion in 2009 to USD 23
leveraging brand core and equity. A m
bn in 2015. With huge investments from
robust innovation pipeline, targeted ty,
venture capitalist and private equity,
communication for newer users, strategic the e-commerce industry is expected to
national / regional rollout of brands, and he
grow to USD 119 bn by 2020 with the
44 Jyothy Laboratories Limited
Annual Report 2015-16

GROWTH DRIVERS
Industry size by value Industry size by volume
˒ NJÞǣÞض OŸŘǣȖŎƼǼÞŸŘ sɮƼsŘ_ÞǼȖNjsʲ
The rising disposable income in the Liquid blue (` in lacs) Liquid blue (in ’000’ litres)

hands of consumers would lead to


rise in total consumption expenses 2014 2015 2014 2015
in the country, which is expected to ǻŸǼĶ ˤˢʰ˧˥ˠ ˤˣʰˢˠˤ ǻŸǼĶ ˡ˨ʰˤˠ˨ ˡ˧ʰˤˢˢ
grow at a compounded rate of 16.89% Urban 27,030 26,663 Urban 13,598 12,659
during 2014-20 and reach USD 3,600 Rural 26,831 27,652 Rural 15,921 15,874
bn. (Source: Indian Brand Equity
Foundation) Detergent (` in lacs) Detergent (in MT)

˒ NJȖNjĶ®ōNµ¶NjŸɠǼÌʲThe rural FMCG 2014 2015 2014 2015


market is expected to grow at a CAGR ǻŸǼĶ ˠˢʰˣ˟ʰ˦ˡˢ ˠˣʰ˥ˤʰˢ˨˦ ǻŸǼĶ ˡˠʰ˦˦ʰ˟ˤ˨ ˡˢʰˠ˦ʰˡ˨ˢ
of 18.1% from USD 18.92 bn in 2015 Urban 7,32,307 7,86,917 Urban 10,65,156 11,12,458
to USD 100 bn in 2025. Moreover, the Rural 6,08,416 6,78,480 Rural 11,11,903 12,04,835
per capita disposable income in rural
India is expected to grow at a CAGR of Dishwasher bars (` in lacs) Dishwasher bars (in MT)

4.4% from USD 516 in 2015 to USD 631


by 2020, enabling the rural consumers 2014 2015 2014 2015
to spend more. (Source: Indian Brand ǻŸǼĶ ˠʰ˨˥ʰ˦˧ˢ ˡʰˠˢʰˣˡ˦ ǻŸǼĶ ˡʰ˧˨ʰ˥ˢ˦ ˢʰˠˢʰ˥ˠ˥
Equity Foundation) Urban 1,29,196 1,36,824 Urban 1,88,398 1,98,464
Rural 67,587 76,603 Rural 1,01,239 1,15,152
˒ NJÞǣÞض ŎŸ_sNjŘ NjsǼÞĶ ÞŘ ÝŘ_Þʲ
The modern retail sector in India is Dishwasher liquids (` in lacs) Dishwasher liquids (in’000’ litres)
expected to grow at a CAGR of 24.57%
from USD 60 bn in 2015 to USD 180 bn 2014 2015 2014 2015
in 2020. (Source: Indian Brand Equity ǻŸǼĶ ˢˠʰˤ˟˟ ˢ˥ʰˠˡ˨ ǻŸǼĶ ˠ˧ʰ˥˟˟ ˡˠʰˢˢˡ
Foundation) Urban 29,090 32,687 Urban 17,162 19,099
Rural 2,410 3,442 Rural 1,438 2,233
˒ NJÞǣÞض ŎÞ__Ķs OĶǣǣʲ The middle class
population is the primary consumers for Mosquito coils (` in lacs) Mosquito coils (in millions)

FMCG goods. The population of middle


income earners in India is likely to grow 2014 2015 2014 2015
at a CAGR of 10.8% to reach 267 million ǻŸǼĶ ˠʰˤ˦ʰˤˠˡ ˠʰˤ˦ʰˡ˥ˢ ǻŸǼĶ ˥ʰ˥˟˧ ˥ʰˢˡ˟
in 2016 from 160 million in 2011. Urban 88,051 86,325 Urban 3,596 3,368
Rural 69,461 70,938 Rural 3,012 2,952
˒ NJÞǣÞضÞŘOŸŎsĶsɚsĶǣʲ The nominal per
capita income in India increased at a Mosquito liquid (` in lacs) Mosquito liquid (in millions)

compounded rate of 5.43% from USD


1,430.2 in 2009-10 to USD 1,702.1 in 2014 2015 2014 2015
2014-15. It is further expected to grow ǻŸǼĶ ˠʰˢˡʰˢ˥˦ ˠʰˣ˥ʰ˨˟˨ ǻŸǼĶ ˨ʰ˨ˤˡ ˠ˟ʰˤˢ˦
at a CAGR of 7.85% during 2015-19 Urban 1,07,779 1,18,564 Urban 8,081 8,478
and reach USD 2,302.5. (Source: Indian Rural 24,588 28,345 Rural 1,871 2,059
Brand Equity Foundation)
Mosquito card (` in lacs) Mosquito card (in millions)

2014 2015 2014 2015


ǻŸǼĶ ˠˠʰˤˠ˨ ˢ˟ʰˢ˨˧ ǻŸǼĶ ˠʰˠˤˣ ˢʰˠˢ˨
Urban 8,242 18,094 Urban 826 1,855
Rural 3,277 12,304 Rural 328 1,284

(Source: AC Nielsen Jan to Dec period) (Source: AC Nielsen Jan to Dec period)
Corporate Overview Performance Governance Financial Statements 45

OUTLOOK of India and develop it into a sourcing COMPANY OVERVIEW


The overall consumer sentiments hub for catering to international FMCG Jyothy Laboratories Limited, founded in
remain positive and the FMCG industry markets. 1983 in Kerala, is a consumer product
is expected to grow at a CAGR of 20.6% manufacturing company that focusses
during 2016-20 and reach USD 103.7 on touching people’s lives through its
The implementation of GST is one of the
bn. Smaller towns and cities would range of world-class products. Over
most anticipated changes for industries
play a decisive role in determining the 33 years, through sheer hard work and
in India. It would change market
future of the industry, and the digital focus on innovation and delivering
dynamics for the better, facilitating easier
medium would increasingly play a value for money, we have become one
movement of inventories across states,
key role in engaging and influencing of India’s leading and most trusted
sŘÌŘOÞض ŸƼsNjǼÞŸŘĶ s¯ʩOÞsŘOÞsǣʳ
consumers. companies in the FMCG industry. The
Moreover, it would lead to reduction
Company operates in the segments
in logistical costs, making goods more
Increasing rural penetration, of fabric care, dishwash, household
affordable for the masses.
product innovation, premiumisation, insecticide, personal care, and laundry
customisation, growth in distribution services.
network, attractive variations in size The above normal forecast for
and design of packaging, and consumer monsoon in 2016 is again a key factor
focus on eco-friendly products are all governing demand for FMCG goods in In 2011, the Company acquired Henkel
likely to contribute to FMCG growth. rural markets, as agricultural growth India with the objective of widening its
Moreover, there is a huge opportunity would lead to higher income for product portfolio, reaching out to the
to leverage the low-cost advantage farmers. premium segment of consumers.

Leadership through key brands

UJALA FABRIC WHITENER EXO BAR PRIL LIQUID

77.6% ˠ˟ʳˣˢ̇ ˠ˥ʳ˥˨̇


All-India market share by value All-India market share by value All-India market share by value

˥ˡʳˢ˥̇ ˨ʳˡ˟̇ ˠˤʳˣ˟̇


All-India market share by volume All-India market share by volume All-India market share by volume

MAXO COIL MAXO LIQUID HENKO

ˠ˧ʳˣˢ̇ ˥ʳ˥˨̇ ˤʳ˟̇


All-India market share by value All-India market share by value All-India market share by value

ˡˠʳˤˠ̇ ˦ʳˠˢ̇ ˤʳ˥̇


All-India market share by volume All-India market share by volume All-India market share by volume

ˡ˥ʳ˨ˣ̇ ˨̇
Rural India market share by volume Rural India market share by volume
46 Jyothy Laboratories Limited
Annual Report 2015-16

Corporate strategy

POST WASH LAUNDRY DISH WASH HOUSEHOLD PERSONAL CARE


INSECTICIDE

˒rɮǼsŘ_Þض  ˒rǣǼEĶÞǣÌÞض  ˒ĵsɚsNj¶ÞضENjŘ_ ˒ÝŘONjsǣÞض¯ŸŸǼƼNjÞŘǼ ˒NJsÞŘɚÞ¶ŸNjǼÞض


dominance uniqueness portfolio ˒ɟÞŘŘÞضǼÌNjŸȖ¶Ì brand
˒DȖÞĶ_Þض¯ŸNj¯ȖǼȖNjs ˒ǢǼNjsضǼÌsŘÞض innovations ˒NJsĶsɚŘǼ 
position extensions

FOCUS ON INNOVATION This initiative has resulted in Powerbrand to the individuals and make them job
Jyothy Laboratories Limited puts utmost offerings such as Maxo Genius and ready. These skills would also allow those
emphasis on product and process Henko Matic LINTelligent. trained to become employable elsewhere
innovation. Through product innovation, other than Jyothy.
we constantly focus on enhancing the HUMAN RESOURCES
quality of existing products and develop The human capital (on-ground workforce As on March 31, 2016, the Company
new ones that meet the expectation and employee) is a key factor driving has 1,978 sales personnel, who ensure
generated by changing lifestyles of growth at Jyothy Laboratories. The continuous supply of products across
consumers. Through process innovation, Company has devised a human resource 6,00,000 retails in India.
we focus on using new techniques to policy that ensures a conducive and
optimise production with the aim of productive work environment. Systems Building an agile and high performance
reducing operational cost. This enables are in place to help employees enhance culture
us to offer value for money brands and their skills and motivate them to work At Jyothy Laboratories Limited,
ensure customer delight. towards the goals of the Company we promote the highest levels of
based on fairness, openness and mutual professional ethics, personal decorum,
R&D initiatives respect. Performance-based incentives adherence to deadlines, compliance with
The Company has a state-of-the-art and promotions boost employee morale. standards and customer service. The
R&D centre at Mumbai, equipped with The Company takes the responsibility to following attributes are imbibed across
advanced lab instruments enabling upgrade employee skills and assign them every function of the organisation:
sustained experimentation and product to suitable roles when manufacturing
development. The Company constantly processes are automated. ˒OOŸȖŘǼEÞĶÞǼɴ
monitors the production process, right ˒ÝŘǼs¶NjÞǼɴ
from the raw material stage to the The Company provides various insurance, ˒NŸŎŎÞǼŎsŘǼ
ʩŘÞǣÌs_ ¶ŸŸ_ǣ ǣǼ¶sʰ ǼŸ sŘǣȖNjs ǼÌǼ medical and accident cover plans for ˒ÝŘÞǼÞǼÞɚsŘ_ƼŸǣÞǼÞɚsǼǼÞǼȖ_s
the highest quality standards are met. employees and their family members.
ŷȖNj ƼĶŘǼǣ Njs ÝǢŷ ˨˟˟ˠ OsNjǼÞʩs_ ¯ŸNj The Company also provides the facility for Employee engagement
manufacturing quality. employees to cover their parents at very The Company attains employee
nominal rates. These plans are equal for engagement through various initiatives
ǻÌs NŸŎƼŘɴ ĶǣŸ ÌÞNjsǣ LJȖĶÞʩs_ Ř_ all employees without any differentiation that nurture talent, excellence and job
skilled professionals having domain on the basis of pay or designation. skills. The employees are driven by
expertise. Our focussed R&D approach motivation and passion to work towards
Þǣ NjsʪsOǼs_ ÞŘ ŸȖNj ȖŘÞLJȖs ENjŘ_ We intend to become a part of the ambitious growth plans of the
characteristics, advanced formulations the government’s ‘Skill India’ Company. Area sales managers hold
Ř__ÞɚsNjǣÞʩs_ƼNjŸ_ȖOǼŸ¯¯sNjÞضǣǼÌǼNjs programme, which focusses on skill Njs¶ȖĶNjǼNjÞŘÞضǣsǣǣÞŸŘǣǼŸsŘÌŘOsʩsĶ_
available at affordable price points. The training for individuals to encourage staff’s skills. Employees are also provided
Company has strategically devised a new entrepreneurship. Under this plan, the periodic soft skill training and advanced
product development (NPD) pipeline. Company plans to provide skill training MS-Excel training.
Corporate Overview Performance Governance Financial Statements 47

The Company encourages employees to ˒ ɟs ÞŎƼĶsŎsŘǼs_ ŘsɮǼ ƼÌǣs Ÿ¯ ŸȖNj ˒ NŸŘŘsOǼs_ ˄^ÞǣÌ˅ ǣȖÞǼs ǼŸ ǼÌs ŎÞŘ
work as a team, share new ideas and give ‘Connect’ 3P Suite, that along with ERP for supply chain automation
feedback for improving work processes providing daily reports on production by providing demand forecasting,
and practices. All necessary safety and dispatch compliance, now also dispatch/ production and material
standards are complied with across all ƼNjŸɚÞ_sǣ __s_ EsŘsʩǼǣ Ÿ¯ OƼǼȖNjÞض planning functions. This has automated
plants to ensure employee welfare. third party costing. most of the supply chain planning and
processes through auto-generated
Competition is a way to stimulate and ˒ ĵȖŘOÌs_ ˄ğNŸŘŘsOǼ˅ʰ Ř ŸŘĶÞŘs reports. The Company keeps adding
encourage personal growth and help employee self-service platform. This new features to this suite, such as
people to excel in something they enjoy as OƼǼȖNjsǣ sŎƼĶŸɴssǣ˅ OŸŎƼĶsǼs ƼNjŸʩĶs trade-claim process and discount
well as giving them sense of achievement and enables them to add information module, to further enhance supply
and togetherness. Given this premise, this EŸȖǼŘsɠǣĨÞĶĶǣˀLJȖĶÞʩOǼÞŸŘʰȖƼ_Ǽs chain automation.
year the Company organised programmes personal details, and apply for and
like ‘Talent ka Challenge’ which was high approve leaves. Employee can also ˒ ˄ĵĨǣÌɴ˅ʰ  ǣsOŸŘ_Njɴ ǣĶsǣ ǣɴǣǼsŎʰ
energy, fresh, innovative cultural theme download his Payslips and Form 16 for tracking distributor secondary sales
programme and ‘play-sport’ which include from Jconnect. The platform provides and inventory.
sporting events like football, cricket and  ǣsŎĶsǣǣ Ř_ ƼƼsNjĶsǣǣ ɠŸNjĨʪŸɠ
indoor games to enhance employee without any human intervention. NŸǣǼǣɴŘsNj¶ÞsǣŘ_EsǣǼ˚ÞŘ˚OĶǣǣƼNjOǼÞOsǣ
engagement and encourage team spirit. The IT infrastructure has enabled the
˒ ĵȖŘOÌs_ ŎŸEÞĶs ƼƼǣ ¯ŸNj ǣǼ¯¯ Company to streamline operations,
INFORMATION TECHNOLOGY medical insurance and Modern Trade resulting in centralised processing of
SYSTEMS Merchandizers. The medical app allows data and timely information sharing.
IT platforms for business and human staff to carry Insurance Card 24*7 for Real-time data transfer, lean inventory
resources emergencies, check claim status and management, automation and demand-
Jyothy Laboratories Limited has invested ʩŘ_OǣÌĶsǣǣÌŸǣƼÞǼĶǣĶÞǣǼs_ȖŘ_sNjǼÌsÞNj _NjÞɚsŘ ǣȖƼƼĶɴ OÌÞŘ ŎsŘǣ ǣÞ¶ŘÞʩOŘǼ
in a superior IT infrastructure as a tool insurance policy. The Merchandizer app cost and time savings. More importantly,
ǼŸ ÞŎƼNjŸɚs ɠŸNjĨ s¯ʩOÞsŘOɴʰ Njs_ȖOs allows the Company to digitally track it helps us to address customer problems
errors/ duplication, enhance business products on shelves and their display and attain greater customer satisfaction.
relationships, manage an extensive arrangement at various Modern trade
business network (1,660 stockists/ super outlets.
stockists managed through 40 CFA
locations), manage inventories better, and ˒ ÝŘÞǼÞǼs_ ^ÞǣǼNjÞEȖǼÞŸŘ ōضsŎsŘǼ
cut down on internal administrative delays. System for roll out across India at all
Super Distributors Point.
The major IT initiatives undertaken by
the Company during the year include: The existing IT infrastructure of the
˒ ÝŘɚsǣǼs_ ÞŘ Ǣƻ ǢˀˣËŗʰ ɠÌÞOÌ Þǣ  Company includes:
next generation business suite that ˒ 
  NjŸEȖǣǼ OsŘǼNjĶÞǣs_ rNJƻ ʹsŘǼsNjƼNjÞǣs
is built on an in-memory computing resource planning) system capable
platform. The platform is designed with of covering business functions across
the modern SAP Fiori user experience; ʩŘŘOsʰ ÞŘɚsŘǼŸNjɴ ŎضsŎsŘǼˀ
the new suite helps to drive instant procurement, transportation/ logistics
business insight across business and HR & payroll. The system can
functions and roles. We plan to covers be connected easily from anywhere.
all critical business processes and have
integrated functions across various
The Company has also deployed MS
Business Intelligence Layer, which
˥ʰ˟˟ʰ˟˟˟
retail outlet reach in India
business lines. This suite is expected to provides a wide range of data analysis
be operational from April 2017. facilities.
48 Jyothy Laboratories Limited
Annual Report 2015-16

FINANCIAL PERFORMANCE
ACCOUNTING POLICY
The Company follows the Generally Accepted Accounting Principles (GAAP) in India. These are the accepted accounting standards
Ÿ¯ǼÌsNŸŎƼŘÞsǣOǼʰˠ˨ˤ˥ʰŘ_ŎsŘ_s_ƼNjŸɚÞǣÞŸŘǣŸ¯ǼÌsǣŎsÞŘˡ˟ˠˢ¯ŸNjǼÌsƼNjsƼNjǼÞŸŘŸ¯ǼÌsNŸŎƼŘɴ˅ǣʩŘŘOÞĶǣǼǼsŎsŘǼǣʳ
The Company uses accrual basis of accounting except in cases of assets for which provision for impairment is made.

NJrəÝrɟŷ®®ɳˡ˟ˠˤ˚ˠ˥ʹŷŗNŷŗǢŷĵÝ^ǻr^DǢÝǢʺ
Net Sales registered a 9.26% growth at ` 1,644.73 crore, other operating income decreased to ` 1.83 crore. The following table
indicates the segment revenue for the 12-month period from April 1, 2015 to March 31, 2016.

ǻÌsƼNjŸʩǼEÞĶÞǼɴŸ¯ǼÌs˄ǢŸƼǣŘ_^sǼsNj¶sŘǼǣ˅ǣs¶ŎsŘǼǣǼŸŸ_Ǽ` 194.11 crore in FY 2015-16 from ` 147.71 crore in FY 2014-15.


ǻÌsƼNjŸʩǼEÞĶÞǼɴŸ¯ǼÌs˄ËŸŎsNNjs˅ǣs¶ŎsŘǼ¯ȖNjǼÌsNjÞŎƼNjŸɚs_ǼŸ` 21.86 crore from ` 8.22 crore in the previous year. The laundry
services division recorded a loss of ` 14.54 crore, compared to a loss of ` 13.07 crore in the previous year.

(` in crores)
ƻNjǼÞOȖĶNjǣ   ˡ˟ˠˤ˚ˠ˥  ˡ˟ˠˣ˚ˠˤ

Soaps and Detergents 1,199.87 1,117.94


Home Care 387.42 332.30
Others 16.18 18.18 Note: Soaps and detergents include fabric
Laundry Services 43.06 42.05 whitener, fabric detergent, dishwash bars and
beauty soaps. Home care products includes
Inter Segment Revenue (1.80) (5.18)
household insecticides, incense sticks and
Net Sales 1,644.73 1,505.29 scrubbers. Others include body care. Laundry
services include dry cleaning and laundry.

COST ANALYSIS
Total cost (excluding interest, ESOP Expenses and depreciation) of the Company grew 6.49% from ` 1,323.11 crore in 2014-15 to
` 1,408.97 crore in 2015-16.

(` in crores)
ƻNjǼÞOȖĶNjǣ        ˡ˟ˠˤ˚ˠ˥   ˡ˟ˠˣ˚ˠˤ

Earnings Before Interest, Tax, Depreciation, Amortisation and Impairment 234.69 172.93
Finance Cost (6.03) (13.77)
Depreciation, Amortisation and Impairment (31.40) (32.55)
Exceptional Item - (2.09)
ƻNjŸʩǼDs¯ŸNjsǻɮ       ˠ˨˦ʳˡ˥    ˠˡˣʳˤˡ

Provision for tax


- Net Current tax including Deferred Tax (39.31) 0.58
Short tax provision / MAT credit reversal of earlier years - (4.12)
ƻNjŸʩǼ¯ǼsNjǻɮ ˠˤ˦ʳ˨ˤ    ˠˡ˟ʳ˨˧

Minority Share (Share in Loss) - 0.14


ƻNjŸʩǼ¯ǼsNjǻɮŘ_ōÞŘŸNjÞǼɴǢÌNjs      ˠˤ˦ʳ˨ˤ    ˠˡˠʳˠˡ
NŸNjƼŸNjǼsŷɚsNjɚÞsɠ Performance µŸɚsNjŘŘOs ®ÞŘŘOÞĶǢǼǼsŎsŘǼǣ ˣ˨

Cost of Goods Sold Equity Inventory


^ȖNjÞض ǼÌs ʩŘŘOÞĶ ɴsNjʰ NŷµǢ Ÿ¯ ǼÌs ǻÌs sLJȖÞǼɴ ǣÌNjs OƼÞǼĶ ʹÞǣǣȖs_ Ř_ ÝŘɚsŘǼŸNjɴ Ÿ¯ ǼÌs NŸŎƼŘɴ ǣǼŸŸ_ Ǽ
NŸŎƼŘɴÞŘONjsǣs_ˡʳ˦˨̇¯NjŸŎ`˦˦˦ʳˣ˥ ǣȖEǣONjÞEs_ʺ Ÿ¯ ǼÌs NŸŎƼŘɴ OŸŘǣÞǣǼǣ Ÿ¯ ` ˠ˧ˡʳ˥ˤ ONjŸNjs ǣ ŸŘ ōNjOÌ ˢˠʰ ˡ˟ˠ˥
ONjŸNjsÞŘ®ɳˡ˟ˠˣ˚ˠˤǼŸ`˦˨˨ʳˠˢONjŸNjsÞŘ ˠ˧ʰˠˠʰˠ˨ʰ˥˧˟sLJȖÞǼɴǣÌNjsǣŸ¯` ˠsOÌʳ OŸŎƼNjs_ǼŸ`ˠ˧ˤʳˡONjŸNjsǣŸŘōNjOÌ
®ɳˡ˟ˠˤ˚ˠ˥_ȖsǼŸNjÞǣsÞŘŸƼsNjǼÞŸŘǣʳ ˢˠʰ ˡ˟ˠˤʳ ÝŘɚsŘǼŸNjɴ ǼȖNjŘŸɚsNj ¯ŸNj ǼÌs
Reserves and Surplus NŸŎƼŘɴ ǣǼŸŸ_ Ǽ ˣˠ _ɴǣ ¯ŸNj ǣ ÞŘ
Employee Cost ǻÌsNjsǣsNjɚsǣŘ_ǣȖNjƼĶȖǣŸ¯ǼÌsNŸŎƼŘɴ ōNjOÌ ˡ˟ˠ˥ ǣ ¶ÞŘǣǼ ˣˤ _ɴǣ ǣ ÞŘ
ǻÌs rŎƼĶŸɴss NŸǣǼ ¶Njsɠ ˠ˟ʳˤˣ̇ ¯NjŸŎ ǣǼŸŸ_Ǽ`˧ˡ˧ʳ˟ˡONjŸNjsʳ ōNjOÌˡ˟ˠˤʳ
`ˠˤ˟ʳˡ˥ONjŸNjsÞŘ®ɳˡ˟ˠˣ˚ˠˤǼŸ`ˠ˥˥ʳˠ˟
ONjŸNjsÞŘ®ɳˡ˟ˠˤ˚ˠ˥ʳrŎƼĶŸɴssNŸǣǼǣ Own Funds Sundry Debtors
ƼNjŸƼŸNjǼÞŸŘǼŸǼŸǼĶOŸǣǼɠǣǼˠˠʳ˦˨̇ÞŘ ǻÌsŘsǼɠŸNjǼÌŸ¯ǼÌsNŸŎƼŘɴÞŘONjsǣs_ ǢȖŘ_Njɴ _sEǼŸNjǣ ¯ŸNj ǼÌs NŸŎƼŘɴ ǣǼŸŸ_
®ɳ ˡ˟ˠˤ˚ˠ˥ OŸŎƼNjs_ ǼŸ ˠˠʳˢ˥̇ ÞŘ ®ɳ Eɴ˧ʳˤˢ̇¯NjŸŎ`˦˧˟ONjŸNjsǣŸŘōNjOÌ Ǽ ` ˨ˣʳˠˠ ONjŸNjs ¯ŸNj  ˠˡ˚ŎŸŘǼÌ ƼsNjÞŸ_
ˡ˟ˠˣ˚ˠˤʳ ˢˠʰˡ˟ˠˤǼŸ`˧ˣ˥ONjŸNjsǣŸŘōNjOÌˢˠʰ sŘ_Þض ōNjOÌ ˡ˟ˠ˥ʳ ^sEǼŸNj ǼȖNjŘŸɚsNj
ˡ˟ˠ˥ʳ ǣǼŸŸ_ Ǽ ˡˠ _ɴǣ ¯ŸNj  ˠˡ˚ŎŸŘǼÌ
Other Expenses ƼsNjÞŸ_ sŘ_Þض ōNjOÌ ˡ˟ˠ˥ʳ ®ŸNj ǼÌs
ʹrɮOĶȖ_Þض_ɚsNjǼÞǣsŎsŘǼŘ_ǢĶsǣ NJsǼȖNjŘ ŸŘ ŗsǼ ɟŸNjǼÌ Ÿ¯ ǼÌs NŸŎƼŘɴ OŸNjNjsǣƼŸŘ_Þض ƼsNjÞŸ_ Ÿ¯ ǼÌs ƼNjsɚÞŸȖǣ
ƻNjŸŎŸǼÞŸŘrɮƼsŘǣsǣʺ ¯ŸNj  ˠˡ˚ŎŸŘǼÌ ƼsNjÞŸ_ sŘ_Þض ōNjOÌ ɴsNjʰǼÌsǣŎsǣǼŸŸ_Ǽˠˣ_ɴǣʳ
ǻÌs NŸŎƼŘɴ˅ǣ ŸǼÌsNj sɮƼsŘǣsǣ ˡ˟ˠ˥ÞŘONjsǣs_ǼŸˠ˧ʳ˦̇ǣOŸŎƼNjs_ǼŸ
ʹOŸŎƼNjÞǣÞض ƼŸɠsNj Ř_ ¯ȖsĶʰ NjsŘǼʰ ˠˤʳˤ̇ ¯ŸNj ǼÌs OŸNjNjsǣƼŸŘ_Þض ƼsNjÞŸ_ Ÿ¯ Cash and Bank Balances
Ķs¶Ķ Ř_ ƼNjŸ¯sǣǣÞŸŘʰ ¯NjsÞ¶ÌǼ ŸȖǼɠNj_ǣʰ ǼÌsƼNjsɚÞŸȖǣɴsNjʳ NǣÌŘ_EŘĨEĶŘOsǣ¯ŸNjǼÌsNŸŎƼŘɴ
OŸŎŎȖŘÞOǼÞŸŘ sɮƼsŘǣsǣʰ NjsƼÞNjǣʰ ǣǼŸŸ_Ǽ`˥ˠʳˡ˟ONjŸNjsʳ
ǼNjɚsĶĶÞض Ř_ ŸǼÌsNj ŎÞǣOsĶĶŘsŸȖǣ Loan Funds
sɮƼsŘǣsǣʺ ¶Njsɠ ˠˡʳ˨ˤ̇ ¯NjŸŎ ` ˡˠˣʳˣˡ ǻÌs _sEǼ ƼŸNjǼ¯ŸĶÞŸ Ÿ¯ ǼÌs NŸŎƼŘɴ Loans and Advances
ONjŸNjs ÞŘ ˡ˟ˠˣ˚ˠˤ ǼŸ ` ˡˣˡʳˠ˧ ONjŸNjs ÞŘ OŸŎƼNjÞǣsǣ ǣsOȖNjs_ʰ Njs_ssŎEĶsʰ ŘŸŘ˚ ĵŸŘǣ Ř_ _ɚŘOsǣ ¯ŸNj ǼÌs NŸŎƼŘɴ
ˡ˟ˠˤ˚ˠ˥ʳŷǼÌsNjrɮƼsŘǣsǣǣƼsNjOsŘǼ¶s OŸŘɚsNjǼÞEĶs _sEsŘǼȖNjsǣ ŎŸȖŘǼÞض ǼŸ ǣǼŸŸ_Ǽ`ˡ˥ˡʳ˥ˠONjŸNjsǣŸŘōNjOÌˢˠʰ
ǼŸŗsǼǢĶsǣÞŘONjsǣs_¯NjŸŎˠˣʳˡˣ̇ÞŘ®ɳ `ˣˤ˟ʳ˧ˡONjŸNjsʳ ˡ˟ˠ˥ʰ¶ÞŘǣǼ`ˡ˟˧ʳˡ˟ONjŸNjsǣŸŘōNjOÌ
ˡ˟ˠˣ˚ˠˤǼŸˠˣʳ˦ˡ̇ÞŘ®ɳˡ˟ˠˤ˚ˠ˥ʳ ˢˠʰˡ˟ˠˤʳ
Net Block Ÿ¯ǼÌsNŸŎƼŘɴǣŸŘōNjOÌ
^NjÞɚsŘ Eɴ Ř ŸEĠsOǼÞɚs ǼŸ ¶sŘsNjǼs  ˢˠʰˡ˟ˠ˥ǣǼŸŸ_Ǽ`ˠʰ˟˥˦ʳ˦˧ONjŸNjsʳ Other Liabilities and Provisions
¶NjsǼsNj ENjŘ_˚ƼȖĶĶʰ ǼÌs _ɚsNjǼÞǣsŎsŘǼ ŷǼÌsNj ĶÞEÞĶÞǼÞsǣ Ř_ ƼNjŸɚÞǣÞŸŘǣ ¯ŸNj ǼÌs
Ř_ ǢĶsǣ ƻNjŸŎŸǼÞŸŘ rɮƼsŘǣsǣ Ÿ¯ Net Working Capital Ÿ¯ ǼÌs NŸŎƼŘɴ NŸŎƼŘɴǣǼŸŸ_Ǽ`ˠˡ˥ʳ˥ˠONjŸNjsʳ
ǼÌs NŸŎƼŘɴ ÞŘONjsǣs_ Eɴ ˠˠʳˢ˧̇ ǣǼŸŸ_ Ǽ ` ˥ˡʳˤ ONjŸNjs ǣ ŸŘ ōNjOÌ ˢˠʰ
¯NjŸŎ ` ˠ˧˟ʳ˨˦ ONjŸNjs ÞŘ ®ɳ ˡ˟ˠˣ˚ ˡ˟ˠ˥ʳǻÌÞǣǼNjŘǣĶǼsǣǼŸˠˣ_ɴǣŸ¯ɠŸNjĨÞض
ˠˤ ǼŸ ` ˡ˟ˠʳˤ˥ ONjŸNjs ÞŘ ®ɳ ˡ˟ˠˤ˚ˠ˥ʳ OƼÞǼĶǣ¶ÞŘǣǼˠ˦_ɴǣÞŘ®ɳˡ˟ˠˣ˚ˠˤʳ
®ȖNjǼÌsNjʰ _ɚsNjǼÞǣsŎsŘǼ sɮƼsŘ_ÞǼȖNjs
ǣ ƼsNjOsŘǼ¶s ǼŸ ŘsǼ ǣĶsǣ ÞŘONjsǣs_ Working Capital (`ÞŘONjŸNjsǣʺ

ǼŸ ˠˡʳˡˤ̇ ÞŘ ®ɳ ˡ˟ˠˤ˚ˠ˥ OŸŎƼNjs_ ǼŸ Particulars 2015-16 2014-15
ˠˡʳ˟ˡ̇ÞŘ®ɳˡ˟ˠˣ˚ˠˤʳ Current Assets
ÝŘɚsŘǼŸNjÞsǣ    ˠ˧ˡʳ˥ˤ   ˠ˧ˤʳˡ˟
Margins ǻNj_sNJsOsÞɚEĶsǣ   ˨ˣʳˠˠ   ˤ˦ʳˣˡ
ŷƼsNjǼÞض rDÝ^ǻ ŎNj¶ÞŘ Ÿ¯ ǼÌs ĵŸŘǣŘ__ɚŘOsǣ   ˡˤʳ˥ˡ   ˢˠʳ˦ˣ
NŸŎƼŘɴ ¶Njsɠ ˠ˦˟ EǣÞǣ ƼŸÞŘǼǣ ¯NjŸŎ ŷǼÌsNjǣǣsǼǣ    ˥ʳˤ˦   ˤʳ˟ˣ
308.95 279.40
ˠˡʳ˦̇ÞŘ®ɳˡ˟ˠˣ˚ˠˤǼŸˠˣʳˣ̇ÞŘ®ɳˡ˟ˠˤ˚
Current Liabilities
ˠ˥ ŸɠÞض ǼŸ OÌضs ÞŘ ǣĶsǣ ŎÞɮ Ř_ ǻNj_sƻɴEĶsǣ    ˠ˥˟ʳ˧ˣ   ˠˢˡʳˣ˥
_sONjsǣs ÞŘ Njɠ ŎǼsNjÞĶ Ř_ ƼOĨ¶Þض ŷǼÌsNjNȖNjNjsŘǼĵÞEÞĶÞǼÞsǣ   ˤ˟ʳ˟ˡ   ˣˡʳˣ˧
ƼNjÞOsǣʳ ƻǻ ǣǼŸŸ_ Ǽ ` ˠˤ˦ʳ˨ˤ ONjŸNjs ÞŘ ƻNjŸɚÞǣÞŸŘǣ    ˢˤʳˤ˨   ˢˢʳ˥˦
®ɳ ˡ˟ˠˤ˚ˠ˥ ǣ OŸŎƼNjs_ ǼŸ ` ˠˡˠʳˠˡ 246.45 208.61
ONjŸNjsÞŘ®ɳˡ˟ˠˣ˚ˠˤŸŘOOŸȖŘǼŸ¯EsǼǼsNj Net Working Capital 62.50 70.79

ŸƼsNjǼÞضƼNjŸʩǼŘ_ĶŸɠsNjʩŘŘOsOŸǣǼǣʳ Sundry Creditors for the Company stood at ` 160.84 crore as on March 31, 2016,
against ` 132.46 crore as on March 31, 2015
ˤ˟ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

SUSTAINABILITY PRACTICES ÞǼǼŸȖŘ_sNjǣǼŘ_OǣÌʪŸɠOɴOĶsŸ¯ÝŘ_ÞŘ ˒ ËȖŎŘNjsǣŸȖNjOsǣNjÞǣĨʲǻÌsNŸŎƼŘɴ


Ǽ ğɴŸǼÌɴ ĵEŸNjǼŸNjÞsǣ ĵÞŎÞǼs_ʰ OŸŘǣȖŎsNjǣʳ OŸŘǣǼŘǼĶɴ ŎŸǼÞɚǼsǣ Ř_ ƼNjŸɚÞ_sǣ
ǣȖǣǼÞŘEÞĶÞǼɴÞǣŘŸǼĠȖǣǼEŸȖǼ_sɚsĶŸƼÞض ǼNjÞŘÞضǼŸÞǼǣsŎƼĶŸɴssǣʰsǣƼsOÞĶĶɴǼÌs
ƼNjŸʩǼ˚_NjÞɚsŘEȖǣÞŘsǣǣŎŸ_sĶʱÞǼÞǣĶǣŸ ˒ NŸŎƼĶÞŘOsNjÞǣĨʲǻÌsNŸŎƼŘɴsŘǣȖNjsǣ ǣĶsǣ ¯ŸNjOsʰ ǼŸ ÞŎƼNjŸɚs ƼsNj¯ŸNjŎŘOs
EŸȖǼ ǼÌs NŸŎƼŘɴ˅ǣ OŸŎŎÞǼŎsŘǼ ÞǼ ¯ŸĶĶŸɠǣ ĶĶ ǣǼǼȖǼŸNjɴ Ř_ Njs¶ȖĶǼŸNjɴ ǣǼŘ_Nj_ǣ Ř_ OŸŘǼNjÞEȖǼs ǼŸɠNj_ǣ
ǼŸ ¶Þɚs EOĨ ǼŸ ǼÌs OŸŎŎȖŘÞǼɴ Eɴ OŸŎƼĶÞŘOsǣʰ ÞŘOĶȖ_Þض OÌضsǣ ÞŘ Ǽɮ ¶NjŸɠǼÌʳ
OÌŘŘsĶÞض ¯ȖŘ_ǣ ÞŘ  ƼNjsOÞǣs ŎŘŘsNjʳ ĶɠǣǣŘ_ɠÌsŘŘss_s_ʳ
ɟsNjsOŸ¶ŘÞǣsǼÌsÞŎƼŸNjǼŘOsŸ¯ŎĨÞض ˒ ǢsǣŸŘĶ NjÞǣĨʲ ǻÌs NŸŎƼŘɴ Ìǣ 
ƼNjŸǣƼsNjÞǼɴ ǣOĶEĶs Ř_ ǣȖǣǼÞŘEĶs ¯ŸNj ˒ NJɠ ŎǼsNjÞĶ NjÞǣĨʲ ÝŘEÞĶÞǼɴ ǼŸ ƼNjŸOȖNjs ɠsĶĶ˚_ÞɚsNjǣÞʩs_ ƼNjŸ_ȖOǼ ƼŸNjǼ¯ŸĶÞŸ ǼÌǼ
ŸȖNj ǣǼĨsÌŸĶ_sNjǣʰ sŎƼĶŸɴssǣʰ ǣȖƼƼĶÞsNjǣʰ Njɠ ŎǼsNjÞĶǣ ÞŘ ǼÞŎs Ř_ Ǽ  ĶŸɠ OŸǣǼ ÌsĶƼǣOŸȖŘǼsNjǣsǣŸŘĶȖƼǣŘ__ŸɠŘǣ
EȖǣÞŘsǣǣ ƼNjǼŘsNjǣ Ř_ ǣŸOÞsǼɴ Ǽ ĶNj¶sʳ ɠŸȖĶ_ ÌŎƼsNj ƼNjŸ_ȖOǼÞŸŘ Ř_ Ķs_ ǼŸ ÞŘŘɴŸŘsOǼs¶ŸNjɴʳ
ǻÌs ŎŸǣǼ s¯¯sOǼÞɚs ɠɴ Ÿ¯ _ŸÞض ǼÌÞǣ Þǣ Njs_ȖOǼÞŸŘ ÞŘ ŎNj¶ÞŘǣʳ ǻÌs NŸŎƼŘɴ
Eɴ NjsÞŘ¯ŸNjOÞض ŸȖNj EȖǣÞŘsǣǣ ŎŸ_sĶ ŸŘ sŎƼĶŸɴǣ ÞŘ_ÞɚÞ_ȖĶǣ ÌɚÞض ǣŸĶÞ_ INTERNAL CONTROL AND SYSTEMS
ǼÌsŸŘsÌŘ_ʰŘ_ȖǼÞĶÞǣÞضǼÌsƼNjŸOss_ǣ sɮƼsNjÞsŘOs ÞŘ ɚsŘ_ŸNj ŎضsŎsŘǼ ǻÌs NŸŎƼŘɴ Ìǣ _sLJȖǼs ÞŘǼsNjŘĶ
ǼŸ ÞŎƼNjŸɚs ǼÌs ĶÞɚsǣ Ÿ¯ ƼsŸƼĶs ŸŘ ǼÌs ǼŸ sŘǣȖNjs ǼÌs ǣǼs_ɴ ǣȖƼƼĶɴ Ÿ¯ Njɠ OŸŘǼNjŸĶ ǣɴǣǼsŎǣ Ř_ ƼNjŸOs_ȖNjsǣ ÞŘ
ŸǼÌsNjʳ ǻÌs NŸŎƼŘɴ˅ǣ NǢNJ ÞŘÞǼÞǼÞɚsǣ ŎǼsNjÞĶǣ ¯ŸNj ǣŎŸŸǼÌ ŸƼsNjǼÞŸŘǣʳ ŷȖNj ƼĶOs ¯ŸNj s¯¯sOǼÞɚs Ř_ ǣŎŸŸǼÌ OŸŘ_ȖOǼ
ȖŘÞ¯ɴ EȖǣÞŘsǣǣ Ř_ ǣŸOÞĶ ÞŘǼsNjsǣǼǣʳ ĶŸŘ¶˚ǼsNjŎ EȖǣÞŘsǣǣ NjsĶǼÞŸŘǣÌÞƼǣ ɠÞǼÌ Ÿ¯ EȖǣÞŘsǣǣ Ř_ ǼŸ ŎssǼ sɮÞ¶sŘOÞsǣ Ÿ¯
ɟs ĶǣŸ ɠŸNjĨ ǼŸɠNj_ǣ Njs_ȖOÞض ŸȖNj Ķs_ÞضǣȖƼƼĶÞsNjǣsŘEĶsȖǣǼŸŘs¶ŸǼÞǼs ŸƼsNjǼÞŸŘŘ_¶NjŸɠǼÌʳǻÌsĨsɴEȖǣÞŘsǣǣ
sŘɚÞNjŸŘŎsŘǼĶ ¯ŸŸǼƼNjÞŘǼ Eɴ ƼNjŸOȖNjÞض ǼÌs ĶŸɠsǣǼ ƼŸǣǣÞEĶs ƼNjÞOsǣʳ ®ȖNjǼÌsNjʰ ǼÌs ƼNjŸOsǣǣsǣ Ìɚs EssŘ _ŸOȖŎsŘǼs_ʳ
NjɠŎǼsNjÞĶǣ¯NjŸŎǣȖǣǼÞŘEĶsǣŸȖNjOsǣʳ NŸŎƼŘɴ Ìǣ ĶǣŸ sŘǼsNjs_ ÞŘǼŸ ĶŸŘ¶˚ ǻÌs ǼNjŘǣOǼÞŸŘǣ Njs NjsOŸNj_s_ Ř_
ǼsNjŎ OŸŘǼNjOǼǣ ɠÞǼÌ Njɠ ŎǼsNjÞĶ Ř_ NjsƼŸNjǼs_ ÞŘ OŸŘ¯ŸNjŎÞǼɴ ɠÞǼÌ ¶sŘsNjĶĶɴ
^ȖNjÞض ǼÌs ɴsNjʰ ǼÌs NŸŎƼŘɴ ǣsŘǼ ƼOĨ¶ÞضŎǼsNjÞĶǣȖƼƼĶÞsNjǣǼŸOÌÞsɚs OOsƼǼs_ OOŸȖŘǼÞض ƼNjOǼÞOsǣʳ ǻÌs
ʩŘŘOÞĶ Þ_ ǼŸ sNjǼÌLJȖĨs ɚÞOǼÞŎǣ ÞŘ OŸǣǼǣɚÞضǣŘ_sŘǣȖNjsNjs¶ȖĶNjǣȖƼƼĶɴʳ ÞŘǼsNjŘĶOŸŘǼNjŸĶǣɴǣǼsŎǣŘ_ƼNjŸOs_ȖNjsǣ
ŗsƼĶ Ř_ ʪŸŸ_ ɚÞOǼÞŎǣ ÞŘ NÌsŘŘÞʳ ÝŘ sŘǣȖNjs NjsĶÞEÞĶÞǼɴ Ÿ¯ ʩŘŘOÞĶ NjsƼŸNjǼÞضʰ
NÌsŘŘÞʰɠsĶǣŸȖŘ_sNjǼŸŸĨNjsǣƼŸŘǣÞEÞĶÞǼɴ ˒ ǢȖƼƼĶɴ OÌÞŘ NjÞǣĨʲ ǻÌs NŸŎƼŘɴ OŸŎƼĶÞŘOsɠÞǼÌǼÌsNŸŎƼŘɴ˅ǣƼŸĶÞOÞsǣ
Ÿ¯_ÞǣǼNjÞEȖǼÞضǼÌsNŸŎƼŘɴ˅ǣƼNjŸ_ȖOǼǣʳ Ìǣ ÞŘɚsǣǼs_ ÞŘ _sɚsĶŸƼÞض _ɚŘOs_ Ř_ƼNjOǼÞOsǣʰ¶ŸɚsNjŘŎsŘǼĶNjs¶ȖĶǼÞŸŘǣ
ÞŘ¯ŸNjŎǼÞŸŘǼsOÌŘŸĶŸ¶ɴǣŸ¯ǼɠNjsǼÌǼÞǣ Ř_ǣǼǼȖǼsǣʳÝŘǼsNjŘĶȖ_ÞǼÞǣOŸŘ_ȖOǼs_
RISK MANAGEMENT OƼEĶsŸ¯_sŎŘ_¯ŸNjsOǣǼÞضEǣs_ŸŘ EɴÞŘ_sƼsŘ_sŘǼʩNjŎŸ¯Ȗ_ÞǼŸNjǣʳÝŘǼsNjŘĶ
NJÞǣĨ Þǣ Ř ÞŘÌsNjsŘǼ ¯sǼȖNjs Ÿ¯ Řɴ ÌÞǣǼŸNjÞOĶ _Ǽʳ ǻÌÞǣ Þǣ ĶÞ¶Řs_ ɠÞǼÌ Njɠ Ȗ_ÞǼŸNjǣ Njs¶ȖĶNjĶɴ OÌsOĨ ǼÌs _sLJȖOɴ
EȖǣÞŘsǣǣʳ ɟs ŘĶɴǣs ǼÌs ȖŘOsNjǼÞŘǼÞsǣ ŎǼsNjÞĶ ǣŸȖNjOÞض Ř_ ŎŘȖ¯OǼȖNjÞضʰ Ÿ¯ ǼÌs ǣɴǣǼsŎʰ ǼÌsÞNj ŸEǣsNjɚǼÞŸŘǣ Njs
ÞŘ ŸȖNj EȖǣÞŘsǣǣ NjÞǣÞض ŸȖǼ Ÿ¯ ɚNjÞŸȖǣ Ķs_Þض ǼŸ ÞŎƼNjŸɚs_ ÞŘɚsŘǼŸNjɴ NjsɚÞsɠs_ Eɴ ǼÌs ŎضsŎsŘǼ Ř_
ÞŘǼsNjŘĶ Ř_ sɮǼsNjŘĶ ¯OǼŸNjǣ Ř_ ŎضsŎsŘǼʰ ŸƼǼÞŎȖŎ ȖǼÞĶÞǣǼÞŸŘ NjsŎs_ÞĶ ŎsǣȖNjsǣʰ ǣ ŘsOsǣǣNjɴʰ
ǼÌsÞNj ÞŎƼOǼ ŸŘ ŸȖNj ƼNjŸʩǼEÞĶÞǼɴʳ NJÞǣĨ Ÿ¯ NjsǣŸȖNjOsǣ ¯ŸNj ŎŘȖ¯OǼȖNjÞضʰ Njs ǼĨsŘʳ ÝŘǼsNjŘĶ Ȗ_ÞǼŸNjǣ NjsƼŸNjǼ
ŎضsŎsŘǼ Þǣ Ř ÞŘǼs¶NjĶ ƼNjǼ Ÿ¯ ŸȖNj ǣŎŸŸǼÌ _ÞǣǼNjÞEȖǼÞŸŘ Ÿ¯ ƼNjŸ_ȖOǼǣ Ř_ _ÞNjsOǼĶɴ ǼŸ ǼÌs NÌÞNjŎŘ Ÿ¯ ǼÌs Ȗ_ÞǼ
NŸŎƼŘɴ Ř_ ÞŘɚŸĶɚsǣ ǣǼNjsضǼÌsŘÞض ÞŎƼNjŸɚsŎsŘǼÞŘǼÌsNŸŎƼŘɴ˅ǣɠŸNjĨÞض NŸŎŎÞǼǼssǼŸŎÞŘǼÞŘÞǼǣŸEĠsOǼÞɚÞǼɴŘ_
ŸƼsNjǼÞŸŘǣ ǼÌNjŸȖ¶Ì _sLJȖǼs ƼĶŘŘÞض OƼÞǼĶʳǻÌsNŸŎƼŘɴÌǣĶǣŸÞŘǼNjŸ_ȖOs_ ÞŘ_sƼsŘ_sŘOsʳ
Ř_ ȖŘ_sNjǼĨÞض OǼÞŸŘǣ ɠÞǼÌ  ¯ŸOȖǣ  ǼNjŘǣƼŸNjǼ ŎŸ_ȖĶs ¯ŸNj ǣsNjɚÞOs ĶsɚsĶ
ŸŘ ¶NjŸɠǼÌ Ř_ sŘÌŘOÞض ǣÌNjsÌŸĶ_sNj ÞŎƼNjŸɚsŎsŘǼ Ř_ EsǼǼsNj OŸŘǼNjŸĶʳ ɟs
ɚĶȖsʳ ÞŘÞǼÞǼs_ ¯ŸOȖǣ ŸŘ OÌŘŘsĶ˚ɠÞǣs ǣsNjɚÞOs
ĶsɚsĶǼŸsŘǣȖNjsŎÞŘÞŎĶǣǼŸOĨŸȖǼǣʳ
˒ rOŸŘŸŎÞO NjÞǣĨʲ  ǼŸȖ¶Ì ŎONjŸ˚
sOŸŘŸŎÞO ǣOsŘNjÞŸ NjsǣȖĶǼǣ ÞŘ ĶŸɠ ˒ NŸŎƼsǼÞǼÞŸŘ NjÞǣĨʲ ǻÌs NŸŎƼŘɴ
sŎƼĶŸɴŎsŘǼ ĶsɚsĶǣʰ ÌÞ¶Ì ÞŘʪǼÞŸŘ sŘǣȖNjsǣ ŎŘȖ¯OǼȖNjs Ÿ¯ ÌÞ¶Ì LJȖĶÞǼɴ
Ř_ Ķsǣǣ ŎŸŘsɴ ÞŘ OŸŘǣȖŎsNjǣ˅ ÌŘ_ʰ ƼNjŸ_ȖOǼǣ ɠÞǼÌ ǣȖƼsNjÞŸNj ƼsNj¯ŸNjŎŘOs
Ķs_ÞضǼŸĶŸɠsNj_sŎŘ_ʳǻÌsOȖNjNjsŘǼ Ř_ ȖŘ_sNjǼĨsǣ sɮǼsŘǣÞɚs ŎNjĨsǼÞض
ŎONjŸ˚sOŸŘŸŎÞO ǣOsŘNjÞŸ ÞŘ ǼÌs Ř_ _ɚsNjǼÞǣÞض OǼÞɚÞǼÞsǣ ǼŸ ONjsǼs
OŸȖŘǼNjɴÞǣǣǼEĶsŘ_ƼŸǣÞǼÞɚsɠÞǼÌĶŸɠ ɠNjsŘsǣǣ Ř_ NjsOĶĶʳ ǻÌs NŸŎƼŘɴ
ÞŘʪǼÞŸŘʳ ōŸNjsŸɚsNjʰ ǼÌs NŸŎƼŘɴ Ìǣ ȖǼÞĶÞǣsǣ _ÞɚsNjǣs OŸŎŎȖŘÞOǼÞŸŘ Ŏs_Þ
_ÞɚsNjǣÞʩs_ƼNjŸ_ȖOǼǣǼNjǼs¶ɴʰsŘEĶÞض ¯ŸNjÞǼǣƻŸɠsNjENjŘ_ǣʳ
NŸNjƼŸNjǼsŷɚsNjɚÞsɠ ƻsNj¯ŸNjŎŘOs Governance ®ÞŘŘOÞĶǢǼǼsŎsŘǼǣ ˤˠ

Corporate Information
BOARD OF DIRECTORS COST AUDITORS
M. P. Ramachandran R. Nanabhoy & Co.
NÌÞNjŎŘ˓ōضÞض^ÞNjsOǼŸNj ʹ®ÞNjŎNJs¶ÞǣǼNjǼÞŸŘŗȖŎEsNj˟˟˟˟ˠ˟ʺ
ʹ^Ýŗʲ˟˟ˤˤˢˣ˟˥ʺ
REGISTERED OFFICE
K. Ullas Kamath Jyothy Laboratories Limited
ğŸÞŘǼōضÞض^ÞNjsOǼŸNj˓NÌÞs¯®ÞŘŘOÞĶŷ¯ʩOsNj ȕĠĶËŸȖǣsʰNJŎĨNjÞǣÌŘōŘ_ÞNjNJŸ_ʰ
ʹ^Ýŗʲ˟˟ˤ˟˥˥˧ˠʺ ħŸŘ_ÞɚÞǼʰŷ¯¯Ř_ÌsNjÞħȖNjĶNJŸ_ʰ
Ř_ÌsNjÞrǣǼʰōȖŎEÞ˚ˣ˟˟˟ˤ˨ʰōÌNjǣÌǼNjʳ
S. Raghunandan ǻsĶsƼÌŸŘsʲ̛˨ˠ˚ˡˡ˚˥˥˧˨ˡ˧˟˟
ɟÌŸĶsǻÞŎs^ÞNjsOǼŸNj˓NÌÞs¯rɮsOȖǼÞɚsŷ¯ʩOsNjʹȕƼǼŸˡˢʳ˟ˤʳˡ˟ˠ˥ʺ ®ɮʲ̛˨ˠ˚ˡˡ˚˥˥˧˨ˡ˧˟ˤ
ʹ^Ýŗʲ˟ˡˡ˥ˢ˧ˣˤʺ rŎÞĶʲÞŘ¯Ÿ˔ĠɴŸǼÌɴʳOŸŎ
ɟsEǣÞǼsʲɠɠɠʳĠɴŸǼÌɴĶEŸNjǼŸNjÞsǣʳOŸŎ
M. R. Jyothy
ɟÌŸĶsǻÞŎs^ÞNjsOǼŸNj CORPORATE IDENTITY NUMBER (CIN)
ʹ^Ýŗʲ˟˟ˤ˦ˠ˧ˡ˧ʺ ĵˡˣˡˣ˟ōËˠ˨˨ˡƻĵNˠˡ˧˥ˤˠ

Nilesh B. Mehta
NJrµÝǢǻNJNJ˓ǢËNJrǻNJŗǢ®rNJµrŗǻ
ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNj
Link Intime India Private Limited
ʹ^Ýŗʲ˟˟ˠ˨˨˟˦ˠʺ
NÝŗ˚ȕ˥˦ˠ˨˟ōËˠ˨˨˨ƻǻNˠˠ˧ˢ˥˧
N˚ˠˢʰƻŘŘĶĶǢÞĶĨōÞĶĶǣNŸŎƼŸȖŘ_ʰ
K. P. Padmakumar
ĵʳDʳǢōNj¶ʰDÌŘ_ȖƼʹɟsǣǼʺʰōȖŎEÞ˚ˣ˟˟˟˦˧ʰōÌNjǣÌǼNjʳ
ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNj
ǻsĶʳʲ̛˨ˠ˚ˡˡ˚ˡˤ˨˥ˢ˧ˢ˧ʰ̛˨ˠ˚ˡˡ˚ˡˤ˨ˣ˥˨˦˟
ʹ^Ýŗʲ˟˟˟ˡˢˠ˦˥ʺ
®ɮʲ̛˨ˠ˚ˡˡ˚ˡˤ˨ˣ˥˨˥˨
rŎÞĶʲNjŘǼʳÌsĶƼ_sǣĨ˔ĶÞŘĨǼÞŎsʳOŸʳÞŘ
Bipin R. Shah
ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNj
ʹ^Ýŗʲ˟˟˟˟˥˟˨ˣʺ DEBENTURE TRUSTEE
Axis Trustee Services Limited
R. Lakshminarayanan NÝŗ˚ȕ˦ˣ˨˨˨ōËˡ˟˟˧ƻĵNˠ˧ˡˡ˥ˣ
ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNj ɮÞǣËŸȖǣsʰˡŘ_®ĶŸŸNjʰ
ʹ^Ýŗʲ˟˟ˡˢ˧˧˧˦ʺ ɟ_ÞÝŘǼsNjŘǼÞŸŘĶNsŘǼNjsʰ
ƻŘ_ȖNjضDȖ_ÌĨNjōNj¶ʰ
ɟŸNjĶÞʰōȖŎEÞ˚ˣ˟˟˟ˡˤ
COMPANY SECRETARY
ƻÌŸŘsʲ˟ˡˡ˚ˡˣˡˤˤˡˡˤʹ^ʺ
M. L. Bansal ʹȕƼǼŸˡˢʳ˟ˤʳˡ˟ˠ˥ʺ
ɟsEǣÞǼsʲɠɠɠʳɮÞǣǼNjȖǣǼssʳOŸŎ
ʹōsŎEsNjǣÌÞƼŗŸʳ®ˡˡ˨˦ʺ

Shreyas Trivediʹɠʳsʳ¯ʳˡˢʳ˟ˤʳˡ˟ˠ˥ʺ
ʹōsŎEsNjǣÌÞƼŗŸʳˠˡ˦ˢ˨ʺ

STATUTORY AUDITORS
S R B C & Co LLP
ʹ®ÞNjŎNJs¶ÞǣǼNjǼÞŸŘŗŸʳˢˡˣ˨˧ˡrˀrˢ˟˟˟˟ˢʺ

INTERNAL AUDITORS
Mahajan And Aibara Chartered Accountants LLP
ʹ®ÞNjŎNJs¶ÞǣǼNjǼÞŸŘŗŸʳˠ˟ˤ˦ˣˡɟʺ
52 Jyothy Laboratories Limited
Annual Report 2015-16

DIRECTORS’ REPORT

To,
The Members,

It is our pleasure to present the 25th Annual Report of your Company together with the Audited Financial Statements for the
ʩŘŘOÞĶɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥ʳ

FINANCIAL PERFORMANCE
ɳŸȖNjNŸŎƼŘɴ˅ǣʩŘŘOÞĶƼsNj¯ŸNjŎŘOs¯ŸNjǼÌsʩŘŘOÞĶɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥OŸŎƼNjs_ɠÞǼÌƼNjsɚÞŸȖǣʩŘŘOÞĶɴsNjÞǣ
summarised below:
(` in Crore)

Financial results Financial Year ended Financial Year ended


March 31, 2016 March 31, 2015

Net Sales ˠʰˤ˦ˢʳˤˠ ˠʰˣˡ˧ʳˡ˦

Other Income ˠˠʳˢ˧ ˠ˥ʳˡˤ

Earnings before interest, tax, depreciation, amortization and impairment ˡˡ˦ʳˠ˨ ˠ˦ˡʳˡˤ

Interest & Finance Charges/(Income) Net ʹˣˡʳˠ˥ʺ ʹˣ˦ʳˠˢʺ

Depreciation, Amortization and Impairment- Tangibles ˡˡʳˣ˧ ˡˣʳˡ˦

Depreciation and Amortization- Intangibles ˣˤʳˣ˥ ˣ˥ʳˠ˟

Exceptional Item - ˡʳ˟˨

ƻNjŸʩǼEs¯ŸNjsǼɮ ˡ˟ˠʳˣˠ ˠˣ˥ʳ˨ˡ

ƻNjŸɚÞǣÞŸŘ¯ŸNjǼɮ

- Current tax- (MAT) ˣˢʳˠˡ ˢ˟ʳ˦ˤ

- MAT Credit entitlement ʹˡ˧ʳ˥˟ʺ ʹˢ˟ʳ˦ˤʺ

˚rɮOsǣǣǼɮƼNjŸɚÞǣÞŸŘˀōǻONjs_ÞǼNjsɚsNjǣĶŸ¯sNjĶÞsNjɴsNjǣ - ˣʳˠˢ

- Deferred Tax change ˡˣʳˤˢ -

ƻNjŸʩǼ¯ǼsNjǼɮ ˠ˥ˡʳˢ˥ ˠˣˡʳ˦˨

Balance as per last Balance Sheet

– Brought forward ˡˠʳ˟˨ ˡˡʳˡ˧

DĶŘOsɚÞĶEĶs¯ŸNjƼƼNjŸƼNjÞǼÞŸŘǣ ˠ˧ˢʳˣˤ ˠ˥ˤʳ˟˦

Appropriations:

^ÞɚÞ_sŘ_ƻÞ_ʹÝŘǼsNjÞŎʺ ˦ˡʳˣˤ -

NŸNjƼŸNjǼs^ÞɚÞ_sŘ_ǻɮŸŘÝŘǼsNjÞŎ^ÞɚÞ_sŘ_ ˠˣʳ˦ˤ -

ƻNjŸƼŸǣs_^ÞɚÞ_sŘ_ʹ®ÞŘĶʺ ˠ˧ʳˠˠ ˦ˡʳˣˠ

NŸNjƼŸNjǼs^ÞɚÞ_sŘ_ǻɮŸŘƼNjŸƼŸǣs__ÞɚÞ_sŘ_ ˢʳ˥˨ ˠˣʳ˦ˣ

^sƼNjsOÞǼÞŸŘǣƼsNjǢOÌs_ȖĶsÝÝŸ¯NŸŎƼŘÞsǣOǼʰˡ˟ˠˢ - ˢʳˠˠ

ǻNjŘǣ¯sNjǼŸµsŘsNjĶNJsǣsNjɚs - -

ǻNjŘǣ¯sNjǼŸ^sEsŘǼȖNjsNJs_sŎƼǼÞŸŘNJsǣsNjɚs ˣˤʳ˥˟ ˤˢʳ˦ˡ

DĶŘOsNNjNjÞs_®ŸNjɠNj_ʹƻNjŸʩǼŘ_ĵŸǣǣOOŸȖŘǼʺ ˡ˧ʳ˧˥ ˡˠʳ˟˨

Earning Per Share (Basic) (In `) ˧ʳ˨˦ ˦ʳ˧˨

Earning Per Share (Diluted) (In `) ˧ʳ˧ˣ ˦ʳ˧ˢ

^ÞɚÞ_sŘ_ƻsNjǢÌNjsŸ¯¯OsɚĶȖsŸ¯` 1/- (In `) ˤʳ˟˟ ˣʳ˟˟


NŸNjƼŸNjǼsŷɚsNjɚÞsɠ Performance Governance Financial Statements ˤˢ

PERFORMANCE HIGHLIGHTS your Company) amalgamated with Jyothy Consumer Products


The gross sales (including Excise Duty) from operations on ōNjĨsǼÞض ĵÞŎÞǼs_ ˚ ğNƻōĵ ʹǢǼsƼ _ŸɠŘ ǣȖEǣÞ_ÞNjɴ Ÿ¯ ɴŸȖNj
ǣǼŘ_ĶŸŘsEǣÞǣŸ¯ɴŸȖNjNŸŎƼŘɴ¯ŸNjǼÌsʩŘŘOÞĶɴsNjˡ˟ˠˤ˚ NŸŎƼŘɴ Þʳsʳ ɟÌŸĶĶɴ ŷɠŘs_ ǢȖEǣÞ_ÞNjɴ Ÿ¯ ÝNƻƻĵʺ ƼȖNjǣȖŘǼ
ˠ˥ ¶Njsɠ Eɴ ˠ˟ʳˡˤ̇ Ř_ ǣǼŸŸ_ Ǽ ` ˠʰ˥ˢˡʳ˧˧ NNjŸNjs OŸŎƼNjs_ to the Scheme of Amalgamation sanctioned by the Hon’ble
to ` ˠʰˣ˧ˠʳˠˣ NNjŸNjs ÞŘ ǼÌs ƼNjsɚÞŸȖǣ ʩŘŘOÞĶ ɴsNjʳ ǻÌs ƼNjŸʩǼ ËÞ¶ÌNŸȖNjǼŸ¯ğȖ_ÞOǼȖNjsǼDŸŎEɴɚÞ_sÞǼǣŷNj_sNj_Ǽs_ğȖĶɴ
before tax was at ` ˡ˟ˠʳˣˠNNjŸNjsǣ¶ÞŘǣǼ` ˠˣ˥ʳ˨ˡNNjŸNjsÞŘǼÌs ˢʰ ˡ˟ˠˤ ɠÌÞOÌ OŎs ÞŘǼŸ s¯¯sOǼ ŸŘ Ȗ¶ȖǣǼ ˥ʰ ˡ˟ˠˤ Ř_ ǣ 
ƼNjsɚÞŸȖǣʩŘŘOÞĶɴsNjʰNjs¶ÞǣǼsNjÞض¶NjŸɠǼÌŸ¯ˢ˦ʳ˟˧̇ʳǻÌsŘsǼ NjsǣȖĶǼʰğNƻōĵɠÌÞOÌɠǣǣǼsƼ_ŸɠŘǣȖEǣÞ_ÞNjɴEsOŎs_ÞNjsOǼ
ƼNjŸʩǼ¯ŸNjǼÌsʩŘŘOÞĶɴsNjˡ˟ˠˤ˚ˠ˥ŎŸȖŘǼs_ǼŸ` ˠ˥ˡʳˢ˥NNjŸNjs ǣȖEǣÞ_ÞNjɴŸ¯ɴŸȖNjNŸŎƼŘɴʳ
compared to `ˠˣˡʳ˦˨NNjŸNjsÞŘǼÌsƼNjsɚÞŸȖǣʩŘŘOÞĶɴsNjʳ rɮOsƼǼ ǣ ŎsŘǼÞŸŘs_ EŸɚsʰ ŘŸ OŸŎƼŘɴ Ìǣ EsOŸŎs ŸNj
The consolidated gross sales (including Excise Duty) from Osǣs_ǼŸEsÞǼǣǣȖEǣÞ_ÞNjɴʰĠŸÞŘǼɚsŘǼȖNjsŸNjǣǣŸOÞǼsOŸŎƼŘɴ
ŸƼsNjǼÞŸŘǣ Ÿ¯ ɴŸȖNj NŸŎƼŘɴ ¯ŸNj ǼÌs ɴsNj ȖŘ_sNj NjsɚÞsɠ ǣǼŸŸ_ Ǽ _ȖNjÞضǼÌsʩŘŘOÞĶɴsNjˡ˟ˠˤ˚ˠ˥ʳ
` ˠʰ˥˥˟ʳ˧ˤNNjŸNjsǣ¶ÞŘǣǼ` ˠʰˤˠˤʳ˨˦NNjŸNjsÞŘǼÌsƼNjsɚÞŸȖǣʩŘŘOÞĶ
ɴsNjʰNjsƼŸNjǼÞض¶NjŸɠǼÌŸ¯˨ʳˤ˥̇ʳǻÌsOŸŘǣŸĶÞ_Ǽs_ƼNjŸʩǼEs¯ŸNjs AMALGAMATION OF SUBSIDIARY
tax was at `ˠ˨˦ʳˡ˥NNjŸNjsNjs¶ÞǣǼsNjÞض¶NjŸɠǼÌŸ¯ˤˤʳ˦˨̇ŸɚsNjǼÌs ǻÌs DŸNj_ Ÿ¯ ^ÞNjsOǼŸNjǣ Ǽ ÞǼǣ ŎssǼÞض ÌsĶ_ ŸŘ ōɴ ˡˢʰ ˡ˟ˠ˥
OŸŘǣŸĶÞ_Ǽs_ƼNjŸʩǼEs¯ŸNjsǼɮŸ¯ǼÌsƼNjsɚÞŸȖǣʩŘŘOÞĶɴsNjʳǻÌs ƼƼNjŸɚs_ ǼÌs ƼNjŸƼŸǣĶ Ÿ¯ ŎĶ¶ŎǼÞŸŘ Ÿ¯ ÞǼǣ ɠÌŸĶĶɴ
OŸŘǣŸĶÞ_Ǽs_ƼNjŸʩǼ¯ǼsNjǼɮǼ`ˠˤ˦ʳ˨˥NNjŸNjsNjsʪsOǼs_¶NjŸɠǼÌŸ¯ ŸɠŘs_ ǣȖEǣÞ_ÞNjɴ ɚÞʊʳʰ ğɴŸǼÌɴ NŸŘǣȖŎsNj ƻNjŸ_ȖOǼǣ ōNjĨsǼÞض
ˢ˟ʳˣˡ̇¶ÞŘǣǼƼNjŸʩǼ¯ǼsNjǼɮŸ¯ǼÌsƼNjsɚÞŸȖǣʩŘŘOÞĶɴsNjʳ ĵÞŎÞǼs_ɠÞǼÌɴŸȖNjNŸŎƼŘɴʳǻÌsƼƼŸÞŘǼs_^Ǽs¯ŸNjǼÌsǣÞ_
ŎĶ¶ŎǼÞŸŘÞǣʩɮs_ǣƼNjÞĶˠʰˡ˟ˠ˥ʳ
DIVIDEND
ǻÌsDŸNj_ÌǣsŘÌŘOs_ǼÌsǼŸǼĶ_ÞɚÞ_sŘ_ʹÝŘǼsNjÞŎŘ_®ÞŘĶʺ DIRECTORS’ RESPONSIBILITY STATEMENT
to ` ˤˀ˚ʹNJȖƼssǣ®ÞɚsʺƼsNjrLJȖÞǼɴǢÌNjsŸ¯` 1/- each for the ÝŘ ǼsNjŎǣ Ÿ¯ ǢsOǼÞŸŘ ˠˢˣʹˤʺ Ÿ¯ ǼÌs NŸŎƼŘÞsǣ OǼʰ ˡ˟ˠˢʰ ÞŘ
ʩŘŘOÞĶɴsNjˡ˟ˠˤ˚ˠ˥ǣ¶ÞŘǣǼ` ˣˀ˚ʹNJȖƼssǣ®ŸȖNjʺƼsNjrLJȖÞǼɴ relation to the Audited Financial Statements of your Company
share ` ˠˀ˚sOÌƼÞ_ÞŘǼÌsƼNjsɚÞŸȖǣʩŘŘOÞĶɴsNjʳ ¯ŸNj ǼÌs ʩŘŘOÞĶ ɴsNj sŘ_s_ ōNjOÌ ˢˠʰ ˡ˟ˠ˥ʰ ǼÌs DŸNj_ Ÿ¯
ǻÌsDŸNj_ÞǣƼĶsǣs_ǼŸNjsOŸŎŎsŘ_®ÞŘĶ^ÞɚÞ_sŘ_Ÿ¯` 1/- ^ÞNjsOǼŸNjǣÌsNjsEɴOŸŘʩNjŎǣǼÌǼʲ
ʹNJȖƼssŷŘsʺƼsNjrLJȖÞǼɴǢÌNjsʹ˔ˠ˟˟̇Ÿ¯¯OsəĶȖsŸ¯rLJȖÞǼɴ ʳ ÝŘǼÌsƼNjsƼNjǼÞŸŘŸ¯ǼÌsŘŘȖĶOOŸȖŘǼǣ¯ŸNjǼÌsʩŘŘOÞĶ
Share of ` ˠˀ˚ sOÌʺ ¯ŸNj ǼÌs ʩŘŘOÞĶ ɴsNj sŘ_s_ ōNjOÌ ˢˠʰ ɴsNj sŘ_s_ ōNjOÌ ˢˠʰ ˡ˟ˠ˥ʰ ǼÌs ƼƼĶÞOEĶs OOŸȖŘǼÞض
ˡ˟ˠ˥ʳǻÌs®ÞŘĶ^ÞɚÞ_sŘ_ƼɴŸȖǼŸ¯` ˡˠʳ˧˟NNjŸNjsʹÞŘOĶȖǣÞɚsŸ¯ ǣǼŘ_Nj_ǣ Njs_ ɠÞǼÌ ǼÌs NjsLJȖÞNjsŎsŘǼǣ ǣsǼ ŸȖǼ ȖŘ_sNj
tax of ` ˢʳ˥˨ NNjŸNjsʺ Þǣ ǣȖEĠsOǼ ǼŸ ǼÌs ƼƼNjŸɚĶ Ÿ¯ ōsŎEsNjǣ Ǽ ǢOÌs_ȖĶsÝÝÝǼŸǼÌsOǼʰÌɚsEssŘ¯ŸĶĶŸɠs_Ř_ǼÌsNjsɠsNjs
ǼÌssŘǣȖÞضŘŘȖĶµsŘsNjĶōssǼÞضŸ¯ɴŸȖNjNŸŎƼŘɴʳ®ȖNjǼÌsNjʰ no material departures from the same;
ɴŸȖNjNŸŎƼŘɴƼÞ_ÞŘōNjOÌˡ˟ˠ˥ʰŘÞŘǼsNjÞŎ_ÞɚÞ_sŘ_Ÿ¯` 4/-
Eʳ ɴŸȖNj ^ÞNjsOǼŸNjǣ Ìɚs ǣsĶsOǼs_ ǣȖOÌ OOŸȖŘǼÞض ƼŸĶÞOÞsǣ
ʹNJȖƼssǣ®ŸȖNjʺƼsNjrLJȖÞǼɴǢÌNjsʹ˔ˣ˟˟̇Ÿ¯¯OsɚĶȖsŸ¯rLJȖÞǼɴ
Ř_ƼƼĶÞs_ǼÌsŎOŸŘǣÞǣǼsŘǼĶɴŘ_Ŏ_sĠȖ_¶ŎsŘǼǣŘ_
Share of ` 1/- each) amounting to `˧˦ʳˡ˟NNjŸNjsʹÞŘOĶȖǣÞɚsŸ¯Ǽɮ
sǣǼÞŎǼsǣǼÌǼɠsNjsNjsǣŸŘEĶsŘ_ƼNjȖ_sŘǼǣŸǣǼŸ¶Þɚs
of `ˠˣʳ˦ˤNNjŸNjsʺʳ
ǼNjȖsŘ_¯ÞNjɚÞsɠŸ¯ǼÌsǣǼǼsŸ¯¯¯ÞNjǣŸ¯ɴŸȖNjNŸŎƼŘɴ
ǣǼōNjOÌˢˠʰˡ˟ˠ˥Ř_Ÿ¯ǼÌsƼNjŸʩǼŸ¯ɴŸȖNjNŸŎƼŘɴ
TRANSFER TO RESERVES
for the year ended on that date;
Your Company transferred a sum of ` ˣˤʳ˥˟NNjŸNjsʹ` ˤˢʳ˦ˡNNjŸNjs
Oʳ ɴŸȖNj ^ÞNjsOǼŸNjǣ Ìɚs ǼĨsŘ ƼNjŸƼsNj Ř_ ǣȖ¯ʩOÞsŘǼ ONjs
ÞŘ ǼÌs ƼNjsɚÞŸȖǣ ʩŘŘOÞĶ ɴsNjʺ ǼŸ ǼÌs ^sEsŘǼȖNjs NJs_sŎƼǼÞŸŘ
¯ŸNj ǼÌs ŎÞŘǼsŘŘOs Ÿ¯ _sLJȖǼs OOŸȖŘǼÞض NjsOŸNj_ǣ ÞŘ
NJsǣsNjɚs_ȖNjÞضǼÌsɴsNjȖŘ_sNjNjsɚÞsɠʳ
OOŸNj_ŘOsɠÞǼÌǼÌsƼNjŸɚÞǣÞŸŘǣŸ¯ǼÌÞǣOǼ¯ŸNjǣ¯s¶ȖNj_Þض
ǼÌs ǣǣsǼǣ Ÿ¯ ɴŸȖNj NŸŎƼŘɴ Ř_ ¯ŸNj ƼNjsɚsŘǼÞض Ř_
CONSOLIDATED ACCOUNTS
detecting fraud and other irregularities;
The Consolidated Financial Statements of your Company are
_ʳ ɴŸȖNj ^ÞNjsOǼŸNjǣ Ìɚs ƼNjsƼNjs_ ŘŘȖĶ OOŸȖŘǼǣ Ÿ¯ ɴŸȖNj
ƼNjsƼNjs_ÞŘOOŸNj_ŘOsɠÞǼÌǼÌsNjsĶsɚŘǼOOŸȖŘǼÞضǢǼŘ_Nj_ǣ
Company on a going concern basis;
ɚÞʊʳʰǢ˚ˡˠÞǣǣȖs_EɴǼÌsÝŘǣǼÞǼȖǼsŸ¯NÌNjǼsNjs_OOŸȖŘǼŘǼǣŸ¯
ÝŘ_ÞŘ_¯ŸNjŎǣÞŘǼs¶NjĶƼNjǼŸ¯ǼÌsŘŘȖĶNJsƼŸNjǼʳ sʳ ɴŸȖNj^ÞNjsOǼŸNjǣÌɚsĶÞ__ŸɠŘÞŘǼsNjŘĶʩŘŘOÞĶOŸŘǼNjŸĶǣ
to be followed by your Company and that such internal
PERFORMANCE OF SUBSIDIARIES, ASSOCIATE ʩŘŘOÞĶ OŸŘǼNjŸĶǣ Njs _sLJȖǼs Ř_ Njs ŸƼsNjǼÞض
COMPANIES/ JOINT VENTURES s¯¯sOǼÞɚsĶɴʱŘ_
NjsƼŸNjǼŸŘǼÌsƼsNj¯ŸNjŎŘOsŘ_ʩŘŘOÞĶƼŸǣÞǼÞŸŘŸ¯sOÌŸ¯ ¯ʳ ɴŸȖNj ^ÞNjsOǼŸNjǣ Ìɚs _sɚÞǣs_ ƼNjŸƼsNj ǣɴǣǼsŎǣ ǼŸ sŘǣȖNjs
ǼÌsǢȖEǣÞ_ÞNjÞsǣʰǣǣŸOÞǼsǣŘ_ğŸÞŘǼəsŘǼȖNjsNŸŎƼŘÞsǣǣƼsNj OŸŎƼĶÞŘOsɠÞǼÌǼÌsƼNjŸɚÞǣÞŸŘǣŸ¯ĶĶƼƼĶÞOEĶsĶɠǣŘ_
ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢÞǣǼǼOÌs_ǣŘŘsɮȖNjsǼŸǼÌÞǣNjsƼŸNjǼ ǼÌǼǣȖOÌǣɴǣǼsŎǣNjs_sLJȖǼsŘ_ŸƼsNjǼÞضs¯¯sOǼÞɚsĶɴʳ
Ř_ÌsŘOsŘŸǼNjsƼsǼs_ÌsNjs¯ŸNjǼÌsǣĨsŸ¯ENjsɚÞǼɴʳƻŸĶÞOɴ¯ŸNj
determining material subsidiaries formulated and adopted by MANAGEMENT DISCUSSION & ANALYSIS REPORT
your Company can be accessed from your Company’s website ÝŘ ǼsNjŎǣ Ÿ¯ ǼÌs ƼNjŸɚÞǣÞŸŘǣ Ÿ¯ NJs¶ȖĶǼÞŸŘ ˢˣʹˡʺ Ÿ¯ ǼÌs
at the link: ÌǼǼƼʲˀˀɠɠɠʳĠɴŸǼÌɴĶEŸNjǼŸNjÞsǣʳOŸŎˀ_ŎÞŘˀ_ŸOǣˀ ǢsOȖNjÞǼÞsǣ Ř_ rɮOÌضs DŸNj_ Ÿ¯ ÝŘ_Þ ʹĵÞǣǼÞض ŷEĶÞ¶ǼÞŸŘǣ
ƻōǢ̬ğĵĵ̬ɟsEǣÞǼsʳƼ_¯ Ř_ ^ÞǣOĶŸǣȖNjs NJsLJȖÞNjsŎsŘǼǣʺ NJs¶ȖĶǼÞŸŘǣʰ ˡ˟ˠˤʰ ǼÌs
^ȖNjÞضǼÌsɴsNjȖŘ_sNjNjsɚÞsɠʰǣǣŸOÞǼs_ÝŘ_ȖǣǼNjÞsǣNŸŘǣȖŎsNj Management Discussion & Analysis Report is attached and
ƻNjŸ_ȖOǼǣƻNjÞɚǼsĵÞŎÞǼs_˚ÝNƻƻĵʹɟÌŸĶĶɴŷɠŘs_ǢȖEǣÞ_ÞNjɴŸ¯ ¯ŸNjŎǣŘÞŘǼs¶NjĶƼNjǼŸ¯ǼÌÞǣNJsƼŸNjǼʳ
54 Jyothy Laboratories Limited
Annual Report 2015-16

ISSUE OF SHARES ǼǼsŘǼÞŸŘ Ÿ¯ ōsŎEsNjǣ Þǣ ĶǣŸ _NjɠŘ ǼŸ ŗŸǼs ŗŸʳ ˢˠ ǼŸ ǼÌs
a) Issue of Equity Shares with differential rights ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣ ¯ŸNj ǼÌs ʩŘŘOÞĶ ɴsNj sŘ_s_ ōNjOÌ ˢˠʰ
ˡ˟ˠ˥ɠÌÞOÌǣsǼǣŸȖǼǼÌsNjsĶǼs_ƼNjǼɴ_ÞǣOĶŸǣȖNjsǣǣƼsNjǢ˚ˠ˧ʳ
 ^ȖNjÞضǼÌsɴsNjȖŘ_sNjNjsɚÞsɠŘ_ǼŸ_ǼsʰɴŸȖNjNŸŎƼŘɴ
has not issued any shares with differential rights, hence CORPORATE SOCIAL RESPONSIBILITY (CSR)
ŘŸ ÞŘ¯ŸNjŎǼÞŸŘ ƼNjsǣONjÞEs_ ȖŘ_sNj ƼNjŸɚÞǣÞŸŘǣ Ÿ¯ ǢsOǼÞŸŘ Your CŸŎƼŘɴ Ìǣ EssŘ  ʩNjŎ EsĶÞsɚsNj ǼÌǼ sOÌ Ř_ sɚsNjɴ
ˣˢʹʺʹÞÞʺŸ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢNjs_ɠÞǼÌNJȖĶsˣʹˣʺŸ¯ ÞŘ_ÞɚÞ_ȖĶ ÞŘOĶȖ_Þض Ř NjǼÞʩOÞĶ ƼsNjǣŸŘ Ÿɠs ǣŸŎsǼÌÞض ǼŸ ǼÌs
the Companies (Share Capital & Debentures) Rules, 2014 ǣŸOÞsǼɴǼĶNj¶sʳōNjʳōʳƻʳNJŎOÌŘ_NjŘʰNÌÞNjŎŘ˓ōضÞض
ÌǣEssŘ¯ȖNjŘÞǣÌs_ʳ ^ÞNjsOǼŸNjŸ¯ɴŸȖNjNŸŎƼŘɴsɚsŘEs¯ŸNjsǼÌsÞŘOsƼǼÞŸŘŸ¯NŸNjƼŸNjǼs
b) Issue of Sweat Equity Shares ǢŸOÞĶ NJsǣƼŸŘǣÞEÞĶÞǼɴ ȖŘ_sNj ǼÌs NŸŎƼŘÞsǣ OǼʰ ˡ˟ˠˢʰ Ìǣ EssŘ
ÞŘɚŸĶɚs_ÞŘOÌNjÞǼEĶsŘ_ǣŸOÞĶOǼÞɚÞǼÞsǣÞŘÌÞǣÞŘ_ÞɚÞ_ȖĶOƼOÞǼɴʳ
 ^ȖNjÞضǼÌsɴsNjȖŘ_sNjNjsɚÞsɠŘ_ǼŸ_ǼsʰɴŸȖNjNŸŎƼŘɴ
Ìǣ ŘŸǼ ÞǣǣȖs_ Řɴ ǣɠsǼ sLJȖÞǼɴ ǣÌNjsǣʳ ËsŘOs ŘŸ ɳŸȖNj NŸŎƼŘɴ Ìǣ ȖŘ_sNjǼĨsŘ ƼNjŸĠsOǼǣ ÞŘ ǼÌs Njs Ÿ¯ NjȖNjĶ
ÞŘ¯ŸNjŎǼÞŸŘ ǣ ƼsNj ǼÌs ƼNjŸɚÞǣÞŸŘǣ Ÿ¯ ǢsOǼÞŸŘ ˤˣʹˠʺʹ_ʺ _sɚsĶŸƼŎsŘǼŘ_ǣŘÞǼǼÞŸŘǣƼNjǼŸ¯ÞǼǣNǢNJÞŘÞǼÞǼÞɚsʳǻÌsǣs
ƼNjŸĠsOǼǣɠsNjsÞŘOOŸNj_ŘOsɠÞǼÌǢOÌs_ȖĶsəÝÝŸ¯ǼÌsNŸŎƼŘÞsǣ
Ÿ¯ ǼÌs NŸŎƼŘÞsǣ OǼʰ ˡ˟ˠˢ Njs_ ɠÞǼÌ NJȖĶs ˧ʹˠˢʺ Ÿ¯ ǼÌs
OǼʰ ˡ˟ˠˢ Ř_ ǼÌs NǢNJ ƻŸĶÞOɴ ¯NjŎs_ Eɴ ɴŸȖNj NŸŎƼŘɴʳ ǻÌs
Companies (Share Capital & Debentures) Rules, 2014 is
NjsƼŸNjǼ ŸŘ NǢNJ OǼÞɚÞǼÞsǣ ǣ NjsLJȖÞNjs_ ȖŘ_sNj ǼÌs NŸŎƼŘÞsǣ
¯ȖNjŘÞǣÌs_ʳ
(Corporate Social Responsibility Policy) Rules, 2014 is appended
c) Issue of Employee Stock Option ǣŘŘsɮȖNjsŘ_¯ŸNjŎǣŘÞŘǼs¶NjĶƼNjǼŸ¯ǼÌÞǣNjsƼŸNjǼʳ
 ^ȖNjÞضǼÌsɴsNjȖŘ_sNjNjsɚÞsɠʰɴŸȖNjNŸŎƼŘɴÞŘǼsNjŎǣŸ¯ Details about the CSR Policy adopted and formulated by your
ǼÌsƼNjŸɚÞǣÞŸŘǣŸ¯ǢsOǼÞŸŘ˥ˡʹˠʺʹEʺNjs_ɠÞǼÌǢsOǼÞŸŘˢ˨Ÿ¯ Company can be accessed from your Company’s website at
ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢÌǣÞǣǣȖs_Ř_ĶĶŸǼǼs_˨˥ʰˠ˧ˣ the link: ÌǼǼƼʲˀˀɠɠɠʳĠɴŸǼÌɴĶEŸNjǼŸNjÞsǣʳOŸŎˀ_ŎÞŘˀ_ŸOǣˀğĵĵ̬
(Ninety Six Thousand One Hundred and Eighty Four) NǢNJ̇ˡ˟ƻŸĶÞOɴ̬ɟsEǣÞǼsʳƼ_¯
rLJȖÞǼɴǢÌNjsǣŸ¯` 1/- each to its employees on exercise ɳŸȖNj NŸŎƼŘɴ ɠǣ NjsLJȖÞNjs_ ǼŸ ǣƼsŘ_ ` ˠʳ˨ˤ NNjŸNjs ʹˡ̇ Ÿ¯
Ÿ¯ŸƼǼÞŸŘǣ¶NjŘǼs_ȖŘ_sNjˆğɴŸǼÌɴĵEŸNjǼŸNjÞsǣrŎƼĶŸɴssǣ ǼÌs ɚsNj¶s ŘsǼ ƼNjŸʩǼǣ Ÿ¯ ĶǣǼ ǼÌNjss ʩŘŘOÞĶ ɴsNjǣʺ ŸŘ NǢNJ
ǢǼŸOĨŷƼǼÞŸŘǢOÌsŎsˡ˟ˠˣˇʹrǢŷǢˡ˟ˠˣʺƼƼNjŸɚs_EɴǼÌs OǼÞɚÞǼÞsǣ_ȖNjÞضǼÌsʩŘŘOÞĶɴsNjˡ˟ˠˤ˚ˠ˥ʳOOŸNj_ÞضĶɴʰɴŸȖNj
ǢÌNjsÌŸĶ_sNjǣŸ¯ɴŸȖNjNŸŎƼŘɴǼǼÌsˡˢrd Annual General Company spent ` ˠʳ˧˨NNjŸNjsŸŘNǢNJOǼÞɚÞǼÞsǣ_ȖNjÞضǼÌsɴsNj
ōssǼÞضÌsĶ_ŸŘȖ¶ȖǣǼˠˢʰˡ˟ˠˣʳ 2015-16 and an amount of ` ˟ʳ˟˥ NNjŸNjs ǣǼŘ_ǣ OŸŎŎÞǼǼs_
 ¯ǼsNj ǼÌs ÞǣǣȖs Ÿ¯ ¯ŸNjsǣÞ_ ˨˥ʰˠ˧ˣ rLJȖÞǼɴ ǢÌNjsǣʰ ǼÌs ǼŸɠNj_ǣ ÌŸȖǣÞض ÞŘ _ÞɚǣÞ Njs Ÿ¯ ǻNjÞOÌȖNj ^ÞǣǼNjÞOǼ  Ř_ ǼÌs
ƻÞ_ ȖƼ rLJȖÞǼɴ ǢÌNjs NƼÞǼĶ Ÿ¯ ɴŸȖNj NŸŎƼŘɴ ǣǼŘ_ǣ ¯ŸNjsǣÞ_ƼNjŸĠsOǼǣEsÞضOŸŘǣǼNjȖOǼÞŸŘƼNjŸĠsOǼǣÌɚsǼÞŎsĶÞŘsʳ
increased to ` ˠ˧ʰˠˠʰˠ˨ʰ˥˧˟ OŸŘǣÞǣǼÞض Ÿ¯ ` ˠ˧ʰˠˠʰˠ˨ʰ˥˧˟ The balance amount of expenditure stands committed and will
rLJȖÞǼɴǢÌNjsǣŸ¯` ˠˀ˚sO̯ȖĶĶɴƼÞ_˚ȖƼʳ EsǣƼsŘǼÞŘǼÌsOȖNjNjsŘǼʩŘŘOÞĶɴsNjʳ

CORPORATE GOVERNANCE MATERIAL CHANGES AND COMMITMENTS


ǻÌs NjsƼŸNjǼ ŸŘ NŸNjƼŸNjǼs µŸɚsNjŘŘOs ǣ ǣǼÞƼȖĶǼs_ ȖŘ_sNj Except as disclosed elsewhere in this report, no material
NJs¶ȖĶǼÞŸŘ ˢˣʹˢʺ Njs_ ɠÞǼÌ ǢOÌs_ȖĶs ə Ÿ¯ ǼÌs ǢrDÝ ʹĵÞǣǼÞض changes and commitments which could affect your Company’s
ŷEĶÞ¶ǼÞŸŘǣ Ř_ ^ÞǣOĶŸǣȖNjs NJsLJȖÞNjsŎsŘǼǣʺ NJs¶ȖĶǼÞŸŘǣʰ ˡ˟ˠˤ ʩŘŘOÞĶ ƼŸǣÞǼÞŸŘ Ìɚs ŸOOȖNjNjs_ EsǼɠssŘ ǼÌs sŘ_ Ÿ¯ ǼÌs
ʹĵÞǣǼÞضNJs¶ȖĶǼÞŸŘǣʺǼŸ¶sǼÌsNjɠÞǼÌǼÌsNsNjǼÞʩOǼsNjsOsÞɚs_¯NjŸŎ ʩŘŘOÞĶɴsNjˡ˟ˠˤ˚ˠ˥Ř__ǼsŸ¯ǼÌÞǣNjsƼŸNjǼʳ
ɴŸȖNjNŸŎƼŘɴ˅ǣǢǼǼȖǼŸNjɴȖ_ÞǼŸNjǣOŸŘʩNjŎÞضOŸŎƼĶÞŘOsŸ¯
NŸNjƼŸNjǼsµŸɚsNjŘŘOsNjsLJȖÞNjsŎsŘǼǣÞǣǼǼOÌs_Ř_¯ŸNjŎǣŘ INTERNAL FINANCIAL CONTROLS
ÞŘǼs¶NjĶƼNjǼŸ¯ǼÌÞǣNjsƼŸNjǼʳ The Internal Financial Controls adopted and followed by your
NŸŎƼŘɴ Njs _sLJȖǼs Ř_ Njs ŸƼsNjǼÞض s¯¯sOǼÞɚsĶɴʳ ɳŸȖNj
RELATED PARTY TRANSACTIONS Company has adopted a dynamic Internal Financial Controls
¯NjŎsɠŸNjĨ¯ŸNjŎȖĶǼs_EɴrNjŘǣǼ˓ɳŸȖضʰĵĵƻEǣs_ŸŘǼÌsEsǣǼ
Particulars of contracts or arrangements with related
ƼNjOǼÞOsǣ¯ŸĶĶŸɠs_ÞŘǼÌsÞŘ_ȖǣǼNjɴʳȕŘ_sNjǼÌsǣÞ_¯NjŎsɠŸNjĨʰNJÞǣĨ
parties referred to in Section 188(1) of the Companies
Ř_NŸŘǼNjŸĶōǼNjÞɮNjs_sʩŘs_¯ŸNjǼÌs¯ŸĶĶŸɠÞضƼNjŸOsǣǣʹsǣʺʲ˚
OǼʰ ˡ˟ˠˢʰ ÞŘ ǼÌs ƼNjsǣONjÞEs_ ®ŸNjŎ ŷN˚ˡ Þǣ ƼƼsŘ_s_ ǣ
ŘŘsɮȖNjs ǼŸ ǼÌÞǣ NJsƼŸNjǼʳ ^ȖNjÞض ǼÌs ɴsNjʰ ɴŸȖNj NŸŎƼŘɴ ˠʳ ®Þɮs_ǣǣsǼǣʱ
had entered into contract/ arrangement/ transaction with ˡʳ ®ÞŘŘOÞĶǢǼǼsŎsŘǼNĶŸǣÞضƻNjŸOsǣǣʱ
related parties which were on arm’s length basis and none ˢʳ ÝŘ¯ŸNjŎǼÞŸŘǻsOÌŘŸĶŸ¶ɴʱ
of which could be considered as material in accordance with ˣʳ ÝŘɚsŘǼŸNjɴōضsŎsŘǼʱ
the policy of your Company on Materiality of Related Party ˤʳ ōNjĨsǼÞضŘ__ɚsNjǼÞǣÞضʱ
ǻNjŘǣOǼÞŸŘǣʳ ®ȖNjǼÌsNj ŘŸŘs Ÿ¯ ǼÌs OŸŘǼNjOǼˀ NjNjضsŎsŘǼˀ ˥ʳ ŷNj_sNjǼŸNǣÌʱ
ǼNjŘǣOǼÞŸŘ ɠÞǼÌ NjsĶǼs_ ƼNjǼÞsǣ NjsLJȖÞNjs_ ƼƼNjŸɚĶ Ÿ¯ ˦ʳ ƻɴNjŸĶĶʱ
Shareholders as the same were within the limits prescribed ˧ʳ ƻNjŸ_ȖOǼÞŸŘƻNjŸOsǣǣʱ
ȖŘ_sNjǢsOǼÞŸŘˠ˧˧ʹˠʺŸ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢŘ_NJȖĶsǣ ˨ʳ ƻȖNjOÌǣsǼŸƻɴʱ
¯NjŎs_ǼÌsNjsȖŘ_sNjʳ ˠ˟ʳ ǻɮǼÞŸŘʱ
ˠˠʳ ǻNjsǣȖNjɴʳ
The Policy on Materiality of Related Party Transactions and
_sĶÞضɠÞǼÌNJsĶǼs_ƻNjǼɴǻNjŘǣOǼÞŸŘǣǣƼƼNjŸɚs_EɴǼÌsDŸNj_ ^ȖNjÞضǼÌsɴsNjȖŘ_sNjNjsɚÞsɠʰŘŸŎǼsNjÞĶŸNjǣsNjÞŸȖǣŸEǣsNjɚǼÞŸŘǣ
may be accessed from your Company’s website at the link: http:// ÌɚsEssŘNjsOsÞɚs_¯NjŸŎǼÌsÝŘǼsNjŘĶȖ_ÞǼŸNjǣŸ¯ɴŸȖNjNŸŎƼŘɴ
ɠɠɠʳĠɴŸǼÌɴĶEŸNjǼŸNjÞsǣʳOŸŎˀ_ŎÞŘˀ_ŸOǣˀNJƻǻ̬ğĵĵ̬ɟsEǣÞǼsʳpdf Njs¶Nj_ÞضÞŘs¯ʩOÞsŘOɴŸNjÞŘ_sLJȖOɴŸ¯ǣȖOÌOŸŘǼNjŸĶǣʳ
NŸNjƼŸNjǼsŷɚsNjɚÞsɠ Performance Governance Financial Statements 55

CHANGE IN NATURE OF BUSINESS PARTICULARS OF LOANS, GUARANTEES AND


^ȖNjÞض ǼÌs ɴsNj ȖŘ_sNj NjsɚÞsɠʰ ǼÌsNjs ɠǣ ŘŸ OÌضs ÞŘ ǼÌs INVESTMENTS
ŘǼȖNjsŸ¯EȖǣÞŘsǣǣŸ¯ɴŸȖNjNŸŎƼŘɴʳ ǻÌs_sǼÞĶǣŸ¯ĵŸŘǣʰµȖNjŘǼssǣŘ_ÝŘɚsǣǼŎsŘǼǣǣƼNjsǣONjÞEs_
ȖŘ_sNjǢsOǼÞŸŘˠ˧˥Ÿ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢNjsƼƼsŘ_s_
SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE ǣŘŘsɮȖNjsŘ_¯ŸNjŎǣÞŘǼs¶NjĶƼNjǼŸ¯ǼÌÞǣNjsƼŸNjǼʳ
REGULATORS OR COURTS
ǻÌsNjs Njs ŘŸ ǣÞ¶ŘÞʩOŘǼ Ř_ ŎǼsNjÞĶ ŸNj_sNjǣ Ƽǣǣs_ Eɴ Řɴ EMPLOYEE STOCK OPTION SCHEME (ESOS)
Regulator/ Court that would impact the going concern status ɳŸȖNj NŸŎƼŘɴ Ìǣ _ŸƼǼs_ ğɴŸǼÌɴ ĵEŸNjǼŸNjÞsǣ rŎƼĶŸɴss
Ÿ¯ɴŸȖNjNŸŎƼŘɴŘ_ÞǼǣ¯ȖǼȖNjsŸƼsNjǼÞŸŘǣʳ Stock Option Scheme 2014-A (“ESOS 2014-A”) for granting of
ŸƼǼÞŸŘǣǼŸōNjʳǢʳNJ¶ÌȖŘŘ_ŘʰɟÌŸĶsǻÞŎs^ÞNjsOǼŸNjŘ_NÌÞs¯
REMUNERATION/ COMMISSION FROM ANY OF ITS rɮsOȖǼÞɚs ŷ¯ʩOsNj Ÿ¯ ɴŸȖNj NŸŎƼŘɴ Ř_ ğɴŸǼÌɴ ĵEŸNjǼŸNjÞsǣ
SUBSIDIARIES Employee Stock Option Scheme 2014 (“ESOS 2014”) for
^ȖNjÞضǼÌsɴsNjȖŘ_sNjNjsɚÞsɠʰŘsÞǼÌsNjǼÌsōضÞض^ÞNjsOǼŸNj granting of options to other eligible employees of your
ŘŸNjǼÌsɟÌŸĶsǻÞŎs^ÞNjsOǼŸNjǣŸ¯ɴŸȖNjNŸŎƼŘɴNjsOsÞɚsŘɴ NŸŎƼŘɴƼƼNjŸɚs_EɴǼÌsōsŎEsNjǣŸ¯ɴŸȖNjNŸŎƼŘɴǼǼÌs
NjsŎȖŘsNjǼÞŸŘŸNjOŸŎŎÞǣǣÞŸŘ¯NjŸŎŘɴŸ¯ÞǼǣǢȖEǣÞ_ÞNjÞsǣʳ ˡˢrdŘŘȖĶµsŘsNjĶōssǼÞضÌsĶ_ŸŘȖ¶ȖǣǼˠˢʰˡ˟ˠˣʳ

^ÞǣOĶŸǣȖNjsǣNjsLJȖÞNjs_ȖŘ_sNjǢsOǼÞŸŘ˥ˡʹˠʺʹEʺŸ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢNjs_ɠÞǼÌNJȖĶsˠˡʹ˨ʺŸ¯ǼÌsNŸŎƼŘÞsǣʹǢÌNjsNƼÞǼĶŘ_
^sEsŘǼȖNjsǣʺNJȖĶsǣʰˡ˟ˠˣŘ_NJs¶ȖĶǼÞŸŘˠˣŸ¯ǼÌsǢsOȖNjÞǼÞsǣrɮOÌضsDŸNj_Ÿ¯ÝŘ_ÞʹǢÌNjsDǣs_rŎƼĶŸɴssDsŘsʩǼǣʺNJs¶ȖĶǼÞŸŘǣʰ
2014 are appended as below:
Jyothy Laboratories Employee Stock Jyothy Laboratories Employee Stock
Option Scheme 2014-A (“ESOS 2014-A”) Option Scheme 2014 (“ESOS 2014”)
1 ^ǼsŸ¯ǢÌNjsÌŸĶ_sNjǣ˅ƼƼNjŸɚĶ Ȗ¶ȖǣǼˠˢʰˡ˟ˠˣ Ȗ¶ȖǣǼˠˢʰˡ˟ˠˣ
2 Total number of options ˡ˦ʰˠˤʰˢˤˡ ˡ˦ʰˠˤʰˢˤˡ
ƼƼNjŸɚs_ȖŘ_sNjrǢŷǢ
ˢ əsǣǼÞضNJsLJȖÞNjsŎsŘǼǣ Options granted under ESOS 2014-A would Options granted under ESOS 2014 would
əsǣǼ¯ǼsNjŷŘsɴsNjEȖǼŘŸǼĶǼsNjǼÌŘ¯ŸȖNj əsǣǼ¯ǼsNjŷŘsɴsNjEȖǼŘŸǼĶǼsNjǼÌŘ¯ŸȖNj
ɴsNjǣ¯NjŸŎǼÌs_ǼsŸ¯¶NjŘǼŸ¯ǣȖOÌŸƼǼÞŸŘǣʳ ɴsNjǣ¯NjŸŎǼÌs_ǼsŸ¯¶NjŘǼŸ¯ǣȖOÌŸƼǼÞŸŘǣʳ
əsǣǼÞض Ÿ¯ ŸƼǼÞŸŘǣ ɠŸȖĶ_ Es ǣȖEĠsOǼ ǼŸ əsǣǼÞض Ÿ¯ ŸƼǼÞŸŘǣ ɠŸȖĶ_ Es ǣȖEĠsOǼ ǼŸ
continued employment with the Company continued employment with the Company
Ř_OsNjǼÞŘƼsNj¯ŸNjŎŘOsƼNjŎsǼsNjǣʳ and certain performance parameters
4 Exercise price or pricing ` 1 per option `1 per option
formula
5 Maximum term of options 5 years 5 years
granted
6 Source of shares Primary Primary
7 əNjÞǼÞŸŘÞŘǼsNjŎǣŸ¯ŸƼǼÞŸŘ ŗŸɚNjÞǼÞŸŘÞŘǼÌsǼsNjŎǣŸ¯ŸƼǼÞŸŘ ŗŸɚNjÞǼÞŸŘÞŘǼÌsǼsNjŎǣŸ¯ǼÌsŸƼǼÞŸŘ
8 ōsǼÌŸ_Ÿ¯ŷƼǼÞŸŘəĶȖǼÞŸŘ ÝŘǼNjÞŘǣÞOəĶȖs ÝŘǼNjÞŘǣÞOəĶȖs
˨ ŷƼǼÞŸŘ ōŸɚsŎsŘǼ _ȖNjÞض ǼÌs
year
Number of Options outstanding ˡ˦ʰˠˤʰˢˤˡ ˣʰ˧ˣʰ˨ˤ˧
at the beginning of the period
Number of options granted - -
during the year
Number of options forfeited/ 4,52,558 ˧˦ʰ˨˦˟
lapsed during the year
ŗȖŎEsNj Ÿ¯ ŸƼǼÞŸŘǣ ɚsǣǼs_ - ˨˥ʰˠ˧ˣ
during the year
Number of options exercised - ˨˥ʰˠ˧ˣ
during the year
Number of shares arising as a - ˨˥ʰˠ˧ˣ
result of exercise of options
56 Jyothy Laboratories Limited
Annual Report 2015-16

Jyothy Laboratories Employee Stock Jyothy Laboratories Employee Stock


Option Scheme 2014-A (“ESOS 2014-A”) Option Scheme 2014 (“ESOS 2014”)
Money realized by exercise of - ˨˥ʰˠ˧ˣ
options (Amount in `)
ĵŸŘNjsƼÞ_EɴǼÌsǻNjȖǣǼ_ȖNjÞض ŗʳʳ ŗʳʳ
the year from exercise price
NjsOsÞɚs_
Number of Options outstanding ˡˡʰ˥ˡʰ˦˨ˣ ˢʰ˟˟ʰ˧˟ˣ
at the end of the year
Number of options exercisable ˡˡʰ˥ˡʰ˦˨ˣ ˢʰ˟˟ʰ˧˟ˣ
at the end of the year

10 rŎƼĶŸɴssɟÞǣs_sǼÞĶǣŸ¯ŷƼǼÞŸŘǣµNjŘǼs_
i. Senior Managerial Personnel
Name Designation Options Granted during the Exercise Price
Year
None - - -

ii. any other employee who receives a grant in any one year of option amounting to 5% or more of option granted during the
year; and
Name Designation Options Granted during the Exercise Price
Year
None - - -

iii. identified employees who were granted option, during any one year, equal to or exceeding 1% of the issued capital(excluding
outstanding warrants and conversations) of the company at the time of grant.
Name Designation Options Granted during the Exercise Price
Year
Mr. S. Raghunandan Whole Time Director & Chief 27,15,352# ` 1/- per Option
Executive Officer*
ˎNsǣs_ǼŸEsɟÌŸĶsǻÞŎs^ÞNjsOǼŸNjŘ_NÌÞs¯rɮsOȖǼÞɚsŷ¯ʩOsNjŸ¯ɴŸȖNjNŸŎƼŘɴŘ_Njs˚_sǣÞ¶ŘǼs_ǣƻNjsǣÞ_sŘǼŸ¯ɴŸȖNjNŸŎƼŘɴ
ɠʳsʳ¯ʳōɴˡˢʰˡ˟ˠ˥ʳ
˞µNjŘǼs__ȖNjÞضǼÌsʩŘŘOÞĶɴsNjˡ˟ˠˣ˚ˠˤʳ
ŗŸǼsʲŷǼÌsNj_sǼÞĶǣǣNjsLJȖÞNjs_ȖŘ_sNjNJs¶ȖĶǼÞŸŘˠˣŸ¯ǼÌsǢsOȖNjÞǼÞsǣrɮOÌضsDŸNj_Ÿ¯ÝŘ_ÞʹǢÌNjsDǣs_rŎƼĶŸɴssDsŘsʩǼǣʺ
NJs¶ȖĶǼÞŸŘǣʰˡ˟ˠˣNjs_ɠÞǼÌǢrDÝOÞNjOȖĶNjEsNjÞضŘȖŎEsNjNÝNJˀN®^ˀƻŷĵÝNɳNrĵĵˀˡˀˡ˟ˠˤ^ǻr^ğȖŘsˠ˥ʰˡ˟ˠˤ¯ŸNjŎƼNjǼŸ¯ǼÌs
Notes to Accounts of the Financial Statements in this Annual Report
®ȖNjǼÌsNjǼÌs¯ŸNjsǣÞ__sǼÞĶǣNjsĶǣŸɚÞĶEĶsŸŘɴŸȖNjNŸŎƼŘɴ˅ǣɠsEǣÞǼsǼǼÌsĶÞŘĨʲÌǼǼƼʲˀˀɠɠɠʳĠɴŸǼÌɴĶEŸNjǼŸNjÞsǣʳOŸŎˀ_ŎÞŘˀ
_ŸOǣˀrǢŷƻ̬NJs¶ʳ̇ˡ˟ˠˣʳƼ_¯
ǻÌsOsNjǼÞʩOǼs¯NjŸŎǼÌsǢǼǼȖǼŸNjɴȖ_ÞǼŸNjǣÞŘNjsǣƼsOǼŸ¯ÞŎƼĶsŎsŘǼǼÞŸŘŸ¯ğɴŸǼÌɴĵEŸNjǼŸNjÞsǣrŎƼĶŸɴssǢǼŸOĨŷƼǼÞŸŘǢOÌsŎs
ˡ˟ˠˣ˚ʹˆrǢŷǢˡ˟ˠˣ˚ˇʺʰğɴŸǼÌɴĵEŸNjǼŸNjÞsǣrŎƼĶŸɴssǢǼŸOĨŷƼǼÞŸŘǢOÌsŎsˡ˟ˠˣʹˆrǢŷǢˡ˟ˠˣˇʺŘ_ǼÌsNjsǣŸĶȖǼÞŸŘƼǣǣs_Eɴ
ǼÌsōsŎEsNjǣǼǼÌsˡˢrdŘŘȖĶµsŘsNjĶōssǼÞضŸ¯ɴŸȖNjNŸŎƼŘɴÌsĶ_ŸŘȖ¶ȖǣǼˠˢʰˡ˟ˠˣʰǣÌĶĶEsƼĶOs_ǼǼÌssŘǣȖÞضŘŘȖĶ
µsŘsNjĶōssǼÞض¯ŸNjÞŘǣƼsOǼÞŸŘEɴōsŎEsNjǣʳ
NŸNjƼŸNjǼsŷɚsNjɚÞsɠ Performance Governance Financial Statements 57

DIRECTORS AND KEY MANAGERIAL PERSONNEL ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNjǣŎÞŘǼÞŘs_EɴǼÌsµŸɚsNjŘŎsŘǼŸNj


ÝŘ OOŸNj_ŘOs ɠÞǼÌ ǼÌs ƼNjŸɚÞǣÞŸŘǣ Ÿ¯ ǼÌs NŸŎƼŘÞsǣ OǼʰ ȖƼŸŘ NjsOŸŎŎsŘ_ǼÞŸŘ Eɴ NÌÞNjŎŘ ŸNj ŸǼÌsNj ^ÞNjsOǼŸNjǣʳ
ˡ˟ˠˢŘ_ǼÌsNjǼÞOĶsˠˣ˟Ÿ¯ǼÌsNjǼÞOĶsǣŸ¯ǣǣŸOÞǼÞŸŘŸ¯ɴŸȖNj ǻÌsƼƼŸÞŘǼŎsŘǼŎɴEsŎ_ssÞǼÌsNjǼŸʩĶĶȖƼɚOŘOɴ
NŸŎƼŘɴʰ ōNjʳ ħʳ ȕĶĶǣ ħŎǼÌʰ ğŸÞŘǼ ōضÞض ^ÞNjsOǼŸNj Ř_ OȖǣs_ Eɴ NjsǣÞ¶ŘǼÞŸŘʰ _sǼÌ ŸNj NjsŎŸɚĶ Ÿ¯ Ř sɮÞǣǼÞض
NÌÞs¯ ®ÞŘŘOÞĶ ŷ¯ʩOsNj Ÿ¯ ɴŸȖNj NŸŎƼŘɴ NjsǼÞNjsǣ Eɴ NjŸǼǼÞŸŘ ŗŸŘ˚rɮsOȖǼÞɚs ^ÞNjsOǼŸNj ŸNj ÞǼ Ŏɴ Es Ř ƼƼŸÞŘǼŎsŘǼ ǣ
at the ensuing Annual General Meeting and being eligible, Ř__ÞǼÞŸŘĶ_ÞNjsOǼŸNjŸNjŘĶǼsNjŘǼs_ÞNjsOǼŸNjʳ
Ÿ¯¯sNjs_ÌÞŎǣsĶ¯¯ŸNjNjs˚ƼƼŸÞŘǼŎsŘǼʳ ʹÝÝʺ džȖĶÞʩOǼÞŸŘǣʰrɮƼsNjÞsŘOsŘ_ƻŸǣÞǼÞɚsǼǼNjÞEȖǼsǣ
ǻÌs DŸNj_ Ǽ ÞǼǣ ŎssǼÞض ÌsĶ_ ŸŘ ōɴ ˡˢʰ ˡ˟ˠ˥ ƼƼNjŸɚs_ ʺ ɟÌÞĶs ƼƼŸÞŘǼÞض  ^ÞNjsOǼŸNjʰ ÞǼ ǣÌĶĶ Ķɠɴǣ Es
ƼƼŸÞŘǼŎsŘǼŸ¯ōNjʳōʳƻʳNJŎOÌŘ_NjŘǣǼÌsNÌÞNjŎŘŘ_ ensured that the candidate possesses appropriate
ōضÞض^ÞNjsOǼŸNjŸ¯ɴŸȖNjNŸŎƼŘɴ¯ŸNjǼsNjŎŸ¯ʩɚsɴsNjǣ skills, experience and knowledge in one or more
ɠÞǼÌs¯¯sOǼ¯NjŸŎȖ¶ȖǣǼˡˡʰˡ˟ˠ˥ǼŸȖ¶ȖǣǼˡˠʰˡ˟ˡˠǣȖEĠsOǼǼŸ ʩsĶ_ǣŸ¯ʩŘŘOsʰĶɠʰŎضsŎsŘǼʰǣĶsǣʰŎNjĨsǼÞضʰ
ǼÌsƼƼNjŸɚĶŸ¯ǢÌNjsÌŸĶ_sNjǣEɴƼǣǣÞضǢƼsOÞĶNJsǣŸĶȖǼÞŸŘ _ŎÞŘÞǣǼNjǼÞŸŘʰ NjsǣsNjOÌʰ OŸNjƼŸNjǼs ¶ŸɚsNjŘŘOsʰ
at the ensuing Annual General Meeting on the terms and technical operations or other disciplines related to
OŸŘ_ÞǼÞŸŘǣǣƼsOÞʩs_ÞŘǼÌsǢƼsOÞĶNJsǣŸĶȖǼÞŸŘǣsǼŸȖǼǼÝǼsŎ ɴŸȖNjNŸŎƼŘɴ˅ǣEȖǣÞŘsǣǣʳ
ŗŸʳ˥Ÿ¯ǼÌsŘŸǼÞOsOŸŘɚsŘÞضˡˤth Annual General Meeting of Eʺ ÝŘ Oǣs Ÿ¯ ƼƼŸÞŘǼŎsŘǼ ǣ Ř rɮsOȖǼÞɚs ^ÞNjsOǼŸNjʰ
ɴŸȖNjNŸŎƼŘɴʳ ǼÌs OŘ_Þ_Ǽs ŎȖǣǼ Ìɚs ǼÌs NjsĶsɚŘǼ ǼsOÌŘÞOĶ ŸNj
ǻÌs DŸNj_ Ǽ ÞǼǣ ŎssǼÞض ÌsĶ_ ŸŘ ōɴ ˡˢʰ ˡ˟ˠ˥ ĶǣŸ ƼNjŸ¯sǣǣÞŸŘĶ LJȖĶÞʩOǼÞŸŘǣ Ř_ sɮƼsNjÞsŘOs ǣ Njs
OOsƼǼs_ ǼÌs NjsǣÞ¶ŘǼÞŸŘ Ÿ¯ ōNjʳ Ǣʳ NJ¶ÌȖŘŘ_Řʰ ɟÌŸĶs OŸŘǣÞ_sNjs_ ŘsOsǣǣNjɴ Eǣs_ ŸŘ ǼÌs ĠŸE _sǣONjÞƼǼÞŸŘ
ǻÞŎs ^ÞNjsOǼŸNj Ř_ NÌÞs¯ rɮsOȖǼÞɚs ŷ¯ʩOsNj Ÿ¯ ɴŸȖNj NŸŎƼŘɴʳ Ÿ¯ ǼÌs ƼŸǣÞǼÞŸŘʳ ÝŘ Oǣs ŘŸ ǣƼsOÞʩO LJȖĶÞʩOǼÞŸŘ
ōNjʳǢʳNJ¶ÌȖŘŘ_ŘÌǣEssŘNjs˚_sǣÞ¶ŘǼs_ǣǼÌsƻNjsǣÞ_sŘǼ or experience is prescribed or thought necessary
Ÿ¯ɴŸȖNjNŸŎƼŘɴʳǻÌsDŸNj_ƼĶOs_ŸŘNjsOŸNj_ʰÞǼǣƼƼsNjÞOÞǼÞŸŘ for the position then, while recommending the
¯ŸNj ǼÌs ǣsNjɚÞOsǣ NjsŘ_sNjs_Eɴ  ōNjʳǢʳ NJ¶ÌȖŘŘ_Ř_ȖNjÞض ÌÞǣ appointment, the Human Resource Department
ǼsŘȖNjs ǣ ɟÌŸĶs ǻÞŎs ^ÞNjsOǼŸNj Ř_ NÌÞs¯ rɮsOȖǼÞɚs ŷ¯ʩOsNjʳ ǣÌĶĶ ƼNjŸɚÞ_s ǼÌs ĠŸE _sǣONjÞƼǼÞŸŘ ǼŸ ǼÌs NŸŎŎÞǼǼss
ǻÌs DŸNj_ ōsŎEsNjǣ ĶǣŸ ǼŸŸĨ ŘŸǼs Ÿ¯ NjsĶÞŘLJȖÞǣÌŎsŘǼ Ÿ¯ Ř_ ĠȖǣǼÞ¯ɴ ǼÌǼ ǼÌs LJȖĶÞʩOǼÞŸŘǣʰ sɮƼsNjÞsŘOs Ř_
ōNjʳōʳĵʳDŘǣĶʰNŸŎƼŘɴǢsONjsǼNjɴŸ¯ɴŸȖNjNŸŎƼŘɴʳÝŘǼÌs expertise of the recommended candidate are
ǣŎsDŸNj_ōssǼÞضʰōNjʳǢÌNjsɴǣǻNjÞɚs_ÞɠǣƼƼŸÞŘǼs_ǣǼÌs ǣǼÞǣ¯OǼŸNjɴ ¯ŸNj ǼÌs NjsĶsɚŘǼ ƼƼŸÞŘǼŎsŘǼʳ ÝŘ ǣȖOÌ
NŸŎƼŘɴǢsONjsǼNjɴʰNŸŎƼĶÞŘOsŷ¯ʩOsNjŘ_ħsɴōضsNjÞĶ circumstances, the Committee may call for an expert
ƻsNjǣŸŘŘsĶ ÞŘ OOŸNj_ŘOs ɠÞǼÌ ǢsOǼÞŸŘ ˡ˟ˢ Ÿ¯ ǼÌs NŸŎƼŘÞsǣ ŸƼÞŘÞŸŘŸŘǼÌsƼƼNjŸƼNjÞǼsŘsǣǣŸ¯ǼÌsLJȖĶÞʩOǼÞŸŘǣ
OǼʰˡ˟ˠˢʳ and experience of the candidate for the position of
ĶĶ ÝŘ_sƼsŘ_sŘǼ ^ÞNjsOǼŸNjǣ Ìɚs ¶ÞɚsŘ _sOĶNjǼÞŸŘǣ ǼÌǼ ǼÌsɴ ǼÌsrɮsOȖǼÞɚs^ÞNjsOǼŸNjʳ
meet the criteria of Independence as laid down under Section Oʺ ÝŘOǣsŸ¯ƼƼŸÞŘǼŎsŘǼǣŗŸŘ˚rɮsOȖǼÞɚs^ÞNjsOǼŸNjʰ
ˠˣ˨ʹ˥ʺŸ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢʳ ǼÌs OŘ_Þ_Ǽs ŎȖǣǼ Ìɚs  ƼŸǣǼ¶Nj_ȖǼs _s¶Njssʰ
^ȖNjÞضǼÌsʩŘŘOÞĶɴsNjˡ˟ˠˤ˚ˠ˥ʰǼÌsNjsɠǣŘŸOÌضsÞŘħsɴ _ÞƼĶŸŎŸNjƼNjŸ¯sǣǣÞŸŘĶLJȖĶÞʩOǼÞŸŘÞŘǼÌsʩsĶ_Ÿ¯
ōضsNjÞĶƻsNjǣŸŘŘsĶŸ¯ɴŸȖNjNŸŎƼŘɴʳ ÌÞǣ ƼNjOǼÞOsˀ ƼNjŸ¯sǣǣÞŸŘˀ ǣsNjɚÞOs Ř_ ǣÌĶĶ Ìɚs ŘŸǼ
Ķsǣǣ ǼÌŘ ʩɚs ɴsNjǣ Ÿ¯ ɠŸNjĨÞض sɮƼsNjÞsŘOs ÞŘ ǣȖOÌ
POLICY ON DIRECTOR''S' APPOINTMENT AND ʩsĶ_ǣƼNjŸ¯sǣǣÞŸŘĶÞŘƼNjOǼÞOsʰ_ɚÞǣŸNjʰOŸŘǣȖĶǼŘǼ
REMUNERATION ŸNj ǣ Ř sŎƼĶŸɴssʳ ƻNjŸɚÞ_s_ ǼÌǼ ǼÌs DŸNj_ Ŏɴ
ɠÞɚs ǼÌs NjsLJȖÞNjsŎsŘǼǣ Ÿ¯ LJȖĶÞʩOǼÞŸŘ Ř_ˀ ŸNj
ǻÌsDŸNj_ÞŘOOŸNj_ŘOsɠÞǼÌǼÌsƼNjŸɚÞǣÞŸŘǣŸ¯ǣȖE˚ǣsOǼÞŸŘʹˢʺŸ¯
sɮƼsNjÞsŘOs ȖŘ_sNj ǼÌÞǣ ƼNj¶NjƼÌ ¯ŸNj  _sǣsNjɚÞض
ǢsOǼÞŸŘˠ˦˧Ÿ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢʰ¯ŸNjŎȖĶǼs_ǼÌsƼŸĶÞOɴ
OŘ_Þ_Ǽsʳ
ǣsǼǼÞضŸȖǼǼÌsONjÞǼsNjÞ¯ŸNj_sǼsNjŎÞŘÞضLJȖĶÞʩOǼÞŸŘǣʰƼŸǣÞǼÞɚs
attributes, independence of a Director and remuneration for d) The Board, while making the appointment of a
^ÞNjsOǼŸNjǣʰħsɴōضsNjÞĶƻsNjǣŸŘŘsĶŘ_ŸǼÌsNjsŎƼĶŸɴssǣʳ Director, shall also try to assess from the information
ɚÞĶEĶsŘ_¯NjŸŎǼÌsÞŘǼsNjOǼÞŸŘɠÞǼÌǼÌsOŘ_Þ_Ǽs
ōĠŸNjONjÞǼsNjÞ_sʩŘs_ÞŘǼÌsƻŸĶÞOɴ¯NjŎs_¯ŸNjƼƼŸÞŘǼŎsŘǼŸ¯
ǼÌǼÌsÞǣ¯ÞNjOÌÞsɚsNjÞŘÌÞǣOÌŸǣsŘʩsĶ_Ř_ǼÌǼÌs
ǼÌs ^ÞNjsOǼŸNjǣ ÞŘOĶȖ_ÞضONjÞǼsNjÞ¯ŸNj_sǼsNjŎÞŘÞضLJȖĶÞʩOǼÞŸŘǣʰ
ÞǣƼsNjǣŸŘɠÞǼÌÞŘǼs¶NjÞǼɴʰ_ÞĶÞ¶sŘOsŘ_ŸƼsŘŎÞŘ_ʳ
ƼŸǣÞǼÞɚsǼǼNjÞEȖǼsǣʰÞŘ_sƼsŘ_sŘOssǼONjsǣȖŘ_sNjʲ
(I) Selection (III) Board Diversity And Independence
 ÝŘ Oǣs Ÿ¯ rɮsOȖǼÞɚs ^ÞNjsOǼŸNjǣ Ř_ ħsɴ ōضsNjÞĶ  ɟÌÞĶs ŎĨÞض ƼƼŸÞŘǼŎsŘǼ Ÿ¯ _ÞNjsOǼŸNjǣʰ ¯ŸĶĶŸɠÞض
Personnel, the selection can be made either by ƼNjÞŘOÞƼĶsǣ ǣÌĶĶ Es ŸEǣsNjɚs_ Eɴ ǼÌs DŸNj_ʰ ǣ ¯Nj ǣ
recruitment from outside or from within your Company practicable:
hierarchy or upon recommendation by the Chairman or
ʺ ǻÌsNjs ǣÌĶĶ Es  ƼNjŸƼsNj ŎÞɮ Ÿ¯ rɮsOȖǼÞɚs Ř_ ŗŸŘ˚
ŸǼÌsNj^ÞNjsOǼŸNjǣʳǻÌsƼƼŸÞŘǼŎsŘǼŎɴEsŎ_ssÞǼÌsNjǼŸ
rɮsOȖǼÞɚs ^ÞNjsOǼŸNjǣ Ř_ ÝŘ_sƼsŘ_sŘǼ Ř_ ŗŸŘ˚
ʩĶĶȖƼɚOŘOɴOȖǣs_EɴNjsǼÞNjsŎsŘǼʰNjsǣÞ¶ŘǼÞŸŘʰ_sǼÌ
ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNjǣŸŘǼÌsDŸNj_ʳɳŸȖNjNŸŎƼŘɴ
ŸNjNjsŎŸɚĶŸ¯ŘsɮÞǣǼÞضrɮsOȖǼÞɚs^ÞNjsOǼŸNjŸNjÞǼŎɴEs
ŎȖǣǼ Ķɠɴǣ Es ÞŘ OŸŎƼĶÞŘOs Ÿ¯ ǼÌs ƼNjŸɚÞǣÞŸŘǣ Ÿ¯
¯NjsǣÌƼƼŸÞŘǼŎsŘǼʳ
ǢsOǼÞŸŘˠˣ˨Ÿ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢŘ_NĶȖǣs
 ÝŘOǣsŸ¯ŗŸŘ˚rɮsOȖǼÞɚs^ÞNjsOǼŸNjǣʰǼÌsǣsĶsOǼÞŸŘOŘEs ˠ˦Ÿ¯ǼÌsĵÞǣǼÞضNJs¶ȖĶǼÞŸŘǣʰǣŎsŘ_s_¯NjŸŎǼÞŎs
made either by way of selection from the data bank of ǼŸǼÞŎsʰÞŘǼÌÞǣNjs¶Nj_ʳ
58 Jyothy Laboratories Limited
Annual Report 2015-16

b) There shall be a workable mix of directors drawn TRAINING OF INDEPENDENT DIRECTORS


¯NjŸŎ ɚNjÞŸȖǣ _ÞǣOÞƼĶÞŘsǣʰ ĶÞĨs ǼsOÌŘÞOĶʰ ʩŘŘOsʰ All Independent Directors are familiarized with your Company,
OŸŎŎsNjOÞĶʰ Ķs¶Ķ sǼOʳ ǻÌs DŸNj_ ǣÌĶĶ ŘŸǼ Ǽ Řɴ their roles, rights and responsibilities in your Company, nature
time be entirely comprised of persons drawn from of the industry in which your Company operates, business
ŸŘs_ÞǣOÞƼĶÞŘsŸNjʩsĶ_ʳ model, strategy, operations and functions of your Company
Oʺ ɟÌÞĶs ƼƼŸÞŘǼÞض  _ÞNjsOǼŸNj ǼŸ ¯ÞĶĶ ÞŘ  OǣȖĶ ǼÌNjŸȖ¶Ì ÞǼǣ rɮsOȖǼÞɚs ^ÞNjsOǼŸNjǣ Ř_ ǢsŘÞŸNj ōضsNjÞĶ
ɚOŘOɴ OȖǣs_ Eɴ _sǼÌʰ NjsǣÞ¶ŘǼÞŸŘ sǼOʳ Ÿ¯ ƼsNjǣŸŘŘsĶʳ ǻÌs _sǼÞĶǣ Ÿ¯ ƼNjŸ¶NjŎǣ ¯ŸNj ¯ŎÞĶÞNjÞʊǼÞŸŘ Ÿ¯
a director, an effort shall be made, as far as ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNjǣɠÞǼÌɴŸȖNjNŸŎƼŘɴNjsɚÞĶEĶsŸŘǼÌs
possible, to appoint such a person in his place website of your Company at the link:
ɠÌŸ Ìǣ ǼÌs NjsĶsɚŘǼ sɮƼsNjÞsŘOs ÞŘ ǼÌs ¯ÞsĶ_ǣ ÌǼǼƼʲˀˀɠɠɠʳĠɴŸǼÌɴĶEŸNjǼŸNjÞsǣʳOŸŎˀ_ŎÞŘˀ_ŸOǣˀ
or disciplines in which the outgoing director ®ŎÞĶÞNjÞǣǼÞŸŘ̇ˡ˟ƻNjŸ¶NjŎŎs̬ğĵĵʳƻ^®
Ì_ ǼÌs sɮƼsNjÞsŘOs ŸNj ǼÌs ƼsNjǣŸŘ ɠÞǼÌ NjsĶsɚŘǼ
experience in the fields or disciplines which are MEETING OF INDEPENDENT DIRECTORS
ŘŸǼ NjsƼNjsǣsŘǼs_ ÞŘ ǼÌs DŸNj_ ǣ NjsLJȖÞǣÞǼs ǼŸ
Your Company’s Independent Directors meet at least once in
EȖǣÞŘsǣǣŸ¯ɴŸȖNjNŸŎƼŘɴʳ
sɚsNjɴʩŘŘOÞĶɴsNjɠÞǼÌŸȖǼǼÌsƼNjsǣsŘOsŸ¯rɮsOȖǼÞɚs^ÞNjsOǼŸNj
d) No preference on the basis of gender, religion or caste or Management Personnel and the meeting is conducted
ǣÌĶĶEs¶ÞɚsŘɠÌÞĶsOŸŘǣÞ_sNjÞضǼÌsƼƼŸÞŘǼŎsŘǼŸ¯ ÞŘ¯ŸNjŎĶĶɴʳ ^ȖNjÞض ǼÌs ɴsNj ȖŘ_sNj NjsɚÞsɠʰ ŸŘs ŎssǼÞض Ÿ¯
_ÞNjsOǼŸNjǣʳ ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNjǣɠǣÌsĶ_ŸŘōɴˡˤʰˡ˟ˠˤʳ
e) Generally, an effort shall be made to maintain
ǼÌs DŸNj_ _ÞɚsNjǣÞǼɴ Eɴ ƼƼŸÞŘǼŎsŘǼ Ÿ¯ ƼsNjǣŸŘǣ BOARD MEETINGS
¯NjŸŎ _ÞɚsNjǣs _ÞǣOÞƼĶÞŘsǣ ʹNjsĶsɚŘǼ ǼŸ ǼÌs ǻÌs DŸNj_ Ÿ¯ ^ÞNjsOǼŸNjǣ ŎsǼ ˥ ǼÞŎsǣ _ȖNjÞض ǼÌs ʩŘŘOÞĶ ɴsNj
Company’s business), of different age groups sŘ_s_ ˢˠst ōNjOÌʰ ˡ˟ˠ˥ ÞŘ OOŸNj_ŘOs ɠÞǼÌ ǼÌs ƼNjŸɚÞǣÞŸŘǣ Ÿ¯
and of both the genders (male as well as female) ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢŘ_NJȖĶsǣŎ_sǼÌsNjsȖŘ_sNjʳ
ǣ^ÞNjsOǼŸNjǣʳ
The dates on which the Board of Directors met during the
¯ʺ ɟÌÞĶs ƼƼŸÞŘǼÞض ÝŘ_sƼsŘ_sŘǼ ^ÞNjsOǼŸNjǣʰ ǼÌs ʩŘŘOÞĶ ɴsNj ȖŘ_sNj NjsɚÞsɠ Njs ƼNjŸɚÞ_s_ ÞŘ ǼÌs NŸNjƼŸNjǼs
criteria for the Independent Directors, as laid down µŸɚsNjŘŘOsNJsƼŸNjǼʳ
ÞŘ ǢsOǼÞŸŘ ˠˣ˨ ʹ˥ʺ Ÿ¯ ǼÌs NŸŎƼŘÞsǣ OǼʰ ˡ˟ˠˢ Ř_
ĵÞǣǼÞضNJs¶ȖĶǼÞŸŘǣNjs¯ŸĶĶŸɠs_ʳ AUDIT COMMITTEE
ǻÌsȖ_ÞǼNŸŎŎÞǼǼssŸ¯ɴŸȖNjNŸŎƼŘɴOŸŘǣÞǣǼǣŸ¯ŎĠŸNjÞǼɴŸ¯
REMUNERATION POLICY
ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNjǣŘ_ǼÌs_sǼÞĶs_OŸŎƼŸǣÞǼÞŸŘÞǣƼNjŸɚÞ_s_
Your Company follows the Policy on Remuneration of Directors ÞŘǼÌsNŸNjƼŸNjǼsµŸɚsNjŘŘOsNJsƼŸNjǼʳĶĶǼÌsNjsOŸŎŎsŘ_ǼÞŸŘǣ
Ř_ ǢsŘÞŸNj ōضsŎsŘǼ rŎƼĶŸɴssǣ ǣ ƼƼNjŸɚs_ Eɴ ǼÌs Ŏ_sEɴǼÌsȖ_ÞǼNŸŎŎÞǼǼssɠsNjsOOsƼǼs_EɴǼÌsDŸNj_ʳ
Nomination, Remuneration and Compensation Committee
Ř_ǼÌsDŸNj_ʳ_sǼÞĶs_NjsƼŸNjǼŸŘǼÌsǣŎsÞǣ¶ÞɚsŘÞŘǼÌs VIGIL MECHANISM/ WHISTLE BLOWER POLICY
NŸNjƼŸNjǼsµŸɚsNjŘŘOsNJsƼŸNjǼʳ ɳŸȖNjNŸŎƼŘɴÌǣəÞ¶ÞĶōsOÌŘÞǣŎÞŘƼĶOsɠÌÞOÌĶǣŸÞŘOĶȖ_sǣ
 ɟÌÞǣǼĶs DĶŸɠsNj ƻŸĶÞOɴ ÞŘ ǼsNjŎǣ Ÿ¯ ǼÌs ĵÞǣǼÞض NJs¶ȖĶǼÞŸŘǣ
PERFORMANCE EVALUATION
¯ŸNj ^ÞNjsOǼŸNjǣ Ř_ sŎƼĶŸɴssǣ Ÿ¯ ɴŸȖNj NŸŎƼŘɴ ǼŸ ƼNjŸɚÞ_s 
ÝŘ OOŸNj_ŘOs ɠÞǼÌ ǼÌs NŸŎƼŘÞsǣ OǼʰ ˡ˟ˠˢ Ř_ NJs¶ȖĶǼÞŸŘ ŎsOÌŘÞǣŎ ɠÌÞOÌ sŘǣȖNjsǣ _sLJȖǼs ǣ¯s¶ȖNj_ǣ ǼŸ rŎƼĶŸɴssǣ
ˣʹˡʺʹ¯ʺŸ¯ǼÌsĵÞǣǼÞضNJs¶ȖĶǼÞŸŘǣʰɴŸȖNjNŸŎƼŘɴÌǣ¯NjŎs_ Ř_^ÞNjsOǼŸNjǣ¯NjŸŎŘɴɚÞOǼÞŎÞʊǼÞŸŘŸŘNjÞǣÞضŸ¯OŸŘOsNjŘǣŸ¯
ƻŸĶÞOɴ¯ŸNjrɚĶȖǼÞŸŘŸ¯ƻsNj¯ŸNjŎŘOsŸ¯ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNjǣʰ ŘɴɚÞŸĶǼÞŸŘǣŸ¯Ķs¶ĶŸNjNjs¶ȖĶǼŸNjɴNjsLJȖÞNjsŎsŘǼǣʰÞŘOŸNjNjsOǼŸNj
DŸNj_ʰ NŸŎŎÞǼǼssǣ Ř_ ŸǼÌsNj ÝŘ_ÞɚÞ_ȖĶ ^ÞNjsOǼŸNjǣ ɠÌÞOÌ ŎÞǣNjsƼNjsǣsŘǼǼÞŸŘŸ¯ŘɴʩŘŘOÞĶǣǼǼsŎsŘǼǣŘ_NjsƼŸNjǼǣsǼOʳ
ÞŘOĶȖ_sǣONjÞǼsNjÞ¯ŸNjƼsNj¯ŸNjŎŘOssɚĶȖǼÞŸŘŸ¯ŗŸŘ˚rɮsOȖǼÞɚs
ǻÌsəÞ¶ÞĶōsOÌŘÞǣŎˀɟÌÞǣǼĶsDĶŸɠsNjƻŸĶÞOɴŸ¯ɴŸȖNjNŸŎƼŘɴ
^ÞNjsOǼŸNjǣŘ_rɮsOȖǼÞɚs^ÞNjsOǼŸNjǣʳLJȖsǣǼÞŸŘŘÞNjsÞǣ¯ŸNjŎȖĶǼs_
can be accessed from your Company’s website at the link:
¯ŸNj sɚĶȖǼÞŸŘ Ÿ¯ ƼsNj¯ŸNjŎŘOs Ÿ¯ ǼÌs DŸNj_ ¯ǼsNj ǼĨÞض ÞŘǼŸ
ÌǼǼƼʲˀˀɠɠɠʳĠɴŸǼÌɴĶEŸNjǼŸNjÞsǣʳOŸŎˀ_ŎÞŘˀ_ŸOǣˀğĵĵ̬əÞ¶ÞĶ̇ˡ˟
OŸŘǣÞ_sNjǼÞŸŘ ǣsɚsNjĶ ǣƼsOǼǣ ǣȖOÌ ǣ EŸNj_ OŸŎƼŸǣÞǼÞŸŘʰ
ōsOÌŘÞǣŎ̇ˡ˟ƻŸĶÞOɴ̬ŎsŘ_s_̬®ÞŘĶ̬ˡ˧˟ˠˡ˟ˠ˥ʳƼ_¯
ǣǼNjǼs¶ÞOŸNjÞsŘǼǼÞŸŘʰEŸNj_¯ȖŘOǼÞŸŘÞضŘ_ǼsŎ_ɴŘŎÞOǣʳ
ǻÌs sŎƼĶŸɴssǣ Ÿ¯ ɴŸȖNj NŸŎƼŘɴ Ìɚs ǼÌs NjÞ¶ÌǼˀ ŸƼǼÞŸŘ ǼŸ
ƻsNj¯ŸNjŎŘOs sɚĶȖǼÞŸŘ Ÿ¯ ÝŘ_sƼsŘ_sŘǼ ^ÞNjsOǼŸNjǣ ɠǣ
NjsƼŸNjǼǼÌsÞNjOŸŘOsNjŘˀ¶NjÞsɚŘOsǼŸǼÌsNÌÞNjŎŘŸ¯ǼÌsȖ_ÞǼ
conducted by the Board of Directors, excluding the Director
NŸŎŎÞǼǼssʳ ^ȖNjÞض ǼÌs ɴsNj ȖŘ_sNj NjsɚÞsɠʰ ŘŸ ƼNjŸǼsOǼs_
EsÞض sɚĶȖǼs_ʳ ǻÌs ONjÞǼsNjÞ ¯ŸNj ƼsNj¯ŸNjŎŘOs sɚĶȖǼÞŸŘ
_ÞǣOĶŸǣȖNjs ¯NjŸŎ Řɴ ɟÌÞǣǼĶs DĶŸɠsNj ɠǣ NjsOsÞɚs_ Eɴ ǼÌs
of Independent Directors laid down by the Nomination,
_sǣÞ¶ŘǼs_Ÿ¯ʩOsNjȖŘ_sNjǼÌsəÞ¶ÞĶōsOÌŘÞǣŎʳ
Remuneration and Compensation Committee include
sǼÌÞOǣ Ř_ ɚĶȖsǣʰ ĨŘŸɠĶs_¶s Ř_ ƼNjŸʩOÞsŘOɴʰ _ÞĶÞ¶sŘOsʰ
RISK MANAGEMENT
EsÌɚÞŸNjĶ ǼNjÞǼǣ Ř_ s¯¯ŸNjǼǣ ¯ŸNj ƼsNjǣŸŘĶ _sɚsĶŸƼŎsŘǼʳ
ǢÞŎÞĶNjĶɴʰ ƼsNj¯ŸNjŎŘOs sɚĶȖǼÞŸŘ Ÿ¯ ǼÌs NÌÞNjŎŘ Ř_ ŗŸŘ The Board of Directors of your Company has designed a
Independent Directors was carried out by the Independent Risk Management Policy in a structured manner taking into
^ÞNjsOǼŸNjǣʳɳŸȖNj^ÞNjsOǼŸNjǣĶǣŸsɮƼNjsǣǣs_ǼÌsÞNjǣǼÞǣ¯OǼÞŸŘɠÞǼÌ consideration the following factors and the same is monitored
ǼÌssɚĶȖǼÞŸŘƼNjŸOsǣǣʳ ŸŘƼsNjÞŸ_ÞOEǣÞǣEɴǼÌsrɮsOȖǼÞɚs^ÞNjsOǼŸNjǣŸ¯ɴŸȖNjNŸŎƼŘɴʳ
NŸNjƼŸNjǼsŷɚsNjɚÞsɠ Performance Governance Financial Statements ˤ˨

ˠʳ ǻÌsōضsŎsŘǼƼƼNjŸOÌʱ ǻÌsŗŸǼsǣŸŘʩŘŘOÞĶǣǼǼsŎsŘǼNjs¯sNjNjs_ǼŸÞŘǼÌsȖ_ÞǼŸNjǣ˅


ˡʳ ğĵĵ˅ǣəÞǣÞŸŘ˓ōÞǣǣÞŸŘʱ Report are self explanatory and do not call for any further
OŸŎŎsŘǼǣʳ ǻÌs Ȗ_ÞǼŸNjǣ˅ NJsƼŸNjǼ _Ÿsǣ ŘŸǼ OŸŘǼÞŘ Řɴ
ˢʳ ħsɴDȖǣÞŘsǣǣµŸĶǣʱ
LJȖĶÞʩOǼÞŸŘʰNjsǣsNjɚǼÞŸŘŸNj_ɚsNjǣsNjsŎNjĨʳ
ˣʳ NJÞǣĨĵÞENjNjɴʱ
ˤʳ NJÞǣĨōضsŎsŘǼ®ŸOȖǣʳ Cost Audit
Also, the Management has adopted the following 5 step ǣ ƼsNj ǣsOǼÞŸŘ ˠˣ˧ Ÿ¯ ǼÌs NŸŎƼŘÞsǣ OǼʰ ˡ˟ˠˢ Njs_ ɠÞǼÌ
ƼƼNjŸOÌĨssƼÞضÞŘɚÞsɠɴŸȖNjNŸŎƼŘɴ˅ǣəÞǣÞŸŘŘ_ōÞǣǣÞŸŘʲ Companies (Cost Records and Audits) Rules, 2014, as amended,
˒ Ý_sŘǼÞ¯ɴÞض˄ħsɴ˅DȖǣÞŘsǣǣ¶ŸĶǣʱ the Board of Directors of your Company on recommendation of
ǼÌsȖ_ÞǼNŸŎŎÞǼǼssʰƼƼŸÞŘǼs_ōˀǣNJʳŗŘEÌŸɴ˓NŸʳʰNŸǣǼ
˒ Ý_sŘǼÞ¯ɴÞضǼÌsNJÞǣĨōضsŎsŘǼ¯ŸOȖǣʱ
OOŸȖŘǼŘǼǣʰ ōȖŎEÞ ʹ®ÞNjŎ NJs¶ÞǣǼNjǼÞŸŘ ŗŸʳ ˟˟˟˟ˠ˟ʺ ǣ ǼÌs
˒ Ý_sŘǼÞ¯ɴÞضDȖǣÞŘsǣǣNjÞǣĨǣʱ NŸǣǼȖ_ÞǼŸNjǣǼŸONjNjɴŸȖǼǼÌsOŸǣǼȖ_ÞǼŸ¯ÞǼǣƼNjŸ_ȖOǼǣOŸɚsNjs_
˒ ƻNjÞŸNjÞǼÞʊÞضǼÌsÞ_sŘǼÞʩs_EȖǣÞŘsǣǣNjÞǣĨǣʱ ȖŘ_sNjǼÌsōÞŘÞǣǼNjɴŸ¯NŸNjƼŸNjǼs¯¯ÞNjǣŷNj_sNj_Ǽs_ğȖŘsˢ˟ʰ
˒ NJǼÞض ǼÌs OȖNjNjsŘǼ NjÞǣĨ ŎضsŎsŘǼ OƼEÞĶÞǼɴ ¯ŸNj ˡ˟ˠˣ ʹǣ ŎsŘ_s_ ŸŘ ^sOsŎEsNj ˢˠʰ ˡ˟ˠˣʺ ¯ŸNj ǼÌs ʩŘŘOÞĶ
Þ_sŘǼÞʩs_NjÞǣĨǣʳ ɴsNj ˡ˟ˠ˥˚ˠ˦ʳ ǻÌs NjsŎȖŘsNjǼÞŸŘ Ÿ¯ NŸǣǼ Ȗ_ÞǼŸNjǣ Ìǣ EssŘ
ƼƼNjŸɚs_EɴǼÌsDŸNj_Ÿ¯^ÞNjsOǼŸNjǣŸŘǼÌsNjsOŸŎŎsŘ_ǼÞŸŘŸ¯
®ȖNjǼÌsNj ɴŸȖNj NŸŎƼŘɴ Ì_ Þ_sŘǼÞʩs_ ħsɴ DȖǣÞŘsǣǣ µŸĶǣ ¯ŸNj
Ȗ_ÞǼNŸŎŎÞǼǼssŘ_ǼÌsNjsLJȖÞǣÞǼsNjsǣŸĶȖǼÞŸŘ¯ŸNjNjǼÞʩOǼÞŸŘŸ¯
ʩɚsɴsNjÌŸNjÞʊŸŘŘ_ĶÞENjNjɴŸ¯NjÞǣĨsɚsŘǼǣɠÌÞOÌOŸȖĶ_Es
remuneration of Cost Auditors by the members has been set
EŸǼǼĶsŘsOĨÞŘOÌÞsɚÞضǼÌsǣŎsʳ¯ǼsNj_sʩŘÞضǼÌsĨsɴEȖǣÞŘsǣǣ
out in the Notice of the 25th Annual General Meeting of your
¶ŸĶǣŘ_ǼÌsĶÞENjNjɴŸ¯NjÞǣĨsɚsŘǼǣʰɴŸȖNjNŸŎƼŘɴÞ_sŘǼÞʩs_ǼÌs
NŸŎƼŘɴʳ
¶ŸĶǣŸŘɠÌÞOÌǼÌsŎضsŎsŘǼɠŸȖĶ_¯ŸOȖǣʳ
ǻÌsƼƼŸÞŘǼŎsŘǼŸ¯ōˀǣNJʳŗŘEÌŸɴ˓NŸʳʰNŸǣǼOOŸȖŘǼŘǼǣʰ
INTERNAL CONTROL SYSTEMS ōȖŎEÞÞǣɠÞǼÌÞŘǼÌsƼNjsǣONjÞEs_ĶÞŎÞǼǣŸ¯NŸŎƼŘÞsǣOǼʰˡ˟ˠˢ
ɳŸȖNj NŸŎƼŘɴ Ìǣ _sLJȖǼs ÞŘǼsNjŘĶ OŸŘǼNjŸĶ ǣɴǣǼsŎǣ Ř_ Ř_¯Njss¯NjŸŎŘɴ_ÞǣLJȖĶÞʩOǼÞŸŘǣǣƼsOÞʩs_ǼÌsNjsȖŘ_sNjʳɳŸȖNj
ƼNjŸOs_ȖNjsǣ ÞŘ ƼĶOs ¯ŸNj s¯¯sOǼÞɚs Ř_ ǣŎŸŸǼÌ OŸŘ_ȖOǼ Ÿ¯ NŸŎƼŘɴÞǣÞŘNjsOsÞƼǼŸ¯ǼÌsNsNjǼÞʩOǼs¯NjŸŎǼÌsNŸǣǼȖ_ÞǼŸNjǣ
EȖǣÞŘsǣǣ Ř_ ǼŸ ŎssǼ sɮÞ¶sŘOÞsǣ Ÿ¯ ŸƼsNjǼÞŸŘ Ř_ ¶NjŸɠǼÌʳ OŸŘʩNjŎÞض ǼÌsÞNj ÞŘ_sƼsŘ_sŘOs Ř_ NjsĶǼÞŸŘǣÌÞƼ ŸŘ NjŎ˅ǣ
Your Company has set up Standard Operating Process (SOP), ĶsضǼÌEǣÞǣʳ
ƼNjŸOs_ȖNjsǣ Ř_ OŸŘǼNjŸĶǣ ƼNjǼ ¯NjŸŎ Njs¶ȖĶNj ÝŘǼsNjŘĶ Ȗ_ÞǼǣʳ
Secretarial Audit
NJŸĶsǣŘ_NjsǣƼŸŘǣÞEÞĶÞǼÞsǣÌɚsEssŘĶÞ__ŸɠŘʳōضsŎsŘǼ
Information System has been established which ensure that ÝŘǼsNjŎǣŸ¯ǢsOǼÞŸŘˡ˟ˣŸ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢʰǼÌsDŸNj_
_sLJȖǼs Ř_ OOȖNjǼs ÞŘ¯ŸNjŎǼÞŸŘ Þǣ ɚÞĶEĶs ¯ŸNj NjsƼŸNjǼÞض had appointed M/s Rathi & Associates, Company Secretaries,
Ř__sOÞǣÞŸŘŎĨÞضʳ ōȖŎEÞ ǼŸ ONjNjɴ ŸȖǼ ǢsONjsǼNjÞĶ Ȗ_ÞǼ ¯ŸNj ǼÌs ʩŘŘOÞĶ ɴsNj
ˡ˟ˠˤ˚ˠ˥ʳ ǻÌs NjsƼŸNjǼ Ÿ¯ ǼÌs ǢsONjsǼNjÞĶ Ȗ_ÞǼŸNj Þǣ ƼƼsŘ_s_
ÝŘǼsNjŘĶ Ȗ_ÞǼ Þǣ OŸŘ_ȖOǼs_ Eɴ ÞŘ_sƼsŘ_sŘǼ ʩNjŎ Ÿ¯ Ȗ_ÞǼŸNjǣʳ
ǣ ŘŘsɮȖNjs ǼŸ ǼÌÞǣ NjsƼŸNjǼʳ ǻÌs NjsƼŸNjǼ _Ÿsǣ ŘŸǼ OŸŘǼÞŘ Řɴ
ÝŘǼsNjŘĶȖ_ÞǼŸNjǣNjs¶ȖĶNjĶɴOÌsOĨǼÌs_sLJȖOɴŸ¯ǼÌsǣɴǣǼsŎʰ
LJȖĶÞʩOǼÞŸŘʰNjsǣsNjɚǼÞŸŘŸNj_ɚsNjǣsNjsŎNjĨʳ
ǼÌsÞNj ŸEǣsNjɚǼÞŸŘǣ Njs NjsɚÞsɠs_ Eɴ ǼÌs ŎضsŎsŘǼ Ř_
NjsŎs_ÞĶ ŎsǣȖNjsǣʰ ǣ ŘsOsǣǣNjɴʰ Njs ǼĨsŘʳ ÝŘǼsNjŘĶ Ȗ_ÞǼŸNjǣ
INSTANCES OF FRAUD, IF ANY REPORTED BY THE
report directly to the Chairman of the Audit Committee to
AUDITORS
ŎÞŘǼÞŘÞǼǣŸEĠsOǼÞɚÞǼɴŘ_ÞŘ_sƼsŘ_sŘOsʳ
ǻÌsNjs Ìɚs EssŘ ŘŸ ÞŘǣǼŘOsǣ Ÿ¯ Řɴ ¯NjȖ_ NjsƼŸNjǼs_ Eɴ ǼÌs
ɳŸȖNjNŸŎƼŘɴÌǣĶǣŸÞŘƼĶOs˄NŸŎƼĶÞŘOsǻŸŸĶ˅_sǣÞ¶Řs_
ǢǼǼȖǼŸNjɴ Ȗ_ÞǼŸNjǣ ȖŘ_sNj ǢsOǼÞŸŘ ˠˣˢʹˠˡʺ Ÿ¯ ǼÌs NŸŎƼŘÞsǣ
Ř_ ÞŎƼĶsŎsŘǼs_ Eɴ rNjŘǣǼ ˓ ɳŸȖضʰ ĵĵƻ ɠÌÞOÌ sŘǣȖNjsǣ
OǼʰˡ˟ˠˢʳ
OŸŎƼĶÞŘOs ɠÞǼÌ ǼÌs ƼNjŸɚÞǣÞŸŘǣ Ÿ¯ ĶĶ ƼƼĶÞOEĶs Ķɠǣ ǼŸ ɴŸȖNj
NŸŎƼŘɴ_sLJȖǼsĶɴŘ_s¯ʩOÞsŘǼĶɴʳ
TRANSFER OF AMOUNT TO INVESTOR EDUCATION AND
AUDITORS & AUDIT REPORTS PROTECTION FUND

Statutory Audit ƻȖNjǣȖŘǼǼŸǼÌsƼNjŸɚÞǣÞŸŘǣŸ¯ǢsOǼÞŸŘˡ˟ˤNŸ¯ǼÌsNŸŎƼŘÞsǣ


OǼʰ ˠ˨ˤ˥ʰ ǼÌs _ÞɚÞ_sŘ_ˀ ÞŘǼsNjsǣǼˀ Njs¯ȖŘ_ Ÿ¯ ƼƼĶÞOǼÞŸŘǣ
ōˀǣǢNJDN˓NŸĵĵƻʰNÌNjǼsNjs_OOŸȖŘǼŘǼǣʹÝNÝNJs¶ÞǣǼNjǼÞŸŘ
ɠÌÞOÌ NjsŎÞŘs_ ȖŘOĶÞŎs_ˀ ȖŘƼÞ_ ¯ŸNj  ƼsNjÞŸ_ Ÿ¯ ǣsɚsŘ
ŗŸʳ ˢˡˣ˨˧ˡrˀ rˢ˟˟˟˟ˢʺʰ ɠsNjs ƼƼŸÞŘǼs_ Eɴ ǼÌs ŎsŎEsNjǣ Ÿ¯
ɴsNjǣ¯NjŸŎǼÌs_ǼsŸ¯ǼNjŘǣ¯sNjǼŸȖŘƼÞ__ÞɚÞ_sŘ_ˀÞŘǼsNjsǣǼˀ
ɴŸȖNj NŸŎƼŘɴ Ǽ ǼÌs ˡˢrd Annual General Meeting (AGM)
Njs¯ȖŘ_ OOŸȖŘǼ ɠǣ NjsLJȖÞNjs_ ǼŸ Es ǼNjŘǣ¯sNjNjs_ ǼŸ ǼÌs
ÌsĶ_ ŸŘ Ȗ¶ȖǣǼ ˠˢʰ ˡ˟ˠˣ ¯ŸNj  ƼsNjÞŸ_ Ÿ¯ ǼÌNjss ɴsNjǣ Þʳsʳ ¯ŸNj
ÝŘɚsǣǼŸNj r_ȖOǼÞŸŘ Ř_ ƻNjŸǼsOǼÞŸŘ ®ȖŘ_ ʹÝrƻ®ʺ sǣǼEĶÞǣÌs_
ǼÌs ʩŘŘOÞĶ ɴsNjǣ ˡ˟ˠˣ˚ˠˤʰ ˡ˟ˠˤ˚ˠ˥ Ř_ ˡ˟ˠ˥˚ˠ˦ ǣȖEĠsOǼ ǼŸ
EɴǼÌsNsŘǼNjĶµŸɚsNjŘŎsŘǼŘ_ŘŸOĶÞŎǣÌĶĶĶÞs¶ÞŘǣǼǼÌs
ŘŘȖĶNjǼÞʩOǼÞŸŘEɴǼÌsǢÌNjsÌŸĶ_sNjǣÞŘǼÌsµōǣǼŸEsÌsĶ_
NŸŎƼŘɴʳ
¯ŸNj®ÞŘŘOÞĶɴsNjˡ˟ˠˤ˚ˠ˥Ř_ˡ˟ˠ˥˚ˠ˦ʳ
OOŸNj_ÞضĶɴʰ ǼÌs ȖŘOĶÞŎs_ˀ ȖŘƼÞ_ _ÞɚÞ_sŘ_ ¯ŸNj ǼÌs ɴsNj
ōsŎEsNjǣNjsNjsLJȖsǣǼs_ǼŸNjǼÞ¯ɴǼÌsƼƼŸÞŘǼŎsŘǼŸ¯ōˀǣǢNJDN
2007-08 which remained unpaid and unclaimed for a period
˓ NŸ ĵĵƻʰ NÌNjǼsNjs_ OOŸȖŘǼŘǼǣ ǣ ǢǼǼȖǼŸNjɴ Ȗ_ÞǼŸNjǣ ¯NjŸŎ
of 7 years has been transferred by your Company to the
the conclusion of the ensuing Annual General Meeting till the
Ýrƻ®ʳ
conclusion of the next Annual General Meeting in 2017 and
ǼŸ ȖǼÌŸNjÞʊs ǼÌs DŸNj_ ǼŸ ʩɮ ǼÌsÞNj NjsŎȖŘsNjǼÞŸŘ ¯ŸNj ǼÌs ɴsNj Your Company updates the details of unclaimed/ unpaid
ˡ˟ˠ˥˚ˠ˦ʳ _ÞɚÞ_sŘ_ŸŘÞǼǣɠsEǣÞǼsɚÞʊʳʰʹɠɠɠʳĠɴŸǼÌɴĶEŸNjǼŸNjÞsǣʳOŸŎ) and
60 Jyothy Laboratories Limited
Annual Report 2015-16

on MCA website (ɠɠɠʳŎOʳ¶ŸɚʳÞŘ) from time to time pursuant FOREIGN EXCHANGE EARNINGS AND OUTGO
ǼŸǼÌsƼNjŸɚÞǣÞŸŘǣŸ¯Ýrƻ®ʹȕƼĶŸ_ÞضŸ¯ÝŘ¯ŸNjŎǼÞŸŘNJs¶Nj_Þض The details of foreign exchange earnings and outgo are as
ȕŘƼÞ_Ř_ȕŘOĶÞŎs_ŎŸȖŘǼĵɴÞضɠÞǼÌNŸŎƼŘÞsǣʺNJȖĶsǣʰ below:
ˡ˟ˠˡʳ
(` in Crore)
®ȖNjǼÌsNjʰǼÌsȖŘƼÞ__ÞɚÞ_sŘ_ŎŸȖŘǼƼsNjǼÞŘÞضǼŸǼÌsʩŘŘOÞĶ
Particulars 2015-16 2014-15
ɴsNj ˡ˟˟˧˚˟˨ ɠÞĶĶ Es ǼNjŘǣ¯sNjNjs_ ǼŸ Ýrƻ® _ȖNjÞض ǼÌs ®ÞŘŘOÞĶ
ɳsNjˡ˟ˠ˥˚ˠ˦ʳ Foreign exchange earnings ˠˡʳˡ˨ ˠˣʳˢ˨
Foreign exchange outgo ˡ˥ʳ˨ˡ ˠˠʳ˧˥
EXTRACT OF ANNUAL RETURN
ǻÌsrɮǼNjOǼŸ¯ŘŘȖĶNJsǼȖNjŘǣƼNjsǣONjÞEs_ȖŘ_sNjǢsOǼÞŸŘ˨ˡʹˢʺ PARTICULARS OF EMPLOYEES
Ÿ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢŘ_NJȖĶsˠˡʹˠʺŸ¯ǼÌsNŸŎƼŘÞsǣ ƻNjǼÞOȖĶNjŸ¯sŎƼĶŸɴssǣǣNjsLJȖÞNjs_ȖŘ_sNjǢsOǼÞŸŘˠ˨˦ʹˠˡʺŸ¯
(Management and Administration) Rules, 2014 is appended as ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢNjs_ɠÞǼÌNŸŎƼŘÞsǣʹƼƼŸÞŘǼŎsŘǼ
ŘŘsɮȖNjsǼŸǼÌÞǣNJsƼŸNjǼʳ and Remuneration of Managerial Personnel) Rules, 2014 and
forming part of the Directors’ Report for the year ended March
EMPLOYEE RELATIONS ˢˠʰˡ˟ˠ˥Þǣ¶ÞɚsŘÞŘǣsƼNjǼsŘŘsɮȖNjsǼŸǼÌÞǣNJsƼŸNjǼʳ
ɳŸȖNj NŸŎƼŘɴ Ìǣ Ķɠɴǣ ƼNjŸɚÞ_s_  OŸŘ¶sŘÞĶ ǼŎŸǣƼÌsNjs
for work to all employees that is free from discrimination and CAUTIONARY NOTE
ÌNjǣǣŎsŘǼʳ rŎƼĶŸɴss NjsĶǼÞŸŘǣ NjsŎÞŘs_ OŸNj_ÞĶ _ȖNjÞض ǼÌs Certain statements in the “Management Discussion and
ɴsNjȖŘ_sNjNjsɚÞsɠʳ ŘĶɴǣÞǣˇ ǣsOǼÞŸŘ Ŏɴ Es ˄¯ŸNjɠNj_˚ĶŸŸĨÞض˅ʳ ǢȖOÌ ˄¯ŸNjɠNj_
ĶŸŸĨÞض˅ǣǼǼsŎsŘǼǣNjsǣȖEĠsOǼǼŸNjÞǣĨǣŘ_ȖŘOsNjǼÞŘǼÞsǣŘ_
PREVENTION OF SEXUAL HARASSMENT therefore actual results could be different from what your
ɳŸȖNj NŸŎƼŘɴ Ìǣ ¯NjŎs_ ˄ŘǼÞ ˛ ǢsɮȖĶ ËNjǣǣŎsŘǼ ƻŸĶÞOɴ˅ ^ÞNjsOǼŸNjǣsŘɚÞǣ¶sÞŘǼsNjŎǣŸ¯¯ȖǼȖNjsƼsNj¯ŸNjŎŘOsŘ_ŸȖǼĶŸŸĨʳ
at workplace and has constituted an Internal Complaints
NŸŎŎÞǼǼssʹÝNNʺǣƼsNjǼÌsNjsLJȖÞNjsŎsŘǼŸ¯ǢsɮȖĶËNjǣǣŎsŘǼ ACKNOWLEDGEMENT
Ÿ¯ɟŸŎsŘǼɟŸNjĨƼĶOsʹƻNjsɚsŘǼÞŸŘʰƻNjŸÌÞEÞǼÞŸŘŘ_NJs_NjsǣǣĶʺ The Board of Directors express their sincere appreciation
OǼʰˡ˟ˠˢŘ_ǼÌsNJȖĶsǣ¯NjŎs_ǼÌsNjsȖŘ_sNjʳŗŸOŸŎƼĶÞŘǼǣɠÞǼÌ for the contribution and commitment of the employees of
allegations of any sexual harassment were reported during the ɴŸȖNj NŸŎƼŘɴ Ř_ ¯ŸNj ǼÌs sɮOsĶĶsŘǼ ǣȖƼƼŸNjǼ ƼNjŸɚÞ_s_ Eɴ ǼÌs
ɴsNjȖŘ_sNjNjsɚÞsɠʳ Shareholders, customers, distributors, suppliers, bankers, media
Ř_ŸǼÌsNjǢǼĨsÌŸĶ_sNjǣʰ_ȖNjÞضǼÌsʩŘŘOÞĶɴsNjȖŘ_sNjNjsɚÞsɠʳ
FIXED DEPOSITS
ɳŸȖNjNŸŎƼŘɴ_Þ_ŘŸǼOOsƼǼˀNjsŘsɠŘɴʩɮs__sƼŸǣÞǼǣ¯NjŸŎ For and on behalf of the Board of Directors
ƼȖEĶÞO Ř_ ŘŸ ʩɮs_ _sƼŸǣÞǼǣ ɠsNjs ŸȖǼǣǼŘ_Þض ŸNj NjsŎÞŘs_ For Jyothy Laboratories Limited
ȖŘOĶÞŎs_ǣŸŘōNjOÌˢˠʰˡ˟ˠ˥ʳ

CONSERVATION OF ENERGY & TECHNOLOGY ABSORPTION M. P. Ramachandran


ɟÞǼÌ Njs¶Nj_ ǼŸ ǼÌs NjsLJȖÞNjsŎsŘǼǣ Ÿ¯ OŸŘǣsNjɚǼÞŸŘ Ÿ¯ sŘsNj¶ɴ Chairman & Managing Director
Ř_ǼsOÌŘŸĶŸ¶ɴEǣŸNjƼǼÞŸŘƼȖNjǣȖŘǼǼŸƼNjŸɚÞǣÞŸŘŸ¯ǢsOǼÞŸŘ (DIN: 00553406)
ˠˢˣ Ÿ¯ ǼÌs NŸŎƼŘÞsǣ OǼʰ ˡ˟ˠˢʰ Njs_ ɠÞǼÌ ǼÌs NŸŎƼŘÞsǣ
ʹOOŸȖŘǼǣʺ NJȖĶsǣʰ ˡ˟ˠˣʰ ɴŸȖNj NŸŎƼŘɴ Ìǣ ŘŸǼÌÞض ǣƼsOÞʩO
ǼŸNjsƼŸNjǼʳ ōȖŎEÞʰōɴˡˢʰˡ˟ˠ˥
Corporate Overview Performance Governance Financial Statements 61

ANNEXURE TO THE DIRECTORS’ REPORT

FORM AOC - I
STATEMENT CONTAINING THE SALIENT FEATURES OF THE FINANCIAL STATEMENT OF SUBSIDIARY /
ASSOCIATES / JOINT VENTURES.
ʹƻȖNjǣȖŘǼǼŸʩNjǣǼƼNjŸɚÞǣŸǼŸǣȖE˚ǣsOǼÞŸŘʹˢʺŸ¯ǢsOǼÞŸŘˠˡ˨Ÿ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢNjs_ɠÞǼÌNJȖĶsˤŸ¯ǼÌsNŸŎƼŘÞsǣ
ʹOOŸȖŘǼǣʺNJȖĶsǣʰˡ˟ˠˣʺ

Part “ A” :Subsidiaries

(`ÞŘĵOǣʺ
Sr. Name of the Subsidiary Jyothy Fabricare Jyothy Kallol Snoways Four Seasons Jyothy
No Company Services Limited Bangladesh Laundrers and Drycleaning Consumer
Limited Drycleaners Company Private Products
Private Ltd # Limited # Marketing Ltd

Country India Bangladesh India India India


Financial Year / Period April 1, 2015 to April 1, 2015 to April 1, 2015 to April 1, 2015 to April 1, 2015 to
March 31, 2016 March 31, 2016 March 31, 2016 March 31, 2016 March 31, 2016
Local Currency INR BDT INR INR INR
Exchange rate as on 1BDT
March 31, 2016 - = 0.82 INR - - -
1 Share Capital 2,385.00 801.84 100.00 220.70 1,491.00
2 Reserves & Surplus 107.64 (114.48) (9.45) (442.30) (47,274.00)
3 Total Assets 8,482.90 710.86 97.78 26.83 2,499.43
4 Total Liabilities 5,990.26 23.50 7.23 248.43 48282.43
5 Details of Investment 1,719.73 0.00 0.00 0.00 0.00
(except investment in
subsidiaries)
6 Turnover (Net) 3,386.63 766.16 0.00 193.30 7,146.77
7 ƻNjŸʩǼˀʹĵŸǣǣʺEs¯ŸNjs (1,405.24) 1.17 (0.55) (38.72) (3,606.15)
taxation
8 Provision for taxation 0.00 2.35 0.00 0.00 0.00
9 ƻNjŸʩǼˀʹĵŸǣǣʺ¯ǼsNj (1,405.24) (1.18) (0.55) (38.72) (3,606.15)
taxation
10 Proposed / Interim Nil Nil Nil Nil Nil
Dividend
11 % of shareholding 86.37% 75.00% 42.32% 86.37% 100.00%
˞ ǢŘŸɠɴǣĵȖŘ_NjsNjǣŘ_^NjɴOĶsŘsNjǣƻNjÞɚǼsĵÞŎÞǼs_Ř_®ŸȖNjǢsǣŸŘǣ^NjɴOĶsŘÞضNŸŎƼŘɴƻɚǼʳĵÞŎÞǼs_NjsǣȖEǣÞ_ÞNjÞsǣŸ¯
ğɴŸǼÌɴ®ENjÞONjsǢsNjɚÞOsǣĵÞŎÞǼs_

Notes:
ˠʳ ŗŸŘsŸ¯ǼÌsǣȖEǣÞ_ÞNjÞsǣŸ¯ǼÌsNŸŎƼŘɴNjsɴsǼǼŸOŸŎŎsŘOsŸƼsNjǼÞŸŘǣʳ
ˡʳ ŗŸŘsŸ¯ǼÌsǣȖEǣÞ_ÞNjÞsǣÌɚsEssŘĶÞLJȖÞ_Ǽs_ŸNjǣŸĶ__ȖNjÞضǼÌsɴsNjȖŘ_sNjNjsɚÞsɠʳËŸɠsɚsNjʰ_ȖNjÞضǼÌs®ÞŘŘOÞĶɴsNjˡ˟ˠˤ˚ˠ˥ʰ
ğɴŸǼÌɴNŸŘǣȖŎsNjƻNjŸ_ȖOǼǣōNjĨsǼÞضĵÞŎÞǼs_ʰǣǼsƼ_ŸɠŘǣȖEǣÞ_ÞNjɴŸ¯ǼÌsNŸŎƼŘɴʹ_ÞNjsOǼǣȖEǣÞ_ÞNjɴŸ¯sNjǣǼɠÌÞĶsǣǣŸOÞǼs_
ÝŘ_ȖǣǼNjÞsǣNŸŘǣȖŎsNjƻNjŸ_ȖOǼǣƻNjÞɚǼsĵÞŎÞǼs_ʺÌǣEsOŸŎs_ÞNjsOǼǣȖEǣÞ_ÞNjɴŸ¯ǼÌsNŸŎƼŘɴƼȖNjǣȖŘǼǼŸŎĶ¶ŎǼÞŸŘŸ¯
ǣǣŸOÞǼs_ÝŘ_ȖǣǼNjÞsǣNŸŘǣȖŎsNjƻNjŸ_ȖOǼǣƻNjÞɚǼsĵÞŎÞǼs_ɠÞǼÌğɴŸǼÌɴNŸŘǣȖŎsNjƻNjŸ_ȖOǼǣōNjĨsǼÞضĵÞŎÞǼs_ʳ
˥ˡ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

ANNEXURE TO THE DIRECTORS’ REPORT

Part ‘’B”: Associates and Joint Ventures

ǢǼǼsŎsŘǼƼȖNjǣȖŘǼǼŸǢsOǼÞŸŘˠˡ˨ʹˢʺŸ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢNjsĶǼs_ǼŸǣǣŸOÞǼsNŸŎƼŘÞsǣŘ_ğŸÞŘǼəsŘǼȖNjsǣ
(`ÞŘĵOǣʺ
Name of Joint Venture ğ®Ǣĵ˛ğĵĵğəʹƻNjǼŘsNjǣÌÞƼʩNjŎʺ
ĵǼsǣǼȖ_ÞǼs_DĶŘOsǢÌssǼ^Ǽs ōNjOÌˢˠʰˡ˟ˠ˥
ǢÌNjsǣŸ¯ǣǣŸOÞǼsˀğŸÞŘǼəsŘǼȖNjsǣÌsĶ_EɴǼÌsOŸŎƼŘɴŸŘǼÌsɴsNjsŘ_ʲ
ˠʳ ŗŸʳ Partnership Interest 25%
ˡʳ ŎŸȖŘǼŸ¯ÝŘɚsǣǼŎsŘǼÞŘğŸÞŘǼəsŘǼȖNjs 84.75
ˢʳ rɮǼsŘǼŸ¯ËŸĶ_Þضʹ̇ʺ ˡˤ̇
^sǣONjÞƼǼÞŸŘŸ¯ÌŸɠǼÌsNjsÞǣǣÞ¶ŘÞʩOŘǼÞŘʪȖsŘOs NŸŘǼNjŸĶŸ¯DȖǣÞŘsǣǣ_sOÞǣÞŸŘǣȖŘ_sNjƻNjǼŘsNjǣÌÞƼ_ss_ʳ
NJsǣŸŘɠÌɴǼÌsĠŸÞŘǼɚsŘǼȖNjsÞǣŘŸǼOŸŘǣŸĶÞ_Ǽs_ ŗʳ
ŗsǼɠŸNjǼÌǼǼNjÞEȖǼEĶsǼŸǢÌNjsÌŸĶ_ÞضǣƼsNjĶǼsǣǼȖ_ÞǼs_DĶŘOsǢÌssǼˎ ˡ˦ˤʳ˥˨
ƻNjŸʩǼˀĵŸǣǣ¯ŸNjǼÌsɴsNj
Þʳ NŸŘǣÞ_sNjs_ÞŘNŸŘǣŸĶÞ_ǼÞŸŘˎ ʹˡ˨ʳˡ˟ʺ
ÞÞ ŗŸǼNŸŘǣÞ_sNjs_ÞŘNŸŘǣŸĶÞ_ǼÞŸŘ ˚

ˠʳ ŗŸŘsŸ¯ǼÌsǣǣŸOÞǼsǣŸNjĠŸÞŘǼɚsŘǼȖNjsǣŸ¯ǼÌsNŸŎƼŘɴNjsɴsǼǼŸOŸŎŎsŘOsŸƼsNjǼÞŸŘǣʳ
ˡʳ ŗŸŘsŸ¯ǼÌsǣǣŸOÞǼsǣŸNjĠŸÞŘǼɚsŘǼȖNjsǣŸ¯ǼÌsNŸŎƼŘɴÌɚsEssŘĶÞLJȖÞ_Ǽs_ŸNjǣŸĶ__ȖNjÞضǼÌsɴsNjȖŘ_sNjNjsɚÞsɠʳ
ˢʳ ǻÌsNŸŎƼŘɴ_ŸsǣŘŸǼÌɚsŘɴǣǣŸOÞǼsOŸŎƼŘɴʳ
 ˎNJsƼNjsǣsŘǼǣ¶NjŸȖƼǣÌNjsǣÞŘƼNjǼŘsNjǣÌÞƼʩNjŎʳ

For and on behalf of the Board of Directors


For Jyothy Laboratories Limited

M.P. Ramachandran K. Ullas Kamath


Chairman and Joint Managing Director
ōضÞض^ÞNjsOǼŸNj Ř_NÌÞs¯®ÞŘŘOÞĶŷ¯ʩOsNj
DIN: 00553406 DIN: 00506681

S. Raghunandan M.L. Bansal


Whole Time Director and Chief Company Secretary
rɮsOȖǼÞɚsŷ¯ʩOsNj ōsŎEsNjǣÌÞƼŗŸʳʲ®ˡˡ˨˦
DIN: 02263845

ƻĶOsʲōȖŎEÞ
ōɴˡˢʰˡ˟ˠ˥
Corporate Overview Performance Governance Financial Statements ˥ˢ

ANNEXURE TO THE DIRECTORS’ REPORT

PARTICULARS OF CONTRACTS/ ARRANGEMENTS MADE WITH RELATED PARTIES


Form No. AOC-2
ʻƻȖNjǣȖŘǼǼŸOĶȖǣsʹÌʺŸ¯ǣȖE˚ǣsOǼÞŸŘʹˢʺŸ¯ǣsOǼÞŸŘˠˢˣŸ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢŘ_NJȖĶs˧ʹˡʺŸ¯ǼÌsNŸŎƼŘÞsǣ
ʹOOŸȖŘǼǣʺNJȖĶsǣʰˡ˟ˠˣʼ

1. Details of Contracts or arrangements or transactions not at arm’s length basis:

ʹʺ ŗŎsʹǣʺŸ¯ǼÌsNjsĶǼs_ƼNjǼɴŘ_ŘǼȖNjsŸ¯NjsĶǼÞŸŘǣÌÞƼ
ʹEʺ ŗǼȖNjsŸ¯OŸŘǼNjOǼǣˀNjNjضsŎsŘǼǣˀǼNjŘǣOǼÞŸŘǣ
ʹOʺ ^ȖNjǼÞŸŘŸ¯ǼÌsOŸŘǼNjOǼǣˀNjNjضsŎsŘǼǣˀǼNjŘǣOǼÞŸŘǣ
ʹ_ʺ ǢĶÞsŘǼǼsNjŎǣŸ¯ǼÌsOŸŘǼNjOǼǣŸNjNjNjضsŎsŘǼǣŸNjǼNjŘǣOǼÞŸŘǣÞŘOĶȖ_ÞضǼÌs
ɚĶȖsʰÞ¯Řɴ
NIL
ʹsʺ ğȖǣǼÞʩOǼÞŸŘ¯ŸNjsŘǼsNjÞضÞŘǼŸǣȖOÌOŸŘǼNjOǼǣŸNjNjNjضsŎsŘǼǣŸNjǼNjŘǣOǼÞŸŘǣ
ʹ¯ʺ ^ǼsʹǣʺŸ¯ƼƼNjŸɚĶEɴǼÌsDŸNj_
ʹ¶ʺ ŎŸȖŘǼƼÞ_ǣ_ɚŘOsǣʰÞ¯Řɴ
ʹÌʺ ^ǼsŸŘɠÌÞOÌǼÌsǣƼsOÞĶNjsǣŸĶȖǼÞŸŘɠǣƼǣǣs_ÞضsŘsNjĶŎssǼÞضǣ
NjsLJȖÞNjs_ȖŘ_sNjʩNjǣǼƼNjŸɚÞǣŸǼŸǢsOǼÞŸŘˠ˧˧

2. Details of material Contracts or arrangements or transactions at arm’s length basis:

ʹʺ ŗŎsʹǣʺŸ¯ǼÌsNjsĶǼs_ƼNjǼɴŘ_ŘǼȖNjsŸ¯NjsĶǼÞŸŘǣÌÞƼ
ʹEʺ ŗǼȖNjsŸ¯OŸŘǼNjOǼǣˀNjNjضsŎsŘǼǣˀǼNjŘǣOǼÞŸŘǣ
ʹOʺ ^ȖNjǼÞŸŘŸ¯ǼÌsOŸŘǼNjOǼǣˀNjNjضsŎsŘǼǣˀǼNjŘǣOǼÞŸŘǣ
ʹ_ʺ ǢĶÞsŘǼǼsNjŎǣŸ¯ǼÌsOŸŘǼNjOǼǣŸNjNjNjضsŎsŘǼǣŸNjǼNjŘǣOǼÞŸŘǣÞŘOĶȖ_ÞضǼÌs NIL
ɚĶȖsʰÞ¯Řɴ
ʹsʺ ^ǼsʹǣʺŸ¯ƼƼNjŸɚĶEɴǼÌsDŸNj_
ʹ¯ʺ ŎŸȖŘǼƼÞ_ǣ_ɚŘOsǣʰÞ¯Řɴ

For and on behalf of the Board of Directors


For Jyothy Laboratories Limited

M. P. Ramachandran
Chairman and Managing Director
(DIN: 00553406)

ƻĶOsʲōȖŎEÞʰ
ōɴˡˢʰˡ˟ˠ˥
˥ˣ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

ANNEXURE TO THE DIRECTORS’ REPORT

ANNUAL REPORT ON CSR ACTIVITIES   ÞŎƼŸNjǼŘOsŘ_ɠŸNjĨǣŸ¯NjǼʱǣsǼǼÞضȖƼƼȖEĶÞOĶÞENjNjÞsǣʱ


  ƼNjŸŎŸǼÞŸŘ Ř_ _sɚsĶŸƼŎsŘǼ Ÿ¯ ǼNj_ÞǼÞŸŘĶ NjǼǣ Ř_
ˠʳ  ENjÞs¯ ŸȖǼĶÞŘs Ÿ¯ ǼÌs NŸŎƼŘɴ˅ǣ NǢNJ ƼŸĶÞOɴʰ ÞŘOĶȖ_Þض   ÌŘ_ÞONj¯Ǽǣʱ
 ŸɚsNjɚÞsɠŸ¯ƼNjŸĠsOǼǣŸNjƼNjŸ¶NjŎǣƼNjŸƼŸǣs_ǼŸEsȖŘ_sNjǼĨsŘ
 Ř_Njs¯sNjsŘOsǼŸǼÌsɠsE˚ĶÞŘĨǼŸǼÌsNǢNJƼŸĶÞOɴŘ_ƼNjŸĠsOǼ  ɚÞʺ ŎsǣȖNjsǣ¯ŸNjǼÌsEsŘsʩǼŸ¯NjŎs_¯ŸNjOsǣɚsǼsNjŘǣʰɠNj
 ŸNjƼNjŸ¶NjŎǣʳ   ɠÞ_ŸɠǣŘ_ǼÌsÞNj_sƼsŘ_sŘǼǣʱ

 ǻÌsNŸŎƼŘɴÌǣ¯NjŎs_NǢNJƻŸĶÞOɴÞŘOŸŎƼĶÞŘOsɠÞǼÌ  ɚÞÞʺ ǼNjÞŘÞضǼŸƼNjŸŎŸǼsNjȖNjĶǣƼŸNjǼǣʰŘǼÞŸŘĶĶɴNjsOŸ¶ŘÞǣs_


 ǼÌsƼNjŸɚÞǣÞŸŘǣŸ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢŘ_ǼÌsǣŎsÞǣ   ǣƼŸNjǼǣʰƼNjĶɴŎƼÞOǣƼŸNjǼǣŘ_ŷĶɴŎƼÞOǣƼŸNjǼǣʱ
 ȖƼĶŸ_s_ŸŘǼÌsNŸŎƼŘɴ˅ǣɠsEǣÞǼsŘ_OŘEsOOsǣǣs_Ǽ
 ǼÌsɠsEĶÞŘĨƼNjŸɚÞ_s_EsĶŸɠʲ  ɚÞÞÞʺ OŸŘǼNjÞEȖǼÞŸŘ ǼŸ ǼÌs ƻNjÞŎs ōÞŘÞǣǼsNj˅ǣ ŗǼÞŸŘĶ NJsĶÞs¯
  ®ȖŘ_ ŸNj Řɴ ŸǼÌsNj ¯ȖŘ_ ǣsǼ ȖƼ Eɴ ǼÌs NsŘǼNjĶ
ÌǼǼƼʲˀˀɠɠɠʳĠɴŸǼÌɴĶEŸNjǼŸNjÞsǣʳOŸŎˀ_ŎÞŘˀ_ŸOǣˀğĵĵ   µŸɚsNjŘŎsŘǼ ¯ŸNj ǣŸOÞŸ˚sOŸŘŸŎÞO _sɚsĶŸƼŎsŘǼ Ř_
NǢNJ̇ˡ˟ƻŸĶÞOɴ̬ɟsEǣÞǼsʳƼ_¯   NjsĶÞs¯ Ř_ ɠsĶ¯Njs Ÿ¯ ǼÌs ǢOÌs_ȖĶs_ NǣǼsǣʰ ǼÌs
  ǢOÌs_ȖĶs_ ǻNjÞEsǣʰ ŸǼÌsNj EOĨɠNj_ OĶǣǣsǣʰ ŎÞŘŸNjÞǼÞsǣ
 ǻÌs NŸŎƼŘɴ Ìǣ ȖŘ_sNjǼĨsŘ ƼNjŸĠsOǼǣ ÞŘ ǼÌs ǣĶȖŎ Njs   Ř_ɠŸŎsŘʱ
 _sɚsĶŸƼŎsŘǼʰǣŘÞǼǼÞŸŘŘ_ƼNjŸŎŸǼÞضs_ȖOǼÞŸŘǣƼNjǼ
 Ÿ¯ ÞǼǣ NǢNJ ÝŘÞǼÞǼÞɚs ¯ŸNj ǼÌs ʩŘŘOÞĶ ɴsNj ˡ˟ˠˤ˚ˠ˥ʳ ǻÌs  Þɮʺ OŸŘǼNjÞEȖǼÞŸŘǣ ŸNj ¯ȖŘ_ǣ ƼNjŸɚÞ_s_ ǼŸ ǼsOÌŘŸĶŸ¶ɴ
 OǼÞɚÞǼÞsǣ Ř_ ¯ȖŘ_Þض Njs ŎŸŘÞǼŸNjs_ ÞŘǼsNjŘĶĶɴ Eɴ ǼÌs   ÞŘOȖEǼŸNjǣĶŸOǼs_ɠÞǼÌÞŘO_sŎÞOÞŘǣǼÞǼȖǼÞŸŘǣɠÌÞOÌ
 NŸŎƼŘɴʳǻÌsNŸŎƼŘɴÌǣÞ_sŘǼÞʩs_ǼÌs¯ŸĶĶŸɠÞضʩsĶ_ǣ   NjsƼƼNjŸɚs_EɴǼÌsNsŘǼNjĶµŸɚsNjŘŎsŘǼʱ
 Ÿ¯ŸƼsNjǼÞŸŘ¯ŸNjǣƼsŘ_ÞضŸ¯sɮƼsŘ_ÞǼȖNjsǼŸɠNj_ǣNǢNJʲ
 ɮʺ NjȖNjĶ_sɚsĶŸƼŎsŘǼƼNjŸĠsOǼǣʱ
 Þʺ sNj_ÞOǼÞض ÌȖضsNjʰ ƼŸɚsNjǼɴ Ř_ ŎĶŘȖǼNjÞǼÞŸŘʰ
  ƼNjŸŎŸǼÞضƼNjsɚsŘǼÞɚsÌsĶǼÌONjsÞŘOĶȖ_ÞضǣŘÞǼǼÞŸŘ  ɮÞʺ ǣĶȖŎNjs_sɚsĶŸƼŎsŘǼʱ
  Ř_ŎŸNjsƼNjǼÞOȖĶNjĶɴOŸŘǼNjÞEȖǼÞŸŘǼŸǼÌsǢɠOÌDÌNjǼ
 ɮÞÞʺ ǣȖOÌŸǼÌsNjƼNjŸĠsOǼǣǣŎɴEsǣƼsOÞʩs_EɴǼÌsNsŘǼNjĶ
  ħŸǣÌ ǣsǼ˚ȖƼ Eɴ ǼÌs NsŘǼNjĶ µŸɚsNjŘŎsŘǼ ¯ŸNj ǼÌs
  µŸɚsNjŘŎsŘǼ¯NjŸŎǼÞŎsǼŸǼÞŎsʳ
  ƼNjŸŎŸǼÞŸŘ Ÿ¯ ǣŘÞǼǼÞŸŘ Ř_ ŎĨÞض ɚÞĶEĶs ǣ¯s
  _NjÞŘĨÞضɠǼsNjʱ ˡʳ ǻÌsNŸŎƼŸǣÞǼÞŸŘŸ¯ǼÌsNǢNJNŸŎŎÞǼǼssʲ

 ÞÞʺ ƼNjŸŎŸǼÞض s_ȖOǼÞŸŘʰ ÞŘOĶȖ_Þض ǣƼsOÞĶ s_ȖOǼÞŸŘ  ōNjʳōʳƻʳNJŎOÌŘ_NjŘʰNÌÞNjŎŘʹNÌÞNjŎŘ˓ōضÞض


  Ř_ sŎƼĶŸɴŎsŘǼ sŘÌŘOÞض ɚŸOǼÞŸŘ ǣĨÞĶĶǣ sǣƼsOÞĶĶɴ ^ÞNjsOǼŸNjʺ
  ŎŸŘ¶ OÌÞĶ_NjsŘʰ ɠŸŎsŘʰ sĶ_sNjĶɴʰ Ř_ ǼÌs _Þ¯¯sNjsŘǼĶɴ
  EĶs_Ř_ĶÞɚsĶÞÌŸŸ_sŘÌŘOsŎsŘǼƼNjŸĠsOǼǣʱ  ōNjʳħʳƻʳƻ_ŎĨȖŎNjʰōsŎEsNjʹÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNjʺ

 ÞÞÞʺ ƼNjŸŎŸǼÞض ¶sŘ_sNj sLJȖĶÞǼɴʰ sŎƼŸɠsNjÞض ɠŸŎsŘʰ  ōǣʳōʳNJʳğɴŸǼÌɴʰōsŎEsNjʹɟÌŸĶsǻÞŎs^ÞNjsOǼŸNjʺ


  ǣsǼǼÞضȖƼÌŸŎsǣŘ_ÌŸǣǼsĶǣ¯ŸNjɠŸŎsŘŘ_ŸNjƼÌŘǣʱ
  ǣsǼǼÞضȖƼŸĶ_¶sÌŸŎsǣʰ_ɴONjsOsŘǼNjsǣŘ_ǣȖOÌ ˢʳ ɚsNj¶sŘsǼƼNjŸʩǼŸ¯ǼÌsNŸŎƼŘɴ¯ŸNjĶǣǼǼÌNjss®ÞŘŘOÞĶ
  ŸǼÌsNj ¯OÞĶÞǼÞsǣ ¯ŸNj ǣsŘÞŸNj OÞǼÞʊsŘǣ Ř_ ŎsǣȖNjsǣ ¯ŸNj  ɴsNjǣʲ`˨˦ʳ˥ˤNNjŸNjs
  Njs_ȖOÞضÞŘsLJȖĶÞǼÞsǣ¯Os_EɴǣŸOÞĶĶɴŘ_sOŸŘŸŎÞOĶĶɴ
ˣʳ ƻNjsǣONjÞEs_NǢNJsɮƼsŘ_ÞǼȖNjsʹǼɠŸƼsNjOsŘǼŸ¯ǼÌsŎŸȖŘǼǣ
  EOĨɠNj_¶NjŸȖƼǣʱ
 ÞŘÞǼsŎˢEŸɚsʺʲ`ˠ˨ˤʳˢ˟ĵOǣ
 Þɚʺ sŘǣȖNjÞض sŘɚÞNjŸŘŎsŘǼĶ ǣȖǣǼÞŘEÞĶÞǼɴʰ sOŸĶŸ¶ÞOĶ
ˤʳ ^sǼÞĶǣŸ¯NǢNJǣƼsŘǼ_ȖNjÞضǼÌs®ÞŘŘOÞĶɳsNjˡ˟ˠˤ˚ˠ˥
  EĶŘOsʰƼNjŸǼsOǼÞŸŘŸ¯ʪŸNjŘ_¯ȖŘʰŘÞŎĶɠsĶ¯Njsʰ
  ¶NjŸ¯ŸNjsǣǼNjɴʰ OŸŘǣsNjɚǼÞŸŘ Ÿ¯ ŘǼȖNjĶ NjsǣŸȖNjOsǣ Ř_  ʺ ǻŸǼĶ ŎŸȖŘǼ ǼŸ Es ǣƼsŘǼ ¯ŸNj ǼÌs ®ÞŘŘOÞĶ ɴsNjʲ
  ŎÞŘǼÞŘÞض LJȖĶÞǼɴ Ÿ¯ ǣŸÞĶʰ ÞNj Ř_ ɠǼsNj ÞŘOĶȖ_Þض `ˠ˨ˤʳˢ˟ĵOǣ
  OŸŘǼNjÞEȖǼÞŸŘ ǼŸ ǼÌs NĶsŘ µض ®ȖŘ_ ǣsǼ˚ȖƼ Eɴ ǼÌs
  NsŘǼNjĶµŸɚsNjŘŎsŘǼ¯ŸNjNjsĠȖɚsŘǼÞŸŘŸ¯NjÞɚsNjµضʱ  Eʺ ŎŸȖŘǼȖŘǣƼsŘǼʰÞ¯Řɴʲ`˥ʳ˟˦ĵOǣ

 ɚʺ ƼNjŸǼsOǼÞŸŘŸ¯ŘǼÞŸŘĶÌsNjÞǼ¶sʰNjǼŘ_OȖĶǼȖNjsÞŘOĶȖ_Þض  Oʺ ōŘŘsNjÞŘɠÌÞOÌǼÌsŎŸȖŘǼǣƼsŘǼ_ȖNjÞضǼÌsʩŘŘOÞĶ


  NjsǣǼŸNjǼÞŸŘ Ÿ¯ EȖÞĶ_Þضǣ Ř_ ǣÞǼsǣ Ÿ¯ ÌÞǣǼŸNjÞOĶ   ɴsNj_sǼÞĶs_EsĶŸɠʲ
Corporate Overview Performance Governance Financial Statements ˥ˤ

ANNEXURE TO THE DIRECTORS’ REPORT

ǻÌs_sǼÞĶǣNjsǣȖŘ_sNjʲ (`ÞŘĵOǣʺ
(1) (2) (3) (4) (5) (6) (7) (8)
Sr. CSR Project Sector in Projects or Amount outlay Amount spent Cumulative Amount
No or activity which the programs (budget) on the projects expenditure spent: Direct
Þ_sŘǼÞʩs_ project is 1) Local area or projects or or programs upto the or through
covered other programs wise Sub-heads: reporting implementing
2) Specify 1) Direct period agency
the State and expenditure
district where on projects
projects or 2) Overheads
programs were
undertaken
1 DȖÞĶ_ÞضŸ¯ Sanitation ǻNjÞOÌȖNj^ÞǣǼNjÞOǼʰ ˠˡʳ˦˧ ˠˤʳˣ˧ ˠˤʳˣ˧ ^ÞNjsOǼ
ǼŸÞĶsǼǣÞŘǢOÌŸŸĶ Kerala
ˡ ǢĶȖŎNjs ǢĶȖŎNjs ǻNjÞOÌȖNj^ÞǣǼNjÞOǼʰ ˠ˦˦ʳˤˡ ˠ˥˧ʳ˦ˤ ˠ˥˧ʳ˦ˤ ^ÞNjsOǼ
^sɚsĶŸƼŎsŘǼÞŘ ^sɚsĶŸƼŎsŘǼ Kerlala
_ÞɚǣÞNjs
ˢ Promotion of ƻNjŸŎŸǼÞض ħNjÞĨĶʰ ˤʳ˟˟ ˤʳ˟˟ ˤʳ˟˟ ǻNjȖǣǼ
r_ȖOǼÞŸŘ r_ȖOǼÞŸŘ ƻȖ_ȖOÌsNjNjɴ
ʹǻÌNjŸȖ¶ÌōŸNjĶ
r_ȖOǼÞŸŘ˓
NÌNjÞǼEĶs
ǻNjȖǣǼʺ
ˠ˨ˤʳˢ˟ ˠ˧˨ʳˡˢ ˠ˧˨ʳˡˢ

˥ʺ ÝŘOǣsǼÌsNŸŎƼŘɴÌǣ¯ÞĶs_ǼŸǣƼsŘ_ǼÌsǼɠŸƼsNjOsŘǼ ˦ʺ ǻÌs NÌÞNjŎŘ Ÿ¯ ǼÌs NǢNJ OŸŎŎÞǼǼss Ìǣ ¶ÞɚsŘ 
 Ÿ¯ ǼÌs ɚsNj¶s ŘsǼ ƼNjŸʩǼ Ÿ¯ ǼÌs ĶǼsǣǼ ®ÞŘŘOÞĶ ɳsNjǣ NjsǣƼŸŘǣÞEÞĶÞǼɴǣǼǼsŎsŘǼŸŘEsÌĶ¯Ÿ¯ǼÌsNǢNJNŸŎŎÞǼǼss
 ŸNjŘɴƼNjǼǼÌsNjsŸ¯ǼÌsNŸŎƼŘɴǣÌĶĶƼNjŸɚÞ_sǼÌsNjsǣŸŘ¯ŸNj ǼÌǼ ǼÌs ÞŎƼĶsŎsŘǼǼÞŸŘ Ř_ ŎŸŘÞǼŸNjÞض Ÿ¯ NǢNJ ƻŸĶÞOɴ
 ŘŸǼǣƼsŘ_ÞضǼÌsŎŸȖŘǼÞŘÞǼǣDŸNj_NjsƼŸNjǼʲ Þǣ ÞŘ  OŸŎƼĶÞŘOs ɠÞǼÌ NǢNJ ŸEĠsOǼÞɚsǣ Ř_ ƼŸĶÞOɴ Ÿ¯ ǼÌs
NŸŎƼŘɴʳ
 ǻÌsNŸŎƼŘɴɠǣNjsLJȖÞNjs_ǼŸǣƼsŘ_`ˠ˨ˤʳˢ˟ĵOǣʹˡ̇Ÿ¯
ǼÌsɚsNj¶sŘsǼƼNjŸʩǼǣŸ¯ĶǣǼǼÌNjssʩŘŘOÞĶɴsNjǣʺŸŘNǢNJ
OǼÞɚÞǼÞsǣ_ȖNjÞضǼÌsʩŘŘOÞĶɴsNjˡ˟ˠˤ˚ˠ˥ʳOOŸNj_ÞضĶɴʰǼÌs
NŸŎƼŘɴÌǣǣƼsŘǼ`ˠ˧˨ʳˡˢĵOǣŸŘNǢNJOǼÞɚÞǼÞsǣ_ȖNjÞض
ǼÌs ʩŘŘOÞĶ ɴsNj ˡ˟ˠˤ˚ˠ˥ Ř_ ǼÌs EĶŘOs ŎŸȖŘǼ Ÿ¯ For and on behalf of the Board of Directors
`˥ʳ˟˦ĵOɠÞĶĶEsǣƼsŘǼ_ȖNjÞضǼÌs®ÞŘŘOÞĶɳsNjˡ˟ˠ˥˚ˠ˦¯ŸNj For Jyothy Laboratories Limited
ÌŸȖǣÞضÞŘ_ÞɚǣÞNjsŸ¯ǻNjÞOÌȖNj^ÞǣǼNjÞOǼʳǻÌsǣÞ_ƼNjŸĠsOǼǣ
EsÞضOŸŘǣǼNjȖOǼÞŸŘƼNjŸĠsOǼǣÌɚsǼÞŎsĶÞŘsʳ M. P. Ramachandran
Chairman & Managing Director
 
 ŘsɮƼsŘ_ÞǼȖNjsŸ¯`ˣˤʳˤ˨ĵOɠÌÞOÌǣǼŸŸ_OŸŎŎÞǼǼs_¯NjŸŎ
and Chairman- CSR Committee
ǼÌsƼNjsɚÞŸȖǣʩŘŘOÞĶɴsNjǼŸɠNj_ǣǢĶȖŎNjs_sɚsĶŸƼŎsŘǼ
(DIN: 00553406)
ÞŘ_ÞɚǣÞNjsŸ¯ǻNjÞOÌȖNj^ÞǣǼNjÞOǼʹ`ˠˠʳˠ˥ĵOʺŘ_DȖÞĶ_Þض
Ÿ¯ǼŸÞĶsǼǣÞŘǣOÌŸŸĶÞŘǻNjÞOÌȖNj^ÞǣǼNjÞOǼʹ`ˢˣʳˣˢĵOʺɠǣǣƼsŘǼ ōȖŎEÞʰ
¯ŸNjǼÌsǣŎsƼȖNjƼŸǣs_ȖNjÞضǼÌsʩŘŘOÞĶɴsNjˡ˟ˠˤ˚ˠ˥ʳ ōɴˡˢʰˡ˟ˠ˥
66 Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

ANNEXURE TO THE DIRECTORS’ REPORT

Particulars of Loans, Guarantees and Investments


ŎŸȖŘǼŸȖǼǣǼŘ_ÞضǣǼōNjOÌˢˠʰˡ˟ˠ˥

Particulars Amount
(` in Crore)
ĵŸŘǣ¶ÞɚsŘ ˣ˦ˡʳˤ˟
µȖNjŘǼss¶ÞɚsŘˎ ˤˣʳˡ˨
ÝŘɚsǣǼŎsŘǼǣŎ_s
Current ˥˥ʳˡˣ
ŗŸŘ˚NȖNjNjsŘǼ ˡˣˢʳˠˢ
ˎNŸNjƼŸNjǼs¶ȖNjŘǼss¶ÞɚsŘ`˥˥ʳˠˡNNjŸNjsǣ˓ʩŘŘOÞĶsɮƼŸǣȖNjs`ˤˣʳˡ˨NNjŸNjsǣ

Name of Entity Relation Amount (` In Crore) Particulars of loan, guarantee Purpose for which the loans,
and investments guarantee and investments
are proposed to be utilized
ğɴŸǼÌɴNŸŘǣȖŎsNj ǢȖEǣÞ_ÞNjɴ ˢ˨ʳ˟˟ Loan ŗŸ __ÞǼÞŸŘĶ ĶŸŘ Ìǣ EssŘ
ƻNjŸ_ȖOǼǣōNjĨsǼÞض ¶ÞɚsŘ _ȖNjÞض ǼÌs ɴsNjʳ ǻÌs
ĵÞŎÞǼs_ʹğNƻōĵʺ ÞŘONjsǣsÞǣŸŘOOŸȖŘǼŸ¯ȖŘƼÞ_
ÞŘǼsNjsǣǼ__s_ǼŸǼÌsĶŸŘ¶ÞɚsŘ
Ř_ĶŸŘǼNjŘǣ¯sNjNjs_ŸŘOOŸȖŘǼ
Ÿ¯ ŎsNj¶sNj Ÿ¯ ǣǣŸOÞǼs_
ÝŘ_ȖǣǼNjÞsǣ NŸŘǣȖŎsNj ƻNjŸ_ȖOǼǣ
ƻNjÞɚǼsĵÞŎÞǼs_ɠÞǼÌğNƻōĵ
ōˀǣğ®Ǣĵ˛ğĵĵʹğəʺ ğŸÞŘǼəsŘǼȖNjs ˟ʳ˟ˤ Investment DȖǣÞŘsǣǣƻȖNjƼŸǣsʳ

For and on behalf of the Board of Directors


For Jyothy Laboratories Limited

M. P. Ramachandran
Chairman & Managing Director
(DIN: 00553406)
ōȖŎEÞʰōɴˡˢʰˡ˟ˠ˥
Corporate Overview Performance Governance Financial Statements ˥˦

ANNEXURE TO THE DIRECTORS’ REPORT

SECRETARIAL AUDIT REPORT


ʻƻȖNjǣȖŘǼǼŸǢsOǼÞŸŘˡ˟ˣʹˠʺŸ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢŘ_NJȖĶsŗŸʳ˨Ÿ¯ǼÌsNŸŎƼŘÞsǣ
ʹƼƼŸÞŘǼŎsŘǼŘ_NJsŎȖŘsNjǼÞŸŘŸ¯ōضsNjÞĶƻsNjǣŸŘŘsĶʺNJȖĶsǣʰˡ˟ˠˣʼ
FOR THE FINANCIAL YEAR ENDED 31ST MARCH 2016

ǻŸ ʹs¯¯sOǼÞɚsȖƼǼŸˠˣǼÌōɴˡ˟ˠˤʺŘ_ǼÌsǢsOȖNjÞǼÞsǣ
ǻÌsōsŎEsNjǣ Ř_ rɮOÌضs DŸNj_ Ÿ¯ ÝŘ_Þ ʹƻNjŸÌÞEÞǼÞŸŘ Ÿ¯
JYOTHY LABORATORIES LIMITED ÝŘǣÞ_sNj ǻNj_Þضʺ NJs¶ȖĶǼÞŸŘǣʰ ˡ˟ˠˤ ʹɠÞǼÌ s¯¯sOǼ
˄ȕĠĶËŸȖǣs˅ʰNJŎĨNjÞǣÌŘōŘ_ÞNjNJŸ_ʰ ¯NjŸŎˠˤǼÌōɴˡ˟ˠˤʺʱ
ħŸŘ_ÞɚÞǼʰŘ_ÌsNjÞʹrǣǼʺʰ
ōȖŎEÞ˚ˣ˟˟˟ˤ˨ ÞÞʳ ǻÌs ǢsOȖNjÞǼÞsǣ Ř_ rɮOÌضs DŸNj_ Ÿ¯ ÝŘ_Þ ʹǢÌNjs
Dǣs_rŎƼĶŸɴssDsŘsʩǼǣʺNJs¶ȖĶǼÞŸŘǣʰˡ˟ˠˣʱ
^sNjǢÞNjǣʰ
ɟs Ìɚs OŸŘ_ȖOǼs_ ǼÌs ǣsONjsǼNjÞĶ Ȗ_ÞǼ Ÿ¯ ǼÌs OŸŎƼĶÞŘOs ÞÞÞʳ ǻÌs ǢsOȖNjÞǼÞsǣ Ř_ rɮOÌضs DŸNj_ Ÿ¯ ÝŘ_Þ
Ÿ¯ ƼƼĶÞOEĶs ǣǼǼȖǼŸNjɴ ƼNjŸɚÞǣÞŸŘǣ Ř_ ǼÌs _ÌsNjsŘOs ǼŸ ¶ŸŸ_ ʹǢȖEǣǼŘǼÞĶ OLJȖÞǣÞǼÞŸŘ Ÿ¯ ǢÌNjsǣ Ř_ ǻĨsŸɚsNjǣʺ
OŸNjƼŸNjǼs¶ŸɚsNjŘŘOsƼNjOǼÞOsEɴJyothy Laboratories Limited NJs¶ȖĶǼÞŸŘǣʰˡ˟ˠˠʱ
ʹÌsNjsÞŘ¯ǼsNj OĶĶs_ ˆthe Companyˇʺʳ ǻÌs ǢsONjsǼNjÞĶ Ȗ_ÞǼ ɠǣ
OŸŘ_ȖOǼs_ÞŘŎŘŘsNjǼÌǼƼNjŸɚÞ_s_ȖǣNjsǣŸŘEĶsEǣÞǣ¯ŸNj Þɚʳ ǻÌs ǢsOȖNjÞǼÞsǣ Ř_ rɮOÌضs DŸNj_ Ÿ¯ ÝŘ_Þ ʹÝǣǣȖs
sɚĶȖǼÞض ǼÌs OŸNjƼŸNjǼs OŸŘ_ȖOǼǣ ˀ ǣǼǼȖǼŸNjɴ OŸŎƼĶÞŘOsǣ Ř_ Ř_ĵÞǣǼÞضŸ¯^sEǼǢsOȖNjÞǼÞsǣʺNJs¶ȖĶǼÞŸŘǣʰˡ˟˟˧ʱ
sɮƼNjsǣǣÞضŸȖNjŸƼÞŘÞŸŘǼÌsNjsŸŘʳ
ˡʳ ƻNjŸɚÞǣÞŸŘǣ Ÿ¯ ǼÌs ¯ŸĶĶŸɠÞض NJs¶ȖĶǼÞŸŘǣ Ř_ µȖÞ_sĶÞŘsǣ
Dǣs_ŸŘŸȖNjɚsNjÞʩOǼÞŸŘŸ¯ǼÌsNŸŎƼŘɴ˅ǣDŸŸĨǣʰƻƼsNjǣʰōÞŘȖǼsǣ ƼNjsǣONjÞEs_ȖŘ_sNjǼÌsǢsOȖNjÞǼÞsǣŘ_rɮOÌضsDŸNj_Ÿ¯ÝŘ_Þ
DŸŸĨǣʰ®ŸNjŎǣŘ_NJsǼȖNjŘǣʩĶs_Ř_ŸǼÌsNjNjsOŸNj_ǣŎÞŘǼÞŘs_Eɴ OǼʰˠ˨˨ˡʹ˄ǢrDÝOǼ˅ʺɠsNjsŘŸǼƼƼĶÞOEĶsǼŸǼÌsNŸŎƼŘɴ
ǼÌsNŸŎƼŘɴŘ_ĶǣŸǼÌsÞŘ¯ŸNjŎǼÞŸŘƼNjŸɚÞ_s_EɴǼÌsNŸŎƼŘɴʰ ȖŘ_sNjǼÌsʩŘŘOÞĶɴsNjȖŘ_sNjNjsƼŸNjǼʲ˚
ÞǼǣ Ÿ¯ʩOsNjǣʰ ¶sŘǼǣ Ř_ ȖǼÌŸNjÞʊs_ NjsƼNjsǣsŘǼǼÞɚsǣ _ȖNjÞض ǼÌs Þʳ ǻÌsǢsOȖNjÞǼÞsǣŘ_rɮOÌضsDŸNj_Ÿ¯ÝŘ_Þʹ^sĶÞǣǼÞض
OŸŘ_ȖOǼŸ¯ǣsONjsǼNjÞĶȖ_ÞǼʰɠsÌsNjsEɴNjsƼŸNjǼǼÌǼÞŘŸȖNjŸƼÞŘÞŸŘʰ Ÿ¯rLJȖÞǼɴǢÌNjsǣʺNJs¶ȖĶǼÞŸŘǣʰˡ˟˟˨ʱ
ǼÌs NŸŎƼŘɴ Ìǣʰ _ȖNjÞض ǼÌs ʩŘŘOÞĶ ɴsNj sŘ_s_ ˢˠst ōNjOÌʰ
ˡ˟ˠ˥ʰ OŸŎƼĶÞs_ ɠÞǼÌ ǼÌs ǣǼǼȖǼŸNjɴ ƼNjŸɚÞǣÞŸŘǣ ĶÞǣǼs_ ÌsNjsȖŘ_sNj ÞÞʳ ǻÌsǢsOȖNjÞǼÞsǣŘ_rɮOÌضsDŸNj_Ÿ¯ÝŘ_ÞʹDȖɴEOĨŸ¯
Ř_ ĶǣŸ ǼÌǼ ǼÌs NŸŎƼŘɴ Ìǣ ƼNjŸƼsNj DŸNj_ ƼNjŸOsǣǣsǣ Ř_ ǢsOȖNjÞǼÞsǣʺNJs¶ȖĶǼÞŸŘǣʰˠ˨˨˧ʱ
OŸŎƼĶÞŘOsŎsOÌŘÞǣŎÞŘƼĶOsǼŸǼÌssɮǼsŘǼʰÞŘǼÌsŎŘŘsNjŘ_
ǣȖEĠsOǼǼŸǼÌsNjsƼŸNjǼÞضŎ_sÌsNjsÞŘ¯ǼsNjʲ ÞÞÞʳ ǻÌsǢsOȖNjÞǼÞsǣŘ_rɮOÌضsDŸNj_Ÿ¯ÝŘ_ÞʹNJs¶ÞǣǼNjNjǣ
ǼŸ  ÝǣǣȖs Ř_ ǢÌNjs ǻNjŘǣ¯sNj ¶sŘǼǣʺ NJs¶ȖĶǼÞŸŘǣʰ
ˠʳ ɟs Ìɚs sɮŎÞŘs_ ǼÌs EŸŸĨǣʰ ƼƼsNjǣʰ ŎÞŘȖǼs EŸŸĨǣʰ
ˠ˨˨ˢʰNjs¶Nj_ÞضǼÌsNŸŎƼŘÞsǣOǼŘ__sĶÞضɠÞǼÌ
¯ŸNjŎǣ Ř_ NjsǼȖNjŘǣ ʩĶs_ Ř_ ŸǼÌsNj NjsOŸNj_ǣ ŎÞŘǼÞŘs_ Eɴ
OĶÞsŘǼʱŘ_
ğɴŸǼÌɴ ĵEŸNjǼŸNjÞsǣ ĵÞŎÞǼs_ ʹˆǼÌs NŸŎƼŘɴˇʺ ǣ ¶ÞɚsŘ ÞŘ
ŘŘsɮȖNjsÝʰ¯ŸNjǼÌsʩŘŘOÞĶɴsNjsŘ_s_ŸŘˢˠstōNjOÌʰˡ˟ˠ˥ʰ
Þɚʳ ǻÌs ǢsOȖNjÞǼÞsǣ Ř_ rɮOÌضs DŸNj_ Ÿ¯ ÝŘ_Þ ʹÝǣǣȖs Ÿ¯
OOŸNj_ÞضǼŸǼÌsƼNjŸɚÞǣÞŸŘǣŸ¯ʲ
NƼÞǼĶŘ_^ÞǣOĶŸǣȖNjsNJsLJȖÞNjsŎsŘǼǣʺNJs¶ȖĶǼÞŸŘǣʰˡ˟˟˨ʳ
 ʹÞʺ ǻÌsNŸŎƼŘÞsǣOǼʰˠ˨ˤ˥Ř_ˀŸNjǼÌsNŸŎƼŘÞsǣOǼʰ
ˡ˟ˠˢʹǼÌsOǼʺŘ_ǼÌsNjȖĶsǣŎ_sǼÌsNjsȖŘ_sNjʱ ˢʳ ƻNjŸɚÞǣÞŸŘǣŸ¯ǼÌs®ŸNjsÞ¶ŘrɮOÌضsōضsŎsŘǼOǼʰˠ˨˨˨
Ř_ ǼÌs NjȖĶsǣ Ř_ Njs¶ȖĶǼÞŸŘǣ Ŏ_s ǼÌsNjs ȖŘ_sNj ǼŸ ǼÌs
 ʹÞÞʺ ǻÌsǢsOȖNjÞǼÞsǣNŸŘǼNjOǼǣʹNJs¶ȖĶǼÞŸŘʺOǼʰˠ˨ˤ˥ʹ˄ǢNNJ˅ʺ
sɮǼsŘǼŸ¯rɮǼsNjŘĶNŸŎŎsNjOÞĶDŸNjNjŸɠÞضǣɠsNjsŘŸǼǼǼNjOǼs_
 Ř_ǼÌsNjȖĶsǣŎ_sǼÌsNjsȖŘ_sNjʱ
ǼŸǼÌsNŸŎƼŘɴÞŘǼÌsʩŘŘOÞĶɴsNjȖŘ_sNjNjsƼŸNjǼʳ
 ʹÞÞÞʺ ǻÌs ^sƼŸǣÞǼŸNjÞsǣ OǼʰ ˠ˨˨˥ Ř_ ǼÌs NJs¶ȖĶǼÞŸŘǣ Ř_
 Dɴs˚Ķɠǣ¯NjŎs_ǼÌsNjsȖŘ_sNjʱ ˣʳ ɟs ¯ȖNjǼÌsNj NjsƼŸNjǼ ǼÌǼʰ ÌɚÞض Njs¶Nj_ ǼŸ ǼÌs OŸŎƼĶÞŘOs
ǣɴǣǼsŎ ƼNjsɚÞĶÞض ÞŘ ǼÌs NŸŎƼŘɴ Ř_ ŸŘ sɮŎÞŘǼÞŸŘ Ÿ¯
 ʹÞɚʺ ®ŸNjsÞ¶Ř rɮOÌضs ōضsŎsŘǼ OǼʰ ˠ˨˨˨ Ř_ ǼÌs ǼÌsNjsĶsɚŘǼ_ŸOȖŎsŘǼǣŘ_NjsOŸNj_ǣÞŘƼȖNjǣȖŘOsǼÌsNjsŸ¯ʰ
 NjȖĶsǣŘ_Njs¶ȖĶǼÞŸŘǣŎ_sǼÌsNjsȖŘ_sNjǼŸǼÌssɮǼsŘǼ ŸŘǼsǣǼ˚OÌsOĨEǣÞǣʰǼÌsNŸŎƼŘɴÌǣOŸŎƼĶÞs_ɠÞǼÌŸǼÌsNj
 Ÿ¯ ®ŸNjsÞ¶Ř ^ÞNjsOǼ ÝŘɚsǣǼŎsŘǼ Ř_ ŷɚsNjǣsǣ ^ÞNjsOǼ OǼǣʰ ĵɠǣ Ř_ NJs¶ȖĶǼÞŸŘǣ ƼƼĶÞOEĶs ǣƼsOÞʩOĶĶɴ ǼŸ ǼÌs
 ÝŘɚsǣǼŎsŘǼʱ NŸŎƼŘɴǣŎsŘǼÞŸŘs_ÌsNjsȖŘ_sNjʲ
Þʳ ĵs¶ĶōsǼNjŸĶŸ¶ɴOǼʰˡ˟˟˨ʱ
 ʹɚʺ ǻÌs ¯ŸĶĶŸɠÞض NJs¶ȖĶǼÞŸŘǣ Ř_ µȖÞ_sĶÞŘsǣ ƼNjsǣONjÞEs_
 ȖŘ_sNjǼÌsǢsOȖNjÞǼÞsǣŘ_rɮOÌضsDŸNj_Ÿ¯ÝŘ_ÞOǼʰ
ÞÞʳ ĵs¶ĶōsǼNjŸĶŸ¶ɴʹƻOĨ¶s_NŸŎŎŸ_ÞǼÞsǣʺNJȖĶsǣʰˡ˟ˠˠʱ
 ˠ˨˨ˡʹ˄ǢrDÝOǼ˅ʺʲ˚
 Þʳ ǻÌs ǢsOȖNjÞǼÞsǣ Ř_ rɮOÌضs DŸNj_ Ÿ¯ ÝŘ_Þ ÞÞÞʳ rŘɚÞNjŸŘŎsŘǼʻƻNjŸǼsOǼÞŸŘʼOǼʰˠ˨˧˥ʱ
ʹƻNjŸÌÞEÞǼÞŸŘŸ¯ÝŘǣÞ_sNjǻNj_ÞضʺNJs¶ȖĶǼÞŸŘǣʰˠ˨˨ˡ
˥˧ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

ANNEXURE TO THE DIRECTORS’ REPORT

Þɚʳ ËʊNj_ŸȖǣɟǣǼsǣʻōضsŎsŘǼŘ_ËŘ_ĶÞضʼNJȖĶsǣʰ ŸEǼÞŘÞض ¯ȖNjǼÌsNj ÞŘ¯ŸNjŎǼÞŸŘ Ř_ OĶNjÞʩOǼÞŸŘǣ ŸŘ ǼÌs ¶sŘ_
ˠ˨˧˨ʱ ÞǼsŎǣEs¯ŸNjsǼÌsŎssǼÞضŘ_¯ŸNjŎsŘÞض¯ȖĶƼNjǼÞOÞƼǼÞŸŘǼǼÌs
ŎssǼÞضʳ
ɚʳ ÝŘǣsOǼÞOÞ_sǣOǼʰˠ˨˥˧ʱ
ōĠŸNjÞǼɴ_sOÞǣÞŸŘÞǣONjNjÞs_ǼÌNjŸȖ¶ÌɠÌÞĶsǼÌs_ÞǣǣsŘǼÞضŎsŎEsNjǣ˅
ɚÞʳ ^NjȖ¶ǣŘ_NŸǣŎsǼÞOǣOǼʰˠ˨ˣ˟ʱ ɚÞsɠǣʰÞ¯ŘɴʰNjsOƼǼȖNjs_Ř_NjsOŸNj_s_ǣƼNjǼŸ¯ǼÌsŎÞŘȖǼsǣʳ
 ɟs Ìɚs ĶǣŸ sɮŎÞŘs_ OŸŎƼĶÞŘOs ɠÞǼÌ ǼÌs ƼƼĶÞOEĶs ɟs¯ȖNjǼÌsNjNjsƼŸNjǼǼÌǼǼÌsNjsNjs_sLJȖǼsǣɴǣǼsŎǣŘ_ƼNjŸOsǣǣsǣ
OĶȖǣsǣŸ¯ǼÌs¯ŸĶĶŸɠÞضʲ ÞŘǼÌsNŸŎƼŘɴOŸŎŎsŘǣȖNjǼsɠÞǼÌǼÌsǣÞʊsŘ_ŸƼsNjǼÞŸŘǣŸ¯
ǼÌsNŸŎƼŘɴǼŸŎŸŘÞǼŸNjŘ_sŘǣȖNjsOŸŎƼĶÞŘOsɠÞǼÌƼƼĶÞOEĶs
ʹÞʺ ǢsONjsǼNjÞĶ ǢǼŘ_Nj_ǣ ÞǣǣȖs_ Eɴ ǼÌs ÝŘǣǼÞǼȖǼs Ÿ¯
ĶɠǣʰNjȖĶsǣʰNjs¶ȖĶǼÞŸŘǣŘ_¶ȖÞ_sĶÞŘsǣʳ
NŸŎƼŘɴǢsONjsǼNjÞsǣŸ¯ÝŘ_ÞȖŘ_sNjǼÌsƼNjŸɚÞǣÞŸŘǣŸ¯
NŸŎƼŘÞsǣOǼʰˡ˟ˠˢʱŘ_ ɟs¯ȖNjǼÌsNjNjsƼŸNjǼǼÌǼ_ȖNjÞضǼÌsɴsNjȖŘ_sNjNjsƼŸNjǼʰǼÌsNŸŎƼŘɴ
ÌǣŘŸǼȖŘ_sNjǼĨsŘŘɴsɚsŘǼˀOǼÞŸŘɠÌÞOÌɠŸȖĶ_ÌɚsŎĠŸNj
ʹÞÞʺ ǻÌsĵÞǣǼÞض¶NjssŎsŘǼǣsŘǼsNjs_ÞŘǼŸEɴǼÌsNŸŎƼŘɴ EsNjÞض ŸŘ ǼÌs NŸŎƼŘɴ˅ǣ ¯¯ÞNjǣ ÞŘ ƼȖNjǣȖŘOs Ÿ¯ ǼÌs EŸɚs
ɠÞǼÌǢǼŸOĨrɮOÌضsʹǣʺʹs¯¯sOǼÞɚsȖƼǼŸˢ˟ǼÌŗŸɚsŎEsNjʰ Njs¯sNjNjs_ Ķɠǣʰ NjȖĶsǣʰ Njs¶ȖĶǼÞŸŘǣʰ ¶ȖÞ_sĶÞŘsǣʰ ǣǼŘ_Nj_ǣʰ sǼOʳ
ˡ˟ˠˤʺŘ_ǼÌsǢsOȖNjÞǼÞsǣŘ_rɮOÌضsDŸNj_Ÿ¯ÝŘ_Þ Njs¯sNjNjs_ǼŸEŸɚsʳ
ʹĵÞǣǼÞض ŷEĶÞ¶ǼÞŸŘǣ Ř_ ^ÞǣOĶŸǣȖNjs NJsLJȖÞNjsŎsŘǼǣʺ
NJs¶ȖĶǼÞŸŘǣʰˡ˟ˠˤʹs¯¯sOǼÞɚs¯NjŸŎˠst^sOsŎEsNjʰˡ˟ˠˤʺʱ
For RATHI & ASSOCIATES
 ^ȖNjÞض ǼÌs ʩŘŘOÞĶ ɴsNj ȖŘ_sNj NjsƼŸNjǼʰ ǼÌs NŸŎƼŘɴ Ìǣ
COMPANY SECRETARIES
OŸŎƼĶÞs_ɠÞǼÌǼÌsƼNjŸɚÞǣÞŸŘǣŸ¯ǼÌsOǼʰNJȖĶsǣʰNJs¶ȖĶǼÞŸŘǣʰ
µȖÞ_sĶÞŘsǣʰǢǼŘ_Nj_ǣʰsǼOʳŎsŘǼÞŸŘs_EŸɚsʳ
HIMANSHU S. KAMDAR
We further report that: PARTNER
FCS No. 5171
ǻÌs DŸNj_ Ÿ¯ ^ÞNjsOǼŸNjǣ Ÿ¯ ǼÌs NŸŎƼŘɴ Þǣ _ȖĶɴ OŸŘǣǼÞǼȖǼs_ ɠÞǼÌ COP No. 3030
ƼNjŸƼsNj EĶŘOs Ÿ¯ rɮsOȖǼÞɚs ^ÞNjsOǼŸNjǣʰ ŗŸŘ˚rɮsOȖǼÞɚs ^ÞNjsOǼŸNjǣ
Ř_ ÝŘ_sƼsŘ_sŘǼ ^ÞNjsOǼŸNjǣʳ ŗŸ OÌضsǣ ÞŘ ǼÌs OŸŎƼŸǣÞǼÞŸŘ Ÿ¯
ƻĶOsʲōȖŎEÞ
ǼÌsDŸNj_Ÿ¯^ÞNjsOǼŸNjǣǼŸŸĨƼĶOs_ȖNjÞضǼÌsʩŘŘOÞĶɴsNjȖŘ_sNj
^Ǽsʲōɴˡˢʰˡ˟ˠ˥
NjsƼŸNjǼʳ

_sLJȖǼsŘŸǼÞOsÞǣ¶ÞɚsŘǼŸĶĶ_ÞNjsOǼŸNjǣǼŸǣOÌs_ȖĶsǼÌsDŸNj_ ŗŸǼsʲ ǻÌÞǣ NjsƼŸNjǼ ǣÌŸȖĶ_ Es Njs_ ɠÞǼÌ ŸȖNj ĶsǼǼsNj Ÿ¯ sɚsŘ _Ǽs
ōssǼÞضǣʰ ¶sŘ_ Ř_ _sǼÞĶs_ ŘŸǼsǣ ŸŘ ¶sŘ_ ɠsNjs ǣsŘǼ Ǽ ɠÌÞOÌ Þǣ ŘŘsɮs_ ǣ ŘŘsɮȖNjs ÝÝ Ř_ ¯ŸNjŎǣ Njs ÞŘǼs¶NjĶ ƼNjǼ Ÿ¯
ĶsǣǼǣsɚsŘ_ɴǣÞŘ_ɚŘOsʰŘ_ǣɴǣǼsŎsɮÞǣǼǣ¯ŸNjǣssĨÞضŘ_ ǼÌÞǣNjsƼŸNjǼʳ
Corporate Overview Performance Governance Financial Statements ˥˨

ANNEXURE TO THE DIRECTORS’ REPORT

ANNEXURE – I
ĵÞǣǼŸ¯_ŸOȖŎsŘǼǣɚsNjÞʩs_

ˠʳ ōsŎŸNjŘ_ȖŎŘ_NjǼÞOĶsǣŸ¯ǣǣŸOÞǼÞŸŘŸ¯ǼÌsNŸŎƼŘɴʱ
ˡʳ ŘŘȖĶNJsƼŸNjǼ¯ŸNjǼÌsʩŘŘOÞĶɴsNjsŘ_s_ˢˠstōNjOÌʰˡ˟ˠˤʱ
ˢʳ ōÞŘȖǼsǣ Ÿ¯ ǼÌs ŎssǼÞضǣ Ÿ¯ ǼÌs DŸNj_ Ÿ¯ ^ÞNjsOǼŸNjǣʰ Ȗ_ÞǼ NŸŎŎÞǼǼssʰ ŗŸŎÞŘǼÞŸŘ Ř_ NJsŎȖŘsNjǼÞŸŘ NŸŎŎÞǼǼssʰ ǢÌNjs
 ǻNjŘǣ¯sNj NŸŎŎÞǼǼssʰ ǢǼĨsÌŸĶ_sNjǣ˅ NJsĶǼÞŸŘǣÌÞƼ NŸŎŎÞǼǼss Ř_ NŸNjƼŸNjǼs ǢŸOÞĶ NJsǣƼŸŘǣÞEÞĶÞǼɴ NŸŎŎÞǼǼss ĶŸŘ¶ ɠÞǼÌ ǼÌs
 NjsǣƼsOǼÞɚsǼǼsŘ_ŘOsNJs¶ÞǣǼsNjǣÌsĶ__ȖNjÞضǼÌsʩŘŘOÞĶɴsNjȖŘ_sNjNjsƼŸNjǼʱ
ˣʳ ōÞŘȖǼsǣŸ¯µsŘsNjĶDŸ_ɴōssǼÞضǣÌsĶ__ȖNjÞضǼÌsʩŘŘOÞĶɴsNjȖŘ_sNjNjsƼŸNjǼʱ
ˤʳ ƻNjŸŸ¯Ÿ¯OÞNjOȖĶǼÞŸŘŘ__sĶÞɚsNjɴŸ¯ŘŸǼÞOsʰ¶sŘ_Ř_ŘŸǼsǣǼŸ¶sŘ_¯ŸNjDŸNj_Ř_NŸŎŎÞǼǼssŎssǼÞضǣʱ
˥ʳ ƻNjŸŸ¯Ÿ¯OÞNjOȖĶǼÞŸŘŸ¯_Nj¯ǼǣɠsĶĶǣOsNjǼÞʩs_ǣÞ¶Řs_DŸNj_Ř_NŸŎŎÞǼǼssŎssǼÞضǣŎÞŘȖǼsǣǣƼsNjǢsONjsǼNjÞĶǢǼŘ_Nj_ǣʱ
˦ʳ ƻŸĶÞOÞsǣ¯NjŎs_EɴǼÌsNŸŎƼŘɴʲ
 ˚ ƻŸĶÞOɴŸŘNJsĶǼs_ƻNjǼɴǻNjŘǣOǼÞŸŘǣʰ
 ˚ ƻŸĶÞOɴŸŘōǼsNjÞĶǢȖEǣÞ_ÞNjÞsǣʰ
 ˚ əÞ¶ÞĶōsOÌŘÞǣŎʰ
 ˚ NŸNjƼŸNjǼsǢŸOÞĶNJsǣƼŸŘǣÞEÞĶÞǼɴƻŸĶÞOɴʰ
 ˚ ŗŸŎÞŘǼÞŸŘ˓NJsŎȖŘsNjǼÞŸŘƻŸĶÞOɴʰ
 ˚ NJÞǣĨōضsŎsŘǼƻŸĶÞOɴ˓ƻNjŸOs_ȖNjsǣʰ
 ˚ ÝŘǼsNjŘĶ®ÞŘŘOÞĶNŸŘǼNjŸĶǣ
 ˚ ƻŸĶÞOɴ¯ŸNj^sǼsNjŎÞŘǼÞŸŘŸ¯ōǼsNjÞĶrɚsŘǼǣ
 ˚ NŸ_sŸ¯NŸŘ_ȖOǼ¯ŸNjÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNjǣʰ
 ˚ NŸ_sŸ¯NŸŘ_ȖOǼ¯ŸNjƻNjsɚsŘǼÞŸŘŸ¯ÝŘǣÞ_sNjǻNj_Þضʰ
 ˚ NŸ_sŸ¯ƻNjOǼÞOsǣŘ_ƻNjŸOs_ȖNjsǣ¯ŸNj®ÞNj^ÞǣOĶŸǣȖNjsŸ¯ȕŘƼȖEĶÞǣÌs_ƻNjÞOsǢsŘǣÞǼÞɚsÝŘ¯ŸNjŎǼÞŸŘʰ
 ˚ NjOÌÞɚĶƻŸĶÞOɴ
˧ʳ ǢǼǼȖǼŸNjɴNJs¶ÞǣǼsNjǣɚÞʊʳ
 ˚ NJs¶ÞǣǼsNjŸ¯NÌNj¶sǣʹ®ŸNjŎŗŸʳN˵˚˦ʺʱ
 ˚ NJs¶ÞǣǼsNjŸ¯^ÞNjsOǼŸNjǣ˓ħsɴōضsNjÞĶƻsNjǣŸŘŘsĶʱ
 ˚ NJs¶ÞǣǼsNjŸ¯^ÞNjsOǼŸNjǣ˅ǢÌNjsÌŸĶ_Þضʱ
 ˚ NJs¶ÞǣǼsNjŸ¯rŎƼĶŸɴssǢǼŸOĨŷƼǼÞŸŘǣʱ
 ˚ NJs¶ÞǣǼsNjŸ¯NŸŘǼNjOǼǣɠÞǼÌNJsĶǼs_ƻNjǼÞsǣʱŘ_OŸŘǼNjOǼǣŘ_DŸ_ÞsǣsǼOʳÞŘɠÌÞOÌ_ÞNjsOǼŸNjǣNjsÞŘǼsNjsǣǼs_ʹ®ŸNjŎŗŸʳōDƻ˚ˣʺʰ
  Ř_
 ˚ NJs¶ÞǣǼsNjŸ¯ĶŸŘǣʰ¶ȖNjŘǼssǣŘ_ǣsOȖNjÞǼɴŘ_OLJȖÞǣÞǼÞŸŘŎ_sEɴǼÌsNŸŎƼŘɴʹ®ŸNjŎŗŸʳōDƻ˚ˡʺʳ
˨ʳ NŸƼÞsǣŸ¯ŗŸǼÞOsʰ¶sŘ_Ř_ŗŸǼsǣǼŸ¶sŘ_ǣȖEŎÞǼǼs_ǼŸĶĶǼÌs_ÞNjsOǼŸNjǣˀŎsŎEsNjǣ¯ŸNjǼÌsDŸNj_ōssǼÞضǣŘ_NŸŎŎÞǼǼss
 ōssǼÞضǣǣɠsĶĶǣNjsǣŸĶȖǼÞŸŘǣƼǣǣs_EɴOÞNjOȖĶǼÞŸŘʱ
ˠ˟ʳ ^sOĶNjǼÞŸŘǣNjsOsÞɚs_¯NjŸŎǼÌs^ÞNjsOǼŸNjǣŸ¯ǼÌsNŸŎƼŘɴƼȖNjǣȖŘǼǼŸǼÌsƼNjŸɚÞǣÞŸŘǣŸ¯ǢsOǼÞŸŘˠ˧ˣʹˠʺʰǢsOǼÞŸŘˠ˥ˣʹˡʺŘ_ǢsOǼÞŸŘ
 ˠˣ˨ʹ˦ʺŸ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢʱ
ˠˠʳ ÝŘǼÞŎǼÞŸŘǣNjsOsÞɚs_¯NjŸŎ_ÞNjsOǼŸNjǣȖŘ_sNjǼÌsƼNjŸÌÞEÞǼÞŸŘŸ¯ÝŘǣÞ_sNjǻNj_ÞضNŸ_sʱ
ˠˡʳ r˚®ŸNjŎǣʩĶs_EɴǼÌsNŸŎƼŘɴʰ¯NjŸŎǼÞŎsǼŸǼÞŎsʰȖŘ_sNjƼƼĶÞOEĶsƼNjŸɚÞǣÞŸŘǣŸ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢŘ_ǼǼOÌŎsŘǼǣǼÌsNjsŸ¯
 _ȖNjÞضǼÌsʩŘŘOÞĶɴsNjȖŘ_sNjNjsƼŸNjǼʱ
ˠˢʳ ÝŘǼÞŎǼÞŸŘǣˀ_ŸOȖŎsŘǼǣˀNjsƼŸNjǼǣˀNjsǼȖNjŘǣʩĶs_ɠÞǼÌǼÌsǢǼŸOĨrɮOÌضsǣƼȖNjǣȖŘǼǼŸǼÌsƼNjŸɚÞǣÞŸŘǣŸ¯ĵÞǣǼÞض¶NjssŎsŘǼsŘǼsNjs_
 ɠÞǼÌ ǼÌs ǢǼŸOĨ rɮOÌضsǣ Ř_ ǼÌs ǢsOȖNjÞǼÞsǣ Ř_ rɮOÌضs DŸNj_ Ÿ¯ ÝŘ_Þ ʹĵÞǣǼÞض ŷEĶÞ¶ǼÞŸŘǣ Ř_ ^ÞǣOĶŸǣȖNjs NJsLJȖÞNjsŎsŘǼǣʺ
 NJs¶ȖĶǼÞŸŘǣʰˡ˟ˠˤ_ȖNjÞضǼÌsʩŘŘOÞĶɴsNjȖŘ_sNjNjsƼŸNjǼʱ
ˠˣʳ ^ŸOȖŎsŘǼǣNjsĶǼs_ǼŸƼɴŎsŘǼǣŸ¯_ÞɚÞ_sŘ_Ŏ_sǼŸÞǼǣǣÌNjsÌŸĶ_sNjǣ_ȖNjÞضǼÌsʩŘŘOÞĶɴsNjȖŘ_sNjNjsƼŸNjǼʱ
ˠˤʳ ^ŸOȖŎsŘǼǣNjsĶǼs_ǼŸÞǣǣȖsŸ¯ǣÌNjsǣȖŘ_sNjrǢŷƻǢOÌsŎsɚÞʊʳrǢŷƻǢOÌsŎsʰrɮsNjOÞǣs¯ŸNjŎǣʰĵÞǣǼÞضƼƼĶÞOǼÞŸŘǣʰNŸNjƼŸNjǼsOǼÞŸŘ
 ®ŸNjŎʰsǼOʳʩĶs_ɠÞǼÌǢǼŸOĨrɮOÌضsǣŘ_ĵÞǣǼÞضƼƼNjŸɚĶǣNjsOsÞɚs_ǼÌsNjsŸŘʱ
ˠ˥ʳ r˚ŎÞĶǣsɚÞ_sŘOÞض_ÞǣǣsŎÞŘǼÞŸŘŸ¯ÞŘ¯ŸNjŎǼÞŸŘNjsĶǼs_ǼŸOĶŸǣȖNjsŸ¯ǻNj_ÞضɠÞŘ_Ÿɠʱ
ˠ˦ʳ ÝŘǼsNjŘĶNŸ_sŸ¯NŸŘ_ȖOǼ¯ŸNjƼNjsɚsŘǼÞŸŘŸ¯ÝŘǣÞ_sNjǻNj_ÞضEɴrŎƼĶŸɴssǣˀ^ÞNjsOǼŸNjǣˀ^sǣÞ¶ŘǼs_ƻsNjǣŸŘǣŸ¯ǼÌsNŸŎƼŘɴʱ
ˠ˧ʳ ǢǼǼsŎsŘǼŸ¯NJsĶǼs_ƻNjǼɴǻNjŘǣOǼÞŸŘǣsŘǼsNjs_ÞŘǼŸEɴǼÌsNŸŎƼŘɴ_ȖNjÞضǼÌsʩŘŘOÞĶɴsNjȖŘ_sNjNjsƼŸNjǼʱ
ˠ˨ʳ ^ŸOȖŎsŘǼǣʩĶs_ɠÞǼÌǢǼŸOĨrɮOÌضsǣʱ
ˡ˟ʳ NŸŎƼĶÞŘOsNsNjǼÞʩOǼsƼĶOs_Es¯ŸNjsǼÌsDŸNj_Ÿ¯^ÞNjsOǼŸNjǣ¯NjŸŎǼÞŎsǼŸǼÞŎsʱ
ˡˠʳ ^sǼÞĶǣŸ¯ǢÞǼǼÞض®ssǣƼÞ_ǼŸĶĶŗŸŘrɮsOȖǼÞɚs^ÞNjsOǼŸNjǣ¯ŸNjǼǼsŘ_ÞضǼÌsDŸNj_ōssǼÞضǣŘ_NŸŎŎÞǼǼssōssǼÞضǣʱ
ˡˡʳ ®ÞĶÞضǣŎ_sɠÞǼÌNJsǣsNjɚsDŘĨŸ¯ÝŘ_Þʳ
˦˟ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

ANNEXURE TO THE DIRECTORS’ REPORT

Annexure II

ǻŸ
ǻÌsōsŎEsNjǣ
JYOTHY LABORATORIES LIMITED
˄ȕĠĶËŸȖǣs˅ʰNJŎĨNjÞǣÌŘōŘ_ÞNjNJŸ_ʰ
ħŸŘ_ÞɚÞǼʰŘ_ÌsNjÞʹrǣǼʺʰ
ōȖŎEÞ˚ˣ˟˟˟ˤ˨

ŷȖNjNjsƼŸNjǼŸ¯sɚsŘ_ǼsÞǣǼŸEsNjs_ĶŸŘ¶ɠÞǼÌǼÌÞǣĶsǼǼsNjʳ
ˠʳ ōÞŘǼsŘŘOsŸ¯ǢsONjsǼNjÞĶNjsOŸNj_ÞǣǼÌsNjsǣƼŸŘǣÞEÞĶÞǼɴŸ¯ǼÌsŎضsŎsŘǼŸ¯ǼÌsNŸŎƼŘɴŸȖNjNjsǣƼŸŘǣÞEÞĶÞǼɴÞǣǼŸsɮƼNjsǣǣŘ
 ŸƼÞŘÞŸŘŸŘǼÌsǣsǣsONjsǼNjÞĶNjsOŸNj_ǣEǣs_ŸŘŸȖNjȖ_ÞǼʳ
ˡʳ ɟsÌɚs¯ŸĶĶŸɠs_ǼÌsȖ_ÞǼƼNjOǼÞOsǣŘ_ƼNjŸOsǣǣsǣǣɠsNjsƼƼNjŸƼNjÞǼsǼŸŸEǼÞŘNjsǣŸŘEĶsǣǣȖNjŘOsEŸȖǼǼÌs
 OŸNjNjsOǼŘsǣǣ Ÿ¯ ǼÌs OŸŘǼsŘǼǣ Ÿ¯ ǼÌs ǢsONjsǼNjÞĶ NjsOŸNj_ǣʳ ǻÌs ɚsNjÞʩOǼÞŸŘ ɠǣ _ŸŘs ŸŘ ǼsǣǼ EǣÞǣ ǼŸ sŘǣȖNjs ǼÌǼ OŸNjNjsOǼ ¯OǼǣ Njs
 NjsʪsOǼs_ÞŘǣsONjsǼNjÞĶNjsOŸNj_ǣʳɟsEsĶÞsɚsǼÌǼǼÌsƼNjŸOsǣǣsǣŘ_ƼNjOǼÞOsǣʰɠs¯ŸĶĶŸɠs_ƼNjŸɚÞ_sNjsǣŸŘEĶsEǣÞǣ¯ŸNjŸȖNjŸƼÞŘÞŸŘʳ
ˢʳ ɟsÌɚsŘŸǼɚsNjÞʩs_ǼÌsOŸNjNjsOǼŘsǣǣŘ_ƼƼNjŸƼNjÞǼsŘsǣǣŸ¯ʩŘŘOÞĶNjsOŸNj_ǣŘ_DŸŸĨǣŸ¯OOŸȖŘǼǣŸ¯ǼÌsOŸŎƼŘɴ
ˣʳ ɟÌsNjssɚsNjNjsLJȖÞNjs_ʰɠsÌɚsŸEǼÞŘs_ǼÌsōضsŎsŘǼNjsƼNjsǣsŘǼǼÞŸŘEŸȖǼǼÌsOŸŎƼĶÞŘOsŸ¯ĶɠǣʰNjȖĶsǣŘ_Njs¶ȖĶǼÞŸŘǣ
 Ř_ÌƼƼsŘÞضŸ¯sɚsŘǼǣsǼOʳ
ˤʳ ǻÌs OŸŎƼĶÞŘOs Ÿ¯ ǼÌs ƼNjŸɚÞǣÞŸŘǣ Ÿ¯ NŸNjƼŸNjǼs Ř_ ŸǼÌsNj ƼƼĶÞOEĶs Ķɠǣʰ NjȖĶsǣʰ Njs¶ȖĶǼÞŸŘǣʰ ǣǼŘ_Nj_ǣ Þǣ ǼÌs NjsǣƼŸŘǣÞEÞĶÞǼɴ Ÿ¯
 ŎضsŎsŘǼʳŷȖNjsɮŎÞŘǼÞŸŘɠǣĶÞŎÞǼs_ǼŸǼÌsɚsNjÞʩOǼÞŸŘŸ¯ƼNjŸOs_ȖNjsǣŸŘǼsǣǼEǣÞǣʳ
˥ʳ ǻÌsǢsONjsǼNjÞĶȖ_ÞǼNjsƼŸNjǼÞǣŘsÞǼÌsNjŘǣǣȖNjŘOsǣǼŸǼÌs¯ȖǼȖNjsɚÞEÞĶÞǼɴŸ¯ǼÌsOŸŎƼŘɴŘŸNjŸ¯ǼÌss¯ʩOOɴŸNjs¯¯sOǼÞɚsŘsǣǣɠÞǼÌ
 ɠÌÞOÌǼÌsŎضsŎsŘǼÌǣOŸŘ_ȖOǼs_ǼÌs¯¯ÞNjǣŸ¯ǼÌsOŸŎƼŘɴʳ

For RATHI & ASSOCIATES


COMPANY SECRETARIES

HIMANSHU S. KAMDAR
PARTNER
FCS No. 5171
COP No. 3030

ƻĶOsʲōȖŎEÞ
^Ǽsʲōɴˡˢʰˡ˟ˠ˥
Corporate Overview Performance Governance Financial Statements ˦ˠ

ANNEXURE TO THE DIRECTORS’ REPORT

ANNEXURE IV TO THE DIRECTORS’ REPORT


Form No. MGT-9
rɭǻNJNǻŷ®ŗŗȕĵNJrǻȕNJŗ
ǣŸŘǼÌsʩŘŘOÞĶɴsNjsŘ_s_ŸŘōNjOÌˢˠʰˡ˟ˠ˥
ʻƻȖNjǣȖŘǼǼŸǢsOǼÞŸŘ˨ˡʹˢʺŸ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢŘ_NJȖĶsˠˡʹˠʺŸ¯ǼÌsNŸŎƼŘÞsǣ
ʹōضsŎsŘǼŘ__ŎÞŘÞǣǼNjǼÞŸŘʺNJȖĶsǣʰˡ˟ˠˣʼ

I. REGISTRATION AND OTHER DETAILS:

Þʺ NÝŗʲ˚ ĵˡˣˡˣ˟ōËˠ˨˨ˡƻĵNˠˡ˧˥ˤˠ


ÞÞʺ NJs¶ÞǣǼNjǼÞŸŘ^Ǽsʲ˚ ˠˤˀ˟ˠˀˠ˨˨ˡ
ÞÞÞʺ ŗŎsŸ¯ǼÌsNŸŎƼŘɴʲ˚ ğɳŷǻËɳĵDŷNJǻŷNJÝrǢĵÝōÝǻr^
Þɚʺ NǼs¶ŸNjɴˀǢȖE˚NǼs¶ŸNjɴŸ¯ǼÌsNŸŎƼŘɴʲ˚ NŸŎƼŘɴĵÞŎÞǼs_EɴǣÌNjsǣˀÝŘ_ÞŘŗŸŘ˚µŸɚsNjŘŎsŘǼ
Company
ɚʺ __NjsǣǣŸ¯ǼÌsNJs¶ÞǣǼsNjs_Ÿ¯ʩOsŘ_OŸŘǼOǼ_sǼÞĶǣʲ˚ ˄ȕĠĶËŸȖǣs˅ʰNJŎĨNjÞǣÌŘōŘ_ÞNjNJŸ_ʰħŸŘ_ÞɚÞǼʰ
Ř_ÌsNjÞʹrǣǼʺʰōȖŎEÞ˚ˣ˟˟˟ˤ˨
ǻsĶʳŗŸʳʲ˟ˡˡ˚˥˥˧˨ˡ˧˟˟ʰ®ɮʲ˟ˡˡ˚˥˥˧˨ˡ˧˟ˤ
rŎÞĶʲǣsONjsǼNjÞĶ˔ĠɴŸǼÌɴʳOŸŎ
ɚÞʺ ɟÌsǼÌsNjĶÞǣǼs_OŸŎƼŘɴʲ˚ ɳsǣ
ɚÞÞʺ ŗŎsʰ__NjsǣǣŘ_NŸŘǼOǼ_sǼÞĶǣŸ¯NJs¶ÞǣǼNjNjŘ_
 ǻNjŘǣ¯sNj¶sŘǼʲ ŗŎsʲĵÞŘĨÝŘǼÞŎsÝŘ_ÞƻɚǼʳĵÞŎÞǼs_
__Njsǣǣ ʲN˚ˠˢʰƻŘŘĶĶǢÞĶĨōÞĶĶǣNŸŎƼŸȖŘ_ʰ
ĵDǢōNj¶ʰDÌŘ_ȖƼʹɟsǣǼʺ
ōȖŎEÞ˚ˣ˟˟˟˦˧
ǻsĶʳŗŸʳ ʲ˟ˡˡ˚ˡˤ˨˥ˢ˧ˢ˧ˀ˟ˡˡ˚ˡˤ˨ˣ˥˨˦˟
®ɮŗŸʳ ʲ˟ˡˡ˚ˡˤ˨ˣ˥˨˥˨ˀ˟ˡˡ˚ˡˤ˨˥ˢ˧ˢ˧ˀ˟ˡˡ˚ˡˤ˨ˣ˥˨˦˟

II. PRINCIPAL BUSINESS ACTIVITIES OF THE COMPANY


 DȖǣÞŘsǣǣOǼÞɚÞǼÞsǣOŸŘǼNjÞEȖǼÞضˠ˟̇ŸNjŎŸNjsŸ¯ǼÌsǼŸǼĶǼȖNjŘŸɚsNjŸ¯ǼÌsNŸŎƼŘɴNjsǣEsĶŸɠʲ˚
Sl. Name and Description of main products NIC Code of the Product % to total turnover of the Company
No.
1 ^sǼsNj¶sŘǼǣ 20233 41
ˡ Soaps 20231 33
ˢ ōŸǣLJȖÞǼŸNJsƼsĶĶŸŘǼ 20211 17
˦ˡ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

ANNEXURE TO THE DIRECTORS’ REPORT

III. PARTICULARS OF HOLDING, SUBSIDIARY AND ASSOCIATE COMPANIES

SR. Name and Address of the Company CIN/ GLN Holding/ % of Shares Applicable Section
No Subsidiary/ Held
Associate
1 ğɴŸǼÌɴħĶĶŸĶDضĶ_sǣÌĵÞŎÞǼs_ N.A. Subsidiary 75% Section2(87)(ii)
ˠ˨˨ʰǻsĠ¶ŸŘÝŘ_ȖǣǼNjÞĶNjsʰ^ÌĨ˚ˠˡ˟˧ʰ
DضĶ_sǣÌʳ
ˡ ®ŸȖNjǢsǣŸŘǣ^NjɴOĶsŘÞضNŸŎƼŘɴ U93010MH2002PTC246838 Subsidiary* 86.37% Section2(87)
ƻNjÞɚǼsĵÞŎÞǼs_
˄ȕĠĶËŸȖǣs˅ʰNJŎĨNjÞǣÌŘōŘ_ÞNjNJŸ_ʰ
ħŸŘ_ÞɚÞǼʰŘ_ÌsNjÞʹrǣǼʺʰ
ōȖŎEÞ˛ˣ˟˟˟ˤ˨ʰōÌNjǣÌǼNjʳ
ˢ Snoways Laundrers & Drycleaners Private U93010KA2008PTC046087 Subsidiary* 42.32% Section2(87)
Limited
N-119, North Block, Manipal Centre,
Dickenson Road, Bangalore – 560042,
Karnataka.
ˣ ğɴŸǼÌɴNŸŘǣȖŎsNjƻNjŸ_ȖOǼǣōNjĨsǼÞض U99999MH1974PLC242045 Subsidiary 100% Section2(87)
ĵÞŎÞǼs_
˄ȕĠĶËŸȖǣs˅ʰNJŎĨNjÞǣÌŘōŘ_ÞNjNJŸ_ʰ
ħŸŘ_ÞɚÞǼʰŘ_ÌsNjÞʹrǣǼʺʰ
ōȖŎEÞ˛ˣ˟˟˟ˤ˨ʰōÌNjǣÌǼNjʳ
ˤ ğɴŸǼÌɴ®ENjÞONjsǢsNjɚÞOsǣĵÞŎÞǼs_ U17120MH2008PLC180246 Subsidiary 86.37% Section2(87)
˄ȕĠĶËŸȖǣs˅ʰNJŎĨNjÞǣÌŘōŘ_ÞNjNJŸ_ʰ
ħŸŘ_ÞɚÞǼʰŘ_ÌsNjÞʹrǣǼʺʰ
ōȖŎEÞ˛ˣ˟˟˟ˤ˨ʰōÌNjǣÌǼNjʳ
ˎɟÌŸĶĶɴŸɠŘs_ǣȖEǣÞ_ÞNjÞsǣŸ¯ğɴŸǼÌɴ®ENjÞONjsǢsNjɚÞOsǣĵÞŎÞǼs_
Corporate Overview Performance Governance Financial Statements ˦ˢ

ANNEXURE TO THE DIRECTORS’ REPORT

IV. SHARE HOLDING PATTERN (Equity Share Capital Breakup as percentage of Total Equity)
i) Category-wise Share Holding

Category of Shareholders No. of Shares held at the beginning of No. of Shares held at the end of the %
the year i.e. as on 01.04.2015 year i.e. as on 31.03.2016 Change
during
the year
Demat Physical Total % of Demat Physical Total % of
Total Total
Shares Shares
A. Promoters
(1) Indian
a) Individual/ HUF 10,58,81,401 - 10,58,81,401 58.49 105881401 - 10,58,81,401 58.46 -0.03*
b) Central Govt - - - - - - - - -
c) State Govt (s) - - - - - - - - -
d) Bodies Corp. 1,50,00,000 - 1,50,00,000 8.29 1,50,00,000 - 1,50,00,000 8.28 -0.01*
e) Banks / FI - - - - - - - - -
f ) Any Other…. - - - - - - - - -
Sub-total (A) (1):- 12,08,81,401 - 12,08,81,401 66.78 12,08,81,401 - 12,08,81,401 66.74 -0.04*
(2) Foreign
a) NRIs Individuals - - - - - - - - -
b) Other – - - - - - - - - -
Individuals
c) Bodies Corp. - - - - - - - - -
d) Banks / FI - - - - - - - - -
e) Any Other…. - - - - - - - - -
Sub-total (A) (2):- - - - - - - - - -
Total shareholding of 12,08,81,401 - 12,08,81,401 66.78 12,08,81,401 - 12,08,81,401 66.74 -0.04*
Promoter (A) = (A)(1)+(A)(2)
B. Public Shareholding
1. Institutions
a) Mutual Funds 73,92,840 550 73,93,390 4.08 1,08,28,825 550 1,08,28,825 5.98 1.90
b) Banks / FI 1,23,381 1,866 1,25,247 0.07 9,378 1,866 11,244 0.01 -0.06
OʺNsŘǼNjĶµŸɚǼ - - - - - - - - -
d) State Govt(s) - - - - - - - - -
e) Venture Capital Funds - - - - - - - - -
f ) Insurance Companies 63,15,404 - 63,15,404 3.49 60,73,329 - 60,73,329 3.35 -0.14
g) FIIs 1,93,60,984 - 1,93,60,984 10.70 1,55,73,147 - 1,55,73,147 8.60 -2.10
h) Foreign Venture Capital - - - - - - - - -
Funds
i) Others (specify)
Foreign Portfolio Investor 1,01,14,771 - 1,01,14,771 5.59 1,06,10,345 - 1,06,10,345 5.86 0.27
(Corporate)
Sub-total (B)(1):- 4,33,07,380 2,416 4,33,09,796 23.92 4,30,94,474 2,416 4,30,96,890 23.79 -0.13
˦ˣ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

ANNEXURE TO THE DIRECTORS’ REPORT

Category of Shareholders No. of Shares held at the beginning of No. of Shares held at the end of the %
the year i.e. as on 01.04.2015 year i.e. as on 31.03.2016 Change
during
the year
2. Non-Institutions
a) Bodies Corp.
i) Indian 61,17,727 3,232 61,20,959 3.38 60,24,878 3,207 60,28,085 3.33 -0.05
ii) Overseas - - - - -
b) Individuals
i) Individual shareholders 89,01,034 8,59,873 97,60,907 5.39 91,55,867 8,31,272 99,87,139 5.51 0.12
holding nominal share capital
upto ` 1 lakh
ii) Individual shareholders 1,50,681 - 1,50,681 0.08 1,50,681 - 1,50,681 .08 -
holding nominal share capital
in excess of ` 1 lakh
c) Others (specify)
1. Qualified Individual - - - - - - - - -
Investors
2. Cleaning Members 1,05,579 - 1,05,579 0.06 1,66,397 - 1,66,397 0.09 0.03
3. Office Bearers and 2,00,818 - 2,00,818 0.11 2,88,291 - 2,88,291 0.16 0.05
Directors/ Relatives
4. Non-Resident Individuals 3,78,428 6,051 3,84,479 0.21 3,30,923 5801 3,36,724 0.19 -0.02
(Repatriable)
5. Non-Resident Individuals 93,860 - 93,860 0.05 93,351 - 93,351 0.05 -
(Non-Repatriable)
6. Trusts 15,016 - 15,016 0.01 90,721 - 90,721 0.05 0.04
Sub-total (B)(2):- 1,59,63,143 8,69,156 1,68,32,299 9.30 1,63,01,109 8,40,280 1,71,41,389 9.47 0.17
Total Public Shareholding 5,92,70,523 8,71,572 6,01,42,095 33.22 5,93,95,583 8,42,696 6,02,38,279 33.26 0.04
(B)=(B)(1)+ (B)(2)
C. Shares held by Custodian - - - - - - - - -
for GDRs & ADRs
Grand Total (A+B+C) 18,01,51,924 8,71,572 18,10,23,496 100 18,02,76,984 8,42,696 18,11,19,680 100 -
*The change in percentage shareholding of Promoters category is due to the increase in Paid Up Share Capital of the Company during the
Financial Year 2015-16 pursuant to the shares allotted by the Company to its eligible employees under the approved ESOP Scheme.
Corporate Overview Performance Governance Financial Statements ˦ˤ

ANNEXURE TO THE DIRECTORS’ REPORT

(ii) Shareholding of Promoters

Sl Shareholder’s Shareholding at the beginning of Shareholding at the end of the year % change in
No. Name the year shareholding
during the
No. of % of total % of Shares No. of % of total % of Shares year
Shares Shares Pledged / Shares Shares Pledged /
of the encumbered of the encumbered
company to total company to total
shares shares
1 ōʳƻʳ ˦ʰˡˠʰˠˡʰ˟˥˟ ˢ˨ʳ˧ˣ ˡˣʳˤˢ ˦ʰˡˠʰˠˡʰ˟˥˟ ˎˢ˨ʳ˧ˠ ˡˢʳˢ˟ ˚˟ʳ˟ˢ
NJōNËŗ^NJŗ
ˡ ǢËɳ^NJÝ ˠʰˤ˟ʰ˟˟ʰ˟˟˟ ˧ʳˡ˨ ˟ʳ˟˟ ˠʰˤ˟ʰ˟˟ʰ˟˟˟ ˎ˧ʳˡ˧ ˟ʳ˟˟ ˚˟ʳ˟ˠ
µrŗNÝrǢĵÝōÝǻr^
ˢ ōʳƻʳ^ÝəħNJŗ ˦˟ʰ˧ˤʰ˟˥ˠ ˢʳ˨ˠ ˟ʳ˟˟ ˦˟ʰ˧ˤʰ˟˥ˠ ˢʳ˨ˠ ˟ʳ˟˟ ŗÝĵ
ˣ ōʳƻʳǢÝ^ËNJǻËŗ ˤˡʰˠˤʰˡˢ˟ ˡʳ˧˧ ˟ʳ˟˟ ˤˡʰˠˤʰˡˢ˟ ˡʳ˧˧ ˟ʳ˟˟ ŗÝĵ
ˤ ōʳNJʳ^rrƻǻËÝ ˤ˟ʰˢ˟ʰ˟ˢˡ ˡʳ˦˧ ˟ʳ˟˟ ˤ˟ʰˢ˟ʰ˟ˢˡ ˡʳ˦˧ ˟ʳ˟˟ ŗÝĵ
6 ōʳNJʳğɳŷǻËɳ ˣ˥ʰˠ˧ʰ˟˧ˣ ˡʳˤˤ ˟ʳ˟˟ ˣ˥ʰˠ˧ʰ˟˧ˣ ˡʳˤˤ ˟ʳ˟˟ ŗÝĵ
˦ ōʳµʳ ˢ˥ʰˠ˦ʰ˨ˤˣ ˡʳ˟˟ ˟ʳ˟˟ ˢ˥ʰˠ˦ʰ˨ˤˣ ˡʳ˟˟ ˟ʳ˟˟ ŗÝĵ
ǢËŗǻËħȕōNJÝ
˧ ȕʳDʳDrrŗ ˢˣʰˣ˥ʰ˥˟˟ ˠʳ˨˟ ˟ʳ˟˟ ˢˣʰˣ˥ʰ˥˟˟ ˠʳ˨˟ ˟ʳ˟˟ ŗÝĵ
˨ ōʳƻʳ^ÝəħNJŗ ˠ˨ʰ˟ˣʰ˟˟˟ ˠʳ˟ˤ ˟ʳ˟˟ ˠ˨ʰ˟ˣʰ˟˟˟ ˠʳ˟ˤ ˟ʳ˟˟ ŗÝĵ
ˠ˟ ħʳȕĵĵǢħōǻË ˠˣʰˤˠʰˢ˧˟ ˟ʳ˧˟ ˟ʳ˟˟ ˠˣʰˤˠʰˢ˧˟ ˟ʳ˧˟ ˟ʳ˟˟ ŗÝĵ
11 ǢÝ^ËNJǻËŗōʳƻʳ ˠˢʰˡ˟ʰ˟˟˟ ˟ʳ˦ˢ ˟ʳ˟˟ ˠˢʰˡ˟ʰ˟˟˟ ˟ʳ˦ˢ ˟ʳ˟˟ ŗÝĵ
ˠˡ ħʳħʳǢȕğǻË ˧ˠʰ˟˟˟ ˟ʳ˟ˣ ˟ʳ˟˟ ˧ˠʰ˟˟˟ ˟ʳ˟ˣ ˟ʳ˟˟ ŗÝĵ

ˎǻÌsOÌضsÞŘƼsNjOsŘǼ¶sǣÌNjsÌŸĶ_ÞضŸ¯ƻNjŸŎŸǼsNjǣÞǣ_ȖsǼŸǼÌsÞŘONjsǣsÞŘƻÞ_ȕƼǢÌNjsNƼÞǼĶŸ¯ǼÌsNŸŎƼŘɴ_ȖNjÞض
ǼÌs®ÞŘŘOÞĶɳsNjˡ˟ˠˤ˚ˠ˥ƼȖNjǣȖŘǼǼŸǼÌsǣÌNjsǣĶĶŸǼǼs_EɴǼÌsNŸŎƼŘɴǼŸÞǼǣsĶÞ¶ÞEĶssŎƼĶŸɴssǣȖŘ_sNjǼÌsƼƼNjŸɚs_rǢŷƻ
ǢOÌsŎsʳ
˦˥ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

ANNEXURE TO THE DIRECTORS’ REPORT

(iii) Change in Promoters’ Shareholding ( please specify, if there is no change):

ǻÌsNjsɠǣŘŸOÌضsÞŘƼNjŸŎŸǼsNj˅ǣǣÌNjsÌŸĶ_Þض_ȖNjÞضǼÌsǣƼsOÞʩs_ƼsNjÞŸ_Þʳsʳ˟ˠʳ˟ˣʳˡ˟ˠˤǼŸˢˠʳ˟ˢʳˡ˟ˠ˥

(iv) Shareholding Pattern of top ten Shareholders (other than Directors, Promoters and Holders of GDRs and ADRs):

Cumulative
Shareholding during
Shareholding
the year (01-04-15 to
Increase / 31-03-16)
Sl Decrease
Name No. of shares at % of total Date Reason No. of shares % of total
No. in Share
the beginning of shares holding shares
the year (01-04- of the of the
15)/End of the company company
year 31-03-16
1 ICICI ˤ˦ʰ˧˧ʰ˟ˠ˥ ˢʳˡ˟ ˟ˠˀ˟ˣˀˡ˟ˠˤ
ƻNJȕ^rŗǻÝĵ
ˠ˟ˀ˟ˣˀˡ˟ˠˤ ˚ˢ˨ʰˢˡˠ ǻNjŘǣ¯sNj ˤ˦ʰˣ˧ʰ˥˨ˤ ˢʳˠ˦
ĵÝ®rÝŗǢȕNJŗNr
Nŷōƻŗɳĵǻ^ ˠ˦ˀ˟ˣˀˡ˟ˠˤ ˧˨ʰˠ˟˟ ǻNjŘǣ¯sNj ˤ˧ʰˢ˦ʰ˦˨ˤ ˢʳˡˡ
ˡ˥ˀ˟ˡˀˡ˟ˠ˥ ˤˤˡ ǻNjŘǣ¯sNj ˤ˧ʰˢ˧ʰˢˣ˦ ˢʳˡˡ
ˤ˧ʰˢ˧ʰˢˣ˦ ˢʳˡˡ ˤ˧ʰˢ˧ʰˢˣ˦ ˢʳˡˡ
ˡ ®Ý^rĵÝǻɳ ˢ˧ʰˣˠʰˢˢ˦ ˡʳˠˡ ˟ˠˀ˟ˣˀˡ˟ˠˤ
ōŗµrōrŗǻ
ˠ˟ˀ˟˦ˀˡ˟ˠˤ ˚ˢˤʰ˟˟˟ ǻNjŘǣ¯sNj ˢ˧ʰ˟˥ʰˢˢ˦ ˡʳˠ˟
˓NJrǢrNJNË
Nŷōƻŗɳ ˟˨ˀˠ˟ˀˡ˟ˠˤ ˚˧ʰ˦˨˟ ǻNjŘǣ¯sNj ˢ˦ʰ˨˦ʰˤˣ˦ ˡʳˠ˟
ˀN®Ý^rĵÝǻɳ
ˠ˥ˀˠ˟ˀˡ˟ˠˤ ˚ˢˠʰˡˠ˟ ǻNjŘǣ¯sNj ˢ˦ʰ˥˥ʰˢˢ˦ ˡʳ˟˧
ÝŗərǢǻōrŗǻ
ǻNJȕǢǻ˚ ˠˢˀˠˠˀˡ˟ˠˤ ˚ˣ˟ʰ˟˟˟ ǻNjŘǣ¯sNj ˢ˦ʰˡ˥ʰˢˢ˦ ˡʳ˟˥
®Ý^rĵÝǻɳǢrNJÝrǢ
ˠˡˀ˟ˡˀˡ˟ˠ˥ ˚˧ʰ˥˧˨ ǻNjŘǣ¯sNj ˢ˦ʰˠ˦ʰ˥ˣ˧ ˡʳ˟ˤ
ÝŗǻrNJŗǻÝŷŗĵ
ǢōĵĵNƻ ˠ˨ˀ˟ˡˀˡ˟ˠ˥ ˚ˣˠʰˢˠˠ ǻNjŘǣ¯sNj ˢ˥ʰ˦˥ʰˢˢ˦ ˡʳ˟ˢ
®ȕŗ^
ˡ˥ˀ˟ˡˀˡ˟ˠ˥ ˚ˡ˧ʰ˧ˢ˧ ǻNjŘǣ¯sNj ˢ˥ʰˣ˦ʰˣ˨˨ ˡʳ˟ˠ
˟ˣˀ˟ˢˀˡ˟ˠ˥ ˚˦ˠʰˠ˥ˡ ǻNjŘǣ¯sNj ˢˤʰ˦˥ʰˢˢ˦ ˠʳ˨˦
ˠˠˀ˟ˢˀˡ˟ˠ˥ ˚˦ˤʰ˟˟˟ ǻNjŘǣ¯sNj ˢˤʰ˟ˠʰˢˢ˦ ˠʳ˨ˢ
ˢˤʰ˟ˠʰˢˢ˦ ˠʳ˨ˢ ˢˠˀ˟ˢˀˡ˟ˠ˥ ˢˤʰ˟ˠʰˢˢ˦ ˠʳ˨ˢ
ˢ ƻNJərǢǻrdžȕÝǻɳ ˡ˧ʰˢˠʰˠ˧ˣ ˠʳˤ˥ ˟ˠˀ˟ˣˀˡ˟ˠˤ
Ýŗ^Ý
ˡˠˀ˟˧ˀˡ˟ˠˤ ˢʰ˟˟ʰ˟˟˟ ǻNjŘǣ¯sNj ˡ˨ʰˣ˟ʰ˟˟˟ ˠʳ˥ˡ
ˢˠˀˠˡˀˡ˟ˠˤ ˠʰˡˤʰˡˤ˟ ǻNjŘǣ¯sNj ˢ˟ʰ˥ˤʰˡˤ˟ ˠʳ˥˨
˟˧ˀ˟ˠˀˡ˟ˠ˥ ˢʰ˟ˤʰ˟˟˟ ǻNjŘǣ¯sNj ˢˢʰ˦˟ʰˡˤ˟ ˠʳ˧˥
ˢˢʰ˦˟ʰˡˤ˟ ˠʳ˧˥ ˢˠˀ˟ˢˀˡ˟ˠ˥ ˢˢʰ˦˟ʰˡˤ˟ ˠʳ˧˥
ˣ rōDĵrō®ÝÝ ˡ˧ʰˢˠʰˠ˧ˣ ˠʳˤ˥ ˟ˠˀ˟ˣˀˡ˟ˠˤ
˟ˠˀ˟ˤˀˡ˟ˠˤ ˤˤʰ˟˟˟ ǻNjŘǣ¯sNj ˡ˧ʰ˧˥ʰˠ˧ˣ ˠʳˤ˨
˟˧ˀ˟ˤˀˡ˟ˠˤ ˧ˤʰ˟˟˟ ǻNjŘǣ¯sNj ˡ˨ʰ˦ˠʰˠ˧ˣ ˠʳ˥ˣ
ˠˤˀ˟ˤˀˡ˟ˠˤ ˢʰ˧ˠ˥ ǻNjŘǣ¯sNj ˡ˨ʰ˦ˤʰ˟˟˟ ˠʰ˥ˣ
ˡ˨ˀ˟ˤˀˡ˟ˠˤ ˠʰ˟˟ʰ˟˟˟ ǻNjŘǣ¯sNj ˢ˟ʰ˦ˤʰ˟˟˟ ˠʳ˦˟

ˢ˟ʰ˦ˤʰ˟˟˟ ˠʳ˦˟ ˢˠˀ˟ˢˀˡ˟ˠ˥ ˢ˟ʰ˦ˤʰ˟˟˟ ˠʳ˦˟


Corporate Overview Performance Governance Financial Statements ˦˦

ANNEXURE TO THE DIRECTORS’ REPORT

Cumulative
Shareholding during
Shareholding
the year (01-04-15 to
Increase / 31-03-16)
Sl Decrease
Name No. of shares at % of total Date Reason No. of shares % of total
No. in Share
the beginning of shares holding shares
the year (01-04- of the of the
15)/End of the company company
year 31-03-16
5 L AND T MUTUAL 26,99,209 1.49 01/04/2015
FUND TRUSTEE
10/04/2015 10,000 Transfer 27,09,209 1.50
LTD- L AND T
TAX ADVANTAGE 17/04/2015 5,000 Transfer 27,14,209 1.50
FUND
24/04/2015 3,908 Transfer 27,18,117 1.50

22/05/2015 14,800 Transfer 27,32,917 1.51

05/06/2015 15,000 Transfer 27,47,917 1.52

12/06/2015 6,133 Transfer 27,54,050 1.52

19/06/2015 5,000 Transfer 27,59,050 1.52

26/06/2015 60,621 Transfer 28,19,671 1.56

31/07/2015 10,000 Transfer 28,29,671 1.56

07/08/2015 68,037 Transfer 28,97,708 1.60

27/08/2015 39,362 Transfer 29,37,070 1.62

25/09/2015 16,900 Transfer 29,53,970 1.63

30/09/2015 2,000 Transfer 29,55,970 1.63

09/10/2015 29,673 Transfer 29,85,643 1.65

16/10/2015 -13,263 Transfer 29,72,380 1.64

23/10/2015 -35,410 Transfer 29,36,970 1.62

30/10/2015 -18,004 Transfer 29,18,966 1.61

13/11/2015 5,000 Transfer 29,23,966 1.61

04/12/2015 9,730 Transfer 29,33,696 1.62

18/12/2015 10,000 Transfer 29,43,696 1.63

25/12/2015 10,000 Transfer 29,53,696 1.63

08/01/2016 3,707 Transfer 29,57,403 1.63

15/01/2016 5,000 Transfer 29,62,403 1.64

19/02/2016 5,000 Transfer 29,67,403 1.64

29,67,403 1.64 31/03/2016 29,67,403 1.64

6 HASHAM Nil - 01/04/2015


INVESTMENT
01/05/2015 25,21,090 Transfer 25,21,090 1.39
AND TRADING
COMPANY 25,21,090 1.39 31.03/2016 25,21,090 1.39
PRIVATE LTD
˦˧ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

ANNEXURE TO THE DIRECTORS’ REPORT

Cumulative
Shareholding during
Shareholding
the year (01-04-15 to
Increase / 31-03-16)
Sl Decrease
Name No. of shares at % of total Date Reason No. of shares % of total
No. in Share
the beginning of shares holding shares
the year (01-04- of the of the
15)/End of the company company
year 31-03-16
7 WF ASIAN 25,05,869 1.38 01/04/2015 0 Nil
COMPANIES movement
25,05,869 1.38 31/03/2016 25,05,869 1.38
SMALLER FUND during
LIMITED the year

8 PI 23,03,446 1.27 01/04/2016 0 Nil


OPPORTUNITIES movement
23,03,446 1.27 31/03/2016 23,03,446 1.27
FUND I during
the year

9 SUNDARAM 15,20,000 0.84 01/04/2015


MUTUAL FUND
30/06/2015 -1,524 Transfer 15,18,476 0.84
A/C SUNDARAM
SELECT MIDCAP 03/07/2015 -8,476 Transfer 15,10,000 0.83

07/08/2015 40,000 Transfer 15,50,000 -.86

11/09/2015 10,000 Transfer 15,60,000 0.86

27/11/2015 3,25,000 Transfer 18,85,000 1.04

08/01/2016 8,627 Transfer 18,93,627 1.05

18,93,627 1.05 31/03/2016 18,93,627 1.05

10 WF ASIAN 4,53,000 0.25 01/04/2015


ECINNAISANCE
04/03/2016 13,21,379 Transfer 17,74,379 0.98
FUND LIMITED
17,74,379 0.98 31/03/2016 17,74,379 0.98
Corporate Overview Performance Governance Financial Statements ˦˨

ANNEXURE TO THE DIRECTORS’ REPORT

(v) Shareholding of Directors and Key Managerial Personnel:

Shareholding at the beginning of the Cumulative Shareholding during the


1. Name
year year
% of total shares of the % of total shares of
Mr. M. P. Ramachandran No. of shares No. of shares
company the company
˟ˠˀ˟ˣˀˡ˟ˠˤ ˦ʰˡˠʰˠˡʰ˟˥˟ ˢ˨ʳ˧ˣ ˦ʰˡˠʰˠˡʰ˟˥˟ ˢ˨ʳ˧ˣ
ÝŘONjsǣsˀ^sONjsǣsÞŘǢÌNjs ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ
ÌŸĶ_Þض
ˢˠˀ˟ˢˀˡ˟ˠ˥ ˦ʰˡˠʰˠˡʰ˟˥˟ ˢ˨ʳ˧ˠ ˦ʰˡˠʰˠˡʰ˟˥˟ ˢ˨ʳ˧ˠˎ
ˎǻÌsOÌضsÞŘƼsNjOsŘǼ¶sǣÌNjsÌŸĶ_ÞضÞǣ_ȖsǼŸǼÌsÞŘONjsǣsÞŘƻÞ_ȕƼǢÌNjsNƼÞǼĶŸ¯ǼÌsNŸŎƼŘɴ_ȖNjÞضǼÌs®ÞŘŘOÞĶ
ɳsNjˡ˟ˠˤ˚ˠ˥ƼȖNjǣȖŘǼǼŸǼÌsǣÌNjsǣĶĶŸǼǼs_EɴǼÌsNŸŎƼŘɴǼŸÞǼǣsĶÞ¶ÞEĶssŎƼĶŸɴssǣȖŘ_sNjǼÌsƼƼNjŸɚs_rǢŷƻǢOÌsŎsʳ

Shareholding at the beginning of the Cumulative Shareholding during the


2. Name
year year
% of total shares of the % of total shares of
Ms. M. R. Jyothy No. of shares No. of shares
company the company
˟ˠˀ˟ˣˀˡ˟ˠˤ ˣ˥ʰˠ˧ʰ˟˧ˣ ˡʳˤˤ ˣ˥ʰˠ˧ʰ˟˧ˣ ˡʳˤˤ
ÝŘONjsǣsˀ^sONjsǣsÞŘǢÌNjs ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ
ÌŸĶ_Þض
ˢˠˀ˟ˢˀˡ˟ˠ˥ ˣ˥ʰˠ˧ʰ˟˧ˣ ˡʳˤˤ ˣ˥ʰˠ˧ʰ˟˧ˣ ˡʳˤˤ

Shareholding at the beginning of the Cumulative Shareholding during the


3. Name
year year
% of total shares of the % of total shares of
Mr. K. Ullas Kamath No. of shares No. of shares
company the company
˟ˠˀ˟ˣˀˡ˟ˠˤ ˠˣʰˤˠʰˢ˧˟ ˟ʳ˧˟ ˠˣʰˤˠʰˢ˧˟ ˟ʳ˧˟
ÝŘONjsǣsˀ^sONjsǣsÞŘǢÌNjs ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ
ÌŸĶ_Þض
ˢˠˀ˟ˢˀˡ˟ˠ˥ ˠˣʰˤˠʰˢ˧˟ ˟ʳ˧˟ ˠˣʰˤˠʰˢ˧˟ ˟ʳ˧˟

Shareholding at the beginning of the Cumulative Shareholding during the


4. Name
year year
% of total shares of the % of total shares of
Mr. S. Raghunandan No. of shares No. of shares
company the company
˟ˠˀ˟ˣˀˡ˟ˠˤ ˠʰ˨ˤʰˢ˧˧ ˟ʳˠˠ ˠʰ˨ˤʰˢ˧˧ ˟ʳˠˠ
ÝŘONjsǣsˀ^sONjsǣsÞŘǢÌNjs ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ
ÌŸĶ_Þض
ˢˠˀ˟ˢˀˡ˟ˠ˥ ˠʰ˨ˤʰˢ˧˧ ˟ʳˠˠ ˠʰ˨ˤʰˢ˧˧ ˟ʳˠˠ

Shareholding at the beginning of the Cumulative Shareholding during the


5. Name
year year
% of total shares of the % of total shares of
Mr. Bipin R. Shah No. of shares No. of shares
company the company
˟ˠˀ˟ˣˀˡ˟ˠˤ ˠ˟˟ ˟ʳ˟˟ ˠ˟˟ ˟ʳ˟˟
ÝŘONjsǣsˀ^sONjsǣsÞŘǢÌNjs ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ
ÌŸĶ_Þض
ˢˠˀ˟ˢˀˡ˟ˠ˥ ˠ˟˟ ˟ʳ˟˟ ˠ˟˟ ˟ʳ˟˟
˧˟ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

ANNEXURE TO THE DIRECTORS’ REPORT

Shareholding at the beginning of the Cumulative Shareholding during the


6. Name
year year
% of total shares of the % of total shares of
Mr. Nilesh B. Mehta No. of shares No. of shares
company the company
˟ˠˀ˟ˣˀˡ˟ˠˤ ŗÞĶ ŗÞĶ ŗÞĶ ŗÞĶ
ÝŘONjsǣsˀ^sONjsǣsÞŘǢÌNjs ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ
ÌŸĶ_Þض
ˢˠˀ˟ˢˀˡ˟ˠ˥ ŗÞĶ ŗÞĶ ŗÞĶ ŗÞĶ

Shareholding at the beginning of the Cumulative Shareholding during the


7. Name
year year
% of total shares of the % of total shares of
Mr. K. P. Padmakumar No. of shares No. of shares
company the company
˟ˠˀ˟ˣˀˡ˟ˠˤ ŗÞĶ ŗÞĶ ŗÞĶ ŗÞĶ
ÝŘONjsǣsˀ^sONjsǣsÞŘǢÌNjs ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ
ÌŸĶ_Þض
ˢˠˀ˟ˢˀˡ˟ˠ˥ ŗÞĶ ŗÞĶ ŗÞĶ ŗÞĶ

Shareholding at the beginning of the Cumulative Shareholding during the


8. Name
year year
% of total shares of the % of total shares of
Mr. R. Lakshminarayanan No. of shares No. of shares
company the company
˟ˠˀ˟ˣˀˡ˟ˠˤ ŗÞĶ ŗÞĶ ŗÞĶ ŗÞĶ
ÝŘONjsǣsˀ^sONjsǣsÞŘǢÌNjs ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ
ÌŸĶ_Þض
ˢˠˀ˟ˢˀˡ˟ˠ˥ ŗÞĶ ŗÞĶ ŗÞĶ ŗÞĶ

Shareholding at the beginning of the Cumulative Shareholding during the


9. Name
year year
% of total shares of the % of total shares of
Mr. M. L. Bansal No. of shares No. of shares
company the company
˟ˠˀ˟ˣˀˡ˟ˠˤ ŗÞĶ ŗÞĶ ŗÞĶ ŗÞĶ
ÝŘONjsǣsˀ^sONjsǣsÞŘǢÌNjs ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ ŗŸŎŸɚsŎsŘǼ
ÌŸĶ_Þض
ˢˠˀ˟ˢˀˡ˟ˠ˥ ŗÞĶ ŗÞĶ ŗÞĶ ŗÞĶ
Corporate Overview Performance Governance Financial Statements ˧ˠ

ANNEXURE TO THE DIRECTORS’ REPORT

V. INDEBTEDNESS
ÝŘ_sEǼs_ŘsǣǣŸ¯ǼÌsNŸŎƼŘɴÞŘOĶȖ_ÞضÞŘǼsNjsǣǼŸȖǼǣǼŘ_ÞضˀOONjȖs_EȖǼŘŸǼ_Ȗs¯ŸNjƼɴŎsŘǼ

ʹŎǼʳÞŘ`ʺ
Secured Loans Total
Unsecured Loans Deposits
excluding deposits Indebtedness
Indebtedness at the beginning of the
ʩŘŘOÞĶɴsNjǣŸŘ˟ˠˀ˟ˣˀˡ˟ˠˤ
Þʺ ƻNjÞŘOÞƼĶŎŸȖŘǼ ˤʰˠˤʰ˟˟ʰ˟˟ʰ˟˟˟ - - ˤʰˠˤʰ˟˟ʰ˟˟ʰ˟˟˟
ÞÞʺ ÝŘǼsNjsǣǼ_ȖsEȖǼŘŸǼƼÞ_ ˚ - - ˚
ÞÞÞʺ ÝŘǼsNjsǣǼOONjȖs_EȖǼŘŸǼ_Ȗs ˢʰ˦˦ʰˠ˥ʰˢ˦ˡ - - ˢʰ˦˦ʰˠ˥ʰˢ˦ˡ
Total (i+ii+iii) 5,18,77,16,372 - - 5,18,77,16,372
Change in Indebtedness during the
ʩŘŘOÞĶɴsNj
˒ __ÞǼÞŸŘʹÝŘOĶȖ_sǣŸŘĶɴƻNjÞŘOÞƼĶʺ ˚ - - ˚
˒ NJs_ȖOǼÞŸŘʹÝŘOĶȖ_sǣŸŘĶɴƻNjÞŘOÞƼĶʺ ʹˠʰˠˤʰ˟˟ʰ˟˟ʰ˟˟˟ʺ - - ʹˠʰˠˤʰ˟˟ʰ˟˟ʰ˟˟˟ʺ
Net Change (1,15,00,00,000) - - (1,15,00,00,000)
ÝŘ_sEǼs_ŘsǣǣǼǼÌssŘ_Ÿ¯ǼÌsʩŘŘOÞĶ
year as on 31/03/2016
Þʺ ƻNjÞŘOÞƼĶŎŸȖŘǼ ˣʰ˟˟ʰ˟˟ʰ˟˟ʰ˟˟˟ - - ˣʰ˟˟ʰ˟˟ʰ˟˟ʰ˟˟˟
ÞÞʺ ÝŘǼsNjsǣǼ_ȖsEȖǼŘŸǼƼÞ_ ˚ - - -
ÞÞÞʺ ÝŘǼsNjsǣǼOONjȖs_EȖǼŘŸǼ_Ȗs - - - -
Total (i+ii+iii) 4,00,00,00,000 - - 4,00,00,00,000
˧ˡ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

ANNEXURE TO THE DIRECTORS’ REPORT

VI. REMUNERATION OF DIRECTORS AND KEY MANAGERIAL PERSONNEL


 ʳ NJsŎȖŘsNjǼÞŸŘǼŸōضÞض^ÞNjsOǼŸNjʰɟÌŸĶs˚ǼÞŎs^ÞNjsOǼŸNjǣŘ_ˀŸNjōضsNjʲ
ʹŎǼʳÞŘ`ʺ
Sl. Total
Particulars of Remuneration Name of MD/ WTD/ Manager
no Amount
ōʳƻʳNJŎOÌŘ_NjŘ ħʳȕĶĶǣħŎǼÌ ǢʳNJ¶ÌȖŘŘ_Ř ōʳNJʳğɴŸǼÌɴ
NÌÞNjŎŘŘ_ Joint ɟÌŸĶsǻÞŎs ɟÌŸĶsǻÞŎs
ōضÞض^ÞNjsOǼŸNj ōضÞض ^ÞNjsOǼŸNj ^ÞNjsOǼŸNj
^ÞNjsOǼŸNj˓N®ŷ ˓Nrŷ
µNjŸǣǣǣĶNjɴ 1 ˠʰ˧˟ʰ˟˟ʰ˟˟˟ ˣʰˢ˦ʰ˥˟ʰ˟˟˟ ˨ˡʰˣ˟ʰ˟˟˟ ˦ʰˠ˟ʰ˟˟ʰ˟˟ˠ
ʹʺ ǢĶNjɴǣƼsNjˠƼNjŸɚÞǣÞŸŘǣ
1 OŸŘǼÞŘs_ÞŘǣsOǼÞŸŘ
ˠ˦ʹˠʺŸ¯ǼÌsÝŘOŸŎs˚Ǽɮ
OǼʰˠ˨˥ˠ
ʹEʺ ə
 ĶȖsŸ¯ƼsNjLJȖÞǣÞǼsǣȖˀǣ - - - - -
ˠ˦ʹˡʺÝŘOŸŎs˚ǼɮOǼʰ
ˠ˨˥ˠ
ʹOʺ ƻNjŸʩǼǣÞŘĶÞsȖŸ¯ǣĶNjɴ - - - - -
ȖŘ_sNjǣsOǼÞŸŘˠ˦ʹˢ
ÝŘOŸŎs˚ǼɮOǼʰˠ˨˥ˠ
ˡ ǢǼŸOĨŷƼǼÞŸŘ ˚ ˚ ˚ ˚ ˚
ˢ ǢɠsǼrLJȖÞǼɴ - - - - -
ˣ Commission
˚ǣ̇Ÿ¯ƼNjŸʩǼ ˣʰˡˠʰ˟ˢʰˤˠ˟ ˢʰ˦˧ʰ˨ˢʰˠˤ˨ ˚ ˚ ˦ʰ˨˨ʰ˨˥ʰ˥˥˨
˚ŸǼÌsNjǣʰǣƼsOÞ¯ɴʴ ˚ ˚ ˚ ˚ ˚
5 ŷǼÌsNjǣʰƼĶsǣsǣƼsOÞ¯ɴ ˚ ˚ ˚ ˚ ˚
ƻNjŸɚÞ_sŘǼ®ȖŘ_ ˚ ˡˠʰ˥˟ʰ˟˟˟ ˣ˦ʰˤˡʰ˟˟˟ ˠ˟ʰ˟˧ʰ˟˟˟ ˦˨ʰˡ˟ʰ˟˟˟
Superannuation ˚ ˠ˧ʰ˟˟ʰ˟˟˟ ˚ ˚ ˠ˧ʰ˟˟ʰ˟˟˟
ǻŸǼĶʹʺ ˣʰˡˠʰ˟ˢʰˤˠˠ ˤʰ˨˧ʰˤˢʰˠˤ˨ ˣʰ˧ˤʰˠˡʰ˟˟˟ ˠʰ˟ˡʰˣ˧ʰ˟˟˟ ˠ˥ʰ˟˦ʰˠ˥ʰ˥˦˟
`ˡˠʰ˟ˤʰˠ˦ʰˤˤ˟ʹEsÞضˠ˟̇Ÿ¯ǼÌsŘsǼƼNjŸʩǼǣŸ¯ǼÌsNŸŎƼŘɴOĶOȖĶǼs_ǣƼsNjǢsOǼÞŸŘ
NsÞĶÞضǣƼsNjǼÌsOǼ
ˠ˨˧Ÿ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢʺʳ
ŗŸǼsʲNJs¯sNj¯ŸŸǼŘŸǼs¶ÞɚsŘǼŸŗŸǼsʳˢˠŸ¯ǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ
Corporate Overview Performance Governance Financial Statements ˧ˢ

ANNEXURE TO THE DIRECTORS’ REPORT

B. Remuneration To Other Directors


ʹŎǼʳÞŘ`ʺ
Sl. Total
Particulars of Remuneration Name of Directors
no Amount
DÞƼÞŘNJʳǢÌÌ ŗÞĶsǣÌDʳōsÌǼ ħʳƻʳ NJʳĵĨǣÌÞŎÞŘNjɴŘŘ
ƻ_ŎĨȖŎNj
1 Independent Directors
˒ ®ss¯ŸNjǼǼsŘ_ÞضEŸNj_ˀ ˠʰˢˤʰ˟˟˟ ˠʰ˦ˤʰ˟˟˟ ˠʰˡ˟ʰ˟˟˟ ˧ˤʰ˟˟˟ ˤʰˠˤʰ˟˟˟
 OŸŎŎÞǼǼssŎssǼÞضǣ
˒ NŸŎŎÞǣǣÞŸŘ ˧ʰ˟˟ʰ˟˟˟ ˧ʰ˟˟ʰ˟˟˟ ˧ʰ˟˟ʰ˟˟˟ ˧ʰ˟˟ʰ˟˟˟ ˢˡʰ˟˟ʰ˟˟˟
˒ ŷǼÌsNjǣʰƼĶsǣsǣƼsOÞ¯ɴ ˚ ˚ ˚ ˚ ˚
Total (1) 9,35,000 9,75,000 9,20,000 8,85,000 37,15,000
Other Non-Executive
ˡ
Directors
˒ ®ss¯ŸNjǼǼsŘ_ÞضEŸNj_ˀ
 OŸŎŎÞǼǼssŎssǼÞضǣ
˒ NŸŎŎÞǣǣÞŸŘ ŗÞĶ
˒ ŷǼÌsNjǣʰƼĶsǣsǣƼsOÞ¯ɴ
Total (2) - - - - ˚
Total (B)=(1+2) 9,35,000 9,75,000 9,20,000 8,85,000 37,15,000
ǻŸǼĶōضsNjÞĶ
NJsŎȖŘsNjǼÞŸŘ
`ˡʰˠ˟ʰˤˠʰ˦ˤˤʹEsÞضˠ̇Ÿ¯ǼÌsŘsǼƼNjŸʩǼǣŸ¯ǼÌsNŸŎƼŘɴOĶOȖĶǼs_ǣƼsNjǢsOǼÞŸŘˠ˨˧
ŷɚsNjĶĶNsÞĶÞضǣƼsNjǼÌsOǼ
Ÿ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢʺʳ

C. Remuneration to Key Managerial Personnel other than MD/ Manager/ WTD


ʹŎǼʳÞŘ`ʺ
Key Managerial Personnel
Sl. Murari Lal Bansal
Particulars of Remuneration
no CEO* CFO* Total
Company Secretary
1 µNjŸǣǣǣĶNjɴ
ʹʺ ǢĶNjɴǣƼsNjƼNjŸɚÞǣÞŸŘǣOŸŘǼÞŘs_ÞŘ  ˚ ˢ˦ʰ˥ˣʰ˨ˠˠ ˚ ˢ˦ʰ˥ˣʰ˨ˠˠ
ǣsOǼÞŸŘˠ˦ʹˠʺŸ¯ǼÌsÝŘOŸŎs˚ǼɮOǼʰˠ˨˥ˠ
ʹEʺ əĶȖsŸ¯ƼsNjLJȖÞǣÞǼsǣȖˀǣˠ˦ʹˡʺÝŘOŸŎs˚ ˚ ˚ ˚ ˚
Ǽɮ  OǼʰˠ˨˥ˠ
Oʺ ƻNjŸʩǼǣÞŘĶÞsȖŸ¯ǣĶNjɴȖŘ_sNjǣsOǼÞŸŘ - - - -
ˠ˦ʹˢʺ  ÝŘOŸŎs˚ǼɮOǼʰˠ˨˥ˠ
ˡ ǢǼŸOĨŷƼǼÞŸŘ ˚ ˚ ˚ ˚
ˢ ǢɠsǼrLJȖÞǼɴ ˚ ˚ ˚ ˚
ˣ Commission
˚ǣ̇Ÿ¯ƼNjŸʩǼ ˚ ˚ ˚ ˚
˚ŸǼÌsNjǣʰǣƼsOÞ¯ɴʴ - - - -
ˤ ŷǼÌsNjǣʰƼĶsǣsǣƼsOÞ¯ɴʴ
ƻNjŸɚÞ_sŘǼ®ȖŘ_ ˚ ˣʰˢˡʰ˟˟˟ ˚ ˣʰˢˡʰ˟˟˟
Superannuation ˚ ˢʰ˥˟ʰ˟˟˟ ˚ ˢʰ˥˟ʰ˟˟˟
Total 45,56,911 45,56,911

ˎōNjʳǢʳNJ¶ÌȖŘŘ_ŘʰɟÌŸĶsǻÞŎs^ÞNjsOǼŸNjÌsĶ_ǼÌsƼŸǣÞǼÞŸŘŸ¯NrŷŘ_ōNjʳħʳȕĶĶǣħŎǼÌʰğŸÞŘǼōضÞض^ÞNjsOǼŸNjÌŸĶ_ǣǼÌs
ƼŸǣÞǼÞŸŘŸ¯N®ŷŘ_ǼÌs_sǼÞĶǣŸ¯NjsŎȖŘsNjǼÞŸŘƼÞ_ǼŸǼÌsŎNjsƼNjŸɚÞ_s_ÞŘəÝʹʺEŸɚsʳ
˧ˣ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

ANNEXURE TO THE DIRECTORS’ REPORT

VII. PENALTIES / PUNISHMENT/ COMPOUNDING OF OFFENCES:


There were no penalties / punishment / compounding of offences for breach of any section of Companies Act against the Company
or its Directors or other officers in default, if any, during the year under review.

For and on behalf of the Board of Directors


For Jyothy Laboratories Limited

M. P. Ramachandran
Chairman & Managing Director
(DIN: 00553406)

ōȖŎEÞʰ
ōɴˡˢʰˡ˟ˠ˥
Corporate Overview Performance Governance Financial Statements ˧ˤ

ANNEXURE TO THE DIRECTORS’ REPORT

DETAILS PERTAINING TO REMUNERATION AS REQUIRED UNDER SECTION 197(12) OF THE COMPANIES ACT, 2013 READ
WITH RULE 5(1) OF THE COMPANIES (APPOINTMENT AND REMUNERATION OF MANAGERIAL PERSONNEL) RULES, 2014

ʹÞʺ ǻÌsƼsNjOsŘǼ¶sÞŘONjsǣsÞŘNjsŎȖŘsNjǼÞŸŘŸ¯sOÌ^ÞNjsOǼŸNjʰNÌÞs¯®ÞŘŘOÞĶŷ¯ʩOsNjŘ_NŸŎƼŘɴǢsONjsǼNjɴ_ȖNjÞضǼÌsʩŘŘOÞĶ
ɴsNjˡ˟ˠˤ˚ˠ˥ʰNjǼÞŸŸ¯ǼÌsNjsŎȖŘsNjǼÞŸŘŸ¯sOÌ^ÞNjsOǼŸNjǼŸǼÌsŎs_ÞŘNjsŎȖŘsNjǼÞŸŘŸ¯ǼÌssŎƼĶŸɴssǣŸ¯ǼÌsNŸŎƼŘɴ¯ŸNjǼÌs
ʩŘŘOÞĶɴsNjˡ˟ˠˤ˚ˠ˥Ř_ǼÌsOŸŎƼNjÞǣŸŘŸ¯NjsŎȖŘsNjǼÞŸŘŸ¯sOÌħsɴōضsNjÞĶƻsNjǣŸŘŘsĶʹħōƻʺ¶ÞŘǣǼǼÌsƼsNj¯ŸNjŎŘOsŸ¯
ǼÌsNŸŎƼŘɴNjsǣȖŘ_sNjʲ
Sr. Name of Director Designation Remuneration % increase in Ratio of Comparison of
No. Current Year Remuneration remuneration Remuneration of
ÞŘǼÌsʩŘŘOÞĶ of each the KMP against
year 2015-16 Director/ Performance of the
to median Company
remuneration
of employees
1 ōʳƻʳNJŎOÌŘ_NjŘ NÌÞNjŎŘŘ_ ˣʰˡˠʰ˟ˢʰˤˠˠ ˢˣʳ˥ˤ ˠ˧ˤʲˠ ƻNjŸʩǼEs¯ŸNjsǻɮ
ōضÞض ÞŘONjsǣs_
^ÞNjsOǼŸNj Eɴˢ˦ʳ˟˨̇Ř_ƼNjŸʩǼ
¯ǼsNjǼɮÞŘONjsǣs_Eɴ
ˠˢʳ˦ˠ̇ÞŘʩŘŘOÞĶɴsNj
ˡ˟ˠˤ˚ˠ˥
ˡ ħʳȕĶĶǣħŎǼÌ ğŸÞŘǼōضÞض ˤʰ˨˧ʰˤˢʰˠˤ˨ ˠ˨ʳˣ˥ ˡ˥ˡʲˠ
^ÞNjsOǼŸNjŘ_
NÌÞs¯®ÞŘŘOÞĶ
ŷ¯ʩOsNj
ˢ ǢʳNJ¶ÌȖŘŘ_Ř ɟÌŸĶsǻÞŎs ˣʰ˧ˤʰˠˡʰ˟˟˟ ˟ʳ˟˟ ˡˠˢʲˠ
^ÞNjsOǼŸNjŘ_
NÌÞs¯rɮsOȖǼÞɚs
ŷ¯ʩOsNj
ˣ ōʳNJʳğɴŸǼÌɴ ɟÌŸĶsǻÞŎs ˠʰ˟ˡʰˣ˧ʰ˟˟˟ ˤʳˣˠ ˣˤʲˠ
^ÞNjsOǼŸNj
ˤ ŗÞĶsǣÌDʳōsÌǼ ÝŘ_sƼsŘ_sŘǼ ˨ʰ˦ˤʰ˟˟˟ ˧ʳˢˢ ˣʲˠ
^ÞNjsOǼŸNj
6 ħʳƻʳƻ_ŎĨȖŎNj ÝŘ_sƼsŘ_sŘǼ ˨ʰˡ˟ʰ˟˟˟ ˥ʳ˨˧ ˣʲˠ
^ÞNjsOǼŸNj
˦ DÞƼÞŘNJʳǢÌÌ ÝŘ_sƼsŘ_sŘǼ ˨ʰˢˤʰ˟˟˟ ˠʳ˟˧ ˣʲˠ
^ÞNjsOǼŸNj
˧ NJʳĵĨǣÌŎÞŘNjɴŘŘ ÝŘ_sƼsŘ_sŘǼ ˧ʰ˧ˤʰ˟˟˟ ˡʳˢˠ ˣʲˠ
^ÞNjsOǼŸNj
˨ ōȖNjNjÞĵĶDŘǣĶ Company ˣˤʰˤ˥ʰ˨ˠˠ ˡʳˡˣ ŗŸǼƼƼĶÞOEĶs ƻNjŸʩǼEs¯ŸNjsǻɮ
Secretary ÞŘONjsǣs_
Eɴˢ˦ʳ˟˨̇Ř_ƼNjŸʩǼ
¯ǼsNjǼɮÞŘONjsǣs_Eɴ
ˠˢʳ˦ˠ̇ÞŘʩŘŘOÞĶɴsNj
ˡ˟ˠˤ˚ˠ˥
(ÞÞʺ ÝŘǼÌsʩŘŘOÞĶɴsNjʰǼÌsNjsɠǣŘÞŘONjsǣsŸ¯˧ʳ˟˨̇ÞŘǼÌsŎs_ÞŘNjsŎȖŘsNjǼÞŸŘŸ¯sŎƼĶŸɴssǣʱ

ʹÞÞÞʺ ǻÌsNjs ɠsNjs ˡʰˢ˨ˤ ƼsNjŎŘsŘǼ sŎƼĶŸɴssǣ ŸŘ ǼÌs NjŸĶĶǣ Ÿ¯ ʹɚʺ NŸŎƼNjÞǣŸŘ Ÿ¯ NJsŎȖŘsNjǼÞŸŘ Ÿ¯ ǼÌs ħsɴ ōضsNjÞĶ
NŸŎƼŘɴǣŸŘōNjOÌˢˠʰˡ˟ˠ˥ʱ ƻsNjǣŸŘŘsĶʹǣʺ¶ÞŘǣǼǼÌsƼsNj¯ŸNjŎŘOsŸ¯ǼÌsNŸŎƼŘɴʲǻÌs
ǼŸǼĶNjsŎȖŘsNjǼÞŸŘŸ¯ħsɴōضsNjÞĶƻsNjǣŸŘŘsĶʹÞʳsʳƼsNjǣŸŘǣ
ʹÞɚʺ NJsĶǼÞŸŘǣÌÞƼ EsǼɠssŘ ɚsNj¶s ÞŘONjsǣs ÞŘ NjsŎȖŘsNjǼÞŸŘ ŎsŘǼÞŸŘs_¶ÞŘǣǼǢNjʳŗŸʳˠǼŸˣŘ_ǢNjʳŗŸʳ˨ʺÞŘONjsǣs_Eɴ
Ř_OŸŎƼŘɴƼsNj¯ŸNjŎŘOsʲ˚ǻÌsƻNjŸʩǼEs¯ŸNjsǻɮ¯ŸNjǼÌs ˠˣʳ˦ˡ̇¯NjŸŎ`ˠˣʳˣˠNNjŸNjsÞŘˡ˟ˠˣ˚ˠˤǼŸ`ˠ˥ʳˤˢNNjŸNjsÞŘ
ʩŘŘOÞĶ ɴsNj sŘ_s_ ōNjOÌ ˢˠʰ ˡ˟ˠ˥ ÞŘONjsǣs_ Eɴ ˢ˦ʳ˟˨̇ ˡ˟ˠˤ˚ˠ˥ɠÌsNjsǣǼÌsƻNjŸʩǼEs¯ŸNjsǻɮÞŘONjsǣs_Eɴˢ˦ʳ˟˨̇
Ř_ǼÌsÞŘONjsǣsÞŘNjsŎȖŘsNjǼÞŸŘɠǣ˧ʳ˥̇ʳ ǼŸˡ˟ˠʳˣˠNNjŸNjsÞŘˡ˟ˠˤ˚ˠ˥ʹˠˣ˥ʳ˨ˡNNjŸNjsÞŘˡ˟ˠˣ˚ˠˤʺʳ
˧˥ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

ANNEXURE TO THE DIRECTORS’ REPORT

ʹɚÞʺ ʺ əNjÞǼÞŸŘǣÞŘǼÌsŎNjĨsǼOƼÞǼĶÞǣǼÞŸŘŸ¯ǼÌsNŸŎƼŘɴʲ ʹɚÞÞʺ ɚsNj¶s ƼsNjOsŘǼ¶s ÞŘONjsǣs Ŏ_s ÞŘ ǼÌs ǣĶNjÞsǣ Ÿ¯
ǻÌs ŎNjĨsǼ OƼÞǼĶÞǣǼÞŸŘ ǣ ŸŘ ōNjOÌ ˢˠʰ ˡ˟ˠ˥ ɠǣ sŎƼĶŸɴssǣŸǼÌsNjǼÌŘǼÌsŎضsNjÞĶƼsNjǣŸŘŘsĶÞŘǼÌsĶǣǼ
` ˤʰˡ˦˦ʳ˧ˢ NNjŸNjs ʹ` ˣʰ˧ˢ˧ʳ˦˥  NNjŸNjs ǣ ŸŘ ōNjOÌ ˢˠʰ ʩŘŘOÞĶɴsNjÞʳsʳˡ˟ˠˤ˚ˠ˥ɠǣ˧ʳ˥̇ɠÌsNjsǣǼÌsŎضsNjÞĶ
ˡ˟ˠˤʺʱ NjsŎȖŘsNjǼÞŸŘ ¯ŸNj ǼÌs ǣŎs ʩŘŘOÞĶ ɴsNj ÞŘONjsǣs_ Eɴ
ˠˣʳˣ˧̇ʳ
 Eʺ ƻNjÞOs rNjŘÞضǣ NjǼÞŸ Ÿ¯ ǼÌs NŸŎƼŘɴ ɠǣ ˢˡʳˣ˨ ǣ Ǽ
ōNjOÌˢˠʰˡ˟ˠ˥Ř_ɠǣˢˢʳ˧˧ǣǼōNjOÌˢˠʰˡ˟ˠˤʱ ʹɚÞÞÞʺ ǻÌs Ĩsɴ ƼNjŎsǼsNjǣ ¯ŸNj ǼÌs ɚNjÞEĶs OŸŎƼŸŘsŘǼ Ÿ¯
NjsŎȖŘsNjǼÞŸŘ ɚÞĶs_ Eɴ ǼÌs _ÞNjsOǼŸNjǣ Njs ǣ ƼsNj ǼÌs
 Oʺ ƻ
 sNjOsŘǼ ÞŘONjsǣs ŸɚsNjˀ _sONjsǣs ÞŘ ǼÌs ŎNjĨsǼ NJsŎȖŘsNjǼÞŸŘƻŸĶÞOɴŸ¯ǼÌsNŸŎƼŘɴʳ
LJȖŸǼǼÞŸŘǣ Ÿ¯ ǼÌs ǣÌNjsǣ Ÿ¯ ǼÌs OŸŎƼŘɴ ǣ
OŸŎƼNjs_ ǼŸ ǼÌs NjǼs Ǽ ɠÌÞOÌ ǼÌs OŸŎƼŘɴ OŎs ʹÞɮʺ ǻÌsNjǼÞŸŸ¯ǼÌsNjsŎȖŘsNjǼÞŸŘŸ¯ǼÌsÌÞ¶ÌsǣǼƼÞ__ÞNjsOǼŸNj
ŸȖǼ ɠÞǼÌ ǼÌs ĶǣǼ ƼȖEĶÞO Ÿ¯¯sNj ÞŘ ǼÌs ɴsNj˚ ǻÌs Ÿ¯¯sNj ǼŸǼÌǼŸ¯ǼÌssŎƼĶŸɴssǣɠÌŸNjsŘŸǼ_ÞNjsOǼŸNjǣEȖǼNjsOsÞɚs
ƼNjÞOs Ǽ ǼÌs ǼÞŎs Ÿ¯ ÝŘÞǼÞĶ ƻȖEĶÞO ŷ¯¯sNj ÞŘ ˡ˟˟˦ ɠǣ NjsŎȖŘsNjǼÞŸŘÞŘsɮOsǣǣŸ¯ǼÌsÌÞ¶ÌsǣǼƼÞ__ÞNjsOǼŸNj_ȖNjÞض
`˥˨˟ƼsNjsLJȖÞǼɴǣÌNjsŸ¯¯OsɚĶȖsŸ¯`ˤˀ˚ƼsNjǣÌNjsʰ ǼÌsɴsNj˛ŗŸǼƼƼĶÞOEĶsʱŘ_
EȖǼ ¯ǼsNj _ĠȖǣǼŎsŘǼ ¯ŸNj ǣÌNjs ǣƼĶÞǼ ÞŘ ˤʲˠ NjǼÞŸ Ř_
EŸŘȖǣÞǣǣȖsŸ¯ˠʲˠʰÞǼɠŸNjĨŸȖǼǼŸ`˥˨ˀ˚ƼsNjǣÌNjsŸ¯ ʹɮʺ ÝǼ Þǣ ÌsNjsEɴ ¯ʩNjŎs_ ǼÌǼ ǼÌs NjsŎȖŘsNjǼÞŸŘ ƼÞ_ Þǣ ǣ ƼsNj
` ˠˀ˚ sOÌʳ  ǻÌs OĶŸǣÞض ǣÌNjs ƼNjÞOs Ÿ¯ ǼÌs NŸŎƼŘɴ NJsŎȖŘsNjǼÞŸŘƻŸĶÞOɴ¯ŸNj^ÞNjsOǼŸNjǣʰħsɴōضsNjÞĶƻsNjǣŸŘŘsĶ
ǼŗǢrŸŘōNjOÌˢˠʰˡ˟ˠ˥EsÞض`ˡ˨ˠʳˣ˟ˀ˚ƼsNjsLJȖÞǼɴ Ř_ŸǼÌsNjrŎƼĶŸɴssǣʳ
ǣÌNjsŸ¯¯OsɚĶȖsŸ¯`ˠˀ˚sOÌÌǣ¶NjŸɠŘˣʳˡˡǼÞŎsǣ
Ÿ¯ǼÌsÝƻŷƼNjÞOsʳ
Corporate Overview Performance Governance Financial Statements ˧˦

ANNEXURE TO THE DIRECTORS’ REPORT

STATEMENT OF PARTICULARS OF EMPLOYEES PURSUANT TO PROVISIONS OF SECTION 197(12) OF THE COMPANIES ACT
2013 READ WITH COMPANIES (APPOINTMENT AND REMUNERATION OF MANAGERIAL PERSONNEL) RULES, 2014
ʳ rŎƼĶŸɴs_ǼÌNjŸȖ¶ÌŸȖǼǼÌs®ÞŘŘOÞĶɳsNjˡ˟ˠˤ˚ˠ˥ɠÞǼÌض¶Njs¶ǼsǣĶNjɴŘŸǼĶsǣǣǼÌŘ`˥˟ʰ˟˟ʰ˟˟˟ˀ˚ƼsNjŘŘȖŎʲ
Name Age džȖĶÞʩOǼÞŸŘ Designation Date of Experience Total Gross Previous Employment
Commencement (years) Remuneration
of employment
ōʳƻʳ ˦˟ ƻŸǣǼ¶Nj_ȖǼs^s¶NjssÞŘ NÌÞNjŎŘŘ_ ˠˤ˚˟ˠ˚ˠ˨˨ˡ ˣˠɴsNjǣ ˣʰˡˠʰ˟ˢʰˤˠˠ ƻNjŸƼNjÞsǼŸNj˛ğɴŸǼÌɴ
NJōNËŗ^NJŗ ®ÞŘŘOÞĶōضsŎsŘǼ ōضÞض^ÞNjsOǼŸNj ĵEŸNjǼŸNjÞsǣ
ħʳȕĵĵǢħōǻË ˤˢ ōʳNŸŎʳʰ®ʳNʳʳʰʳNʳǢʳʰ ğŸÞŘǼōضÞض ˡ˥˚˟ˢ˚ˠ˨˨˦ ˢ˟ɴsNjǣ ˤʰ˨˧ʰˤˢʰˠˤ˨ ƻNjOǼÞOÞضNÌNjǼsNjs_
ĵʳĵʳDʳʰʳōʳƻʳ˛ɟÌNjǼŸŘ ^ÞNjsOǼŸNjŘ_NÌÞs¯ OOŸȖŘǼŘǼ
DȖǣÞŘsǣǣǢOÌŸŸĶŘ_ ®ÞŘŘOÞĶŷ¯ʩOsNj
ËNjɠNj_DȖǣÞŘsǣǣ
ǢOÌŸŸĶʰȕʳǢʳ
ǢNJµËȕŗŗ^ŗ ˤˠ ƻµ^Dō˛ÝÝōNĶOȖǼǼ ^ÞNjsOǼŸNjŘ_NÌÞs¯ ˡˢ˚˟ˤ˚ˡ˟ˠˡ ˡ˥ɴsNjǣ ˣʰ˧ˤʰˠˡʰ˟˟˟ ōضÞض^ÞNjsOǼŸNj˚
ōʳǢOʳʰDrËŸŘǣÞŘ rɮsOȖǼÞɚsŷ¯ʩOsNj NJsOĨÞǼǼDsŘOĨÞǣsNjÝŘ_Þ
NÌsŎÞOĶrض¶˛DÝǻǢ ĵÞŎÞǼs_
Pilani
ōʳNJʳğɳŷǻËɳ ˢ˧ DOŸŎʰōDʰ®ŎÞĶɴ ^ÞNjsOǼŸNj ˟ˠ˚˟ˠ˚ˡ˟˟ˣ ˠˡɴsNjǣ ˠʰ˟ˡʰˣ˧ʰ˟˟˟ ˚
ōضs_DȖǣÞŘsǣǣ
_ŎÞŘÞǣǼNjǼÞŸŘ¯NjŸŎ
ǢʳƻʳğÞŘÝŘǣǼÞǼȖǼsŸ¯
ōضsŎsŘǼʰŷɠŘsNjˀ
ƻNjsǣÞ_sŘǼōضsŎsŘǼ
ƻNjŸ¶NjŎŎs¯NjŸŎ
ËNjɚNj_ȕŘÞɚsNjǣÞǼɴʰȕǢ

NJğŗÝħŗǻ ˣ˨ DʳrʳʹōsOÌʺʰōDʳ əÞOsƻNjsǣÞ_sŘǼ˚ ˡˠ˚ˠ˟˚ˡ˟ˠˢ ˡˤɴsNjǣ ˢʰˠ˨ʰˢˢʰ˧ˡ˦ ȕŘÞĶsɚsNjˀNJs¶ÞŸŘĶ


ǢDŗəÝǢ ǢĶsǣ˓ōNjĨsǼÞض NǼs¶ŸNjɴəÞOs
ƻNjsǣÞ_sŘǼʹËÞNjNNjs˚
ǢŸȖǼÌǣÞʺ
ŗrrǻȕ ˣˡ DʳNŸŎʰNʳ əÞOsƻNjsǣÞ_sŘǼ˚ ˡˠ˚ˠˠ˚ˡ˟˟˟ ˠ˧ɴsNjǣ ˨˧ʰˢˤʰˣˢˣ ħsɠĶħÞNjŘ˓NŸ˚ǣǣǼʳ
ħǢËÝNJōħ Finance ōضsNj˚OOŸȖŘǼǣ
^ÝŗrǢËħȕōNJ ˣ˧ DʳǢOʳʰōD ŗǼÞŸŘĶǢĶsǣ ˟˨˚ˠˡ˚ˡ˟ˠˣ ˡ˦ɴsNjǣ ˠʰˤ˥ʰˢˡʰ˥ˣˠ ^EȖNjÝŘ_ÞĵǼ_ˀµō
ğËōD ōضsNj ˚ǢĶsǣ
S ˣ˥ DʳǢOʳ əƻ˚ǢŸȖNjOÞض˓ ˠ˦˚˟˧˚ˡ˟ˠˡ ˡ˟ʳ˦ɴsNjǣ ˨˟ʰˢˤʰ˦˦ˢ ħȖŎNjŷNj¶ŘÞO
ǢŷōǢȕŗ^NJō ǢȖƼƼĶɴNÌÞŘ ƻNjŸ_ȖOǼĵÞŎÞǼs_˚əÞOs
ƻNjsǣÞ_sŘǼŷƼsNjǼÞŸŘ
ərŗħÝǻNËĵō ˤˣ DʳNŸŎ Ës_˚NŸNjƼŸNjǼs ˟˦˚ˠˡ˚ˠ˨˨˨ ˠ˥ʳ˧ɴsNjǣ ˨ˣʰˢ˟ʰ˟ˤ˨ ËsŘĨsĶÝŘ_ÞĵÞŎÞǼs_˚
ÝɳrNJ Sales Ës_˚NŸNjƼŸNjǼsǢĶsǣ

Dʳ rŎƼĶŸɴs_¯ŸNjƼNjǼŸ¯ǼÌsʩŘŘOÞĶɴsNjˡ˟ˠˤ˚ˠ˥ɠÞǼÌض¶Njs¶ǼsǣĶNjɴŘŸǼĶsǣǣǼÌŘ`ˤʰ˟˟ʰ˟˟˟ˀ˚ƼsNjŎŸŘǼÌʲ
Name Age džȖĶÞʩOǼÞŸŘ Designation Date of Experience Total Gross Previous Employment
Commencement (years) Remuneration
of employment
ƻNJǻɳɳ ˣˤ DrʹNÌsŎÞOĶʺ əÞOsƻNjsǣÞ_sŘǼ˚ ˠˡ˚˟˨˚ˡ˟ˠˡ ˡˢɴsNjǣ ˦˟ʰ˥ˢʰˤ˟ˤ ȕŘÞĶɚsNjˀËs_˚NJ˓^
NËħNJDNJǻÝ ˛ğ_ɚƼȖNj ōŘȖ¯OǼȖNjÞضŘ_
ʹNjsǣÞ¶Řs_ɠʳsʳ¯ʳ University NJ˓^
ˢˠʳ˟˧ʳˡ˟ˠˤʺˎ
ğµ^ÝǢËħŗʹsɮƼÞNjs_ ˤ˨ µNj_ȖǼs ǣǣǼəÞOsƻNjsǣÞ_sŘǼ˚ ˟ˠ˚ˠˠ˚ˠ˨˧˧ ˢ˨ʳ˦ɴsNjǣ ˡ˦ʰˡˣʰˢ˨˦ ǢsĶ¯rŎƼĶŸɴs_
ŸŘˠˤˀ˟˥ˀˡ˟ˠˤʺ Sales
ǢÝ^^ËNJǻ˵ȕƻǻ ˣˣ DʳrʳʹōsOÌʺʰ Ër^˚ħsɴOOŸȖŘǼǣ ˠ˥˚˟˧˚ˡ˟ˠˡ ˠˤɴsNjǣ ˨ʰˤ˦ʰ˟ˡˣ ƻNjǣƻÌNjŎOsȖǼÞOĶĵǼ_
ōDʳ ˚µōʰǢȖƼsNjŎɮƻsNjǣŸŘĶ
NNjsÝŘ_ÞƻɚǼĵǼ_˚Ës_
ōŸ_sNjŘǻNj_s
ŗŗ^ħȕōNJƻħ ˤˠ D ǢNjʳŷ¯ʩOsNj˚OOŸȖŘǼǣ ˟ˢ˚ˠˡ˚ˠ˨˧˦ ˡ˦ʳˤɴsNjǣ ˠˠʰˤ˟ʰˣ˨˦ ˚
Notes:
ˠʳ ǻÌs¯ŸNjsǣÞ_NjsŎȖŘsNjǼÞŸŘÞǣÞŘOĶȖǣÞɚsŸ¯ɚĶȖsŸ¯ƼsNjLJȖÞǣÞǼsǣNjÞǣÞضŸȖǼŸ¯sɮsNjOÞǣsŸ¯rǢŷƻ¶NjŘǼǣEɴNjsǣƼsOǼÞɚssŎƼĶŸɴssǣʳ
ˡʳ ĶĶƼƼŸÞŘǼŎsŘǼǣNjsOŸŘǼNjOǼȖĶŘ_ǼsNjŎÞŘEĶsEɴŘŸǼÞOsŸŘsÞǼÌsNjǣÞ_sʳ
ˢʳ ŗŸŘsŸ¯ǼÌssŎƼĶŸɴssǣŎsŘǼÞŸŘs_EŸɚsNjsNjsĶǼs_ǼŸŘɴ_ÞNjsOǼŸNjŸ¯ǼÌsNŸŎƼŘɴsɮOsƼǼōNjʳōʳƻʳNJŎOÌŘ_NjŘŘ_ōǣʳōʳ
NJʳğɴŸǼÌɴʰɠÌŸNjsNjsĶǼs_ǼŸsOÌŸǼÌsNjʳ
ˣʳ ŗŸŘsŸ¯ǼÌssŎƼĶŸɴssÞǣ_NjɠÞضNjsŎȖŘsNjǼÞŸŘŎŸNjsǼÌŘǼÌsNjsŎȖŘsNjǼÞŸŘ_NjɠŘEɴŎضÞض_ÞNjsOǼŸNjˀɠÌŸĶsǼÞŎs_ÞNjsOǼŸNjŘ_Þǣ
ÌŸĶ_ÞضEɴǼÌsŎǣsĶɚsǣŸNjĶŸŘ¶ɠÞǼÌǼÌsÞNjǣƼŸȖǣsŘ__sƼsŘ_sŘǼOÌÞĶ_NjsŘʰǼɠŸƼsNjOsŘǼŸNjŎŸNjsŸ¯ǼÌssLJȖÞǼɴǣÌNjsǣŸ¯ǼÌsNŸŎƼŘɴʳ
˧˧ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

REPORT ON CORPORATE GOVERNANCE


COMPANY’S PHILOSOPHY ON CORPORATE GOVERNANCE BOARD OF DIRECTORS
ǻÌs NŸŎƼŘɴ˅ǣ ƼÌÞĶŸǣŸƼÌɴ Þǣ ǼŸ OŸŘ_ȖOǼ EȖǣÞŘsǣǣ Ř_ ÞǼǣ Composition:
_sĶÞضǣ ɠÞǼÌ ĶĶ ǣǼĨsÌŸĶ_sNjǣ ÞŘ OŸŎƼĶÞŘOs ɠÞǼÌ Ķɠ Ř_ ǻÌs DŸNj_ Ÿ¯ ^ÞNjsOǼŸNjǣ Ÿ¯ ǼÌs NŸŎƼŘɴ Ìɚs Ř ŸƼǼÞŎȖŎ
ÌÞ¶ÌǣǼŘ_Nj_ǣŸ¯EȖǣÞŘsǣǣsǼÌÞOǣŘ_ǼŸsɮOss_ǼÌsǣǼǼȖǼŸNjɴ OŸŎEÞŘǼÞŸŘ Ÿ¯ rɮsOȖǼÞɚs Ř_ ŗŸŘ˚rɮsOȖǼÞɚs ^ÞNjsOǼŸNjǣ
NjsLJȖÞNjsŎsŘǼǣ ɠÞǼÌ Njs¶Nj_ ǼŸ NŸNjƼŸNjǼs µŸɚsNjŘŘOsʳ ǻÌs ɠÞǼÌ ŸŘs ɟŸŎŘ ^ÞNjsOǼŸNj Ř_ ʩ¯Ǽɴ ƼsNjOsŘǼ Ÿ¯ ǼÌs DŸNj_ Ÿ¯
NŸŎƼŘɴ ɠŸȖĶ_ OŸŘǼÞŘȖs ǼŸ ǣǼNjsضǼÌsŘ ÞǼǣ ƼNjÞŘOÞƼĶsǣ Ÿ¯ ^ÞNjsOǼŸNjǣ OŸŎƼNjÞǣÞض Ÿ¯ ŗŸŘ˚rɮsOȖǼÞɚs ^ÞNjsOǼŸNjǣʳ ^ȖNjÞض ǼÌs
ǼNjŘǣƼNjsŘOɴʰ ¯ÞNjŘsǣǣ Ř_ OOŸȖŘǼEÞĶÞǼɴ ǼŸ ¶sŘsNjǼs ĶŸŘ¶˚
ɴsNj ˡ˟ˠˤ˚ˠ˥ʰ ǼÌs DŸNj_ OŸŎƼNjÞǣs_ Ÿ¯ ˧ ʹrÞ¶ÌǼʺ ŎsŎEsNjǣ Ÿ¯
ǼsNjŎɚĶȖs¯ŸNjÞǼǣǣÌNjsÌŸĶ_sNjǣŸŘOŸŘǼÞŘȖŸȖǣŘ_ǣȖǣǼÞŘEĶs
ɠÌŸŎˣʹ®ŸȖNjʺNjsrɮsOȖǼÞɚs^ÞNjsOǼŸNjǣŘ_ˣʹ®ŸȖNjʺNjsŗŸŘ˚
EǣÞǣÞŘÌNjŎŸŘɴɠÞǼÌǼÌsÞŘǼsNjsǣǼǣŸ¯ĶĶŸǼÌsNjǣǼĨsÌŸĶ_sNjǣʳ
rɮsOȖǼÞɚsˀÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNjǣʳōNjʳōʳƻʳNJŎOÌŘ_NjŘÞǣ
ǻÌsNŸŎƼŘɴÞǣÞŘOŸŎƼĶÞŘOsɠÞǼÌĶĶǼÌsƼNjŸɚÞǣÞŸŘǣǣǼÞƼȖĶǼs_ÞŘ ǼÌs ƻNjŸŎŸǼsNj Ř_ ǼÌs NÌÞNjŎŘ ˓ ōضÞض ^ÞNjsOǼŸNj Ÿ¯ ǼÌs
ǼÌs NŸŎƼŘÞsǣ OǼʰ ˡ˟ˠˢ Ř_ ǼÌs NJȖĶsǣ ¯NjŎs_ ǼÌsNjsȖŘ_sNjʰ Ř_ NŸŎƼŘɴŘ_ÌsŘOsˤ˟̇Ÿ¯ǼÌsDŸNj_OŸŘǣÞǣǼǣŸ¯ÝŘ_sƼsŘ_sŘǼ
NJs¶ȖĶǼÞŸŘǣ ȖŘ_sNj NÌƼǼsNj Ýə Ÿ¯ ǢrDÝ ʹĵÞǣǼÞض ŷEĶÞ¶ǼÞŸŘǣ Ř_ ^ÞNjsOǼŸNjǣʳ ǻÌs OŸŎƼŸǣÞǼÞŸŘ Ÿ¯ ǼÌs DŸNj_ Ÿ¯ ^ÞNjsOǼŸNjǣ Ÿ¯ ǼÌs
^ÞǣOĶŸǣȖNjs NJsLJȖÞNjsŎsŘǼǣʺ NJs¶ȖĶǼÞŸŘǣʰ ˡ˟ˠˤ ʹÌsNjsÞŘ¯ǼsNj Njs¯sNjNjs_ NŸŎƼŘɴ Þǣ ÞŘ OŸŘ¯ŸNjŎÞǼɴ ɠÞǼÌ ǼÌs ƼNjŸɚÞǣÞŸŘǣ Ÿ¯ NŸŎƼŘÞsǣ
ǼŸǣ˄ĵÞǣǼÞضNJs¶ȖĶǼÞŸŘǣ˅ʺʳǻÌs¯ŸĶĶŸɠÞضNJsƼŸNjǼǼŸ¶sǼÌsNjɠÞǼÌǼÌs OǼʰˡ˟ˠˢŘ_NJs¶ȖĶǼÞŸŘˠ˦Ÿ¯ǼÌsĵÞǣǼÞضNJs¶ȖĶǼÞŸŘǣʹsNjĶÞsNj
ÞŘ¯ŸNjŎǼÞŸŘOŸŘǼÞŘs_ÞŘǼÌsōضsŎsŘǼ^ÞǣOȖǣǣÞŸŘŘ_ŘĶɴǣÞǣ NĶȖǣsˣ˨Ÿ¯ǼÌsĵÞǣǼÞض¶NjssŎsŘǼʺʳ
NJsƼŸNjǼŘ_ŸǼÌsNjƼNjǼǣŸ¯ŘŘȖĶNJsƼŸNjǼOŸŘǣǼÞǼȖǼsǣǼÌsNŸŎƼŘɴ˅ǣ
OŸŎƼĶÞŘOsɠÞǼÌǼÌsNŸNjƼŸNjǼsµŸɚsNjŘŘOsNjsLJȖÞNjsŎsŘǼǣʳ

ǻÌsOŸŎƼŸǣÞǼÞŸŘŸ¯ǼÌsDŸNj_Ÿ¯^ÞNjsOǼŸNjǣÞǣǣȖŘ_sNjʲ

Name of the Member of the Board Category Relationship with other Directors
ōNjʳōʳƻʳNJŎOÌŘ_NjŘ ƻNjŸŎŸǼsNjˀNÌÞNjŎŘ˓ōضÞض^ÞNjsOǼŸNj ®ǼÌsNjŸ¯ōǣʳōʳNJʳğɴŸǼÌɴ
ōNjʳħʳȕĶĶǣħŎǼÌ ğŸÞŘǼōضÞض^ÞNjsOǼŸNj˓N®ŷ ŗŸŘs
ōNjʳǢʳNJ¶ÌȖŘŘ_Řˎ ɟÌŸĶsǻÞŎs^ÞNjsOǼŸNj˓Nrŷ ŗŸŘs
ōǣʳōʳNJʳğɴŸǼÌɴ ɟÌŸĶsǻÞŎs^ÞNjsOǼŸNj ^Ȗ¶ÌǼsNjŸ¯ōNjʳōʳƻʳNJŎOÌŘ_NjŘ
ōNjʳŗÞĶsǣÌDʳōsÌǼ ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNj ŗŸŘs
ōNjʳħʳƻʳƻ_ŎĨȖŎNj ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNj ŗŸŘs
ōNjʳDÞƼÞŘNJʳǢÌÌ ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNj ŗŸŘs
ōNjʳNJʳĵĨǣÌŎÞŘNjɴŘŘ ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNj ŗŸŘs
ˎNsǣs_ǼŸEsǼÌsɟÌŸĶsǻÞŎs^ÞNjsOǼŸNjŘ_NÌÞs¯rɮsOȖǼÞɚsŷ¯ʩOsNjɠʳsʳ¯ʳōɴˡˢʰˡ˟ˠ˥ʳ

Attendance of Directors at Board Meetings and Annual General Meeting:


^ȖNjÞضǼÌsɴsNjsŘ_s_ŸŘōNjOÌˢˠʰˡ˟ˠ˥ʰǼÌsDŸNj_Ÿ¯^ÞNjsOǼŸNjǣŎsǼǣÞɮǼÞŎsǣɚÞʊʳʰŸŘōɴˡˤʰˡ˟ˠˤʰğȖĶɴˢ˟ʰˡ˟ˠˤʰŷOǼŸEsNjˡ˟ʰ
ˡ˟ˠˤʰğŘȖNjɴˡ˧ʰˡ˟ˠ˥ʰōNjOÌˠ˟ʰˡ˟ˠ˥Ř_ōNjOÌˠˣʰˡ˟ˠ˥ʳǻÌsĶǣǼŘŘȖĶµsŘsNjĶōssǼÞضʹµōʺŸ¯ǼÌsNŸŎƼŘɴɠǣÌsĶ_ŸŘ
ğȖĶɴˢ˟ʰˡ˟ˠˤʳǻÌs^sǼÞĶǣŸ¯ǼǼsŘ_ŘOsŸ¯^ÞNjsOǼŸNjǣǼǼÌs¯ŸNjsǣÞ_DŸNj_ōssǼÞضǣŘ_ǼǼÌsĶǣǼµōÞǣǣȖŘ_sNjʲ

Name of Director Number of Board Meeting in FY 2015-16 Attendance at the Last


Annual General Meeting
Held Attended
ōNjʳōʳƻʳNJŎOÌŘ_NjŘ 6 6 ɳsǣ
ōNjʳħʳȕĶĶǣħŎǼÌ 6 ˤ ɳsǣ
ōNjʳǢʳNJ¶ÌȖŘŘ_Ř 6 6 ɳsǣ
ōǣʳōʳNJʳğɴŸǼÌɴ 6 6 ɳsǣ
ōNjʳŗÞĶsǣÌDʳōsÌǼ 6 6 ɳsǣ
ōNjʳħʳƻʳƻ_ŎĨȖŎNj 6 ˣ ɳsǣ
ōNjʳDÞƼÞŘNJʳǢÌÌ 6 ˤ ɳsǣ
ōNjʳNJʳĵĨǣÌŎÞŘNjɴŘŘ 6 ˣ ɳsǣ
Corporate Overview Performance Governance Financial Statements ˧˨

DŸNj_ōsŎEsNjǣŘ_ǼÌsÞNj^ÞNjsOǼŸNjǣÌÞƼǣÞŘŸǼÌsNjƻȖEĶÞOĵÞŎÞǼs_ˀĵÞǣǼs_NŸŎƼŘÞsǣǣŸŘōNjOÌˢˠʰˡ˟ˠ˥ÞǣǣȖŘ_sNjʲ

Name of Director Directorships in other Public Limited Committee positions in other Public Limited
Companies# Companies@
Public Listed Member Chairman
ōNjʳōʳƻʳNJŎOÌŘ_NjŘ ˢ 1 ˢ 1
ōNjʳħʳȕĶĶǣħŎǼÌ 1 1 ˡ ˚
ōNjʳǢʳNJ¶ÌȖŘŘ_Ř 1 ˚ 1 ˚
ōǣʳōʳNJʳğɴŸǼÌɴ 1 ˚ ˚ ˚
ōNjʳŗÞĶsǣÌDʳōsÌǼ 1 1 ˚ 1
ōNjʳħʳƻʳƻ_ŎĨȖŎNj ˢ ˚ 1 ˡ
ōNjʳDÞƼÞŘNJʳǢÌÌ ˡ 1 ˡ 1
ōNjʳNJʳĵĨǣÌŎÞŘNjɴŘŘ ˡ ˚ ˡ ˚

˞rɮOĶȖ_sǣ_ÞNjsOǼŸNjǣÌÞƼÞŘÝŘ_ÞŘƻNjÞɚǼsĵÞŎÞǼs_NŸŎƼŘÞsǣʰ®ŸNjsÞ¶ŘNŸŎƼŘÞsǣʰNŸŎƼŘÞsǣȖŘ_sNjǢsOǼÞŸŘ˧Ÿ¯ǼÌsNŸŎƼŘÞsǣ
OǼʰˡ˟ˠˢʳ
˔ŷŘĶɴOÌÞNjŎŘǣÌÞƼˀŎsŎEsNjǣÌÞƼŸ¯Ȗ_ÞǼNŸŎŎÞǼǼssŘ_ǢǼĨsÌŸĶ_sNjǣ˅NJsĶǼÞŸŘǣÌÞƼNŸŎŎÞǼǼssNjsOŸŘǣÞ_sNjs_ʳ

FAMILIARIZATION PROGRAMMES
ǻÌs_sǼÞĶǣŸ¯¯ŎÞĶÞNjÞʊǼÞŸŘƼNjŸ¶NjŎŎsǣÞŎƼNjǼs_ǼŸÞŘ_sƼsŘ_sŘǼ_ÞNjsOǼŸNjǣNjsȖƼĶŸ_s_ŸŘǼÌsɠsEǣÞǼsŸ¯ǼÌsNŸŎƼŘɴŘ_
OŘEsOOsǣǣs_ǼÌNjŸȖ¶ÌɠsEĶÞŘĨʲ˚ÌǼǼƼʲˀˀɠɠɠʳĠɴŸǼÌɴĶEŸNjǼŸNjÞsǣʳOŸŎˀOŸNjƼŸNjǼs˚¶ŸɚsNjŘŘOsʳƼÌƼ

AUDIT COMMITTEE
ǻÌs DŸNj_ Ìǣ OŸŘǣǼÞǼȖǼs_  ɠsĶĶ LJȖĶÞʩs_ ʩŘŘOÞĶĶɴ ĶÞǼsNjǼs ÞŘ_sƼsŘ_sŘǼ Ȗ_ÞǼ NŸŎŎÞǼǼss ɠÞǼÌ ŎŸNjs ǼÌŘ ǼɠŸ ǼÌÞNj_ Ÿ¯ ÞǼǣ
ōsŎEsNjǣǣÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNjǣŘ_ŗŸŘ˚rɮsOȖǼÞɚs^ÞNjsOǼŸNjǣʳĶĶōsŎEsNjǣŸ¯ǼÌsȖ_ÞǼNŸŎŎÞǼǼssƼŸǣǣsǣǣsɮƼsNjǼĨŘŸɠĶs_¶s
Ÿ¯OOŸȖŘǼǣʰȖ_ÞǼŘ_®ÞŘŘOsʳǻÌsNŸŎƼŘɴǢsONjsǼNjɴOǼǣǣǼÌsǢsONjsǼNjɴǼŸǼÌsȖ_ÞǼNŸŎŎÞǼǼssʳ

Composition, Meetings and Attendance


ǻÌsȖ_ÞǼNŸŎŎÞǼǼssÌ_ˤŎssǼÞضǣ_ȖNjÞضǼÌsɴsNjˡ˟ˠˤ˚ˠ˥ɚÞʊʳʰŸŘōɴˡˤʰˡ˟ˠˤʰğȖĶɴˢ˟ʰˡ˟ˠˤʰŷOǼŸEsNjˡ˟ʰˡ˟ˠˤʰğŘȖNjɴˡ˧ʰ
ˡ˟ˠ˥Ř_ōNjOÌˠˣʰˡ˟ˠ˥ʳǻÌsNŸŎƼŸǣÞǼÞŸŘŸ¯ǼÌsOŸŎŎÞǼǼssŘ_ǼǼsŘ_ŘOsŸ¯sOÌNŸŎŎÞǼǼssōsŎEsNjÞǣǣȖŘ_sNjʲ

Sr. No. Name of the Director No. of Meetings


Held Attended
1 ōNjʳŗÞĶsǣÌDʳōsÌǼʹNÌÞNjŎŘʺ˛ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNj ˤ ˤ
ˡ ōNjʳħʳƻʳƻ_ŎĨȖŎNj˚ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNj ˤ ˣ
ˢ ōNjʳDÞƼÞŘNJʳǢÌÌ˛ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNj ˤ ˣ
ˣ ōNjʳħʳȕĶĶǣħŎǼÌ˛ğŸÞŘǼōضÞض^ÞNjsOǼŸNj˓N®ŷ ˤ ˤ

NJsƼNjsǣsŘǼǼÞɚsǣ Ÿ¯ ÝŘǼsNjŘĶ Ȗ_ÞǼŸNjǣ Ř_ ǢǼǼȖǼŸNjɴ Ȗ_ÞǼŸNjǣ ǼÌǼ ǼÌs ʩŘŘOÞĶ ǣǼǼsŎsŘǼ Þǣ OŸNjNjsOǼʰ ǣȖ¯ʩOÞsŘǼ Ř_
ɠsNjsÞŘɚÞǼssǣǼŸǼÌsȖ_ÞǼNŸŎŎÞǼǼssōssǼÞضʳ ONjs_ÞEĶsʱ

Terms of Reference of Audit Committee ˡʳ NJsOŸŎŎsŘ_ǼÞŸŘ ¯ŸNj ƼƼŸÞŘǼŎsŘǼʰ NjsŎȖŘsNjǼÞŸŘ Ř_
ǻÌsǻsNjŎǣŸ¯Njs¯sNjsŘOsŸ¯ǼÌsȖ_ÞǼNŸŎŎÞǼǼssŸ¯ǼÌsNŸŎƼŘɴ ǼsNjŎǣŸ¯ƼƼŸÞŘǼŎsŘǼŸ¯Ȗ_ÞǼŸNjǣŸ¯ǼÌsNŸŎƼŘɴʱ
Njs ÞŘ OOŸNj_ŘOs ɠÞǼÌ ǼÌs ǢsOǼÞŸŘ ˠ˦˦ Ř_ ŸǼÌsNj ƼƼĶÞOEĶs
ƼNjŸɚÞǣÞŸŘǣŸ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢʰŘ_ǼÌsNJȖĶsǣ¯NjŎs_ ˢʳ ƼƼNjŸɚĶŸ¯ƼɴŎsŘǼǼŸǢǼǼȖǼŸNjɴȖ_ÞǼŸNjǣ¯ŸNjŘɴŸǼÌsNj
ǼÌsNjsȖŘ_sNjŘ_NJs¶ȖĶǼÞŸŘˠ˧ʹsNjĶÞsNjNĶȖǣsˣ˨Ÿ¯ǼÌsĵÞǣǼÞض ǣsNjɚÞOsǣNjsŘ_sNjs_EɴǼÌsǢǼǼȖǼŸNjɴȖ_ÞǼŸNjǣʱ
¶NjssŎsŘǼʺŸ¯ǼÌsĵÞǣǼÞضNJs¶ȖĶǼÞŸŘǣɠÌÞOÌÞŘǼsNjĶÞÞŘOĶȖ_s
ǼÌs¯ŸĶĶŸɠÞضʲ ˣʳ NJsɚÞsɠÞض ɠÞǼÌ ǼÌs ŎضsŎsŘǼʰ ǼÌs ŘŘȖĶ ®ÞŘŘOÞĶ
ǢǼǼsŎsŘǼǣ Ř_ Ȗ_ÞǼŸNj˅ǣ NJsƼŸNjǼ ǼÌsNjsŸŘ Es¯ŸNjs
ˠʳ ŷɚsNjǣÞ¶ÌǼ Ÿ¯ ǼÌs NŸŎƼŘɴ˅ǣ ʩŘŘOÞĶ NjsƼŸNjǼÞض ƼNjŸOsǣǣ ǣȖEŎÞǣǣÞŸŘ ǼŸ ǼÌs DŸNj_ ¯ŸNj ƼƼNjŸɚĶʰ ɠÞǼÌ ƼNjǼÞOȖĶNj
Ř_ ǼÌs _ÞǣOĶŸǣȖNjs Ÿ¯ ÞǼǣ ʩŘŘOÞĶ ÞŘ¯ŸNjŎǼÞŸŘ ǼŸ sŘǣȖNjs Njs¯sNjsŘOsǼŸʲ
˨˟ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

 ʳ ōǼǼsNjǣ NjsLJȖÞNjs_ ǼŸ Es ÞŘOĶȖ_s_ ÞŘ ǼÌs ^ÞNjsOǼŸNj˅ǣ 1ˠʳ rɚĶȖǼÞŸŘ Ÿ¯ ÞŘǼsNjŘĶ ʩŘŘOÞĶ OŸŘǼNjŸĶǣ Ř_ NjÞǣĨ
NJsǣƼŸŘǣÞEÞĶÞǼɴ ǢǼǼsŎsŘǼ ǼŸ Es ÞŘOĶȖ_s_ ÞŘ ǼÌs ŎضsŎsŘǼǣɴǣǼsŎǣʱ
DŸNj_˅ǣNjsƼŸNjǼÞŘǼsNjŎǣŸ¯OĶȖǣsʹOʺŸ¯ǣȖE˚ǣsOǼÞŸŘˢ
Ÿ¯ǢsOǼÞŸŘˠˢˣŸ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢʱ ˠˡʳ NJsɚÞsɠÞضʰ ɠÞǼÌ ǼÌs ŎضsŎsŘǼʰ ƼsNj¯ŸNjŎŘOs Ÿ¯
ǣǼǼȖǼŸNjɴŘ_ÞŘǼsNjŘĶȖ_ÞǼŸNjǣʰ_sLJȖOɴŸ¯ǼÌsÞŘǼsNjŘĶ
Eʳ NÌضsǣʰÞ¯ŘɴʰÞŘOOŸȖŘǼÞضƼŸĶÞOÞsǣŘ_ƼNjOǼÞOsǣ OŸŘǼNjŸĶǣɴǣǼsŎǣʱ
Ř_NjsǣŸŘǣ¯ŸNjǼÌsǣŎsʱ
ˠˢʳ NJsɚÞsɠÞضǼÌs_sLJȖOɴŸ¯ÞŘǼsNjŘĶȖ_ÞǼ¯ȖŘOǼÞŸŘʰÞ¯Řɴʰ
 Oʳ ōĠŸNjOOŸȖŘǼÞضsŘǼNjÞsǣÞŘɚŸĶɚÞضsǣǼÞŎǼsǣEǣs_ ÞŘOĶȖ_ÞضǼÌsǣǼNjȖOǼȖNjsŸ¯ǼÌsÞŘǼsNjŘĶȖ_ÞǼ_sƼNjǼŎsŘǼʰ
ŸŘǼÌssɮsNjOÞǣsŸ¯ĠȖ_¶ŎsŘǼEɴŎضsŎsŘǼʱ ǣǼ¯ʩض Ř_ ǣsŘÞŸNjÞǼɴ Ÿ¯ ǼÌs Ÿ¯ʩOÞĶ Ìs_Þض ǼÌs
_sƼNjǼŎsŘǼʰNjsƼŸNjǼÞضǣǼNjȖOǼȖNjsʰOŸɚsNj¶sŘ_¯NjsLJȖsŘOɴ
 _ʳ ǢÞ¶ŘÞʩOŘǼ _ĠȖǣǼŎsŘǼǣ Ŏ_s ÞŘ ǼÌs ʩŘŘOÞĶ Ÿ¯ÞŘǼsNjŘĶȖ_ÞǼʱ
ǣǼǼsŎsŘǼǣNjÞǣÞضŸȖǼŸ¯Ȗ_ÞǼʩŘ_Þضǣʱ
ˠˣʳ ^ÞǣOȖǣǣÞŸŘ ɠÞǼÌ ÝŘǼsNjŘĶ Ȗ_ÞǼŸNjǣ Ÿ¯ Řɴ ǣÞ¶ŘÞʩOŘǼ
 sʳ NŸŎƼĶÞŘOs ɠÞǼÌ ǼÌs ĶÞǣǼÞض Ř_ ŸǼÌsNj Ķs¶Ķ ʩŘ_ÞضǣŘ_¯ŸĶĶŸɠȖƼǼÌsNjsŸŘʱ
NjsLJȖÞNjsŎsŘǼǣNjsĶǼÞضǼŸʩŘŘOÞĶǣǼǼsŎsŘǼǣʱ
ˠˤʳ NJsɚÞsɠÞض ǼÌs ʩŘ_Þضǣ Ÿ¯ Řɴ ÞŘǼsNjŘĶ ÞŘɚsǣǼÞ¶ǼÞŸŘǣ Eɴ
ǼÌsÝŘǼsNjŘĶȖ_ÞǼŸNjǣÞŘǼŸŎǼǼsNjǣɠÌsNjsǼÌsNjsÞǣǣȖǣƼsOǼs_
 ¯ʳ ^ÞǣOĶŸǣȖNjsŸ¯ŘɴNjsĶǼs_ƼNjǼɴǼNjŘǣOǼÞŸŘǣʱ
¯NjȖ_ŸNjÞNjNjs¶ȖĶNjÞǼɴŸNj¯ÞĶȖNjsŸ¯ÞŘǼsNjŘĶOŸŘǼNjŸĶǣɴǣǼsŎǣ
Ÿ¯ŎǼsNjÞĶŘǼȖNjsŘ_NjsƼŸNjǼÞضǼÌsŎǼǼsNjǼŸǼÌsDŸNj_ʱ
 ¶ʳ ōŸ_Þʩs_ŸƼÞŘÞŸŘʹǣʺÞŘǼÌs_Nj¯ǼȖ_ÞǼNJsƼŸNjǼʱ

ˠ˥ʳ ^ÞǣOȖǣǣÞŸŘ ɠÞǼÌ ǼÌs ǢǼǼȖǼŸNjɴ Ȗ_ÞǼŸNjǣ Es¯ŸNjs ǼÌs Ȗ_ÞǼ


ˤʳ NJsɚÞsɠÞضʰɠÞǼÌǼÌsŎضsŎsŘǼʰsɮŎÞŘsǼÌsLJȖNjǼsNjĶɴ
OŸŎŎsŘOsǣʰEŸȖǼǼÌsŘǼȖNjsŘ_ǣOŸƼsŸ¯Ȗ_ÞǼǣɠsĶĶ
Ř_ ŘŘȖĶ ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣ Ř_ Ȗ_ÞǼŸNjǣ˅ NjsƼŸNjǼ
ǣƼŸǣǼ˚Ȗ_ÞǼ_ÞǣOȖǣǣÞŸŘǼŸǣOsNjǼÞŘŘɴNjsŸ¯OŸŘOsNjŘʱ
Es¯ŸNjsǣȖEŎÞǣǣÞŸŘǼŸǼÌsDŸNj_¯ŸNjƼƼNjŸɚĶʱ
ˠ˦ʳ ǻŸ ĶŸŸĨ ÞŘǼŸ ǼÌs NjsǣŸŘǣ ¯ŸNj ǣȖEǣǼŘǼÞĶ _s¯ȖĶǼǣ ÞŘ
˥ʳ NJsɚÞsɠÞضʰɠÞǼÌǼÌsŎضsŎsŘǼʰǼÌsǣǼǼsŎsŘǼŸ¯Ȗǣsǣˀ
ǼÌs ƼɴŎsŘǼ ǼŸ ǼÌs _sƼŸǣÞǼŸNjǣʰ _sEsŘǼȖNjs ÌŸĶ_sNjǣʰ
ƼƼĶÞOǼÞŸŘ Ÿ¯ ¯ȖŘ_ǣ NjÞǣs_ ǼÌNjŸȖ¶Ì Ř ÞǣǣȖs ʹƼȖEĶÞO
ǣÌNjsÌŸĶ_sNjǣ ʹÞŘ Oǣs Ÿ¯ ŘŸŘ˚ƼɴŎsŘǼ Ÿ¯ _sOĶNjs_
ÞǣǣȖsʰNjÞ¶ÌǼǣÞǣǣȖsʰƼNjs¯sNjsŘǼÞĶÞǣǣȖsʰsǼOʳʺʰǼÌsǣǼǼsŎsŘǼ
_ÞɚÞ_sŘ_ǣʺŘ_ONjs_ÞǼŸNjǣʱ
Ÿ¯¯ȖŘ_ǣȖǼÞĶÞʊs_¯ŸNjƼȖNjƼŸǣsǣŸǼÌsNjǼÌŘǼÌŸǣsǣǼǼs_ÞŘ
ǼÌs Ÿ¯¯sNj _ŸOȖŎsŘǼˀ ƼNjŸǣƼsOǼȖǣˀ ŘŸǼÞOs Ř_ ǼÌs NjsƼŸNjǼ ˠ˧ʳ ǻŸ NjsɚÞsɠ ǼÌs ¯ȖŘOǼÞŸŘÞض Ÿ¯ ǼÌs ɟÌÞǣǼĶs DĶŸɠsNj
ǣȖEŎÞǼǼs_ Eɴ ǼÌs ŎŸŘÞǼŸNjÞض ¶sŘOɴ ŎŸŘÞǼŸNjÞض ǼÌs ōsOÌŘÞǣŎŸNjəÞ¶ÞĶōsOÌŘÞǣŎʱ
ȖǼÞĶÞǣǼÞŸŘ Ÿ¯ ƼNjŸOss_ǣ Ÿ¯  ƼȖEĶÞO ŸNj NjÞ¶ÌǼǣ ÞǣǣȖsʰ Ř_
ŎĨÞض ƼƼNjŸƼNjÞǼs NjsOŸŎŎsŘ_ǼÞŸŘǣ ǼŸ ǼÌs DŸNj_ ǼŸ ˠ˨ʳ ƼƼNjŸɚĶŸ¯ƼƼŸÞŘǼŎsŘǼŸ¯NÌÞs¯®ÞŘŘOÞĶŷ¯ʩOsNjʹÞʳsʳǼÌs
ǼĨsȖƼǣǼsƼǣÞŘǼÌÞǣŎǼǼsNjʱ ɟÌŸĶsǻÞŎs®ÞŘŘOs^ÞNjsOǼŸNjŸNjŘɴŸǼÌsNjƼsNjǣŸŘÌs_Þض
ǼÌs ʩŘŘOs ¯ȖŘOǼÞŸŘ ŸNj _ÞǣOÌNj¶Þض ǼÌǼ ¯ȖŘOǼÞŸŘʺ ¯ǼsNj
˦ʳ NJsɚÞsɠ Ř_ ŎŸŘÞǼŸNj ǼÌs Ȗ_ÞǼŸNj˅ǣ ÞŘ_sƼsŘ_sŘOs Ř_ ǣǣsǣǣÞضǼÌsLJȖĶÞʩOǼÞŸŘǣʰsɮƼsNjÞsŘOsŘ_EOĨ¶NjŸȖŘ_ʰ
ƼsNj¯ŸNjŎŘOsŘ_s¯¯sOǼÞɚsŘsǣǣŸ¯Ȗ_ÞǼƼNjŸOsǣǣʱ sǼOʳŸ¯ǼÌsOŘ_Þ_Ǽsʱ

ˡ˟ʳ NNjNjɴÞض ŸȖǼ Řɴ ŸǼÌsNj ¯ȖŘOǼÞŸŘ ǣ Þǣ ŎsŘǼÞŸŘs_ ÞŘ ǼÌs
˧ʳ ƼƼNjŸɚĶŸNjŘɴǣȖEǣsLJȖsŘǼŎŸ_ÞʩOǼÞŸŘŸ¯ǼNjŘǣOǼÞŸŘǣ
ǼsNjŎǣŸ¯Njs¯sNjsŘOsŸ¯ǼÌsȖ_ÞǼNŸŎŎÞǼǼssʱ
Ÿ¯ǼÌsNŸŎƼŘɴɠÞǼÌNjsĶǼs_ƼNjǼÞsǣʱ
ǻÌs NjŸĶs Ÿ¯ ǼÌs Ȗ_ÞǼ NŸŎŎÞǼǼss Þǣ ÞŘ OOŸNj_ŘOs ɠÞǼÌ ǼÌs
˨ʳ ǢONjȖǼÞŘɴŸ¯ÞŘǼsNj˚OŸNjƼŸNjǼsĶŸŘǣŘ_ÞŘɚsǣǼŎsŘǼǣʱ ƼNjŸɚÞǣÞŸŘǣŸ¯NJs¶ȖĶǼÞŸŘˠ˧ʹˢʺŸ¯ǼÌsĵÞǣǼÞضNJs¶ȖĶǼÞŸŘǣNjs_
ɠÞǼÌƻNjŸ¯ƻNjǼNŸ¯ǢOÌs_ȖĶsÝÝǼŸǼÌsĵÞǣǼÞضNJs¶ȖĶǼÞŸŘǣ
ˠ˟ʳ əĶȖǼÞŸŘ Ÿ¯ ȖŘ_sNjǼĨÞضǣ ŸNj ǣǣsǼǣ Ÿ¯ ǼÌs NŸŎƼŘɴʰ ʹsNjĶÞsNjNĶȖǣsˣ˨Ÿ¯ǼÌsĵÞǣǼÞض¶NjssŎsŘǼʺŘ_ǢsOǼÞŸŘˠ˦˦Ÿ¯
ɠÌsNjsɚsNjÞǼÞǣŘsOsǣǣNjɴʱ ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢʳ

ÝŘ__ÞǼÞŸŘʰǼÌsNŸŎŎÞǼǼssĶǣŸNjsɚÞsɠǣǼÌsÞŘ¯ŸNjŎǼÞŸŘǣǣƼsOÞʩs_ÞŘƻNjDŸ¯ƻNjǼNŸ¯ǢOÌs_ȖĶsÝÝǼŸǼÌsĵÞǣǼÞضNJs¶ȖĶǼÞŸŘǣʳ

NOMINATION, REMUNERATION AND COMPENSATION COMMITTEE


Composition, Meetings and Attendance
ǻÌsŗŸŎÞŘǼÞŸŘʰNJsŎȖŘsNjǼÞŸŘŘ_NŸŎƼsŘǣǼÞŸŘNŸŎŎÞǼǼssOŸŎƼNjÞǣsǣŸ¯ǼÌs¯ŸĶĶŸɠÞض¯ŸȖNjōsŎEsNjǣʳǻÌsNŸŎŎÞǼǼss_ȖNjÞض
ǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥ŎsǼˢǼÞŎsǣɚÞʊʳʰŸŘōɴˡˤʰˡ˟ˠˤʰğȖĶɴˢ˟ʰˡ˟ˠˤŘ_ōNjOÌˠˣʰˡ˟ˠ˥ʳ
Corporate Overview Performance Governance Financial Statements ˨ˠ

ǻÌsǼǼsŘ_ŘOsǼǼÌsǣsŎssǼÞضǣɠǣǣȖŘ_sNjʲ
Sr. No. Name of the Director Category No. of Meetings
Held Attended
1 ōNjʳŗÞĶsǣÌDʳōsÌǼʹNÌÞNjŎŘʺ ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNj ˢ ˢ
ˡ ōNjʳōʳƻʳNJŎOÌŘ_NjŘ NÌÞNjŎŘ˓ōضÞض^ÞNjsOǼŸNj ˢ ˢ
ˢ ōNjʳħʳƻʳƻ_ŎĨȖŎNj ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNj ˢ ˢ
ˣ ōNjʳNJʳĵĨǣÌŎÞŘNjɴŘŘ ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNj ˢ ˡ

Terms of Reference of Nomination, Remuneration and ʹ˦ʺ ǻŸ _sǼsNjŎÞŘsʰ ƼsNjȖǣs Ř_ ʩŘĶÞʊs ǼsNjŎǣ Ř_ OŸŘ_ÞǼÞŸŘǣ
Compensation Committee ÞŘOĶȖ_ÞضNjsŎȖŘsNjǼÞŸŘƼɴEĶsǼŸrɮsOȖǼÞɚsˀɟÌŸĶsǻÞŎs
ǻÌs NŸŎŎÞǼǼss Þǣ _ȖĶɴ OŸŘǣǼÞǼȖǼs_ ÞŘ OOŸNj_ŘOs ɠÞǼÌ ^ÞNjsOǼŸNjǣŘ_ħsɴōضsNjÞĶƻsNjǣŸŘŘsĶŸ¯ǼÌsNŸŎƼŘɴ
ǢsOǼÞŸŘˠ˦˧Ř_ŸǼÌsNjƼNjŸɚÞǣÞŸŘǣŸ¯NŸŎƼŘÞsǣOǼʰˡ˟ˠˢŘ_ ¯NjŸŎǼÞŎsǼŸǼÞŎsʱ
NJs¶ȖĶǼÞŸŘˠ˨Ÿ¯ǼÌsĵÞǣǼÞضNJs¶ȖĶǼÞŸŘǣʹsNjĶÞsNjNĶȖǣsˣ˨Ÿ¯
ǼÌsĵÞǣǼÞض¶NjssŎsŘǼʺŘ_ÞǣsŎƼŸɠsNjs_ǼŸ_ŸǼÌs¯ŸĶĶŸɠÞضʲ ʹ˧ʺ ǻŸ NjsɚÞsɠʰ ŎsŘ_ ŸNj NjǼÞ¯ɴ ǼÌs sɮÞǣǼÞض ǼsNjŎǣ Ř_
OŸŘ_ÞǼÞŸŘǣÞŘOĶȖ_ÞضNjsŎȖŘsNjǼÞŸŘƼɴEĶsǼŸrɮsOȖǼÞɚsˀ
ʹˠʺ ǻŸ ¯ŸNjŎȖĶǼs ONjÞǼsNjÞ ¯ŸNj _sǼsNjŎÞŘÞض LJȖĶÞʩOǼÞŸŘǣʰ ɟÌŸĶs ǻÞŎs ^ÞNjsOǼŸNjǣ Ř_ ħsɴ ōضsNjÞĶ ƻsNjǣŸŘŘsĶ Ÿ¯
ƼŸǣÞǼÞɚs ǼǼNjÞEȖǼsǣ Ř_ ÞŘ_sƼsŘ_sŘOs Ÿ¯  _ÞNjsOǼŸNj Ř_ ǼÌsNŸŎƼŘɴʱ
NjsOŸŎŎsŘ_ǼŸǼÌsDŸNj_ʰƼŸĶÞOɴNjsĶǼÞضǼŸƼƼŸÞŘǼŎsŘǼ
Ř_NjsŎȖŘsNjǼÞŸŘ¯ŸNj^ÞNjsOǼŸNjǣʰħsɴōضsNjÞĶƻsNjǣŸŘŘsĶ ʹ˨ʺ ǻŸƼƼĶɴǼŸǼÌsōÞŘÞǣǼNjɴŸ¯NŸNjƼŸNjǼs¯¯ÞNjǣʰŗsɠ^sĶÌÞ
Ř_ŸǼÌsNjǣsŘÞŸNjsŎƼĶŸɴssǣʱ ŸNj Řɴ ȖǼÌŸNjÞǼɴ ǣȖEŸNj_ÞŘǼs_ ǼÌsNjs ȖŘ_sNj Njs¶Nj_Þض
ǼÌsÞNjƼƼNjŸɚĶ¯ŸNjƼɴŎsŘǼŸ¯NjsŎȖŘsNjǼÞŸŘǼŸrɮsOȖǼÞɚsˀ
ʹˡʺ ǻŸ¯ŸNjŎȖĶǼsONjÞǼsNjÞ¯ŸNjsɚĶȖǼÞŸŘŸ¯ǼÌsŎsŎEsNjǣŸ¯ǼÌs ɟÌŸĶsǻÞŎs^ÞNjsOǼŸNjǣǣŎɴEsNjsLJȖÞNjs_ȖŘ_sNjǼÌsǣÞ_
DŸNj_ Ÿ¯ ^ÞNjsOǼŸNjǣ ÞŘOĶȖ_Þض ÝŘ_sƼsŘ_sŘǼ ^ÞNjsOǼŸNjǣʰ ǼÌs OǼʱ
DŸNj_Ÿ¯^ÞNjsOǼŸNjǣŘ_ǼÌsNŸŎŎÞǼǼssǣǼÌsNjsŸ¯ʱ
ʹˠ˟ʺ ǻŸOŸŘǣÞ_sNjŘ_ƼƼNjŸɚsrǢŷƻǢOÌsŎsŘ_ǼŸƼsNj¯ŸNjŎĶĶ
ʹˢʺ ǻŸ_sɚÞǣsƼŸĶÞOɴŸŘDŸNj_^ÞɚsNjǣÞǼɴʱ ǣȖOÌOǼǣʰ_ss_ǣŘ_¯ȖŘOǼÞŸŘǣÞŘOĶȖ_ÞضʰEȖǼŘŸǼĶÞŎÞǼs_
ǼŸʰǼÌsŎǼǼsNjǣǣƼsOÞʩs_ÞŘNĶȖǣsˤŸ¯ǼÌsǢsOȖNjÞǼÞsǣŘ_
ʹˣʺ ǻŸÞ_sŘǼÞ¯ɴƼsNjǣŸŘǣʰLJȖĶÞʩs_ǼŸEsOŸŎs^ÞNjsOǼŸNjǣŘ_ɠÌŸ
rɮOÌضsDŸNj_Ÿ¯ÝŘ_ÞʹrŎƼĶŸɴssǢǼŸOĨŷƼǼÞŸŘǢOÌsŎs
Ŏɴ Es ƼƼŸÞŘǼs_ ÞŘ ǣsŘÞŸNj ŎضsŎsŘǼ ÞŘ OOŸNj_ŘOs
Ř_rŎƼĶŸɴssǢǼŸOĨƻȖNjOÌǣsǢOÌsŎsʺµȖÞ_sĶÞŘsǣʰˠ˨˨˨
ɠÞǼÌǼÌsONjÞǼsNjÞĶÞ__ŸɠŘŘ_NjsOŸŎŎsŘ_ǼŸǼÌsDŸNj_ʰ
ǣ ŎsŘ_s_ ¯NjŸŎ ǼÞŎs ǼŸ ǼÞŎs Ř_ ŎǼǼsNjǣ ÞŘOÞ_sŘǼĶˀ
ǼÌsÞNjƼƼŸÞŘǼŎsŘǼŘ_ɠÌsNjsŘsOsǣǣNjɴʰǼÌsÞNjNjsŎŸɚĶʱ
ǣȖƼƼĶsŎsŘǼĶǼÌsNjsǼŸʱ
ʹˤʺ ǻŸ¯ŸNjŎȖĶǼsƼŸĶÞOɴsŘǣȖNjÞضǼÌs¯ŸĶĶŸɠÞضʲ
ʹˠˠʺ ǻŸNjsOŸŎŎsŘ_ǼŸǼÌsDŸNj_Ÿ¯^ÞNjsOǼŸNjǣʰǼÌsÞNj_sOÞǣÞŸŘǣ
 ʳ ǻÌs ĶsɚsĶ Ř_ OŸŎƼŸǣÞǼÞŸŘ Ÿ¯ NjsŎȖŘsNjǼÞŸŘ Þǣ Ř_¯ȖNjǼÌsNjOǼÞŸŘǣǣǼÌsɴŎɴ_ssŎʩǼʳ
NjsǣŸŘEĶs Ř_ ǣȖ¯ʩOÞsŘǼ ǼŸ ǼǼNjOǼʰ NjsǼÞŘ Ř_
ŎŸǼÞɚǼs_ÞNjsOǼŸNjǣŸ¯ǼÌsLJȖĶÞǼɴNjsLJȖÞNjs_ǼŸNjȖŘǼÌs Performance evaluation criteria for Independent Directors:
NŸŎƼŘɴǣȖOOsǣǣ¯ȖĶĶɴʰ ǣ ƼsNj ǼÌs NJsŎȖŘsNjǼÞŸŘ ƻŸĶÞOɴ Ÿ¯ ǼÌs NŸŎƼŘɴʰ ǼÌs
ÝŘ_sƼsŘ_sŘǼ ^ÞNjsOǼŸNjǣ ɠÞĶĶ Es sɚĶȖǼs_ ŸŘ ʩɚs ONjÞǼsNjÞ ǣ
 Eʳ NJsĶǼÞŸŘǣÌÞƼŸ¯NjsŎȖŘsNjǼÞŸŘǼŸƼsNj¯ŸNjŎŘOsÞǣOĶsNj ŎsŘǼÞŸŘs_EsĶŸɠʲ
Ř_ ŎssǼǣ ƼƼNjŸƼNjÞǼs ƼsNj¯ŸNjŎŘOs EsŘOÌŎNjĨǣʰ
 ˠʺ rǼÌÞOǣŘ_əĶȖsǣ
Ř_
 ˡʺ ħŘŸɠĶs_¶sŘ_ƼNjŸʩOÞsŘOɴ
 Oʳ NjsŎȖŘsNjǼÞŸŘǼŸ_ÞNjsOǼŸNjǣʰĨsɴŎضsNjÞĶƼsNjǣŸŘŘsĶ  ˢʺ ^ÞĶÞ¶sŘOs
Ř_ǣsŘÞŸNjŎضsŎsŘǼÞŘɚŸĶɚsǣEĶŘOsEsǼɠssŘ  ˣʺ DsÌɚÞŸNjĶǼNjÞǼǣʱŘ_
ʩɮs_ Ř_ ÞŘOsŘǼÞɚs Ƽɴ NjsʪsOǼÞض ǣÌŸNjǼ Ř_ ĶŸŘ¶
 ˤʺ r¯¯ŸNjǼǣ¯ŸNjƼsNjǣŸŘĶ_sɚsĶŸƼŎsŘǼ
ǼsNjŎ ƼsNj¯ŸNjŎŘOs ŸEĠsOǼÞɚsǣ ƼƼNjŸƼNjÞǼs ǼŸ ǼÌs
ɠŸNjĨÞضŸ¯ǼÌsNŸŎƼŘɴŘ_ÞǼǣ¶ŸĶǣʱ
ǻÌsEŸɚsʩɚsONjÞǼsNjÞɠÞĶĶEs¯ȖNjǼÌsNj_ÞɚÞ_s_ÞŘǼŸǣȖE˚ONjÞǼsNjÞʰ
ʹ˥ʺ ǻŸ_sǣÞ¶ŘǼÌsNŸŎƼŘɴ˅ǣƼŸĶÞOɴŸŘǣƼsOÞʩONjsŎȖŘsNjǼÞŸŘ ŘŸǼ sɮOss_Þض ʩɚs ¯ŸNj sOÌ Ÿ¯ ǼÌs ONjÞǼsNjÞʳ ǻÌsǣs ɠÞĶĶ ĶǣŸ
ƼOĨ¶sǣ ¯ŸNj rɮsOȖǼÞɚsˀ ɟÌŸĶs ǻÞŎs ^ÞNjsOǼŸNjǣ Ř_ ħsɴ ENjÞض ŸȖǼ ɠÌsǼÌsNj ŸNj ŘŸǼ  ^ÞNjsOǼŸNj Ìǣ ŘsOsǣǣNjɴ ƼŸǣÞǼÞɚs
ōضsNjÞĶ ƻsNjǣŸŘŘsĶ ÞŘOĶȖ_Þض ƼsŘǣÞŸŘ NjÞ¶ÌǼǣ Ř_ Řɴ ǼǼNjÞEȖǼsǣ NjsLJȖÞNjs_ ¯ŸNj _ÞǣOÌNj¶Þض ÌÞǣ _ȖǼÞsǣʰ ¯ȖŘOǼÞŸŘǣ Ř_
ŸǼÌsNjOŸŎƼsŘǣǼÞŸŘƼɴŎsŘǼʱ NjsǣƼŸŘǣÞEÞĶÞǼÞsǣǣǼÌs^ÞNjsOǼŸNjŸ¯ǼÌsNŸŎƼŘɴʳ
˨ˡ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

NjǼÞضǣOĶsŸ¯ˤʹʩɚsʺÞǣȖǣs_ǼŸ¶ÞɚsǣOŸNjsǣ¯ŸNjsOÌŸ¯ǼÌs  ÞÞʺ rɮÞǣǼÞضNjsŎȖŘsNjǼÞŸŘ_NjɠŘʳ


ǣȖEONjÞǼsNjÞʲ  ÞÞÞʺ ÝŘ_ȖǣǼNjɴ ǣǼŘ_Nj_ǣʰ Þ¯ ǼÌs _Ǽ ÞŘ ǼÌÞǣ Njs¶Nj_ Þǣ
 ˠʺ ŷȖǼǣǼŘ_Þض˚ˤ ɚÞĶEĶsʳ
 ˡʺ əsNjɴµŸŸ_˚ˣ  Þɚʺ ǻÌsĠŸE_sǣONjÞƼǼÞŸŘʳ
 ˢʺ µŸŸ_˚ˢ  ɚʺ džȖĶÞʩOǼÞŸŘǣŘ_sɮƼsNjÞsŘOsĶsɚsĶǣŸ¯ǼÌsOŘ_Þ_Ǽsʳ
 ˣʺ ȕŘǣǼÞǣ¯OǼŸNjɴ˚ˡ  ɚÞʺ NJsŎȖŘsNjǼÞŸŘ_NjɠŘEɴǼÌsŸȖǼ¶ŸÞضsŎƼĶŸɴssʰÞŘ
 ˤʺ ƻŸŸNj˚ˠ OǣsǼÌsƼƼŸÞŘǼŎsŘǼÞǣǼŸʩĶĶɚOŘOɴŸŘǼÌs_sǼÌʰ
NjsǣÞ¶ŘǼÞŸŘʰNjsŎŸɚĶsǼOʳŸ¯ŘsɮÞǣǼÞضsŎƼĶŸɴssʳ
rOÌ sɚĶȖǼÞض ^ÞNjsOǼŸNj ɠÞĶĶ ƼNjŸɚÞ_s ǣOŸNjs ¯ŸNj sOÌ Ÿ¯ ǼÌs  ɚÞÞʺ ǻÌsNjsŎȖŘsNjǼÞŸŘ_NjɠŘEɴŸǼÌsNjsŎƼĶŸɴssǣÞŘǼÌs
ÝŘ_sƼsŘ_sŘǼ ^ÞNjsOǼŸNjʳ ǻÌs sɚĶȖǼÞض ^ÞNjsOǼŸNj ɠÞĶĶ ¶Þɚs ǣOŸNjs ¶Nj_s ɠÞǼÌ ŎǼOÌÞض LJȖĶÞʩOǼÞŸŘǣ Ř_ ǣsŘÞŸNjÞǼɴʰ Þ¯
¯ŸNj sOÌ Ÿ¯ ǼÌs ǣȖE˚ONjÞǼsNjÞ OŸŎƼNjÞǣÞض sOÌ Ÿ¯ ǼÌs ONjÞǼsNjÞ ƼƼĶÞOEĶsʳ
ŎsŘǼÞŸŘs_EŸɚsʳǻÌsǣOŸNjsɠÞĶĶEsEǣs_ŸŘǼÌsNjǼÞضǣOĶs
ǣŎsŘǼÞŸŘs_EŸɚsʳ Eʺ ǻÌs_sǼsNjŎÞŘǼÞŸŘŸ¯NjsŎȖŘsNjǼÞŸŘ¯ŸNjŸǼÌsNjsŎƼĶŸɴssǣ
ǣÌĶĶEs¶ŸɚsNjŘs_EɴǼÌsËNJƻŸĶÞOɴʳ
ǻÌssɚĶȖǼŸNjɠÞĶĶÌɚsǼŸƼNjŸɚÞ_sNjsǣŸŘǣ¯ŸNjNjǼÞضǣOŸNjsŸ¯ˠ
ŸNjˡŘ_ǣȖ¶¶sǣǼÞŸŘǣʰÞ¯Řɴʰ¯ŸNjÞŎƼNjŸɚsŎsŘǼʳǻÌsʩŘĶǣOŸNjs Oʺ ǻÌs ƼNjŸƼŸǣĶ ¯ŸNj ǼÌs ƼƼŸÞŘǼŎsŘǼ Ÿ¯ Ř rɮsOȖǼÞɚs
¯ŸNjsOÌŸ¯ǼÌsÞŘ_sƼsŘ_sŘǼ_ÞNjsOǼŸNjɠÞĶĶEsNjNjÞɚs_ǼÞŘǼÌs ^ÞNjsOǼŸNjˀ ħsɴ ōضsNjÞĶ ƻsNjǣŸŘŘsĶ ǣÌĶĶ ƼNjŸɚÞ_s
ŎŘŘsNj¶ÞɚsŘEsĶŸɠʲ ŘsOsǣǣNjɴÞŘ¯ŸNjŎǼÞŸŘÞŘǼÌÞǣNjs¶Nj_ɠÌÞOÌǼÌsDŸNj_ɠÞĶĶ
OŸŘǣÞ_sNjÞŘNjNjÞɚÞضǼǼÌsOŸŘOĶȖǣÞŸŘǣǼŸɠÌsǼÌsNjŸNjŘŸǼ
Þʺ ǻÌs ǣOŸNjs ¯ŸNj sOÌ Ÿ¯ ǼÌs ONjÞǼsNjÞ ɠÞĶĶ Es NjNjÞɚs_ Ǽ Eɴ ǼÌsNjsŎȖŘsNjǼÞŸŘŸ¯¯sNjs_ǼŸǼÌsOŘ_Þ_ǼsÞǣƼƼNjŸƼNjÞǼsʰ
¶¶Njs¶ǼÞضǼÌsǣOŸNjsǣ¯ŸNjǣȖE˚ONjÞǼsNjÞŘ__ÞɚÞ_ÞضǼÌsŎ NjsǣŸŘEĶs Ř_ EĶŘOs_ ǣ ǼŸ ǼÌs ʩɮs_ Ř_ ɚNjÞEĶs
EɴǼÌsŘȖŎEsNjŸ¯ǣȖEONjÞǼsNjÞʳ ƼŸNjǼÞŸŘǣʹÞŘOĶȖ_ÞضǼÌsOŸŎŎÞǣǣÞŸŘʺʳ
ÞÞʺ ǻÌsǼŸǼĶǣOŸNjs¯NjŸŎsOÌsɚĶȖǼŸNjɠÞĶĶEsNjNjÞɚs_ǼEɴ _ʺ ǻÌs NjsŎȖŘsNjǼÞŸŘ ƼɴEĶs ǼŸ ǼÌs rɮsOȖǼÞɚs ^ÞNjsOǼŸNjǣʰ
__ÞضȖƼǼÌsǣOŸNjsǣŸ¯ĶĶONjÞǼsNjÞŘ__ÞɚÞ_ÞضǼÌsǼŸǼĶ ÞŘOĶȖ_Þض ǼÌs NŸŎŎÞǣǣÞŸŘ Ř_ ɚĶȖs Ÿ¯ ǼÌs ƼsNjLJȖÞǣÞǼsǣʰ
Eɴˤʹʩɚsʺʳ ǣÌĶĶŘŸǼsɮOss_ǼÌsƼsNjŎÞǣǣÞEĶsĶÞŎÞǼǣǣNjsŎsŘǼÞŸŘs_
ɠÞǼÌÞŘǼÌsƼNjŸɚÞǣÞŸŘǣŸ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢʳ
ÞÞÞʺ ǻÌsǼŸǼĶǣOŸNjs¯ŸNjŘÞŘ_sƼsŘ_sŘǼ_ÞNjsOǼŸNjɠÞĶĶEsNjNjÞɚs_
ǼEɴ__ÞضǼÌsǣOŸNjsǣ¯NjŸŎĶĶsɚĶȖǼŸNjǣŘ__ÞɚÞ_Þض sʺ ǻÌs rɮsOȖǼÞɚs ^ÞNjsOǼŸNjǣ ǣÌĶĶ ŘŸǼ Es sĶÞ¶ÞEĶs ǼŸ NjsOsÞɚs
ǣȖOÌǼŸǼĶǣOŸNjsEɴǼÌsŘȖŎEsNjŸ¯sɚĶȖǼŸNjǣʳ ǢÞǼǼÞض ¯ssǣ ¯ŸNj ǼǼsŘ_Þض ǼÌs ŎssǼÞضǣ Ÿ¯ ǼÌs DŸNj_ ŸNj
NŸŎŎÞǼǼssǣ ǼÌsNjsŸ¯ Ÿ¯ ǼÌs NŸŎƼŘɴ Ř_ ÞǼǣ ǢȖEǣÞ_ÞNjɴ
ǻÌsNÌÞNjŎŘɠÞĶĶOŸŘɚsɴǼÌsNjsǣȖĶǼŸ¯ǼÌssɚĶȖǼÞŸŘǼŸǼÌs NŸŎƼŘÞsǣʳ
OŸŘOsNjŘs_ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNjʳÝŘOǣsǼÌsǼŸǼĶǣOŸNjsŸ¯Ř
ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNjÞǣĶsǣǣǼÌŘŸNjsLJȖĶǼŸˡʰǼÌsNÌÞNjŎŘ ¯ʺ ǻÌs ŗŸŘ˚rɮsOȖǼÞɚs ^ÞNjsOǼŸNjǣ ǣÌĶĶ ŘŸǼ Es sĶÞ¶ÞEĶs ǼŸ
ǣÌĶĶ OŸŘɚsɴ ǼŸ ǣȖOÌ ÝŘ_sƼsŘ_sŘǼ ^ÞNjsOǼŸNj ǼÌs NjsǣŸŘǣ ¯ŸNj NjsOsÞɚs Řɴ NjsŎȖŘsNjǼÞŸŘˀ ǣĶNjɴ ¯NjŸŎ ǼÌs NŸŎƼŘɴʳ
ǼÌsǣOŸNjsŎsŘǼÞŸŘs_EɴǼÌssɚĶȖǼŸNjʹǣʺʰŘ_ǣȖ¶¶sǣǼÞŸŘǣ¯ŸNj ËŸɠsɚsNjʰ ǼÌs ŗŸŘ˚rɮsOȖǼÞɚs ^ÞNjsOǼŸNjǣ ǣÌĶĶ Es ƼÞ_
ÞŎƼNjŸɚsŎsŘǼǣʰÞ¯ŘɴʳݯŘÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNj¶sǼǣǣOŸNjs ǣÞǼǼÞض ¯ssǣ ¯ŸNj ǼǼsŘ_Þض ǼÌs ŎssǼÞض Ÿ¯ ǼÌs DŸNj_ ŸNj
Ÿ¯ĶsǣǣǼÌŘŸNjsLJȖĶǼŸˡ¯ŸNjÌÞǣɠÌŸĶsǼsŘȖNjsʹǣƼNjŸɚÞ_s_ NŸŎŎÞǼǼssǣǼÌsNjsŸ¯Ř_OŸŎŎÞǣǣÞŸŘʰǣŎɴEs_sOÞ_s_
ȖŘ_sNj ǼÌs ƼNjŸɚÞǣÞŸŘǣ Ÿ¯ ǼÌs NŸŎƼŘÞsǣ OǼʰ ˡ˟ˠˢʺʰ Ìsˀ ǣÌs EɴǼÌsDŸNj_ˀǢÌNjsÌŸĶ_sNjǣ¯NjŸŎǼÞŎsǼŸǼÞŎsʳ
ǣÌĶĶŘŸǼEssĶÞ¶ÞEĶs¯ŸNjNjs˚ƼƼŸÞŘǼŎsŘǼ¯ŸNj¯ȖNjǼÌsNjǼsNjŎǣ
^ÞNjsOǼŸNjŸ¯ǼÌsNŸŎƼŘɴʳ ¶ʺ ǻÌs ŗŸŘ˚rɮsOȖǼÞɚs ^ÞNjsOǼŸNjǣ ǣÌĶĶ ĶǣŸ Es sĶÞ¶ÞEĶs ¯ŸNj
NjsÞŎEȖNjǣsŎsŘǼ Ÿ¯ NjsǣŸŘEĶs ŸȖǼ˚Ÿ¯˚ƼŸOĨsǼ sɮƼsŘǣsǣ
ǻÌs ƻsNj¯ŸNjŎŘOs rɚĶȖǼÞŸŘ Ÿ¯ rɮsOȖǼÞɚs ^ÞNjsOǼŸNjǣ Ř_ ħsɴ ÞŘOȖNjNjs_ Eɴ ǼÌsŎ ¯ŸNj ǼǼsŘ_Þض ŎssǼÞضǣ Ÿ¯ ǼÌs DŸNj_ʰ
ōضsNjÞĶƻsNjǣŸŘŘsĶǣÌĶĶEsONjNjÞs_ŸȖǼEɴǼÌsÝŘ_sƼsŘ_sŘǼ NŸŎŎÞǼǼssǣŸNjǢÌNjsÌŸĶ_sNjǣʰÞŘOĶȖ_ÞضǼÌsǼNjɚsĶĶÞضŘ_
^ÞNjsOǼŸNjǣÞŘǼÌsŎŘŘsNjŎsŘǼÞŸŘs_EŸɚsǼĨÞضÞŘǼŸOOŸȖŘǼ ĶŸ_¶Þض˓EŸNj_ÞضsɮƼsŘǣsǣŸŘŘOǼȖĶEǣÞǣʳ
ǼÌs ƼsNj¯ŸNjŎŘOs ¶ÞŘǣǼ ǼÌs OŸNjƼŸNjǼs ¶ŸĶǣ Ř_ ŸEĠsOǼÞɚsǣ
ǻÌsŎŸȖŘǼŸ¯ǣÞǼǼÞض¯ssŘ_OŸŎŎÞǣǣÞŸŘƼɴEĶsǼŸŗŸŘ˚
ŸŘǼÌsEǣÞǣŸ¯ƼsNj¯ŸNjŎŘOsƼNjŎsǼsNjǣsǼ¯ŸNjsOÌrɮsOȖǼÞɚs
rɮsOȖǼÞɚs^ÞNjsOǼŸNjǣǣÌĶĶŘŸǼsɮOss_ǼÌsĶÞŎÞǼǣƼNjsǣONjÞEs_
^ÞNjsOǼŸNjŘ_ħsɴōضsNjÞĶƻsNjǣŸŘŘsĶʳ
ȖŘ_sNj ǼÌs ƼNjŸɚÞǣÞŸŘǣ Ÿ¯ ǼÌs NŸŎƼŘÞsǣ OǼʰ ˡ˟ˠˢ Ř_
ƼƼNjŸɚs_EɴōsŎEsNjǣŸ¯ǼÌsNŸŎƼŘɴʳ
Remuneration Policy
ǻÌs NŸŎƼŘɴ ¯ŸĶĶŸɠǣ  ƼŸĶÞOɴ ŸŘ NjsŎȖŘsNjǼÞŸŘ Ÿ¯ ^ÞNjsOǼŸNjǣ  rɮƼĶŘǼÞŸŘʲ®ŸNjǼÌsƼȖNjƼŸǣsǣŸ¯ǼÌÞǣƻŸĶÞOɴʰNJsŎȖŘsNjǼÞŸŘ
Ř_ǢsŘÞŸNjōضsŎsŘǼrŎƼĶŸɴssǣʳ ǣÌĶĶŎsŘǼÌsNŸǣǼǼŸǼÌsNŸŎƼŘɴŘ_ǣÌĶĶÞŘOĶȖ_sǼÌs
ǣĶNjɴʰĶĶŸɠŘOsǣʰƼsNjLJȖÞǣÞǼsǣʰƼsNj¯ŸNjŎŘOsÞŘOsŘǼÞɚsŘ_
ʺ ɟÌÞĶs _sǼsNjŎÞŘÞض ǼÌs NjsŎȖŘsNjǼÞŸŘ Ÿ¯ rɮsOȖǼÞɚs Řɴ ŸǼÌsNj ¯OÞĶÞǼɴ ƼNjŸɚÞ_s_ ŸNj ƼɴŎsŘǼ Ŏ_s ǼŸ ŸNj ŸŘ
^ÞNjsOǼŸNjǣ Ř_ ħsɴ ōضsNjÞĶ ƻsNjǣŸŘŘsĶʰ ǼÌs DŸNj_ EsÌĶ¯Ÿ¯ǼÌssŎƼĶŸɴssʳ
OŸŘǣÞ_sNjǣ¯ŸĶĶŸɠÞض¯OǼŸNjǣʲ
 Þʺ NNjÞǼsNjÞˀŘŸNjŎǣ¯ŸNj_sǼsNjŎÞŘÞضǼÌsNjsŎȖŘsNjǼÞŸŘŸ¯ Ìʺ ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNjǣǣÌĶĶŘŸǼEssĶÞ¶ÞEĶsǼŸƼNjǼÞOÞƼǼs
ǣȖOÌsŎƼĶŸɴssǣƼNjsǣONjÞEs_ÞŘǼÌsËNJƻŸĶÞOɴʳ ÞŘǼÌsrǢŷƻǢOÌsŎsʰÞ¯Řɴʳ
Corporate Overview Performance Governance Financial Statements ˨ˢ

^sǼÞĶǣŸ¯NJsŎȖŘsNjǼÞŸŘƼÞ_ǼŸ^ÞNjsOǼŸNjǣ¯ŸNjǼÌsʩŘŘOÞĶɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥ʲ
Executive Directors
ʹŎŸȖŘǼÞŘ`sɮOsƼǼǢǼŸOĨŷƼǼÞŸŘǣ^Ǽʺ
ŗŎsŸ¯ǼÌs^ÞNjsOǼŸNj ǢĶNjɴÞŘOĶȖ_Þض ƻNjŸɚÞ_sŘǼ®ȖŘ_ Superannuation Commission ǻŸǼĶ ǢǼŸOĨŷƼǼÞŸŘǣ
DsŘsʩǼǣ˓ ƼɴEĶs µNjŘǼs_ʹÝŘŗŸǣʳʺ
ƻsNjLJȖÞǣÞǼsǣ
ōNjʳōʳƻʳNJŎOÌŘ_NjŘ 1 ˚ ˚ ˣʰˡˠʰ˟ˢʰˤˠ˟ ˣʰˡˠʰ˟ˢʰˤˠˠ ˚
ōNjʳħʳȕĶĶǣħŎǼÌ ˠʰ˧˟ʰ˟˟ʰ˟˟˟ ˡˠʰ˥˟ʰ˟˟˟ ˠ˧ʰ˟˟ʰ˟˟˟ ˢʰ˦˧ʰ˨ˢʰˠˤ˨ ˤʰ˨˧ʰˤˢʰˠˤ˨ ˚
ōNjʳǢʳNJ¶ÌȖŘŘ_Ř ˣʰˢ˦ʰ˥˟ʰ˟˟˟ ˣ˦ʰˤˡʰ˟˟˟ ˚ ˚ ˣʰ˧ˤʰˠˡʰ˟˟˟ ˡˡʰ˥ˡʰ˦˨ˢˎ
ōǣʳōʳNJʳğɴŸǼÌɴ ˨ˡʰˣ˟ʰ˟˟˟ ˠ˟ʰ˟˧ʰ˟˟˟ ˚ ˚ ˠʰ˟ˡʰˣ˧ʰ˟˟˟ ˚
®ŸNj¯ȖNjǼÌsNj_sǼÞĶǣƼĶsǣsNjs¯sNjǼŸŗŸǼsŗŸʳˢˠŸ¯ǼÌsŗŸǼsǣǼŸ®ÞŘŘOÞĶǢǼǼsŎsŘǼǣɠÌÞO̯ŸNjŎǣƼNjǼŸ¯ǼÌsŘŘȖĶNJsƼŸNjǼʳ

ˎÝŘÞǼÞĶĶɴˡ˦ʰˠˤʰˢˤˡǣǼŸOĨŸƼǼÞŸŘǣɠsNjs¶NjŘǼs_ʰŸȖǼŸ¯ɠÌÞOÌˣʰˤˡʰˤˤ˧ŸƼǼÞŸŘǣɠsNjsOŘOsĶĶs_EɴŎȖǼȖĶOŸŘǣsŘǼEsǼɠssŘǼÌs
NŸŎƼŘɴŘ_ǼÌsµNjŘǼssʳǻÌsŸƼǼÞŸŘǣǣÌĶĶɚsǣǼŸɚsNjƼsNjÞŸ_Ÿ¯ˣɴsNjǣŸŘǼÌsEǣÞǣŸ¯ǼÞŎsŘ_ƼsNj¯ŸNjŎŘOsʳrɮsNjOÞǣsƼsNjÞŸ_
ɠÞĶĶEsˤɴsNjǣ¯NjŸŎǼÌs_ǼsŸ¯ɚsǣǼÞضŸ¯ŸƼǼÞŸŘǣŘ_rɮsNjOÞǣsƼNjÞOsɠÞĶĶEs` ˠˀ˚ƼsNjǣÌNjsʳ

ŗŸǼÞOsƼsNjÞŸ_Ř_ǣsɚsNjŘOs¯ssǣ¯ŸNjĶĶrɮsOȖǼÞɚs^ÞNjsOǼŸNjǣÞǣǣÞɮŎŸŘǼÌǣ˅ŘŸǼÞOsŸNjǣÞɮŎŸŘǼÌǣ˅ǣĶNjɴÞŘĶÞsȖǼÌsNjsŸ¯ŸNjǣŎɴEs
ŎȖǼȖĶĶɴ_sOÞ_s_EsǼɠssŘǼÌs^ÞNjsOǼŸNjŘ_ǼÌsNŸŎƼŘɴʳ

Non-Executive Directors’ Compensation and Shareholding:


ǣƼsNjǼÌsNjsǣŸĶȖǼÞŸŘƼǣǣs_EɴǼÌsǣÌNjsÌŸĶ_sNjǣŸ¯ǼÌsNŸŎƼŘɴǼÌNjŸȖ¶ÌƻŸǣǼĶDĶĶŸǼ_Ǽs_ōɴˡˢʰˡ˟ˠˡʰǼÌsŎsŎEsNjǣÌ_
ƼƼNjŸɚs_OŸŎŎÞǣǣÞŸŘƼɴEĶsǼŸǼÌsŗŸŘ˚rɮsOȖǼÞɚsŘ_ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNjǣŸ¯ǼÌsNŸŎƼŘɴ¯ŸNjŘŎŸȖŘǼŘŸǼsɮOss_Þض
ˠ̇Ÿ¯ǼÌsŘsǼƼNjŸʩǼǣŸ¯ǼÌsNŸŎƼŘɴOĶOȖĶǼs_ÞŘOOŸNj_ŘOsɠÞǼÌǼÌsƼNjŸɚÞǣÞŸŘǣŸ¯ǢsOǼÞŸŘˢˣ˨Ř_ˢˤ˟Ÿ¯ǼÌsNŸŎƼŘÞsǣOǼʰ
ˠ˨ˤ˥ʹǢsOǼÞŸŘˠ˨˧Ÿ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢʺÞŘǣȖOÌŎŘŘsNjǣŎɴEs_sǼsNjŎÞŘs_EɴǼÌsDŸNj_Ÿ¯^ÞNjsOǼŸNjǣ¯NjŸŎǼÞŎsǼŸǼÞŎs
ɠÞǼÌÞŘǼÌsǣÞ_ĶÞŎÞǼǣʳ

OOŸNj_ÞضĶɴʰÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNjǣɠsNjsƼÞ_ǣÞǼǼÞض¯ssǣŘ_OŸŎŎÞǣǣÞŸŘ_ȖNjÞضǼÌsɴsNjȖŘ_sNjNjsɚÞsɠʳ

^sǼÞĶǣŸ¯ǣÞǼǼÞض¯ssǣ˓OŸŎŎÞǣǣÞŸŘƼÞ_ǼŸǼÌsÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNjǣ_ȖNjÞضǼÌsɴsNjˡ˟ˠˤ˚ˠ˥ĶŸŘ¶ɠÞǼÌǼÌsÞNjǢÌNjsÌŸĶ_Þضǣ
ŸŘ_ǼsŸ¯ǼÌÞǣNJsƼŸNjǼNjsǣȖŘ_sNjʲ
Sr. No. Name of the Directors Sitting Fees (`) Commission (`) No. of Shares held
1 ōNjʳŗÞĶsǣÌDʳōsÌǼ ˠʰ˦ˤʰ˟˟˟ ˧ʰ˟˟ʰ˟˟˟ ˚
ˡ ōNjʳħʳƻʳƻ_ŎĨȖŎNj ˠʰˡ˟ʰ˟˟˟ ˧ʰ˟˟ʰ˟˟˟ ˚
ˢ ōNjʳDÞƼÞŘNJʳǢÌÌ ˠʰˢˤʰ˟˟˟ ˧ʰ˟˟ʰ˟˟˟ ˠ˟˟
ˣ ōNjʳNJʳĵĨǣÌŎÞŘNjɴŘŘ ˧ˤʰ˟˟˟ ˧ʰ˟˟ʰ˟˟˟ ˚

STAKEHOLDERS’ RELATIONSHIP COMMITTEE


ǻÌs ǢǼĨsÌŸĶ_sNjǣ˅ NJsĶǼÞŸŘǣÌÞƼ NŸŎŎÞǼǼss ÞŘǼsNj˚ĶÞ ŎŸŘÞǼŸNjǣ Ř_ NjsɚÞsɠǣ ÞŘɚsǣǼŸNjǣ˅ ¶NjÞsɚŘOsǣ Ř_ Þǣ NjsǣƼŸŘǣÞEĶs ¯ŸNj ǼÌs
ǣǼÞǣ¯OǼŸNjɴNjs_NjsǣǣĶŸ¯ÞŘɚsǣǼŸNjǣ˅OŸŎƼĶÞŘǼǣŘ_NjsOŸŎŎsŘ_ǣŎsǣȖNjsǣ¯ŸNjŸɚsNjĶĶÞŎƼNjŸɚsŎsŘǼÞŘǼÌsLJȖĶÞǼɴŸ¯ǣsNjɚÞOsǣʳ

ǻÌsNŸŎŎÞǼǼssÞǣÌs_s_EɴōNjʳŗÞĶsǣÌDʳōsÌǼʰÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNjŘ_ǼÌsNŸŎŎÞǼǼssOŸŘǣÞǣǼǣŸ¯ǼÌNjssŎsŎEsNjǣǣǣǼǼs_
EsĶŸɠʳ^ȖNjÞضǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥ʰǼÌÞǣNŸŎŎÞǼǼssÌ_ˣŎssǼÞضǣɠÌÞOÌɠsNjsÌsĶ_ŸŘōɴˡˤʰˡ˟ˠˤʰğȖĶɴˢ˟ʰˡ˟ˠˤʰ
ŷOǼŸEsNjˡ˟ʰˡ˟ˠˤŘ_ğŘȖNjɴˡ˧ʰˡ˟ˠ˥Ř_ǼǼsŘ_s_EɴǼÌsŎsŎEsNjǣǣȖŘ_sNjʲ

Sr. No. Name of the Director Category No. of Meetings


Held Attended
1 ōNjʳŗÞĶsǣÌDʳōsÌǼʹNÌÞNjŎŘʺ ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNj ˣ ˣ
ˡ ōNjʳDÞƼÞŘNJʳǢÌÌ ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNj ˣ ˢ
ˢ ōNjʳōʳƻʳNJŎOÌŘ_NjŘ NÌÞNjŎŘ˓ōضÞض^ÞNjsOǼŸNj ˣ ˣ
˨ˣ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

ōNjʳōʳĵʳDŘǣĶʰNŸŎƼŘɴǢsONjsǼNjɴÞǣ_sǣÞ¶ŘǼs_ǣNŸŎƼĶÞŘOsŷ¯ʩOsNjŸ¯ǼÌsNŸŎƼŘɴɠÌŸŸɚsNjǣssǣǼÌsNjs_NjsǣǣĶŸ¯ÞŘɚsǣǼŸNj
¶NjÞsɚŘOsǣʳ

^ȖNjÞض ǼÌs ʩŘŘOÞĶ ɴsNjʰ ǼÌs NŸŎƼŘɴ NjsOsÞɚs_ ˠˤˤ OŸŎƼĶÞŘǼǣˀ OŸNjNjsǣƼŸŘ_sŘOsǣ Ř_ ˠˤ˥ ɠsNjs _ÞǣƼŸǣs_ Ÿ¯¯ʳ ǻÌsNjs ɠǣ ˠ
OŸŎƼĶÞŘǼƼsŘ_ÞضǼǼÌsEs¶ÞŘŘÞضŸ¯ǼÌsʩŘŘOÞĶɴsNjɠÌÞOÌɠǣ_ÞǣƼŸǣs_Ÿ¯¯_ȖNjÞضǼÌsɴsNjʳǼǼÌssŘ_Ÿ¯ǼÌsʩŘŘOÞĶɴsNj
ˡ˟ˠˤ˚ˠ˥ʰǼÌsNjsÞǣŘŸOŸŎƼĶÞŘǼƼsŘ_ÞضʳĶĶOŸŎƼĶÞŘǼǣˀLJȖsNjÞsǣɠsNjs¶sŘsNjĶĶɴ_ÞǣƼŸǣs_Ÿ¯¯ɠÞǼÌÞŘŸŘsɠssĨŸ¯ÞǼǣNjsOsÞƼǼʳ

CORPORATE SOCIAL RESPONSIBILITY (CSR) COMMITTEE


NǢNJ NŸŎŎÞǼǼss ɠǣ OŸŘǣǼÞǼȖǼs_ ƼȖNjǣȖŘǼ ǼŸ ǢsOǼÞŸŘ ˠˢˤ Ÿ¯ ǼÌs NŸŎƼŘÞsǣ OǼʰ ˡ˟ˠˢ Njs_ ɠÞǼÌ NŸŎƼŘÞsǣ ʹNŸNjƼŸNjǼs ǢŸOÞĶ
NJsǣƼŸŘǣÞEÞĶÞǼɴƻŸĶÞOɴʺNJȖĶsǣʰˡ˟ˠˣʰŸŘōɴˡˡʰˡ˟ˠˤʳǻÌsNŸŎƼŸǣÞǼÞŸŘŸ¯ǼÌsNŸŎŎÞǼǼssŘ_ǼǼsŘ_ŘOsŸ¯ǼÌsŎsŎEsNjǣŸ¯ǼÌs
NŸŎŎÞǼǼssǼǼÌsŎssǼÞضǣÌsĶ_ÞǣǣEsĶŸɠʳǻÌsNǢNJNŸŎŎÞǼǼssŎsǼǼɠŸǼÞŎsǣ_ȖNjÞضǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥ɚÞʊʳʰŸŘ
ōɴˡˤʰˡ˟ˠˤŘ_ğŘȖNjɴˡ˧ʰˡ˟ˠ˥ʳ

Sr. No. Name of the Director Category No. of Meetings


Held Attended
1 ōNjʳōʳƻʳNJŎOÌŘ_NjŘʹNÌÞNjŎŘʺ NÌÞNjŎŘ˓ōضÞض^ÞNjsOǼŸNj ˡ ˡ
ˡ ōNjʳħʳƻʳƻ_ŎĨȖŎNj ÝŘ_sƼsŘ_sŘǼ^ÞNjsOǼŸNj ˡ ˡ
ˢ ōǣʳōʳNJʳğɴŸǼÌɴ ɟÌŸĶsǻÞŎs^ÞNjsOǼŸNj ˡ ˡ
ōNjʳōʳƻʳNJŎOÌŘ_NjŘÞǣǼÌsNÌÞNjŎŘŸ¯ǼÌsNŸŎŎÞǼǼssʳǻÌsNŸŎƼŘɴÌǣ¯ŸNjŎȖĶǼs_NǢNJƻŸĶÞOɴŘ_ǼÌsǣŎsÞǣȖƼĶŸ_s_
ŸŘǼÌsɠsEǣÞǼsŸ¯ǼÌsNŸŎƼŘɴʰɠÌÞOÌOŘEsOOsǣǣs_ǼǼÌsɠsEĶÞŘĨ˛

ÌǼǼƼʲˀˀɠɠɠʳĠɴŸǼÌɴĶEŸNjǼŸNjÞsǣʳOŸŎˀ_ŎÞŘˀ_ŸOǣˀğĵĵ̬NǢNJ̇ˡ˟ƻŸĶÞOɴ̬ɟsEǣÞǼsʳƼ_¯

ǻÌsǼsNjŎǣŸ¯Njs¯sNjsŘOsŸ¯ǼÌsNŸNjƼŸNjǼsǢŸOÞĶNJsǣƼŸŘǣÞEÞĶÞǼɴNŸŎŎÞǼǼssENjŸ_ĶɴÞŘOĶȖ_sǣǼÌs¯ŸĶĶŸɠÞضʲ

ʹʺ ǻŸ¯ŸNjŎȖĶǼsŘ_NjsOŸŎŎsŘ_ǼŸǼÌsDŸNj_ʰNŸNjƼŸNjǼsǢŸOÞĶNJsǣƼŸŘǣÞEÞĶÞǼɴƻŸĶÞOɴɠÌÞOÌǣÌĶĶÞŘ_ÞOǼsǼÌsOǼÞɚÞǼÞsǣǼŸEs
ȖŘ_sNjǼĨsŘEɴǼÌsNŸŎƼŘɴǣǣƼsOÞʩs_ÞŘǢOÌs_ȖĶsəÝÝŸ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢŘ_ǼÌsNjsɚÞsɠǼÌsNjsŸ¯ǼƼsNjÞŸ_ÞOĶ
ÞŘǼsNjɚĶǣʱ
ʹEʺ ǻŸNjsOŸŎŎsŘ_ǼÌsŎŸȖŘǼŸ¯sɮƼsŘ_ÞǼȖNjsǼŸEsÞŘOȖNjNjs_ŸŘǼÌsOǼÞɚÞǼÞsǣNjs¯sNjNjs_EŸɚsʱ
ʹOʺ ǻŸŎŸŘÞǼŸNjǼÌssɮƼsŘ_ÞǼȖNjsÞŘOȖNjNjs_ŸŘǼÌsǣƼsOÞʩs_OǼÞɚÞǼÞsǣʱŘ_
ʹ_ʺ ǻŸŎŸŘÞǼŸNjǼÌsÞŎƼĶsŎsŘǼǼÞŸŘŸ¯NŸNjƼŸNjǼsǢŸOÞĶNJsǣƼŸŘǣÞEÞĶÞǼɴƻŸĶÞOɴŸ¯ǼÌsNŸŎƼŘɴ¯NjŸŎǼÞŎsǼŸǼÞŎsʳ

DEPOSITORY ESCROW ACCOUNT


ǣŸŘōNjOÌˢˠʰˡ˟ˠ˥ʰˢ˟˟rLJȖÞǼɴǢÌNjsǣEsĶŸŘ¶ÞضǼŸˢƼƼĶÞOŘǼǣɠsNjsĶɴÞضÞŘǼÌs^sƼŸǣÞǼŸNjɴrǣONjŸɠOOŸȖŘǼʳ

¶¶Njs¶ǼsŘȖŎEsNjŸ¯ǣÌNjsÌŸĶ_sNjǣÞŘǢȖǣƼsŘǣsOOŸȖŘǼĶɴÞضǼǼÌsEs¶ÞŘŘÞضŸ¯ǼÌsɴsNj ˢ
¶¶Njs¶ǼsŘȖŎEsNjŸ¯ŸȖǼǣǼŘ_ÞضǣÌNjsǣÞŘǢȖǣƼsŘǣsOOŸȖŘǼĶɴÞضǼǼÌsEs¶ÞŘŘÞضŸ¯ǼÌsɴsNj ˢ˟˟
ŗȖŎEsNjŸ¯ǣÌNjsÌŸĶ_sNjǣɠÌŸƼƼNjŸOÌs_¯ŸNjǼNjŘǣ¯sNjŸ¯ǣÌNjsǣ¯NjŸŎǢȖǣƼsŘǣsOOŸȖŘǼ_ȖNjÞضǼÌsɴsNj ˚
ŗȖŎEsNjŸ¯ǢÌNjsÌŸĶ_sNjǣǼŸɠÌŸŎǣÌNjsǣɠsNjsǼNjŘǣ¯sNjNjs_¯NjŸŎǢȖǣƼsŘǣsOOŸȖŘǼ_ȖNjÞضǼÌsɴsNj ˚
ŗȖŎEsNjŸ¯ǢÌNjsǣǼNjŘǣ¯sNjNjs_¯NjŸŎǢȖǣƼsŘǣsOOŸȖŘǼ_ȖNjÞضǼÌsɴsNj ˚
¶¶Njs¶ǼsŘȖŎEsNjŸ¯ǣÌNjsÌŸĶ_sNjǣɠÌŸǣsǣÌNjsǣNjsĶɴÞضÞŘǢȖǣƼsŘǣsOOŸȖŘǼǼǼÌssŘ_Ÿ¯ǼÌsɴsNj ˢ
¶¶Njs¶ǼsŘȖŎEsNjŸ¯ŸȖǼǣǼŘ_ÞضǣÌNjsǣÞŘǢȖǣƼsŘǣsOOŸȖŘǼĶɴÞضǼǼÌssŘ_Ÿ¯ǼÌsɴsNj ˢ˟˟

GENERAL BODY MEETING


Annual General Meetings
ĵǣǼǼÌNjssŘŘȖĶµsŘsNjĶōssǼÞضǣŸ¯ǼÌsNŸŎƼŘɴɠsNjsÌsĶ_ǼǼÌsɚsŘȖsŘ_ǼÞŎsǣȖŘ_sNjʲ

Year Date of Annual Time of Whether Special Venue


General Meeting Meeting Resolutions passed
ˡ˟ˠˣ˚ˠˤ ğȖĶɴˢ˟ʰˡ˟ˠˤ ˠˠʳ˟˟ʳŎʳ ŗŸ ōʳ Nʳ µÌÞ ËĶĶʰ ÝŘ_ÞŘ ǻsɮǼÞĶs OOsǣǣŸNjÞsǣ ˓ ōOÌÞŘsNjɴ
ˡˣǼ̵ō ōŘȖ¯OǼȖNjsNjǣ˅ ǣǣŸOÞǼÞŸŘʰ DÌŸ¶ÞĶĶ ËNj¶ŸɚÞŘ_ǣ DȖÞĶ_Þضʰ ˣǼÌ
®ĶŸŸNjʰˠ˧ˀˡ˟ħʳ^ȖEÌǣÌōNj¶ʰħĶµÌŸ_ʰōȖŎEÞ˛ˣ˟˟˟˟ˠ
ˡ˟ˠˢ˚ˠˣ Ȗ¶ȖǣǼˠˢʰˡ˟ˠˣ ˠ˟ʳˢ˟ʳŎʳ ɳsǣ ōʳ Nʳ µÌÞ ËĶĶʰ ÝŘ_ÞŘ ǻsɮǼÞĶs OOsǣǣŸNjÞsǣ ˓ ōOÌÞŘsNjɴ
ˡˢNj_µō ōŘȖ¯OǼȖNjsNjǣ˅ ǣǣŸOÞǼÞŸŘʰ DÌŸ¶ÞĶĶ ËNj¶ŸɚÞŘ_ǣ DȖÞĶ_Þضʰ ˣǼÌ
®ĶŸŸNjʰˠ˧ˀˡ˟ħʳ^ȖEÌǣÌōNj¶ʰħĶµÌŸ_ʰōȖŎEÞ˛ˣ˟˟˟˟ˠ
ˡ˟ˠˡ˚ˠˢ Ȗ¶ȖǣǼˠˡʰˡ˟ˠˢ ˠ˟ʳˢ˟ʳŎʳ ɳsǣ ōʳ Nʳ µÌÞ ËĶĶʰ ÝŘ_ÞŘ ǻsɮǼÞĶs OOsǣǣŸNjÞsǣ ˓ ōOÌÞŘsNjɴ
Ř_
ˡˡ µō ōŘȖ¯OǼȖNjsNjǣ˅ ǣǣŸOÞǼÞŸŘʰ DÌŸ¶ÞĶĶ ËNj¶ŸɚÞŘ_ǣ DȖÞĶ_Þضʰ ˣǼÌ
®ĶŸŸNjʰˠ˧ˀˡ˟ħʳ^ȖEÌǣÌōNj¶ʰħĶµÌŸ_ʰōȖŎEÞ˛ˣ˟˟˟˟ˠ
Corporate Overview Performance Governance Financial Statements ˨ˤ

ĶĶ NjsǣŸĶȖǼÞŸŘǣ Ǽ ǼÌs ˡˢNj_ Ř_ ˡˣǼÌ ŘŘȖĶ µsŘsNjĶ ōssǼÞضǣ Ÿ¯ ǼÌs ōsŎŸNjŘ_ȖŎ Ÿ¯ ǣǣŸOÞǼÞŸŘ Ÿ¯ ǼÌs NŸŎƼŘɴ Ř_
ɠsNjsƼǣǣs_ǼÌNjŸȖ¶Ìs˚ɚŸǼÞضŘ_ƼÌɴǣÞOĶEĶĶŸǼǣɠsNjsǣsŘǼ ƼNjǼÞĶ ŎŸ_ÞʩOǼÞŸŘ Ÿ¯ ŷNj_ÞŘNjɴ NJsǣŸĶȖǼÞŸŘ ƼƼNjŸɚs_ Eɴ ǼÌs
EɴƼŸǣǼŸNjOǣǼǼǼÌsµōʳ ǣÌNjsÌŸĶ_sNjǣ Ǽ ǼÌs ŘŘȖĶ µsŘsNjĶ ōssǼÞض ÌsĶ_ ŸŘ Ȗ¶ȖǣǼ
ˠˢʰ ˡ˟ˠˣ ɠÞǼÌ Njs¶Nj_ ǼŸ Njs˚ƼƼŸÞŘǼŎsŘǼ Ř_ ƼɴŎsŘǼ Ÿ¯
ĶĶ ǣƼsOÞĶ NjsǣŸĶȖǼÞŸŘǣ Ǽ ǼÌs ˡˡŘ_ ŘŘȖĶ µsŘsNjĶ ōssǼÞضǣ NjsŎȖŘsNjǼÞŸŘ ǼŸ ōNjʳ Ǣʳ NJ¶ÌȖŘŘ_Ř ǼÌNjŸȖ¶Ì ƼŸǣǼĶ EĶĶŸǼ
ɠsNjsƼǣǣs_EɴǣÌŸɠŸ¯ÌŘ_ǣʳ s¯¯sOǼÞɚsğȖĶɴˢ˟ʰˡ˟ˠˤŘ_ǢsƼǼsŎEsNj˟ˡʰˡ˟ˠˤNjsǣƼsOǼÞɚsĶɴʳ

Special Resolutions Passed through Postal Ballot ǻÌs DŸNj_ Ì_ ƼƼŸÞŘǼs_ ōNjʳ ËÞŎŘǣÌȖ Ǣʳ ħŎ_Njʰ ƻNjǼŘsNjʰ
^ȖNjÞضǼÌsɴsNjʰǼÌsŎsŎEsNjǣŸ¯ǼÌsNŸŎƼŘɴÌ_ƼƼNjŸɚs_ NJǼÌÞ˓ǣǣŸOÞǼsǣǣǢONjȖǼÞŘÞʊsNjǼŸOŸŘ_ȖOǼǼÌsƼŸǣǼĶEĶĶŸǼ
ǣƼsOÞĶ NjsǣŸĶȖǼÞŸŘǣ ¯ŸNj ŎsŘ_ŎsŘǼ ÞŘ ǼÌs ŷEĠsOǼǣ NĶȖǣs ɚŸǼÞضƼNjŸOsǣǣÞŘ¯ÞNjŘ_ǼNjŘǣƼNjsŘǼŎŘŘsNjʳ

Special Resolutions Votes cast in favour Votes cast against Date of


declaration of
No. of Votes % Member %
results
ĶǼsNjǼÞŸŘ Ÿ¯ ǼÌs ŷEĠsOǼǣ NĶȖǣs Ÿ¯ ǼÌs ˠˣʰ˧ˢʰ˧ˢʰˡ˧ˤ ˨˨ʳ˨˨ ˦ʰˤˡ˧ ˟ʳ˟ˠ ǢsƼǼsŎEsNjˠˣʰ
ōsŎŸNjŘ_ȖŎŸ¯ǣǣŸOÞǼÞŸŘŸ¯ǼÌsNŸŎƼŘɴ ˡ˟ˠˤ
ƻNjǼÞĶ ŎŸ_ÞʩOǼÞŸŘ Ÿ¯ ŷNj_ÞŘNjɴ NJsǣŸĶȖǼÞŸŘ ˠˢʰˤ˦ʰˢˢʰˢ˧ˤ ˨˟ʳˡˡ ˠʰˣ˦ʰ˟˨ʰˣˤˢ ˨ʳ˦˧ ŷOǼŸEsNjˠ˥ʰˡ˟ˠˤ
ƼƼNjŸɚs_ Eɴ ǼÌs ǣÌNjsÌŸĶ_sNjǣ Ǽ ǼÌs ŘŘȖĶ
µsŘsNjĶ ōssǼÞض ÌsĶ_ ŸŘ Ȗ¶ȖǣǼ ˠˢʰ ˡ˟ˠˣ ɠÞǼÌ
Njs¶Nj_ ǼŸ Njs˚ƼƼŸÞŘǼŎsŘǼ Ř_ ƼɴŎsŘǼ Ÿ¯
NjsŎȖŘsNjǼÞŸŘǼŸōNjʳǢʳNJ¶ÌȖŘŘ_Ř

Procedure for Postal Ballot ǻÌsǣONjȖǼÞŘÞʊsNjǣȖEŎÞǼǣÌÞǣNjsƼŸNjǼǼŸǼÌsNÌÞNjŎŘ¯ǼsNjǼÌs


ÝŘOŸŎƼĶÞŘOsɠÞǼÌNĶȖǣsˢˤDŸ¯ǼÌsĵÞǣǼÞض¶NjssŎsŘǼŘ_ǢsOǼÞŸŘ OŸŎƼĶsǼÞŸŘ Ÿ¯ ǣONjȖǼÞŘɴ Ř_ ǼÌs OŸŘǣŸĶÞ_Ǽs_ NjsǣȖĶǼǣ Ÿ¯ ǼÌs
ˠ˟˧ʰˠˠ˟Ř_ŸǼÌsNjƼƼĶÞOEĶsƼNjŸɚÞǣÞŸŘǣŸ¯ǼÌsNŸŎƼŘÞsǣOǼʰ ɚŸǼÞض Eɴ ƻŸǣǼĶ DĶĶŸǼ Ř_ s˚ɚŸǼÞض Njs ǼÌsŘ ŘŘŸȖŘOs_
ˡ˟ˠˢʹǼÌsOǼʺʰNjs_ɠÞǼÌNJȖĶsˡˡŸ¯ǼÌsNŸŎƼŘÞsǣʹōضsŎsŘǼ Eɴ ǼÌs NÌÞNjŎŘˀ ȖǼÌŸNjÞʊs_ ŷ¯ʩOsNjʳ ǻÌs NjsǣȖĶǼǣ Njs ĶǣŸ
Ř_ _ŎÞŘÞǣǼNjǼÞŸŘʺ NJȖĶsǣʰ ˡ˟ˠˣʰ ǼÌs NŸŎƼŘɴ Ì_ ƼNjŸɚÞ_s_ _ÞǣƼĶɴs_ ŸŘ ǼÌs ɠsEǣÞǼs Ÿ¯ ǼÌs NŸŎƼŘɴʰ ÌǼǼƼʲˀˀɠɠɠʳ
sĶsOǼNjŸŘÞOɚŸǼÞض¯OÞĶÞǼɴǼŸĶĶÞǼǣŎsŎEsNjǣʰǼŸsŘEĶsǼÌsŎǼŸOǣǼ ĠɴŸǼÌɴĶEŸNjǼŸNjÞsǣʳOŸŎʰ EsǣÞ_sǣ EsÞض OŸŎŎȖŘÞOǼs_ ǼŸ
ǼÌsÞNjɚŸǼsǣsĶsOǼNjŸŘÞOĶĶɴʳǻÌsNŸŎƼŘɴsض¶sǣǼÌsǣsNjɚÞOsǣŸ¯ ǼÌsǣǼŸOĨsɮOÌضsǣʰǼÌs_sƼŸǣÞǼŸNjÞsǣŘ_NJs¶ÞǣǼNjNjŘ_ǼÌs
N^Ǣĵ¯ŸNjǼÌsƼȖNjƼŸǣsŸ¯ƼNjŸɚÞ_ÞضNjsŎŸǼss˚ɚŸǼÞض¯OÞĶÞǼɴǼŸĶĶ ǢÌNjs ǻNjŘǣ¯sNj ¶sŘǼʳ ǻÌs _Ǽs Ÿ¯ _sOĶNjǼÞŸŘ Ÿ¯ ǼÌs NjsǣȖĶǼǣ
ÞǼǣŎsŎEsNjǣʳōsŎEsNjǣÌɚsǼÌsŸƼǼÞŸŘǼŸɚŸǼssÞǼÌsNjEɴƼÌɴǣÞOĶ EɴǼÌsNŸŎƼŘɴÞǣ_ssŎs_ǼŸEsǼÌs_ǼsŸ¯ƼǣǣÞضŸ¯ǼÌs
EĶĶŸǼŸNjǼÌNjŸȖ¶ÌNjsŎŸǼss˚ɚŸǼÞضʳ NjsǣŸĶȖǼÞŸŘǣʳ

ǻÌsNŸŎƼŘɴ_ÞǣƼǼOÌsǣǼÌsƼŸǣǼĶEĶĶŸǼŘŸǼÞOsǣŘ_¯ŸNjŎǣ ŗŸŘs Ÿ¯ ǼÌs EȖǣÞŘsǣǣsǣ ƼNjŸƼŸǣs_ ǼŸ Es ǼNjŘǣOǼs_ Ǽ ǼÌs
ĶŸŘ¶ ɠÞǼÌ ƼŸǣǼ¶s ƼNjsƼÞ_ EȖǣÞŘsǣǣ NjsƼĶɴ sŘɚsĶŸƼsǣ ǼŸ ÞǼǣ sŘǣȖÞضˡˤǼÌŘŘȖĶµsŘsNjĶōssǼÞضNjsLJȖÞNjsǼÌsƼǣǣÞضŸ¯
ōsŎEsNjǣɠÌŸǣsŘŎsǣƼƼsNjŸŘǼÌsNJs¶ÞǣǼsNjŸ¯ōsŎEsNjǣˀ ǣƼsOÞĶNjsǣŸĶȖǼÞŸŘEɴɠɴŸ¯ƻŸǣǼĶDĶĶŸǼʳ
ĶÞǣǼ Ÿ¯ EsŘsʩOÞNjÞsǣ ǣ ŸŘ  OȖǼ˚Ÿ¯¯ _Ǽsʳ ǻÌs ƼŸǣǼĶ EĶĶŸǼ
ŘŸǼÞOs Þǣ ǣsŘǼ ǼŸ ōsŎEsNjǣ ÞŘ sĶsOǼNjŸŘÞO ¯ŸNjŎ Ǽ ǼÌs sŎÞĶ DISCLOSURES
__Njsǣǣsǣ Njs¶ÞǣǼsNjs_ ɠÞǼÌ ǼÌsÞNj _sƼŸǣÞǼŸNjɴ ƼNjǼÞOÞƼŘǼǣ ʹÞŘ ˠʳ ^ȖNjÞض ǼÌs ɴsNj ȖŘ_sNj NjsɚÞsɠʰ ǼÌsNjs ɠsNjs ŘŸ ŎǼsNjÞĶĶɴ
OǣsŸ¯sĶsOǼNjŸŘÞOǣÌNjsÌŸĶ_ÞضʺˀǼÌsNŸŎƼŘɴ˅ǣNJs¶ÞǣǼNjNjŘ_ ǣÞ¶ŘÞʩOŘǼ NjsĶǼs_ ƼNjǼɴ ǼNjŘǣOǼÞŸŘǣ ǼÌǼ Ŏɴ Ìɚs
ǢÌNjsǻNjŘǣ¯sNj¶sŘǼǣʹÞŘOǣsŸ¯ƼÌɴǣÞOĶǣÌNjsÌŸĶ_ÞضʺʳǻÌs ƼŸǼsŘǼÞĶ OŸŘʪÞOǼ Ÿ¯ ÞŘǼsNjsǣǼ ɠÞǼÌ ǼÌs ÞŘǼsNjsǣǼǣ Ÿ¯ ǼÌs
NŸŎƼŘɴĶǣŸƼȖEĶÞǣÌsǣŘŸǼÞOsÞŘǼÌsŘsɠǣƼƼsNj_sOĶNjÞض NŸŎƼŘɴǼĶNj¶sʳ
ǼÌs_sǼÞĶǣŸ¯OŸŎƼĶsǼÞŸŘŸ¯_ÞǣƼǼOÌŘ_ŸǼÌsNjNjsLJȖÞNjsŎsŘǼǣ
ǣŎŘ_Ǽs_ȖŘ_sNjǼÌsOǼŘ_ƼƼĶÞOEĶsNJȖĶsǣʳ ǻÌs NŸŎƼŘɴ Ìǣ ¯ŸNjŎȖĶǼs_ ǼÌs ƻŸĶÞOɴ ŸŘ _sĶÞض ɠÞǼÌ
NjsĶǼs_ƼNjǼɴǼNjŘǣOǼÞŸŘǣŘ_ǼÌsǣŎsÞǣɚÞĶEĶsŸŘǼÌs
əŸǼÞض NjÞ¶ÌǼǣ Njs NjsOĨŸŘs_ ŸŘ ǼÌs ŘȖŎEsNj Ÿ¯ sLJȖÞǼɴ ǣÌNjsǣ ɠsEǣÞǼsŸ¯ǼÌsNŸŎƼŘɴŘ_ɠsEĶÞŘĨǼÌsNjsǼŸÞǣǣEsĶŸɠʲ
Njs¶ÞǣǼsNjs_ÞŘǼÌsŘŎsŸ¯ǼÌsōsŎEsNjǣǣŸŘǼÌsOȖǼ˚Ÿ¯¯_Ǽsʳ
ōsŎEsNjǣ_sǣÞNjÞضǼŸsɮsNjOÞǣsǼÌsÞNjɚŸǼsǣEɴƼŸǣǼĶEĶĶŸǼ¯ŸNjŎǣ ÌǼǼƼʲˀˀɠɠɠʳĠɴŸǼÌɴĶEŸNjǼŸNjÞsǣʳOŸŎˀ_ŎÞŘˀ_ŸOǣˀNJƻǻ̬ğĵĵ̬
NjsNjsLJȖsǣǼs_ǼŸNjsǼȖNjŘǼÌs¯ŸNjŎǣ_ȖĶɴOŸŎƼĶsǼs_Ř_ǣÞ¶Řs_ʰ ɟsEǣÞǼsʳƼ_¯
ǼŸ ǼÌs ǣONjȖǼÞŘÞʊsNj ŸŘ ŸNj Es¯ŸNjs ǼÌs OĶŸǣs Ÿ¯ ɚŸǼÞض ƼsNjÞŸ_ʳ
ōsŎEsNjǣ _sǣÞNjÞض ǼŸ sɮsNjOÞǣsǼÌsÞNjɚŸǼsǣEɴsĶsOǼNjŸŘÞOŎŸ_s ˡʳ ǻNjŘǣOǼÞŸŘǣ ɠÞǼÌ NjsĶǼs_ ƼNjǼÞsǣʰ ǣ ƼsNj NjsLJȖÞNjsŎsŘǼǣ
Njs NjsLJȖsǣǼs_ ǼŸ ɚŸǼs Es¯ŸNjs OĶŸǣs Ÿ¯ EȖǣÞŘsǣǣ ÌŸȖNjǣ ŸŘ ǼÌs Ÿ¯ OOŸȖŘǼÞض ǢǼŘ_Nj_ ˠ˧ʰ Njs _ÞǣOĶŸǣs_ ÞŘ ŗŸǼsǣ ǼŸ
ĶǣǼ_ǼsŸ¯s˚ɚŸǼÞضʳ OOŸȖŘǼǣŘŘsɮs_ǼŸǼÌs®ÞŘŘOÞĶǢǼǼsŎsŘǼǣʳ
˨˥ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

ˢʳ ǻÌs NŸŎƼŘɴ Ìǣ ¯ŸĶĶŸɠs_ ĶĶ NjsĶsɚŘǼ OOŸȖŘǼÞض NJs¶ȖĶǼÞŸŘǣʳǻÌsǣÞ_OsNjǼÞʩOǼsÞǣŘŘsɮs_Ř_¯ŸNjŎǣƼNjǼŸ¯


ǢǼŘ_Nj_ǣ ɠÌÞĶs ƼNjsƼNjÞض ®ÞŘŘOÞĶ ǢǼǼsŎsŘǼǣ Ř_ ŘŸ ǼÌsŘŘȖĶNJsƼŸNjǼʳ
ǼNjsǼŎsŘǼ_Þ¯¯sNjsŘǼ¯NjŸŎǼÌǼƼNjsǣONjÞEs_ÞŘǼÌsOOŸȖŘǼÞض
ǢǼŘ_Nj_ÌǣEssŘ¯ŸĶĶŸɠs_ʳ COMPLIANCE UNDER DISCRETIONARY REQUIREMENT OF
LISTING REGULATIONS
ˣʳ ǻÌsNjs Njs ŘŸ ƼsOȖŘÞNjɴ NjsĶǼÞŸŘǣÌÞƼǣ ŸNj ǼNjŘǣOǼÞŸŘǣ Ÿ¯ ǻÌsNŸŎƼŘɴOŸŎƼĶÞs_ɠÞǼÌĶĶŎŘ_ǼŸNjɴNjsLJȖÞNjsŎsŘǼǣŘ_
ŗŸŘ˚rɮsOȖǼÞɚs ^ÞNjsOǼŸNjǣ ɚÞǣ˚˚ɚÞǣ ǼÌs NŸŎƼŘɴ ɠÌÞOÌ Ìǣ _ŸƼǼs_ ŘŸŘ˚ŎŘ_ǼŸNjɴ NjsLJȖÞNjsŎsŘǼ ǣ ƼsNj ǼÌs _sǼÞĶǣ
ÌǣƼŸǼsŘǼÞĶOŸŘʪÞOǼŸ¯ÞŘǼsNjsǣǼɠÞǼÌǼÌsÞŘǼsNjsǣǼǣŸ¯ǼÌs ¶ÞɚsŘEsĶŸɠʲ
NŸŎƼŘɴǼĶNj¶sʳ
ʺ The Board:ǻÌsNŸŎƼŘɴ_ŸsǣŘŸǼÌɚsŗŸŘ˚rɮsOȖǼÞɚs
ˤʳ ŗŸ ƼsŘĶǼÞsǣ ŸNj ǣǼNjÞOǼȖNjsǣ Ìɚs EssŘ ÞŎƼŸǣs_ ŸŘ ǼÌs NÌÞNjŎŘʳ
NŸŎƼŘɴEɴǼÌsǢǼŸOĨrɮOÌضsǣŸNjǢrDÝŸNjŘɴǣǼǼȖǼŸNjɴ
ȖǼÌŸNjÞǼɴŸŘŘɴŎǼǼsNjNjsĶǼs_ǼŸOƼÞǼĶŎNjĨsǼǣ_ȖNjÞض Eʺ Shareholder’s Rights: ǻÌs LJȖNjǼsNjĶɴ Ř_ ÌĶ¯ ɴsNjĶɴ
ǼÌsĶǣǼǼÌNjssɴsNjǣʳ ʩŘŘOÞĶNjsǣȖĶǼǣNjsƼȖEĶÞǣÌs_ÞŘǼÌsŘsɠǣƼƼsNjʰ_ÞǣƼĶɴs_
ŸŘ ǼÌs ɠsEǣÞǼs Ÿ¯ ǼÌs NŸŎƼŘɴ Ř_ Njs ǣsŘǼ ǼŸ ǼÌs
˥ʳ ǻÌs NŸŎƼŘɴ Ìǣ ÞŘ ƼĶOs əÞ¶ÞĶ ōsOÌŘÞǣŎˀ ɟÌÞǣǼĶs ǢǼŸOĨ rɮOÌضsǣ ɠÌsNjs ǼÌs ǣÌNjsǣ Ÿ¯ ǼÌs NŸŎƼŘɴ Njs
DĶŸɠsNjƻŸĶÞOɴŘ_ǼÌs_sǼÞĶǣŸ¯ǣŎsNjsƼNjŸɚÞ_s_ÞŘǼÌs ĶÞǣǼs_ʳǻÌsÌĶ¯˚ɴsNjĶɴʩŘŘOÞĶNjsǣȖĶǼǣNjsŘŸǼǣsƼNjǼsĶɴ
DŸNj_˅ǣ NJsƼŸNjǼʳ ®ȖNjǼÌsNjʰ ÞǼ Þǣ ¯ʩNjŎs_ ǼÌǼ ŘŸ ƼsNjǣŸŘŘsĶ OÞNjOȖĶǼs_ǼŸǼÌsǣÌNjsÌŸĶ_sNjǣʳ
ÌǣEssŘ_sŘÞs_OOsǣǣǼŸǼÌsȖ_ÞǼNŸŎŎÞǼǼssʳ
Oʺ ōŸ_Þʩs_ ŷƼÞŘÞŸŘǣ ÞŘ Ȗ_ÞǼ NJsƼŸNjǼʲ ǻÌs NŸŎƼŘɴ˅ǣ
˦ʳ ǻÌs NŸŎƼŘɴ Ìǣ ĶÞ_ _ŸɠŘ ƼNjŸOs_ȖNjsǣ ǼŸ ÞŘ¯ŸNjŎ ®ÞŘŘOÞĶǢǼǼsŎsŘǼǣNjsȖŘLJȖĶÞʩs_ʳ
ǼÌs DŸNj_ ŎsŎEsNjǣ EŸȖǼ ǼÌs NjÞǣĨ ǣǣsǣǣŎsŘǼ Ř_
ŎÞŘÞŎÞʊǼÞŸŘƼNjŸOs_ȖNjsǣʳ _ʺ Separate posts of Chairman and CEO:ǻÌsNŸŎƼŘɴÌǣ
ǼÌsōضÞض^ÞNjsOǼŸNjǣǼÌsNÌÞNjŎŘŸ¯ǼÌsNŸŎƼŘɴʳ
˧ʳ ^ȖNjÞضǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥ʰğɴŸǼÌɴ®ENjÞONjs ®ȖNjǼÌsNjǣsƼNjǼsƼsNjǣŸŘÌǣEssŘƼƼŸÞŘǼs_ǣɟÌŸĶs
ǢsNjɚÞOsǣ ĵÞŎÞǼs_ EsOŎs  ŎǼsNjÞĶ ǣȖEǣÞ_ÞNjɴ Ÿ¯ ǼÌs ǻÞŎs^ÞNjsOǼŸNjŘ_NrŷŸ¯ǼÌsNŸŎƼŘɴʳËŸɠsɚsNjʰɟÌŸĶs
NŸŎƼŘɴǣ_sʩŘs_ÞŘǼÌsƼŸĶÞOɴ¯ŸNj_sǼsNjŎÞŘÞضONjÞǼsNjÞ ǻÞŎs^ÞNjsOǼŸNj˓NrŷOsǣs_ǼŸEsǣǣȖOÌɠʳsʳ¯ʳōɴˡˢʰ
Ÿ¯ ŎǼsNjÞĶ ǣȖEǣÞ_ÞNjÞsǣ ǣ ¯ŸNjŎȖĶǼs_ Eɴ ǼÌs NŸŎƼŘɴ ˡ˟ˠ˥ʳ
Ř_ǼÌsɠsEĶÞŘĨǼÌsNjsǼŸÞǣ
sʺ Reporting of Internal Auditors:ǻÌsÝŘǼsNjŘĶȖ_ÞǼŸNjǣŸ¯
ÌǼǼƼʲˀˀɠɠɠʳĠɴŸǼÌɴĶEŸNjǼŸNjÞsǣʳOŸŎˀ_ŎÞŘˀ_ŸOǣˀƻōǢ̬ ǼÌsNŸŎƼŘɴNjsƼŸNjǼǼŸǼÌsȖ_ÞǼNŸŎŎÞǼǼssʳ
ğĵĵ̬ɟsEǣÞǼsʳƼ_¯
COMMODITY PRICE RISK OR FOREIGN EXCHANGE RISK
CODE OF CONDUCT AND HEDGING ACTIVITIES:
ǻÌsDŸNj_Ìǣ_ŸƼǼs_ǼÌsOŸ_sŸ¯OŸŘ_ȖOǼ¯ŸNjĶĶÞǼǣ^ÞNjsOǼŸNjǣ
ǻÌsNŸŎƼŘɴÌǣsɮƼŸǣȖNjsǼŸɚNjÞŸȖǣOŸŎŎŸ_ÞǼÞsǣÞŘɚŸĶɚs_
Ř_ ǢsŘÞŸNj ōضsŎsŘǼ ɠÌÞOÌ Ìǣ EssŘ _ÞǣƼĶɴs_ ŸŘ ǼÌs
ÞŘ ǼÌs ŎŘȖ¯OǼȖNjÞض Ÿ¯ ǼÌs ʩŘĶ ƼNjŸ_ȖOǼǣ Ÿ¯ ǼÌs NŸŎƼŘɴʳ
NŸŎƼŘɴ˅ǣ ɠsEǣÞǼs ɠɠɠʳĠɴŸǼÌɴĶEŸNjǼŸNjÞsǣʳOŸŎʳ ĶĶ DŸNj_
ŘɴʪȖOǼȖǼÞŸŘÞŘƼNjÞOsǣŸ¯EǣÞOOŸŎŎŸ_ÞǼÞsǣĶÞĨsDsŘʊsŘsʰ
ŎsŎEsNjǣ Ř_ ǢsŘÞŸNj ōضsŎsŘǼ ƻsNjǣŸŘŘsĶ Ìɚs ¯ʩNjŎs_
NNjȖ_sʰ ŗƼǼÌʰ ƻĶŎ Ř_ ƻĶŎ ħsNjŘsĶ Ŏɴ Ìɚs _ÞNjsOǼ
OŸŎƼĶÞŘOs ɠÞǼÌ ǼÌs OŸ_s Ÿ¯ OŸŘ_ȖOǼ ŸŘ ŘŘȖĶ EǣÞǣʳ 
ÞŎƼOǼ ŸŘ ǼÌs ƼNjŸ_ȖOǼǣ ¯ĶĶÞض ȖŘ_sNj _sǼsNj¶sŘǼ Ř_ _ÞǣÌ
_sOĶNjǼÞŸŘǼŸǼÌÞǣs¯¯sOǼEɴǼÌsɟÌŸĶsǻÞŎs^ÞNjsOǼŸNj˓NrŷŸ¯
ɠǣÌ OǼs¶ŸNjɴʳ ǢÞŎÞĶNjĶɴʰ ɚŸĶǼÞĶÞǼɴ ÞŘ ƼNjÞOsǣ Ÿ¯ ƻŸĶɴsǼÌɴĶsŘs
ǼÌsNŸŎƼŘɴ¯ŸNjŎǣƼNjǼŸ¯ǼÌÞǣŘŘȖĶNJsƼŸNjǼʳ
ǼsNjsƼÌǼÌĶǼs ʹƻrǻʺ Ř_ ƻŸĶɴƼNjŸƼɴĶsŘs ʹƻƻʺ Ŏɴ Ķs_ ǼŸ
ÞŘONjsǣsÞŘƼNjÞOsǣŸ¯OŸŘǼÞŘsNjʳŘɴNjÞǣsÞŘħNj¯ǼƼƼsNjƼNjÞOsǣ
MEANS OF COMMUNICATION
OŘÞŎƼOǼǼÌsǣsOŸŘ_NjɴƼOĨ¶ÞضOŸǣǼ¯ŸNjǼÌsƼNjŸ_ȖOǼǣŸ¯
ǻÌs NŸŎƼŘɴ ƼȖEĶÞǣÌsǣ ÞǼǣ džȖNjǼsNjĶɴ Ř_ ŘŘȖĶ ʩŘŘOÞĶ ǼÌsNŸŎƼŘɴʳ
NjsǣȖĶǼǣ¶sŘsNjĶĶɴÞŘDȖǣÞŘsǣǣǢǼŘ_Nj_Ř_ǢĨĶ¯ǼsNjǣȖEŎÞǼǼÞض
ÞǼ ǼŸ ǼÌs ǢǼŸOĨ rɮOÌضsǣ ŸŘOs ƼƼNjŸɚs_ Eɴ ǼÌs DŸNj_ Ÿ¯ ǻÌsNŸŎƼŘɴÌǣŎsOÌŘÞǣŎÞŘƼĶOsɠÌsNjsÞŘ_s_ÞOǼs_
^ÞNjsOǼŸNjǣ Ÿ¯ ǼÌs NŸŎƼŘɴʳ ǻÌs ǣÞ_ NjsǣȖĶǼǣ Njs ĶǣŸ ɚÞĶEĶs ǼsŎ ĨssƼǣ  OĶŸǣs ɠǼOÌ ŸŘ ǼÌs ŎNjĨsǼ EsÌɚÞŸNj Ř_
ŸŘ ǼÌs ɠsEǣÞǼs Ÿ¯ ǼÌs NŸŎƼŘɴ Ǽ ɠɠɠʳĠɴŸǼÌɴĶEŸNjǼŸNjÞsǣʳ _ŸƼǼǣ EsǣǼ ƼȖNjOÌǣs ƼNjOǼÞOsǣ ǼŸ ŎÞŘÞŎÞʊs ǼÌs s¯¯sOǼ Ÿ¯
OŸŎʳ ŷ¯ʩOÞĶ ƻNjsǣǣ NjsĶsǣsǣʰ NŸŘ¯sNjsŘOs OĶĶ ǼNjŘǣONjÞƼǼǣ Ř_ ÞŘ¯ĶǼÞŸŘʳ
ƼNjsǣsŘǼǼÞŸŘŎ_sǼŸǼÌsÞŘǣǼÞǼȖǼÞŸŘĶÞŘɚsǣǼŸNjǣˀŘĶɴǣǼǣNjs
ĶǣŸɚÞĶEĶsŸŘǼÌs¯ŸNjsǣÞ_ɠsEǣÞǼsŸ¯ǼÌsNŸŎƼŘɴʳ ǻÌs NŸŎƼŘɴ Ìǣ ŎÞŘÞŎĶ sɮƼŸǣȖNjs ǼŸ ¯ŸNjsÞ¶Ř sɮOÌضs
NjÞǣĨ ɚÞǣ˚˚ɚÞǣʰ ǼŸǼĶ ǢĶsǣˀ ƻȖNjOÌǣsǣ Ÿ¯ ǼÌs NŸŎƼŘɴ Ř_ ǼÌs
CEO/ CFO CERTIFICATE ǼNjŘǣOǼÞŸŘǣNjsǣÞ¶ŘÞʩOŘǼĶɴÞŘÝŘ_ÞŘNȖNjNjsŘOɴʳ
ōضÞض^ÞNjsOǼŸNjʰğŸÞŘǼōضÞض^ÞNjsOǼŸNj˓NÌÞs¯®ÞŘŘOÞĶ
ŷ¯ʩOsNj ʹN®ŷʺ Ř_ ɟÌŸĶs ǻÞŎs ^ÞNjsOǼŸNj ˓ NÌÞs¯ rɮsOȖǼÞɚs ǻÌsNŸŎƼŘɴÌǣŘŸǼȖŘ_sNjǼĨsŘŘɴÌs_¶ÞضOǼÞɚÞǼÞsǣ_ȖNjÞض
ŷ¯ʩOsNjʹNrŷʺÌɚsÞǣǣȖs_ǼÌsOsNjǼÞʩOǼsÞŘǼsNjŎǣŸ¯ǼÌsĵÞǣǼÞض ǼÌsɴsNjȖŘ_sNjNjsɚÞsɠʳ
Corporate Overview Performance Governance Financial Statements ˨˦

DISCLOSURE ON COMPLIANCE WITH CORPORATE e) Listing on Stock Exchanges and Stock Codes:
GOVERNANCE REQUIREMENTS:  ǻÌs sLJȖÞǼɴ ǣÌNjsǣ Ÿ¯ ǼÌs NŸŎƼŘɴ Njs ĶÞǣǼs_ ŸŘ DǢr
ǻÌsNŸŎƼŘɴÌǣOŸŎƼĶÞs_ɠÞǼÌĶĶǼÌsNŸNjƼŸNjǼsµŸɚsNjŘŘOs ĵÞŎÞǼs_ ʹDǢrʺ Ř_ ǼÌs ŗǼÞŸŘĶ ǢǼŸOĨ rɮOÌضs Ÿ¯ ÝŘ_Þ
NjsLJȖÞNjsŎsŘǼǣ ǣƼsOÞʩs_ ÞŘ NJs¶ȖĶǼÞŸŘ ˠ˦ ǼŸ ˡ˦ Ř_ OĶȖǣsǣ ĵÞŎÞǼs_ʹŗǢrʺʳǻÌsŘŘȖĶĶÞǣǼÞض¯ssǣ¯ŸNjǼÌsɴsNjˡ˟ˠˤ˚ˠ˥
ʹEʺǼŸʹÞʺŸ¯ǣȖE˚Njs¶ȖĶǼÞŸŘʹˡʺŸ¯NJs¶ȖĶǼÞŸŘˣ˥Ÿ¯ǼÌsĵÞǣǼÞض Ìɚs EssŘ ƼÞ_ ǼŸ EŸǼÌ ǼÌs ǣǼŸOĨ sɮOÌضsǣʳ ®ŸĶĶŸɠÞض
ǼEĶsÞŘ_ÞOǼsǣǼÌsNŸŎƼŘɴ˅ǣǣǼŸOĨsɮOÌضsOŸ_sǣʳ
NJs¶ȖĶǼÞŸŘǣʰɠÌsNjsɚsNjƼƼĶÞOEĶsǼŸǼÌsNŸŎƼŘɴʳ
ŗŎsŘ___NjsǣǣŸ¯ǢǼŸOĨrɮOÌضs ǢǼŸOĨNŸ_s
ǻÌs NŸŎƼŘɴ Ìǣ OŸŎƼĶÞs_ ɠÞǼÌ ĶĶ ǼÌs NjsLJȖÞNjsŎsŘǼǣ Ÿ¯ DǢrĵÞŎÞǼs_ʹDǢrʺʰ ˤˢˡ˨ˡ˥
NŸNjƼŸNjǼsµŸɚsNjŘŘOsNJsƼŸNjǼǣǣƼsOÞʩs_ÞŘǣȖE˚ƼNjǣʹˡʺǼŸ ƻÌÞNjŸʊsğssĠssEÌŸɴǻŸɠsNjǣʰ^ĶĶǢǼNjssǼʰ
ʹˠ˟ʺŸ¯ǢOÌs_ȖĶsəʹOʺŸ¯ǼÌsĵÞǣǼÞضNJs¶ȖĶǼÞŸŘǣʳ ōȖŎEÞ˛ˣ˟˟˟˟ˠ
ŗǼÞŸŘĶǢǼŸOĨrɮOÌضsŸ¯ÝŘ_ÞĵÞŎÞǼs_ʹŗǢrʺ ğɳŷǻËɳĵD
GENERAL SHAREHOLDER INFORMATION rɮOÌضsƻĶʊʰƻĶŸǼŗŸʳNˀˠʰµDĶŸOĨʰ
a) Annual General Meeting: ˡˤǼÌ ŘŘȖĶ µsŘsNjĶōssǼÞض DŘ_NjħȖNjĶNŸŎƼĶsɮʰDŘ_NjʹrǣǼʺʰ
Ÿ¯ǼÌsNŸŎƼŘɴɠÞĶĶEsÌsĶ_ŸŘğȖĶɴˡˠʰˡ˟ˠ˥Ǽˠˠʳ˟˟ʳŎʳ ōȖŎEÞ˛ˣ˟˟˟ˤˠ
ǼōʳNʳµÌÞËĶĶʰÝŘ_ÞŘǻsɮǼÞĶsOOsǣǣŸNjÞsǣ˓ōOÌÞŘsNjɴ ÝǢÝŗŗȖŎEsNj Ýŗr˥˥˧®˟ˠ˟ˢˠ
ōŘȖ¯OǼȖNjsNjǣ˅ ǣǣŸOÞǼÞŸŘʰ DÌŸ¶ÞĶĶ ËNj¶ŸɚÞŘ_ǣ
f) Registrar & Share Transfer Agents:
DȖÞĶ_ÞضʰˣǼÌ®ĶŸŸNjʰˠ˧ˀˡ˟ʰħʳ^ȖEÌǣÌōNj¶ʰħĶµÌŸ_ʰ
 ĵÞŘĨÝŘǼÞŎsÝŘ_ÞƻNjÞɚǼsĵÞŎÞǼs_
ōȖŎEÞ˛ˣ˟˟˟˟ˠ
 N˚ˠˢʰƻŘŘĶĶǢÞĶĨōÞĶĶǣNŸŎƼŸȖŘ_ʰĵʳDʳǢʳōNj¶ʰ
 DÌŘ_ȖƼʹɟsǣǼʺʰōȖŎEÞˣ˟˟˟˦˧ʰ
b) The Financial year covered by this Annual Report:ƼNjÞĶ
 ƻÌŸŘsʲ˟˟˨ˠʹ˟ʺˡˡˡˤ˨ˣ˥˨˦˟ʰ®ɮʲ˟˟˨ˠʹ˟ʺˡˡˡˤ˨ˣ˥˨˥˨
ˠʰˡ˟ˠˤǼŸōNjOÌˢˠʰˡ˟ˠ˥ʳ  r˚ŎÞĶʲNjŘǼʳÌsĶƼ_sǣĨ˔ĶÞŘĨÞŘǼÞŎsʳOŸʳÞŘ

c) Book Closure Dates:®NjŸŎğȖĶɴˠ˥ʰˡ˟ˠ˥ǼŸğȖĶɴˡˠʰˡ˟ˠ˥ g) Share Transfer System:


ʹEŸǼÌ_ɴǣÞŘOĶȖǣÞɚsʺʳ  ǻNjŘǣ¯sNjǣNjsNjs¶ÞǣǼsNjs_Ř_NjsǼȖNjŘs_EɴǼÌsNJs¶ÞǣǼNjNj˓
ǢÌNjsǻNjŘǣ¯sNj¶sŘǼɠÞǼÌÞŘƼsNjÞŸ_Ÿ¯ˠˤ_ɴǣ¯NjŸŎǼÌs
d) Dividend Payment Date: ŷŘ ŸNj Es¯ŸNjs ğȖĶɴ ˢˠʰ ˡ˟ˠ˥ʰ _ǼsŸ¯NjsOsÞƼǼŸ¯ǼÌs_ŸOȖŎsŘǼǣʰƼNjŸɚÞ_s_ǼÌsǣŎsNjs
ǣȖEĠsOǼ ǼŸ ǼÌs ƼƼNjŸɚĶ Ÿ¯ ǢÌNjsÌŸĶ_sNjǣ Ǽ ǼÌs sŘǣȖÞض ÞŘŸNj_sNjʳǻÌsNŸŎƼŘɴÌǣOŸŘǣǼÞǼȖǼs_ǢsOȖNjÞǼÞsǣǻNjŘǣ¯sNj
ŘŘȖĶµsŘsNjĶōssǼÞضʳ NŸŎŎÞǼǼssɠÌÞOÌOŸŘǣÞ_sNjǣǼÌsǼNjŘǣ¯sNjƼNjŸƼŸǣĶǣʳ

h) Stock Market Price for the year:


BSE Market Price (`) NSE Market Price (`)
Month High Low High Low
ƼNjÞĶˡ˟ˠˤ ˡ˧˦ʳ˟˟ ˡˣˡʳ˥˟ ˡ˧˦ʳˢˤ ˡˣˡʳ˥˟
ōɴˡ˟ˠˤ ˡ˦ˣʳ˟˟ ˡˢ˦ʳ˟˟ ˡ˦ˤʳ˟˟ ˡˢ˥ʳ˟˟
ğȖŘsˡ˟ˠˤ ˢ˟˨ʳ˥˟ ˡˢ˨ʳˤˤ ˢ˟˨ʳˤ˟ ˡˣ˟ʳˢ˟
ğȖĶɴˡ˟ˠˤ ˢˢˠʳ˨˟ ˡ˧˨ʳˢ˟ ˢˢˠʳ˧˟ ˡ˧˥ʳ˟˟
Ȗ¶ȖǣǼˡ˟ˠˤ ˢˣˡʳ˟˟ ˡ˥˥ʳ˥ˤ ˢˣˠʳˤ˟ ˡ˥ˠʳ˟˟
ǢsƼǼsŎEsNjˡ˟ˠˤ ˢˢˣʳ˟˟ ˡ˧ˤʳˠ˟ ˢˢˣʳ˨˟ ˡ˧ˣʳˤ˟
ŷOǼŸEsNjˡ˟ˠˤ ˢˢ˟ʳ˟˟ ˢ˟ˤʳ˟˟ ˢˡ˥ʳ˦ˤ ˢ˟ˤʳ˟˟
ŗŸɚsŎEsNjˡ˟ˠˤ ˢˠˢʳ˨˟ ˡ˨ˤʳˠˤ ˢˠˣʳ˟˟ ˡ˨ˠʳˡˤ
^sOsŎEsNjˡ˟ˠˤ ˢˠ˧ʳ˦ˤ ˡ˧ˤʳ˟˟ ˢˠ˧ʳˤˤ ˡ˧ˤʳ˟˟
ğŘȖNjɴˡ˟ˠ˥ ˢˡˡʳ˟˟ ˡ˥˦ʳ˟˟ ˢˡˢʳ˟˟ ˡ˥˥ʳ˟˟
®sENjȖNjɴˡ˟ˠ˥ ˡ˨˟ʳˢˤ ˡˤˡʳ˥˟ ˡ˨ˠʳ˟˟ ˡˤˡʳˠ˟
ōNjOÌˡ˟ˠ˥ ˡ˨ˢʳ˟˟ ˡˤˢʳˣ˟ ˡ˨ˤʳ˟˟ ˡˤˡʳ˟˟

i) Shareholding Pattern as on March 31, 2016:


Category No. of Shares % to Total Share Capital
1 Promoter and Promoter Group ˠˡʰ˟˧ʰ˧ˠʰˣ˟ˠ ˥˥ʳ˦ˣ
2 Institutions
ōȖǼȖĶ®ȖŘ_ǣ ˠʰ˟˧ʰˡ˧ʰ˧ˡˤ ˤʳ˨˧
˨˧ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

Category No. of Shares % to Total Share Capital


®ÞŘŘOÞĶÝŘǣǼÞǼȖǼÞŸŘǣˀDŘĨǣ ˠˠʰˡˣˣ ˟ʳ˟ˠ
Insurance Companies ˥˟ʰ˦ˢʰˢˡ˨ ˢʳˢˤ
®ŸNjsÞ¶ŘƻŸNjǼ¯ŸĶÞŸÝŘɚsǣǼŸNjǣʹÞŘOĶȖ_Þض®ŸNjsÞ¶ŘÝŘǣǼÞǼȖǼÞŸŘĶÝŘɚsǣǼŸNjǣʺ ˡʰ˥ˠʰ˧ˢʰˣ˨ˡ ˠˣʳˣˤ
3 Non-Institutions
DŸ_ÞsǣNŸNjƼŸNjǼs ˥˟ʰˡ˧ʰ˟˧ˤ ˢʳˢˢ
ÝŘ_ÞɚÞ_ȖĶǣ ˨˧ʰˠ˥ʰ˥˦ˤ ˤʳˣˡ
ŗŸŘNJsǣÞ_sŘǼÝŘ_ÞŘǣʹNJsƼǼNjÞEĶsˀŗŸŘNjsƼǼNjÞEĶsʺ ˣʰˢ˟ʰ˟˦ˤ ˟ʳˡˣ
rŎƼĶŸɴssǣ ˡʰ˧ˢʰ˥˨ˠ ˟ʳˠ˥
ǻNjȖǣǼǣ ˨˟ʰ˦ˡˠ ˟ʳ˟ˤ
NĶsNjÞضōsŎEsNjǣ ˠʰ˥˥ʰˢ˨˦ ˟ʳ˟˨
ËÞŘ_ȖȕŘ_ÞɚÞ_s_®ŎÞĶɴ ˢʰˡˤʰ˦ˣˤ ˟ʳˠ˧
Total: 18,11,19,680 100.00

j) Distribution of Shareholding as on March 31, 2016:

Sr. No Slab of shareholding Shareholders Shares Value


No. of Equity shares held Number % Face Value %
From To (`)
ˠʳ 1 ˤʰ˟˟˟ 78,403 99.62 91,14,708 5.03
ˡʳ ˤʰ˟˟ˠ ˠ˟ʰ˟˟˟ 120 0.15 8,50,032 0.47
ˢʳ ˠ˟ʰ˟˟ˠ ˡ˟ʰ˟˟˟ 70 0.09 9,98,534 0.55
ˣʳ ˡ˟ʰ˟˟ˠ ˢ˟ʰ˟˟˟ 11 0.01 2,84,357 0.16
ˤʳ ˢ˟ʰ˟˟ˠ ˣ˟ʰ˟˟˟ 9 0.01 3,06,779 0.17
˥ʳ ˣ˟ʰ˟˟ˠ ˤ˟ʰ˟˟˟ 5 0.01 2,28,588 0.13
˦ʳ ˤ˟ʰ˟˟ˠ ˠʰ˟˟ʰ˟˟˟ 22 0.03 15,88,806 0.88
˧ʳ ˠʰ˟˟ʰ˟˟ˠ ˓EŸɚs 62 0.08 16,77,47,876 92.62
Total 78,702 100.00 18,11,19,680 100.00

k) Share Price (`) in comparison with BSE Sensex:


Corporate Overview Performance Governance Financial Statements ˨˨

l) Dematerialization of shares: ˒ ƻĵŷǻ ŗŷʳ ˥ʰ ˦ ˓ ˧ʰ DrNJÝŗµ ħËǢNJ ŗŸǣʳ ˢ˥ˠʰ
 ǣŸŘōNjOÌˢˠʰˡ˟ˠ˥ʰ˨˨ʳˤˢ̇Ÿ¯ǼŸǼĶsLJȖÞǼɴǣÌNjsOƼÞǼĶ ˢ˥˥ ˓ ˢ˦˟ʰ ħÝr Ýŗ^ȕǢǻNJÝĵ rǢǻǻrʰ əÝĵĵµr ʲ
Ÿ¯ǼÌsNŸŎƼŘɴɠǣÌsĶ_ÞŘ_sŎǼsNjÞĶÞʊs_¯ŸNjŎʳ ōȕŗ^ÝɳħÝ˚ˡˣ˦˥˥˦ʰȕǻǻNJħËŗ^ʳ

m) Outstanding GDRs/ ADRs/ Warrants or any convertible ˒ ħËǢNJŗŷʳˠˠ˨ʰƻNJµŗD˵ɟŗƻȕNJʰəÝĵĵµr


instruments:^ȖNjÞضǼÌsɴsNjˡ˟ˠˤ˚ˠ˥ʰǼÌsNŸŎƼŘɴÌǣ NJÝƻȕNJʰËNJÝ^ɟNJʰˡˣ˦˥˥ˠʰȕǻǻNJħËŗ^ʳ
ŘŸǼÞǣǣȖs_Řɴµ^NJǣˀ^NJǣˀɟNjNjŘǼǣŸNjŘɴOŸŘɚsNjǼÞEĶs
ÞŘǣǼNjȖŎsŘǼǣʳ ˒ ƻĵŷǻ ŗŷʳ˥ˤ˥ʰ ŗrɟ ĵݵËǻ ËŷȕǢr ōŷNJrʰ
DÝǢËŗȕƻȕNJʰ ^ÝǢǻʳʲ DŗħȕNJ ˚˦ˡˡˠˡˡʰ ɟrǢǻ
n) Plant Locations: ōŘȖ¯OǼȖNjÞض ƻĶŘǼǣ Ÿ¯ ǼÌs NŸŎƼŘɴ Drŗµĵʳ
NjsǣÞǼȖǼs_ǼǼÌs¯ŸĶĶŸɠÞضĶŸOǼÞŸŘǣʲ˚
o) Shareholders & Investors Correspondence:
˒ ǢËr^ ŗŷʳ ˡˤˀˡ˥ʰ Ý^ ħŷǻËȕNJʰ ^ÝǢǻʳʲ ōrËDŷŷD  ǢÌNjsÌŸĶ_sNjǣǣÌŸȖĶ___NjsǣǣǼÌsÞNjOŸNjNjsǣƼŸŘ_sŘOsǼŸǼÌs
ŗµNJ˚ˤ˟˨ˡˡ˧ʰǻrĵŗµŗʳ NŸŎƼŘɴŘ_ˀŸNjÞǼǣNJs¶ÞǣǼNjNjŘ_ǢÌNjsǻNjŘǣ¯sNj¶sŘǼ
ǼǼÌs¯ŸĶĶŸɠÞض__Njsǣǣʲ
˒ rʳƻʳÝʳƻ Nŷōƻĵrɭʰ Ý^N˚ ōÝŗµŷŗʰ µȕɟËǻÝ ˚
˦˧ˠ˟ˢˠʰǢǢōʳ 1. Link Intime India Private Limited
Unit: Jyothy Laboratories Limited
˒ ǢȕNJərɳŗŷʳ˨ˠ˟ˀ˦ˀˠʰ^ŷħōNJ^ÝʰōĵÝʰǢÝĵəǢǢ˚ N˚ˠˢƻŘŘĶĶǢÞĶĨōÞĶĶǣNŸŎƼŸȖŘ_ʰ
ˢ˨˥ˡˢ˟ʰ^^NJ˓ŗµNJËərĵÝʳ ĵʳDʳǢʳōNj¶ʰDÌŘ_ȖƼʹɟsǣǼʺʰ
ōȖŎEÞ˛ˣ˟˟˟˦˧ʰ
˒ əÝĵĵµrʲ ħǻËʰ ƻʳŷʳʲ D^^Ýʰ ^ÝǢǻʳʲ Ǣŷĵŗ ˚ ƻÌŸŘsʲ˟˟˨ˠʹ˟ʺˡˡˡˤ˨ˣ˥˨˦˟ʰ®ɮʲ˟˟˨ˠʹ˟ʺˡˡˡˤ˨ˣ˥˨˥˨
ˠ˦ˢˡ˟ˤʰËÝōNËĵƻNJ^rǢËʳ r˚ŎÞĶʲNjŘǼʳÌsĶƼ_sǣĨ˔ĶÞŘĨÞŘǼÞŎsʳOŸʳÞŘ
NŸŘǼOǼƻsNjǣŸŘʲōNjʳ^sNjsĨ^˅ǢÞĶɚ
˒ ĵŗr ŗŷ ˡʰ ƻËǢr ŗŷ ˡʰ ǢÝ^Nŷ Ýŗ^ȕǢǻNJÝĵ
Nŷōƻĵrɭʰ DNJÝ DNJËōŗʰ ^ÝǢǻʳʲ ǢōD 2. The Company Secretary
ʹğōōȕʺ˚ˠ˧˟˟˟ˠʰğōōȕ˓ħǢËōÝNJʳ Jyothy Laboratories Limited
 ˄ȕĠĶËŸȖǣs˅ʰNJŎĨNjÞǣÌŘōŘ_ÞNjNJŸ_ʰ
˒ ōƻ Ýəˀ ˠ˟ˠ Dʰ ƻʳŷʳʲ ħŷĵµƻƻNJʰ ǢȕĵǻËŗ  ħŸŘ_ÞɚÞǼʰŘ_ÌsNjÞʹrǣǼʺʰ
DǻËrNJɳ˚˥˦ˢˤ˨ˠʰħrNJĵʳ  ōȖŎEÞ˛ˣ˟˟˟ˤ˨
 ƻÌŸŘsʲ˟˟˨ˠʹ˟ʺˡˡ˥˥˧˨ˡ˧˟˟ʰ®ɮʲ˟˟˨ˠʹ˟ʺˡˡ˥˥˧˨ˡ˧˟ˤ
˒ ħŗ^ŗǢǢrNJɳʰ əÝ˚NJÝɳŗŗȕNJʰ  µȕNJȕəɳȕNJ˚  r˚ŎÞĶʲǣsONjsǼNjÞĶ˔ĠɴŸǼÌɴʳOŸŎ
˥˧˟ˠ˟ˠʰ^ÝǢǻʳʲǻNJÝNËȕNJʰħrNJĵ

˒ ƻĶŸǼ ŗŸ ˡ˟ˠʰ ǢrNǻŷNJ Ýʰ ƻÝǻËōƻȕNJ Ýŗ^ȕǢǻNJÝĵ For and on behalf of the Board of Directors
NJrʰ^ÝǢǻʳ^ËNJ˚ˣˤˣ˦˦ˤʰō^ËɳƻNJ^rǢËʳ For Jyothy Laboratories Limited

˒ ˠˢˠ ƻrNJĵō ōÝŗ NJŷ^ʰ ƻʳŷʳʲ ǻËÝNJȕŗĵĵNJʰ


^ÝǢǻʳʲħNJÝħħĵ˚˥˟˨˥˟˦ʰƻŷŗ^ÝNËrNJNJɳʳ M. P. Ramachandran
Chairman & Managing Director
˒ NJʳǢʳŗŸˠˡˀˠ˓ˡʰȕğĵŗµNJÝŗ^ĵʳrǢǻǻrʰȕğĵ (DIN: 00553406)
NJŷ^ʰǻËrǻËōƻħħōʰəÝəʉËȕ^əȕNJʰƻʳŷʳʲ
ǢȕǻËȕħrŗɳ˚˥˟ˤˤ˟ˡʰƻŷŗ^ÝNËrNJNJɳʳ ōȖŎEÞʰōɴˡˢʰˡ˟ˠ˥ʳ
ˠ˟˟ Jyothy Laboratories Limited
ŘŘȖĶNJsƼŸNjǼˡ˟ˠˤ˚ˠ˥

DECLARATION BY THE CHIEF EXECUTIVE OFFICER UNDER SEBI (LISTING OBLIGATIONS AND DISCLOSURE
REQUIREMENTS) REGULATIONS, 2015 REGARDING COMPLIANCE WITH CODE OF CONDUCT

ÝŘOOŸNj_ŘOsɠÞǼÌNJs¶ȖĶǼÞŸŘˢˣʹˢʺNjs_ɠÞǼÌǢOÌs_ȖĶsəŸ¯ǢrDÝʹĵÞǣǼÞضŷEĶÞ¶ǼÞŸŘǣŘ_^ÞǣOĶŸǣȖNjsNJsLJȖÞNjsŎsŘǼǣʺNJs¶ȖĶǼÞŸŘǣʰ
ˡ˟ˠˤʰÝÌsNjsEɴOŸŘʩNjŎǼÌǼʰĶĶǼÌs^ÞNjsOǼŸNjǣŘ_ǼÌsǢsŘÞŸNjōضsŎsŘǼƻsNjǣŸŘŘsĶŸ¯ǼÌsNŸŎƼŘɴÌɚs¯ʩNjŎs_OŸŎƼĶÞŘOs
ɠÞǼÌǼÌsNŸ_sŸ¯NŸŘ_ȖOǼʰǣƼƼĶÞOEĶsǼŸǼÌsŎʰ¯ŸNjǼÌsʩŘŘOÞĶɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥ʳ

For Jyothy Laboratories Limited

S. Raghunandan
NÌÞs¯rɮsOȖǼÞɚsŷ¯ʩOsNj˓ɟÌŸĶsǻÞŎs^ÞNjsOǼŸNj
(DIN: 02263845)

ōȖŎEÞʰōɴˡˢʰˡ˟ˠ˥

CERTIFICATION BY MANAGING DIRECTOR, CHIEF EXECUTIVE OFFICER (CEO) AND CHIEF FINANCIAL OFFICER (CFO)
PURSUANT TO REGULATION 17(8) READ WITH PART B OF SCHEDULE II OF SEBI (LISTING OBLIGATIONS AND
DISCLOSURE REQUIREMENTS) REGULATIONS, 2015

ɟsʰōʳƻʳNJŎOÌŘ_NjŘʰNÌÞNjŎŘ˓ōضÞض^ÞNjsOǼŸNjʰħʳȕĶĶǣħŎǼÌʰğŸÞŘǼōضÞض^ÞNjsOǼŸNjŘ_NÌÞs¯®ÞŘŘOÞĶŷ¯ʩOsNjŘ_
ōNjʳǢʳNJ¶ÌȖŘŘ_ŘʰɟÌŸĶsǻÞŎs^ÞNjsOǼŸNjŘ_NÌÞs¯rɮsOȖǼÞɚsŷ¯ʩOsNjŸ¯ğɴŸǼÌɴĵEŸNjǼŸNjÞsǣĵÞŎÞǼs_ʰOsNjǼÞ¯ɴǼÌǼʲ˚

ˠʳ ɟsÌɚsNjsɚÞsɠs_ǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣŘ_ǼÌsOǣÌʪŸɠǣǼǼsŎsŘǼ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥Ř_ǼÌǼǼŸǼÌs
EsǣǼŸ¯ŸȖNjĨŘŸɠĶs_¶sŘ_EsĶÞs¯ʲ

ʺ ǼÌsǣsǣǼǼsŎsŘǼǣ_ŸŘŸǼOŸŘǼÞŘŘɴŎǼsNjÞĶĶɴȖŘǼNjȖsǣǼǼsŎsŘǼŸNjŸŎÞǼŘɴŎǼsNjÞĶ¯OǼŸNjOŸŘǼÞŘǣǼǼsŎsŘǼǣǼÌǼ
ŎÞ¶ÌǼEsŎÞǣĶs_Þضʱ

Eʺ ǼÌsǣsǣǼǼsŎsŘǼǣǼŸ¶sǼÌsNjƼNjsǣsŘǼǼNjȖsŘ_¯ÞNjɚÞsɠŸ¯ǼÌsNŸŎƼŘɴ˅ǣ¯¯ÞNjǣŘ_NjsÞŘOŸŎƼĶÞŘOsɠÞǼÌsɮÞǣǼÞض
OOŸȖŘǼÞضǣǼŘ_Nj_ǣʰƼƼĶÞOEĶsĶɠǣŘ_Njs¶ȖĶǼÞŸŘǣʳ

ˡʳ ǻÌsNjsNjsʰǼŸǼÌsEsǣǼŸ¯ŸȖNjĨŘŸɠĶs_¶sŘ_EsĶÞs¯ʰŘŸǼNjŘǣOǼÞŸŘǣsŘǼsNjs_ÞŘǼŸEɴǼÌsNŸŎƼŘɴ_ȖNjÞضǼÌsɴsNjɠÌÞOÌNjs
¯NjȖ_ȖĶsŘǼʰÞĶĶs¶ĶŸNjɚÞŸĶǼÞɚsŸ¯ǼÌsNŸŎƼŘɴ˅ǣOŸ_sŸ¯OŸŘ_ȖOǼʳ

ˢʳ ɟsOOsƼǼNjsǣƼŸŘǣÞEÞĶÞǼɴ¯ŸNjsǣǼEĶÞǣÌÞضŘ_ŎÞŘǼÞŘÞضÞŘǼsNjŘĶOŸŘǼNjŸĶǣ¯ŸNjʩŘŘOÞĶNjsƼŸNjǼÞضŘ_ǼÌǼɠsÌɚssɚĶȖǼs_
ǼÌss¯¯sOǼÞɚsŘsǣǣŸ¯ÞŘǼsNjŘĶOŸŘǼNjŸĶǣɴǣǼsŎǣŸ¯ǼÌsNŸŎƼŘɴƼsNjǼÞŘÞضǼŸʩŘŘOÞĶNjsƼŸNjǼÞضŘ_ɠsÌɚs_ÞǣOĶŸǣs_ǼŸǼÌs
Ȗ_ÞǼŸNjǣŘ_ǼÌsȖ_ÞǼNŸŎŎÞǼǼssʰ_sʩOÞsŘOÞsǣÞŘǼÌs_sǣÞ¶ŘŸNjŸƼsNjǼÞŸŘŸ¯ǣȖOÌÞŘǼsNjŘĶOŸŘǼNjŸĶǣʰÞ¯ŘɴʰŸ¯ɠÌÞOÌɠsNjs
ɠNjsŘ_ǼÌsǣǼsƼǣɠsÌɚsǼĨsŘŸNjƼNjŸƼŸǣsǼŸǼĨsǼŸNjsOǼÞ¯ɴǼÌsǣs_sʩOÞsŘOÞsǣʳ

ˣʳ ɟsÌɚsÞŘ_ÞOǼs_ǼŸǼÌsȖ_ÞǼŸNjǣŘ_ǼÌsȖ_ÞǼNŸŎŎÞǼǼssǼÌǼǼÌsNjsNjsŘŸ˚

 ʺ ǣÞ¶ŘÞʩOŘǼOÌضsǣÞŘÞŘǼsNjŘĶOŸŘǼNjŸĶŸɚsNjʩŘŘOÞĶNjsƼŸNjǼÞض_ȖNjÞضǼÌsɴsNjʱ

 Eʺ ǣ Þ¶ŘÞʩOŘǼOÌضsǣÞŘOOŸȖŘǼÞضƼŸĶÞOÞsǣ_ȖNjÞضǼÌsɴsNjŘ_ǼÌǼǼÌsǣŎsÌɚsEssŘ_ÞǣOĶŸǣs_ÞŘǼÌsŘŸǼsǣǼŸǼÌs
ʩŘŘOÞĶǣǼǼsŎsŘǼǣʱŘ_

 Oʺ ÞŘǣǼŘOsǣŸ¯ǣÞ¶ŘÞʩOŘǼ¯NjȖ_Ÿ¯ɠÌÞOÌɠsÌɚsEsOŸŎsɠNjsŘ_ǼÌsÞŘɚŸĶɚsŎsŘǼǼÌsNjsÞŘʰÞ¯ŘɴʰŸ¯ǼÌsŎضsŎsŘǼŸNj
ŘsŎƼĶŸɴssÌɚÞضǣÞ¶ŘÞʩOŘǼNjŸĶsÞŘǼÌsNŸŎƼŘɴ˅ǣÞŘǼsNjŘĶOŸŘǼNjŸĶǣɴǣǼsŎŸɚsNjʩŘŘOÞĶNjsƼŸNjǼÞضʳ

For Jyothy Laboratories Limited

M. P. Ramachandran K. Ullas Kamath S. Raghunandan


Chairman & Managing Director Joint Managing Director and CFO Whole Time Director and CEO
(DIN: 00553406) (DIN: 00506681) (DIN: 02263845)

ōȖŎEÞʰōɴˡˢʰˡ˟ˠ˥
Corporate Overview Performance Governance Financial Statements 101

AUDITORS’ CERTIFICATE
To
The Members of Jyothy Laboratories Limited

We have examined the compliance of conditions of Corporate Governance by Jyothy Laboratories Limited (“the Company”),
for the year ended March 31, 2016, as stipulated in Clause 49 of the Listing Agreement (“Listing Agreement”) of the Company
with the stock exchanges for the period April 1, 2015 to November 30, 2015 and as per the relevant provisions of Securities and
Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations)” as referred to
in Regulation 15(2) of the Listing Regulations, for the period December 1, 2015 to March 31, 2016.

The compliance of conditions of Corporate Governance is the responsibility of the Management. Our examination was limited to
procedures and implementation thereof, adopted by the Company for ensuring the compliance of the conditions of Corporate
µŸɚsNjŘŘOsʳÝǼÞǣŘsÞǼÌsNjŘȖ_ÞǼŘŸNjŘsɮƼNjsǣǣÞŸŘŸ¯ŸƼÞŘÞŸŘŸŘǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣŸ¯ǼÌsNŸŎƼŘɴʳ

In our opinion and to the best of our information and according to the explanations given to us, we certify that the Company
has complied with the conditions of Corporate Governance as stipulated in the above mentioned Listing Agreement/ Listing
Regulations, as applicable.

ɟs ¯ȖNjǼÌsNj ǣǼǼs ǼÌǼ ǣȖOÌ OŸŎƼĶÞŘOs Þǣ ŘsÞǼÌsNj Ř ǣǣȖNjŘOs ǣ ǼŸ ǼÌs ¯ȖǼȖNjs ɚÞEÞĶÞǼɴ Ÿ¯ ǼÌs NŸŎƼŘɴ ŘŸNj ǼÌs s¯ʩOÞsŘOɴ ŸNj
effectiveness with which the management has conducted the affairs of the Company.

For S R B C & CO LLP


Chartered Accountants
ICAI Firm Registration Number: 324982E/ E300003

per Vikram Mehta


Partner
Membership Number: 105938

Place of Signature: Mumbai


Date: May 23, 2016
102 Jyothy Laboratories Limited
Annual Report 2015-16

INDEPENDENT AUDITOR’S REPORT


To the Members of Jyothy Laboratories Limited An audit involves performing procedures to obtain audit
sɚÞ_sŘOs EŸȖǼ ǼÌs ŎŸȖŘǼǣ Ř_ _ÞǣOĶŸǣȖNjsǣ ÞŘ ǼÌs ʩŘŘOÞĶ
REPORT ON THE FINANCIAL STATEMENTS statements. The procedures selected depend on the
auditor’s judgment, including the assessment of the risks of
ɟs Ìɚs Ȗ_ÞǼs_ ǼÌs OOŸŎƼŘɴÞض ǣǼŘ_ĶŸŘs ʩŘŘOÞĶ ŎǼsNjÞĶ ŎÞǣǣǼǼsŎsŘǼ Ÿ¯ ǼÌs ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣʰ ɠÌsǼÌsNj
statements of Jyothy Laboratories Limited (“the Company”), due to fraud or error. In making those risk assessments, the
which comprise the Balance Sheet as at March 31, 2016, the Ȗ_ÞǼŸNj OŸŘǣÞ_sNjǣ ÞŘǼsNjŘĶ ʩŘŘOÞĶ OŸŘǼNjŸĶ NjsĶsɚŘǼ ǼŸ ǼÌs
ǢǼǼsŎsŘǼŸ¯ƻNjŸʩǼŘ_ĵŸǣǣŘ_NǣÌ®ĶŸɠǢǼǼsŎsŘǼ¯ŸNjǼÌs NŸŎƼŘɴ˅ǣ ƼNjsƼNjǼÞŸŘ Ÿ¯ ǼÌs ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣ ǼÌǼ ¶Þɚs
ɴsNj ǼÌsŘ sŘ_s_ʰ Ř_  ǣȖŎŎNjɴ Ÿ¯ ǣÞ¶ŘÞʩOŘǼ OOŸȖŘǼÞض a true and fair view in order to design audit procedures that
policies and other explanatory information. are appropriate in the circumstances. An audit also includes
evaluating the appropriateness of accounting policies used
MANAGEMENT’S RESPONSIBILITY FOR THE FINANCIAL
and the reasonableness of the accounting estimates made
STATEMENTS
by the Company’s Directors, as well as evaluating the overall
ƼNjsǣsŘǼǼÞŸŘ Ÿ¯ ǼÌs ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣʳ ɟs EsĶÞsɚs ǼÌǼ ǼÌs
The Company’s Board of Directors is responsible for the
Ȗ_ÞǼsɚÞ_sŘOsɠsÌɚsŸEǼÞŘs_ÞǣǣȖ¯ʩOÞsŘǼŘ_ƼƼNjŸƼNjÞǼs
matters stated in Section 134(5) of the Companies Act, 2013
to provide a basis for our audit opinion on the standalone
(“the Act”) with respect to the preparation of these standalone
ʩŘŘOÞĶǣǼǼsŎsŘǼǣʳ
ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣ ǼÌǼ ¶Þɚs  ǼNjȖs Ř_ ¯ÞNj ɚÞsɠ Ÿ¯ ǼÌs
ʩŘŘOÞĶƼŸǣÞǼÞŸŘʰʩŘŘOÞĶƼsNj¯ŸNjŎŘOsŘ_OǣÌʪŸɠǣŸ¯ǼÌs
Company in accordance with accounting principles generally OPINION
accepted in India, including the Accounting Standards
In our opinion and to the best of our information and according
ǣƼsOÞʩs_ ȖŘ_sNj ǣsOǼÞŸŘ ˠˢˢ Ÿ¯ ǼÌs OǼʰ Njs_ ɠÞǼÌ NJȖĶs ˦ Ÿ¯
ǼŸ ǼÌs sɮƼĶŘǼÞŸŘǣ ¶ÞɚsŘ ǼŸ Ȗǣʰ ǼÌs ǣǼŘ_ĶŸŘs ʩŘŘOÞĶ
the Companies (Accounts) Rules, 2014. This responsibility
statements give the information required by the Act in the
also includes maintenance of adequate accounting records in
manner so required and give a true and fair view in conformity
accordance with the provisions of the Act for safeguarding of
with the accounting principles generally accepted in India of
the assets of the Company and for preventing and detecting
the state of affairs of the Company as at March 31, 2016, its
frauds and other irregularities; selection and application of
ƼNjŸʩǼʰŘ_ÞǼǣOǣÌʪŸɠǣ¯ŸNjǼÌsɴsNjsŘ_s_ŸŘǼÌǼ_Ǽsʳ
appropriate accounting policies; making judgments and
estimates that are reasonable and prudent; and the design,
REPORT ON OTHER LEGAL AND REGULATORY
implementation and maintenance of adequate internal
REQUIREMENTS
ʩŘŘOÞĶ OŸŘǼNjŸĶ ǼÌǼ ɠsNjs ŸƼsNjǼÞض s¯¯sOǼÞɚsĶɴ ¯ŸNj sŘǣȖNjÞض
the accuracy and completeness of the accounting records,
1. As required by the Companies (Auditor’s report) Order,
NjsĶsɚŘǼ ǼŸ ǼÌs ƼNjsƼNjǼÞŸŘ Ř_ ƼNjsǣsŘǼǼÞŸŘ Ÿ¯ ǼÌs ʩŘŘOÞĶ
2016 (“the Order”) issued by the Central Government of
statements that give a true and fair view and are free from
India in terms of sub-section (11) of section 143 of the
material misstatement, whether due to fraud or error.
Act, we give in the Annexure 1 a statement on the matters
ǣƼsOÞʩs_ÞŘƼNj¶NjƼÌǣˢŘ_ˣŸ¯ǼÌsŷNj_sNjʳ
AUDITOR’S RESPONSIBILITY

2. As required by section 143 (3) of the Act, we report that:


Our responsibility is to express an opinion on these standalone
ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣ Eǣs_ ŸŘ ŸȖNj Ȗ_ÞǼʳ ɟs Ìɚs ǼĨsŘ ÞŘǼŸ
(a) We have sought and obtained all the information and
account the provisions of the Act, the accounting and auditing
explanations which to the best of our knowledge and
standards and matters which are required to be included in
belief were necessary for the purpose of our audit;
the audit report under the provisions of the Act and the Rules
made thereunder. We conducted our audit in accordance with (b) In our opinion proper books of account as required
the Standards on Auditing, issued by the Institute of Chartered by law have been kept by the Company so far as it
OOŸȖŘǼŘǼǣ Ÿ¯ ÝŘ_Þʰ ǣ ǣƼsOÞʩs_ ȖŘ_sNj ǢsOǼÞŸŘ ˠˣˢʹˠ˟ʺ Ÿ¯ appears from our examination of those books;
the Act. Those Standards require that we comply with ethical
requirements and plan and perform the audit to obtain  ʹOʺ ǻÌsDĶŘOsǢÌssǼʰǢǼǼsŎsŘǼŸ¯ƻNjŸʩǼŘ_ĵŸǣǣŘ_
NjsǣŸŘEĶsǣǣȖNjŘOsEŸȖǼɠÌsǼÌsNjǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ Cash Flow Statement dealt with by this Report are in
are free from material misstatement. agreement with the books of account;
Corporate Overview Performance Governance Financial Statements 103

 ʹ_ʺ ÝŘ ŸȖNj ŸƼÞŘÞŸŘʰ ǼÌs ¯ŸNjsǣÞ_ ǣǼŘ_ĶŸŘs ʩŘŘOÞĶ i. The Company has disclosed the impact of
statements comply with the Accounting Standards ƼsŘ_Þض ĶÞǼÞ¶ǼÞŸŘǣ ŸŘ ÞǼǣ ʩŘŘOÞĶ ƼŸǣÞǼÞŸŘ ÞŘ
ǣƼsOÞʩs_ȖŘ_sNjǣsOǼÞŸŘˠˢˢŸ¯ǼÌsOǼʰNjs_ɠÞǼÌNJȖĶs ÞǼǣ ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣ ˛ NJs¯sNj ŗŸǼs ˢˢ ǼŸ ǼÌs
˦Ÿ¯ǼÌsNŸŎƼŘÞsǣʹOOŸȖŘǼǣʺNJȖĶsǣʰˡ˟ˠˣʱ ʩŘŘOÞĶǣǼǼsŎsŘǼǣʱ

(e) On the basis of written representations received ii. The Company did not have any long-term
from the directors as on March 31, 2016 , and taken contracts including derivative contracts for which
on record by the Board of Directors, none of the there were any material foreseeable losses.
_ÞNjsOǼŸNjǣÞǣ_ÞǣLJȖĶÞʩs_ǣŸŘōNjOÌˢˠʰˡ˟ˠ˥ʰ¯NjŸŎ iii. There has been no delay in transferring amounts,
being appointed as a director in terms of section 164 required to be transferred, to the Investor
(2) of the Act; Education and Protection Fund by the Company.

 ʹ¯ʺ ɟÞǼÌNjsǣƼsOǼǼŸǼÌs_sLJȖOɴŸ¯ǼÌsÞŘǼsNjŘĶʩŘŘOÞĶ For S R B C & CO LLP


OŸŘǼNjŸĶǣŸɚsNjʩŘŘOÞĶNjsƼŸNjǼÞضŸ¯ǼÌsNŸŎƼŘɴŘ_ Chartered Accountants
the operating effectiveness of such controls, refer to ICAI Firm Registration Number: 324982E/ E300003
our separate Report in “Annexure 2” to this report;
per Vikram Mehta
(g) With respect to the other matters to be included in
Partner
the Auditor’s Report in accordance with Rule 11 of
Membership Number: 105938
the Companies (Audit and Auditors) Rules, 2014, in
our opinion and to the best of our information and Place of Signature: Mumbai
according to the explanations given to us: Date: May 23, 2016
104 Jyothy Laboratories Limited
Annual Report 2015-16

ANNEXURE 1 TO INDEPENDENT AUDITOR’S REPORT


on even date on the Standalone Financials Statements of Jyothy Laboratories Limited
(i) (a) The Company has maintained proper records (c) There is no amount of loans granted to Companies,
showing full particulars, including quantitative details ʩNjŎǣŸNjŸǼÌsNjƼNjǼÞsǣĶÞǣǼs_ÞŘǼÌsNjs¶ÞǣǼsNjŎÞŘǼÞŘs_
Ř_ǣÞǼȖǼÞŸŘŸ¯ʩɮs_ǣǣsǼǣʳ under section 189 of the Companies Act, 2013 which
are outstanding for more than ninety days.
 ʹEʺ ĶĶ ʩɮs_ ǣǣsǼǣ Ìɚs ŘŸǼ EssŘ ƼÌɴǣÞOĶĶɴ ɚsNjÞʩs_ Eɴ
the management during the year but there is a regular
(iv) In our opinion and according to the information and
ƼNjŸ¶NjŎŎs Ÿ¯ ɚsNjÞʩOǼÞŸŘ ɠÌÞOÌʰ ÞŘ ŸȖNj ŸƼÞŘÞŸŘʰ Þǣ
explanations given to us, the Company has not advanced
reasonable having regards to size of the Company
loans to directors / to a Company in which the Director
and nature of its assets. No material discrepancies
is interested to which provisions of section 185 of the
ɠsNjsÞ_sŘǼÞʩs_ŸŘǣȖOÌɚsNjÞʩOǼÞŸŘʳ
Companies Act 2013 apply and hence not commented
(c) According to information and explanations given upon.
by the management the title deeds of immovable
ƼNjŸƼsNjǼÞsǣ ÞŘOĶȖ_s_ ÞŘ ŗŸǼs ˠˡ ǼŸ ǼÌs ʩŘŘOÞĶ In our opinion and according to the information and
statements are held in the name of the Company, explanations given to us, provisions of section 186 of the
except as noted below:- Companies Act 2013 in respect of loans and advances
given, investments made and, guarantees, and securities
  ˒ ÝŘNjsǣƼsOǼŸ¯ǼɠŸÞŎŎŸɚEĶsƼNjŸƼsNjǼÞsǣʹ¯NjssÌŸĶ_ given have been complied with by the Company.
land) aggregating to ` 2.21 lacs as at March 31,
2016, the title deeds were not available with the (v) The Company has not accepted any deposits from the
Company and hence we are unable to comment public.
on the same.
(vi) We have broadly reviewed the books of account maintained
  ˒ ÝŘ NjsǣƼsOǼ Ÿ¯ ǼÌs ¯ŸĶĶŸɠÞضʰ ǼÌs ÞŎŎŸɚEĶs
by the Company pursuant to the rules made by the Central
properties are not held in the name of the
Government for the maintenance of cost records under
Company. The same is held in the name of the
section 148(1) of the Companies Act, 2013, related to the
erstwhile entities which have been merged with
manufacture of products of the Company, and are of the
the Company.
ŸƼÞŘÞŸŘǼÌǼƼNjÞŎ¯OÞsʰǼÌsǣƼsOÞʩs_OOŸȖŘǼǣŘ_NjsOŸNj_ǣ
Total Nature Gross block Net Block have been made and maintained. We have not, however,
Number of (` in lacs) (` in lacs) made a detailed examination of the same.
Cases
(vii) (a) The Company is regular in depositing with appropriate
2 Freehold land ˣʰ˨˦ˣ ˣʰˣ˨˦
authorities undisputed statutory dues including
and building
provident fund, employees’ state insurance, income-
ʹÞÞʺ ǻÌs ŎضsŎsŘǼ Ìǣ OŸŘ_ȖOǼs_ ƼÌɴǣÞOĶ ɚsNjÞʩOǼÞŸŘ tax, sales-tax, service tax, duty of custom, duty of
of inventory at reasonable intervals during the year and excise, value added tax, cess and other material
no material discrepancies were noticed on such physical statutory dues applicable to it.
ɚsNjÞʩOǼÞŸŘʳ
(b) According to the information and explanations given
(iii) (a) The Company has granted loan to one Company
to us, no undisputed amounts payable in respect of
covered in the register maintained under section
provident fund, employees’ state insurance, income-
189 of the Companies Act, 2013. In our opinion and
tax, service tax, sales-tax, duty of custom, duty of
according to the information and explanations given
excise, value added tax, cess and other material
to us, the terms and conditions of the loan are not
statutory dues were outstanding, at the year end, for
prejudicial to the Company’s interest.
a period of more than six months from the date they
(b) The Company has granted loans that are re-payable became payable.
on demand, to a Company covered in the register
maintained under section 189 of the Companies Act, (c) According to the records of the Company, the dues
2013. We are informed that the Company has not outstanding of income-tax, sales-tax, wealth-tax,
demanded repayment of any such loan and interest service tax, customs duty, excise duty, value added tax
during the year, and thus, there has been no default on and cess that have not been deposited on account of
the part of the parties to whom the money has been lent. any dispute, are as follows:
Corporate Overview Performance Governance Financial Statements 105

Matter Year Forum where dispute is pending (Amounts in Lacs)


Commissioner Tribunal High Court Supreme court Grand total
and Appellate
Excise 1998-2000 10 - - - 10
2006-2014 134 1 - - 135
Service Tax 2005-2006 ˦ - - - ˦
2010-2012 91 - - - 91
Sales Tax 1999-2001 18 4 - - 22
2001-2009 54 - - - 54
2001-2004 352 153 200 - ˦˟ˤ
2004-2005 18 293 - - 311
2005-2006 334 213 - - ˤˣ˦
ˡ˟˟˥˚ˡ˟˟˦ ˤˢ˦ 181 52 - ˦˦˟
2006-2011 31 - - - 31
ˡ˟˟˦˚ˡ˟˟˧ 204 23 8 - 235
2008-2010 ˢ˦ˢ 39 - - 412
2009-2010 108 128 108 - 344
2010-2011 ˡˠ˦ - - 168 385
2010-2012 ˠ˦ - - - ˠ˦
2010-2013 40 - - - 40
2011-2012 60 - - - 60
2011-2013 44 - - - 44
2011-2014 - - - - -
2012-2013 69 - - - 69
2012-2014 4 - - - 4
2013-2014 ˦˧ - - - ˦˧
2014-2015 ˠ˦ - - - ˠ˦
Income Tax AY 2008-2013 ˤʰˠ˦˦ 95 - - ˤʰˡ˦ˡ
Total 7,994 1,130 368 168 9,660

(viii) In our opinion and according to the information and (xi) According to the information and explanations given by
explanations given by the management, the Company the management, the managerial remuneration has been
Ìǣ ŘŸǼ _s¯ȖĶǼs_ ÞŘ NjsƼɴŎsŘǼ Ÿ¯ _Ȗsǣ ǼŸ  ʩŘŘOÞĶ paid / provided in accordance with the requisite approvals
institution, bank, debenture holders or government. ŎŘ_Ǽs_ Eɴ ǼÌs ƼNjŸɚÞǣÞŸŘǣ Ÿ¯ ǣsOǼÞŸŘ ˠ˨˦ Njs_ ɠÞǼÌ
Schedule V to the Companies Act, 2013.
(ix) According to the information and explanations given by
the management, the Company has not raised any money
(xii) In our opinion, the Company is not a nidhi Company.
by way of initial public offer / further public offer / debt
Therefore, the provisions of clause 3(xii) of the order are
instruments and term loans. Hence, reporting under
not applicable to the Company and hence not commented
clause (ix) is not applicable to the Company and hence not
upon.
commented upon.

(x) Based upon the audit procedures performed for the purpose (xiii) According to the information and explanations given by
Ÿ¯NjsƼŸNjǼÞضǼÌsǼNjȖsŘ_¯ÞNjɚÞsɠŸ¯ǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ the management, transactions with the related parties are
and according to the information and explanations given by ÞŘOŸŎƼĶÞŘOsɠÞǼÌǣsOǼÞŸŘˠ˦˦Ř_ˠ˧˧Ÿ¯NŸŎƼŘÞsǣOǼʰ
the management, we report that no fraud by the Company 2013 where applicable and the details have been disclosed
ŸNjŸŘǼÌsNŸŎƼŘɴEɴǼÌsŸ¯ʩOsNjǣŘ_sŎƼĶŸɴssǣŸ¯ǼÌs ÞŘǼÌsŘŸǼsǣǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣʰǣNjsLJȖÞNjs_EɴǼÌs
Company has been noticed or reported during the year. applicable accounting standards.
106 Jyothy Laboratories Limited
Annual Report 2015-16

(xiv) According to the information and explanations given to (xvi) According to the information and explanations given to
us and on an overall examination of the balance sheet, us, the provisions of section 45-IA of the Reserve Bank of
the Company has not made any preferential allotment or India Act, 1934 are not applicable to the Company.
private placement of shares or fully or partly convertible
debentures during the year under review. Accordingly, For S R B C & CO LLP
the reporting requirements under clause 3(xiv) are not Chartered Accountants
applicable to the Company and not commented upon. ICAI Firm Registration Number: 324982E/ E300003

per Vikram Mehta


(xv) According to the information and explanations given by
Partner
the management, the Company has not entered into any
Membership Number: 105938
non-cash transactions with directors or persons connected
with him as referred to in Section 192 of the Companies Place of Signature: Mumbai
Act, 2013. Date: May 23, 2016
Corporate Overview Performance Governance Financial Statements ˠ˟˦

ANNEXURE 2 TO INDEPENDENT AUDITOR’S REPORT


of even date on the Standalone Financial Statements of Jyothy Laboratories Limited
Report on the Internal Financial Controls under Clause (i) MEANING OF INTERNAL FINANCIAL CONTROLS OVER
of Sub-section 3 of Section 143 of the Companies Act, 2013 FINANCIAL REPORTING
(“the Act”)
OŸŎƼŘɴ˅ǣÞŘǼsNjŘĶʩŘŘOÞĶOŸŘǼNjŸĶŸɚsNjʩŘŘOÞĶNjsƼŸNjǼÞضÞǣ
ɟsÌɚsȖ_ÞǼs_ǼÌsÞŘǼsNjŘĶʩŘŘOÞĶOŸŘǼNjŸĶǣŸɚsNjʩŘŘOÞĶ a process designed to provide reasonable assurance regarding
reporting of Jyothy Laboratories Limited (“the Company”) as of ǼÌs NjsĶÞEÞĶÞǼɴ Ÿ¯ ʩŘŘOÞĶ NjsƼŸNjǼÞض Ř_ ǼÌs ƼNjsƼNjǼÞŸŘ Ÿ¯
March 31, 2016 in conjunction with our audit of the standalone
ʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjsɮǼsNjŘĶƼȖNjƼŸǣsǣÞŘOOŸNj_ŘOsɠÞǼÌ
ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣ Ÿ¯ ǼÌs NŸŎƼŘɴ ¯ŸNj ǼÌs ɴsNj sŘ_s_ ŸŘ
generally accepted accounting principles. A company’s internal
that date.
ʩŘŘOÞĶOŸŘǼNjŸĶŸɚsNjʩŘŘOÞĶNjsƼŸNjǼÞضÞŘOĶȖ_sǣǼÌŸǣsƼŸĶÞOÞsǣ
and procedures that: (1) pertain to the maintenance of records
MANAGEMENT’S RESPONSIBILITY FOR INTERNAL
ǼÌǼʰ ÞŘ NjsǣŸŘEĶs _sǼÞĶʰ OOȖNjǼsĶɴ Ř_ ¯ÞNjĶɴ NjsʪsOǼ ǼÌs
FINANCIAL CONTROLS
transactions and dispositions of the assets of the company; (2)
The Company’s Management is responsible for establishing provide reasonable assurance that transactions are recorded
Ř_ ŎÞŘǼÞŘÞض ÞŘǼsNjŘĶ ʩŘŘOÞĶ OŸŘǼNjŸĶǣ Eǣs_ ŸŘ ǼÌs ǣ ŘsOsǣǣNjɴ ǼŸ ƼsNjŎÞǼ ƼNjsƼNjǼÞŸŘ Ÿ¯ ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣ ÞŘ
ÞŘǼsNjŘĶOŸŘǼNjŸĶŸɚsNjʩŘŘOÞĶNjsƼŸNjǼÞضONjÞǼsNjÞsǣǼEĶÞǣÌs_Eɴ
accordance with generally accepted accounting principles, and
the Company considering the essential components of internal
control stated in the Guidance Note on Audit of Internal Financial that receipts and expenditures of the company are being made
Controls Over Financial Reporting issued by the Institute of only in accordance with authorisations of management and
Chartered Accountants of India. These responsibilities include directors of the company; and (3) provide reasonable assurance
the design, implementation and maintenance of adequate regarding prevention or timely detection of unauthorised
ÞŘǼsNjŘĶ ʩŘŘOÞĶ OŸŘǼNjŸĶǣ ǼÌǼ ɠsNjs ŸƼsNjǼÞض s¯¯sOǼÞɚsĶɴ ¯ŸNj acquisition, use, or disposition of the company’s assets that
sŘǣȖNjÞض ǼÌs ŸNj_sNjĶɴ Ř_ s¯ʩOÞsŘǼ OŸŘ_ȖOǼ Ÿ¯ ÞǼǣ EȖǣÞŘsǣǣʰ OŸȖĶ_ÌɚsŎǼsNjÞĶs¯¯sOǼŸŘǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣʳ
including adherence to the Company’s policies, the safeguarding
of its assets, the prevention and detection of frauds and errors, INHERENT LIMITATIONS OF INTERNAL FINANCIAL
the accuracy and completeness of the accounting records, CONTROLS OVER FINANCIAL REPORTING
Ř_ǼÌsǼÞŎsĶɴƼNjsƼNjǼÞŸŘŸ¯NjsĶÞEĶsʩŘŘOÞĶÞŘ¯ŸNjŎǼÞŸŘʰǣ
required under the Companies Act, 2013. DsOȖǣs Ÿ¯ ǼÌs ÞŘÌsNjsŘǼ ĶÞŎÞǼǼÞŸŘǣ Ÿ¯ ÞŘǼsNjŘĶ ʩŘŘOÞĶ
OŸŘǼNjŸĶǣ ŸɚsNj ʩŘŘOÞĶ NjsƼŸNjǼÞضʰ ÞŘOĶȖ_Þض ǼÌs ƼŸǣǣÞEÞĶÞǼɴ
AUDITOR’S RESPONSIBILITY of collusion or improper management override of controls,
material misstatements due to error or fraud may occur and
Our responsibility is to express an opinion on the Company’s
not be detected. Also, projections of any evaluation of the
ÞŘǼsNjŘĶ ʩŘŘOÞĶ OŸŘǼNjŸĶǣ ŸɚsNj ʩŘŘOÞĶ NjsƼŸNjǼÞض Eǣs_ ŸŘ
our audit. We conducted our audit in accordance with the ÞŘǼsNjŘĶ ʩŘŘOÞĶ OŸŘǼNjŸĶǣ ŸɚsNj ʩŘŘOÞĶ NjsƼŸNjǼÞض ǼŸ ¯ȖǼȖNjs
Guidance Note on Audit of Internal Financial Controls Over ƼsNjÞŸ_ǣNjsǣȖEĠsOǼǼŸǼÌsNjÞǣĨǼÌǼǼÌsÞŘǼsNjŘĶʩŘŘOÞĶOŸŘǼNjŸĶ
Financial Reporting (the “Guidance Note”) and the Standards on ŸɚsNj ʩŘŘOÞĶ NjsƼŸNjǼÞض Ŏɴ EsOŸŎs ÞŘ_sLJȖǼs EsOȖǣs Ÿ¯
Ȗ_ÞǼÞضǣǣƼsOÞʩs_ȖŘ_sNjǣsOǼÞŸŘˠˣˢʹˠ˟ʺŸ¯ǼÌsNŸŎƼŘÞsǣ changes in conditions, or that the degree of compliance with
Act, 2013, to the extent applicable to an audit of internal the policies or procedures may deteriorate.
ʩŘŘOÞĶ OŸŘǼNjŸĶǣʰ EŸǼÌ ƼƼĶÞOEĶs ǼŸ Ř Ȗ_ÞǼ Ÿ¯ ÝŘǼsNjŘĶ
Financial Controls and, both issued by the Institute of Chartered OPINION
Accountants of India. Those Standards and the Guidance Note
In our opinion, the Company has, in all material respects, an
require that we comply with ethical requirements and plan
_sLJȖǼs ÞŘǼsNjŘĶ ʩŘŘOÞĶ OŸŘǼNjŸĶǣ ǣɴǣǼsŎ ŸɚsNj ʩŘŘOÞĶ
and perform the audit to obtain reasonable assurance about
ɠÌsǼÌsNj _sLJȖǼs ÞŘǼsNjŘĶ ʩŘŘOÞĶ OŸŘǼNjŸĶǣ ŸɚsNj ʩŘŘOÞĶ NjsƼŸNjǼÞض Ř_ ǣȖOÌ ÞŘǼsNjŘĶ ʩŘŘOÞĶ OŸŘǼNjŸĶǣ ŸɚsNj ʩŘŘOÞĶ
reporting was established and maintained and if such controls reporting were operating effectively as at March 31,2016
operated effectively in all material respects. Eǣs_ ŸŘ ǼÌs ÞŘǼsNjŘĶ OŸŘǼNjŸĶ ŸɚsNj ʩŘŘOÞĶ NjsƼŸNjǼÞض ONjÞǼsNjÞ
Our audit involves performing procedures to obtain audit established by the Company considering the essential
sɚÞ_sŘOs EŸȖǼ ǼÌs _sLJȖOɴ Ÿ¯ ǼÌs ÞŘǼsNjŘĶ ʩŘŘOÞĶ components of internal control stated in the Guidance Note
OŸŘǼNjŸĶǣ ǣɴǣǼsŎ ŸɚsNj ʩŘŘOÞĶ NjsƼŸNjǼÞض Ř_ ǼÌsÞNj ŸƼsNjǼÞض on Audit of Internal Financial Controls Over Financial Reporting
s¯¯sOǼÞɚsŘsǣǣʳ ŷȖNj Ȗ_ÞǼ Ÿ¯ ÞŘǼsNjŘĶ ʩŘŘOÞĶ OŸŘǼNjŸĶǣ ŸɚsNj issued by the Institute of Chartered Accountants of India.
ʩŘŘOÞĶ NjsƼŸNjǼÞض ÞŘOĶȖ_s_ ŸEǼÞŘÞض Ř ȖŘ_sNjǣǼŘ_Þض Ÿ¯
ÞŘǼsNjŘĶʩŘŘOÞĶOŸŘǼNjŸĶǣŸɚsNjʩŘŘOÞĶNjsƼŸNjǼÞضʰǣǣsǣǣÞضǼÌs
risk that a material weakness exists, and testing and evaluating For S R B C & CO LLP
the design and operating effectiveness of internal control Chartered Accountants
based on the assessed risk. The procedures selected depend ICAI Firm Registration Number: 324982E/ E300003
on the auditor’s judgement, including the assessment of the
NjÞǣĨǣ Ÿ¯ ŎǼsNjÞĶ ŎÞǣǣǼǼsŎsŘǼ Ÿ¯ ǼÌs ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣʰ per Vikram Mehta
whether due to fraud or error. Partner
We believe that the audit evidence we have obtained is Membership Number: 105938
ǣȖ¯ʩOÞsŘǼ Ř_ ƼƼNjŸƼNjÞǼs ǼŸ ƼNjŸɚÞ_s  EǣÞǣ ¯ŸNj ŸȖNj Ȗ_ÞǼ
ŸƼÞŘÞŸŘŸŘǼÌsÞŘǼsNjŘĶʩŘŘOÞĶOŸŘǼNjŸĶǣǣɴǣǼsŎŸɚsNjʩŘŘOÞĶ Place of Signature: Mumbai
reporting. Date: May 23, 2016
108 Jyothy Laboratories Limited
Annual Report 2015-16

BALANCE SHEET
as at March 31, 2016
` In Lacs
Note 2016 2015
EQUITY AND LIABILITIES
Shareholders’ funds
Share capital 4 1,811.20 1,810.23
Reserves and surplus 5 ˠ˟ˠʰˣˣ˥ʳ˦˧ 94,360.14
103,257.98 96,170.37
Non-current liabilities
Long-term borrowings 6 - 40,000.00
Deferred tax liabilities (Net) ˦ 2,453.11 -
Other Long-term liabilities 8 - ˠˣʰ˦˨ˤʳ˨˟
Provisions 9 1,632.60 ˠʰˡ˥˨ʳ˦˨
4,085.71 56,065.69
Current liabilities
Trade payables 10
Total outstanding dues of micro enterprises and small enterprises 4,682.31 ˢʰ˦ˡ˧ʳˠ˦
Total outstanding dues of creditors other than micro enterprises and small enterprises ˠ˟ʰ˧ˡˤʳ˦˟ ˨ʰ˟˧˦ʳ˥ˤ
Other current liabilities 11 ˤ˨ʰˠ˦ˤʳˤ˥ 15,149.98
Provisions 9 5,099.19 11,441.15
79,782.76 39,406.95
TOTAL 187,126.45 191,643.01
ASSETS
Non-current assets
Fixed assets
(i) Tangible assets 12 ˡˣʰ˟˦˨ʳˤˢ 25,143.90
(ii) Intangible assets 12 ˡ˦ʰˢ˧ˣʳˠˢ 31,888.59
(iii) Capital work-in-progress 523.11 536.36
(iv) Intangible assets under development 240.00 -
Non-current investments 13 ˡˣʰˢˠˡʳ˦˧ 24,454.88
Loans and advances 14 ˦˟ʰˠˡˢʳˤˠ ˥˟ʰˠˢˤʳˡ˦
Other assets 15 ˦˧ʳˠˢ 219.28
146,741.19 142,378.28
Current assets
Current investments 16 ˥ʰ˥ˡˣʳˡ˦ 16,450.00
Inventories ˠ˦ ˠ˦ʰ˨˟˥ʳ˟ˣ 18,101.82
Trade receivables 18 ˧ʰˢ˦˨ʳˡˢ 5,091.46
Cash and Bank balances 19 ˣʰ˨ˢ˦ʳˡ˨ 6,525.81
Loans and advances 14 2,149.18 ˡʰ˧˟ˣʳ˦ˢ
Other assets 15 389.25 290.91
40,385.26 49,264.73
TOTAL 187,126.45 191,643.01
ǢȖŎŎNjɴŸ¯ǣÞ¶ŘÞʩOŘǼOOŸȖŘǼÞضƼŸĶÞOÞsǣ 3
ǻÌsOOŸŎƼŘɴÞضŘŸǼsǣNjsŘÞŘǼs¶NjĶƼNjǼŸ¯ǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣʳ
As per our report of even date

For S R B C & CO LLP For and on behalf of the Board of Directors of


Chartered Accountants Jyothy Laboratories Limited
ICAI Firm Registration No. 324982E/ E300003

per Vikram Mehta M.P. Ramachandran K.Ullas Kamath


Partner Chairman and Managing Director ğŸÞŘǼōضÞض^ÞNjsOǼŸNjŘ_NÌÞs¯®ÞŘŘOÞĶŷ¯ʩOsNj
Membership No.: 105938 DIN: 00553406 DIN: 00506681
M.L. Bansal S.Raghunandan
Company Secretary ɟÌŸĶsǻÞŎs^ÞNjsOǼŸNjŘ_NÌÞs¯rɮsOȖǼÞɚsŷ¯ʩOsNj
ōsŎEsNjǣÌÞƼŗŸʳʲ®ˡˡ˨˦ DIN: 02263845
Place: Mumbai Place: Mumbai
Date: May 23, 2016 Date: May 23, 2016
Corporate Overview Performance Governance Financial Statements 109

STATEMENT OF PROFIT AND LOSS


for the year ended March 31, 2016
` In Lacs
Note 2015-16 2014-15
REVENUE
Sales (net of trade discount) ˠ˥ˢʰˡ˧˦ʳ˧˧ 148,113.63
Less: Excise duty (5,936.94) (5,286.81)
Net sales 29 (H) ˠˤ˦ʰˢˤ˟ʳ˨ˣ 142,826.82
Other operating income 20 ˠ˧˥ʳ˟˦ 955.13
Revenue from operations 157,537.01 143,781.95
Other income 21 952.02 ˥˦˟ʳˠ˥
Total Revenue ( I ) 158,489.03 144,452.11
EXPENSES
Cost of raw material and components consumed 22 48,640.52 45,635.68
Purchase of traded goods 29 (H) ˢ˟ʰ˦ˠˡʳˣ˟ ˢˠʰ˦˧˨ʳ˨˦
ʹÝŘONjsǣsʺˀ_sONjsǣsÞŘÞŘɚsŘǼŸNjÞsǣŸ¯ʩŘÞǣÌs_¶ŸŸ_ǣʰɠŸNjĨ˚ÞŘ˚ƼNjŸ¶NjsǣǣŘ_ǼNj_s_¶ŸŸ_ǣ 23 ˠˠˤʳ˧˦ (1,361.56)
rŎƼĶŸɴssEsŘsʩǼǣsɮƼsŘǣs 24 ˠˣʰˠ˟˨ʳ˦˨ ˠˡʰ˦ˠˠʳ˟ˣ
Employee stock option expenses 24 ˠʰ˦ˤ˟ʳˡ˥ ˡʰ˧˦ˠʳˠˢ
ǢÌNjsŸ¯ʹƼNjŸʩǼʺˀĶŸǣǣ¯NjŸŎÞŘɚsǣǼŎsŘǼÞŘƼNjǼŘsNjǣÌÞƼʩNjŎ ˦ʳˢ˟ ʹˡ˦ʳˠ˦ʺ
Other expenses 25 ˣ˟ʰˣˢˣʳ˟˦ 35,608.03
Total Expense ( II ) 135,770.21 127,227.12
EARNINGS BEFORE INTEREST, TAX, DEPRECIATION,
AMORTIZATION AND IMPAIRMENT (EBITDA) (I) – (II) 22,718.82 17,224.99
Depreciation, amortisation and impairment 12 ˥ʰ˦˨ˢʳ˨˨ ˦ʰ˟ˢ˦ʳ˟˦
Finance Costs 26 485.56 1,202.98
Interest Income ˡ˦ ˣʰ˦˟ˠʳ˧ˠ 5,915.82
PROFIT BEFORE EXCEPTIONAL ITEMS AND TAX 20,141.08 14,900.76
Exceptional item 43 - 209.18
PROFIT BEFORE TAX 20,141.08 14,691.58
Current tax (MAT) 4,312.00 ˢʰ˟˦ˤʳ˟˟
Less MAT credit entitlement (2,860.00) ʹˢʰ˟˦ˤʳ˟˟ʺ
- Net current tax 1,452.00 -
- Deferred tax charge/ (credit) 2,453.12 -
- Excess tax provision/ MAT credit reversal of earlier years - 412.63
PROFIT AFTER TAX 16,235.96 14,278.95
EARNINGS PER SHARE (EPS)
Basic (`) 39 ˧ʳ˨˦ ˦ʳ˧˨
Diluted (`) 8.84 ˦ʳ˧ˢ
Nominal value per share (`) 1 1
ǢȖŎŎNjɴŸ¯ǣÞ¶ŘÞʩOŘǼOOŸȖŘǼÞضƼŸĶÞOÞsǣ 3

ǻÌsOOŸŎƼŘɴÞضŘŸǼsǣNjsŘÞŘǼs¶NjĶƼNjǼŸ¯ǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣʳ
As per our report of even date

For S R B C & CO LLP For and on behalf of the Board of Directors of


Chartered Accountants Jyothy Laboratories Limited
ICAI Firm Registration No. 324982E/ E300003

per Vikram Mehta M.P. Ramachandran K.Ullas Kamath


Partner Chairman and Managing Director ğŸÞŘǼōضÞض^ÞNjsOǼŸNjŘ_NÌÞs¯®ÞŘŘOÞĶŷ¯ʩOsNj
Membership No.: 105938 DIN: 00553406 DIN: 00506681
M.L. Bansal S.Raghunandan
Company Secretary ɟÌŸĶsǻÞŎs^ÞNjsOǼŸNjŘ_NÌÞs¯rɮsOȖǼÞɚsŷ¯ʩOsNj
ōsŎEsNjǣÌÞƼŗŸʳʲ®ˡˡ˨˦ DIN: 02263845
Place: Mumbai Place: Mumbai
Date: May 23, 2016 Date: May 23, 2016
110 Jyothy Laboratories Limited
Annual Report 2015-16

STATEMENT OF CASH FLOWS


for the year ended March 31, 2016
` In Lacs
2015-16 2014-15

A. CASH FLOWS PROVIDED BY/(USED IN) OPERATING ACTIVITIES:


 ƻNjŸʩǼEs¯ŸNjsǻɮ 20,141.08 14,691.58
 _ĠȖǣǼŎsŘǼǣǼŸNjsOŸŘOÞĶsƼNjŸʩǼEs¯ŸNjsǼɮǼŸŘsǼOǣÌʪŸɠǣʲ
Depreciation, amortisation and impairment ˥ʰ˦˨ˢʳ˨˨ ˦ʰ˟ˢ˦ʳ˟˦
 ĵŸǣǣŸŘʩɮs_ǣǣsǼǣ_ÞǣONj_s_ ˧˟ʳˤ˦ 91.42
 ƻNjŸʩǼŸŘǣĶsŸ¯ƼĶŘǼʰƼNjŸƼsNjǼɴŘ_sLJȖÞƼŎsŘǼ ʹˣ˨ʳ˦ˣʺ ʹˠ˦ʳˠ˥ʺ
 ƻNjŸʩǼŸŘǣĶsŸ¯ÞŘɚsǣǼŎsŘǼÞŘǣȖEǣÞ_ÞNjɴ - (82.55)
 ÝŘǼsNjsǣǼŘ_ʩŘŘOsOÌNj¶sǣ 485.56 1,202.98
Interest Income ʹˣʰ˦˟ˠʳ˧ˠʺ (5,915.82)
 ǢÌNjsŸ¯ʹƼNjŸʩǼʺˀĶŸǣǣ¯NjŸŎÞŘɚsǣǼŎsŘǼÞŘƼNjǼŘsNjǣÌÞƼʩNjŎ ˦ʳˢ˟ ʹˡ˦ʳˠ˦ʺ
Liabilities no longer required written back (net) - ʹˢ˧˨ʳˠ˦ʺ
Differential tariff towards power and fuel expenses of earlier years - (400.31)
 ®ŸNjsÞ¶ŘsɮOÌضsʪȖOǼȖǼÞŸŘ¶ÞŘʹŘsǼʺ ˧˥ˢʳ˦ˣ (4.66)
 ƻNjŸʩǼŸŘǣĶsŸ¯OȖNjNjsŘǼÞŘɚsǣǼŎsŘǼǣ (829.33) ʹˣ˦˥ʳ˨˧ʺ
Provision for doubtful advances ˦˟ʳ˟˟ -
Employee stock option expenses ˠʰ˦ˤ˟ʳˡ˥ ˡʰ˧˦ˠʳˠˢ
 ŷƼsNjǼÞضƼNjŸʩǼEs¯ŸNjsɠŸNjĨÞضOƼÞǼĶOÌضsǣ 24,611.62 18,580.36
Movements in working capital :
Increase/ (decrease) in trade payables 2,692.19 2,421.13
Increase / (decrease) in provisions 396.36 ˧˦ˡʳˠˠ
Increase/ (decrease) in other liabilities ˠʰˢ˦˦ʳ˧ˠ ʹ˦˥ˠʳ˨ˤʺ
Decrease / (increase) in trade receivables (4,151.51) ˣ˦˥ʳˡˣ
Decrease / (increase) in inventories ˠ˨ˤʳ˦˧ (1,982.62)
Decrease / (increase) in loans and advances ʹ˨˦ˡʳˤ˥ʺ ˠ˧˦ʳ˨ˠ
Decrease / (increase) in other current assets 46.95 66.14
Cash generated from operations 24,196.64 19,859.33
Taxes paid (net) (5,131.69) (4,102.12)
Net cash generated from operating activities ( A ) 19,064.95 15,757.21
B. CASH FLOWS PROVIDED BY/(USED IN) INVESTING ACTIVITIES:
 ƻȖNjOÌǣsŸ¯ʩɮs_ǣǣsǼǣÞŘOĶȖ_ÞضOƼÞǼĶɠŸNjĨ˚ÞŘ˚ƼNjŸ¶NjsǣǣŘ_OƼÞǼĶ_ɚŘOsǣ (2,459.40) (631.11)
 ƻNjŸOss_ǣ¯NjŸŎǣĶsŸ¯ʩɮs_ǣǣsǼǣ 195.32 145.98
 ÝŘɚsǣǼŎsŘǼÞŘʩɮs__sƼŸǣÞǼʹÌɚÞضŸNjÞ¶ÞŘĶŎǼȖNjÞǼɴŸ¯ŎŸNjsǼÌŘǼÌNjssŎŸŘǼÌǣʺ 1,032.24 (1,369.90)
Investment in shares of subsidiaries - (15,000.00)
 ƻNjŸʩǼŸŘǣĶsŸ¯OȖNjNjsŘǼÞŘɚsǣǼŎsŘǼǣ 829.33 ˣ˦˥ʳ˨˧
Proceed from sale of investment in subsidiary - 82.55
 ʹÝŘɚsǣǼŎsŘǼʺˀNJs¯ȖŘ_ÞŘƼNjǼŘsNjǣÌÞƼʩNjŎ (12.50) 43.00
Proceeds of loan given to subsidiary company 434.88 15,835.13
Interest Income received 368.46 ˢ˥˦ʳ˦ˤ
Net cash used in investing activities ( B ) 388.33 (49.62)
Corporate Overview Performance Governance Financial Statements 111

STATEMENT OF CASH FLOWS


for the year ended March 31, 2016
` In Lacs
2015-16 2014-15

C. CASH FLOWS PROVIDED BY/(USED IN) FINANCING ACTIVITIES:


 ÝŘǼsNjsǣǼŘ_ʩŘŘOsOÌNj¶sǣƼÞ_ ʹ˧˥ˡʳ˦ˢʺ (1,202.98)
Allotment of equity shares under ESOP scheme ˟ʳ˨˦ -
Repayment of Long Term Borrowings (11,500.00) -
Repayment of deferred payment liability (180.00) -
Dividend paid ʹˠˣʰˣ˧ˤʳ˦ˢʺ ʹˢʰ˥ˡ˟ʳˣ˦ʺ
Dividend tax paid (2,948.95) (615.30)
 ŗsǼOǣÌʹȖǣs_ÞŘʺˀ¶sŘsNjǼs_¯NjŸŎʩŘŘOÞضOǼÞɚÞǼÞsǣʹNʺ (29,976.44) (5,438.74)
Net increase / (decrease) in cash and cash equivalents (A+B+C) (10,523.16) 10,268.84
Cash and cash equivalents at the beginning of the year 18,604.68 8,335.84
Cash and cash equivalents at the end of the year 8,081.52 18,604.68
Reconciliation of cash and cash equivalents
Cash in hand 13.03 16.31
Balance with scheduled banks - Current account 1,304.94 2,085.03
Unclaimed dividend accounts * 139.28 53.34
Cash and cash equivalents (Note 19) 1,457.25 2,154.68
Mutual fund Investments (Note 16) ˥ʰ˥ˡˣʳˡ˦ 16,450.00
 NǣÌŘ_OǣÌsLJȖÞɚĶsŘǼǣOŸŘǣÞ_sNjs_¯ŸNjOǣÌʪŸɠǣǣǼǼsŎsŘǼ 8,081.52 18,604.68
* Not available for use by the management for any other purpose
ǢȖŎŎNjɴŸ¯ǣÞ¶ŘÞʩOŘǼOOŸȖŘǼÞضƼŸĶÞOÞsǣŗŸǼsˢ

As per our report of even date

For S R B C & CO LLP For and on behalf of the Board of Directors of


Chartered Accountants Jyothy Laboratories Limited
ICAI Firm Registration No. 324982E/ E300003

per Vikram Mehta M.P. Ramachandran K.Ullas Kamath


Partner Chairman and Managing Director ğŸÞŘǼōضÞض^ÞNjsOǼŸNjŘ_NÌÞs¯®ÞŘŘOÞĶŷ¯ʩOsNj
Membership No.: 105938 DIN: 00553406 DIN: 00506681
M.L. Bansal S.Raghunandan
Company Secretary ɟÌŸĶsǻÞŎs^ÞNjsOǼŸNjŘ_NÌÞs¯rɮsOȖǼÞɚsŷ¯ʩOsNj
ōsŎEsNjǣÌÞƼŗŸʳʲ®ˡˡ˨˦ DIN: 02263845
Place: Mumbai Place: Mumbai
Date: May 23, 2016 Date: May 23, 2016
112 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
NOTE 1 - BACKGROUND Gains or losses arising from derecognition of tangible assets are
measured as the difference between the net disposal proceeds
Jyothy Laboratories Limited (‘the Company’) is a public company
and the carrying amount of the asset and are recognized in the
domiciled in India. Its shares are listed on two stock exchanges in India.
ǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣɠÌsŘǼÌsǣǣsǼÞǣ_sNjsOŸ¶ŘÞʊs_ʳ
The Company is principally engaged in manufacturing and marketing
of fabric whiteners, soaps, detergents, mosquito repellents, scrubber,  ǻÌsOŸŎƼŘɴÞ_sŘǼÞʩsǣŘ__sǼsNjŎÞŘsǣOŸǣǼŸ¯ǣǣsǼǣÞ¶ŘÞʩOŘǼ
bodycare and incense sticks. to the total cost of the asset having useful life that is materially
different from that of the remaining life.
NOTE 2 - BASIS OF PREPARATION
c) Intangible assets
ǻÌs ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣ Ÿ¯ ǼÌs NŸŎƼŘɴ Ìɚs EssŘ ƼNjsƼNjs_ ÞŘ
accordance with generally accepted accounting principles in India Intangible assets acquired separately are measured on initial
ʹÝŘ_ÞصƻʺʳǻÌsOŸŎƼŘɴÌǣƼNjsƼNjs_ǼÌsǣsʩŘŘOÞĶǣǼǼsŎsŘǼǣ recognition at cost. The cost of the intangible assets acquired in
to comply in all material respects with the accounting standards an amalgamation in the nature of purchase is their fair value as at
ŘŸǼÞʩs_ȖŘ_sNjǣsOǼÞŸŘˠˢˢŸ¯ǼÌsNŸŎƼŘÞsǣOǼˡ˟ˠˢʰNjs_ǼŸ¶sǼÌsNj the date of amalgamation.
ɠÞǼÌ ƼNj¶NjƼÌ ˦ Ÿ¯ ǼÌs NŸŎƼŘÞsǣ ʹOOŸȖŘǼǣʺ NJȖĶsǣ ˡ˟ˠˣʳ ǻÌs
Following initial recognition, intangible assets are carried at cost
ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣ Ìɚs EssŘ ƼNjsƼNjs_ ȖŘ_sNj ǼÌs ÌÞǣǼŸNjÞOĶ OŸǣǼ
less accumulated amortization and accumulated impairment losses,
convention on an accrual basis except in case of assets which has been
if any. Intangible assets are amortized on a straight line basis over
recorded on fair value and assets for which provision for impairment
the estimated useful economic life. The Company uses a rebuttable
is made. The accounting policies have been consistently applied by
presumption that the useful life of an intangible asset will not exceed
the Company and are consistent with those used in the previous year.
ten years from the date when the asset is available for use.
NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Gains or losses arising from derecognition of an intangible asset
ǻÌsǣÞ¶ŘÞʩOŘǼOOŸȖŘǼÞضƼŸĶÞOÞsǣNjsǣ¯ŸĶĶŸɠǣʲ are measured as the difference between the net disposal proceeds
and the carrying amount of the asset and are recognized in the
a) Use of estimates
ǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣɠÌsŘǼÌsǣǣsǼÞǣ_sNjsOŸ¶ŘÞʊs_ʳ
 ǻÌsƼNjsƼNjǼÞŸŘŸ¯ʩŘŘOÞĶǣǼǼsŎsŘǼǣʰÞŘOŸŘ¯ŸNjŎÞǼɴɠÞǼÌÝŘ_ÞŘ
GAAP requires management to make judgments, estimates and d) Depreciation and amortisation

assumptions that affect the reported amounts of revenues ,  ^sƼNjsOÞǼÞŸŘŸŘʩɮs_ǣǣsǼǣÞǣOĶOȖĶǼs_ŸŘǢǼNjÞ¶ÌǼĵÞŘsEǣÞǣ


expenses ,assets, liabilities and disclosure of contingent liabilities using the rates arrived at based on useful lives estimated by the
at the end of the reporting period. Although these estimates are management. Intangible assets are amortised on straight line
based upon management’s best knowledge of current events basis on the estimated useful economic life.
and actions, uncertainty about these assumptions and estimates
could result in the outcomes requiring a material adjustment to The estimated useful life of the assets is as follows:
the carrying amounts of assets or liabilities in future periods.
Category Estimated useful
Eʺ ǻضÞEĶsʩɮs_ǣǣsǼǣ life (in years)
Factory Buildings 10-30
Fixed assets are initially recorded at cost . Cost comprises the Building (Other than Factory Building) 30-60
purchase price and any directly attributable cost of bringing the Building (Fences and temporary structure) 3-6
asset to its working condition for its intended use. The cost of Plant and machinery 13-15
the tangible assets acquired in an amalgamation in the nature ®ȖNjŘÞǼȖNjsŘ_ʩɮǼȖNjsǣ 5-10
of purchase is their fair value as at the date of amalgamation. Dies and moulds 3
Following initial recognition, tangible assets are carried at cost Computers 3-6
less accumulated depreciation and impairment losses, if any. ŷ¯ʩOssLJȖÞƼŎsŘǼǣ 5
Vehicles 6-10
 ǢȖEǣsLJȖsŘǼ sɮƼsŘ_ÞǼȖNjs NjsĶǼs_ ǼŸ Ř ÞǼsŎ Ÿ¯ ʩɮs_ ǣǣsǼ Þǣ Know-how 3-5
__s_ ǼŸ ÞǼǣ EŸŸĨ ɚĶȖs ŸŘĶɴ Þ¯ ÞǼ ÞŘONjsǣsǣ ǼÌs ¯ȖǼȖNjs EsŘsʩǼǣ Trademarks and Copyrights 9-10
from the existing asset beyond its previously assessed standard Brands 10
Ÿ¯ ƼsNj¯ŸNjŎŘOsʳ ĶĶ ŸǼÌsNj sɮƼsŘǣsǣ ŸŘ sɮÞǣǼÞض ʩɮs_ ǣǣsǼǣʰ Softwares and Licences 10
including day-to-day repair and maintenance expenditure and Goodwill purchased is not amortized but tested for impairment
OŸǣǼŸ¯NjsƼĶOÞضƼNjǼǣʰNjsOÌNj¶s_ǼŸǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ every year. The goodwill arising on amalgamation is amortized to
loss for the period during which such expenses are incurred. ǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣŸɚsNjˠ˟ɴsNjǣʳ
Corporate Overview Performance Governance Financial Statements 113

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
Assets costing less then ` 5,000 are depreciated at the rate of 100 determine the asset’s recoverable amount since the last
%. Leasehold land is amortized over the period of the lease on a impairment loss was recognized. The reversal is limited
straight-line basis which ranges between 60-90 years. so that the carrying amount of the asset does not exceed
its recoverable amount, nor exceed the carrying amount
The management has estimated, supported by independent
that would have been determined, net of depreciation, had
assessment by professionals, the useful lives of the following
no impairment loss been recognized for the asset in prior
classes of assets (which were taken over during the merger of
years.
erstwhile Jyothy Consumer Prodcuts Limited), which are lower
than those indicated in Schedule II. f) Borrowing Costs

Category Estimated useful Borrowing costs consist of interest and amortization of ancillary
life (in years) costs incurred in connection with the arrangement of borrowings.
Factory Buildings 10 Borrowing costs directly attributable to the acquisition,
Building (Other than Factory Building) 30 construction or production of an asset that necessarily takes a
Plant and machinery 13 substantial period of time to get ready for its intended use or sale
®ȖNjŘÞǼȖNjsŘ_ʩɮǼȖNjsǣ 5
are capitalized as part of the respective asset. All other borrowing
Vehicles 6
costs are expensed in the period they occur.
The amortization/ depreciation period and the amortization/
g) Operating Leases
_sƼNjsOÞǼÞŸŘŎsǼÌŸ_NjsNjsɚÞsɠs_ǼĶsǣǼǼsOÌʩŘŘOÞĶɴsNj
sŘ_ʳݯǼÌssɮƼsOǼs_Ȗǣs¯ȖĶĶÞ¯sŸ¯ǼÌsǣǣsǼÞǣǣÞ¶ŘÞʩOŘǼĶɴ_Þ¯¯sNjsŘǼ i. Where the Company is a lessee;
from previous estimates, the amortization/ depreciation period
Leases, where the lessor effectively retains substantially all
ÞǣOÌضs_OOŸNj_ÞضĶɴʳݯǼÌsNjsÌǣEssŘǣÞ¶ŘÞʩOŘǼOÌضsÞŘ
ǼÌsNjÞǣĨǣŘ_EsŘsʩǼǣŸ¯ŸɠŘsNjǣÌÞƼŸ¯ǼÌsĶsǣs_ÞǼsŎʰNjs
ǼÌs sɮƼsOǼs_ ƼǼǼsNjŘ Ÿ¯ sOŸŘŸŎÞO EsŘsʩǼǣ ¯NjŸŎ ǼÌs ǣǣsǼʰ ǼÌs
OĶǣǣÞʩs_ǣŸƼsNjǼÞضĶsǣsǣʳĵsǣsƼɴŎsŘǼǣŸŘŸƼsNjǼÞض
ŎŸNjǼÞʊǼÞŸŘˀ _sƼNjsOÞǼÞŸŘ ŎsǼÌŸ_ Þǣ OÌضs_ ǼŸ NjsʪsOǼ ǼÌs
leases are recognized as an expense in the statement of
changed pattern. Such changes are accounted for in accordance
ƼNjŸʩǼŘ_ĶŸǣǣŸŘǣǼNjÞ¶ÌǼ˚ĶÞŘsEǣÞǣʰŸɚsNjǼÌsĶsǣsǼsNjŎʳ
with AS 5 ŗsǼƻNjŸʩǼŸNjĵŸǣǣ¯ŸNjǼÌsƻsNjÞŸ_ʰƻNjÞŸNjƻsNjÞŸ_ÝǼsŎǣŘ_
Changes in Accounting Policies. ii. Where the Company is a lessor;

e) Impairment Leases in which the Company does not transfer substantially


ĶĶ ǼÌs NjÞǣĨǣ Ř_ EsŘsʩǼǣ Ÿ¯ ŸɠŘsNjǣÌÞƼ Ÿ¯ ǼÌs ǣǣsǼ Njs
i. The Company assesses at each reporting date whether
OĶǣǣÞʩs_ ǣ ŸƼsNjǼÞض Ķsǣsǣʳ ǣǣsǼǣ ǣȖEĠsOǼ ǼŸ ŸƼsNjǼÞض
there is an indication that an asset may be impaired. If any
Ķsǣsǣ Njs ÞŘOĶȖ_s_ ÞŘ ʩɮs_ ǣǣsǼǣʳ ĵsǣs ÞŘOŸŎs ŸŘ Ř
indication exists, or when annual impairment testing for
ŸƼsNjǼÞض Ķsǣs Þǣ NjsOŸ¶ŘÞʊs_ ÞŘ ǼÌs ǣǼǼsŎsŘǼ Ÿ¯ ƼNjŸʩǼ
an asset is required, the Company estimates the asset’s
and loss on a straight-line basis over the lease term. Costs,
recoverable amount. An asset’s recoverable amount is the
including depreciation, are recognized as an expense in the
higher of an asset’s or cash-generating unit’s (CGU) net
ǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣʳ
selling price and its value in use. The recoverable amount
is determined for an individual asset, unless the asset does Initial direct costs such as legal costs, brokerage costs, etc.
ŘŸǼ ¶sŘsNjǼs OǣÌ ÞŘʪŸɠǣ ǼÌǼ Njs ĶNj¶sĶɴ ÞŘ_sƼsŘ_sŘǼ Ÿ¯ Njs NjsOŸ¶ŘÞʊs_ ÞŎŎs_ÞǼsĶɴ ÞŘ ǼÌs ǣǼǼsŎsŘǼ Ÿ¯ ƼNjŸʩǼ Ř_
those from other assets or groups of assets. An impairment loss.
loss is recognized wherever the carrying amount of an asset
h) Government grants and subsidies
exceed its recoverable amount. The recoverable amount is
the greater of the assets net selling price and value in use. Grants and subsidies from the government are recognized
ÝŘǣǣsǣǣÞضɚĶȖsÞŘȖǣsʰǼÌssǣǼÞŎǼs_¯ȖǼȖNjsOǣÌʪŸɠǣNjs when there is reasonable assurance that the grant/ subsidy
discounted to their present value at the pre-tax discount rate. will be received and all attaching conditions will be complied
In determining net selling price , recent market transaction with. When the grant or subsidy relates to revenue item, it is
are taken into account, if available. If no such transaction can recognized as income over the periods necessary to match
EsÞ_sŘǼÞʩs_ʰŘƼƼNjŸƼNjÞǼsɚĶȖǼÞŸŘŎŸ_sĶÞǣȖǣs_ʳ them on a systematic basis to the costs, which it is intended
to compensate. Where the grant or subsidy relates to an asset,
ii. After impairment, depreciation is provided on the revised
its value is deducted from the gross value in arriving at the
carrying amount of the assets over its remaining useful life.
carrying amount of the related asset. Government grant in the
iii. A previously recognized impairment loss is reversed only nature of promoters’ contribution is credited to the investment
if there has been a change in the assumptions used to subsidy reserve.
114 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
i) Investment EsNjsĶÞEĶɴŎsǣȖNjs_ʳǻÌs¯ŸĶĶŸɠÞضǣƼsOÞʩOONjÞǼsNjÞŎȖǣǼĶǣŸEs
met before revenue is recognised;
Investments that are readily realisable and intended to be held for
not more than one year from the date on which such investments Sale of Goods
NjsŎ_sNjsOĶǣǣÞʩs_ǣOȖNjNjsŘǼÞŘɚsǣǼŎsŘǼǣʳĶĶŸǼÌsNjÞŘɚsǣǼŎsŘǼǣ
 NJsɚsŘȖsÞǣNjsOŸ¶ŘÞǣs_ɠÌsŘĶĶǼÌsǣÞ¶ŘÞʩOŘǼNjÞǣĨǣŘ_NjsɠNj_ǣ
Njs OĶǣǣÞʩs_ ǣ ĶŸŘ¶˚ǼsNjŎ ÞŘɚsǣǼŎsŘǼǣʳ ŷŘ ÞŘÞǼÞĶ NjsOŸ¶ŘÞǼÞŸŘʰ ĶĶ
of ownership of the goods have passed to the buyer, usually on
investments are measured at cost. The cost comprises purchase price
delivery of the goods. Excise Duty, Sales Tax and VAT deducted
and directly attributable acquisition charges such as brokerage, fees
from turnover (gross) is the amount that is included in the amount
and duties and other costs that arise on acquisition of investment.
of turnover (gross) and not the entire amount of liability arised
Current investments are carried at lower of cost and fair value during the year. The Company collects sales taxes and value
determined on an individual investment basis. added taxes (VAT) on behalf of the government and, therefore,
ǼÌsǣsNjsŘŸǼsOŸŘŸŎÞOEsŘsʩǼǣʪŸɠÞضǼŸǼÌsNŸŎƼŘɴʳËsŘOsʰ
Long-term investments are carried at cost. However, provision for
they are excluded from revenue.
diminution in value is made to recognise a decline other than
temporary in the value of the investments. Revenue includes the amount of excise duty refund received /
due in accordance with incentive scheme. Revenue is net of trade
On disposal of investment, the difference between its carrying
discount given.
amount and net disposal proceeds is charged or credited to the
ǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣʳ Interest

An investment in land or building, which is not intended to Revenue is recognised on a time proportion basis taking into
be occupied substantially for use by, or in the operations of account the amount outstanding and at the applicable interest rate.
ǼÌs NŸŎƼŘɴ Þǣ OĶǣǣÞʩs_ ǣ ÞŘɚsǣǼŎsŘǼ ƼNjŸƼsNjǼɴʳ ÝŘɚsǣǼŎsŘǼ
l) Foreign currency translation
properties are stated at cost, net of accumulated depreciation
and impairment losses, if any. i. Initial Recognition

j) Inventories Foreign currency transactions are recorded in the reporting


currency, by applying to the foreign currency amount the
Inventories of raw materials, packing materials, work-in-progress, exchange rate between the reporting currency and the
ʩŘÞǣÌs_¶ŸŸ_ǣʰǣǼŸNjsǣŘ_OŸŘǣȖŎEĶsǣÞǼsŎǣNjsɚĶȖs_ǼOŸǣǼ foreign currency at the date of the transaction.
or net realizable value, whichever is lower. However, materials and
other items held for use in the production of inventories are not ii. Conversion

ɠNjÞǼǼsŘ_ŸɠŘEsĶŸɠOŸǣǼÞ¯ǼÌsʩŘÞǣÌs_ƼNjŸ_ȖOǼǣÞŘɠÌÞOÌǼÌsɴɠÞĶĶ Foreign currency monetary items are reported using the


be incorporated are expected to be sold at or above cost. exchange rate prevailing at the reporting date.

Cost is ascertained on First-in-First out (‘FIFO’) basis and includes Non-monetary items which are carried in terms of historical
all applicable costs incurred in bringing goods to their present cost denominated in a foreign currency are reported using
location and condition. Cost of work in progress, manufactured the exchange rate at the date of the transaction. Non-
ƼOĨÞض ŎǼsNjÞĶ Ř_ ʩŘÞǣÌs_ ¶ŸŸ_ǣ ÞŘOĶȖ_sǣ ŎǼsNjÞĶǣ Ř_ ĶĶ monetary items, which are measured at fair value or other
applicable manufacturing overheads. The Company accrues for similar valuation denominated in a foreign currency, are
sɮOÞǣs _ȖǼɴ ĶÞEÞĶÞǼɴ ÞŘ NjsǣƼsOǼ Ÿ¯ ŎŘȖ¯OǼȖNjs_ ʩŘÞǣÌs_ ¶ŸŸ_ǣˀ translated using the exchange rate at the date when such
intermediary inventories lying in the factory. value was determined.

Traded goods are valued at lower of cost and net realizable iii. Exchange Differences
value. Cost includes cost of purchase and other costs incurred in
Exchange differences arising on the settlement of monetary
bringing the inventories to their present location and condition.
items or on reporting Company’s monetary items at rates
Cost is determined on a FIFO basis.
different from those at which they were initially recorded
Net realisable value is the estimated selling price in the ordinary _ȖNjÞضǼÌsɴsNjʰŸNjNjsƼŸNjǼs_ÞŘƼNjsɚÞŸȖǣʩŘŘOÞĶǣǼǼsŎsŘǼǣʰ
course of business, less estimated cost of completion and are recognised as income or as expenses in the year in which
estimated cost necessary to make the sale. they arise.

k) Revenue recognition Ŏʺ NJsǼÞNjsŎsŘǼŘ_ŸǼÌsNjsŎƼĶŸɴssEsŘsʩǼǣ

Revenue is recognized to the extent that it is probable that the  Þʳ NJsǼÞNjsŎsŘǼEsŘsʩǼÞŘǼÌs¯ŸNjŎŸ¯ƼNjŸɚÞ_sŘǼ¯ȖŘ_Ř_ǣȖƼsNj
sOŸŘŸŎÞOEsŘsʩǼǣɠÞĶĶʪŸɠǼŸǼÌsNŸŎƼŘɴŘ_ǼÌsNjsɚsŘȖsOŘ ŘŘȖǼÞŸŘ¯ȖŘ_Þǣ_sʩŘs_OŸŘǼNjÞEȖǼÞŸŘǣOÌsŎsʳ
Corporate Overview Performance Governance Financial Statements 115

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
The company has no obligation, other than the contribution In the situations where the Company is entitled to a tax holiday
payable to the respective fund. The company recognizes under the Income-tax Act, 1961 enacted in India or tax laws
contribution payable to the provident fund/ super annuation prevailing in the respective tax jurisdictions where it operates,
scheme as an expenditure, when an employee renders the no deferred tax (asset or liability) is recognized in respect of
related service. timing differences which reverse during the tax holiday period,
to the extent the Company’s gross total income is subject to the
 ÞÞʳ µNjǼȖÞǼɴEsŘsʩǼÞǣ_sʩŘs_EsŘsʩǼŸEĶÞ¶ǼÞŸŘŘ_ÞǣƼNjŸɚÞ_s_
deduction during the tax holiday period. Deferred tax in respect
for on the basis of an actuarial valuation on projected unit
of timing differences which reverse after the tax holiday period is
ONjs_ÞǼŎsǼÌŸ_Ŏ_sǼǼÌssŘ_Ÿ¯sOÌʩŘŘOÞĶɴsNjʳ
recognized in the year in which the timing differences originate.
iii. Accumulated leave, which is expected to be utilized within However, the Company restricts recognition of deferred tax assets
the next 12 months, is treated as short-term employee to the extent that it has become reasonably certain or virtually
EsŘsʩǼʳ ǻÌs OŸŎƼŘɴ ŎsǣȖNjsǣ ǼÌs sɮƼsOǼs_ OŸǣǼ Ÿ¯ ǣȖOÌ OsNjǼÞŘʰǣǼÌsOǣsŎɴEsʰǼÌǼǣȖ¯ʩOÞsŘǼ¯ȖǼȖNjsǼɮEĶsÞŘOŸŎs
absences as the additional amount that it expects to pay as will be available against which such deferred tax assets can be
a result of the unused entitlement that has accumulated at realized. For recognition of deferred taxes, the timing differences
the reporting date. ɠÌÞOÌŸNjÞ¶ÞŘǼsʩNjǣǼNjsOŸŘǣÞ_sNjs_ǼŸNjsɚsNjǣsʩNjǣǼʳ

iv. The Company treats accumulated leave expected to be At each balance sheet date the Company re-assesses unrecognized
carried forward beyond twelve months, as long-term deferred tax assets. It recognises unrecognized deferred tax assets
sŎƼĶŸɴss EsŘsʩǼ ¯ŸNj ŎsǣȖNjsŎsŘǼ ƼȖNjƼŸǣsǣʳ ǢȖOÌ ĶŸŘ¶˚ to the extent that it has become reasonably certain or virtually
term compensated absences are provided for based on the OsNjǼÞŘʰǣǼÌsOǣsŎɴEsǼÌǼǣȖ¯ʩOÞsŘǼ¯ȖǼȖNjsǼɮEĶsÞŘOŸŎs
actuarial valuation using the projected unit credit method at will be available against which such deferred tax assets can be
the year-end. The Company presents the leave as a current realised.
liability in the balance sheet to the extent it does not have
The carrying amount of deferred tax assets are reviewed at each
an unconditional legal and contractual right to defer its
balance sheet date. The Company writes-down the carrying
settlement for 12 months after the reporting date.
amount of a deferred tax asset to the extent that it is no longer
v. Actuarial gains/ losses are immediately taken to the reasonably certain or virtually certain, as the case may be, that
ǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣŘ_NjsŘŸǼ_s¯sNjNjs_ʳ ǣȖ¯ʩOÞsŘǼ ¯ȖǼȖNjs ǼɮEĶs ÞŘOŸŎs ɠÞĶĶ Es ɚÞĶEĶs ¶ÞŘǣǼ ɠÌÞOÌ
deferred tax asset can be realised. Any such write-down is
n) Sales promotion items
reversed to the extent that it becomes reasonably certain or
Sales promotion items are valued at cost. Cost is ascertained on ɚÞNjǼȖĶĶɴOsNjǼÞŘʰǣǼÌsOǣsŎɴEsʰǼÌǼǣȖ¯ʩOÞsŘǼ¯ȖǼȖNjsǼɮEĶs
First-in-First out (‘FIFO’) basis and includes all applicable costs income will be available.
incurred in bringing goods to their present location and condition.
Minimum alternative tax (MAT) paid in a year is charged to the

o) Income-tax ǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣǣOȖNjNjsŘǼǼɮʳ

Tax expense comprises of current and deferred tax. Current MAT credit is recognised as an asset only when and to the extent

income tax is measured at the amount expected to be paid to there is convincing evidence that the company will pay normal

the tax authorities in accordance with the Income Tax Act, 1961. ÞŘOŸŎs Ǽɮ _ȖNjÞض ǼÌs ǣƼsOÞʩs_ ƼsNjÞŸ_ʳ ÝŘ ǼÌs ɴsNj ÞŘ ɠÌÞOÌ

^s¯sNjNjs_ÞŘOŸŎsǼɮsǣNjsʪsOǼǣǼÌsÞŎƼOǼŸ¯OȖNjNjsŘǼɴsNjǼÞŎÞض the MAT credit becomes eligible to be recognized as an asset

differences between taxable income and accounting income for in accordance with the Guidance Note on Accounting for credit

the year and reversal of timing differences of earlier years. Available in respect of Minimum Alternate Tax under the Income
Tax Act, 1961, the said asset is created by way of a credit to the
Deferred tax is measured based on the tax rates for deductible ǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣŘ_ǣÌŸɠŘǣōǻNNjs_ÞǼrŘǼÞǼĶsŎsŘǼʳ
timing differences and the tax laws enacted or substantively The Company reviews the MAT credit entitlement at each balance
enacted at the balance sheet date. Deferred tax assets are sheet date and writes down the carrying amount of MAT Credit
recognised only to the extent that there is reasonable certainty Entitlement to the extent there is no longer convincing evidence
ǼÌǼ ǣȖ¯ʩOÞsŘǼ ¯ȖǼȖNjs ǼɮEĶs ÞŘOŸŎs ɠÞĶĶ Es ɚÞĶEĶs ¶ÞŘǣǼ to the effect that Company will pay normal Income Tax during the
which such deferred tax assets can be realised. In situations where ǣƼsOÞʩs_ƼsNjÞŸ_ʳ
the Company has unabsorbed depreciation or carry forward tax
losses, all deferred tax assets are recognised only if there is virtual p) Provisions

certainty supported by convincing evidence that they can be A provision is recognised when the company has a present
NjsĶÞǣs_¶ÞŘǣǼ¯ȖǼȖNjsǼɮEĶsƼNjŸʩǼǣʳ ŸEĶÞ¶ǼÞŸŘǣNjsǣȖĶǼŸ¯ƼǣǼsɚsŘǼʱÞǼÞǣƼNjŸEEĶsǼÌǼŘŸȖǼʪŸɠ
116 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
of resources will be required to settle the obligation, in respect rights issue to existing shareholders, share split, and reverse share
of which a reliable estimate can be made. Provisions are not split that have changed the number of equity shares outstanding,
discounted to its present value and are determined based on best without a corresponding change in resources.
estimate required to settle the obligation at the reporting date.
For the purpose of calculating diluted earnings per share, the net
ǻÌsǣsNjsNjsɚÞsɠs_ǼsOÌNjsƼŸNjǼÞض_ǼsŘ__ĠȖǣǼs_ǼŸNjsʪsOǼ
ƼNjŸʩǼ ŸNj ĶŸǣǣ ¯ŸNj ǼÌs ƼsNjÞŸ_ ǼǼNjÞEȖǼEĶs ǼŸ sLJȖÞǼɴ ǣÌNjsÌŸĶ_sNjǣ
the current best estimates.
and the weighted average number of shares outstanding during
q) Excise duty the period are adjusted for the effects of all dilutive potential
equity shares.
Excise duty on turnover is reduced from turnover. Excise duty
relating to the difference between the opening stock and closing t) Contingent liabilities
stock is recognized as income/ expense as the case may be, A contingent liability is a possible obligation that arises from past
ǣsƼNjǼsĶɴÞŘǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣʳ sɚsŘǼǣ ɠÌŸǣs sɮÞǣǼsŘOs ɠÞĶĶ Es OŸŘʩNjŎs_ Eɴ ǼÌs ŸOOȖNjNjsŘOs ŸNj
non-occurrence of one or more uncertain future events beyond
r) Segment Reporting
the control of the company or a present obligation that is not
 Ý_sŘǼÞʩOǼÞŸŘŸ¯ǣs¶ŎsŘǼǣʲ NjsOŸ¶ŘÞʊs_EsOȖǣsÞǼÞǣŘŸǼƼNjŸEEĶsǼÌǼŘŸȖǼʪŸɠŸ¯NjsǣŸȖNjOsǣ
will be required to settle the obligation. A contingent liability also
The Company’s operating businesses are organized and arises in extremely rare cases where there is a liability that cannot
managed separately according to the nature of products, with be recognized because it cannot be measured reliably. The
each segment representing a strategic business unit that offers Company does not recognize a contingent liability but discloses
different products and serves different markets. The analysis of ÞǼǣsɮÞǣǼsŘOsÞŘǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣʳ

geographical segments is based on the areas in which major u) Cash and Cash equivalents
operating divisions of the Company operate.
 NǣÌŘ_OǣÌsLJȖÞɚĶsŘǼǣ¯ŸNjǼÌsƼȖNjƼŸǣsŸ¯OǣÌʪŸɠǣǼǼsŎsŘǼ
Segment accounting policies : comprise cash at bank and in hand and short-term investments
with an original maturity of three months or less.
The Company prepares its segment information in conformity with
v) Measurement of EBITDA
the accounting policies adopted for preparing and presenting the
ʩŘŘOÞĶǣǼǼsŎsŘǼǣŸ¯ǼÌsOŸŎƼŘɴǣɠÌŸĶsʳ The Company has elected to present earnings before interest, tax,
depreciation and amortization (EBITDA) as a separate line item on
Intersegment transfer :
ǼÌs¯OsŸ¯ǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣʳÝŘÞǼǣŎsǣȖNjsŎsŘǼʰ
The Company generally accounts for inter segment sales and the company does not include depreciation and amortization
sɮƼsŘǣsʰʩŘŘOsOŸǣǼǣʰÞŘǼsNjsǣǼÞŘOŸŎsŘ_ǼɮsɮƼsŘǣsʳ
transfers as if the sales or transfer were to third parties at market
price. w) Employee stock compensation cost

Allocation of common costs: Employees in senior management of the company receive


remuneration in the form of share based payment transactions,
Common allocable costs are allocated to each segment according whereby employees render services as consideration for equity
to the relative contribution of each segment to the total common instruments (equity-settled transactions).
costs.
In accordance with the Securities and Exchange Board of India
Unallocated items: ʹǢÌNjs Dǣs_ rŎƼĶŸɴss DsŘsʩǼǣʺ NJs¶ȖĶǼÞŸŘǣʰ ˡ˟ˠˣ Ř_ ǼÌs
Guidance Note on Accounting for Employee Share-based
It includes general corporate income and expense items which Payments, the cost of equity-settled transactions is measured
are not allocated to any business segment. using the intrinsic value method. The cumulative expense
recognized for equity-settled transactions at each reporting
s) Earnings per Share
_Ǽs ȖŘǼÞĶ ǼÌs ɚsǣǼÞض _Ǽs NjsʪsOǼǣ ǼÌs sɮǼsŘǼ ǼŸ ɠÌÞOÌ ǼÌs
 DǣÞOsNjŘÞضǣƼsNjǣÌNjsNjsOĶOȖĶǼs_Eɴ_ÞɚÞ_ÞضǼÌsŘsǼƼNjŸʩǼŸNj vesting period has expired and the company’s best estimate of
the number of equity instruments that will ultimately vest. The
loss for the year attributable to equity shareholders by the weighted
sɮƼsŘǣsŸNjONjs_ÞǼNjsOŸ¶ŘÞʊs_ÞŘǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣ
average number of equity shares outstanding during the year. The
for a period represents the movement in cumulative expense
weighted average number of equity shares outstanding during recognized as at the beginning and end of that period and is
the year are adjusted for event of bonus issue, bonus element in a NjsOŸ¶ŘÞʊs_ÞŘsŎƼĶŸɴssEsŘsʩǼǣsɮƼsŘǣsʳ
Corporate Overview Performance Governance Financial Statements ˠˠ˦

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
` In Lacs

As at As at
March 31, 2016 March 31, 2015
NOTE 4
SHARE CAPITAL
AUTHORISED CAPITAL
ˡʰˤ˦˟ʰ˟˟˟ʰ˟˟˟ʹˡ˟ˠˤ˚ˡʰˤ˦˟ʰ˟˟˟ʰ˟˟˟ʺsLJȖÞǼɴǣÌNjsǣŸ¯` 1 (2015 - ` 1) each ˡˤʰ˦˟˟ʳ˟˟ ˡˤʰ˦˟˟ʳ˟˟
25,700.00 25,700.00
ISSUED, SUBSCRIBED AND PAID UP CAPITAL
181,119,680 (2015 - 181,023,496) equity shares of ` 1 (2015 - ` 1) each fully paid 1,811.20 1,810.23
1,811.20 1,810.23

a. Reconciliation of the shares outstanding at the beginning and at the end of the reporting period

As at March 31, 2016 As at March 31, 2015


No. Amount No. Amount
At the beginning of the period 181,023,496 1,810.23 181,023,496 1,810.23
Issued during the year (ESOP) 96,184 ˟ʳ˨˦ - -
Outstanding at the end of the period 181,119,680 1,811.20 181,023,496 1,810.23

b. Details of shareholders holding more than 5% shares in the Company

As at March 31, 2016 As at March 31, 2015


No. % Holding No. % Holding
in the class in the class
Equity shares of ` 1 each fully paid
M. P. Ramachandran ˦ˡʰˠˠˡʰ˟˥˟ 39.81% ˦ˡʰˠˠˡʰ˟˥˟ 39.84%
Sahyadri Agencies Limited 15,000,000 8.28% 15,000,000 8.29%

As per records of the Company, including its register of shareholders/ members and other declarations received from shareholders regarding
EsŘsʩOÞĶÞŘǼsNjsǣǼʰǼÌsEŸɚsǣÌNjsÌŸĶ_ÞضNjsƼNjsǣsŘǼǣEŸǼÌĶs¶ĶŘ_EsŘsʩOÞĶŸɠŘsNjǣÌÞƼǣŸ¯ǣÌNjsǣʳ

c. Terms/ rights attached to equity shares


The Company has only one class of equity shares having par value of 1 ` per share. Each holder of equity shares is entitled to one vote per
share. The Company declares and pays dividends in Indian rupees. The dividend proposed by the Board of Directors is subject to the approval
of the shareholders in the ensuing Annual General Meeting.
During the year ended March 31, 2016, the amount of per share dividend recognized as distributions to equity shareholders was ` 5 (2015
- ` 4) including interim dividend of ` 4 per equity share paid during the year.
In the event of liquidation of the Company, the holders of equity shares will be entitled to receive remaining assets of the Company, after
distribution of all preferential amounts. The distribution will be in proportion to the number of equity shares held by the shareholders.

_ʳ ¶¶Njs¶ǼsŘȖŎEsNjŸ¯EŸŘȖǣǣÌNjsǣÞǣǣȖs_ʰǣÌNjsǣÞǣǣȖs_¯ŸNjOŸŘǣÞ_sNjǼÞŸŘŸǼÌsNjǼÌŘOǣÌ_ȖNjÞضǼÌsƼsNjÞŸ_Ÿ¯ʩɚsɴsNjǣÞŎŎs_ÞǼsĶɴ
preceding the reporting date:

As at As at
March 31, 2016 March 31, 2015
No. No.
Equity shares allotted as fully paid bonus shares by capitalization of securities premium ˡʰˢ˦˨ʰ˦ˣ˧ ˡʰˢ˦˨ʰ˦ˣ˧
(FY 2013 - 2014)
Equity shares issued for consideration other than cash, pursuant to scheme of amalgamation ˡʰˢ˦˨ʰ˦ˣ˧ ˡʰˢ˦˨ʰ˦ˣ˧
with erstwhile Jyothy Consumer Products Limited (JCPL) (FY 2013 - 2014)
4,759,496 4,759,496

ÝŘ __ÞǼÞŸŘ ǼÌs OŸŎƼŘɴ Ìǣ ÞǣǣȖs_ ˨˥ʰˠ˧ˣ ǣÌNjs ʹˡ˟ˠˤ ŗÞĶʺ _ȖNjÞض ǼÌs ƼsNjÞŸ_ Ÿ¯ ʩɚs ɴsNjǣ ÞŎŎs_ÞǼsĶɴ ƼNjsOs_Þض ǼÌs NjsƼŸNjǼÞض _Ǽs ŸŘ
exercise of option granted under the employee stock option plan (ESOP) wherein part consideration was received in form of employee services.

e. Share reserve for issue under option

For details of shares reserved for issue under the employee stock option (ESOP) plan of the company, please refer note 36
118 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
` In Lacs

As at As at
March 31, 2016 March 31, 2015

NOTE 5
RESERVES AND SURPLUS
ǢȖNjƼĶȖǣÞŘǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣʲ
Balance, beginning of the year ˡʰˠ˟˨ʳˠ˦ 2,228.39
ƻNjŸʩǼ¯ŸNjǼÌsɴsNj 16,235.96 ˠˣʰˡ˦˧ʳ˨ˤ
18,345.13 16,507.34
Less: Appropriations
Proposed dividend (amount per share ` 1 (2015 - ` 4)) (1,811.20) ʹ˦ʰˡˣ˟ʳ˨ˣʺ
Tax on proposed dividend ʹˢ˥˧ʳ˦ˡʺ ʹˠʰˣ˦ˣʳ˟˧ʺ
Interim dividend (amount per share ` 4 (2015 - ` Nil)) ʹ˦ʰˡˣˣʳ˦˨ʺ -
Tax on Interim dividend ʹˠʰˣ˦ˣʳ˧˦ʺ -
Depreciation as per Schedule II of Companies Act, 2013* - (310.64)
Transfer to Debenture Redemption Reserve (4,560.01) ʹˤʰˢ˦ˡʳˤˠʺ
ŗsǼǣȖNjƼĶȖǣÞŘǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣ 2,885.54 2,109.17
Capital Reserve 5,505.27 5,505.27
Securities premium
Balance, beginning of the year 39,191.21 39,191.21
Add: Addition on ESOP’s exercised 180.54 -
Balance, end of the year 39,371.75 39,191.21
Debenture Redemption Reserve
Balance, beginning of the year 11,995.02 6,622.51
__ʲŎŸȖŘǼǼNjŘǣ¯sNjNjs_¯NjŸŎǣȖNjƼĶȖǣÞŘǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣ 4,560.01 ˤʰˢ˦ˡʳˤˠ
Less: Amount transferred to general reserves ʹˡʰ˧˦ˤʳ˟˟ʺ -
Balance, end of the year 13,680.03 11,995.02
Investment subsidy 106.90 106.90
General reserves
Balance, beginning of the year 32,581.44 32,581.44
Add: Amount transferred from debenture redemption reserves ˡʰ˧˦ˤʳ˟˟ -
Balance, end of the year 35,456.44 32,581.44
Employee stock option outstanding
Balance, beginning of the year ˡʰ˧˦ˠʳˠˢ -
Add: Compensation on stock option granted during the year ˡʰˢ˨˦ʳ˧˦ ˡʰ˧˦ˠʳˠˢ
Less: Compensation on stock option cancelled during the year ʹ˥ˣ˦ʳ˥ˠʺ -
Less: Transfer to securities premium on exercise of stock options (180.54) -
4,440.85 2,871.13
101,446.78 94,360.14

* The Company had not recognised deferred tax assets on the same in the absence of virtual certainty supported by convincing evidence that they
OŘEsNjsĶÞʊs_¶ÞŘǣǼ¯ȖǼȖNjsǼɮEĶsƼNjŸʩǼǣʳ
Corporate Overview Performance Governance Financial Statements 119

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
` In Lacs

NON CURRENT CURRENT


As at As at As at As at
March 31, 2016 March 31, 2015 March 31, 2016 March 31, 2015
NOTE 6
LONG-TERM BORROWINGS
Secured Redeemable Zero Coupon Non
Convertible Debentures
4,000 (2015 - 4,000) Debentures of ` 10,00,000 - 40,000.00 40,000.00 -
(2015 - ` 10,00,000) each
9.65% Secured Redeemable Non Convertible
Debentures
Nil (2015 - 650) Debentures of ` Nil (2015 - - - - 6,500.00
` 10,00,000) each
10.25% Secured Redeemable Non Convertible
Debentures
Nil (2015 - 500) Debentures of ` Nil (2015 - - - - 5,000.00
` 10,00,000) each
Deferred Payment Liability (Unsecured) - - 180.00 360.00
Amount disclosed under ‘Other Current - - (40,180.00) (11,860.00)
Liabilities’ (Note 11)
- 40,000.00 - -

Details of loan :
ʺ ^sEsŘǼȖNjsǣNjsǣsOȖNjs_EɴʩNjǣǼOÌNj¶sŸŘĶĶʩɮs_ǣǣsǼǣŘ_ǣsĶsOǼDNjŘ_ǣʹōɮŸŘ_rɮŸʺʳ
b 4,000 Zero coupon non convertible redeemable debentures of ` 10,00,000 each is redeemable at premium of ` 368,022 per debenture after
3 years from the date of allotment i.e. November 14, 2013.
c) Deferred payment liabilities is repayable over a period of three years in equal installments.

As at As at
March 31, 2016 March 31, 2015
NOTE 7
DEFERRED TAX LIABILITY (Net)
a) Deferred tax liability
Depreciation ˣʰ˟ˣ˦ʳˤˡ 4,209.68
Gross Deferred tax liability (A) 4,047.52 4,209.68
b) Deferred tax assets
Technical royalty 1.19 1.58
Provision for gratuity 565.01 439.45
Provision for doubtful debts 113.44 113.44
Provision for doubtful advances ˤˡˢʳ˦˥ 503.03
Provision for leave encashment 255.65 ˡˣˡʳˣ˦
Provision for impairment losses 59.05 ˥˟ʳˡ˦
Other disallowances ˦˥ʳˢˠ ˢˡʳ˧˦
Carry forward losses and unabsorbed depreciation - ˡʰ˧ˠ˥ʳˤ˦
Gross Deferred tax assets (B) 1,594.41 4,209.68
Net Deferred Tax Liabilities (A-B) 2,453.11 -

As at As at
March 31, 2016 March 31, 2015
NOTE 8
OTHER LONG-TERM LIABILITIES
Premium payable on redemption of Debentures ˠˣʰ˦ˡ˟ʳ˟˨ ˠˣʰ˦ˡ˟ʳ˟˨
Creditors for capital goods - ˦ˤʳ˧ˠ
Amount disclosed under ‘Other Current Liabilities’ (Note 11) ʹˠˣʰ˦ˡ˟ʳ˟˨ʺ -
- 14,795.90
120 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
` In Lacs

NON CURRENT CURRENT


As at As at As at As at
March 31, 2016 March 31, 2015 March 31, 2016 March 31, 2015
NOTE 9
PROVISIONS
ƻNjŸɚÞǣÞŸŘ¯ŸNjsŎƼĶŸɴssEsŘsʩǼǣ
Provision for leave encashment - - ˦ˢ˧ʳ˦˟ ˦˟˟ʳ˥˟
Provision for gratuity (Note 28 ) 1,632.60 ˠʰˡ˥˨ʳ˦˨ - -
1,632.60 1,269.79 738.70 700.60
Other provisions
Provision for wealth tax - - ˣʳˠ˦ ˧ʳ˦ˢ
Provision for income tax (net of advance tax of - - 534.48 ˢ˦ˣʳ˧˧
` ˢʰ˦˦˦ʳˤˡʹˡ˟ˠˤ˚`ˡʰ˦˟˟ʳˠˡʺʺ
Provision for litigation* - - 1,641.92 1,641.92
Proposed dividend - - 1,811.20 ˦ʰˡˣ˟ʳ˨ˣ
Tax on proposed dividend - - ˢ˥˧ʳ˦ˡ ˠʰˣ˦ˣʳ˟˧
- - 4,360.49 10,740.55
1,632.60 1,269.79 5,099.19 11,441.15

*Provision for litigation relates to certain indirect tax cases pending at various levels.

As at As at
March 31, 2016 March 31, 2015
NOTE 10
TRADE PAYABLES
Total outstanding dues of micro enterprises and small enterprises (refer note 35 for details of 4,682.31 ˢʰ˦ˡ˧ʳˠ˦
dues to micro and small enterprises)
Total outstanding dues of creditors other than micro enterprises and small enterprises
Other trade payables 5,302.23 4,016.85
Accrual for expenses ˤʰˤˡˢʳˣ˦ ˤʰ˟˦˟ʳ˧˟
15,508.01 12,815.82

As at As at
March 31, 2016 March 31, 2015
NOTE 11
OTHER CURRENT LIABILITIES
Statutory dues 1,804.64 1,519.03
Unclaimed dividend * 139.28 53.34
Interest accrued but not due on loans - ˢ˦˦ʳˠ˥
Security deposits 29.68 32.08
Advances from customers 580.03 201.86
_ɚŘOsǣǼŸɠNj_ǣʩɮs_ǣǣsǼǣˀÞŘɚsǣǼŎsŘǼƼNjŸƼsNjǼɴÌsĶ_¯ŸNjǣĶs 20.00 95.83
Creditors for capital goods ˦ˤʳ˧ˠ ˨˟ʳ˨˦
Current maturities of long term borrowings (Note 6) 40,180.00 11,860.00
Current maturities of Premium payable on redemption of Debentures (Note 8) ˠˣʰ˦ˡ˟ʳ˟˨ -
Accrual for sales promotion schemes 1,626.03 ˨ˠ˨ʳ˦ˠ
59,175.56 15,149.98

* There are no amounts payable / due to be credited to Investor Education and Protection Fund.
NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
` In Lacs

NOTE 12

TANGIBLE ASSETS

Gross Block Depreciation and Amortisation Impairment Net Block

Particulars As at Addition Deletions As at As at For the year Charge Deletions As at As at Charge/ Deletion As at As at As at
April 1, March April 1, adjusted to reserve for the March April 1, Reversal March March March
2015 31, 2016 2015 as per Schedule II year 31, 2016 2015 for the 31, 2016 31, 2016 31, 2015
of the Companies year
Act 2013*

Freehold land @ ˤʰ˥ˣ˧ʳ˥˦ - - ˤʰ˥ˣ˧ʳ˥˦ - - - - - - - - - ˤʰ˥ˣ˧ʳ˥˦ ˤʰ˥ˣ˧ʳ˥˦

5,615.34 33.33 - ˤʰ˥ˣ˧ʳ˥˦ - - - - - - - - -

Leasehold land ˡ˦ˣʳ˧ˢ - - ˡ˦ˣʳ˧ˢ ˢ˦ʳˤ˨ - ˢʳ˦ˤ - 41.34 - - - - 233.49 ˡˢ˦ʳˡˣ

ˡ˦ˣʳ˧ˢ - - ˡ˦ˣʳ˧ˢ 33.84 - ˢʳ˦ˤ - ˢ˦ʳˤ˨ - - - -

Building # @ 13,656.68 ˠ˨˥ʳ˟˦ 60.51 ˠˢʰ˦˨ˡʳˡˣ 3,325.26 - ˣ˦ˠʳ˦˨ 20.25 ˢʰ˦˦˥ʳ˧˟ - - - - 10,015.44 10,331.42
Corporate Overview

ˠˢʰˣ˦ˣʳ˦˦ 196.69 ˠˣʳ˦˧ 13,656.68 ˡʰ˧ˤ˦ʳ˨˨ - ˣ˦ˡʳ˥˨ 5.42 3,325.26 - - - -

Plant and machinery 13,960.18 1,028.28 690.69 ˠˣʰˡ˨˦ʳ˦˦ ˥ʰ˟˦˟ʳ˥ˢ - ˠʰˢ˨˧ʳˢ˦ 514.99 6,954.01 84.24 - 3.53 ˧˟ʳ˦ˠ ˦ʰˡ˥ˢʳ˟ˤ ˦ʰ˧˟ˤʳˢˠ

ˠˣʰˠˡ˥ʳˤ˦ ˦˟ˠʳ˨˨ 868.38 13,960.18 ˣʰ˧˥˦ʳ˨ˠ 89.22 1,486.12 ˢ˦ˡʳ˥ˡ ˥ʰ˟˦˟ʳ˥ˢ 392.92 - 308.68 84.24

Dies and moulds ˥˦ˠʳ˥˨ ˣ˦ʳ˨ˤ 61.99 ˥ˤ˦ʳ˥ˤ ˤ˟ˢʳ˦˟ - 92.09 ˤ˨ʳ˦˨ 536.00 - - - - 121.65 ˠ˥˦ʳ˨˨
Performance

˥˥˥ʳ˧˦ ˠ˦ˤʳ˧˥ ˠ˦ˠʳ˟ˣ ˥˦ˠʳ˥˨ 546.91 4.59 121.00 168.80 ˤ˟ˢʳ˦˟ - - - -

®ȖNjŘÞǼȖNjsŘ_ʩɮǼȖNjs ˦ˢˤʳˢ˥ ˢ˦ʳ˟ˢ ˢˢʳˡ˦ ˦ˢ˨ʳˠˡ ˣˡ˦ʳ˟ˤ - ˦˦ʳ˨ˢ ˢˠʳ˦˦ ˣ˦ˢʳˡˠ ˠʳ˟˦ - - ˠʳ˟˦ 264.84 ˢ˟˦ʳˡˣ

˦˧ˠʳˡ˧ 15.33 61.25 ˦ˢˤʳˢ˥ 349.00 24.10 114.12 ˥˟ʳˠ˦ ˣˡ˦ʳ˟ˤ ˠʳ˟˦ - - ˠʳ˟˦

ŷ¯ʩOssLJȖÞƼŎsŘǼǣ 993.06 83.59 108.00 968.65 ˦ˣˠʳˣ˥ - 108.48 ˠ˟˦ʳˤˢ ˦ˣˡʳˣˠ ˠˡʳ˦˥ - - ˠˡʳ˦˥ 213.48 238.84

901.00 152.63 ˥˟ʳˤ˦ 993.06 491.99 185.58 ˠˡˠʳ˦˦ ˤ˦ʳ˧˧ ˦ˣˠʳˣ˥ 14.09 - 1.33 ˠˡʳ˦˥
Governance

Vehicle ˧ˠ˦ʳˡ˟ 16.42 ˣ˧ʳ˦˥ ˦˧ˣʳ˧˥ 409.10 - 95.15 39.21 465.04 0.91 - - 0.91 318.91 ˣ˟˦ʳˠ˨

˥˦˨ʳˡˣ ˡˢˡʳ˦˥ 94.80 ˧ˠ˦ʳˡ˟ ˢ˦˟ʳ˟ˡ ˦ʳˠˤ ˠ˟˦ʳ˥ˠ ˦ˤʳ˥˧ 409.10 0.91 - - 0.91

Total tangible assets 36,757.67 1,409.34 1,003.22 37,163.79 11,514.79 - 2,247.56 773.54 12,988.81 98.98 - 3.53 95.45 24,079.53 25,143.90

36,519.90 1,508.59 ˠʰˡ˦˟ʳ˧ˡ ˢ˥ʰ˦ˤ˦ʳ˥˦ ˨ʰˤˠ˦ʳ˥˥ 310.64 ˡʰˣˡ˦ʳ˟˥ ˦ˣ˟ʳˤ˦ ˠˠʰˤˠˣʳ˦˨ 408.99 - 310.01 98.98

# Includes ` 452.19 (2015 - ` 452.19) represented by unquoted fully paid shares at cost in various co-operative societies. Further, also refer Note 32.
ˎr¯¯sOǼÞɚsƼNjÞĶˠʰˡ˟ˠˣʰǼÌsNŸŎƼŘɴÌ_NjsɚÞǣs_ǼÌsȖǣs¯ȖĶĶÞ¯sŸ¯OsNjǼÞŘʩɮs_ǣǣsǼǣEǣs_ŸŘǢOÌs_ȖĶsÝÝǼŸǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢ¯ŸNjǼÌsƼȖNjƼŸǣsǣŸ¯ƼNjŸɚÞ_Þض_sƼNjsOÞǼÞŸŘŸŘʩɮs_ǣǣsǼǣʳ
OOŸNj_ÞضĶɴʰǼÌsONjNjɴÞضŎŸȖŘǼŸ¯ǼÌsǣǣsǼǣǣŸŘƼNjÞĶˠʰˡ˟ˠˣɠǣ_sƼNjsOÞǼs_ŸɚsNjǼÌsNjsŎÞŘÞضNjsɚÞǣs_Ȗǣs¯ȖĶĶÞ¯sŸ¯ǼÌsʩɮs_ǣǣsǼǣʳ®ȖNjǼÌsNjʰŘŎŸȖŘǼŸ¯` Nil (2015 - ` 310.64) (Net of tax
Financial Statements

` Nil) representing the carrying amount of the assets with revised useful life as Nil was charged to the opening reserves as on April 1, 2014.
@ Freehold land and building includes asset which are not transferred in the name of the company amounting to `ˣʰ˨˦ˣʹµNjŸǣǣEĶŸOĨʺʹˡ˟ˠˤ˚`ˣʰ˨˦ˣʺʳǻÌsǣsNjsÌsĶ_ÞŘǼÌsŘŎsŸ¯ǼÌssŘǼÞǼÞsǣɠÌÞOÌ
have been merged with the company in earlier years.
121

Figures in italics are in respect of the previous year.


NOTES
122

ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
` In Lacs
NOTE 12
INTANGIBLE ASSETS

Gross Block Depreciation and Amortisation Impairment Net Block

Particulars As at Addition Deletions As at March As at Charge Deletions As at March As at Charge/ Deletion As at March As at March As at
Annual Report 2015-16

April 1, 31, 2016 April 1, for the 31, 2016 April 1, Reversal 31, 2016 31, 2016 March
2015 2015 year 2015 for the 31, 2015
year
Jyothy Laboratories Limited

Goodwill on Amalgamation 14,339.41 - - 14,339.41 4,301.82 1,433.94 - ˤʰ˦ˢˤʳ˦˥ - - - - 8,603.65 ˠ˟ʰ˟ˢ˦ʳˤ˨

14,339.41 - - 14,339.41 ˡʰ˧˥˦ʳ˧˧ 1,433.94 - 4,301.82 - - - -

Goodwill 301.60 - - 301.60 - - - - 51.50 - - 51.50 250.10 250.10

301.60 - - 301.60 - - - - 51.50 - - 51.50

Brands 30,366.00 - - 30,366.00 9,109.80 3,036.60 - 12,146.40 - - - - 18,219.60 21,256.20

30,366.00 - - 30,366.00 ˥ʰ˟˦ˢʳˡ˟ 3,036.60 - 9,109.80 - - - -

Trademarks and Copyrights$ 580.81 - - 580.81 ˣ˦ˠʳ˥ˤ 41.14 - ˤˠˡʳ˦˨ 23.68 - - 23.68 44.34 85.48

580.81 - - 580.81 430.23 41.42 - ˣ˦ˠʳ˥ˤ 23.68 - - 23.68

Know-how ˥ˣ˦ʳˠˡ - - ˥ˣ˦ʳˠˡ ˥ˣ˦ʳˠˡ - - ˥ˣ˦ʳˠˡ - - - - - -

˥ˣ˦ʳˠˡ - - ˥ˣ˦ʳˠˡ ˤ˦ˤʳˣˤ ˦ˠʳ˥˦ - ˥ˣ˦ʳˠˡ - - - -

Softwares and Licences ˢˡˤʳ˦˦ ˣˠʳ˨˦ - ˢ˥˦ʳ˦ˣ 66.55 ˢˣʳ˦ˤ - 101.30 - - - - 266.44 259.22

228.20 ˨˦ʳˤ˦ - ˢˡˤʳ˦˦ ˣ˟ʳˠ˦ 26.38 - 66.55 - - - -

Total intangible assets 46,560.71 41.97 - 46,602.68 14,596.94 4,546.43 - 19,143.37 75.18 - - 75.18 27,384.13 31,888.59

46,463.14 ˨˦ʳˤ˦ - ˣ˥ʰˤ˥˟ʳ˦ˠ 9,986.93 4,610.01 - 14,596.94 ˦ˤʳˠ˧ - - ˦ˤʳˠ˧

$ Includes trademarks and copyrights of ` 315.63 (2015 - ` 315.63) pending for registration in the name of the Company.

Figures in italics are in respect of the previous year


Corporate Overview Performance Governance Financial Statements 123

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
` In Lacs

As at As at
March 31, 2016 March 31, 2015
NOTE 13
NON CURRENT INVESTMENTS ( at cost)
Investment property ( Freehold land) # - ˠˣ˦ʳˢ˟
Trade Investments (Unquoted)
Investment in subsidiaries -
Jyothy Consumer Products Marketing Ltd $
ˣʰ˨˦˟ʰ˟˟˟ʹˡ˟ˠˤ˚ˣʰ˨˦˟ʰ˟˟˟ʺsLJȖÞǼɴǣÌNjsǣŸ¯` 10 (2015 - ` 10) each fully paid up ˣ˨˦ʳ˟˟ ˣ˨˦ʳ˟˟
Jyothy Fabricare Services Limited
9,800,000 (2015 - 9,800,000) equity shares of ` 10 (2015 - ` 10) each fully paid up ˠʰˢˣˢʳ˦ˢ ˠʰˢˣˢʳ˦ˢ
3,300,000 (2015 - 3,300,000) compulsory convertible preference shares of ` 100 (2015 - ` 100)
6,804.24 6,804.24
each fully paid up
˦ʰˤ˟˟ʰ˟˟˟ʹˡ˟ˠˤ˚ŗÞĶʺˡ̇ŸƼǼÞŸŘĶĶɴOŸŘɚsNjǼÞEĶsƼNjs¯sNjsŘOsǣÌNjsŸ¯` 10 (2015 - ` Nil) each fully paid up 15,000.00 15,000.00
Jyothy Kallol Bangladesh Limited
˧ʰˣ˧ˤʰˣˢˠʹˡ˟ˠˤ˚˦ʰˣ˨ˣʰ˥˨˥ʺsLJȖÞǼɴǣÌNjsǣŸ¯D^ǻˠ˟ʹˡ˟ˠˤ˚D^ǻˠ˟ʺsO̯ȖĶĶɴƼÞ_ȖƼ ˤ˧˟ʳˣ˦ 501.65
Investment in others -
Henkel SPIC Employees Co-operative Thrift and Credit Society Limited 2.00 2.00
2,000 (2015 - 2,000) equity shares of ` 100 (2015 - ` 100) each fully paid up
Capexil (Agencies) Ltd*
5 (2015 - 5) equity shares of ` 10,000 (2015 - ` 10,000) each fully paid up - -
Madras Industrial Cooperative Analytical Laboratory Limited*
2 (2015 - 2) equity shares of ` 500 (2015 - ` 500) each fully paid up - -
Ambattur Industrial Estate Manufacturers Service Industrial Cooperative Society Ltd*
1 (2015 - 1) equity shares of ` 100 (2015 - ` 100) each fully paid up - -
24,227.44 24,148.62
Investments in Partnership Firm
M/s JFSL - JLL (Note 38) ˧ˣʳ˦ˤ ˦˨ʳˤˤ
Non-Trade Investment (Unquoted)
Investment in Government Securities
Indira Vikas Patra 0.02 0.02
ŗǼÞŸŘĶǢɚÞضNsNjǼÞʩOǼsǣʹƻĶs_¶s_ɠÞǼ̵ŸɚsNjŘŎsŘǼȖǼÌŸNjÞǼÞsǣʺ ˟ʳˤ˦ ˟ʳˤ˦
0.59 0.59
Share application money pending allotment - ˦˧ʳ˧ˡ
24,312.78 24,454.88
Aggregate amount of unquoted investments ˡˣʰˢˠˡʳ˦˧ 24,454.88
Aggregate amount of quoted investments - -
Market Value of quoted investments - -

# Since this is a freehold land, no depreciation is charged on the same.


* Investment has been fair valued on amalgamation with Jyothy Consumer Products Limited at a nominal value of ` 1/-
$ Previous Year includes investment in Associated Industries Consumer Products Private Limited which has been merged with Jyothy Consumer
Products Marketing Limited w.e.f. April 1, 2014.
124 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
` In Lacs

NON CURRENT CURRENT


As at As at As at As at
March 31, 2016 March 31, 2015 March 31, 2016 March 31, 2015

NOTE 14
LOANS AND ADVANCES
Unsecured, considered good unless
otherwise stated
Capital Advances ˦˦ˡʳ˥˧ 82.31 - -
_ɚŘOsǣŘ_ĶŸŘǣǼŸǣȖEǣÞ_ÞNjÞsǣʹŗŸǼsˢ˦ʺ ˣ˦ʰˡˤ˟ʳˢˠ 43,349.83 - -
Advance to suppliers * 58.45 58.45 ˠʰˤˢˤʳ˦ˤ 1,454.92
Balance with excise and VAT authorities * - - 1,326.88 1,919.20
MAT Credit entitlement 9,194.39 6,334.39 - -
Deposits* 1,648.01 ˤ˦ˣʳˢˤ - -
Balance with government authorities* (Note 40) ˦ʰ˦ˠˡʳˠˣ ˦ʰˠˠˡʳˢ˟ - -
Prepaid Expenses - - 140.94 ˠ˦ˡʳ˥˥
Advance income tax (net of provisions of 2,895.52 1,916.24 - -
` 9,952.90 (2015 - `˥ʰ˧˦˦ʳ˨˟ʺʺ
Other receivables * 838.50 964.00 412.52 454.86
Less: Provisions for doubtful advances (246.49) (256.60) (1,266.91) (1,196.91)
70,123.51 60,135.27 2,149.18 2,804.73

Note:

* Advances to suppliers, Balance with excise and VAT authorities, Balance with government authorities, Deposits and Other receivables include
`ˣˡˡʳ˦˨ʹˡ˟ˠˤ˚`ˢˤˡʳ˦˨ʺʰ` 881.50 (2015 - ` 881.50) , `ˠ˥˦ʳ˟˟ʹˡ˟ˠˤ˚`ˠ˥˦ʳ˟˟ʺʰ` 21.04 (2015 - ` 31.15) and ` ˡˠʳ˟˦ʹˡ˟ˠˤ˚`ˡˠʳ˟˦ʺNjsǣƼsOǼÞɚsĶɴʰ
considered doubtful and fully provided for.

NON CURRENT CURRENT


As at As at As at As at
March 31, 2016 March 31, 2015 March 31, 2016 March 31, 2015

NOTE 15
OTHER ASSETS
Unsecured, considered good
Inventory-Sales Promotions Items - - 241.95 288.90
Interest accrued but not due - - - 2.01
Investment property (Freehold land) held for - - ˠˣ˦ʳˢ˟ -
sale
Fixed deposit with Banks having original ˦˧ʳˠˢ 219.28 - -
maturity of more than 12 months ( Note 19)
78.13 219.28 389.25 290.91
Corporate Overview Performance Governance Financial Statements 125

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
` In Lacs

As at As at
March 31, 2016 March 31, 2015
NOTE 16
CURRENT INVESTMENT ( Quoated -Cost or Fair value whichever is lower)
Axis Banking Debt Fund - Growth
ŗÞĶʹˡ˟ˠˤ˚ˠˢˢʰ˧ˤ˨ʳ˨˦ʺȖŘÞǼǣŸ¯` Nil (2015 - ` 1,000) each - ˠʰ˦˟˟ʳ˟˟
Axis Liquid Fund - Growth
ˠ˨˟ʰ˧˧ˤʳ˥˦ʹˡ˟ˠˤ˚ŗÞĶʺȖŘÞǼǣŸ¯` 1,000 (2015 - ` Nil) each 3,200.00 -
Axis Short Term Fund
Nil (2015 - 3,298,544.68) units of ` Nil (2015 - ` 10) each - 500.00
Axis Treasury Advantage Fund - Growth
ŗÞĶʹˡ˟ˠˤ˚ˡ˥ˤʰ˟ˠ˧ʳ˦ˠʺȖŘÞǼǣŸ¯` Nil (2015 - ` 1,000) each - 4,050.00
HDFC Gilt Fund Long Term Plan -Direct Plan - Growth
ŗÞĶʹˡ˟ˠˤ˚ˤʰ˥˦ˡʰˣˢ˧ʳˤˣʺȖŘÞǼǣŸ¯` Nil (2015 - ` 10) each - 1,600.00
HDFC High Interest Fund - Dynamic Plan
Nil (2015 - 815,281.64) units of ` Nil (2015 - ` 10) each - 400.00
ICICI Prudential Stp - Growth
ŗÞĶʹˡ˟ˠˤ˚ˠʰ˦˧ˤʰ˨ˠˡʳ˟ˠʺȖŘÞǼǣŸ¯` Nil (2015 - ` 10) each - 500.00
ICICI Prudential Ultra Short Term Plan - Dir - Gr
ŗÞĶʹˡ˟ˠˤ˚ˠˠʰˣ˦ˤʰ˨˥ˠʳˣˤʺȖŘÞǼǣŸ¯` Nil (2015 - ` 10) each - 1,600.00
Indiabulls Ultra Short Term Fund
˦˦ʰˠ˦˨ʳ˥˟ʹˡ˟ˠˤ˚ˠˠˤʰˤˤ˥ʳˣ˧ʺȖŘÞǼǣŸ¯` 1,000 (2015 - ` 1,000) each 1,100.00 1,550.00
Reliance Short Term Fund
Nil (2015 - 5,143,139.64) units of ` Nil (2015 - ` 10) each - 1,350.00
Religare Invesco Short Term Fund
ŗÞĶʹˡ˟ˠˤ˚ˤˢʰˠˣ˨ʳ˦ˡʺȖŘÞǼǣŸ¯` Nil (2015 - ` 1,000) each - 1,000.00
Religare Invesco Ultra Short Term Fund - Direct Pl
Nil (2015 - 51,584.63) units of ` Nil (2015 - ` 1,000) each - 1,000.00
Taurus Short Term Income Fund
Nil (2015 - 20,401.56) units of ` Nil (2015 - ` 1,000) each - 500.00
Taurus Ultra Short Term Bond Fund Super Institution
16,293.49 (2015 - 41,593.42) units of ` 1,000 (2015 - ` 1,000) each 300.00 ˦˟˟ʳ˟˟
Taurus Dynamic Income Fund - Growth Option
68,32,489.20(2015 - Nil) units of ` 10 (2015 - ` Nil) each 1,001.49 -
Kotak Low Duration Fund
58,351.96 (2015 - Nil) units of ` 1,000 (2015 - ` Nil) each ˠʰ˟ˡˡʳ˦˧ -
6,624.27 16,450.00
Aggregate amount of quoted investments ˥ʰ˥ˡˣʳˡ˦ 16,450.00
Market Value of quoted investments ˥ʰ˦ˤˣʳ˦˨ ˠ˥ʰ˦˟˟ʳˢˡ

As at As at
March 31, 2016 March 31, 2015
NOTE 17
INVENTORIES (Valued at lower of cost or net realisable value)
Raw and packing materials ( including goods in transit ` 2.19 ( 2015 - ` Nil )) ˣʰ˦˨˦ʳˠ˧ ˣʰ˨˥˟ʳˠ˦
Work in progress (Note 29 (I)) ˠʰˤˣ˥ʳ˟˦ ˠʰˢ˥˨ʳ˟˦
Finished goods manufactured (Note 29 (H)) 8,049.32 ˦ʰˢˡ˟ʳ˟˥
Traded Goods (including goods in transit ` 253.66 ( 2015 - ` 322.89)) (Note 29 (H)) 3,112.64 ˣʰˠ˟˥ʳ˦ˣ
Stores and spare parts 400.83 ˢˣˤʳ˦˧
17,906.04 18,101.82
126 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
` In Lacs

As at As at
March 31, 2016 March 31, 2015
NOTE 18
TRADE RECEIVABLES
Unsecured
a) Outstanding for a period exceeding six months from the date they are due for payment
Considered good ˦˟˥ʳ˧ˤ ˦˥ˠʳ˧ˣ
Considered doubtful ˢˡ˦ʳ˦˧ ˢˡ˦ʳ˦˧
Less: Provision for doubtful receivables ʹˢˡ˦ʳ˦˧ʺ ʹˢˡ˦ʳ˦˧ʺ
706.85 761.84
b) Other receivable, considered good ˦ʰ˥˦ˡʳˢ˧ 4,329.62
8,379.23 5,091.46
Refer Note 31 for dues receivable from related parties

NON CURRENT CURRENT


As at As at As at As at
March 31, 2016 March 31, 2015 March 31, 2016 March 31, 2015

NOTE 19
CASH AND BANK BALANCES
Cash and cash equivalents
Cash in hand - - 13.03 16.31
Balance with banks - Current account - - 1,304.94 2,085.03
Unclaimed dividend accounts - - 139.28 53.34
- - 1,457.25 2,154.68
Other bank balances
Deposits with original maturity for more than ˦˧ʳˠˢ 219.28 3,480.04 ˣʰˢ˦ˠʳˠˢ
12 months*
Amount disclosed under ‘other assets’ (Note 15) ʹ˦˧ʳˠˢʺ (219.28) - -
- - 3,480.04 4,371.13
- - 4,937.29 6,525.81
* Includes deposits provided as securities against bank guarantees and debenture redemption reserves - ` 2,442.18 (2015 - `ˡʰˡˠˤʳ˦ˠʺ

2015-16 2014-15
NOTE 20
OTHER OPERATING INCOME
Export incentives 22.10 25.92
Royalty income 2.68 4.35
Sales of scrap 35.04 13.30
Agricultural income 6.05 4.28
Liabilities no longer required written back (net) - ˢ˧˨ʳˠ˦
Differential tariff towards power and fuel expenses of earlier years - 400.31
Others 120.20 ˠˠ˦ʳ˧˟
186.07 955.13
Corporate Overview Performance Governance Financial Statements ˠˡ˦

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
` In Lacs

2015-16 2014-15
NOTE 21
OTHER INCOME
Lease rent income 66.30 ˦ˤʳ˧ˣ
®ŸNjsÞ¶ŘsɮOÌضsʪȖOǼȖǼÞŸŘ¶ÞŘʹŘsǼʺ - 4.66
ƻNjŸʩǼŸŘǣĶsŸ¯OȖNjNjsŘǼÞŘɚsǣǼŎsŘǼǣ 829.33 ˣ˦˥ʳ˨˧
ƻNjŸʩǼŸŘǣĶsŸ¯ÞŘɚsǣǼŎsŘǼÞŘǣȖEǣÞ_ÞNjɴ - 82.55
ƻNjŸʩǼŸŘǣĶsŸ¯ʩɮs_ǣǣsǼǣ ˣ˨ʳ˦ˣ ˠ˦ʳˠ˥
Miscellaneous income 6.65 ˠˡʳ˨˦
952.02 670.16

2015-16 2014-15
NOTE 22
COST OF RAW MATERIALS AND COMPONENTS CONSUMED
Opening stock ˣʰ˨˥˟ʳˠ˦ 4,196.23
Add: Cost of purchases ˣ˧ʰˣ˦˦ʳˤˢ 46,399.62
53,437.70 50,595.85
Less: Closing stock ˣʰ˦˨˦ʳˠ˧ ˣʰ˨˥˟ʳˠ˦
48,640.52 45,635.68
For details of raw material consumed, refer Note 29 (F)

2015-16 2014-15
NOTE 23
(INCREASE)/ DECREASE IN INVENTORIES OF FINISHED GOODS,WORK IN PROGRESS AND
TRADED GOODS
Closing stock
Finished goods 8,049.32 ˦ʰˢˡ˟ʳ˟˥
Traded Goods 3,112.64 ˣʰˠ˟˥ʳ˦ˣ
Work in progress ˠʰˤˣ˥ʳ˟˦ ˠʰˢ˥˨ʳ˟˦
12,708.03 12,795.87
Opening stock
Finished goods ˦ʰˢˡ˟ʳ˟˥ 6,098.90
Traded Goods ˣʰˠ˟˥ʳ˦ˣ 4,019.24
Work in progress ˠʰˢ˥˨ʳ˟˦ 1,405.00
12,795.87 11,523.14
Sub-total (A) 87.84 (1,272.73)
(Increase)/ decrease in excise duty
Excise duty on closing stock ˠ˦ˣʳ˨˟ ˠˣ˥ʳ˧˦
Excise duty on opening stock ˠˣ˥ʳ˧˦ ˡˢˤʳ˦˟
Sub-total (B) (28.03) 88.83
Total (A-B) 115.87 (1,361.56)

2015-16 2014-15
NOTE 24
EMPLOYEE BENEFITS EXPENSES
Salaries, wages and bonus ˠ˟ʰˢ˧˦ʳˡ˨ 9,392.61
Contribution to provident and other funds (Note 28) ˦ˤˢʳˢ˧ 634.52
Gratuity (Note 28) ˢ˦˟ʳ˧˟ ˣˠ˦ʳ˨˦
Staff welfare expenses 620.58 658.69
Directors’ remuneration ˧˟˦ʳˡ˟ 801.94
Commission to directors ˦˨˨ʳ˨˦ 594.10
Field staff incentives ˢ˦˟ʳˤ˦ 211.21
Sub-total (A) 14,109.79 12,711.04
Employee stock option expenses (Note 36) ˠʰ˦ˤ˟ʳˡ˥ ˡʰ˧˦ˠʳˠˢ
Sub-total (B) 1,750.26 2,871.13
Total (A+B) 15,860.05 15,582.17
128 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
` In Lacs

2015-16 2014-15
NOTE 25
OTHER EXPENSES
Power and fuel expenses ˠʰ˧˦˨ʳˠˤ 2,105.92
Rent 1,266.10 1,160.19
Insurance 101.19 ˥˦ʳˠ˨
Repairs and maintenance
- Building ˤ˦ʳˣˢ ˦˧ʳ˥ˡ
- Plant and machinery ˠ˦˦ʳ˥˨ ˡˢˡʳ˦ˣ
- Others 256.02 210.30
Consumption of stores and spares ˦ˢˢʳˠˤ 626.31
Research and development 150.35 52.50
Excise duty on captive consumption ˦˟˥ʳˡˠ 613.91
Printing and stationery ˧ˡʳ˧˦ ˤ˦ʳ˧ˤ
Communication costs 296.02 255.12
Legal and professional fees (Note 29 (E)) ˠʰˠˣ˦ʳ˧˟ 1,069.30
Rates and taxes ˤ˦ˠʳ˨ˢ ˣ˦˦ʳ˟ˤ
Directors’ sitting fees 5.15 3.50
Vehicle maintenance ˠˤ˥ʳˣ˦ 159.04
Donation 6.61 15.36
Provision for doubtful advances ˦˟ʳ˟˟ -
ĵŸǣǣŸŘʩɮs_ǣǣsǼǣ_ÞǣONj_s_ ˧˟ʳˤ˦ 91.42
Conversion charges ˧˥ˢʳ˦ˣ 250.39
Advertisement and Sales promotion expense 18,985.63 ˠ˦ʰ˟˦ˠʳ˦ˠ
Freight, handling and forwarding charges ˨ʰˢ˨˦ʳˤˠ 8,486.81
Field staff expenses 1,411.41 ˠʰˡˡˤʳ˦ˠ
Travelling and conveyance ˢˠˤʳ˦ˢ 292.03
Royalty 288.33 ˡˣˣʳ˦˧
Corporate social responsibility expenses ( Note 29(J)) 234.84 121.33
Miscellaneous expenses ˠʰˠ˨ˡʳˠ˦ 638.95
40,434.07 35,608.03

2015-16 2014-15
NOTE 26
FINANCE COST
Interest on bank overdraft 9.21 9.32
Interest on debentures 448.10 ˠʰˠˢ˨ʳ˦ˤ
Other borrowing cost 28.25 53.91
485.56 1,202.98

2015-16 2014-15
NOTE 27
INTEREST INCOME
ÝŘǼsNjsǣǼŸŘʩɮs__sƼŸǣÞǼ 349.40 310.45
Interest on loans to subsidiaries 4,335.36 ˤʰˤˣ˨ʳ˦˥
ÝŘǼsNjsǣǼŸŘOƼÞǼĶÞŘɚsǣǼs_ÞŘƼNjǼŘsNjǣÌÞƼʩNjŎ 11.15 8.68
Interest on intercorporate deposit - 42.45
Interest others 5.90 4.48
4,701.81 5,915.82
Corporate Overview Performance Governance Financial Statements 129

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
NOTE 28 EMPLOYEE BENEFIT:
ʹÞʺ ^sʩŘs_DsŘsʩǼƻĶŘǣ˚
ǻÌsNŸŎƼŘɴÌǣ_sʩŘs_EsŘsʩǼ¶NjǼȖÞǼɴƼĶŘʳrɚsNjɴsŎƼĶŸɴssɠÌŸÌǣOŸŎƼĶsǼs_ʩɚsɴsNjǣŸNjŎŸNjsŸ¯ǣsNjɚÞOs¶sǼǣ¶NjǼȖÞǼɴŸŘ_sƼNjǼȖNjs
at 15 days salary (last drawn salary) for each completed year of service. The scheme is funded with Life Insurance Corporation of India.
 ǻÌs¯ŸĶĶŸɠÞضǼEĶsǣǣȖŎŎNjÞǣsǣǼÌsOŸŎƼŸŘsŘǼǣŸ¯ŘsǼEsŘsʩǼsɮƼsŘǣsNjsOŸ¶ŘÞǣs_ÞŘǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣŘ_ǼÌs¯ȖŘ_s_ǣǼǼȖǣ
and amounts recognised in the balance sheet for the respective plans.
` in Lacs

2015-16 2014-15
Gratuity Funded Gratuity Funded
(A) Summary of the Actuarial Assumptions
Mortality IALM (2006-08) Ult. IALM (2006-08) Ult.
Discount rate ˦ʳ˧˟̇ ˦ʳ˧˟̇
Rate of increase in compensation 8.00% 8.00%
Withdrawal rates 10.00% 10.00%
Rate of return (expected) on plan assets 8.50% ˧ʳ˦ˤ̇
The estimates of future salary increases considered in actuarial valuation take account of
ÞŘʪǼÞŸŘʰǣsŘÞŸNjÞǼɴʰƼNjŸŎŸǼÞŸŘŘ_ŸǼÌsNjNjsĶsɚŘǼ¯OǼŸNjǣǣȖOÌǣǣȖƼƼĶɴŘ__sŎŘ_ÞŘǼÌs
employment market.
The overall expected rate of return on assets is determined based on the market price
prevailing on that date, applicable to the period over which the obligation is to be settled.
(B) Changes in present value of obligations (PVO)
PVO at beginning of period 1,892.22 ˠʰˤ˦˟ʳ˨˧
Interest cost ˠˣ˦ʳ˨ˠ 144.53
Current Service Cost ˠ˦ˣʳˢ˨ 184.02
DsŘsʩǼǣƻÞ_ ʹˢ˟˦ʳˣˡʺ ʹˠˠˢʳ˥˦ʺ
Actuarial (gain) / loss on obligation ˦˥ʳˤ˟ 106.36
PVO at end of period 1,983.60 1,892.22
(C) Changes in fair value of plan assets
Fair value of plan assets at the beginning of period 622.43 618.55
Adjustment to opening fair value of plan assets - ʹˠ˧ʳ˦˧ʺ
Expected return on plan assets 54.56 ˤˡʳ˦ˣ
Contributions ˦ʳ˨˨ 119.39
DsŘsʩǼƼÞ_ ʹˢ˟˦ʳˣˡʺ ʹˠˠˢʳ˥˦ʺ
Actuarial gain / (loss) on plan assets (26.56) (35.80)
Fair value of plan assets at end of period 351.00 622.43
(D) Net Assets/(Liabilities) recognised in the balance sheet
PVO at end of period (1,983.60) (1,892.22)
Fair value of plan assets at end of period 351.00 622.43
®ȖŘ_s_ǣǼǼȖǣʹ_sʩOÞǼÞŘƼĶŘǣǣsǼǣŸɚsNj¯ÞNjɚĶȖsŸ¯ƻəŷʺ (1,632.60) ʹˠʰˡ˥˨ʳ˦˨ʺ
Net assets / (Liability) recognised in the balance sheet (1,632.60) (1,269.79)
(E) rɮƼsŘǣsǣNjsOŸ¶ŘÞǣs_ÞŘǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣ
Current service cost ˠ˦ˣʳˢ˨ 184.02
Interest cost ˠˣ˦ʳ˨ˠ 144.53
Expected return on plan assets (54.56) ʹˤˡʳ˦ˣʺ
Net Actuarial (Gain)/Loss recognised for the period 103.06 142.16
rɮƼsŘǣsNjsOŸ¶ŘÞǣs_ÞŘǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣ 370.80 417.97
(F) The major categories of plan assets as a percentage of the fair value of total plan
assets are as follows:
Investment with insurer 100.00% 100.00%
130 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
NOTE 28 EMPLOYEE BENEFIT: (contd.)
` in Lacs
(G) Amounts for the current and previous four periods are as follows:

April to March 16 April to March 15 April to March 14 April to March 13 April to March 12
^sʩŘs_ EsŘsʩǼ 1,983.60 1,892.22 ˠʰˤ˦˟ʳ˨˦ 1,533.12 ˠʰˡ˧˦ʳˤ˥
obligation
Plan assets 351.00 622.43 618.55 615.44 655.80
ǢȖNjƼĶȖǣˀʹ^sʩOÞǼʺ 1,632.60 ˠʰˡ˥˨ʳ˦˨ 952.42 ˨ˠ˦ʳ˥˧ ˥ˢˠʳ˦˥
Experience adjustment ˦˥ʳˤ˟ 106.36 59.50 20.16 1.09
on plan liabilities
Experience adjustment (26.56) (35.80) 2.44 1.28 ˟ʳ˦ˣ
on plan assets

(H) The Company expects to contribute ` 300.00 (2015- ` Nil) to gratuity fund and ` 35.53 (2015 - ` 34.63) to Superannuation fund in the next
year.

ʹÞÞʺ ^sʩŘs_NŸŘǼNjÞEȖǼÞŸŘƻĶŘǣ˚

Amount of ` 850.58 (2015 - `˦ˢ˨ʳˣ˥ʺÞǣNjsOŸ¶ŘÞǣs_ǣŘsɮƼsŘǣsŘ_ÞŘOĶȖ_s_ÞŘŗŸǼsˡˣÞŘǼÌsǢǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣʳ

NOTE 29 - SUPPLEMENTARY INFORMATION

2015-16 2014-15
A) Earnings in foreign currency (accrual basis):
FOB value of exports 1,228.86 ˠʰˣˢ˨ʳˠ˦
B) Expenditure in foreign currency (accrual basis):
i) Royalty 254.55 223.52
ii) Travelling and Conveyance - 9.50
iii) Professional Consulting Fees 5.68 5.19
iv) Others ˠˠʳˠ˦ ˡˠʳ˦˥
C) CIF value of imports
(i) Raw material and Packing Material 2,416.19 926.30
(ii) Capital goods 4.85 -

D) Unhedged foreign currency exposure:

2015-16 2014-15
Particulars Foreign Currency ` in Lacs Amount in Foreign ` in Lacs Amount in Foreign
Currency Currency
Trade Receivables USD ˠ˦˧ʳˡˣ ˡ˥˧ʰ˦˟˨ 100.39 160,385
Trade Payables USD 132.42 199,636 ˤ˦ʳ˥˟ 92,020
Trade Payables Euro 39.88 53,100 ˦ˠʳ˦˟ 106,200

E) Payment to auditors (excluding service tax)

2015-16 2014-15
As Auditors
Audit fee ˤˡʳ˦ˤ 41.50
Tax audit fees 8.00 8.00
Limited review 26.00 ˡˣʳ˦ˤ
In other capacity
Transfer pricing fee 1.25 1.00
NsNjǼÞʩOǼÞŸŘ¯ss 1.50 0.25
Reimbursement of expenses 4.84 ˣʳ˟˦
94.34 79.57
Corporate Overview Performance Governance Financial Statements 131

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
NOTE 29 - SUPPLEMENTARY INFORMATION (contd.)
` in Lacs
F) Details of Raw and packing material consumed:

Particulars Consumption Value


2015-16 2014-15
Synthetic Dye 630.20 ˦ˡˡʳˤ˧
Soap Noodles 51.35 34.91
Dyes & Chemicals 15,208.29 ˠˢʰˢ˨ˠʳ˦ˤ
Fatty Oils, Powder & Perfumes ˠˤʰ˟˧ˠʳ˦˟ 13,298.93
Plastic 2,423.66 ˡʰ˧˦ˣʳˣ˦
Others 2,616.01 2,834.91
Packing materials 12,629.31 ˠˡʰˣ˦˧ʳˠˢ
Total 48,640.52 45,635.68

G) Value of Imported and Indigenous Raw Materials, Packing Materials, Stores and Spare Parts Consumed

Particulars Raw Materials / Packing Materials Stores and Spare parts


2015-16 2014-15 2015-16 2014-15
Value % Value % Value % Value %
Imported ˠʰˠ˥˦ʳ˧ˤ 2.40% ˥˦˨ʳ˨˥ 1.49% 0.52 ˟ʳ˟˦̇ 0.05 0.01%
Indigenous ˣ˦ʰˣ˦ˡʳ˥˦ ˨˦ʳ˥˟̇ ˣˣʰ˨ˤˤʳ˦ˡ 98.51% ˦ˢˡʳ˥ˢ 99.93% 626.26 99.99%
Total 48,640.52 45,635.68 733.15 626.31

H) Details of product sold, inventory and purchase of traded goods

Item Type Opening Inventory Purchases Sales Closing Inventory


Home Care Traded 1,310.44 12,421.53 15,801.56 1,253.85
9,853.98 12,538.66
Manufactured ˡʰ˥ˤˠʳ˥˦ - ˡˡʰ˥˦ˣʳ˥ˢ ˡʰˤˣ˟ʳ˥˦
- ˠ˨ʰˡ˨˦ʳ˨ˣ
Soaps & Detergents Traded 2,350.09 ˠ˦ʰˤˣ˦ʳˠˤ ˡ˦ʰˢˢˣʳˤ˥ 1,694.84
20,609.40 31,518.66
Manufactured 4,668.38 - 89,965.63 5,445.56
- ˦˦ʰ˥˦ˢʳ˟˟
Others Traded 446.22 ˦ˣˢʳ˦ˡ 1,533.31 163.95
1,326.59 ˠʰ˦˨˧ʳˤ˥
Manufactured - - 41.25 63.09
- -
Total 11,426.80 30,712.40 157,350.94 11,161.96
ˢˠʰ˦˧˨ʳ˨˦ 142,826.82

Figures in italics are in respect of the previous year

I) Value of closing stock of work in progress

Particulars 2016 2015


Home Care ˢˡˣʳ˧˦ ˢˤ˨ʳ˧˦
Soaps & Detergents 1,218.65 1,009.20
Others 2.55 -
Total 1,546.07 1,369.07

J) Expenditure related to Corporate Social Responsibility as per Section 135 of the Companies Act, 2013 read with Schedule VII is as
given below:

Particulars 2015-16 2014-15


Promoting preventing health care and sanitation 44.28 91.44
Contribution to Prime Ministers National Relief Fund - 19.86
Promotion of Education 5.00 -
Rural/ slum area development 185.56 10.03
Total 234.84 121.33
Gross amount required to be spent during the year 195.30 166.92
132 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
NOTE 30 - SEGMENT REPORTING

Information about Business Segments

Business segments:

The primary segment of the Company has been determined on the basis of business segment. The Company is organized into following business
ǣs¶ŎsŘǼǣ˚ǢŸƼǣŘ_^sǼsNj¶sŘǼǣʰËŸŎsNNjsŘ_ŸǼÌsNjǣʳǢs¶ŎsŘǼǣÌɚsEssŘÞ_sŘǼÞʩs_ǼĨÞضÞŘǼŸOOŸȖŘǼǼÌsŘǼȖNjsŸ¯ǼÌsƼNjŸ_ȖOǼǣʰǼÌs
differing risks and returns, the organization structure and the internal reporting system.

Soaps and Detergents includes fabric whiteners, fabric detergents, dish wash bar and soaps including ayurvedic soaps. Home Care products
include incense sticks, scrubber, dhoop and mosquito repellents. Others includes bodycare,tea and coffee.

Secondary segment:

ǻÌsNŸŎƼŘɴŎÞŘĶɴOǼsNjǣǼŸǼÌsŘss_ǣŸ¯ǼÌs_ŸŎsǣǼÞOŎNjĨsǼʳǻÌssɮƼŸNjǼǼȖNjŘŸɚsNjÞǣŘŸǼǣÞ¶ŘÞʩOŘǼÞŘǼÌsOŸŘǼsɮǼŸ¯ǼŸǼĶǼȖNjŘŸɚsNjʳǣǣȖOÌʰ
there is only one reportable geographical segment.

Segment revenue and result:

The income/ expense that are not directly attributable to the business segments are shown as unallocated corporate costs.

Segment assets and liabilities:

Ǣs¶ŎsŘǼǣǣsǼǣÞŘOĶȖ_sĶĶŸƼsNjǼÞضǣǣsǼǣȖǣs_Eɴǣs¶ŎsŘǼŘ_OŸŘǣÞǣǼƼNjÞŘOÞƼĶĶɴŸ¯_sEǼŸNjǣʰÞŘɚsŘǼŸNjÞsǣʰ_ɚŘOsǣŘ_ʩɮs_ǣǣsǼǣʳǣǣsǼǣ
at corporate level are not allocable to segments on a reasonable basis and thus the same have not been allocated. Segment liabilities include all
operating liabilities and consist principally of creditors and accrued liability.

` in Lacs
Soaps and Detergents Home care Others Eliminations Total
2015-16 2014-15 2015-16 2014-15 2015-16 2014-15 2015-16 2014-15 2015-16 2014-15
Revenue
External Revenue ˠˠ˦ʰˢ˟˟ʳˠ˨ 109,191.66 ˢ˧ʰˣ˦˥ʳˠ˨ 31,836.60 ˠʰˤ˦ˣʳˤ˥ ˠʰ˦˨˧ʳˤ˥ - - ˠˤ˦ʰˢˤ˟ʳ˨ˣ 142,826.82
Inter Segment Revenue 35.39 - 144.44 ˤˠ˦ʳ˥˨ - - ʹˠ˦˨ʳ˧ˢʺ ʹˤˠ˦ʳ˥˨ʺ - -
Net Revenue 117,335.58 109,191.66 38,620.63 32,354.29 1,574.56 1,798.56 (179.83) (517.69) 157,350.94 142,826.82
Segment Result 15,906.66 11,520.80 2,085.56 ˨ˤˤʳˢ˦ (15.30) ˠˣʳ˦˨ - - ˠ˦ʰ˨˦˥ʳ˨ˡ 12,490.96
Unallocated expenditure ʹˡʰ˨ˣˤʳˡ˦ʺ ʹˡʰ˨ˢ˦ʳ˦ˣʺ
Unallocated Income 5,594.99 6,550.52
ÝŘǼsNjsǣǼŘ_ʩŘŘOssɮƼsŘǣsǣ (485.56) (1,202.98)
ƻNjŸʩǼ Es¯ŸNjs sɮOsƼǼÞŸŘĶ 20,141.08 14,900.76
items and tax
Exceptional Item - (209.18)
ƻNjŸʩǼEs¯ŸNjsǼɮ 20,141.08 14,691.58
Tax expenses 3,905.12 412.63
ƻNjŸʩǼ¯ǼsNjǼɮ 16,235.96 14,278.95
Other Information
Segment assets ˤ˥ʰ˦˨ˤʳ˧ˢ 58,112.58 15,865.43 ˠˢʰˣ˥˥ʳˠ˦ 2,110.06 2,250.46 - - ˦ˣʰ˦˦ˠʳˢˡ ˦ˢʰ˧ˡ˨ʳˡˠ
Unallocated assets 112,355.13 ˠˠ˦ʰ˧ˠˢʳ˧˟
Total assets 187,126.45 191,643.01
Segment liabilities 13,942.12 12,313.11 ˦ʰˢ˥ˡʳˢ˟ 4,912.56 ˠ˦˟ʳˡˡ 95.50 - - ˡˠʰˣ˦ˣʳ˥ˣ ˠ˦ʰˢˡˠʳˠ˦
Unallocated liabilities 62,393.82 ˦˧ʰˠˤˠʳˣ˦
Total liabilities 83,868.46 95,472.64
Corporate Overview Performance Governance Financial Statements 133

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
NOTE 30 - SEGMENT REPORTING (contd.)
` in Lacs
Soaps and Detergents Home care Others Eliminations Total
2015-16 2014-15 2015-16 2014-15 2015-16 2014-15 2015-16 2014-15 2015-16 2014-15
Segment capital expenditure 913.81 1,016.85 291.36 ˣˡˤʳ˦˧ ˠ˥˥ʳ˨˦ - - - ˠʰˢ˦ˡʳˠˣ 1,442.63
(including capital work in
progress)
Unallocated capital 305.92 351.55
expenditure (including
capital work in progress)
Total capital expenditure 1,678.06 1,794.18
(including capital work in
progress)
Segment depreciation and 4,413.04 ˣʰˤ˟ˤʳ˦ˠ 363.13 459.55 246.35 ˡˣˣʳ˦˟ - - 5,022.52 5,209.96
amortisation
Unallocated depreciation ˠʰ˦˦ˠʳˣ˦ ˠʰ˧ˡ˦ʳˠˠ
and amortisation
Total depreciation and 6,793.99 7,037.07
amortisation
Segment non cash expenses 60.36 ˦˧ʳˣˤ 19.52 12.30 - - - - ˦˨ʳ˧˧ ˨˟ʳ˦ˤ
other than depreciation
Unallocated non cash expenses ˦˦ʳ˨˨ (26.50)
other than depreciation
Total non cash expenses 157.87 64.25
other than depreciation

Information about geographical segment :

2015-16 2014-15
India Outside India India Outside India
Revenue ˠˤˢʰ˨ˡ˥ʳ˦ˢ 3,424.21 139,510.13 3,316.69

All assets of the Company are located in India

NOTE 31 - RELATED PARTY DISCLOSURES

a) Parties where control exists


Individual having control
M.P. Ramachandran Chairman and Managing Director
As the Managing Director of the Company is an individual having control and hence not separately
disclosed as a Key management personnel.
Wholly Owned Subsidiaries
Jyothy Consumer Products Marketing Limited
Other Subsidiaries
Jyothy Kallol Bangladesh Limited
Four Seasons Drycleaning Company Private Limited
Snoways Laundrers & Drycleaners Private Limited
Jyothy Fabricare Services Limited
b) Related party relationships where transactions have taken place during the year
ƻNjǼŘsNjǣÌÞƼʩNjŎ
M/S JFSL-JLL (JV)
Firm / HUF in which the relatives of individual having control are partners / members / proprietor
Quilon Trading Co.
M.P. Divakaran - H.U.F.
M.P. Sidharthan - H.U.F.
Relative of individual having control
M.P. Sidharthan
134 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
NOTE 31 - RELATED PARTY DISCLOSURES (contd.)
M.R. Jyothy
M.R. Deepthi
Ananth Rao T
Ravi Razdan
M.P. Divakaran
rŘǼsNjƼNjÞǣsǣǣÞ¶ŘÞʩOŘǼĶɴÞŘʪȖsŘOs_EɴĨsɴŎضsŎsŘǼƼsNjǣŸŘŘsĶŸNjǼÌsÞNjNjsĶǼÞɚsǣ
Sahyadri Agencies Ltd.
Key management personnel
K. Ullas Kamath Joint Managing Director & CFO
S.Raghunandan Whole Time Director & CEO
Additional related party as per Companies Act, 2013.
M.L. Bansal Company Secretary

c) Transactions with related parties during the year

` in Lacs
2015-16 2014-15
Individual having control
Remuneration* 0.00 0.00
Commission 421.04 312.69
Dividend ˤʰ˦˥˧ʳ˨˥ 1,442.24
Associated Industries Consumer Products Pvt Ltd
(merged with Jyothy Consumer Products Marketing Limited)
Sale of Finished goods (net of sales return), Raw material, - ˣˠʳ˟˦
Packing material and Stores & spares
Sale of Fixed assets - 89.42
Royalty Income ( including service tax) - 4.88
Rent Income - 1.68
Purchase of Finished goods (Net of purchase return), raw and packing material - ˣˤ˨ʳ˨˦
Purchase of Fixed assets - ˠˣʳˤ˦
Conversion Charges and excise net of cenvat / (refund) - ˦˟ʳˢ˟
Interest Income - ˡ˦ʳˤ˧
Reimbursement of Expenses - 3.59
Sale of shares held in Jyothy Consumer Products Marketing Limited - 82.55
Sahyadri Agencies Limited
Dividend 1,200.00 300.00
Assignment of receivables - ˠʰˣ˦˧ʳ˟˟
Quilon Trading Company
Rent Paid 1.20 1.20
Dividend (M.P. Divakaran - H.U.F. and M.P. Sidharthan - H.U.F.) ˡˤ˦ʳ˨ˡ 64.48
Jyothy Fabricare Services Limited
Repayment of loan given - 13,500.00
Reimbursement of expenses 19.41 26.14
Interest Income - ˦ˠ˟ʳ˧˥
Sale of Finished goods (net of sales return ) 12.54 ˥ʳ˦˧
Purchases of services 0.15 0.08
ǢȖEǣONjÞƼǼÞŸŘǼŸ˦ˤʰ˟˟ʰ˟˟˟ˡ̇ŷƼǼÞŸŘĶĶɴNŸŘɚsNjǼÞEĶsƻNjs¯sNjsŘOsǢÌNjsǣ - 15,000.00
Corporate Guarantees given for borrowings taken
Balance outstanding as at year end is : 4,000.00 4,000.00
Jyothy Consumer Products Marketing Ltd
Interest Income 4,335.36 4,811.32
Corporate Overview Performance Governance Financial Statements 135

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
NOTE 31 - RELATED PARTY DISCLOSURES (contd.)
` in Lacs
2015-16 2014-15
Rent Income ˥ˤʳ˦˨ ˦ˣʳˡˠ
Purchase of Finished goods and Raw Material (Net of purchase return) ˧˟˟ʳ˦ˢ 1,405.61
Purchases of Fixed Assets 0.69 -
Sale of Finished goods (net of sales return ) ˤʰ˟ˠ˦ʳˢ˦ 3,012.86
Royalty Income ( including service tax) 3.04 -
Conversion Charges 2.10 -
Sale of Fixed Assets ˡ˦ʳˢ˧ -
M/S JFSL-JLL (JV)
ƻNjŸʩǼˀʹĶŸǣǣʺÞŘƼNjǼŘsNjǣÌÞƼ ʹ˦ʳˢˡʺ ˡ˦ʳˠ˦
Interest on partner capital 11.15 8.68
Withdrawal of capital 12.50 43.00
Corporate Guarantees given for borrowings taken
Balance outstanding as at year end is : 902.44 ˠʰ˟˦˦ʳˣˣ
Jyothy Kallol Bangladesh Limited
ǢĶsǣŸ¯ʩŘÞǣÌs_¶ŸŸ_ǣ 65.35 145.09
Investment in share capital ˦˧ʳ˧ˡ -
Relatives of individuals having control
Remuneration*
M.R. Jyothy 102.48 96.32
M P Sidharthan 24.00 24.00
M R Deepthi ˢ˦ʳˤˠ ˡ˦ʳ˥˟
Ananth Rao T 45.03 ˢˣʳ˦ˣ
Ravi Razdan ˢ˦ʳˤˠ ˡ˦ʳ˥˟
M.P. Divakaran 24.00 24.00
Dividend ˡʰˢˡ˦ʳˤˡ ˤ˧ˠʳ˨˦
Contribution to Superannuation fund
M R Jyothy - 0.90
M R Deepthi - 2.40
Ravi Razdan - 2.40
Key management personnel
Remuneration*# ˦ˡ˧ʳ˥˨ ˦ˡˠʳ˟˨
Commission ˢ˦˧ʳ˨ˢ 281.42
Dividend ˠˢˠʳ˦ˤ 32.94
Contribution to Superannuation fund 21.60 28.20

* As the future liabilities for gratuity is provided on an actuarial basis for the Company as a whole, the amount pertaining to individual is not
ascertainable and therefore not included above.

# The Company has accrued ` 1,544.53 in respect of employee stock options granted to whole time director and CEO. The same has not been
OŸŘǣÞ_sNjs_ǣŎضsNjÞĶNjsŎȖŘsNjǼÞŸŘŸ¯ǼÌsOȖNjNjsŘǼɴsNjǣ_sʩŘs_ȖŘ_sNjǢsOǼÞŸŘˡʹ˦˧ʺŸ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢǣǼÌsŸƼǼÞŸŘǣÌɚsŘŸǼ
been exercised.
136 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
NOTE 31 - RELATED PARTY DISCLOSURES (contd.)
` in Lacs
d) Related party balances
2015-16 2014-15
Amounts receivable
Loans and advances :
Associated Industries Consumer Products Pvt Ltd - 349.83
Jyothy Consumer Products Marketing Ltd ˣ˦ʰˡˤ˟ʳˢˠ 43,000.00
Trade receivables :
Jyothy Consumer Products Marketing Ltd - 415.39
Jyothy Kallol Bangladesh Limited 11.31 -
Amounts payable
Trade payables :
Individual having control 421.04 312.69
Key management personnel ˢ˦˧ʳ˨ˢ 281.42
Advance from customer
Jyothy Consumer Products Marketing Ltd 22.38 -

NOTE 32 - OPERATING LEASES


In case of assets taken on lease
ǻÌsNŸŎƼŘɴÌǣsŘǼsNjs_ÞŘǼŸĵsǣs¶NjssŎsŘǼǣ¯ŸNjƼNjsŎÞǣsǣʰɠÌÞOÌsɮƼÞNjsǼɚNjÞŸȖǣ_ǼsǣŸɚsNjǼÌsŘsɮǼʩɚsɴsNjǣʳNsNjǼÞضNjssŎsŘǼǣƼNjŸɚÞ_s
for increase in rent. Lease rental expense for the year ended March 31, 2016 was ` 1,266.10 (2015 - ` 1,160.19). There are no restrictions imposed
by lease arrangements.

2015-16 2014-15
Future lease payment under non - cancellable operating leases are as follows:
Payable not later than one year 295.69 45.82
ƻɴEĶsĶǼsNjǼÌŘŸŘsɴsNjŘ_ŘŸǼĶǼsNjǼÌŘʩɚsɴsNjǣ ˦˟˥ʳˤˠ 0.64
ƻɴEĶsĶǼsNjǼÌŘʩɚsɴsNjǣ 104.51 -
1,106.71 46.46
In case of assets given on lease

The Company has leased out few of its premises on operating lease. The Gross carrying amount and accumulated depreciation as at March 31,
2016 is `˨˦ʳˣ˥Ř_` 24.45 (2015 - `˨˦ʳˣ˥Ř_`ˡˢʳˣ˦ʺNjsǣƼsOǼÞɚsĶɴʳĵsǣsNjsŘǼÞŘOŸŎs¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥ɠǣ`˥˥ʳˢ˟ʹˡ˟ˠˤ˛
` ˦ˤʳ˧ˣʺʳǻÌsNjsÞǣŘŸsǣOĶǼÞŸŘOĶȖǣsÞŘǼÌsĶsǣs¶NjssŎsŘǼŘ_ǼÌsĶsǣsÞǣOŘOsĶĶEĶsÞŘŘǼȖNjsʳǻÌsNjsNjsŘŸNjsǣǼNjÞOǼÞŸŘǣÞŎƼŸǣs_EɴĶsǣs
arrangements.

NOTE 33 - CONTINGENT LIABILITIES

2016 2015
Based on management’s evaluation following contingent liabilities is not probable and hence
not provided by the Company in respect of:
(i) Amount outstanding in respect of corporate guarantees 4,902.44 ˤʰ˟˦˦ʳˣˣ
(ii) Tax matters
 ʹʺ^ÞǣƼȖǼs_ǣĶsǣǼɮ_sŎŘ_ǣ˛ŎǼǼsNjǣȖŘ_sNjƼƼsĶ ˠʰ˧˦˟ʳˠˢ 1,843.20
(b) Disputed excise duty and service tax demand - matter under appeal 3,864.18 ˡʰ˨˥ˢʳ˦ˤ
(c) Disputed income tax demand - matter under appeal * ˥ʰ˦ˢˢʳˠˤ ˢʰ˦ˣˠʳ˥˟
(iii) Other statutory dues 3.83 ˦ʳ˦ˡ

* The amount shown above does not include contingent liability for assessment years which have been reopened (unless demand order is raised)
and those pending assessments.
Corporate Overview Performance Governance Financial Statements ˠˢ˦

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
` in Lacs
NOTE 34 - CAPITAL COMMITMENTS (NET OF ADVANCES)

2016 2015
Estimated amount of contracts remaining to be executed on capital account and ˠʰ˟ˤ˟ʳ˦ˡ 441.50
not provided for
1,050.72 441.50

NOTE 35 : MICRO, SMALL AND MEDIUM ENTERPRISES DEVELOPMENT ACT, 2006 ( ‘MSMED’)

The disclosure pursuant to the said Act is as under :

2016 2015
Principal amount due to suppliers under MSMED Act 4,682.31 ˢʰ˦ˡ˧ʳˠ˦
Interest accrued and due to suppliers under Section 16 of MSMED Act, 2006 on the above ˣʳ˨˦ 4.05
amount, unpaid
Interest paid to suppliers under the MSMED Act - -
Interest due and payable towards suppliers under MSMED Act towards payment already made - -
Interest accrued and remaining unpaid at the end of accounting year ˣʳ˨˦ 4.05

ǻÌsEŸɚsÞŘ¯ŸNjŎǼÞŸŘÌǣEssŘ_sǼsNjŎÞŘs_ǼŸǼÌssɮǼsŘǼǣȖOÌƼNjǼÞsǣÌɚsEssŘÞ_sŘǼÞʩs_ŸŘǼÌsEǣÞǣŸ¯ÞŘ¯ŸNjŎǼÞŸŘɚÞĶEĶsɠÞǼÌǼÌsNŸŎƼŘɴʳ

NOTE 36 - EMPLOYEE STOCK OPTION PLANS (‘ESOP’)

On August 16, 2014 the Remuneration and Compensation Committee of the Board of Directors of the Company approved the Employee Stock
Option Scheme 2014 (“ESOS-2014”) for issue of stock options to the key employees and Employee Stock Option Scheme 2014-A (“ESOS- 2014-A”)
for issue of stock options to Whole Time Director & CEO of the Company. According to the scheme, whole time Director and CEO and eligible
employees selected by the Remuneration and Compensation Committee will be entitled to options from time to time, subject to satisfaction of
prescribed vesting conditions. The relevant terms of the grant are as below : -

(“ESOS -2014”) (“ESOS -2014”) ("ESOS -2014 - A")


Particulars
Grant – I Grant – II
Date of Grant August 16, 2014 ğŘȖNjɴˡ˦ʰˡ˟ˠˤ August 16, 2014
Number of options granted 5,03,445 ˢˣʰˤ˟˦ ˡ˦ʰˠˤʰˢˤˡ
Vesting period 33% - Year 1 33% - Year 1 ˥˥ʳ˥˦̇˚ɳsNjˠ
33% - Year 2 33% - Year 2 ˠ˥ʳ˥˦̇˚ɳsNjˡ
34% - Year 3 34% - Year 3 16.66% - Year 3
Exercise period 5 years from the respective dates of vesting
Exercise Price - Per share `1 `1 `1
Market price at grant date - Per share `ˠ˧˧ʳ˦˟ ` 289.80 `ˠ˧˧ʳ˦˟

The details of the activity under the above schemes are summarised as below;

(“ESOS -2014”) (“ESOS -2014”) ("ESOS -2014 - A")


Particulars
Grant – I Grant – II
Outstanding at April 1, 2014 - - -
Granted during 2014-15 5,03,445 ˢˣʰˤ˟˦ ˡ˦ʰˠˤʰˢˤˡ
Cancelled during 2014-15 52,994 - -
Exercised during 2014-15 - - -
Outstanding at March 31, 2015 4,50,451 ˢˣʰˤ˟˦ ˡ˦ʰˠˤʰˢˤˡ
Exercisable at March 31, 2015 4,50,451 ˢˣʰˤ˟˦ ˡ˦ʰˠˤʰˢˤˡ

Outstanding at April 1, 2015 4,50,451 ˢˣʰˤ˟˦ ˡ˦ʰˠˤʰˢˤˡ


Granted during 2015-16 - - -
Cancelled during 2015-16 ˧˦ʰ˨˦˟ ˢˣʰˤ˟˦ 4,52,559
Exercised during 2015-16 96,184 - -
Outstanding at March 31, 2016 ˡʰ˥˥ʰˡ˨˦ - ˡˡʰ˥ˡʰ˦˨ˢ
Exercisable at March 31, 2016 ˡʰ˥˥ʰˡ˨˦ - ˡˡʰ˥ˡʰ˦˨ˢ
138 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
` in Lacs
NOTE 36 - EMPLOYEE STOCK OPTION PLANS (‘ESOP’) (contd.)
For option excercised during the period, the weighted average share price at the exercise date was `ˡ˨˦ʳˣˣƼsNjǣÌNjsʹˡ˟ˠˤ˚ŘŸǼƼƼĶÞOEĶsǣÞŘOs
no option were exercised).
No new stock option have been granted by the company in the current year.
The Black Scholes valuation model has been used for computing the weighted average fair value of the stock granted considering the following
inputs for the year ended March 31, 2016 and March 31, 2015 :-

(“ESOS -2014”)- GRANT – I


Variables Vest 1 Vest 2 Vest 3
August 16, 2015 August 16, 2016 August 16, 2017
Volatility 36.19% ˢ˦ʳˢˡ̇ 40.33%
Riskfree Rate ˧ʳ˦ˢ̇ ˧ʳ˦ˡ̇ ˧ʳ˦ˡ̇
Exercise Price (`) 1.00 1.00 1.00
Time To Maturity (In Years) 3.50 4.50 5.50
Dividend yield 1.59% 1.59% 1.59%
Weighted average fair Value of per stock option granted (`) 174.98

(“ESOS -2014 - A”)


Variables Vest 1 Vest 2 Vest 3
August 16, 2015 August 16, 2016 August 16, 2017
Volatility 36.19% ˢ˦ʳˢˡ̇ 40.33%
Riskfree Rate ˧ʳ˦ˢ̇ ˧ʳ˦ˡ̇ ˧ʳ˦ˡ̇
Exercise Price (`) 1.00 1.00 1.00
Time To Maturity (In Years) 3.50 4.50 5.50
Dividend yield 1.59% 1.59% 1.59%
Weighted average fair Value of per stock option granted (`) 176.38

ǻÌssɮƼsOǼs_ɚŸĶǼÞĶÞǼɴNjsʪsOǼǣǼÌsǣǣȖŎƼǼÞŸŘǼÌǼǼÌsÌÞǣǼŸNjÞOĶɚŸĶǼÞĶÞǼɴŸɚsNjƼsNjÞŸ_ǣÞŎÞĶNjǼŸǼÌsĶÞ¯sŸ¯ǼÌsŸƼǼÞŸŘǣÞǣÞŘ_ÞOǼÞɚsŸ¯¯ȖǼȖNjs
trends, which may not necessarily be the actual outcome.
The Company measures the cost of ESOP using the intrinsic value method. Had the company used the fair value model to determine compensation,
ÞǼǣƼNjŸʩǼ¯ǼsNjǼɮŘ_sNjŘÞضǣƼsNjǣÌNjsǣNjsƼŸNjǼs_ɠŸȖĶ_ÌɚsOÌضs_ǼŸǼÌsŎŸȖŘǼǣǣÞŘ_ÞOǼs_EsĶŸɠʲ

As at March 31, 2016 As at March 31, 2015


ƻNjŸʩǼ¯ǼsNjǼɮǣNjsƼŸNjǼs_ 16,235.96 ˠˣʰˡ˦˧ʳ˨ˤ
Add: ESOP cost using the intrinsic value method ˠʰ˦ˤ˟ʳˡ˥ ˡʰ˧˦ˠʳˠˢ
Less: ESOP cost using the fair value method ʹˠʰ˥ˢ˥ʳ˦˧ʺ ʹˡʰ˥˥ˠʳˠ˦ʺ
ƻNjŸ¯ŸNjŎƼNjŸʩǼ¯ǼsNjǼɮ 16,349.44 14,488.91

Earnings Per Share As at March 31, 2016 As at March 31, 2015


Basic
- As reported ˧ʳ˨˦ ˦ʳ˧˨
- Proforma 9.03 8.00
Diluted
- As reported 8.84 ˦ʳ˧ˢ
- Proforma 8.91 ˦ʳ˨ˤ

NOTE - 37 - DETAILS OF LOAN / ADVANCES GIVEN TO SUBSIDIARY COMPANIES (SECTION 186(4) OF COMPANIES ACT, 2013)

Particulars Secured/ Unsecured 2016 2015


Associated Industries Consumer Products Pvt Ltd (AICPPL) * Unsecured - 349.83
Jyothy Consumer Products Marketing Ltd(JCPML)** Unsecured ˣ˦ʰˡˤ˟ʳˢˠ 43,000.00

The above loans are repayable on demand and utilised by the subsidiaries towards their working capital requirements.
* Merged with Jyothy Consumer Products Marketing Limited w.e.f. April 1, 2014
** No additional loan has been given during the year. The increase is on account of unpaid interest added to the loan given and loan transferred
on account of merger of AICPPL with JCPML.
Corporate Overview Performance Governance Financial Statements 139

NOTES
ǼŸǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥
` in Lacs
NOTE - 38 - DETAILS OF INVESTMENTS IN PARTNERSHIP FIRM

ǢÌNjsŸ¯ƼNjǼŘsNjÞŘƼNjŸʩǼǣʹ̇ʺ
2016 2015
Name of Partner
ǢÌNjsŸ¯ƼNjǼŘsNjÞŘƼNjŸʩǼǣʹ̇ʺ
Jyothy Fabricare Services Limited ˦ˤʳ˟˟̇ ˦ˤʳ˟˟̇
Jyothy Laboratories Limited 25.00% 25.00%
ǻŸǼĶOƼÞǼĶŸ¯ǼÌsʩNjŎ 339.00 318.20

NOTE 39 - EARNINGS PER SHARE

2016 2015
ŗsǼƻNjŸʩǼ¯ŸNjOĶOȖĶǼÞŸŘŸ¯EǣÞOŘ__ÞĶȖǼs_rƻǢ 16,235.96 ˠˣʰˡ˦˧ʳ˨ˤ
Weighted average number of shares for calculation of basic EPS ˠ˧ʰˠ˟ʰ˦˦ʰ˦˥ˣ 18,10,23,496
Effect of dilution :
Stock option granted under ESOP 25,06,850 12,24,545
Weighted average number of shares for calculation of diluted EPS 18,35,84,614 18,22,48,041
Basic EPS (`) ˧ʳ˨˦ ˦ʳ˧˨
Diluted EPS (`) 8.84 ˦ʳ˧ˢ

NOTE - 40
ǣƼsNjǼÌsŗŸǼÞʩOǼÞŸŘŘŸʳˢˡˀ˨˨˚Nr_Ǽs_ğȖĶɴ˧ʰˠ˨˨˨ʰǼÌsNŸŎƼŘɴɠǣsŘǼÞǼĶs_ǼŸNjs¯ȖŘ_Ÿ¯sɮOÞǣs_ȖǼɴÞصȖɠÌǼÞŘ_ğŎŎȖȖŘÞǼǣsLJȖÞɚĶsŘǼ
ǼŸˠ˟˟̇Ÿ¯ǼÌsŎŸȖŘǼŸ¯ǼÌs_ȖǼɴƼÞ_ǼÌNjŸȖ¶ÌƻsNjǣŸŘĶĵs_¶sNjOOŸȖŘǼʹ˄ƻĵ˅ʺʳ^ȖNjÞضŘsNjĶÞsNjɴsNjʰǼÌsµŸɚsNjŘŎsŘǼÞǣǣȖs_ŘŸǼÞʩOǼÞŸŘǣ
ŘŸʳˠ˦ˀˡ˟˟˧˚NrŘ_ˠ˨ˀˡ˟˟˧˚Nr_Ǽs_ōNjOÌˡ˦ʰˡ˟˟˧NjsǣǼNjÞOǼÞضǼÌsNjs¯ȖŘ_ŎŸȖŘǼǼŸŎɮÞŎȖŎƼsNjOsŘǼ¶sǣƼsOÞʩs_ÞŘǼÌsŘŸǼÞʩOǼÞŸŘʳǻÌs
Company has received a favourable order from the High Court of Guwahati & Jammu and Kashmir in earlier years. Accordingly, the Company has
OONjȖs_Ř__ÞǼÞŸŘĶEsŘsʩǼŸ¯` 940.48 (2015 - `˨˟˦ʳ˟˥ʺÞŘǼÌsOȖNjNjsŘǼɴsNjʳ

NOTE - 41
At its meeting held on May 23, 2016 the Board of Directors have approved the scheme of amalgamation of Jyothy Consumer Products Marketing
Limited (wholly owned subsidiary) with the Company on May 23, 2016. The appointed date under the scheme will be April 1, 2016.

NOTE 42
The Company has entered into an option agreement dated May 5, 2011 with Henkel AG & Co. KGaA (Henkel AG) whereby the Company has
¶NjŘǼs_ËsŘĨsĶµʩNjŎŘ_ÞNjNjsɚŸOEĶsŸƼǼÞŸŘʰǼÞǼǣǣŸĶs_ÞǣONjsǼÞŸŘǼŘɴǼÞŎs¯ǼsNjǼÌsEs¶ÞŘŘÞضŸ¯ǼÌsʩ¯ǼÌɴsNjŘ_sŘ_ÞضȖƼŸŘǼÌssɮƼÞNjɴ
of the sixth year of the said agreement or such other mutually extended period, to acquire a maximum of 26% of the issued equity share capital of
the Company at a price which will be mutually determined by the parties at a later date.

NOTE 43 - EXCEPTIONAL ITEM


Exceptional item relates additional payment towards retrenchment of employees for the Kandanassery unit in previous year.

NOTE 44 - PREVIOUS YEAR FIGURES


ƻNjsɚÞŸȖǣɴsNjʩ¶ȖNjsǣÌɚsEssŘNjs¶NjŸȖƼs_ˀNjsOĶǣǣÞʩs_ʰɠÌsNjsŘsOsǣǣNjɴʰǼŸOŸŘ¯ŸNjŎǼŸǼÌÞǣɴsNjOĶǣǣÞʩOǼÞŸŘʳ

Signatures to Notes 1 to 44
As per our report of even date
For S R B C & CO LLP For and on behalf of the Board of Directors of
Chartered Accountants Jyothy Laboratories Limited
ICAI Firm Registration No. 324982E/ E300003
per Vikram Mehta M.P. Ramachandran K.Ullas Kamath
Partner Chairman and Managing Director ğŸÞŘǼōضÞض^ÞNjsOǼŸNjŘ_NÌÞs¯®ÞŘŘOÞĶŷ¯ʩOsNj
Membership No.: 105938 DIN: 00553406 DIN: 00506681

M.L. Bansal S.Raghunandan


Company Secretary ɟÌŸĶsǻÞŎs^ÞNjsOǼŸNjŘ_NÌÞs¯rɮsOȖǼÞɚsŷ¯ʩOsNj
ōsŎEsNjǣÌÞƼŗŸʳʲ®ˡˡ˨˦ DIN: 02263845
Place: Mumbai Place: Mumbai
Date: May 23, 2016 Date: May 23, 2016
140 Jyothy Laboratories Limited
Annual Report 2015-16

INDEPENDENT AUDITOR’S REPORT


To audit in accordance with the Standards on Auditing, issued by
The Members of ǼÌs ÝŘǣǼÞǼȖǼs Ÿ¯ NÌNjǼsNjs_ OOŸȖŘǼŘǼǣ Ÿ¯ ÝŘ_Þʰ ǣ ǣƼsOÞʩs_
Jyothy Laboratories Limited ȖŘ_sNjǢsOǼÞŸŘˠˣˢʹˠ˟ʺŸ¯ǼÌsOǼʳǻÌŸǣsǢǼŘ_Nj_ǣNjsLJȖÞNjsǼÌǼ
we comply with ethical requirements and plan and perform
REPORT ON THE CONSOLIDATED FINANCIAL STATEMENTS the audit to obtain reasonable assurance about whether the
ʩŘŘOÞĶǣǼǼsŎsŘǼǣNjs¯Njss¯NjŸŎŎǼsNjÞĶŎÞǣǣǼǼsŎsŘǼʳ
ɟs Ìɚs Ȗ_ÞǼs_ ǼÌs OOŸŎƼŘɴÞض OŸŘǣŸĶÞ_Ǽs_ ʩŘŘOÞĶ
statements of Jyothy Laboratories Limited (hereinafter referred An audit involves performing procedures to obtain audit
to as “the Holding Company”) and its subsidiaries (the Holding evidence about the amounts and disclosures in the consolidated
Company and its subsidiaries together referred to as “the ʩŘŘOÞĶǣǼǼsŎsŘǼǣʳǻÌsƼNjŸOs_ȖNjsǣǣsĶsOǼs__sƼsŘ_ŸŘǼÌs
Group”) comprising of the consolidated Balance Sheet as at Ȗ_ÞǼŸNj˅ǣ ĠȖ_¶ŎsŘǼʰ ÞŘOĶȖ_Þض ǼÌs ǣǣsǣǣŎsŘǼ Ÿ¯ ǼÌs NjÞǣĨǣ Ÿ¯
ōNjOÌ ˢˠʰ ˡ˟ˠ˥ʰ ǼÌs OŸŘǣŸĶÞ_Ǽs_ ǢǼǼsŎsŘǼ Ÿ¯ ƻNjŸʩǼ Ř_ ŎǼsNjÞĶŎÞǣǣǼǼsŎsŘǼŸ¯ǼÌsOŸŘǣŸĶÞ_Ǽs_ʩŘŘOÞĶǣǼǼsŎsŘǼǣʰ
Loss and consolidated Cash Flow Statement for the year then ɠÌsǼÌsNj_ȖsǼŸ¯NjȖ_ŸNjsNjNjŸNjʳÝŘŎĨÞضǼÌŸǣsNjÞǣĨǣǣsǣǣŎsŘǼǣʰ
sŘ_s_ʰŘ_ǣȖŎŎNjɴŸ¯ǣÞ¶ŘÞʩOŘǼOOŸȖŘǼÞضƼŸĶÞOÞsǣŘ_ ǼÌsȖ_ÞǼŸNjOŸŘǣÞ_sNjǣÞŘǼsNjŘĶʩŘŘOÞĶOŸŘǼNjŸĶNjsĶsɚŘǼǼŸǼÌs
other explanatory information (hereinafter referred to as ‘the ËŸĶ_ÞضNŸŎƼŘɴ˅ǣƼNjsƼNjǼÞŸŘŸ¯ǼÌsOŸŘǣŸĶÞ_Ǽs_ʩŘŘOÞĶ
OŸŘǣŸĶÞ_Ǽs_ʩŘŘOÞĶǣǼǼsŎsŘǼǣ˅ʺʳ statements that give a true and fair view in order to design
Ȗ_ÞǼ ƼNjŸOs_ȖNjsǣ ǼÌǼ Njs ƼƼNjŸƼNjÞǼs ÞŘ ǼÌs OÞNjOȖŎǣǼŘOsǣʳ
MANAGEMENT’S RESPONSIBILITY FOR THE An audit also includes evaluating the appropriateness of
CONSOLIDATED FINANCIAL STATEMENTS accounting policies used and the reasonableness of the
ǻÌsËŸĶ_ÞضNŸŎƼŘɴ˅ǣDŸNj_Ÿ¯^ÞNjsOǼŸNjǣÞǣNjsǣƼŸŘǣÞEĶs¯ŸNj OOŸȖŘǼÞضsǣǼÞŎǼsǣŎ_sEɴǼÌsËŸĶ_ÞضNŸŎƼŘɴ˅ǣDŸNj_
ǼÌs ƼNjsƼNjǼÞŸŘ Ÿ¯ ǼÌsǣs OŸŘǣŸĶÞ_Ǽs_ ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣ Ÿ¯^ÞNjsOǼŸNjǣʰǣɠsĶĶǣsɚĶȖǼÞضǼÌsŸɚsNjĶĶƼNjsǣsŘǼǼÞŸŘŸ¯
in terms with the requirement of the Companies Act, 2013 ǼÌs OŸŘǣŸĶÞ_Ǽs_ ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣʳ ɟs EsĶÞsɚs ǼÌǼ ǼÌs
(“the Act”) that give a true and fair view of the consolidated audit evidence obtained by us and the audit evidence obtained
by the other auditors in terms of their reports referred to in
ʩŘŘOÞĶ ƼŸǣÞǼÞŸŘʰ OŸŘǣŸĶÞ_Ǽs_ ʩŘŘOÞĶ ƼsNj¯ŸNjŎŘOs Ř_
ƼNj¶NjƼÌ ʹʺ Ÿ¯ ǼÌs ŷǼÌsNj ōǼǼsNjǣ EsĶŸɠʰ Þǣ ǣȖ¯ʩOÞsŘǼ Ř_
OŸŘǣŸĶÞ_Ǽs_ OǣÌ ʪŸɠǣ Ÿ¯ ǼÌs µNjŸȖƼ ÞŘ OOŸNj_ŘOs ɠÞǼÌ
appropriate to provide a basis for our audit opinion on the
accounting principles generally accepted in India, including
OŸŘǣŸĶÞ_Ǽs_ʩŘŘOÞĶǣǼǼsŎsŘǼǣʳ
ǼÌsOOŸȖŘǼÞضǢǼŘ_Nj_ǣǣƼsOÞʩs_ȖŘ_sNjǢsOǼÞŸŘˠˢˢŸ¯ǼÌs
OǼʰNjs_ɠÞǼÌNJȖĶs˦Ÿ¯ǼÌsNŸŎƼŘÞsǣʹOOŸȖŘǼǣʺNJȖĶsǣʰˡ˟ˠˣʳ OPINION
ǻÌs NjsǣƼsOǼÞɚs DŸNj_ Ÿ¯^ÞNjsOǼŸNjǣŸ¯ǼÌsOŸŎƼŘÞsǣ ÞŘOĶȖ_s_ In our opinion and to the best of our information and according
in the Group are responsible for maintenance of adequate ǼŸ ǼÌs sɮƼĶŘǼÞŸŘǣ ¶ÞɚsŘ ǼŸ Ȗǣʰ ǼÌs OŸŘǣŸĶÞ_Ǽs_ ʩŘŘOÞĶ
accounting records in accordance with the provisions of the Act statements give the information required by the Act in the
for safeguarding of the assets of the Group and for preventing manner so required and give a true and fair view in conformity
and detecting frauds and other irregularities; the selection with the accounting principles generally accepted in India of
and application of appropriate accounting policies; making the consolidated state of affairs of the Group as at March 31,
judgments and estimates that are reasonable and prudent; ˡ˟ˠ˥ʰ ǼÌsÞNj OŸŘǣŸĶÞ_Ǽs_ ƼNjŸʩǼʰ Ř_ ǼÌsÞNj OŸŘǣŸĶÞ_Ǽs_ OǣÌ
and the design, implementation and maintenance of adequate ʪŸɠǣ¯ŸNjǼÌsɴsNjsŘ_s_ŸŘǼÌǼ_Ǽsʳ
ÞŘǼsNjŘĶ ʩŘŘOÞĶ OŸŘǼNjŸĶ ǼÌǼ ɠsNjs ŸƼsNjǼÞض s¯¯sOǼÞɚsĶɴ ¯ŸNj
ensuring the accuracy and completeness of the accounting REPORT ON OTHER LEGAL AND REGULATORY
records, relevant to the preparation and presentation of the REQUIREMENTS
ʩŘŘOÞĶǣǼǼsŎsŘǼǣǼÌǼ¶ÞɚsǼNjȖsŘ_¯ÞNjɚÞsɠŘ_Njs¯Njss As required by section 143 (3) of the Act, we report, to the
from material misstatement, whether due to fraud or error, extent applicable, that:
which have been used for the purpose of preparation of the
OŸŘǣŸĶÞ_Ǽs_ ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣ Eɴ ǼÌs ^ÞNjsOǼŸNjǣ Ÿ¯ ǼÌs (a) We / the other auditors whose reports we have relied
ËŸĶ_ÞضNŸŎƼŘɴʰǣ¯ŸNjsǣÞ_ʳ upon have sought and obtained all the information and
explanations which to the best of our knowledge and
AUDITOR’S RESPONSIBILITY belief were necessary for the purpose of our audit of the
¯ŸNjsǣÞ_OŸŘǣŸĶÞ_Ǽs_ʩŘŘOÞĶǣǼǼsŎsŘǼǣʱ
Our responsibility is to express an opinion on these consolidated
ʩŘŘOÞĶǣǼǼsŎsŘǼǣEǣs_ŸŘŸȖNjȖ_ÞǼʳɟÌÞĶsOŸŘ_ȖOǼÞضǼÌs (b) In our opinion proper books of account as required by
audit, we have taken into account the provisions of the Act, law relating to preparation of the aforesaid consolidation
the accounting and auditing standards and matters which are Ÿ¯ ǼÌs ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣ Ìɚs EssŘ ĨsƼǼ ǣŸ ¯Nj ǣ ÞǼ
required to be included in the audit report under the provisions appears from our examination of those books and reports
Ÿ¯ǼÌsOǼŘ_ǼÌsNJȖĶsǣŎ_sǼÌsNjsȖŘ_sNjʳɟsOŸŘ_ȖOǼs_ŸȖNj of the other auditors;
Corporate Overview Performance Governance Financial Statements 141

(c) The consolidated Balance Sheet, consolidated Statement ÞÞÞʳ ǻÌsNjs Ìǣ EssŘ ŘŸ _sĶɴ ÞŘ ǼNjŘǣ¯sNjNjÞض ŎŸȖŘǼǣʰ
Ÿ¯ƻNjŸʩǼŘ_ĵŸǣǣʰŘ_OŸŘǣŸĶÞ_Ǽs_NǣÌ®ĶŸɠǢǼǼsŎsŘǼ required to be transferred, to the Investor Education
dealt with by this Report are in agreement with the books and Protection Fund by the Holding Company and
of account maintained for the purpose of preparation of ÞǼǣǣȖEǣÞ_ÞNjÞsǣÞŘOŸNjƼŸNjǼs_ÞŘÝŘ_Þʳ
ǼÌsOŸŘǣŸĶÞ_Ǽs_ʩŘŘOÞĶǣǼǼsŎsŘǼǣʱ
OTHER MATTER
ʹ_ʺ ÝŘ ŸȖNj ŸƼÞŘÞŸŘʰ ǼÌs ¯ŸNjsǣÞ_ OŸŘǣŸĶÞ_Ǽs_ ʩŘŘOÞĶ (ʺ ǻÌs OOŸŎƼŘɴÞض OŸŘǣŸĶÞ_Ǽs_ ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣ
statements comply with the Accounting Standards ÞŘOĶȖ_s ǼŸǼĶ ǣǣsǼǣ Ÿ¯ NJǣ ˡʰˠˠˤʳˠ˟ ĶOǣ ǣ Ǽ ōNjOÌ ˢˠʰ
ǣƼsOÞʩs_ȖŘ_sNjǣsOǼÞŸŘˠˢˢŸ¯ǼÌsOǼʰNjs_ɠÞǼÌNJȖĶs˦Ÿ¯
ˡ˟ˠ˥ʰ Ř_ ǼŸǼĶ NjsɚsŘȖsǣ Ř_ ŘsǼ OǣÌ ÞŘʪŸɠǣ Ÿ¯ NJǣ
the Companies (Accounts) Rules, 2014;
ˠʰ˥˧˨ʳˣ˦ ĶOǣ Ř_ NJǣ ˡˡˣʳˣˤ ĶOǣ ¯ŸNj ǼÌs ɴsNj sŘ_s_ ŸŘ
(e) On the basis of the written representations received from that date, in respect of four subsidiaries, which have been
the directors of the Holding Company as on March 31, Ȗ_ÞǼs_ Eɴ ŸǼÌsNj Ȗ_ÞǼŸNjǣʰ ɠÌÞOÌ ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣʰ
ˡ˟ˠ˥ ǼĨsŘ ŸŘ NjsOŸNj_ Eɴ ǼÌs DŸNj_ Ÿ¯ ^ÞNjsOǼŸNjǣ Ÿ¯ ǼÌs ŸǼÌsNj ʩŘŘOÞĶ ÞŘ¯ŸNjŎǼÞŸŘ Ř_ Ȗ_ÞǼŸNj˅ǣ NjsƼŸNjǼǣ Ìɚs
Holding Company and the reports of the auditors who are EssŘ¯ȖNjŘÞǣÌs_ǼŸȖǣEɴǼÌsŎضsŎsŘǼʳŷȖNjŸƼÞŘÞŸŘŸŘ
appointed under Section 139 of the Act, of its subsidiary ǼÌsOŸŘǣŸĶÞ_Ǽs_ʩŘŘOÞĶǣǼǼsŎsŘǼǣʰÞŘǣŸ¯NjǣÞǼNjsĶǼsǣ
companies incorporated in India, none of the directors to the amounts and disclosures included in respect of
Ÿ¯ ǼÌs µNjŸȖƼ˅ǣ OŸŎƼŘÞsǣ ÞŘOŸNjƼŸNjǼs_ ÞŘ ÝŘ_Þ Þǣ these subsidiaries and our report in terms of sub-sections
_ÞǣLJȖĶÞʩs_ǣŸŘˢˠǣǼōNjOÌʰˡ˟ˠ˥¯NjŸŎEsÞضƼƼŸÞŘǼs_ (3) and (11) of Section 143 of the Act, in so far as it relates
ǣ_ÞNjsOǼŸNjÞŘǼsNjŎǣŸ¯ǢsOǼÞŸŘˠ˥ˣʹˡʺŸ¯ǼÌsOǼʳ to the aforesaid subsidiaries is based solely on the reports
Ÿ¯ǣȖOÌŸǼÌsNjȖ_ÞǼŸNjǣʳ
(f) With respect to the adequacy and the operating
s¯¯sOǼÞɚsŘsǣǣ Ÿ¯ ǼÌs ÞŘǼsNjŘĶ ʩŘŘOÞĶ OŸŘǼNjŸĶǣ ŸɚsNj ŷȖNjŸƼÞŘÞŸŘŸŘǼÌsOŸŘǣŸĶÞ_Ǽs_ʩŘŘOÞĶǣǼǼsŎsŘǼǣʰŘ_ŸȖNj
ʩŘŘOÞĶ NjsƼŸNjǼÞض Ÿ¯ ǼÌs ËŸĶ_Þض NŸŎƼŘɴ Ř_ ÞǼǣ report on Other Legal and Regulatory Requirements above, is
subsidiary companies incorporated in India, refer to our ŘŸǼŎŸ_Þʩs_ÞŘNjsǣƼsOǼŸ¯ǼÌsEŸɚsŎǼǼsNjǣɠÞǼÌNjsǣƼsOǼǼŸ
separate report in “Annexure 1” to this report; our reliance on the work done and the reports of the other
(g) With respect to the other matters to be included in Ȗ_ÞǼŸNjǣ Ř_ ǼÌs ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣ Ř_ ŸǼÌsNj ʩŘŘOÞĶ
ǼÌs Ȗ_ÞǼŸNj˅ǣ NJsƼŸNjǼ ÞŘ OOŸNj_ŘOs ɠÞǼÌ NJȖĶs ˠˠ Ÿ¯ ǼÌs ÞŘ¯ŸNjŎǼÞŸŘOsNjǼÞʩs_EɴǼÌsōضsŎsŘǼʳ
Companies (Audit and Auditors) Rules, 2014, in our
opinion and to the best of our information and according
to the explanations given to us: For S R B C & CO LLP
Chartered Accountants
Þʳ ǻÌs OŸŘǣŸĶÞ_Ǽs_ ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣ _ÞǣOĶŸǣs ǼÌs ÝNÝ®ÞNjŎNJs¶ÞǣǼNjǼÞŸŘŗȖŎEsNjʲˢˡˣ˨˧ˡrˀrˢ˟˟˟˟ˢ
impact of pending litigations on its consolidated
ʩŘŘOÞĶƼŸǣÞǼÞŸŘŸ¯ǼÌsµNjŸȖƼʳNJs¯sNjŗŸǼsˢˣǼŸǼÌs per Vikram Mehta
OŸŘǣŸĶÞ_Ǽs_ʩŘŘOÞĶǣǼǼsŎsŘǼǣʱ Partner
ōsŎEsNjǣÌÞƼŗȖŎEsNjʲˠ˟ˤ˨ˢ˧
ÞÞʳ ǻÌs µNjŸȖƼ _Þ_ ŘŸǼ Ìɚs Řɴ ŎǼsNjÞĶ ¯ŸNjsǣssEĶs
losses in long-term contracts including derivative Place of Signature: Mumbai
OŸŘǼNjOǼǣʳ ^Ǽsʲōɴˡˢʰˡ˟ˠ˥
142 Jyothy Laboratories Limited
Annual Report 2015-16

ANNEXURE 1 TO THE INDEPENDENT AUDITOR’S REPORT weakness exists, and testing and evaluating the design and
OF EVEN DATE ON THE CONSOLIDATED FINANCIAL operating effectiveness of internal control based on the assessed
STATEMENTS OF JYOTHY LABORATORIES LIMTED NjÞǣĨʳǻÌsƼNjŸOs_ȖNjsǣǣsĶsOǼs__sƼsŘ_ŸŘǼÌsȖ_ÞǼŸNj˅ǣĠȖ_¶sŎsŘǼʰ
Report on the Internal Financial Controls under Clause (i) of Sub- including the assessment of the risks of material misstatement of
section 3 of Section 143 of the Companies Act, 2013 (“the Act”) ǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣʰɠÌsǼÌsNj_ȖsǼŸ¯NjȖ_ŸNjsNjNjŸNjʳ

To the Members of Jyothy Laboratories Limited We believe that the audit evidence we have obtained and the
audit evidence obtained by the other auditors in terms of their
ÝŘ OŸŘĠȖŘOǼÞŸŘ ɠÞǼÌ ŸȖNj Ȗ_ÞǼ Ÿ¯ ǼÌs OŸŘǣŸĶÞ_Ǽs_ ʩŘŘOÞĶ
reports referred to in the Other Matters paragraph below, is
statements of Jyothy Laboratories Limited as of and for the year
ǣȖ¯ʩOÞsŘǼŘ_ƼƼNjŸƼNjÞǼsǼŸƼNjŸɚÞ_sEǣÞǣ¯ŸNjŸȖNjȖ_ÞǼŸƼÞŘÞŸŘ
sŘ_s_ ōNjOÌ ˢˠʰ ˡ˟ˠ˥ʰ ɠs Ìɚs Ȗ_ÞǼs_ ǼÌs ÞŘǼsNjŘĶ ʩŘŘOÞĶ
ŸŘǼÌsÞŘǼsNjŘĶʩŘŘOÞĶOŸŘǼNjŸĶǣǣɴǣǼsŎŸɚsNjʩŘŘOÞĶNjsƼŸNjǼÞضʳ
OŸŘǼNjŸĶǣ ŸɚsNj ʩŘŘOÞĶ NjsƼŸNjǼÞض Ÿ¯ ğɴŸǼÌɴ ĵEŸNjǼŸNjÞsǣ ĵÞŎÞǼs_
(hereinafter referred to as the “Holding Company”) and its
Meaning of Internal Financial Controls Over Financial
subsidiary companies which are companies incorporated in India,
Reporting
ǣŸ¯ǼÌǼ_Ǽsʳ
OŸŎƼŘɴ˅ǣÞŘǼsNjŘĶʩŘŘOÞĶOŸŘǼNjŸĶŸɚsNjʩŘŘOÞĶNjsƼŸNjǼÞضÞǣ
Management’s Responsibility for Internal Financial Controls process designed to provide reasonable assurance regarding the
ǻÌsNjsǣƼsOǼÞɚsDŸNj_Ÿ¯^ÞNjsOǼŸNjǣŸ¯ǼÌsËŸĶ_ÞضNŸŎƼŘɴŘ_ÞǼǣ NjsĶÞEÞĶÞǼɴ Ÿ¯ ʩŘŘOÞĶ NjsƼŸNjǼÞض Ř_ ǼÌs ƼNjsƼNjǼÞŸŘ Ÿ¯ ʩŘŘOÞĶ
subsidiary companies, which are companies incorporated in India, statements for external purposes in accordance with generally
NjsNjsǣƼŸŘǣÞEĶs¯ŸNjsǣǼEĶÞǣÌÞضŘ_ŎÞŘǼÞŘÞضÞŘǼsNjŘĶʩŘŘOÞĶ OOsƼǼs_ OOŸȖŘǼÞض ƼNjÞŘOÞƼĶsǣʳ  OŸŎƼŘɴ˅ǣ ÞŘǼsNjŘĶ ʩŘŘOÞĶ
OŸŘǼNjŸĶǣ Eǣs_ ŸŘ ǼÌs ÞŘǼsNjŘĶ OŸŘǼNjŸĶ ŸɚsNj ʩŘŘOÞĶ NjsƼŸNjǼÞض OŸŘǼNjŸĶ ŸɚsNj ʩŘŘOÞĶ NjsƼŸNjǼÞض ÞŘOĶȖ_sǣ ǼÌŸǣs ƼŸĶÞOÞsǣ Ř_
criteria established by the Holding Company considering the procedures that (1) pertain to the maintenance of records that,
essential components of internal control stated in the Guidance ÞŘNjsǣŸŘEĶs_sǼÞĶʰOOȖNjǼsĶɴŘ_¯ÞNjĶɴNjsʪsOǼǼÌsǼNjŘǣOǼÞŸŘǣ
ŗŸǼs ŸŘ Ȗ_ÞǼ Ÿ¯ ÝŘǼsNjŘĶ ®ÞŘŘOÞĶ NŸŘǼNjŸĶǣ ŷɚsNj ®ÞŘŘOÞĶ and dispositions of the assets of the company; (2) provide
Reporting issued by the Institute of Chartered Accountants of reasonable assurance that transactions are recorded as necessary
ÝŘ_ÞʳǻÌsǣsNjsǣƼŸŘǣÞEÞĶÞǼÞsǣÞŘOĶȖ_sǼÌs_sǣÞ¶ŘʰÞŎƼĶsŎsŘǼǼÞŸŘ ǼŸƼsNjŎÞǼƼNjsƼNjǼÞŸŘŸ¯ʩŘŘOÞĶǣǼǼsŎsŘǼǣÞŘOOŸNj_ŘOsɠÞǼÌ
Ř_ ŎÞŘǼsŘŘOs Ÿ¯ _sLJȖǼs ÞŘǼsNjŘĶ ʩŘŘOÞĶ OŸŘǼNjŸĶǣ ǼÌǼ generally accepted accounting principles, and that receipts and
ɠsNjsŸƼsNjǼÞضs¯¯sOǼÞɚsĶɴ¯ŸNjsŘǣȖNjÞضǼÌsŸNj_sNjĶɴŘ_s¯ʩOÞsŘǼ expenditures of the company are being made only in accordance
conduct of its business, including adherence to the respective with authorisations of management and directors of the company;
OŸŎƼŘɴ˅ǣƼŸĶÞOÞsǣʰǼÌsǣ¯s¶ȖNj_ÞضŸ¯ÞǼǣǣǣsǼǣʰǼÌsƼNjsɚsŘǼÞŸŘ and (3) provide reasonable assurance regarding prevention or
and detection of frauds and errors, the accuracy and completeness timely detection of unauthorised acquisition, use, or disposition
of the accounting records, and the timely preparation of reliable Ÿ¯ǼÌsOŸŎƼŘɴ˅ǣǣǣsǼǣǼÌǼOŸȖĶ_ÌɚsŎǼsNjÞĶs¯¯sOǼŸŘǼÌs
ʩŘŘOÞĶÞŘ¯ŸNjŎǼÞŸŘʰǣNjsLJȖÞNjs_ȖŘ_sNjǼÌsOǼʳ ʩŘŘOÞĶǣǼǼsŎsŘǼǣʳ

Auditor’s Responsibility Inherent Limitations of Internal Financial Controls Over


Financial Reporting
ŷȖNj NjsǣƼŸŘǣÞEÞĶÞǼɴ Þǣ ǼŸ sɮƼNjsǣǣ Ř ŸƼÞŘÞŸŘ ŸŘ ǼÌs OŸŎƼŘɴ˅ǣ
ÞŘǼsNjŘĶʩŘŘOÞĶOŸŘǼNjŸĶǣŸɚsNjʩŘŘOÞĶNjsƼŸNjǼÞضEǣs_ŸŘŸȖNj DsOȖǣsŸ¯ǼÌsÞŘÌsNjsŘǼĶÞŎÞǼǼÞŸŘǣŸ¯ÞŘǼsNjŘĶʩŘŘOÞĶOŸŘǼNjŸĶǣ
Ȗ_ÞǼʳɟsOŸŘ_ȖOǼs_ŸȖNjȖ_ÞǼÞŘOOŸNj_ŘOsɠÞǼÌǼÌsµȖÞ_ŘOs ŸɚsNj ʩŘŘOÞĶ NjsƼŸNjǼÞضʰ ÞŘOĶȖ_Þض ǼÌs ƼŸǣǣÞEÞĶÞǼɴ Ÿ¯ OŸĶĶȖǣÞŸŘ
ŗŸǼs ŸŘ Ȗ_ÞǼ Ÿ¯ ÝŘǼsNjŘĶ ®ÞŘŘOÞĶ NŸŘǼNjŸĶǣ ŷɚsNj ®ÞŘŘOÞĶ or improper management override of controls, material
NJsƼŸNjǼÞضʹǼÌsˆµȖÞ_ŘOsŗŸǼsˇʺŘ_ǼÌsǢǼŘ_Nj_ǣŸŘȖ_ÞǼÞضʰ misstatements due to error or fraud may occur and not be
both, issued by Institute of Chartered Accountants of India, and _sǼsOǼs_ʳ ĶǣŸʰ ƼNjŸĠsOǼÞŸŘǣ Ÿ¯ Řɴ sɚĶȖǼÞŸŘ Ÿ¯ ǼÌs ÞŘǼsNjŘĶ
deemed to be prescribed under section 143(10) of the Act, to the ʩŘŘOÞĶ OŸŘǼNjŸĶǣ ŸɚsNj ʩŘŘOÞĶ NjsƼŸNjǼÞض ǼŸ ¯ȖǼȖNjs ƼsNjÞŸ_ǣ Njs
sɮǼsŘǼ ƼƼĶÞOEĶs ǼŸ Ř Ȗ_ÞǼ Ÿ¯ ÞŘǼsNjŘĶ ʩŘŘOÞĶ OŸŘǼNjŸĶǣ ŸɚsNj ǣȖEĠsOǼǼŸǼÌsNjÞǣĨǼÌǼǼÌsÞŘǼsNjŘĶʩŘŘOÞĶOŸŘǼNjŸĶŸɚsNjʩŘŘOÞĶ
ÞŘǼsNjŘĶ NjsƼŸNjǼÞضʳ  ǻÌŸǣs ǢǼŘ_Nj_ǣ Ř_ ǼÌs µȖÞ_ŘOs ŗŸǼs reporting may become inadequate because of changes in
require that we comply with ethical requirements and plan and conditions, or that the degree of compliance with the policies or
perform the audit to obtain reasonable assurance about whether ƼNjŸOs_ȖNjsǣŎɴ_sǼsNjÞŸNjǼsʳ
_sLJȖǼs ÞŘǼsNjŘĶ ʩŘŘOÞĶ OŸŘǼNjŸĶǣ ŸɚsNj ʩŘŘOÞĶ NjsƼŸNjǼÞض
was established and maintained and if such controls operated Opinion
s¯¯sOǼÞɚsĶɴÞŘĶĶŎǼsNjÞĶNjsǣƼsOǼǣʳ In our opinion, the Holding Company and its subsidiary companies,
which are companies incorporated in India, have, maintained in all
Our audit involves performing procedures to obtain audit ŎǼsNjÞĶNjsǣƼsOǼǣʰŘ_sLJȖǼsÞŘǼsNjŘĶʩŘŘOÞĶOŸŘǼNjŸĶǣǣɴǣǼsŎ
sɚÞ_sŘOs EŸȖǼ ǼÌs _sLJȖOɴ Ÿ¯ ǼÌs ÞŘǼsNjŘĶ ʩŘŘOÞĶ OŸŘǼNjŸĶǣ ŸɚsNjʩŘŘOÞĶNjsƼŸNjǼÞضŘ_ǣȖOÌÞŘǼsNjŘĶʩŘŘOÞĶOŸŘǼNjŸĶǣŸɚsNj
ǣɴǣǼsŎŸɚsNjʩŘŘOÞĶNjsƼŸNjǼÞضŘ_ǼÌsÞNjŸƼsNjǼÞضs¯¯sOǼÞɚsŘsǣǣʳ ʩŘŘOÞĶ NjsƼŸNjǼÞض ɠsNjs ŸƼsNjǼÞض s¯¯sOǼÞɚsĶɴ ǣ Ǽ ōNjOÌ ˢˠʰ
ŷȖNj Ȗ_ÞǼ Ÿ¯ ÞŘǼsNjŘĶ ʩŘŘOÞĶ OŸŘǼNjŸĶǣ ŸɚsNj ʩŘŘOÞĶ NjsƼŸNjǼÞض ˡ˟ˠ˥ʰEǣs_ŸŘǼÌsÞŘǼsNjŘĶOŸŘǼNjŸĶŸɚsNjʩŘŘOÞĶNjsƼŸNjǼÞضONjÞǼsNjÞ
ÞŘOĶȖ_s_ ŸEǼÞŘÞض Ř ȖŘ_sNjǣǼŘ_Þض Ÿ¯ ÞŘǼsNjŘĶ ʩŘŘOÞĶ established by the Holding Company considering the essential
OŸŘǼNjŸĶǣŸɚsNjʩŘŘOÞĶNjsƼŸNjǼÞضʰǣǣsǣǣÞضǼÌsNjÞǣĨǼÌǼŎǼsNjÞĶ OŸŎƼŸŘsŘǼǣ Ÿ¯ ÞŘǼsNjŘĶ OŸŘǼNjŸĶ ǣǼǼs_ ÞŘ ǼÌs µȖÞ_ŘOs ŗŸǼs
Corporate Overview Performance Governance Financial Statements 143

on Audit of Internal Financial Controls Over Financial Reporting NŸŘǣŸĶÞ_Ǽs_ ǢǼǼsŎsŘǼ Ÿ¯ ƻNjŸʩǼ Ř_ ĵŸǣǣ Ř_ NŸŘǣŸĶÞ_Ǽs_
ÞǣǣȖs_EɴǼÌsÝŘǣǼÞǼȖǼsŸ¯NÌNjǼsNjs_OOŸȖŘǼŘǼǣŸ¯ÝŘ_Þʳ Cash Flow Statement for the year then ended, and a summary of
ǣÞ¶ŘÞʩOŘǼOOŸȖŘǼÞضƼŸĶÞOÞsǣŘ_ŸǼÌsNjsɮƼĶŘǼŸNjɴÞŘ¯ŸNjŎǼÞŸŘʰ
Other Matters Ř_ŸȖNjNjsƼŸNjǼ_Ǽs_ōNjOÌˡˢʰˡ˟ˠ˥sɮƼNjsǣǣs_ŘȖŘLJȖĶÞʩs_
Our report under Section 143(3)(i) of the Act on the adequacy ŸƼÞŘÞŸŘǼÌsNjsŸŘʳ
Ř_ŸƼsNjǼÞضs¯¯sOǼÞɚsŘsǣǣŸ¯ǼÌsÞŘǼsNjŘĶʩŘŘOÞĶOŸŘǼNjŸĶǣŸɚsNj
ʩŘŘOÞĶNjsƼŸNjǼÞضŸ¯ǼÌsËŸĶ_ÞضNŸŎƼŘɴʰÞŘǣŸ¯NjǣÞǼNjsĶǼsǣ For S R B C & CO LLP
to 2 subsidiary companies, which are companies incorporated in Chartered Accountants
India, is based on the corresponding reports of the auditors of ÝNÝ®ÞNjŎNJs¶ÞǣǼNjǼÞŸŘŗȖŎEsNjʲˢˡˣ˨˧ˡrˀrˢ˟˟˟ˢ
ǣȖOÌǣȖEǣÞ_ÞNjɴOŸŎƼŘÞsǣÞŘOŸNjƼŸNjǼs_ÞŘÝŘ_Þʳ

We also have audited, in accordance with the Standards on Vikram Mehta


Auditing issued by the Institute of Chartered Accountants of India Partner
ǣ ǣƼsOÞʩs_ ȖŘ_sNj ǣsOǼÞŸŘ ˠˣˢʹˠ˟ʺ Ÿ¯ ǼÌs OǼʰ ǼÌs OŸŘǣŸĶÞ_Ǽs_ ōsŎEsNjǣÌÞƼŗȖŎEsNjʲˠ˟ˤ˨ˢ˧
ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣ Ÿ¯ ǼÌs ËŸĶ_Þض NŸŎƼŘɴʰ ɠÌÞOÌ OŸŎƼNjÞǣs Place of Signature: Mumbai
the Consolidated Balance Sheet as at March 31, 2016, and the ^Ǽsʲōɴˡˢʰˡ˟ˠ˥
144 Jyothy Laboratories Limited
Annual Report 2015-16

CONSOLIDATED BALANCE SHEET


as at March 31, 2016
` In Lacs

Note 2016 2015


EQUITY AND LIABILITIES
Shareholders’ funds
Share capital 4 ˠʰ˧ˠˠʳˡ˟ ˠʰ˧ˠ˟ʳˡˢ
Reserves and surplus 5 ˧ˡʰ˧˟ˡʳˣ˥ ˦˥ʰˠˤˤʳ˦ˣ
84,613.66 77,965.97
Minority Interest ˠ˥˨ʳ˦ˣ ˠˣˢʳ˦ˣ
Non-current liabilities
Long-term borrowings 6 ˦ˡ˦ʳˣˣ ˣˣʰ˨˟ˡʳˣˣ
^s¯sNjNjs_ǼɮĶÞEÞĶÞǼÞsǣʹŗsǼʺ ˦ ˡʰˤˢ˟ʳˢ˧ ˤˣʳˡˣ
Other long term liabilities ˧ ˣ˨˧ʳˤ˟ ˠ˥ʰˠˤ˦ʳ˦ˡ
Provisions ˨ ˠʰ˦˦˥ʳ˥ˤ ˠʰˢ˦˟ʳˣˡ
5,532.97 62,484.82
Current liabilities
Trade payables 10
Total outstanding dues of micro enterprises and small enterprises ˣʰ˦ˠ˧ʳˤˣ ˢʰ˦ˣˠʳ˦˧
Total outstanding dues of creditors other than micro enterprises and small enterprises ˠˠʰˢ˥ˤʳˤ˟ ˨ʰˤ˟ˤʳ˟ˠ
Other current liabilities 11 ˥ˣʰˤ˧ˤʳ˦˥ ˠˤʰ˦ˣ˧ʳ˦˥
Provisions ˨ ˤʰ˦ˢ˧ʳˤˢ ˠˡʰ˟˧ˡʳˣˠ
86,408.33 41,077.96
TOTAL 176,724.70 181,672.49

ASSETS
Non-current assets
®Þɮs_ǣǣsǼǣ
ʹÞʺ ǻضÞEĶsǣǣsǼǣ 12 ˡ˦ʰ˦˨ˣʳ˧˟ ˡ˧ʰˢ˦ˠʳˡˠ
ʹÞÞʺ ÝŘǼضÞEĶsǣǣsǼǣ 12 ˦˧ʰ˨˧ˡʳ˨ˢ ˦˨ʰ˟ˢˠʳ˟ˠ
ʹÞÞÞʺ NƼÞǼĶɠŸNjĨ˚ÞŘ˚ƼNjŸ¶Njsǣǣ ˤˤˡʳˠ˧ ˠʰ˥ˠ˨ʳˣ˨
ʹÞɚʺ ÝŘǼضÞEĶsǣǣsǼǣȖŘ_sNj_sɚsĶŸƼŎsŘǼ ˡˣ˟ʳ˟˟ -
Non-current investments ˠˢ ˡʳˤ˨ ˠˣ˨ʳ˧˨
Loans and advances 14 ˡˢʰ˥˨˨ʳˣ˧ ˠ˦ʰ˥ˣˤʳ˥ˣ
Other assets 15 ˨ˢʳ˧˦ ˡˤ˟ʳ˨ˢ
131,365.85 127,068.17
Current assets
Current investments 16 ˧ʰˢˣˣʳ˟˟ ˠ˨ʰˡ˟ˠʳ˥ˣ
Inventories ˠ˦ ˠ˧ʰˡ˥ˤʳˤ˟ ˠ˧ʰˤˡ˟ʳˢ˥
Trade receivables ˠ˧ ˨ʰˣˠˠʳ˟ˢ ˤʰ˦ˣˠʳ˨˟
NǣÌŘ_DŘĨEĶŘOsǣ ˠ˨ ˥ʰˠˠ˨ʳ˧ˣ ˦ʰˣ˥ˡʳ˥˨
Loans and advances 14 ˡʰˤ˥ˠʳ˥ˤ ˢʰˠ˦ˣʳ˟˦
Other assets 15 ˥ˤ˥ʳ˧ˢ ˤ˟ˢʳ˥˥
45,358.85 54,604.32
TOTAL 176,724.70 181,672.49
ǢȖŎŎNjɴŸ¯ǣÞ¶ŘÞʩOŘǼOOŸȖŘǼÞضƼŸĶÞOÞsǣ ˢ

ǻÌsOOŸŎƼŘɴÞضŘŸǼsǣNjsŘÞŘǼs¶NjĶƼNjǼŸ¯ǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣʳ
As per our report of even date

For S R B C & CO LLP For and on behalf of the Board of Directors of


Chartered Accountants Jyothy Laboratories Limited
ÝNÝ®ÞNjŎNJs¶ÞǣǼNjǼÞŸŘŗŸʳˢˡˣ˨˧ˡrˀrˢ˟˟˟˟ˢ

per Vikram Mehta M.P. Ramachandran K.Ullas Kamath


Partner Chairman and Managing Director ğŸÞŘǼōضÞض^ÞNjsOǼŸNjŘ_NÌÞs¯®ÞŘŘOÞĶŷ¯ʩOsNj
ōsŎEsNjǣÌÞƼŗŸʳʲˠ˟ˤ˨ˢ˧ ^Ýŗʲ˟˟ˤˤˢˣ˟˥ ^Ýŗʲ˟˟ˤ˟˥˥˧ˠ
M.L. Bansal S.Raghunandan
Company Secretary ɟÌŸĶsǻÞŎs^ÞNjsOǼŸNjŘ_NÌÞs¯rɮsOȖǼÞɚsŷ¯ʩOsNj
ōsŎEsNjǣÌÞƼŗŸʳʲ®ˡˡ˨˦ ^Ýŗʲ˟ˡˡ˥ˢ˧ˣˤ
ƻĶOsʲōȖŎEÞ ƻĶOsʲōȖŎEÞ
^Ǽsʲōɴˡˢʰˡ˟ˠ˥ ^Ǽsʲōɴˡˢʰˡ˟ˠ˥
Corporate Overview Performance Governance Financial Statements 145

CONSOLIDATED STATEMENT OF PROFIT AND LOSS


for the year ended March 31, 2016
` In Lacs

Note 2015-16 2014-15


REVENUE
Sales (net of trade discount) ˠ˥˥ʰ˟˧ˣʳ˦ˤ ˠˤˠʰˤ˨˥ʳ˦ˤ
ĵsǣǣʲrɮOÞǣs_ȖǼɴ ʹˤʰ˨ˠ˦ʳˢ˥ʺ ʹˤʰˡ˦ˡʳˢ˟ʺ
Net sales ˠ˥˟ʰˠ˥˦ʳˢ˨ ˠˣ˥ʰˢˡˣʳˣˤ
Sale of services ˣʰˢ˟ˤʳ˨ˣ ˣʰˡ˟ˤʳ˟ˡ
Other operating income 20 ˠ˧ˢʳˢ˨ ˨ˤˣʳ˟ˢ
Revenue from operations 164,656.72 151,483.50
Other income 21 ˠʰ˟ˡˤʳˣˤ ˤ˥ˡʳˣˤ
Total Revenue (I) 165,682.17 152,045.95

EXPENSES
Cost of raw material and components consumed 22 ˣ˨ʰ˥˥ˡʳ˨ˠ ˣ˥ʰ˦˦˥ʳˢˣ
Purchase of traded goods ˢ˟ʰˠˢˣʳˤˠ ˢˠʰˣ˧ˤʳ˥˧
ʹÝŘONjsǣsʺˀ_sONjsǣsÞŘÞŘɚsŘǼŸNjÞsǣŸ¯ʩŘÞǣÌs_¶ŸŸ_ǣʰɠŸNjĨ˚ÞŘ˚ƼNjŸ¶NjsǣǣŘ_ǼNj_s_¶ŸŸ_ǣ ˡˢ ˠˠˤʳˢ˟ ʹˤˠˤʳ˨ˤʺ
rŎƼĶŸɴssEsŘsʩǼǣsɮƼsŘǣs 24 ˠ˥ʰ˥ˠ˟ʳˡˡ ˠˤʰ˟ˡ˥ʳˠˣ
rŎƼĶŸɴssǣǼŸOĨŸƼǼÞŸŘsɮƼsŘǣsǣ 24 ˠʰ˦ˤ˟ʳˡ˥ ˡʰ˧˦ˠʳˠˢ
ŷǼÌsNjsɮƼsŘǣsǣ 25 ˣˣʰˢ˦ˢʳ˨ˤ ˢ˨ʰˤˢ˨ʳˠ˟
Total Expense (II) 142,647.15 135,182.44
EARNINGS BEFORE INTEREST, TAX, DEPRECIATION,
AMORTIZATION AND IMPAIRMENT (EBITDA) (I) – (II) 23,035.02 16,863.51

^sƼNjsOÞǼÞŸŘʰŎŸNjǼÞǣǼÞŸŘŘ_ÞŎƼÞNjŎsŘǼ 12 ˢʰˠˣ˟ʳˠˤ ˢʰˡˤˣʳˤˤ


Finance Costs 26 ˥˟ˢʳˢ˟ ˠʰˢ˦˥ʳ˦˥
Interest Income ˡ˦ ˣˢˣʳ˥˦ ˣˡ˨ʳ˥˥
PROFIT BEFORE EXCEPTIONAL ITEMS AND TAX 19,726.24 12,661.86
rɮOsƼǼÞŸŘĶÝǼsŎ 42 - ˡ˟˨ʳˠ˧
PROFIT BEFORE TAX 19,726.24 12,452.68
NȖNjNjsŘǼǼɮʹōǻʺ ˣʰˢˠˣʳˢ˧ ˢʰ˟˧˦ʳ˟˥
Less MAT credit entitlement ʹˡʰ˧˥˟ʳ˟ˢʺ ʹˢʰ˟˧ˣʳ˦ˤʺ
˚ŗsǼNȖNjNjsŘǼǻɮ 1,454.35 2.31
˚^s¯sNjNjs_ǼɮOÌNj¶sˀʹONjs_ÞǼʺ ˡʰˣ˦˥ʳˠˣ ʹ˥˟ʳˤˠʺ
˚rɮOsǣǣǼɮƼNjŸɚÞǣÞŸŘˀōǻONjs_ÞǼNjsɚsNjǣĶŸ¯sNjĶÞsNjɴsNjǣ - ˣˠˡʳˣˤ
PROFIT AFTER TAX 15,795.75 12,098.43
ōÞŘŸNjÞǼɴǢÌNjsʹǣÌNjsÞŘĶŸǣǣʺ ʹ˟ʳˡ˨ʺ ʹˠˢʳ˨˥ʺ
PROFIT AFTER TAX AND MINORITY SHARE 15,796.04 12,112.39
rNJŗÝŗµǢƻrNJǢËNJrʹrƻǢʺ
DǣÞOʹ`ʺ 41 ˧ʳ˦ˡ ˥ʳ˥˨
^ÞĶȖǼs_ʹ`ʺ 41 ˧ʳ˥˟ ˥ʳ˥ˤ
ŗŸŎÞŘĶɚĶȖsƼsNjǣÌNjsʹ`ʺ ˠʳ˟˟ ˠʳ˟˟
ǢȖŎŎNjɴŸ¯ǣÞ¶ŘÞʩOŘǼOOŸȖŘǼÞضƼŸĶÞOÞsǣ ˢ
ǻÌsOOŸŎƼŘɴÞضŘŸǼsǣNjsŘÞŘǼs¶NjĶƼNjǼŸ¯ǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣʳ
As per our report of even date

For S R B C & CO LLP For and on behalf of the Board of Directors of


Chartered Accountants Jyothy Laboratories Limited
ÝNÝ®ÞNjŎNJs¶ÞǣǼNjǼÞŸŘŗŸʳˢˡˣ˨˧ˡrˀrˢ˟˟˟˟ˢ

per Vikram Mehta M.P. Ramachandran K.Ullas Kamath


Partner Chairman and Managing Director ğŸÞŘǼōضÞض^ÞNjsOǼŸNjŘ_NÌÞs¯®ÞŘŘOÞĶŷ¯ʩOsNj
ōsŎEsNjǣÌÞƼŗŸʳʲˠ˟ˤ˨ˢ˧ ^Ýŗʲ˟˟ˤˤˢˣ˟˥ ^Ýŗʲ˟˟ˤ˟˥˥˧ˠ
M.L. Bansal S.Raghunandan
Company Secretary ɟÌŸĶsǻÞŎs^ÞNjsOǼŸNjŘ_NÌÞs¯rɮsOȖǼÞɚsŷ¯ʩOsNj
ōsŎEsNjǣÌÞƼŗŸʳʲ®ˡˡ˨˦ ^Ýŗʲ˟ˡˡ˥ˢ˧ˣˤ
ƻĶOsʲōȖŎEÞ ƻĶOsʲōȖŎEÞ
^Ǽsʲōɴˡˢʰˡ˟ˠ˥ ^Ǽsʲōɴˡˢʰˡ˟ˠ˥
146 Jyothy Laboratories Limited
Annual Report 2015-16

CONSOLIDATED STATEMENT OF CASH FLOWS


for the year ended March 31, 2016
` In Lacs
2015-16 2014-15

A. CASH FLOWS PROVIDED BY/(USED IN) OPERATING ACTIVITIES:


 ƻNjŸʩǼEs¯ŸNjsǻɮ ˠ˨ʰ˦ˡ˥ʳˡˣ ˠˡʰˣˤˡʳ˥˧

 _ĠȖǣǼŎsŘǼǼŸNjsOŸŘOÞĶsƼNjŸʩǼEs¯ŸNjsǼɮǼŸŘsǼOǣÌʪŸɠʲ
 ^sƼNjsOÞǼÞŸŘʰŎŸNjǼÞǣǼÞŸŘŘ_ÞŎƼÞNjŎsŘǼʹŘsǼʺ ˢʰˠˣ˟ʳˠˤ ˢʰˡˤˣʳˤˤ
 ĵŸǣǣŸŘʩɮs_ǣǣsǼǣ_ÞǣONj_s_ ˠˠˤʳ˟˧ ˠˢˣʳˠˣ
 ƻNjŸʩǼŸŘǣĶsŸ¯ʩɮs_ǣǣsǼǣ ʹˣ˧ʳ˨˟ʺ ʹˠ˥ʳˠ˦ʺ
 ƻNjŸʩǼŸŘǣĶsŸ¯OȖNjNjsŘǼÞŘɚsǣǼŎsŘǼǣ ʹ˨ˢˣʳ˦ˠʺ ʹˤ˟˟ʳ˨ˢʺ
 ÝŘǼsNjsǣǼŘ_ʩŘŘOsOÌNj¶sǣ ˥˟ˢʳˢ˟ ˠʰˢ˦˥ʳ˦˥
Interest income ʹˣˢˣʳ˥˦ʺ ʹˣˡ˨ʳ˥˥ʺ
 ĵÞEÞĶÞǼÞsǣŘŸĶŸŘ¶sNjNjsLJȖÞNjs_ɠNjÞǼǼsŘEOĨʹŘsǼʺ - ʹˢ˧˨ʳˠ˦ʺ
 ^Þ¯¯sNjsŘǼÞĶǻNjÞ¯¯ǼŸɠNj_ǣƼŸɠsNjŘ_¯ȖsĶsɮƼsŘǣsǣŸ¯sNjĶÞsNjɴsNjǣ - ʹˣ˟˟ʳˢˠʺ
 ®ŸNjsÞ¶ŘsɮOÌضsʪȖOǼȖǼÞŸŘ¶ÞŘʹŘsǼʺ ʹˠˣʳˣ˦ʺ ʹˠˢʳˤˠʺ
 ƻNjŸɚÞǣÞŸŘ¯ŸNj_ŸȖEǼ¯ȖĶ_sEǼǣˀE__sEǼɠNjÞǼǼsŘŸ¯¯ ˡˢʳ˨ˠ ˠˢ˟ʳˡˠ
Provision for doubtful advances ˦ˣʳ˥˦ ˠˣʳˣˢ
 rŎƼĶŸɴssǣǼŸOĨŸƼǼÞŸŘsɮƼsŘǣsǣ ˠʰ˦ˤ˟ʳˡ˥ ˡʰ˧˦ˠʳˠˢ
 ŷƼsNjǼÞضƼNjŸʩǼEs¯ŸNjsɠŸNjĨÞضOƼÞǼĶOÌضsǣ 24,000.86 18,484.15
 ōŸɚsŎsŘǼǣÞŘɠŸNjĨÞضOƼÞǼĶʲ
 ÝŘONjsǣsˀʹ_sONjsǣsʺÞŘǼNj_sƼɴEĶsǣ ˡʰ˧ˤ˥ʳˢˢ ˡʰˢ˨˧ʳ˥˦
 ÝŘONjsǣsˀʹ_sONjsǣsʺÞŘƼNjŸɚÞǣÞŸŘǣ ˣˢ˦ʳ˧ˤ ˤ˟˨ʳ˨˦
 ÝŘONjsǣsˀʹ_sONjsǣsʺÞŘŸǼÌsNjĶÞEÞĶÞǼÞsǣ ˠʰˢ˧ˠʳˣˢ ʹ˥ˡˢʳˡ˦ʺ
 ^sONjsǣsˀʹÞŘONjsǣsʺÞŘǼNj_sNjsOsÞɚEĶsǣ ʹˢʰ˥˦˧ʳˤ˦ʺ ˧ˡˣʳˢ˦
 ^sONjsǣsˀʹÞŘONjsǣsʺÞŘÞŘɚsŘǼŸNjÞsǣ ˡˤˣʳ˧˥ ʹˠʰˠˣ˟ʳˢˢʺ
 ^sONjsǣsˀʹÞŘONjsǣsʺÞŘĶŸŘǣŘ__ɚŘOsǣ ʹ˨˧˥ʳ˟˦ʺ ˠˤ˦ʳ˟˨
 ^sONjsǣsˀʹÞŘONjsǣsʺÞŘŸǼÌsNjOȖNjNjsŘǼǣǣsǼǣ ˤˠʳ˨˥ ˠ˧˨ʳ˨˥
Cash generated from operations 24,318.65 20,800.61
 ǻɮsǣƼÞ_ʹŘsǼʺ ʹˤʰˠ˦ˠʳ˦˥ʺ ʹˣʰˠ˦˟ʳ˧˥ʺ
Net cash (Used in) / generated from operating activities (A) 19,146.89 16,629.75
B. CASH FLOWS PROVIDED BY/(USED IN) INVESTING ACTIVITIES:
 ƻȖNjOÌǣsŸ¯ʩɮs_ǣǣsǼǣÞŘOĶȖ_ÞضOƼÞǼĶɠŸNjĨ˚ÞŘ˚ƼNjŸ¶NjsǣǣŘ_NƼÞǼĶ_ɚŘOsǣ ʹˡʰ˦ˣ˟ʳ˦˧ʺ ʹˠʰ˦˟˦ʳ˟ˣʺ
 ƻNjŸOss_ǣ¯NjŸŎǣĶsŸ¯ʩɮs_ǣǣsǼǣ ˠ˥˨ʳˤˤ ˥˥ʳ˥ˤ
 ƻNjŸOss_ǣ¯NjŸŎˀʹÝŘɚsǣǼŎsŘǼÞŘʩɮs__sƼŸǣÞǼʺʻÌɚÞضŸNjÞ¶ÞŘĶŎǼȖNjÞǼɴŸ¯ŎŸNjsǼÌŘǼÌNjssŎŸŘǼÌǣʼ ˠʰˡˢˢʳˣ˦ ʹˠʰ˧˥˟ʳˢˠʺ
 ƻNjŸʩǼŸŘǣĶsŸ¯OȖNjNjsŘǼÞŘɚsǣǼŎsŘǼǣ ˨ˢˣʳ˦ˠ ˤ˟˟ʳ˨ˢ
Interest Income received ˣˢ˥ʳ˥˧ ˣˢˠʳˢˣ
Net cash (Used in) / generated from investing activities (B) 33.63 (2,568.43)
Corporate Overview Performance Governance Financial Statements ˠˣ˦

CONSOLIDATED STATEMENT OF CASH FLOWS


for the year ended March 31, 2016
` In Lacs
2015-16 2014-15

C. CASH FLOWS PROVIDED BY/(USED IN) FINANCING ACTIVITIES:


 ÝŘǼsNjsǣǼŘ_ʩŘŘOsOÌNj¶sǣƼÞ_ ʹ˨˧ˡʳˢˣʺ ʹˠʰˢ˥˦ʳˠ˧ʺ
 ĶĶŸǼŎsŘǼŸ¯sLJȖÞǼɴǣÌNjsǣȖŘ_sNjrǢŷƻǢOÌsŎs ˟ʳ˨˦ -
 ƻNjŸOss_ǣ¯NjŸŎˀʹNJsƼɴŎsŘǼŸ¯ʺĶŸŘ¶˚ǼsNjŎEŸNjNjŸɠÞضǣ ʹˠˠʰ˥˦ˤʳ˟˟ʺ ˢʰ˧ˠ˟ʳˤ˟
Repayment of Deferred Payment Liability ʹˠ˧˟ʳ˟˟ʺ -
Proceed from issue of shares by subsidiary ˡ˥ʳˡ˨ -
 rɮƼsŘ_ÞǼȖNjsÞŘOȖNjNjs_ŸŘÞǣǣȖsŸ¯^sEsŘǼȖNjsǣ - ʹˠˤʳ˟˟ʺ
Dividend paid ʹˠˣʰˣ˧ˤʳ˦ˢʺ ʹˢʰ˥ˡ˟ʳˣ˦ʺ
 ^ÞɚÞ_sŘ_ǼɮƼÞ_ ʹˡʰ˨ˣ˧ʳ˨ˤʺ ʹ˥ˠˤʳˢ˟ʺ
 ŗsǼOǣÌʹȕǣs_ÞŘʺˀ¶sŘsNjǼs_¯NjŸŎʩŘŘOÞضOǼÞɚÞǼÞsǣʹNʺ (30,244.76) (1,807.45)
Net increase / (decrease) in cash and cash equivalents (A+B+C) (11,064.24) 12,253.87
Cash and cash equivalents at the beginning of the year ˡˠʰ˦˦ˤʳ˥ˣ ˨ʰˤˡˠʳ˦˦
Cash and cash equivalents at the end of the year 10,711.40 21,775.64
Components of cash and cash equivalents
Cash in hand ˢ˦ʳ˧ˣ ˣˡʳ˥˨
 DĶŘOsɠÞǼÌǣOÌs_ȖĶs_EŘĨǣ˚NȖNjNjsŘǼOOŸȖŘǼ ˠʰ˦˥ˣʳ˨˥ ˡʰˣ˦˦ʳ˨˦
- Deposit account ˣˡˤʳˢˡ -
Unclaimed dividend accounts * ˠˢ˨ʳˡ˧ ˤˢʳˢˣ
Cash and cash equivalents (Note 19) 2,367.40 2,574.00
 ōȖǼȖĶ®ȖŘ_ÝŘɚsǣǼŎsŘǼǣʹŗŸǼsˠ˥ʺ ˧ʰˢˣˣʳ˟˟ ˠ˨ʰˡ˟ˠʳ˥ˣ
 NǣÌŘ_OǣÌsLJȖÞɚĶsŘǼǣOŸŘǣÞ_sNjs_¯ŸNjOǣÌʪŸɠǣǣǼǼsŎsŘǼ 10,711.40 21,775.64
* Not available for use by the management for any other purpose
ǢȖŎŎNjɴŸ¯ǣÞ¶ŘÞʩOŘǼOOŸȖŘǼÞضƼŸĶÞOÞsǣŗŸǼsˢ

As per our report of even date

For S R B C & CO LLP For and on behalf of the Board of Directors of


Chartered Accountants Jyothy Laboratories Limited
ÝNÝ®ÞNjŎNJs¶ÞǣǼNjǼÞŸŘŗŸʳˢˡˣ˨˧ˡrˀrˢ˟˟˟˟ˢ

per Vikram Mehta M.P. Ramachandran K.Ullas Kamath


Partner Chairman and Managing Director ğŸÞŘǼōضÞض^ÞNjsOǼŸNjŘ_NÌÞs¯®ÞŘŘOÞĶŷ¯ʩOsNj
ōsŎEsNjǣÌÞƼŗŸʳʲˠ˟ˤ˨ˢ˧ ^Ýŗʲ˟˟ˤˤˢˣ˟˥ ^Ýŗʲ˟˟ˤ˟˥˥˧ˠ
M.L. Bansal S.Raghunandan
Company Secretary ɟÌŸĶsǻÞŎs^ÞNjsOǼŸNjŘ_NÌÞs¯rɮsOȖǼÞɚsŷ¯ʩOsNj
ōsŎEsNjǣÌÞƼŗŸʳʲ®ˡˡ˨˦ ^Ýŗʲ˟ˡˡ˥ˢ˧ˣˤ
ƻĶOsʲōȖŎEÞ ƻĶOsʲōȖŎEÞ
^Ǽsʲōɴˡˢʰˡ˟ˠ˥ ^Ǽsʲōɴˡˢʰˡ˟ˠ˥
ˠˣ˧ Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
NOTE 1 - BACKGROUND Eʺ ǻÌs OŸŘǣŸĶÞ_Ǽs_ ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣ Ÿ¯ ǼÌs µNjŸȖƼ Ìɚs EssŘ

ǻÌsNŸŘǣŸĶÞ_Ǽs_ʩŘŘOÞĶǣǣǼǼsŎsŘǼOŸŎƼNjÞǣsǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣ OŸŘǣŸĶÞ_Ǽs_ŸŘĶÞŘs˚Eɴ˚ĶÞŘsEǣÞǣEɴ__ÞضǼŸ¶sǼÌsNjǼÌsEŸŸĨ
Ÿ¯ ğɴŸǼÌɴ ĵEŸNjǼŸNjÞsǣ ĵÞŎÞǼs_ ʹ˄ǼÌs NŸŎƼŘɴ˅ʺ Ř_ ÞǼǣ ǣȖEǣÞ_ÞNjÞsǣ ɚĶȖsǣ Ÿ¯ ǣȖEǣÞ_ÞNjɴ OŸŎƼŘÞsǣ ĶÞĨs ÞǼsŎǣ Ÿ¯ ǣǣsǼǣʰ ĶÞEÞĶÞǼÞsǣʰ
ÌsNjsÞŘ¯ǼsNjNjs¯sNjNjs_ǼŸǣ˄ǼÌsµNjŸȖƼ˅ʳǻÌsµNjŸȖƼÞǣƼNjÞŘOÞƼĶĶɴsض¶s_ ÞŘOŸŎs Ř_ sɮƼsŘǣsǣʰ ¯ǼsNj sĶÞŎÞŘǼÞض ÞŘǼNj˚¶NjŸȖƼ EĶŘOsǣ
ÞŘŎŘȖ¯OǼȖNjÞضŘ_ŎNjĨsǼÞضŸ¯¯ENjÞOɠÌÞǼsŘsNjǣʰǣŸƼǣʰ_sǼsNj¶sŘǼǣʰ Ř_ ǼÌs ȖŘNjsĶÞǣs_ ƼNjŸʩǼǣ ˀ ȖŘNjsĶÞǣs_ ĶŸǣǣsǣ ŸŘ ÞŘǼNj˚¶NjŸȖƼ
ŎŸǣLJȖÞǼŸOŸÞĶǣŘ_ÞŘOsŘǣsǣǼÞOĨǣŘ_ĶǣŸƼNjŸɚÞ_sǣĶȖŘ_NjɴŘ__Njɴ
ǼNjŘǣOǼÞŸŘǣǣƼsNjOOŸȖŘǼÞضǢǼŘ_Nj_ˡˠʹǢˡˠʺˆNŸŘǣŸĶÞ_Ǽs_
OĶsŘÞضǣsNjɚÞOsǣʳ
®ÞŘŘOÞĶ ǢǼǼsŎsŘǼǣˇʳ ǻÌs NjsǣȖĶǼǣ Ÿ¯ ǣȖEǣÞ_ÞNjÞsǣ Njs ÞŘOĶȖ_s_
NOTE 2 - BASIS OF PREPARATION OF FINANCIAL STATEMENTS ¯NjŸŎǼÌs_ǼsŸ¯OLJȖÞǣÞǼÞŸŘŸ¯OŸŘǼNjŸĶĶÞضÞŘǼsNjsǣǼʳǻÌssɮOsǣǣˀ
ʺ ǻÌs ʩŘŘOÞĶ ǣǼǼsŎsŘǼǣ Ÿ¯ ǼÌs µNjŸȖƼ Ìɚs EssŘ ƼNjsƼNjs_ ÞŘ shortfall of cost to the Group of its investments in the subsidiary
accordance with generally accepted accounting principles in OŸŎƼŘÞsǣÞǣNjsOŸ¶ŘÞǣs_ÞŘǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣǣ¶ŸŸ_ɠÞĶĶˀ
ÝŘ_Þ ʹÝŘ_ÞŘ µƻʺʳ ǻÌs µNjŸȖƼ Ìǣ ƼNjsƼNjs_ ǼÌsǣs ʩŘŘOÞĶ OƼÞǼĶNjsǣsNjɚsǣʰǣǼÌsOǣsŎɴEsʳµŸŸ_ɠÞĶĶŸŘOŸŘǣŸĶÞ_ǼÞŸŘÞǣ
statements to comply in all material respects with the accounting
ǼsǣǼs_¯ŸNjÞŎƼÞNjŎsŘǼǼsɚsNjɴNjsƼŸNjǼÞض_Ǽsʳ
ǣǼŘ_Nj_ǣŘŸǼÞʩs_ȖŘ_sNjǣsOǼÞŸŘˠˢˢŸ¯ǼÌsNŸŎƼŘÞsǣOǼˡ˟ˠˢʰ
Njs_ ǼŸ¶sǼÌsNj ɠÞǼÌ ƼNj¶NjƼÌ ˦ Ÿ¯ ǼÌs NŸŎƼŘÞsǣ ʹOOŸȖŘǼǣʺ
NJȖĶsǣˡ˟ˠˣʳǻÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣÌɚsEssŘƼNjsƼNjs_ȖŘ_sNj Oʺ ōÞŘŸNjÞǼɴ ÞŘǼsNjsǣǼ ÞŘ ŘsǼ ǣǣsǼ Ÿ¯ OŸŘǣŸĶÞ_Ǽs_ ǣȖEǣÞ_ÞNjɴ OŸŘǣÞǣǼ
ǼÌsÌÞǣǼŸNjÞOĶOŸǣǼOŸŘɚsŘǼÞŸŘŸŘŘOONjȖĶEǣÞǣsɮOsƼǼÞŘOǣsŸ¯ of the amount of equity attributable to the minority shareholders
assets which has been recorded on fair value and assets for which at the dates on which investments are made by the company in
ƼNjŸɚÞǣÞŸŘ¯ŸNjÞŎƼÞNjŎsŘǼÞǣŎ_sʳǻÌsOOŸȖŘǼÞضƼŸĶÞOÞsǣÌɚs subsidiary companies and further movement in their share in
been consistently applied by the Group and are consistent with
sLJȖÞǼɴʰǣȖEǣsLJȖsŘǼǼŸǼÌs_ǼsǣŸ¯ÞŘɚsǣǼŎsŘǼʳ
ǼÌŸǣsȖǣs_ÞŘǼÌsƼNjsɚÞŸȖǣɴsNjʳ

_ʺ ǻÌsNŸŘǣŸĶÞ_Ǽs_®ÞŘŘOÞĶǢǼǼsŎsŘǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥ÞŘOĶȖ_sǣǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣŸ¯ǼÌs¯ŸĶĶŸɠÞضǣȖEǣÞ_ÞNjÞsǣʲ

Name of the Company Country of ƻsNjOsŘǼ¶sŸ¯ŸɠŘsNjǣÌÞƼsÞǼÌsNj_ÞNjsOǼĶɴŸNj


incorporation indirectly through subsidiaries as at
March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ

(a) Direct Subsidiaries


 ˠʳ ǣǣŸOÞǼs_ÝŘ_ȖǣǼNjÞsǣNŸŘǣȖŎsNjƻNjŸ_ȖOǼǣƻɚǼĵǼ_̱ India ʹŗŸǼsÝÝʺ ˠ˟˟ʳ˟˟
 ˡʳ ğɴŸǼÌɴ®ENjÞONjsǢsNjɚÞOsǣĵÞŎÞǼs_ India ˦ˤʳˠ˟ ˦ˤʳˠ˟
 ˢʳ ğɴŸǼÌɴNŸŘǣȖŎsNjƻNjŸ_ȖOǼǣĵǼ_ India ʹŗŸǼsÝÝʺ ʹŗŸǼsÝÝʺ
 ˣʳ ğɴŸǼÌɴħĶĶŸĶDضĶ_sǣÌĵÞŎÞǼs_ Bangladesh ˦ˤʳ˟˟ ˦ˤʳ˟˟
 ˤʳ ğɴŸǼÌɴNŸŘǣȖŎsNjƻNjŸ_ȖOǼǣōNjĨsǼÞضĵǼ_ India ˠ˟˟ʳ˟˟ ˠ˟˟ʳ˟˟
(b) Indirect Subsidiaries *
 ˥ʳ ǢŘŸɠɴǣĵȖŘ_NjsNjǣŘ_^NjɴOĶsŘsNjǣƻɚǼʳĵǼ_ʹŗŸǼsÝʺ India ˢ˥ʳ˧˟ ˢ˥ʳ˧˟
 ˦ʳ ^ÞŎŸŘ_®EONjsƻNjÞɚǼsĵÞŎÞǼs_ India ʹŗŸǼsÝÝʺ ʹŗŸǼsÝÝʺ
 ˧ʳ ĨǣÌNĶsŘsNjǣƻNjÞɚǼsĵÞŎÞǼs_ India ʹŗŸǼsÝÝʺ ʹŗŸǼsÝÝʺ
 ˨ʳ ®ENĶsŘ˓NNjsƻNjÞɚǼsĵÞŎÞǼs_ India ʹŗŸǼsÝÝʺ ʹŗŸǼsÝÝʺ
 ˠ˟ʳ ®ŸȖNjǢsǣŸŘǣ^NjɴNĶsŘÞضNŸʳƻNjÞɚǼsĵÞŎÞǼs_ India ˦ˤʳˠ˟ ˦ˤʳˠ˟
 ˠˠʳ ğ®Ǣĵ˚ğĵĵʹğəʺ India ˧ˠʳˢˡ ˧ˠʳˢˡ

ˎr¯¯sOǼÞɚsÌŸĶ_Þض̇Ÿ¯NŸŎƼŘɴ_ÞNjsOǼĶɴŘ_ÞŘ_ÞNjsOǼĶɴǼÌNjŸȖ¶ÌÞǼǣǣȖEǣÞ_ÞNjÞsǣʳ

̱ōsNj¶s_ɠÞǼÌğɴŸǼÌɴNŸŘǣȖŎsNjƻNjŸ_ȖOǼǣōNjĨsǼÞضĵÞŎÞǼs_ɠʳsʳ¯ʳ˟ˠƼNjÞĶʰˡ˟ˠˣ

ŗŸǼsʲ

Ý ğɴŸǼÌɴ®ENjÞONjsǢsNjɚÞOsǣĵÞŎÞǼs_Ìǣˣ˨̇ǣÌNjsÞŘǢŘŸɠɴǣĵȖŘ_NjsNjǣ˓^NjɴOĶsŘsNjǣƻɚǼʳĵǼ_Ř_ÌǣsŘǼsNjs_ÞŘǼŸ¶NjssŎsŘǼɠÌÞOÌsŘEĶs
ÞǼǼŸOŸŘǼNjŸĶǼÌsOŸŎƼŸǣÞǼÞŸŘŸ¯ǼÌsDŸNj_Ÿ¯^ÞNjsOǼŸNjǣŸ¯ǼÌsĶǼǼsNjʰŎĨÞضÞǼǣȖEǣÞ_ÞNjɴOŸŎƼŘɴŸ¯ğɴŸǼÌɴ®ENjÞONjsǢsNjɚÞOsǣĵÞŎÞǼs_ʳ

ÝÝ ǻÌsǣssŘǼÞǼÞsǣÌɚsEssŘŎsNj¶s_ɠÞǼÌǼÌsNŸŎƼŘɴŸNjÞǼǣǣȖEǣÞ_ÞNjÞsǣȖŘ_sNjŘƼƼNjŸɚs_ǣOÌsŎsŸ¯ŎĶ¶ŎǼÞŸŘŸ¯ËÞ¶ÌNŸȖNjǼÞŘsNjĶÞsNj
ɴsNjǣʳǻÌsNjsÞǣŘŸÞŎƼOǼŸ¯ǼÌÞǣŎsNj¶sNjŸŘǼÌsOŸŘǣŸĶÞ_Ǽs_ʩŘŘOÞĶǣǼǼsŎsŘǼǣŸ¯ǼÌsµNjŸȖƼʰǣÞŘOsǼÌsEȖǣÞŘsǣǣɠǣĶNjs_ɴÞŘOĶȖ_s_ÞŘǼÌs
OŸŘǣŸĶÞ_Ǽs_ʩŘŘOÞĶǣǼǼsŎsŘǼǣŸ¯sNjĶÞsNjɴsNjǣʳ
Corporate Overview Performance Governance Financial Statements ˠˣ˨

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES and the carrying amount of the asset and are recognized in the
ǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣɠÌsŘǼÌsǣǣsǼÞǣ_sNjsOŸ¶ŘÞʊs_ʳ
ǻÌsǣÞ¶ŘÞʩOŘǼOOŸȖŘǼÞضƼŸĶÞOÞsǣ_ŸƼǼs_EɴǼÌsµNjŸȖƼʰÞŘNjsǣƼsOǼŸ¯
ǼÌsOŸŘǣŸĶÞ_Ǽs_ʩŘŘOÞĶǣǼǼsŎsŘǼǣNjsǣ¯ŸĶĶŸɠǣʲ d) Depreciation and amortisation

a) Use of estimates Depreciation is provided using the Straight Line Method as per
ǼÌsȖǣs¯ȖĶĶÞɚsǣŸ¯ǼÌsǣǣsǼǣsǣǼÞŎǼs_EɴǼÌsŎضsŎsŘǼʳ
 ǻÌsƼNjsƼNjǼÞŸŘŸ¯ʩŘŘOÞĶǣǼǼsŎsŘǼǣʰÞŘOŸŘ¯ŸNjŎÞǼɴɠÞǼÌÝŘ_ÞŘ
µƻNjsLJȖÞNjsǣŎضsŎsŘǼǼŸŎĨsĠȖ_¶ŎsŘǼǣʰsǣǼÞŎǼsǣŘ_  ǻÌssǣǼÞŎǼs_Ȗǣs¯ȖĶĶÞ¯sŸ¯ǼÌsǣǣsǼǣÞǣǣ¯ŸĶĶŸɠǣʲ
ǣǣȖŎƼǼÞŸŘǣ ǼÌǼ ¯¯sOǼ ǼÌs NjsƼŸNjǼs_ ŎŸȖŘǼǣ Ÿ¯ NjsɚsŘȖsǣ ʰ
Category Estimated useful
sɮƼsŘǣsǣʰǣǣsǼǣʰĶÞEÞĶÞǼÞsǣŘ__ÞǣOĶŸǣȖNjsŸ¯OŸŘǼÞضsŘǼĶÞEÞĶÞǼÞsǣ
life (in years)
ǼǼÌssŘ_Ÿ¯ǼÌsNjsƼŸNjǼÞضƼsNjÞŸ_ʳĶǼÌŸȖ¶ÌǼÌsǣssǣǼÞŎǼsǣNjs
Factory Buildings ˠ˟˚ˢ˟
Eǣs_ ȖƼŸŘ ŎضsŎsŘǼ˅ǣ EsǣǼ ĨŘŸɠĶs_¶s Ÿ¯ OȖNjNjsŘǼ sɚsŘǼǣ DȖÞĶ_ÞضʹŷǼÌsNjǼÌŘ®OǼŸNjɴDȖÞĶ_Þضʺ ˢ˟˚˥˟
Ř_OǼÞŸŘǣʰȖŘOsNjǼÞŘǼɴEŸȖǼǼÌsǣsǣǣȖŎƼǼÞŸŘǣŘ_sǣǼÞŎǼsǣ DȖÞĶ_Þضʹ®sŘOsǣŘ_ǼsŎƼŸNjNjɴǣǼNjȖOǼȖNjsʺ ˢ˚˥
OŸȖĶ_NjsǣȖĶǼÞŘǼÌsŸȖǼOŸŎsǣNjsLJȖÞNjÞضŎǼsNjÞĶ_ĠȖǣǼŎsŘǼǼŸ Plant and machinery ˠˢ˚ˠˤ
ǼÌsONjNjɴÞضŎŸȖŘǼǣŸ¯ǣǣsǼǣŸNjĶÞEÞĶÞǼÞsǣÞŘ¯ȖǼȖNjsƼsNjÞŸ_ǣʳ ®ȖNjŘÞǼȖNjsŘ_ʩɮǼȖNjsǣ 5-10
ĵsǣsÌŸĶ_ÝŎƼNjŸɚsŎsŘǼǣʹŷȖǼĶsǼǣŸŘĶsǣsʺ ˢ
Eʺ ǻضÞEĶsʩɮs_ǣǣsǼǣ
Dies and moulds ˢ
 ®Þɮs_ ǣǣsǼǣ Njs ÞŘÞǼÞĶĶɴ NjsOŸNj_s_ Ǽ OŸǣǼ ʳ NŸǣǼ OŸŎƼNjÞǣsǣ ǼÌs Computers ˢ˚˥
purchase price and any directly attributable cost of bringing the ŷ¯ʩOssLJȖÞƼŎsŘǼǣ 5
əsÌÞOĶsǣ 6-10
ǣǣsǼ ǼŸ ÞǼǣ ɠŸNjĨÞض OŸŘ_ÞǼÞŸŘ ¯ŸNj ÞǼǣ ÞŘǼsŘ_s_ Ȗǣsʳ ǻÌs OŸǣǼ Ÿ¯
ħŘŸɠ˚ÌŸɠ ˢ˚ˤ
the tangible assets acquired in an amalgamation in the nature
ǻNj_sŎNjĨǣŘ_NŸƼɴNjÞ¶ÌǼǣ ˨˚ˠ˟
Ÿ¯ ƼȖNjOÌǣs Þǣ ǼÌsÞNj ¯ÞNj ɚĶȖs ǣ Ǽ ǼÌs _Ǽs Ÿ¯ ŎĶ¶ŎǼÞŸŘʳ
Softwares and Licences 10
®ŸĶĶŸɠÞض ÞŘÞǼÞĶ NjsOŸ¶ŘÞǼÞŸŘʰ ǼضÞEĶs ǣǣsǼǣ Njs ONjNjÞs_ Ǽ OŸǣǼ
ĶsǣǣOOȖŎȖĶǼs__sƼNjsOÞǼÞŸŘŘ_ÞŎƼÞNjŎsŘǼĶŸǣǣsǣʰÞ¯Řɴʳ The goodwill purchased is not amortised but tested for
ÞŎƼÞNjŎsŘǼ ƼȖNjƼŸǣsǣ ¯ŸNj sɚsNjɴ ɴsNjʳ ǣǣsǼǣ OŸǣǼÞض Ķsǣǣ ǼÌsŘ
 ǢȖEǣsLJȖsŘǼ sɮƼsŘ_ÞǼȖNjs NjsĶǼs_ ǼŸ Ř ÞǼsŎ Ÿ¯ ʩɮs_ ǣǣsǼ Þǣ
` ˤʰ˟˟˟ Njs _sƼNjsOÞǼs_ Ǽ ǼÌs NjǼs Ÿ¯ ˠ˟˟ ̇ʳ ĵsǣsÌŸĶ_ ĶŘ_ Þǣ
__s_ ǼŸ ÞǼǣ EŸŸĨ ɚĶȖs ŸŘĶɴ Þ¯ ÞǼ ÞŘONjsǣsǣ ǼÌs ¯ȖǼȖNjs EsŘsʩǼǣ
amortised over the period of the lease on a straight-line basis
¯NjŸŎǼÌssɮÞǣǼÞضǣǣsǼEsɴŸŘ_ÞǼǣƼNjsɚÞŸȖǣĶɴǣǣsǣǣs_ǣǼŘ_Nj_
ɠÌÞOÌNjضsǣEsǼɠssŘ˥˟˚˨˟ɴsNjǣʳ
Ÿ¯ ƼsNj¯ŸNjŎŘOsʳ ĶĶ ŸǼÌsNj sɮƼsŘǣsǣ ŸŘ sɮÞǣǼÞض ʩɮs_ ǣǣsǼǣʰ
ÞŘOĶȖ_Þض _ɴ˚ǼŸ˚_ɴ NjsƼÞNj Ř_ ŎÞŘǼsŘŘOs sɮƼsŘ_ÞǼȖNjs Ř_  ǻÌs ŎضsŎsŘǼ Ìǣ sǣǼÞŎǼs_ʰ ǣȖƼƼŸNjǼs_ Eɴ ÞŘ_sƼsŘ_sŘǼ
OŸǣǼŸ¯NjsƼĶOÞضƼNjǼǣʰNjsOÌNj¶s_ǼŸǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ ǣǣsǣǣŎsŘǼ Eɴ ƼNjŸ¯sǣǣÞŸŘĶǣʰ ǼÌs Ȗǣs¯ȖĶ ĶÞɚsǣ Ÿ¯ ǼÌs ¯ŸĶĶŸɠÞض
ĶŸǣǣ¯ŸNjǼÌsƼsNjÞŸ__ȖNjÞضɠÌÞOÌǣȖOÌsɮƼsŘǣsǣNjsÞŘOȖNjNjs_ʳ OĶǣǣsǣ Ÿ¯ ǣǣsǼǣ ʹɠÌÞOÌ ɠsNjs ǼĨsŘ ŸɚsNj _ȖNjÞض ǼÌs ŎsNj¶sNj Ÿ¯
sNjǣǼɠÌÞĶs ğɴŸǼÌɴ NŸŘǣȖŎsNj ƻNjŸ_ȖOǼǣ ĵÞŎÞǼs_ʺʰ ɠÌÞOÌ Njs ĶŸɠsNj
Gains or losses arising from derecognition of tangible assets are
ǼÌŘǼÌŸǣsÞŘ_ÞOǼs_ÞŘǢOÌs_ȖĶsÝÝʳ
measured as the difference between the net disposal proceeds
and the carrying amount of the asset and are recognized in the Category Estimated useful
ǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣɠÌsŘǼÌsǣǣsǼÞǣ_sNjsOŸ¶ŘÞʊs_ʳ life (in years)
Factory Buildings 10
 ǻÌs ¶NjŸȖƼ Þ_sŘǼÞʩsǣ Ř_ _sǼsNjŎÞŘsǣ OŸǣǼ Ÿ¯ ǣǣsǼ ǣÞ¶ŘÞʩOŘǼ
DȖÞĶ_ÞضʹŷǼÌsNjǼÌŘ®OǼŸNjɴDȖÞĶ_Þضʺ ˢ˟
to the total cost of the asset having useful life that is materially Plant and machinery ˠˢ
_Þ¯¯sNjsŘǼ¯NjŸŎǼÌǼŸ¯ǼÌsNjsŎÞŘÞضĶÞ¯sʳ ®ȖNjŘÞǼȖNjsŘ_ʩɮǼȖNjsǣ 5
əsÌÞOĶsǣ 6
c) Intangible assets

Intangible assets acquired separately are measured on initial  ǻÌs ŎŸNjǼÞʊǼÞŸŘˀ _sƼNjsOÞǼÞŸŘ ƼsNjÞŸ_ Ř_ ǼÌs ŎŸNjǼÞʊǼÞŸŘˀ

NjsOŸ¶ŘÞǼÞŸŘǼOŸǣǼʳ®ŸĶĶŸɠÞضÞŘÞǼÞĶNjsOŸ¶ŘÞǼÞŸŘʰÞŘǼضÞEĶsǣǣsǼǣ _sƼNjsOÞǼÞŸŘŎsǼÌŸ_NjsNjsɚÞsɠs_ǼĶsǣǼǼsOÌʩŘŘOÞĶɴsNjsŘ_ʳ

are carried at cost less accumulated amortization and accumulated  ݯ ǼÌs sɮƼsOǼs_ Ȗǣs¯ȖĶ ĶÞ¯s Ÿ¯ ǼÌs ǣǣsǼ Þǣ ǣÞ¶ŘÞʩOŘǼĶɴ _Þ¯¯sNjsŘǼ
ÞŎƼÞNjŎsŘǼ ĶŸǣǣsǣʰ Þ¯ Řɴʳ ÝŘǼضÞEĶs ǣǣsǼǣ Njs ŎŸNjǼÞʊs_ ŸŘ  ¯NjŸŎƼNjsɚÞŸȖǣsǣǼÞŎǼsǣʰǼÌsŎŸNjǼÞʊǼÞŸŘˀ_sƼNjsOÞǼÞŸŘƼsNjÞŸ_
ǣǼNjÞ¶ÌǼ ĶÞŘs EǣÞǣ ŸɚsNj ǼÌs sǣǼÞŎǼs_ Ȗǣs¯ȖĶ sOŸŘŸŎÞO ĶÞ¯sʳ ǻÌs ÞǣOÌضs_OOŸNj_ÞضĶɴʳݯǼÌsNjsÌǣEssŘǣÞ¶ŘÞʩOŘǼOÌضsÞŘ
Group uses a rebuttable presumption that the useful life of an ǼÌs sɮƼsOǼs_ ƼǼǼsNjŘ Ÿ¯ sOŸŘŸŎÞO EsŘsʩǼǣ ¯NjŸŎ ǼÌs ǣǣsǼʰ ǼÌs
ÞŘǼضÞEĶsǣǣsǼɠÞĶĶŘŸǼsɮOss_ǼsŘɴsNjǣ¯NjŸŎǼÌs_ǼsɠÌsŘǼÌs ŎŸNjǼÞʊǼÞŸŘˀ _sƼNjsOÞǼÞŸŘ ŎsǼÌŸ_ Þǣ OÌضs_ ǼŸ NjsʪsOǼ ǼÌs
ǣǣsǼÞǣɚÞĶEĶs¯ŸNjȖǣsʳ OÌضs_ƼǼǼsNjŘʳǢȖOÌOÌضsǣNjsOOŸȖŘǼs_¯ŸNjÞŘOOŸNj_ŘOs

Gains or losses arising from derecognition of an intangible asset with ǢˤŗsǼƻNjŸʩǼŸNjĵŸǣǣ¯ŸNjǼÌsƻsNjÞŸ_ʰƻNjÞŸNjƻsNjÞŸ_ÝǼsŎǣŘ_

are measured as the difference between the net disposal proceeds NÌضsǣÞŘOOŸȖŘǼÞضƻŸĶÞOÞsǣʳ
150 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
e) Impairment g) Government grants and subsidies

 Þʺ ǻÌs OŸŎƼŘɴ ǣǣsǣǣsǣ Ǽ sOÌ NjsƼŸNjǼÞض _Ǽs ɠÌsǼÌsNj Grants and subsidies from the government are recognized when
ǼÌsNjs Þǣ Ř ÞŘ_ÞOǼÞŸŘ ǼÌǼ Ř ǣǣsǼ Ŏɴ Es ÞŎƼÞNjs_ʳ ݯ ǼÌsNjs Þǣ NjsǣŸŘEĶs ǣǣȖNjŘOs ǼÌǼ ǼÌs ¶NjŘǼˀ ǣȖEǣÞ_ɴ ɠÞĶĶ Es
Řɴ ÞŘ_ÞOǼÞŸŘ sɮÞǣǼǣʰ ŸNj ɠÌsŘ ŘŘȖĶ ÞŎƼÞNjŎsŘǼ ǼsǣǼÞض NjsOsÞɚs_Ř_ĶĶǼǼOÌÞضOŸŘ_ÞǼÞŸŘǣɠÞĶĶEsOŸŎƼĶÞs_ɠÞǼÌʳɟÌsŘ
¯ŸNj Ř ǣǣsǼ Þǣ NjsLJȖÞNjs_ʰ ǼÌs µNjŸȖƼ sǣǼÞŎǼsǣ ǼÌs ǣǣsǼ˅ǣ ǼÌs¶NjŘǼŸNjǣȖEǣÞ_ɴNjsĶǼsǣǼŸNjsɚsŘȖsÞǼsŎʰÞǼÞǣNjsOŸ¶ŘÞʊs_ǣ
NjsOŸɚsNjEĶs ŎŸȖŘǼʳ Ř ǣǣsǼ˅ǣ NjsOŸɚsNjEĶs ŎŸȖŘǼ Þǣ ǼÌs income over the periods necessary to match them on a systematic
ÌÞ¶ÌsNj Ÿ¯ Ř ǣǣsǼ˅ǣ ŸNj OǣÌ˚¶sŘsNjǼÞض ȖŘÞǼ˅ǣ ʹNµȕʺ ŘsǼ EǣÞǣǼŸǼÌsOŸǣǼǣʰɠÌÞOÌÞǼÞǣÞŘǼsŘ_s_ǼŸOŸŎƼsŘǣǼsʳɟÌsNjsǼÌs
ǣsĶĶÞض ƼNjÞOs Ř_ ÞǼǣ ɚĶȖs ÞŘ Ȗǣsʳ ǻÌs NjsOŸɚsNjEĶs ŎŸȖŘǼ ¶NjŘǼ ŸNj ǣȖEǣÞ_ɴ NjsĶǼsǣ ǼŸ Ř ǣǣsǼʰ ÞǼǣ ɚĶȖs Þǣ _s_ȖOǼs_ ¯NjŸŎ
Þǣ_sǼsNjŎÞŘs_¯ŸNjŘÞŘ_ÞɚÞ_ȖĶǣǣsǼʰȖŘĶsǣǣǼÌsǣǣsǼ_Ÿsǣ the gross value in arriving at the carrying amount of the related
ŘŸǼ ¶sŘsNjǼs OǣÌ ÞŘʪŸɠǣ ǼÌǼ Njs ĶNj¶sĶɴ ÞŘ_sƼsŘ_sŘǼ Ÿ¯ ǣǣsǼʳµŸɚsNjŘŎsŘǼ¶NjŘǼÞŘǼÌsŘǼȖNjsŸ¯ƼNjŸŎŸǼsNjǣ˅OŸŘǼNjÞEȖǼÞŸŘ
ǼÌŸǣs¯NjŸŎŸǼÌsNjǣǣsǼǣŸNj¶NjŸȖƼǣŸ¯ǣǣsǼǣʳŘÞŎƼÞNjŎsŘǼ ÞǣONjs_ÞǼs_ǼŸǼÌsÞŘɚsǣǼŎsŘǼǣȖEǣÞ_ɴNjsǣsNjɚsʳ
loss is recognized wherever the carrying amount of an asset
h) Investment
sɮOss_ ÞǼǣ NjsOŸɚsNjEĶs ŎŸȖŘǼʳ ǻÌs NjsOŸɚsNjEĶs ŎŸȖŘǼ Þǣ
ǼÌs¶NjsǼsNjŸ¯ǼÌsǣǣsǼǣŘsǼǣsĶĶÞضƼNjÞOsŘ_ɚĶȖsÞŘȖǣsʳ Investments that are readily realisable and intended to be
ÝŘǣǣsǣǣÞضɚĶȖsÞŘȖǣsʰǼÌssǣǼÞŎǼs_¯ȖǼȖNjsOǣÌʪŸɠǣNjs held for not more than one year from the date on which such
_ÞǣOŸȖŘǼs_ǼŸǼÌsÞNjƼNjsǣsŘǼɚĶȖsǼǼÌsƼNjs˚Ǽɮ_ÞǣOŸȖŘǼNjǼsʳ ÞŘɚsǣǼŎsŘǼǣ Njs Ŏ_s Njs OĶǣǣÞʩs_ ǣ OȖNjNjsŘǼ ÞŘɚsǣǼŎsŘǼǣʳ ĶĶ
ÝŘ_sǼsNjŎÞŘÞضŘsǼǣsĶĶÞضƼNjÞOsʰNjsOsŘǼŎNjĨsǼǼNjŘǣOǼÞŸŘ ŸǼÌsNjÞŘɚsǣǼŎsŘǼǣNjsOĶǣǣÞʩs_ǣĶŸŘ¶˚ǼsNjŎÞŘɚsǣǼŎsŘǼǣʳ
NjsǼĨsŘÞŘǼŸOOŸȖŘǼʰÞ¯ɚÞĶEĶsʳݯŘŸǣȖOÌǼNjŘǣOǼÞŸŘOŘ
 ŷŘÞŘÞǼÞĶNjsOŸ¶ŘÞǼÞŸŘʰĶĶÞŘɚsǣǼŎsŘǼǣNjsŎsǣȖNjs_ǼOŸǣǼʳǻÌs
EsÞ_sŘǼÞʩs_ʰŘƼƼNjŸƼNjÞǼsɚĶȖǼÞŸŘŎŸ_sĶÞǣȖǣs_ʳ
cost comprises purchase price and directly attributable acquisition
 ÞÞʺ ¯ǼsNj ÞŎƼÞNjŎsŘǼʰ _sƼNjsOÞǼÞŸŘ Þǣ ƼNjŸɚÞ_s_ ŸŘ ǼÌs NjsɚÞǣs_ OÌNj¶sǣǣȖOÌǣENjŸĨsNj¶sʰ¯ssǣŘ__ȖǼÞsǣŘ_ŸǼÌsNjOŸǣǼǣǼÌǼ
ONjNjɴÞضŎŸȖŘǼŸ¯ǼÌsǣǣsǼǣŸɚsNjÞǼǣNjsŎÞŘÞضȖǣs¯ȖĶĶÞ¯sʳ NjÞǣs ŸŘ OLJȖÞǣÞǼÞŸŘ Ÿ¯ ÞŘɚsǣǼŎsŘǼʳ NȖNjNjsŘǼ ÞŘɚsǣǼŎsŘǼǣ Njs
carried at lower of cost and fair value determined on an individual
 ÞÞÞʺ  ƼNjsɚÞŸȖǣĶɴ NjsOŸ¶ŘÞʊs_ ÞŎƼÞNjŎsŘǼ ĶŸǣǣ Þǣ NjsɚsNjǣs_ ŸŘĶɴ
ÞŘɚsǣǼŎsŘǼ EǣÞǣʳ ĵŸŘ¶˚ǼsNjŎ ÞŘɚsǣǼŎsŘǼǣ Njs ONjNjÞs_ Ǽ OŸǣǼʳ
if there has been a change in the assumptions used to
ËŸɠsɚsNjʰƼNjŸɚÞǣÞŸŘ¯ŸNj_ÞŎÞŘȖǼÞŸŘÞŘɚĶȖsÞǣŎ_sǼŸNjsOŸ¶ŘÞǣs
_sǼsNjŎÞŘs ǼÌs ǣǣsǼ˅ǣ NjsOŸɚsNjEĶs ŎŸȖŘǼ ǣÞŘOs ǼÌs ĶǣǼ
_sOĶÞŘsŸǼÌsNjǼÌŘǼsŎƼŸNjNjɴÞŘǼÌsɚĶȖsŸ¯ǼÌsÞŘɚsǣǼŎsŘǼǣʳ
ÞŎƼÞNjŎsŘǼ ĶŸǣǣ ɠǣ NjsOŸ¶ŘÞʊs_ʳ ǻÌs NjsɚsNjǣĶ Þǣ ĶÞŎÞǼs_ ǣŸ
ŷŘ _ÞǣƼŸǣĶ Ÿ¯ ÞŘɚsǣǼŎsŘǼʰ ǼÌs _Þ¯¯sNjsŘOs EsǼɠssŘ ÞǼǣ ONjNjɴÞض
ǼÌǼ ǼÌs ONjNjɴÞض ŎŸȖŘǼ Ÿ¯ ǼÌs ǣǣsǼ _Ÿsǣ ŘŸǼ sɮOss_ ÞǼǣ
amount and net disposal proceeds is charged or credited to the
NjsOŸɚsNjEĶs ŎŸȖŘǼʰ ŘŸNj sɮOss_ ǼÌs ONjNjɴÞض ŎŸȖŘǼ ǼÌǼ
ǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣʳ
ɠŸȖĶ_ Ìɚs EssŘ _sǼsNjŎÞŘs_ʰ ŘsǼ Ÿ¯ _sƼNjsOÞǼÞŸŘʰ Ì_ ŘŸ
ÞŎƼÞNjŎsŘǼĶŸǣǣEssŘNjsOŸ¶ŘÞʊs_¯ŸNjǼÌsǣǣsǼÞŘƼNjÞŸNjɴsNjǣʳ  Ř ÞŘɚsǣǼŎsŘǼ ÞŘ ĶŘ_ ŸNj EȖÞĶ_Þضʰ ɠÌÞOÌ Þǣ ŘŸǼ ÞŘǼsŘ_s_ ǼŸ Es
ŸOOȖƼÞs_ǣȖEǣǼŘǼÞĶĶɴ¯ŸNjȖǣsEɴʰŸNjÞŘǼÌsŸƼsNjǼÞŸŘǣŸ¯ǼÌsµNjŸȖƼ
f) Operating Leases
Þǣ OĶǣǣÞʩs_ ǣ ÞŘɚsǣǼŎsŘǼ ƼNjŸƼsNjǼɴʳ ÝŘɚsǣǼŎsŘǼ ƼNjŸƼsNjǼÞsǣ Njs
i. Where the company is a lessee; ǣǼǼs_ǼOŸǣǼʰŘsǼŸ¯OOȖŎȖĶǼs__sƼNjsOÞǼÞŸŘŘ_ÞŎƼÞNjŎsŘǼ
ĶŸǣǣsǣʰÞ¯Řɴʳ
  ĵsǣsǣʰ ɠÌsNjs ǼÌs ĶsǣǣŸNj s¯¯sOǼÞɚsĶɴ NjsǼÞŘǣ ǣȖEǣǼŘǼÞĶĶɴ ĶĶ
ǼÌsNjÞǣĨǣŘ_EsŘsʩǼǣŸ¯ŸɠŘsNjǣÌÞƼŸ¯ǼÌsĶsǣs_ÞǼsŎʰNjs i) Inventories
OĶǣǣÞʩs_ǣŸƼsNjǼÞضĶsǣsǣʳĵsǣsƼɴŎsŘǼǣŸŘŸƼsNjǼÞض
 ÝŘɚsŘǼŸNjÞsǣŸ¯NjɠŎǼsNjÞĶǣʰƼOĨÞضŎǼsNjÞĶǣʰɠŸNjĨ˚ÞŘ˚ƼNjŸ¶Njsǣǣʰ
Ķsǣsǣ Njs NjsOŸ¶ŘÞʊs_ ǣ Ř sɮƼsŘǣs ÞŘ ǼÌs ǣǼǼsŎsŘǼ Ÿ¯
ʩŘÞǣÌs_¶ŸŸ_ǣʰŸƼsNjǼÞضǣȖƼƼĶÞsǣʰǣǼŸNjsǣŘ_OŸŘǣȖŎEĶsǣÞǼsŎǣ
ƼNjŸʩǼŘ_ĶŸǣǣŸŘǣǼNjÞ¶ÌǼ˚ĶÞŘsEǣÞǣʰŸɚsNjǼÌsĶsǣsǼsNjŎʳ
Njs ɚĶȖs_ Ǽ OŸǣǼ ŸNj ŘsǼ NjsĶÞʊEĶs ɚĶȖsʰ ɠÌÞOÌsɚsNj Þǣ ĶŸɠsNjʳ
ii. Where the company is a lessor; ËŸɠsɚsNjʰŎǼsNjÞĶǣŘ_ŸǼÌsNjÞǼsŎǣÌsĶ_¯ŸNjȖǣsÞŘǼÌsƼNjŸ_ȖOǼÞŸŘ
Ÿ¯ ÞŘɚsŘǼŸNjÞsǣ Njs ŘŸǼ ɠNjÞǼǼsŘ _ŸɠŘ EsĶŸɠ OŸǣǼ Þ¯ ǼÌs ʩŘÞǣÌs_
Leases in which the company does not transfer substantially
ƼNjŸ_ȖOǼǣÞŘɠÌÞOÌǼÌsɴɠÞĶĶEsÞŘOŸNjƼŸNjǼs_NjssɮƼsOǼs_ǼŸEsǣŸĶ_
ĶĶ ǼÌs NjÞǣĨǣ Ř_ EsŘsʩǼǣ Ÿ¯ ŸɠŘsNjǣÌÞƼ Ÿ¯ ǼÌs ǣǣsǼ Njs
ǼŸNjEŸɚsOŸǣǼʳ
OĶǣǣÞʩs_ ǣ ŸƼsNjǼÞض Ķsǣsǣʳ ǣǣsǼǣ ǣȖEĠsOǼ ǼŸ ŸƼsNjǼÞض
Ķsǣsǣ Njs ÞŘOĶȖ_s_ ÞŘ ʩɮs_ ǣǣsǼǣʳ ĵsǣs ÞŘOŸŎs ŸŘ Ř  NŸǣǼÞǣǣOsNjǼÞŘs_ŸŘ®ÞNjǣǼ˚ÞŘ˚®ÞNjǣǼŸȖǼʹ˄®Ý®ŷ˅ʺEǣÞǣŘ_ÞŘOĶȖ_sǣ
ŸƼsNjǼÞض Ķsǣs Þǣ NjsOŸ¶ŘÞʊs_ ÞŘ ǼÌs ǣǼǼsŎsŘǼ Ÿ¯ ƼNjŸʩǼ all applicable costs incurred in bringing goods to their present
Ř_ĶŸǣǣŸŘǣǼNjÞ¶ÌǼ˚ĶÞŘsEǣÞǣŸɚsNjǼÌsĶsǣsǼsNjŎʳNŸǣǼǣʰ ĶŸOǼÞŸŘŘ_OŸŘ_ÞǼÞŸŘʳNŸǣǼŸ¯ɠŸNjĨÞŘƼNjŸ¶NjsǣǣʰŎŘȖ¯OǼȖNjs_
ÞŘOĶȖ_Þض_sƼNjsOÞǼÞŸŘʰNjsNjsOŸ¶ŘÞʊs_ǣŘsɮƼsŘǣsÞŘǼÌs ƼOĨÞض ŎǼsNjÞĶ Ř_ ʩŘÞǣÌs_ ¶ŸŸ_ǣ ÞŘOĶȖ_sǣ ŎǼsNjÞĶǣ Ř_ ĶĶ
ǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣʳÝŘÞǼÞĶ_ÞNjsOǼOŸǣǼǣǣȖOÌǣĶs¶Ķ ƼƼĶÞOEĶs ŎŘȖ¯OǼȖNjÞض ŸɚsNjÌs_ǣʳ ǻÌs µNjŸȖƼ OONjȖsǣ ¯ŸNj
OŸǣǼǣʰ ENjŸĨsNj¶s OŸǣǼǣʰ sǼOʳ Njs NjsOŸ¶ŘÞʊs_ ÞŎŎs_ÞǼsĶɴ ÞŘ sɮOÞǣs _ȖǼɴ ĶÞEÞĶÞǼɴ ÞŘ NjsǣƼsOǼ Ÿ¯ ŎŘȖ¯OǼȖNjs_ ʩŘÞǣÌs_ ¶ŸŸ_ǣˀ
ǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣʳ ÞŘǼsNjŎs_ÞNjɴÞŘɚsŘǼŸNjÞsǣĶɴÞضÞŘǼÌs¯OǼŸNjɴʳ
Corporate Overview Performance Governance Financial Statements 151

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
Traded goods are valued at lower of cost and net realizable monetary items which are carried in terms of historical cost
ɚĶȖsʳNŸǣǼÞŘOĶȖ_sǣOŸǣǼŸ¯ƼȖNjOÌǣsŘ_ŸǼÌsNjOŸǣǼǣÞŘOȖNjNjs_ÞŘ denominated in a foreign currency are reported using the
ENjÞضÞضǼÌsÞŘɚsŘǼŸNjÞsǣǼŸǼÌsÞNjƼNjsǣsŘǼĶŸOǼÞŸŘŘ_OŸŘ_ÞǼÞŸŘʳ sɮOÌضsNjǼsǼǼÌs_ǼsŸ¯ǼÌsǼNjŘǣOǼÞŸŘʳŗŸŘ˚ŎŸŘsǼNjɴ
NŸǣǼÞǣ_sǼsNjŎÞŘs_ŸŘ®Ý®ŷEǣÞǣʳ ÞǼsŎǣʰ ɠÌÞOÌ Njs ŎsǣȖNjs_ Ǽ ¯ÞNj ɚĶȖs ŸNj ŸǼÌsNj ǣÞŎÞĶNj
ɚĶȖǼÞŸŘ_sŘŸŎÞŘǼs_ÞŘ¯ŸNjsÞ¶ŘOȖNjNjsŘOɴʰNjsǼNjŘǣĶǼs_
 ŷƼsNjǼÞض ǣȖƼƼĶÞsǣ Njs ÞǼsŎǣ ÞŘ OÞNjOȖĶǼÞŸŘʳ NŸǣǼ Þǣ ǣOsNjǼÞŘs_
ȖǣÞض ǼÌs sɮOÌضs NjǼs Ǽ ǼÌs _Ǽs ɠÌsŘ ǣȖOÌ ɚĶȖs ɠǣ
ŸŘ®ÞNjǣǼ˚ÞŘ˚®ÞNjǣǼŸȖǼʹ˄®Ý®ŷ˅ʺEǣÞǣŘ_ÞŘOĶȖ_sǣĶĶƼƼĶÞOEĶsOŸǣǼǣ
_sǼsNjŎÞŘs_ʳ
incurred in bringing goods to their present location and condition
Ř_ǼÌsŘɠNjÞǼǼsŘŸ¯¯ŸɚsNjǼÌsÞNjsǣǼÞŎǼs_ƼsNjÞŸ_Ÿ¯Ȗǣ¶sʳ (iii) Exchange Differences

Net realisable value is the estimated selling price in the ordinary   rɮOÌضs_Þ¯¯sNjsŘOsǣNjÞǣÞضŸŘǼÌsǣsǼǼĶsŎsŘǼŸ¯ŎŸŘsǼNjɴ
OŸȖNjǣs Ÿ¯ EȖǣÞŘsǣǣʰ Ķsǣǣ sǣǼÞŎǼs_ OŸǣǼ Ÿ¯ OŸŎƼĶsǼÞŸŘ Ř_ items or on reporting monetary items at rates different from
sǣǼÞŎǼs_OŸǣǼŘsOsǣǣNjɴǼŸŎĨsǼÌsǣĶsʳ ǼÌŸǣsǼɠÌÞOÌǼÌsɴɠsNjsÞŘÞǼÞĶĶɴNjsOŸNj_s__ȖNjÞضǼÌsɴsNjʰ
ŸNjNjsƼŸNjǼs_ÞŘƼNjsɚÞŸȖǣʩŘŘOÞĶǣǼǼsŎsŘǼǣʰNjsNjsOŸ¶ŘÞǣs_
j) Revenue recognition
ǣÞŘOŸŎsŸNjǣsɮƼsŘǣsǣÞŘǼÌsɴsNjÞŘɠÌÞOÌǼÌsɴNjÞǣsʳ
 NJsɚsŘȖsÞǣNjsOŸ¶ŘÞǣs_ǼŸǼÌssɮǼsŘǼǼÌǼÞǼÞǣƼNjŸEEĶsǼÌǼǼÌs
sOŸŘŸŎÞOEsŘsʩǼǣɠÞĶĶʪŸɠǼŸǼÌsµNjŸȖƼŘ_ǼÌsNjsɚsŘȖsOŘEs Ķʺ NJsǼÞNjsŎsŘǼŘ_ŸǼÌsNjsŎƼĶŸɴssEsŘsʩǼǣ

NjsĶÞEĶɴŎsǣȖNjs_ʳǻÌs¯ŸĶĶŸɠÞضǣƼsOÞʩOONjÞǼsNjÞŎȖǣǼĶǣŸEsŎsǼ  Þʺ NJsǼÞNjsŎsŘǼEsŘsʩǼÞŘǼÌs¯ŸNjŎŸ¯ƼNjŸɚÞ_sŘǼ¯ȖŘ_Ř_ǣȖƼsNj


before revenue is recognised; ŘŘȖǼÞŸŘ¯ȖŘ_Þǣ_sʩŘs_OŸŘǼNjÞEȖǼÞŸŘǣOÌsŎsʳǻÌsµNjŸȖƼ

Sale of Goods : Ìǣ ŘŸ ŸEĶÞ¶ǼÞŸŘʰ ŸǼÌsNj ǼÌŘ ǼÌs OŸŘǼNjÞEȖǼÞŸŘ ƼɴEĶs ǼŸ
ǼÌs NjsǣƼsOǼÞɚs ¯ȖŘ_ʳ ǻÌs µNjŸȖƼ NjsOŸ¶ŘÞʊsǣ OŸŘǼNjÞEȖǼÞŸŘ
 NJsɚsŘȖs Þǣ NjsOŸ¶ŘÞǣs_ ɠÌsŘ ǼÌs ǣÞ¶ŘÞʩOŘǼ NjÞǣĨǣ Ř_ NjsɠNj_ǣ Ÿ¯ ƼɴEĶsǼŸǼÌsƼNjŸɚÞ_sŘǼ¯ȖŘ_ˀǣȖƼsNjŘŘȖǼÞŸŘǣOÌsŎsǣŘ
ŸɠŘsNjǣÌÞƼŸ¯ǼÌs¶ŸŸ_ǣÌɚsƼǣǣs_ǼŸǼÌsEȖɴsNjʰȖǣȖĶĶɴŸŘ_sĶÞɚsNjɴ sɮƼsŘ_ÞǼȖNjsʰɠÌsŘŘsŎƼĶŸɴssNjsŘ_sNjǣǼÌsNjsĶǼs_ǣsNjɚÞOsʳ
Ÿ¯ǼÌs¶ŸŸ_ǣʳrɮOÞǣs^ȖǼɴʰǢĶsǣǻɮŘ_əǻ_s_ȖOǼs_¯NjŸŎǼȖNjŘŸɚsNj
ʹ¶NjŸǣǣʺÞǣǼÌsŎŸȖŘǼǼÌǼÞǣÞŘOĶȖ_s_ÞŘǼÌsŎŸȖŘǼŸ¯ǼȖNjŘŸɚsNjʹ¶NjŸǣǣʺ  ÞÞʺ µNjǼȖÞǼɴĶÞEÞĶÞǼɴÞǣ_sʩŘs_EsŘsʩǼŸEĶÞ¶ǼÞŸŘŘ_ÞǣƼNjŸɚÞ_s_

Ř_ ŘŸǼ ǼÌs sŘǼÞNjs ŎŸȖŘǼ Ÿ¯ ĶÞEÞĶÞǼɴ NjÞǣÞض _ȖNjÞض ǼÌs ɴsNjʳ ǻÌs ¯ŸNjŸŘǼÌsEǣÞǣŸ¯ŘOǼȖNjÞĶɚĶȖǼÞŸŘŸŘƼNjŸĠsOǼs_ȖŘÞǼ

µNjŸȖƼOŸĶĶsOǼǣǣĶsǣǼɮsǣŘ_ɚĶȖs__s_ǼɮsǣʹəǻʺŸŘEsÌĶ¯Ÿ¯ǼÌs ONjs_ÞǼŎsǼÌŸ_Ŏ_sǼǼÌssŘ_Ÿ¯sOÌʩŘŘOÞĶɴsNjʳ

¶ŸɚsNjŘŎsŘǼŘ_ʰǼÌsNjs¯ŸNjsʰǼÌsǣsNjsŘŸǼsOŸŘŸŎÞOEsŘsʩǼǣʪŸɠÞضǼŸ  ÞÞÞʺ OOȖŎȖĶǼs_ĶsɚsʰɠÌÞOÌÞǣsɮƼsOǼs_ǼŸEsȖǼÞĶÞʊs_ɠÞǼÌÞŘ


ǼÌsµNjŸȖƼʳËsŘOsʰǼÌsɴNjssɮOĶȖ_s_¯NjŸŎNjsɚsŘȖsʳNJsɚsŘȖsÞŘOĶȖ_sǣ ǼÌs ŘsɮǼ ˠˡ ŎŸŘǼÌǣʰ Þǣ ǼNjsǼs_ ǣ ǣÌŸNjǼ˚ǼsNjŎ sŎƼĶŸɴss
ǼÌsŎŸȖŘǼŸ¯sɮOÞǣs_ȖǼɴNjs¯ȖŘ_NjsOsÞɚs_ˀ_ȖsÞŘOOŸNj_ŘOsɠÞǼÌ EsŘsʩǼʳ ǻÌs µNjŸȖƼ ŎsǣȖNjsǣ ǼÌs sɮƼsOǼs_ OŸǣǼ Ÿ¯ ǣȖOÌ
ÞŘOsŘǼÞɚsǣOÌsŎsʳNJsɚsŘȖsÞǣŘsǼŸ¯ǼNj_s_ÞǣOŸȖŘǼ¶ÞɚsŘʳ EǣsŘOsǣǣǼÌs__ÞǼÞŸŘĶŎŸȖŘǼǼÌǼÞǼsɮƼsOǼǣǼŸƼɴǣ

Sale of Services : a result of the unused entitlement that has accumulated at


ǼÌsNjsƼŸNjǼÞض_Ǽsʳ
Service revenue is recognised on completion of services and
ɠÌsNjsŘŸǣÞ¶ŘÞʩOŘǼȖŘOsNjǼÞŘǼɴsɮÞǣǼǣNjs¶Nj_ÞضǼÌsŎŸȖŘǼŸ¯  Þɚʺ ǻÌsµNjŸȖƼǼNjsǼǣOOȖŎȖĶǼs_ĶsɚssɮƼsOǼs_ǼŸEsONjNjÞs_

ǼÌsOŸŘǣÞ_sNjǼÞŸŘǼÌǼɠÞĶĶEs_sNjÞɚs_¯NjŸŎNjsŘ_sNjÞضǼÌsǣsNjɚÞOsʳ ¯ŸNjɠNj_ EsɴŸŘ_ ǼɠsĶɚs ŎŸŘǼÌǣʰ ǣ ĶŸŘ¶˚ǼsNjŎ sŎƼĶŸɴss

ǢsNjɚÞOsNjsɚsŘȖsNjsŘsǼŸ¯ǣsNjɚÞOsǼɮʳ EsŘsʩǼ ¯ŸNj ŎsǣȖNjsŎsŘǼ ƼȖNjƼŸǣsǣʳ ǢȖOÌ ĶŸŘ¶˚ǼsNjŎ


compensated absences are provided for based on the
Interest : OǼȖNjÞĶɚĶȖǼÞŸŘȖǣÞضǼÌsƼNjŸĠsOǼs_ȖŘÞǼONjs_ÞǼŎsǼÌŸ_Ǽ
 NJsɚsŘȖs Þǣ NjsOŸ¶ŘÞǣs_ ŸŘ  ǼÞŎs ƼNjŸƼŸNjǼÞŸŘ EǣÞǣ ǼĨÞض ÞŘǼŸ ǼÌsɴsNj˚sŘ_ʳ
OOŸȖŘǼǼÌsŎŸȖŘǼŸȖǼǣǼŘ_ÞضŘ_ǼǼÌsƼƼĶÞOEĶsÞŘǼsNjsǣǼNjǼsʳ  ɚʺ OǼȖNjÞĶ ¶ÞŘǣˀ ĶŸǣǣsǣ Njs ÞŎŎs_ÞǼsĶɴ ǼĨsŘ ǼŸ ǼÌs
k) Foreign currency translation ǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣŘ_NjsŘŸǼ_s¯sNjNjs_ʳ

(i) Initial Recognition m) Sales promotion items

Foreign currency transactions are recorded in the reporting  ǢĶsǣ ƼNjŸŎŸǼÞŸŘ ÞǼsŎǣ Njs ɚĶȖs_ Ǽ OŸǣǼʳ NŸǣǼ Þǣ ǣOsNjǼÞŘs_
OȖNjNjsŘOɴʰ Eɴ ƼƼĶɴÞض ǼŸ ǼÌs ¯ŸNjsÞ¶Ř OȖNjNjsŘOɴ ŎŸȖŘǼ ǼÌs ŸŘ ®ÞNjǣǼ˚ÞŘ˚®ÞNjǣǼ ŸȖǼ ʹ˄®Ý®ŷ˅ʺ EǣÞǣ Ř_ ÞŘOĶȖ_sǣ ĶĶ ƼƼĶÞOEĶs
sɮOÌضs NjǼs EsǼɠssŘ ǼÌs NjsƼŸNjǼÞض OȖNjNjsŘOɴ Ř_ ǼÌs costs incurred in bringing goods to their present location and
¯ŸNjsÞ¶ŘOȖNjNjsŘOɴǼǼÌs_ǼsŸ¯ǼÌsǼNjŘǣOǼÞŸŘʳ OŸŘ_ÞǼÞŸŘʳ

(ii) Conversion n) Income-tax

Foreign currency monetary items are reported using the  ǻɮ sɮƼsŘǣs OŸŎƼNjÞǣsǣ Ÿ¯ OȖNjNjsŘǼ Ř_ _s¯sNjNjs_ Ǽɮʳ NȖNjNjsŘǼ
sɮOÌضs NjǼs ƼNjsɚÞĶÞض Ǽ ǼÌs NjsƼŸNjǼÞض _Ǽsʳ ŗŸŘ˚ ÞŘOŸŎs Ǽɮ Þǣ ŎsǣȖNjs_ Ǽ ǼÌs ŎŸȖŘǼ sɮƼsOǼs_ ǼŸ Es ƼÞ_ ǼŸ
152 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
ǼÌsǼɮȖǼÌŸNjÞǼÞsǣÞŘOOŸNj_ŘOsɠÞǼÌǼÌsÝŘ_ÞŘÝŘOŸŎsǻɮOǼʳ ¯ŸNj ONjs_ÞǼ ɚÞĶEĶs ÞŘ NjsǣƼsOǼ Ÿ¯ ōÞŘÞŎȖŎ ĶǼsNjŘǼs ǻɮ ȖŘ_sNj
^s¯sNjNjs_ÞŘOŸŎsǼɮsǣNjsʪsOǼǣǼÌsÞŎƼOǼŸ¯OȖNjNjsŘǼɴsNjǼÞŎÞض ǼÌs ÝŘOŸŎs ǻɮ OǼʰ ˠ˨˥ˠʰ ǼÌs ǣÞ_ ǣǣsǼ Þǣ ONjsǼs_ Eɴ ɠɴ Ÿ¯
_Þ¯¯sNjsŘOsǣEsǼɠssŘǼɮEĶsÞŘOŸŎsŘ_OOŸȖŘǼÞضÞŘOŸŎs¯ŸNj  ONjs_ÞǼ ǼŸ ǼÌs ǣǼǼsŎsŘǼ Ÿ¯ ƼNjŸʩǼ Ř_ ĶŸǣǣ Ř_ ǣÌŸɠŘ ǣ ōǻ
ǼÌsɴsNjŘ_NjsɚsNjǣĶŸ¯ǼÞŎÞض_Þ¯¯sNjsŘOsǣŸ¯sNjĶÞsNjɴsNjǣʳ NNjs_ÞǼ rŘǼÞǼĶsŎsŘǼʳ ōǻ ONjs_ÞǼ sŘǼÞǼĶsŎsŘǼ Þǣ NjsɚÞsɠs_ Ǽ sOÌ
EĶŘOsǣÌssǼ_ǼsŘ_ÞǣɠNjÞǼǼsŘ_ŸɠŘǼŸǼÌssɮǼsŘǼǼÌsNjsÞǣŘŸ
 ^s¯sNjNjs_ Ǽɮ Þǣ ŎsǣȖNjs_ Eǣs_ ŸŘ ǼÌs Ǽɮ NjǼsǣ Ř_ ǼÌs Ǽɮ
ĶŸŘ¶sNjOŸŘɚÞŘOÞضsɚÞ_sŘOsǼŸǼÌss¯¯sOǼǼÌǼŘŸNjŎĶÝŘOŸŎsǻɮ
ĶɠǣsŘOǼs_ŸNjǣȖEǣǼŘǼÞɚsĶɴsŘOǼs_ǼǼÌsEĶŘOsǣÌssǼ_Ǽsʳ
ɠÞĶĶEsƼÞ__ȖNjÞضǼÌsǣƼsOÞʩs_ƼsNjÞŸ_ʳ
^s¯sNjNjs_ǼɮǣǣsǼǣNjsNjsOŸ¶ŘÞǣs_ŸŘĶɴǼŸǼÌssɮǼsŘǼǼÌǼǼÌsNjsÞǣ
NjsǣŸŘEĶsOsNjǼÞŘǼɴǼÌǼǣȖ¯ʩOÞsŘǼ¯ȖǼȖNjsǼɮEĶsÞŘOŸŎsɠÞĶĶEs o) Provisions
ɚÞĶEĶs¶ÞŘǣǼɠÌÞOÌǣȖOÌ_s¯sNjNjs_ǼɮǣǣsǼǣOŘEsNjsĶÞǣs_ʳ
ÝŘ ǣÞǼȖǼÞŸŘǣ Ÿ¯ ȖŘEǣŸNjEs_ _sƼNjsOÞǼÞŸŘ ŸNj ONjNjɴ ¯ŸNjɠNj_ Ǽɮ A provision is recognised when there is a present obligation as a

ĶŸǣǣsǣʰĶĶ_s¯sNjNjs_ǼɮǣǣsǼǣNjsNjsOŸ¶ŘÞǣs_ŸŘĶɴÞ¯ǼÌsNjsÞǣɚÞNjǼȖĶ NjsǣȖĶǼŸ¯ƼǣǼsɚsŘǼʱÞǼÞǣƼNjŸEEĶsǼÌǼŘŸȖǼʪŸɠŸ¯NjsǣŸȖNjOsǣɠÞĶĶ

certainty supported by convincing evidence that they can be Es NjsLJȖÞNjs_ ǼŸ ǣsǼǼĶs ǼÌs ŸEĶÞ¶ǼÞŸŘʰ ÞŘ NjsǣƼsOǼ Ÿ¯ ɠÌÞOÌ  NjsĶÞEĶs

NjsĶÞǣs_¶ÞŘǣǼ¯ȖǼȖNjsǼɮEĶsƼNjŸʩǼǣʳ sǣǼÞŎǼsOŘEsŎ_sʳƻNjŸɚÞǣÞŸŘǣNjsŘŸǼ_ÞǣOŸȖŘǼs_ǼŸÞǼǣƼNjsǣsŘǼ
value and are determined based on best estimate required to settle
In the situations where an entity in the Group is entitled to ǼÌsŸEĶÞ¶ǼÞŸŘǼǼÌsEĶŘOsǣÌssǼ_ǼsʳǻÌsǣsNjsNjsɚÞsɠs_ǼsOÌ
 Ǽɮ ÌŸĶÞ_ɴ ȖŘ_sNj ǼÌs ÝŘOŸŎs˚Ǽɮ OǼʰ ˠ˨˥ˠ sŘOǼs_ ÞŘ ÝŘ_Þ EĶŘOsǣÌssǼ_ǼsŘ__ĠȖǣǼs_ǼŸNjsʪsOǼǼÌsOȖNjNjsŘǼEsǣǼsǣǼÞŎǼsǣʳ
ŸNj Ǽɮ Ķɠǣ ƼNjsɚÞĶÞض ÞŘ ǼÌs NjsǣƼsOǼÞɚs Ǽɮ ĠȖNjÞǣ_ÞOǼÞŸŘǣ ɠÌsNjs
ÞǼ ŸƼsNjǼsǣʰ ŘŸ _s¯sNjNjs_ Ǽɮ ʹǣǣsǼ ŸNj ĶÞEÞĶÞǼɴʺ Þǣ NjsOŸ¶ŘÞʊs_ ÞŘ p) Excise duty

NjsǣƼsOǼŸ¯ǼÞŎÞض_Þ¯¯sNjsŘOsǣɠÌÞOÌNjsɚsNjǣs_ȖNjÞضǼÌsǼɮÌŸĶÞ_ɴ  rɮOÞǣs _ȖǼɴ ŸŘ ǼȖNjŘŸɚsNj Þǣ Njs_ȖOs_ ¯NjŸŎ ǼȖNjŘŸɚsNjʳ rɮOÞǣs _ȖǼɴ
ƼsNjÞŸ_ʰ ǼŸ ǼÌs sɮǼsŘǼ ǼÌs sŘǼÞǼɴ˅ǣ ¶NjŸǣǣ ǼŸǼĶ ÞŘOŸŎs Þǣ ǣȖEĠsOǼ NjsĶǼÞضǼŸǼÌs_Þ¯¯sNjsŘOsEsǼɠssŘǼÌsŸƼsŘÞضǣǼŸOĨŘ_OĶŸǣÞض
ǼŸ ǼÌs _s_ȖOǼÞŸŘ _ȖNjÞض ǼÌs Ǽɮ ÌŸĶÞ_ɴ ƼsNjÞŸ_ʳ ^s¯sNjNjs_ Ǽɮ ÞŘ ǣǼŸOĨ Þǣ NjsOŸ¶ŘÞǣs_ ǣ ÞŘOŸŎsˀ sɮƼsŘǣs ǣ ǼÌs Oǣs Ŏɴ Esʰ
NjsǣƼsOǼŸ¯ǼÞŎÞض_Þ¯¯sNjsŘOsǣɠÌÞOÌNjsɚsNjǣs¯ǼsNjǼÌsǼɮÌŸĶÞ_ɴ ǣsƼNjǼsĶɴÞŘǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣʳ
period is recognized in the year in which the timing differences
ŸNjÞ¶ÞŘǼsʳ ËŸɠsɚsNjʰ ǼÌs sŘǼÞǼɴ NjsǣǼNjÞOǼǣ NjsOŸ¶ŘÞǼÞŸŘ Ÿ¯ _s¯sNjNjs_ q) Segment Reporting

ǼɮǣǣsǼǣǼŸǼÌssɮǼsŘǼǼÌǼÞǼÌǣEsOŸŎsNjsǣŸŘEĶɴOsNjǼÞŘŸNj  Ý_sŘǼÞʩOǼÞŸŘŸ¯ǣs¶ŎsŘǼǣʲ
ɚÞNjǼȖĶĶɴOsNjǼÞŘʰǣǼÌsOǣsŎɴEsʰǼÌǼǣȖ¯ʩOÞsŘǼ¯ȖǼȖNjsǼɮEĶs
 ǻÌs µNjŸȖƼ˅ǣ ŸƼsNjǼÞض EȖǣÞŘsǣǣsǣ Njs ŸNj¶ŘÞʊs_ Ř_ Ŏضs_
ÞŘOŸŎs ɠÞĶĶ Es ɚÞĶEĶs ¶ÞŘǣǼ ɠÌÞOÌ ǣȖOÌ _s¯sNjNjs_ Ǽɮ ǣǣsǼǣ
ǣsƼNjǼsĶɴ OOŸNj_Þض ǼŸ ǼÌs ŘǼȖNjs Ÿ¯ ƼNjŸ_ȖOǼǣʰ ɠÞǼÌ sOÌ
OŘ Es NjsĶÞʊs_ʳ ®ŸNj NjsOŸ¶ŘÞǼÞŸŘ Ÿ¯ _s¯sNjNjs_ Ǽɮsǣʰ ǼÌs ǼÞŎÞض
segment representing a strategic business unit that offers
_Þ¯¯sNjsŘOsǣɠÌÞOÌŸNjÞ¶ÞŘǼsʩNjǣǼNjsOŸŘǣÞ_sNjs_ǼŸNjsɚsNjǣsʩNjǣǼʳ
_Þ¯¯sNjsŘǼ ƼNjŸ_ȖOǼǣ Ř_ ǣsNjɚsǣ _Þ¯¯sNjsŘǼ ŎNjĨsǼǣʳ ǻÌs ŘĶɴǣÞǣ Ÿ¯
 ǼsOÌEĶŘOsǣÌssǼ_ǼsȖŘNjsOŸ¶ŘÞǣs__s¯sNjNjs_ǼɮǣǣsǼǣNjs ¶sŸ¶NjƼÌÞOĶ ǣs¶ŎsŘǼǣ Þǣ Eǣs_ ŸŘ ǼÌs Njsǣ ÞŘ ɠÌÞOÌ ŎĠŸNj
Njs˚ǣǣsǣǣs_ʳÝǼNjsOŸ¶ŘÞǣsǣȖŘNjsOŸ¶ŘÞʊs__s¯sNjNjs_ǼɮǣǣsǼǣǼŸǼÌs ŸƼsNjǼÞض_ÞɚÞǣÞŸŘǣŸ¯ǼÌsµNjŸȖƼŸƼsNjǼsʳ
sɮǼsŘǼǼÌǼÞǼÌǣEsOŸŎsNjsǣŸŘEĶɴOsNjǼÞŘŸNjɚÞNjǼȖĶĶɴOsNjǼÞŘʰ
Segment accounting policies :
ǣǼÌsOǣsŎɴEsǼÌǼǣȖ¯ʩOÞsŘǼ¯ȖǼȖNjsǼɮEĶsÞŘOŸŎsɠÞĶĶEs
ɚÞĶEĶs¶ÞŘǣǼɠÌÞOÌǣȖOÌ_s¯sNjNjs_ǼɮǣǣsǼǣOŘEsNjsĶÞǣs_ʳ The Group prepares its segment information in conformity with
the accounting policies adopted for preparing and presenting the
 ǻÌsONjNjɴÞضŎŸȖŘǼŸ¯_s¯sNjNjs_ǼɮǣǣsǼǣNjsNjsɚÞsɠs_ǼsOÌ
ʩŘŘOÞĶǣǼǼsŎsŘǼǣŸ¯ǼÌsµNjŸȖƼǣɠÌŸĶsʳ
NjsƼŸNjǼÞض_ǼsʳɟNjÞǼs˚_ŸɠŘŸ¯ǼÌsONjNjɴÞضŎŸȖŘǼŸ¯_s¯sNjNjs_
Ǽɮ ǣǣsǼ Þǣ _ŸŘs ǼŸ ǼÌs sɮǼsŘǼ ǼÌǼ ÞǼ Þǣ ŘŸ ĶŸŘ¶sNj NjsǣŸŘEĶɴ Intersegment transfer :

OsNjǼÞŘ ŸNj ɚÞNjǼȖĶĶɴ OsNjǼÞŘʰ ǣ ǼÌs Oǣs Ŏɴ Esʰ ǼÌǼ ǣȖ¯ʩOÞsŘǼ The Group generally accounts for inter segment sales and
¯ȖǼȖNjs ǼɮEĶs ÞŘOŸŎs ɠÞĶĶ Es ɚÞĶEĶs ¶ÞŘǣǼ ɠÌÞOÌ _s¯sNjNjs_ ǼNjŘǣ¯sNjǣǣÞ¯ǼÌsǣĶsǣŸNjǼNjŘǣ¯sNjɠsNjsǼŸǼÌÞNj_ƼNjǼÞsǣǼŎNjĨsǼ
Ǽɮ ǣǣsǼ OŘ Es NjsĶÞǣs_ʳ Řɴ ǣȖOÌ ɠNjÞǼs˚_ŸɠŘ Þǣ NjsɚsNjǣs_ ǼŸ ƼNjÞOsʳ
ǼÌssɮǼsŘǼǼÌǼÞǼEsOŸŎsǣNjsǣŸŘEĶɴOsNjǼÞŘŸNjɚÞNjǼȖĶĶɴOsNjǼÞŘʰ
Allocation of common costs:
ǣǼÌsOǣsŎɴEsʰǼÌǼǣȖ¯ʩOÞsŘǼ¯ȖǼȖNjsǼɮEĶsÞŘOŸŎsɠÞĶĶEs
ɚÞĶEĶsʳ Common allocable costs are allocated to each segment according
to the relative contribution of each segment to the total common
 ōÞŘÞŎȖŎ ĶǼsNjŘǼs ǻɮ ʹōǻʺ ONjs_ÞǼ Þǣ NjsOŸ¶ŘÞǣs_ ǣ Ř ǣǣsǼ
OŸǣǼǣʳ
ŸŘĶɴ ɠÌsŘ Ř_ ǼŸ ǼÌs sɮǼsŘǼ ǼÌsNjs Þǣ OŸŘɚÞŘOÞض sɚÞ_sŘOs ǼÌǼ
ŘŸNjŎĶÞŘOŸŎsǼɮɠÞĶĶEsƼÞ__ȖNjÞضǼÌsǣƼsOÞʩs_ƼsNjÞŸ_ʳÝŘǼÌs Unallocated items:
year in which the MAT credit becomes eligible to be recognized  ÝǼ ÞŘOĶȖ_sǣ ¶sŘsNjĶ OŸNjƼŸNjǼs ÞŘOŸŎs Ř_ sɮƼsŘǣs ÞǼsŎǣ ɠÌÞOÌ
as an asset in accordance with the Guidance Note on Accounting NjsŘŸǼĶĶŸOǼs_ǼŸŘɴEȖǣÞŘsǣǣǣs¶ŎsŘǼʳ
Corporate Overview Performance Governance Financial Statements ˠˤˢ

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
r) Earnings per Share non-occurrence of one or more uncertain future events beyond
the control of the Group or a present obligation that is not
 DǣÞOsNjŘÞضǣƼsNjǣÌNjsNjsOĶOȖĶǼs_Eɴ_ÞɚÞ_ÞضǼÌsŘsǼƼNjŸʩǼŸNj
NjsOŸ¶ŘÞʊs_EsOȖǣsÞǼÞǣŘŸǼƼNjŸEEĶsǼÌǼŘŸȖǼʪŸɠŸ¯NjsǣŸȖNjOsǣ
loss for the year attributable to equity shareholders by the weighted
ɚsNj¶sŘȖŎEsNjŸ¯sLJȖÞǼɴǣÌNjsǣŸȖǼǣǼŘ_Þض_ȖNjÞضǼÌsɴsNjʳǻÌs ɠÞĶĶ Es NjsLJȖÞNjs_ ǼŸ ǣsǼǼĶs ǼÌs ŸEĶÞ¶ǼÞŸŘʳ  OŸŘǼÞضsŘǼ ĶÞEÞĶÞǼɴ

weighted average number of equity shares outstanding during ĶǣŸ NjÞǣsǣ ÞŘ sɮǼNjsŎsĶɴ NjNjsOǣsǣ ɠÌsNjsǼÌsNjs Þǣ  ĶÞEÞĶÞǼɴ ǼÌǼ

ǼÌsɴsNjNjs_ĠȖǣǼs_¯ŸNjsɚsŘǼŸ¯EŸŘȖǣÞǣǣȖsʰEŸŘȖǣsĶsŎsŘǼÞŘ OŘŘŸǼ Es NjsOŸ¶ŘÞʊs_ EsOȖǣs ÞǼ OŘŘŸǼ Es ŎsǣȖNjs_ NjsĶÞEĶɴʳ
NjÞ¶ÌǼǣÞǣǣȖsǼŸsɮÞǣǼÞضǣÌNjsÌŸĶ_sNjǣʰǣÌNjsǣƼĶÞǼʰŘ_NjsɚsNjǣsǣÌNjs The Group does not recognize a contingent liability but discloses
ǣƼĶÞǼǼÌǼÌɚsOÌضs_ǼÌsŘȖŎEsNjŸ¯sLJȖÞǼɴǣÌNjsǣŸȖǼǣǼŘ_Þضʰ ÞǼǣsɮÞǣǼsŘOsÞŘǼÌsʩŘŘOÞĶǣǼǼsŎsŘǼǣʳ
ɠÞǼÌŸȖǼOŸNjNjsǣƼŸŘ_ÞضOÌضsÞŘNjsǣŸȖNjOsǣʳ v) Measurement of EBITDA
 ®ŸNj ǼÌs ƼȖNjƼŸǣs Ÿ¯ OĶOȖĶǼÞض _ÞĶȖǼs_ sNjŘÞضǣ ƼsNj ǣÌNjsʰ ǼÌs ŘsǼ  ǻÌs OŸŎƼŘɴ Ìǣ sĶsOǼs_ ǼŸ ƼNjsǣsŘǼ sNjŘÞضǣ Es¯ŸNjs ÞŘǼsNjsǣǼʰ
ƼNjŸʩǼŸNjĶŸǣǣ¯ŸNjǼÌsɴsNjǼǼNjÞEȖǼEĶsǼŸsLJȖÞǼɴǣÌNjsÌŸĶ_sNjǣŘ_ǼÌs Ǽɮʰ _sƼNjsOÞǼÞŸŘ Ř_ ŎŸNjǼÞʊǼÞŸŘ ʹrDÝǻ^ʺ ǣ  ǣsƼNjǼs
weighted average number of shares outstanding during the year are ĶÞŘsÞǼsŎŸŘǼÌs¯OsŸ¯ǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣʳÝŘÞǼǣ
ŎsǣȖNjsŎsŘǼʰǼÌsOŸŎƼŘɴ_ŸsǣŘŸǼÞŘOĶȖ_s_sƼNjsOÞǼÞŸŘŘ_
_ĠȖǣǼs_¯ŸNjǼÌss¯¯sOǼǣŸ¯ĶĶ_ÞĶȖǼÞɚsƼŸǼsŘǼÞĶsLJȖÞǼɴǣÌNjsǣʳ
ŎŸNjǼÞʊǼÞŸŘ sɮƼsŘǣsʰ ʩŘŘOs OŸǣǼǣʰ ÞŘǼsNjsǣǼ ÞŘOŸŎs Ř_ Ǽɮ
s) Cash and Cash equivalents sɮƼsŘǣsʳ

 NǣÌŘ_OǣÌsLJȖÞɚĶsŘǼǣ¯ŸNjǼÌsƼȖNjƼŸǣsŸ¯OǣÌʪŸɠǣǼǼsŎsŘǼ ɠʺ rŎƼĶŸɴssǣǼŸOĨOŸŎƼsŘǣǼÞŸŘOŸǣǼ


OŸŎƼNjÞǣsOǣÌǼEŘĨŘ_ÞŘÌŘ_Ř_ǣÌŸNjǼ˚ǼsNjŎÞŘɚsǣǼŎsŘǼǣ  rŎƼĶŸɴssǣ ÞŘ ǣsŘÞŸNj ŎضsŎsŘǼ Ÿ¯ ǼÌs OŸŎƼŘɴ NjsOsÞɚs
ɠÞǼÌŘŸNjÞ¶ÞŘĶŎǼȖNjÞǼɴŸ¯ǼÌNjssŎŸŘǼÌǣŸNjĶsǣǣʳ NjsŎȖŘsNjǼÞŸŘÞŘǼÌs¯ŸNjŎŸ¯ǣÌNjsEǣs_ƼɴŎsŘǼǼNjŘǣOǼÞŸŘǣʰ
whereby employees render services as consideration for equity
Ǽʺ DŸNjNjŸɠÞضNŸǣǼǣ ÞŘǣǼNjȖŎsŘǼǣʹsLJȖÞǼɴ˚ǣsǼǼĶs_ǼNjŘǣOǼÞŸŘǣʺʳ

Borrowing costs consist of interest and amortisation of ancillary  ÝŘ OOŸNj_ŘOs ɠÞǼÌ ǼÌs ǢsOȖNjÞǼÞsǣ Ř_ rɮOÌضs DŸNj_ Ÿ¯ ÝŘ_Þ
OŸǣǼǣÞŘOȖNjNjs_ÞŘOŸŘŘsOǼÞŸŘɠÞǼÌǼÌsNjNjضsŎsŘǼŸ¯EŸNjNjŸɠÞضǣʳ ʹǢÌNjs Dǣs_ rŎƼĶŸɴss DsŘsʩǼǣʺ NJs¶ȖĶǼÞŸŘǣʰ ˡ˟ˠˣ Ř_ ǼÌs
µȖÞ_ŘOs ŗŸǼs ŸŘ OOŸȖŘǼÞض ¯ŸNj rŎƼĶŸɴss ǢÌNjs˚Eǣs_
DŸNjNjŸɠÞض OŸǣǼǣ _ÞNjsOǼĶɴ ǼǼNjÞEȖǼEĶs ǼŸ ǼÌs OLJȖÞǣÞǼÞŸŘʰ
ƻɴŎsŘǼǣʰ ǼÌs OŸǣǼ Ÿ¯ sLJȖÞǼɴ˚ǣsǼǼĶs_ ǼNjŘǣOǼÞŸŘǣ Þǣ ŎsǣȖNjs_
OŸŘǣǼNjȖOǼÞŸŘ ŸNj ƼNjŸ_ȖOǼÞŸŘ Ÿ¯ Ř ǣǣsǼ ǼÌǼ ŘsOsǣǣNjÞĶɴ ǼĨsǣ  ȖǣÞض ǼÌs ÞŘǼNjÞŘǣÞO ɚĶȖs ŎsǼÌŸ_ʳ ǻÌs OȖŎȖĶǼÞɚs sɮƼsŘǣs
substantial period of time to get ready for its intended use or sale recognized for equity-settled transactions at each reporting
NjsOƼÞǼĶÞʊs_ǣƼNjǼŸ¯ǼÌsNjsǣƼsOǼÞɚsǣǣsǼʳĶĶŸǼÌsNjEŸNjNjŸɠÞض _Ǽs ȖŘǼÞĶ ǼÌs ɚsǣǼÞض _Ǽs NjsʪsOǼǣ ǼÌs sɮǼsŘǼ ǼŸ ɠÌÞOÌ ǼÌs
OŸǣǼǣNjssɮƼsŘǣs_ÞŘǼÌsƼsNjÞŸ_ǼÌsɴŸOOȖNjʳ ɚsǣǼÞض ƼsNjÞŸ_ Ìǣ sɮƼÞNjs_ Ř_ ǼÌs OŸŎƼŘɴ˅ǣ EsǣǼ sǣǼÞŎǼs Ÿ¯
ǼÌs ŘȖŎEsNj Ÿ¯ sLJȖÞǼɴ ÞŘǣǼNjȖŎsŘǼǣ ǼÌǼ ɠÞĶĶ ȖĶǼÞŎǼsĶɴ ɚsǣǼʳ ǻÌs
u) Contingent liabilities sɮƼsŘǣsŸNjONjs_ÞǼNjsOŸ¶ŘÞʊs_ÞŘǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣ
¯ŸNj  ƼsNjÞŸ_ NjsƼNjsǣsŘǼǣ ǼÌs ŎŸɚsŎsŘǼ ÞŘ OȖŎȖĶǼÞɚs sɮƼsŘǣs
A contingent liability is a possible obligation that arises from past recognized as at the beginning and end of that period and is
sɚsŘǼǣ ɠÌŸǣs sɮÞǣǼsŘOs ɠÞĶĶ Es OŸŘʩNjŎs_ Eɴ ǼÌs ŸOOȖNjNjsŘOs ŸNj NjsOŸ¶ŘÞʊs_ÞŘsŎƼĶŸɴssEsŘsʩǼǣsɮƼsŘǣsʳ
154 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
` In Lacs
As at As at
March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ
NOTE 4
SHARE CAPITAL
AUTHORISED CAPITAL
ˡʰˤ˦˟ʰ˟˟˟ʰ˟˟˟ʹˡ˟ˠˤ˚ˡʰˤ˦˟ʰ˟˟˟ʰ˟˟˟ʺsLJȖÞǼɴǣÌNjsǣŸ¯` ˠʹˡ˟ˠˤ˚` ˠʺsOÌ ˡˤʰ˦˟˟ʳ˟˟ ˡˤʰ˦˟˟ʳ˟˟
25,700.00 25,700.00
ISSUED, SUBSCRIBED AND PAID UP CAPITAL
ˠ˧ˠʰˠˠ˨ʰ˥˧˟ʹˡ˟ˠˤ˚ˠ˧ˠʰ˟ˡˢʰˣ˨˥ʺsLJȖÞǼɴǣÌNjsǣŸ¯` ˠʹˡ˟ˠˤ˚` ˠʺsO̯ȖĶĶɴƼÞ_ ˠʰ˧ˠˠʳˡ˟ ˠʰ˧ˠ˟ʳˡˢ
1,811.20 1,810.23

a. Reconciliation of the shares outstanding at the beginning and at the end of the reporting period

As at March 31, 2016 ǣǼōNjOÌˢˠʰˡ˟ˠˤ


No. Amount ŗŸʳ Amount
At the beginning of the period ˠ˧ˠʰ˟ˡˢʰˣ˨˥ ˠʰ˧ˠ˟ʳˡˢ ˠ˧ˠʰ˟ˡˢʰˣ˨˥ ˠʰ˧ˠ˟ʳˡˢ
ÝǣǣȖs_ˀǢȖEǣONjÞEs__ȖNjÞضǼÌsɴsNjʹrǢŷƻʺ ˨˥ʰˠ˧ˣ ˟ʳ˨˦ - -
Outstanding at the end of the period ˠ˧ˠʰˠˠ˨ʰ˥˧˟ ˠʰ˧ˠˠʳˡ˟ ˠ˧ˠʰ˟ˡˢʰˣ˨˥ ˠʰ˧ˠ˟ʳˡˢ

b. Details of shareholders holding more than 5% shares in the Company

As at March 31, 2016 ǣǼōNjOÌˢˠʰˡ˟ˠˤ


No. % Holding ŗŸʳ ̇ËŸĶ_Þض
in the class in the class
rLJȖÞǼɴǣÌNjsǣŸ¯` 1 each fully paid
ōʳƻʳNJŎOÌŘ_NjŘ ˦ˡʰˠˠˡʰ˟˥˟ ˢ˨ʳ˧ˠ̇ ˦ˡʰˠˠˡʰ˟˥˟ ˢ˨ʳ˧ˠ̇
Sahyadri Agencies Limited ˠˤʰ˟˟˟ʰ˟˟˟ ˧ʳˡ˧̇ ˠˤʰ˟˟˟ʰ˟˟˟ ˧ʳˡ˧̇

 ǣƼsNjNjsOŸNj_ǣŸ¯ǼÌsNŸŎƼŘɴʰÞŘOĶȖ_ÞضÞǼǣNjs¶ÞǣǼsNjŸ¯ǣÌNjsÌŸĶ_sNjǣˀŎsŎEsNjǣŘ_ŸǼÌsNj_sOĶNjǼÞŸŘǣNjsOsÞɚs_¯NjŸŎǣÌNjsÌŸĶ_sNjǣNjs¶Nj_Þض
EsŘsʩOÞĶÞŘǼsNjsǣǼʰǼÌsEŸɚsǣÌNjsÌŸĶ_ÞضNjsƼNjsǣsŘǼǣEŸǼÌĶs¶ĶŘ_EsŘsʩOÞĶŸɠŘsNjǣÌÞƼǣŸ¯ǣÌNjsǣʳ

c. Terms/ rights attached to equity shares

The Company has only one class of equity shares having par value of 1 ` ƼsNjǣÌNjsʳrOÌÌŸĶ_sNjŸ¯sLJȖÞǼɴǣÌNjsǣÞǣsŘǼÞǼĶs_ǼŸŸŘsɚŸǼsƼsNj
ǣÌNjsʳǻÌsNŸŎƼŘɴ_sOĶNjsǣŘ_Ƽɴǣ_ÞɚÞ_sŘ_ǣÞŘÝŘ_ÞŘNjȖƼssǣʳǻÌs_ÞɚÞ_sŘ_ƼNjŸƼŸǣs_EɴǼÌsDŸNj_Ÿ¯^ÞNjsOǼŸNjǣÞǣǣȖEĠsOǼǼŸǼÌsƼƼNjŸɚĶ
Ÿ¯ǼÌsǣÌNjsÌŸĶ_sNjǣÞŘǼÌssŘǣȖÞضŘŘȖĶµsŘsNjĶōssǼÞضʳ

 ^ȖNjÞضǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥ǼÌsŎŸȖŘǼŸ¯ƼsNjǣÌNjs_ÞɚÞ_sŘ_NjsOŸ¶ŘÞʊs_ǣ_ÞǣǼNjÞEȖǼÞŸŘǣǼŸsLJȖÞǼɴǣÌNjsÌŸĶ_sNjǣɠǣ`ˤʹˡ˟ˠˤ˚`ˣʺ
including interim dividend of `ˣƼsNjsLJȖÞǼɴǣÌNjsƼÞ__ȖNjÞضǼÌsɴsNjʳ

 ÝŘǼÌssɚsŘǼŸ¯ĶÞLJȖÞ_ǼÞŸŘŸ¯ǼÌsNŸŎƼŘɴʰǼÌsÌŸĶ_sNjǣŸ¯sLJȖÞǼɴǣÌNjsǣɠÞĶĶEssŘǼÞǼĶs_ǼŸNjsOsÞɚsNjsŎÞŘÞضǣǣsǼǣŸ¯ǼÌsNŸŎƼŘɴʰ¯ǼsNj
_ÞǣǼNjÞEȖǼÞŸŘŸ¯ĶĶƼNjs¯sNjsŘǼÞĶŎŸȖŘǼǣʳǻÌs_ÞǣǼNjÞEȖǼÞŸŘɠÞĶĶEsÞŘƼNjŸƼŸNjǼÞŸŘǼŸǼÌsŘȖŎEsNjŸ¯sLJȖÞǼɴǣÌNjsǣÌsĶ_EɴǼÌsǣÌNjsÌŸĶ_sNjǣʳ

_ʳ ¶¶Njs¶ǼsŘȖŎEsNjŸ¯EŸŘȖǣǣÌNjsǣÞǣǣȖs_ʰǣÌNjsǣÞǣǣȖs_¯ŸNjOŸŘǣÞ_sNjǼÞŸŘŸǼÌsNjǼÌŘOǣÌ_ȖNjÞضǼÌsƼsNjÞŸ_Ÿ¯ʩɚsɴsNjǣÞŎŎs_ÞǼsĶɴ
preceding the reporting date:

As at As at
March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ
No. ŗŸʳ
rLJȖÞǼɴ ǣÌNjsǣ ĶĶŸǼǼs_ ǣ ¯ȖĶĶɴ ƼÞ_ EŸŘȖǣ ǣÌNjsǣ Eɴ OƼÞǼĶÞʊǼÞŸŘ Ÿ¯ ǣsOȖNjÞǼÞsǣ ƼNjsŎÞȖŎ ˡʰˢ˦˨ʰ˦ˣ˧ ˡʰˢ˦˨ʰ˦ˣ˧
ʹ®ɳˡ˟ˠˢ˚ˡ˟ˠˣʺ
rLJȖÞǼɴǣÌNjsǣÞǣǣȖs_¯ŸNjOŸŘǣÞ_sNjǼÞŸŘŸǼÌsNjǼÌŘOǣÌʰƼȖNjǣȖŘǼǼŸǣOÌsŎsŸ¯ŎĶ¶ŎǼÞŸŘ ˡʰˢ˦˨ʰ˦ˣ˧ ˡʰˢ˦˨ʰ˦ˣ˧
ɠÞǼÌsNjǣǼɠÌÞĶsğɴŸǼÌɴNŸŘǣȖŎsNjƻNjŸ_ȖOǼǣĵÞŎÞǼs_ʹğNƻĵʺʹ®ɳˡ˟ˠˢ˚ˡ˟ˠˣʺ
4,759,496 4,759,496

ÝŘ __ÞǼÞŸŘ ǼÌs OŸŎƼŘɴ Ìǣ ÞǣǣȖs_ ˨˥ʰˠ˧ˣ ǣÌNjs ʹˡ˟ˠˤ ŗÞĶʺ _ȖNjÞض ǼÌs ƼsNjÞŸ_ Ÿ¯ ʩɚs ɴsNjǣ ÞŎŎs_ÞǼsĶɴ ƼNjsOs_Þض ǼÌs NjsƼŸNjǼÞض _Ǽs ŸŘ
sɮsNjOÞǣsŸ¯ŸƼǼÞŸŘ¶NjŘǼs_ȖŘ_sNjǼÌssŎƼĶŸɴssǣǼŸOĨŸƼǼÞŸŘƼĶŘʹrǢŷƻʺɠÌsNjsÞŘƼNjǼOŸŘǣÞ_sNjǼÞŸŘɠǣNjsOsÞɚs_ÞŘ¯ŸNjŎŸ¯sŎƼĶŸɴssǣsNjɚÞOsǣʳ

e. Share received for issue under option

 ®ŸNj_sǼÞĶǣŸ¯ǣÌNjsǣNjsǣsNjɚs_¯ŸNjÞǣǣȖsȖŘ_sNjǼÌssŎƼĶŸɴssǣǼŸOĨŸƼǼÞŸŘƼĶŘʹrǢŷƻʺŸ¯ǼÌsOŸŎƼŘɴʰƼĶsǣsNjs¯sNjŗŸǼsˢ˥ʳ
Corporate Overview Performance Governance Financial Statements 155

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
` In Lacs

As at As at
March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ
NOTE 5
RESERVES AND SURPLUS
ǢȖNjƼĶȖǣÞŘǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣʲ
DĶŘOsʰEs¶ÞŘŘÞضŸ¯ǼÌsɴsNj ʹˠˣʰ˥ˤˠʳ˟˨ʺ ʹˠˡʰˢˠˡʳˢ˟ʺ
ƻNjŸʩǼ¯ŸNjǼÌsɴsNj ˠˤʰ˦˨˥ʳ˟ˣ ˠˡʰˠˠˡʳˣˠ
1,144.95 (199.89)
ĵsǣǣʲƼƼNjŸƼNjÞǼÞŸŘǣ
ƻNjŸƼŸǣs__ÞɚÞ_sŘ_ʹŎŸȖŘǼƼsNjǣÌNjs`ˠʹˡ˟ˠˤ˚`ˣʺʺ ʹˠʰ˧ˠˠʳˡ˟ʺ ʹ˦ʰˡˣ˟ʳ˨ˣʺ
ǻɮŸŘƼNjŸƼŸǣs__ÞɚÞ_sŘ_ ʹˢ˥˧ʳ˦ˡʺ ʹˠʰˣ˦ˣʳ˟˧ʺ
ÝŘǼsNjÞŎ_ÞɚÞ_sŘ_ʹŎŸȖŘǼƼsNjǣÌNjs`ˣʹˡ˟ˠˤ˚`ŗÞĶʺʺ ʹ˦ʰˡˣˣʳ˦˨ʺ -
ǻɮŸŘÝŘǼsNjÞŎ_ÞɚÞ_sŘ_ ʹˠʰˣ˦ˣʳ˧˦ʺ -
Transfer to Debenture Redemption Reserve ʹˣʰˤ˥˟ʳ˟ˠʺ ʹˤʰˢ˦ˡʳˤˠʺ
^sƼNjsOÞǼÞŸŘǣƼsNjǢOÌs_ȖĶsÝÝŸ¯NŸŎƼŘÞsǣOǼʰˡ˟ˠˢˎ - ʹˢ˥ˢʳ˥˦ʺ
ŗsǼʹ_sʩOÞǼʺÞŘǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣ (14,314.64) (14,651.09)
Capital Reserve 5,480.32 5,480.32
Securities premium
DĶŘOsʰEs¶ÞŘŘÞضŸ¯ǼÌsɴsNj ˢ˦ʰ˧ˠˣʳˢ˧ ˢ˨ʰˠ˨ˠʳˡ˟
__ʲ__ÞǼÞŸŘŸŘrǢŷƻǣsɮsNjOÞǣs_ ˠ˧˟ʳˤˣ -
ĵsǣǣʲrɮƼsŘǣsǣÞŘOȖNjNjs_ŸŘÞǣǣȖsŸ¯^sEsŘǼȖNjsǣ - ʹˠˤʳ˟˟ʺ
ĵsǣǣʲƻNjsŎÞȖŎƼɴEĶsŸŘNjs_sŎƼǼÞŸŘŸ¯ŘŸŘOŸŘɚsNjǼÞEĶs_sEsŘǼȖNjsǣÞǣǣȖs_ - ʹˠʰˢ˥ˠʳ˧ˡʺ
DĶŘOsʰsŘ_Ÿ¯ǼÌsɴsNj 37,994.92 37,814.38
Investment subsidy 106.90 106.90
Debenture Redemption Reserve
DĶŘOsʰEs¶ÞŘŘÞضŸ¯ǼÌsɴsNj ˠˠʰ˨˨ˤʳ˟ˡ ˥ʰ˥ˡˡʳˤˠ
__ʲŎŸȖŘǼǼNjŘǣ¯sNjNjs_¯NjŸŎǣȖNjƼĶȖǣEĶŘOsÞŘǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣ ˣʰˤ˥˟ʳ˟ˠ ˤʰˢ˦ˡʳˤˠ
ĵsǣǣʲŎŸȖŘǼǼNjŘǣ¯sNjNjs_ǼŸµsŘsNjĶNJsǣsNjɚsǣ ʹˡʰ˧˦ˤʳ˟˟ʺ -
DĶŘOsʰsŘ_Ÿ¯ǼÌsɴsNj 13,680.03 11,995.02
General reserves
DĶŘOsʰEs¶ÞŘŘÞضŸ¯ǼÌsɴsNj ˢˡʰˤˢ˨ʳ˟˧ ˢˡʰˤˢ˨ʳ˟˧
__ʲŎŸȖŘǼǼNjŘǣ¯sNjNjs_¯NjŸŎ^sEsŘǼȖNjsNJs_sŎƼǼÞŸŘNJsǣsNjɚs ˡʰ˧˦ˤʳ˟˟ -
DĶŘOsʰsŘ_Ÿ¯ǼÌsɴsNj 35,414.08 32,539.08
Employee Stock Option Outstanding
DĶŘOsʰEs¶ÞŘŘÞضŸ¯ǼÌsɴsNj ˡʰ˧˦ˠʳˠˢ -
__ʲNŸŎƼsŘǣǼÞŸŘŸŘǣǼŸOĨŸƼǼÞŸŘ¶NjŘǼs__ȖNjÞضǼÌsɴsNj ˡʰˢ˨˦ʳ˧˦ ˡʰ˧˦ˠʳˠˢ
ĵsǣǣʲNŸŎƼsŘǣǼÞŸŘŸŘǣǼŸOĨŸƼǼÞŸŘOŘOsĶĶs__ȖNjÞضǼÌsɴsNj ʹ˥ˣ˦ʳ˥ˠʺ -
ĵsǣǣʲǻNjŘǣ¯sNjǼŸǣsOȖNjÞǼÞsǣƼNjsŎÞȖŎŸŘsɮsNjOÞǣsŸ¯ǣǼŸOĨŸƼǼÞŸŘǣ ʹˠ˧˟ʳˤˣʺ -
4,440.85 2,871.13
82,802.46 76,155.74

ˎǻÌsµNjŸȖƼÌǣŘŸǼNjsOŸ¶ŘÞǣs__s¯sNjNjs_ǼɮǣǣsǼǣŸŘǼÌsǣŎsÞŘǼÌsEǣsŘOsŸ¯ɚÞNjǼȖĶOsNjǼÞŘǼɴǣȖƼƼŸNjǼs_EɴOŸŘɚÞŘOÞضsɚÞ_sŘOsǼÌǼǼÌsɴ
OŘEsNjsĶÞʊs_¶ÞŘǣǼ¯ȖǼȖNjsǼɮEĶsƼNjŸʩǼǣʳ
156 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
` In Lacs

NON CURRENT CURRENT


As at As at As at As at
March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ
NOTE 6
LONG-TERM BORROWINGS
ǻsNjŎĶŸŘǣ¯NjŸŎDŘĨʹǣsOȖNjs_ʺ ˦ˡ˦ʳˣˣ ˨˟ˡʳˣˣ ˠ˦ˤʳ˟˟ ˠ˦ˤʳ˟˟
Secured Redeemable Zero Coupon Non
Convertible Debentures
ˣʰ˟˟˟ʹˡ˟ˠˤ˚ˣʰ˟˟˟ʺ^sEsŘǼȖNjsǣŸ¯`ˠ˟ʰ˟˟ʰ˟˟˟ - ˣ˟ʰ˟˟˟ʳ˟˟ ˣ˟ʰ˟˟˟ʳ˟˟ -
ʹˡ˟ˠˤ˚`ˠ˟ʰ˟˟ʰ˟˟˟ʺsOÌ
˨ʳ˥ˤ̇ǢsOȖNjs_NJs_ssŎEĶsŗŸŘNŸŘɚsNjǼÞEĶs
Debentures
ŗÞĶʹˡ˟ˠˤ˚˥ˤ˟ʺ^sEsŘǼȖNjsǣŸ¯` Nil - - - ˥ʰˤ˟˟ʳ˟˟
ʹˡ˟ˠˤ˚`ˠ˟ʰ˟˟ʰ˟˟˟ʺsOÌ
ˠ˟ʳˡˤ̇ǢsOȖNjs_NJs_ssŎEĶsŗŸŘNŸŘɚsNjǼÞEĶs
Debentures
ŗÞĶʹˡ˟ˠˤ˚ˤ˟˟ʺ^sEsŘǼȖNjsǣŸ¯` Nil - - - ˤʰ˟˟˟ʳ˟˟
ʹˡ˟ˠˤ˚`ˠ˟ʰ˟˟ʰ˟˟˟ʺsOÌ
ȕŘĶÞǣǼs_ʰNJs_ssŎEĶsʰŗŸŘNŸŘɚsNjǼÞEĶs^sEsŘǼȖNjsǣ
ˣ˟˟ʹˡ˟ˠˤ˚ˣ˟˟ʺ^sEsŘǼȖNjsǣŸ¯`ˠ˟ʰ˟˟ʰ˟˟˟ - ˣʰ˟˟˟ʳ˟˟ ˣʰ˟˟˟ʳ˟˟ -
ʹˡ˟ˠˤ˚`ˠ˟ʰ˟˟ʰ˟˟˟ʺsOÌ
^s¯sNjNjs_ƻɴŎsŘǼĵÞEÞĶÞǼɴʹȕŘǣsOȖNjs_ʺ - - ˠ˧˟ʳ˟˟ ˢ˥˟ʳ˟˟
ŎŸȖŘǼ_ÞǣOĶŸǣs_ȖŘ_sNj˄ŷǼÌsNjNȖNjNjsŘǼ - - ʹˣˣʰˢˤˤʳ˟˟ʺ ʹˠˡʰ˟ˢˤʳ˟˟ʺ
ĵÞEÞĶÞǼÞsǣ˅ʹŗŸǼsˠˠʺ
727.44 44,902.44 - -
Details of loan:
ʺ ǻsNjŎĶŸŘŸ¯`˨˟ˡʳˣˣʹˡ˟ˠˤ˚` ˠʰ˟˦˦ʳˣˣʺ¯NjŸŎEŘĨÌǣEssŘǼĨsŘÞŘʩŘŘOÞĶɴsNjˡ˟ˠˡ˚ˠˢʳǻÌsĶŸŘÞǣNjsƼɴEĶsÞŘˢˡLJȖNjǼsNjĶɴÞŘǣǼĶĶŎsŘǼǣ
Es¶ÞŘŘÞض¯NjŸŎȖ¶ȖǣǼˡ˟ˠˢʳǻÌsĶŸŘÞǣǣsOȖNjs_EɴsɮOĶȖǣÞɚsʩNjǣǼOÌNj¶sŸŘǼÌssŘǼÞNjsʩɮs_ǣǣsǼǣŘ_OȖNjNjsŘǼǣǣsǼǣŸ¯ǼÌsğ®Ǣĵ˚ğĵĵʹğəʺŘ_
¯ȖNjǼÌsNjǣsOȖNjs_EɴOŸNjƼŸNjǼs¶ȖNjŘǼss¶ÞɚsŘEɴǼÌsOŸŎƼŘɴʳ
Eʺ ˣʰ˟˟˟ʉsNjŸNŸȖƼŸŘŗŸŘNŸŘɚsNjǼÞEĶsNJs_ssŎEĶs^sEsŘǼȖNjsǣŸ¯`ˠ˟ʰ˟˟ʰ˟˟˟sOÌ˚NJs_ssŎEĶsǼƼNjsŎÞȖŎŸ¯`ˢ˥˧ʰ˟ˡˡƼsNj_sEsŘǼȖNjs¯ǼsNj
ˢɴsNjǣ¯NjŸŎǼÌs_ǼsŸ¯ĶĶŸǼŎsŘǼÞʳsʳŗŸɚsŎEsNjˠˣʰˡ˟ˠˢʳǻÌsǣs_sEsŘǼȖNjsǣNjsǣsOȖNjs_EɴʩNjǣǼOÌNj¶sŸŘĶĶʩɮs_ǣǣsǼǣŘ_ǣsĶsOǼDNjŘ_ǣ
ʹōɮŸŘ_rɮŸʺʳ
Oʺ ˣ˟˟ȕŘĶÞǣǼs_ʰNJs_ssŎEĶsʰŗŸŘNŸŘɚsNjǼÞEĶs^sEsŘǼȖNjsǣŸ¯`ˠ˟ʰ˟˟ʰ˟˟˟sOÌ˚NJs_ssŎEĶsǼƼNjsŎÞȖŎŸ¯`ˢˣ˟ʰˣˤˤƼsNj_sEsŘǼȖNjs¯ǼsNj
ˢɴsNjǣ¯NjŸŎǼÌs_ǼsŸ¯ĶĶŸǼŎsŘǼÞʳsʳğŘȖNjɴˠˡʰˡ˟ˠˤʳǻÌs^sEsŘǼȖNjsǣNjsȖŘǣsOȖNjs_Ř_OŸɚsNjs_EɴOŸNjƼŸNjǼs¶ȖNjŘǼss¶ÞɚsŘEɴǼÌs
NŸŎƼŘɴʳ
_ʺ ^s¯sNjNjs_ƼɴŎsŘǼĶÞEÞĶÞǼɴNjsNjsƼɴEĶsŸɚsNjƼsNjÞŸ_Ÿ¯ˢɴsNjǣÞŘsLJȖĶÞŘǣǼĶĶŎsŘǼǣʳ

As at As at
March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ
NOTE 7
DEFERRED TAX LIABILITIES, (NET)
a) Deferred tax liability
Depreciation ˣʰˢ˨ˡʳ˟ˤ ˣʰˣ˥ˢʳ˧˧
Gross Deferred tax liability (A) 4,392.05 4,463.88
b) Deferred tax assets
Technical royalty ˠʳˠ˨ ˠʳˤ˧
Provision for gratuity ˤ˨ˣʳˠˡ ˣ˥˧ʳˤ˥
Provision for doubtful debts ˠˤ˨ʳ˦ˤ ˠˤ˨ʳ˦ˤ
Provision for doubtful advances ˤˣˡʳ˟ˠ ˤˡˠʳˡ˧
Provision for leave encashment ˡ˧ˡʳ˨˟ ˡ˥˨ʳ˦ˡ
Provision for impairment losses ˤ˨ʳ˟ˤ ˥˟ʳˡ˦
Provision for bonus ˥ʳˤ˧ ˥ʳˤ˧
Other Disallowances ˦˥ʳˢˠ ˢˡʳ˧˦
On carry forward loss and unabsorbed depreciation ˠˢ˨ʳ˦˥ ˡʰ˧˧˨ʳ˟ˢ
Gross Deferred tax assets (B) 1,861.67 4,409.64
Net deferred tax liabilities (A - B) 2,530.38 54.24
Corporate Overview Performance Governance Financial Statements ˠˤ˦

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
` In Lacs

As at As at
March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ
NOTE 8
OTHER LONG-TERM LIABILITIES
Premium payable on redemption of Debentures ˠ˥ʰ˟˧ˠʳ˨ˠ ˠ˥ʰ˟˧ˠʳ˨ˠ
Creditors for Capital Goods - ˦ˤʳ˧ˠ
ŎŸȖŘǼ_ÞǣOĶŸǣs_ȖŘ_sNj˄ŷǼÌsNjNȖNjNjsŘǼĵÞEÞĶÞǼÞsǣ˅ʹŗŸǼsˠˠʺ ʹˠˤʰˤ˧ˢʳˣˠʺ -
498.50 16,157.72

NON CURRENT CURRENT


As at As at As at As at
March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ
NOTE 9
PROVISIONS
ƻNjŸɚÞǣÞŸŘ¯ŸNjsŎƼĶŸɴssEsŘsʩǼǣ
Provision for leave encashment - - ˧ˢ˟ʳ˨˟ ˦˨˦ʳ˦ˣ
ƻNjŸɚÞǣÞŸŘ¯ŸNj¶NjǼȖÞǼɴʹŗŸǼsˡ˧ʺ ˠʰ˦˦˥ʳ˥ˤ ˠʰˢ˦˟ʳˣˡ ˠˢʳˣ˦ ˠ˟ʳˣˤ
1,776.65 1,370.42 844.37 808.19
Other provisions
ƻNjŸɚÞǣÞŸŘ¯ŸNjɠsĶǼÌǼɮ - - ˣʳˠ˦ ˧ʳ˦ˢ
ƻNjŸɚÞǣÞŸŘ¯ŸNjÞŘOŸŎsǼɮʹŘsǼŸ¯_ɚŘOsǼɮŸ¯ - - ˤˢˣʳˣ˧ ˢ˦ˣʳ˧˧
` ˢʰ˦˦˦ʳˤˡʹˡ˟ˠˤ˚`ˡʰ˦˟˟ʳˠˡʺʺ
Provision for litigation* - - ˡʰˠ˦ˤʳˤ˨ ˡʰˠ˦ˤʳˤ˨
Proposed dividend - - ˠʰ˧ˠˠʳˡ˟ ˦ʰˡˣ˟ʳ˨ˣ
ǻɮŸŘƼNjŸƼŸǣs__ÞɚÞ_sŘ_ - - ˢ˥˧ʳ˦ˡ ˠʰˣ˦ˣʳ˟˧
- - 4,894.16 11,274.22
1,776.65 1,370.42 5,738.53 12,082.41

ˎƻNjŸɚÞǣÞŸŘ¯ŸNjĶÞǼÞ¶ǼÞŸŘNjsĶǼsǣǼŸOsNjǼÞŘÞŘ_ÞNjsOǼǼɮOǣsǣƼsŘ_ÞضǼɚNjÞŸȖǣĶsɚsĶǣʳǻÌsNjsÞǣŘŸŎŸɚsŎsŘǼÞŘǼÌsƼNjŸɚÞǣÞŸŘÞŘOȖNjNjsŘǼɴsNjʳ

As at As at
March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ
NOTE 10
TRADE PAYABLES
ǻŸǼĶŸȖǼǣǼŘ_Þض_ȖsǣŸ¯ŎÞONjŸsŘǼsNjƼNjÞǣsǣŘ_ǣŎĶĶsŘǼsNjƼNjÞǣsǣʹNjs¯sNjŘŸǼsˣˢ¯ŸNj_sǼÞĶǣŸ¯ ˣʰ˦ˠ˧ʳˤˣ ˢʰ˦ˣˠʳ˦˧
_ȖsǣǼŸŎÞONjŸŘ_ǣŎĶĶsŘǼsNjƼNjÞǣsǣʺ
Total outstanding dues of creditors other than micro enterprises and small enterprises
Other trade payable ˤʰˤ˨˟ʳ˨ˤ ˣʰˡˤ˦ʳˠ˨
OONjȖĶ¯ŸNjsɮƼsŘǣsǣ ˤʰ˦˦ˣʳˤˤ ˤʰˡˣ˦ʳ˧ˡ
16,084.04 13,246.79

As at As at
March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ
NOTE 11
OTHER CURRENT LIABILITIES
Interest accrued but not due on Long Term Borrowings - ˢ˦˦ʳˠ˥
Interest accrued and due on Long Term Borrowings ˨ʳ˟ˠ ˠ˟ʳ˧˨
Statutory Dues ˠʰ˨ˤˡʳˡ˨ ˠʰ˥˨˥ʳ˟ˣ
Unclaimed dividend * ˠˢ˨ʳˡ˧ ˤˢʳˢˣ
Security deposits ˢˢʳ˥ˤ ˥ˢʳ˟˨
Advances from customers ˥ˠˣʳˡ˧ ˡˠˡʳˣˢ
_ɚŘOsǣǼŸɠNj_ǣʩɮs_ǣǣsǼǣˀÞŘɚsǣǼŎsŘǼƼNjŸƼsNjǼɴÌsĶ_¯ŸNjǣĶs ˡ˟ʳ˟˟ ˨ˤʳ˧ˣ
Creditors for capital goods ˨˧ʳˢ˨ ˠ˧˥ʳˡ˦
Accrual for sales promotion schemes ˠʰ˦˧˟ʳˣˤ ˠʰ˟ˠ˧ʳ˦˟
NȖNjNjsŘǼŎǼȖNjÞǼÞsǣŸ¯ĵŸŘ¶ǻsNjŎDŸNjNjŸɠÞضǣʹŗŸǼs˥ʺ ˣˣʰˢˤˤʳ˟˟ ˠˡʰ˟ˢˤʳ˟˟
NȖNjNjsŘǼŎǼȖNjÞǼÞsǣŸ¯ƼNjsŎÞȖŎƼɴEĶsŸŘNjs_sŎƼǼÞŸŘŸ¯^sEsŘǼȖNjsǣʹŗŸǼs˧ʺ ˠˤʰˤ˧ˢʳˣˠ -
64,585.76 15,748.76
ˎǻÌsNjsNjsŘŸŎŸȖŘǼǣƼɴEĶsˀ_ȖsǼŸEsONjs_ÞǼs_ǼŸÝŘɚsǣǼŸNjr_ȖOǼÞŸŘŘ_ƻNjŸǼsOǼÞŸŘ®ȖŘ_ʳ
NOTES
ˠˤ˧

to the Consolidated Financial Statements for the year ended March 31, 2016
` In Lacs
NOTE 12
TANGIBLE AND INTANGIBLE ASSETS
Gross Block Depreciation and Amortisation Impairment Net Block
Particulars As at April 1, Addition Deletions As at March As at April 1, For the year For the year Deletions As at March As at April 1, Charge For Deletion As at March As at March As at March
2015 31, 2016 2015 adjusted to taken to 31, 2016 2015 the year* 31, 2016 31, 2016 31, 2015
reserve as statement of
per Schedule ƼNjŸʩǼ˓ĶŸǣǣ
II of the
Annual Report 2015-16

Companies
Act 2013*
Intangible assets
Jyothy Laboratories Limited

Goodwill ˦˨ʰ˟ˤ˧ʳˡˢ - - ˦˨ʰ˟ˤ˧ʳˡˢ ˢ˦ˢʳˤˣ - - - ˢ˦ˢʳˤˣ ˤˠʳˤ˟ - - ˤˠʳˤ˟ ˦˧ʰ˥ˢˢʳˠ˨ ˦˧ʰ˥ˢˢʳˠ˨


˦˨ʰ˟ˤˣʳ˦˧ ˢʳˣˤ - ˦˨ʰ˟ˤ˧ʳˡˢ ˢ˦ˢʳˤˣ - - - ˢ˦ˢʳˤˣ ˤˠʳˤ˟ - - ˤˠʳˤ˟
ǻNj_sŎNjĨǣŘ_NŸƼɴNjÞ¶ÌǼǣ̱ ˥ˠ˧ʳˣˣ - - ˥ˠ˧ʳˣˣ ˣ˧˨ʳ˨˨ - ˣˤʳˡ˧ - ˤˢˤʳˡ˦ ˡˢʳ˥˧ - - ˡˢʳ˥˧ ˤ˨ʳˣ˨ ˠ˟ˣʳ˦˦
˥ˠ˧ʳˣˣ - - ˥ˠ˧ʳˣˣ ˣˣˣʳˣˢ - ˣˤʳˤ˥ - ˣ˧˨ʳ˨˨ ˡˢʳ˥˧ - - ˡˢʳ˥˧
ħŘŸɠ˚ÌŸɠ ˥ˣ˦ʳˠˡ - - ˥ˣ˦ʳˠˡ ˥ˣ˦ʳˠˡ - - - ˥ˣ˦ʳˠˡ - - - - - -
˥ˣ˦ʳˠˡ - - ˥ˣ˦ʳˠˡ ˤ˦ˤʳˣˤ - ˦ˠʳ˥˦ - ˥ˣ˦ʳˠˡ - - - -
Software's and Licences ˣ˧ˠʳˠˤ ˣ˦ʳˣˢ - ˤˡ˧ʳˤ˧ ˠ˧˧ʳˠ˟ - ˤ˟ʳˡˢ - ˡˢ˧ʳˢˢ - - - - ˡ˨˟ʳˡˤ ˡ˨ˢʳ˟ˤ
ˢ˧˨ʳ˧ˡ ˠˠ˦ʳ˦ˡ ˡ˥ʳˢ˨ ˣ˧ˠʳˠˤ ˠ˥ˢʳˣˠ - ˤˠʳ˟˥ ˡ˥ʳˢ˦ ˠ˧˧ʳˠ˟ - - - -
Total intangible assets 80,804.94 47.43 - 80,852.37 1,698.75 - 95.51 - 1,794.26 75.18 - - 75.18 78,982.93 79,031.01
˧˟ʰ˦ˠ˟ʳˠ˥ ˠˡˠʳˠ˦ ˡ˥ʳˢ˨ ˧˟ʰ˧˟ˣʳ˨ˣ ˠʰˤˤ˥ʳ˧ˢ - ˠ˥˧ʳˡ˨ ˡ˥ʳˢ˦ ˠʰ˥˨˧ʳ˦ˤ ˦ˤʳˠ˧ - - ˦ˤʳˠ˧
Tangible assets
Freehold land ^ ˢʰ˦ˡ˦ʳˢ˟ - - ˢʰ˦ˡ˦ʳˢ˟ - - - - - - - - - ˢʰ˦ˡ˦ʳˢ˟ ˢʰ˦ˡ˦ʳˢ˟
ˢʰ˥˨ˢʳ˨˦ ˢˢʳˢˢ - ˢʰ˦ˡ˦ʳˢ˟ - - - - - - - - -
Leasehold land ˢ˨˟ʳ˦ˣ - - ˢ˨˟ʳ˦ˣ ˢ˧ʳˤˤ - ˢʳ˨˨ - ˣˡʳˤˣ - - - - ˢˣ˧ʳˡ˟ ˢˤˡʳˠ˨
ˢ˨˟ʳ˦ˣ - - ˢ˨˟ʳ˦ˣ ˢˣʳˤ˥ - ˢʳ˨˨ - ˢ˧ʳˤˤ - - - -
Building # ˠˤʰ˨˦ˤʳˣ˥ ˥˟˨ʳ˧˟ ˥ˡʳ˧˧ ˠ˥ʰˤˡˡʳˢ˧ ˢʰ˨ˡˤʳ˥ˣ - ˤˤ˟ʳˤ˧ ˡˡʳ˥ˡ ˣʰˣˤˢʳ˥˟ - - - - ˠˡʰ˟˥˧ʳ˦˧ ˠˡʰ˟ˣ˨ʳ˧ˡ
ˠˤʰ˦˨ˢʳˡˣ ˠ˨˦ʳ˟˟ ˠˣʳ˦˧ ˠˤʰ˨˦ˤʳˣ˥ ˢʰˢ˨˟ʳˤ˧ - ˤˣ˟ʳˣ˧ ˤʳˣˡ ˢʰ˨ˡˤʳ˥ˣ - - - -
Plant and machinery ˡˣʰˡ˧ˢʳˤ˧ ˠʰ˧ˡˠʳ˦ˠ ˠʰ˟ˡ˟ʳ˦ˢ ˡˤʰ˟˧ˣʳˤ˥ ˠˠʰˣ˥˦ʳˤˠ - ˠʰ˨˥˨ʳˡ˟ ˧ˤˣʳ˧˨ ˠˡʰˤ˧ˠʳ˧ˡ ˡʰ˟˨˧ʳˣ˧ - ˢʳˤˢ ˡʰ˟˨ˣʳ˨ˤ ˠ˟ʰˣ˟˦ʳ˦˨ ˠ˟ʰ˦ˠ˦ʳˤ˨
ˡˣʰˣˡˣʳ˟ˡ ˦ˣˡʳ˨˨ ˧˧ˢʳˣˢ ˡˣʰˡ˧ˢʳˤ˧ ˨ʰ˨ˤˡʳ˨˟ ˨ˤʳˠ˧ ˠʰ˧ˣ˥ʳˡˢ ˣˡ˥ʳ˧˟ ˠˠʰˣ˥˦ʳˤˠ ˡʰˣ˟˦ʳˠ˥ - ˢ˟˧ʳ˥˧ ˡʰ˟˨˧ʳˣ˧
Dies and moulds ˥˧ˤʳ˥ˤ ˣ˧ʳ˟˟ ˥˥ʳ˧ˠ ˥˥˥ʳ˧ˣ ˤˠˠʳ˧˨ - ˨ˤʳ˟ˢ ˥ˣʳ˥ˠ ˤˣˡʳˢˠ - - - - ˠˡˣʳˤˢ ˠ˦ˢʳ˦˥
˥˧ˠʳˢ˨ ˠ˦˥ʳ˨ˢ ˠ˦ˡʳ˥˦ ˥˧ˤʳ˥ˤ ˤˤˤʳˤˠ ˣʳˤ˧ ˠˡˢʳ˦ˠ ˠ˦ˠʳ˨ˠ ˤˠˠʳ˧˨ - - - -
®ȖNjŘÞǼȖNjsŘ_ʩɮǼȖNjs ˠʰ˟ˠ˦ʳ˥˥ ˥ˤʳˢ˟ ˣˠʳˡˤ ˠʰ˟ˣˠʳ˦ˠ ˤ˥ˤʳ˥ˤ - ˠ˟˧ʳ˥˟ ˢˤʳˡ˧ ˥ˢ˧ʳ˨˦ ˠʳ˟˦ - - ˠʳ˟˦ ˣ˟ˠʳ˥˦ ˣˤ˟ʳ˨ˣ
ˠʰ˟˦ˡʳ˟ˠ ˠ˧ʳˠˢ ˦ˡʳˣ˧ ˠʰ˟ˠ˦ʳ˥˥ ˣˤ˥ʳ˨˟ ˡˤʳ˨˧ ˠˤˠʳ˨˥ ˥˨ʳˠ˨ ˤ˥ˤʳ˥ˤ ˠʳ˟˦ - - ˠʳ˟˦
Leasehold Improvements ˣ˟ˡʳ˟ˠ ˠʳˠ˟ ˨ˤʳ˟˥ ˢ˟˧ʳ˟ˤ ˢˠ˦ʳˢˤ - ˣ˧ʳ˥ˤ ˧ˡʳˤ˥ ˡ˧ˢʳˣˣ - - - - ˡˣʳ˥ˠ ˧ˣʳ˥˥
ˤˢˠʳˤˣ ˨˥ʳˢˡ ˡˡˤʳ˧ˤ ˣ˟ˡʳ˟ˠ ˣ˥ˢʳˠ˦ - ˧˟ʳ˟ˢ ˡˡˤʳ˧ˤ ˢˠ˦ʳˢˤ - - - -
ŷ¯ʩOssLJȖÞƼŎsŘǼǣ ˠʰˣ˥˥ʳ˧˧ ˠˡˣʳ˧˦ ˠˣ˟ʳ˦ˤ ˠʰˣˤˠʳ˟˟ ˠʰˠˠ˥ʳˤˠ - ˠˣ˥ʳ˟˧ ˠˢ˦ʳ˧˦ ˠʰˠˡˣʳ˦ˡ ˠˡʳ˦ˤ - - ˠˡʳ˦ˤ ˢˠˢʳˤˢ ˢˢ˦ʳ˥ˡ
ˠʰˣˠ˦ʳˤ˟ ˠ˦ˣʳ˟˧ ˠˡˣʳ˦˟ ˠʰˣ˥˥ʳ˧˧ ˧˟ˡʳ˥ˡ ˡˢ˟ʳ˦˧ ˡ˟ˣʳ˦ˤ ˠˡˠʳ˥ˣ ˠʰˠˠ˥ʳˤˠ ˠˣʳ˟˧ - ˠʳˢˢ ˠˡʳ˦ˤ
əsÌÞOĶs ˠʰ˟˟˥ʳ˧˟ ˢˢʳˠ˧ ˣ˨ʳ˟ˡ ˨˨˟ʳ˨˥ ˤˡ˧ʳˤ˥ - ˠˡˡʳˤˠ ˢ˨ʳˣˠ ˥ˠˠʳ˥˥ ˟ʳ˨ˠ - - ˟ʳ˨ˠ ˢ˦˧ʳˢ˨ ˣ˦˦ʳˢˢ
˧˧˧ʳ˦ˤ ˡˢ˥ʳˢ˨ ˠˠ˧ʳˢˣ ˠʰ˟˟˥ʳ˧˟ ˣ˧ˢʳˠˢ ˦ʳˠˤ ˠˢˤʳˠˠ ˨˥ʳ˧ˢ ˤˡ˧ʳˤ˥ ˟ʳ˨ˠ - - ˟ʳ˨ˠ
Total tangible assets 48,956.08 2,703.96 1,476.50 50,183.54 18,471.66 - 3,044.64 1,237.24 20,279.06 2,113.21 - 3.53 2,109.68 27,794.80 28,371.21
ˣ˧ʰ˧˨ˢʳˠ˥ ˠʰ˥˦ˤʳˠ˦ ˠʰ˥ˠˡʳˡˤ ˣ˧ʰ˨ˤ˥ʳ˟˧ ˠ˥ʰˠˢ˨ʳˢ˦ ˢ˥ˢʳ˥˦ ˢʰ˟˧˥ʳˡ˥ ˠʰˠˠ˦ʳ˥ˣ ˠ˧ʰˣ˦ˠʳ˥˥ ˡʰˣˡˢʳˡˡ - ˢˠ˟ʳ˟ˠ ˡʰˠˠˢʳˡˠ
Total 1,29,761.02 2,751.39 1,476.50 1,31,035.91 20,170.41 - 3,140.15 1,237.24 22,073.32 2,188.39 - 3.53 2,184.86 1,06,777.73 1,07,402.22
Previous year ˠʰˡ˨ʰ˥˟ˢʳˢˡ ˠʰ˦˨˥ʳˢˣ ˠʰ˥ˢ˧ʳ˥ˣ ˠʰˡ˨ʰ˦˥ˠʳ˟ˠ ˠ˦ʰ˥˨˥ʳˡ˟ ˢ˥ˢʳ˥˦ ˢʰˡˤˣʳˤˤ ˠʰˠˣˣʳ˟ˠ ˡ˟ʰˠ˦˟ʳˣˠ ˡʰˣ˨˧ʳˣ˟ - ˢˠ˟ʳ˟ˠ ˡʰˠ˧˧ʳˢ˨
̱ ÝŘOĶȖ_sǣǼNj_sŎNjĨǣŘ_OŸƼɴNjÞ¶ÌǼǣŸ¯`ˢˠˤʳ˥ˢʹˡ˟ˠˤ˚` ˢˠˤʳ˥ˢʺƼsŘ_Þض¯ŸNjNjs¶ÞǣǼNjǼÞŸŘÞŘǼÌsŘŎsŸ¯ǼÌsNŸŎƼŘɴŘ_`ˢ˦ʳ˥ˢʹˡ˟ˠˤ˚`ˢ˦ʳ˥ˢʺƼsŘ_Þض¯ŸNjNjs¶ÞǣǼNjǼÞŸŘÞŘǼÌsŘŎsŸ¯ǼÌsğɴŸǼÌɴ®ENjÞONjsǢsNjɚÞOsǣĵÞŎÞǼs_ʳ
# Includes `ˣˤˡʳˠ˨ʹˡ˟ˠˤ˚`ˣˤˡʳˠ˨ʺNjsƼNjsǣsŘǼs_EɴȖŘLJȖŸǼs_¯ȖĶĶɴƼÞ_ǣÌNjsǣǼOŸǣǼÞŘɚNjÞŸȖǣOŸ˚ŸƼsNjǼÞɚsǣŸOÞsǼÞsǣʳ®ȖNjǼÌsNjʰĶǣŸNjs¯sNjŗŸǼsˢˢʳ
^ Land title deed relating to freehold land of `ˤˢ˥ʳˣˠʹˡ˟ˠˤ˚`ˤˢ˥ʳˣˠʺNjsƼsŘ_Þض¯ŸNjNjs¶ÞǣǼNjǼÞŸŘÞŘǼÌsŘŎsŸ¯ğɴŸǼÌɴ®ENjÞONjsǢsNjɚÞOsǣĵÞŎÞǼs_ʳ
ˎ r¯¯sOǼÞɚsƼNjÞĶˠʰˡ˟ˠˣʰǼÌs¶NjŸȖƼÌ_NjsɚÞǣs_ǼÌsȖǣs¯ȖĶĶÞɚsǣŸ¯OsNjǼÞŘʩɮs_ǣǣsǼǣEǣs_ŸŘǢOÌs_ȖĶsÝÝǼŸǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢ¯ŸNjǼÌsƼȖNjƼŸǣsǣŸ¯ƼNjŸɚÞ_Þض_sƼNjsOÞǼÞŸŘŸŘʩɮs_ǣǣsǼǣʳOOŸNj_ÞضĶɴʰǼÌsONjNjɴÞضŎŸȖŘǼ
Ÿ¯ǼÌsǣǣsǼǣǣŸŘƼNjÞĶˠʰˡ˟ˠˣɠǣ_sƼNjsOÞǼs_ŸɚsNjǼÌsNjsŎÞŘÞضNjsɚÞǣs_Ȗǣs¯ȖĶĶÞ¯sŸ¯ǼÌsʩɮs_ǣǣsǼǣʳ®ȖNjǼÌsNjʰŘŎŸȖŘǼŸ¯`ŗÞĶʹˡ˟ˠˤ˚`ˢ˥ˢʳ˥˦ʺʹŗsǼŸ¯Ǽɮ`ŗÞĶʺNjsƼNjsǣsŘǼÞضǼÌsONjNjɴÞضŎŸȖŘǼŸ¯ǼÌsǣǣsǼǣɠÞǼÌ
NjsɚÞǣs_Ȗǣs¯ȖĶĶÞ¯sǣŗÞĶʰɠǣOÌNj¶s_ǼŸǼÌsŸƼsŘÞضNjsǣsNjɚsǣǣŸŘƼNjÞĶˠʰˡ˟ˠˣʳ
Figures in italics are in respect of the previous year
Corporate Overview Performance Governance Financial Statements ˠˤ˨

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
` In Lacs

As at As at
March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ
NOTE 13
ŗŷŗNȕNJNJrŗǻÝŗərǢǻōrŗǻǢʹǼOŸǣǼʰȖŘĶsǣǣǣǼǼs_ŸǼÌsNjɠÞǣsʺ
ÝŘɚsǣǼŎsŘǼƼNjŸƼsNjǼɴʹ®NjssÌŸĶ_ĶŘ_ʺ˞ - ˠˣ˦ʳˢ˟
Trade Investments (Unquoted)
ËsŘĨsĶǢƻÝNrŎƼĶŸɴssǣNŸ˚ŸƼsNjǼÞɚsǻÌNjÞ¯ǼŘ_NNjs_ÞǼǢŸOÞsǼɴĵÞŎÞǼs_
ˡʰ˟˟˟ʹˡ˟ˠˤ˚ˡʰ˟˟˟ʺsLJȖÞǼɴǣÌNjsǣŸ¯`ˠ˟˟ʹˡ˟ˠˤ˚`ˠ˟˟ʺsO̯ȖĶĶɴƼÞ_ȖƼ ˡʳ˟˟ ˡʳ˟˟
NƼsɮÞĶʹ¶sŘOÞsǣʺĵǼ_
ˤʹˡ˟ˠˤ˚ˤʺsLJȖÞǼɴǣÌNjsǣŸ¯`ˠʰ˟˟˟ʹˡ˟ˠˤ˚`ˠʰ˟˟˟ʺsO̯ȖĶĶɴƼÞ_ȖƼ ˟ʳ˟ˤ ˟ʳ˟ˤ
Madras Industrial Cooperative Analytical Laboratory Limited
ˡʹˡ˟ˠˤ˚ˡʺsLJȖÞǼɴǣÌNjsǣŸ¯`ˤ˟˟ʹˡ˟ˠˤ˚`ˤ˟˟ʺsO̯ȖĶĶɴƼÞ_ȖƼ ˟ʳ˟ˠ ˟ʳ˟ˠ
2.06 2.06
ĵsǣǣʲƻNjŸɚÞǣÞŸŘ¯ŸNj_ÞŎÞŘȖǼÞŸŘÞŘǼÌsɚĶȖsŸ¯ÞŘɚsǣǼŎsŘǼǣ ʹ˟ʳ˟˥ʺ ʹ˟ʳ˟˥ʺ
2.00 2.00
Non-Trade Investment (Unquoted)
Investment in Government Securities
ÝŘ_ÞNjəÞĨǣƻǼNj ˟ʳ˟ˡ ˟ʳ˟ˡ
ŗǼÞŸŘĶǢɚÞضNsNjǼÞʩOǼsǣʹƻĶs_¶s_ɠÞǼ̵ŸɚsNjŘŎsŘǼȖǼÌŸNjÞǼÞsǣʺ ˟ʳˤ˦ ˟ʳˤ˦
0.59 0.59
2.59 149.89
Aggregate amount of unquoted investments ˡʳˤ˨ ˠˣ˨ʳ˧˨

˞ǢÞŘOsǼÌÞǣÞǣ¯NjssÌŸĶ_ĶŘ_ŘŸ_sƼNjsOÞǼÞŸŘÞǣOÌNj¶s_ŸŘǣŎsʳ

NON CURRENT CURRENT

As at As at As at As at
March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ

NOTE 14
LOANS AND ADVANCES
Unsecured, considered good unless
ŸǼÌsNjɠÞǣsǣǼǼs_
Capital Advances ˧˟ˤʳ˨˟ ˠˤˡʳ˧˨ - -
Advance to suppliers* ˤ˧ʳˣˤ ˥ˤʳ˧ˤ ˠʰˤ˧ˤʳˤ˨ ˠʰˤ˟˟ʳ˨˦
DĶŘOsɠÞǼÌsɮOÞǣsŘ_əǻȖǼÌŸNjÞǼÞsǣˎ - - ˠʰˢˢˢʳˠ˥ ˠʰ˨ˣ˨ʳ˨˥
MAT Credit entitlement ˨ʰˠ˨ˣʳˢ˨ ˥ʰˢˣˣʳˠˣ - -
Deposits* ˠʰ˨˦˥ʳˣ˧ ˨˥ˤʳ˦ˢ ˡˠ˧ʳˠˤ ˠ˥ˢʳ˦˟
DĶŘOsɠÞǼ̶ŸɚsNjŘŎsŘǼȖǼÌŸNjÞǼÞsǣˎʹŗŸǼsˢ˧ʺ ˦ʰ˨ˤˤʳ˟˦ ˦ʰˢˣ˥ʳ˧ˡ ˨ˤʳ˟ˠ ˨ˤʳˤ˨
ƻNjsƼÞ_rɮƼsŘǣsǣ ˣʳˣ˧ ˠʳˠ˧ ˠˤ˟ʳ˨˥ ˠ˨ˡʳˣˣ
_ɚŘOs ÞŘOŸŎs Ǽɮ ʹŘsǼ Ÿ¯ ƼNjŸɚÞǣÞŸŘǣ Ÿ¯ ˢʰˠ˟ˡʳ˥˥ ˡʰ˟˧˨ʳˤ˨ ˤˡʳ˨ˣ ˢ˨ʳˡˤ
`˨ʰ˨˥˥ʳ˨˟ʹˡ˟ˠˤ˚`˥ʰ˧˨ˠʳ˨˟ʺʺ
Other receivables* ˧ˤˢʳ˦˨ ˨˦˨ʳˣˠ ˣˡˣʳˡˢ ˣ˥ˠʳ˧˟
ĵsǣǣʲƻNjŸɚÞǣÞŸŘǣ¯ŸNj_ŸȖEǼ¯ȖĶ_ɚŘOsǣ ʹˡˤˠʳ˦ˣʺ ʹˡ˨˨ʳ˨˦ʺ ʹˠʰˡ˨˧ʳˢ˨ʺ ʹˠʰˡˡ˨ʳ˥ˣʺ
23,699.48 17,645.64 2,561.65 3,174.07

ˎ _ɚŘOsǣ ǼŸ ǣȖƼƼĶÞsNjǣʰ DĶŘOs ɠÞǼÌ sɮOÞǣs Ř_ əǻ ȖǼÌŸNjÞǼÞsǣʰ DĶŘOs ɠÞǼÌ ¶ŸɚsNjŘŎsŘǼ ȖǼÌŸNjÞǼÞsǣʰ ^sƼŸǣÞǼǣʰ NƼÞǼĶ _ɚŘOsǣ Ř_ ŷǼÌsNj
receivables include `ˣˤˣʳˡ˦ʹˡ˟ˠˤ˚ˢ˧ˤʳˤˡʺʰ`˧˧ˠʳˤ˟ʹˡ˟ˠˤ˚`˧˧ˠʳˤ˟ʺʰ`ˠ˥˦ʳ˟ˠʹˡ˟ˠˤ˚`ˠ˥˦ʳ˟˟ʺʰ`ˡˠʳ˟ˢʹˡ˟ˠˤ˚`ˣ˨ʳˡ˥ʺʰ`ŗÞĶʹˡ˟ˠˤ˚`ˡ˟ʳ˟ˠʺ
and `ˡ˥ʳˢˡʹˡ˟ˠˤ˚`ˡ˥ʳˢˡʺNjsǣƼsOǼÞɚsĶɴʰOŸŘǣÞ_sNjs__ŸȖEǼ¯ȖĶŘ_¯ȖĶĶɴƼNjŸɚÞ_s_¯ŸNjʳ
160 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
` In Lacs

NON CURRENT CURRENT

As at As at As at As at
March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ

NOTE 15

OTHER ASSETS

Unsecured, considered good

Inventory-Sales Promotions Items - - ˡˣˡʳ˥ˤ ˡ˨ˣʳ˥ˠ

Interest accrued but not due - - - ˡʳ˟ˠ

ÝŘɚsǣǼŎsŘǼƼNjŸƼsNjǼɴʹ®NjssÌŸĶ_ĶŘ_ʺÌsĶ_¯ŸNjǣĶs - - ˠˣ˦ʳˢ˟ -

®Þɮs__sƼŸǣÞǼɠÞǼÌDŘĨǣʹŗŸǼsˠ˨ʺ ˨ˢʳ˧˦ ˡˤ˟ʳ˨ˢ ˡ˥˥ʳ˧˧ ˡ˟˦ʳ˟ˣ

93.87 250.93 656.83 503.66

As at As at
March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ
NOTE 16
NȕNJNJrŗǻÝŗərǢǻōrŗǻǢdžȖŸǼs_ʹNŸǣǼŸNj®ÞNjɚĶȖsɠÌÞOÌsɚsNjÞǣĶŸɠsNjʺ
ɮÞǣDŘĨÞض^sEǼ®ȖŘ_˚µNjŸɠǼÌ
ŗÞĶʹˡ˟ˠˤ˚ˠˢˢʰ˧ˤ˨ʳ˨˦ʺȖŘÞǼǣŸ¯`ŗÞĶʹˡ˟ˠˤ˚`ˠʰ˟˟˟ʺsOÌ - ˠʰ˦˟˟ʳ˟˟
ɮÞǣĵÞLJȖÞ_®ȖŘ_˚µNjŸɠǼÌ
ˠ˨˟ʰ˧˧ˤʳ˥˥˧ʹˡ˟ˠˤ˚ŗÞĶʺȖŘÞǼǣŸ¯`ˠʰ˟˟˟ʹˡ˟ˠˤ˚`ŗÞĶʺsOÌ ˢʰˡ˟˟ʳ˟˟ -
ɮÞǣǢÌŸNjǼǻsNjŎ®ȖŘ_
ŗÞĶʹˡ˟ˠˤ˚ˢʰˡ˨˧ʰˤˣˣʳ˥˧ʺȖŘÞǼǣŸ¯`ŗÞĶʹˡ˟ˠˤ˚`ˠ˟ʺsOÌ - ˤ˟˟ʳ˟˟
ɮÞǣǻNjsǣȖNjɴ_ɚŘǼ¶s®ȖŘ_˚µNjŸɠǼÌ
ŗÞĶʹˡ˟ˠˤ˚ˡ˥ˤʰ˟ˠ˧ʳ˦ˠʺȖŘÞǼǣŸ¯`ŗÞĶʹˡ˟ˠˤ˚`ˠʰ˟˟˟ʺsOÌ - ˣʰ˟ˤ˟ʳ˟˟
Ë^®NµÞĶǼ®ȖŘ_ĵŸŘ¶ǻsNjŎƻĶŘ˚^ÞNjsOǼƻĶŘ˚µNjŸɠǼÌ
ŗÞĶʹˡ˟ˠˤ˚ˤʰ˥˦ˡʰˣˢ˧ʳˤˣʺȖŘÞǼǣŸ¯`ŗÞĶʹˡ˟ˠˤ˚`ˠ˟ʺsOÌ - ˠʰ˥˟˟ʳ˟˟
Ë^®NËÞ¶ÌÝŘǼsNjsǣǼ®ȖŘ_˚^ɴŘŎÞOƻĶŘ
ŗÞĶʹˡ˟ˠˤ˚˧ˠˤʰˡ˧ˠʳ˥ˣʺȖŘÞǼǣŸ¯`ŗÞĶʹˡ˟ˠˤ˚`ˠ˟ʺsOÌ - ˣ˟˟ʳ˟˟
ICICI Prudential STP - Growth
ŗÞĶʹˡ˟ˠˤ˚ˠʰ˦˧ˤʰ˨ˠˡʳ˟ˠʺȖŘÞǼǣŸ¯`ŗÞĶʹˡ˟ˠˤ˚`ˠ˟ʺsOÌ - ˤ˟˟ʳ˟˟
ICICI Prudential Ultra Short Term Plan - Dir - Gr
ŗÞĶʹˡ˟ˠˤ˚ˠˠʰˣ˦ˤʰ˨˥ˠʳˣˤʺȖŘÞǼǣŸ¯`ŗÞĶʹˡ˟ˠˤ˚`ˠ˟ʺsOÌ - ˠʰ˥˟˟ʳ˟˟
Indiabulls Ultra Short Term Fund
˦˦ʰˠ˦˨ʳ˥˟ˢʹˡ˟ˠˤ˚ˠˠˤʰˤˤ˥ʳˣ˧ʺȖŘÞǼǣŸ¯`ˠʰ˟˟˟ʹˡ˟ˠˤ˚`ˠʰ˟˟˟ʺsOÌ ˠʰˠ˟˟ʳ˟˟ ˠʰˤˤ˟ʳ˟˟
Reliance Short Term Fund
ŗÞĶʹˡ˟ˠˤ˚ˤʰˠˣˢʰˠˢ˨ʳ˥ˣʺȖŘÞǼǣŸ¯`ŗÞĶʹˡ˟ˠˤ˚`ˠ˟ʺsOÌ - ˠʰˢˤ˟ʳ˟˟
Religare Invesco Short Term Fund
ŗÞĶʹˡ˟ˠˤ˚ˤˢʰˠˣ˨ʳ˦ˡʺȖŘÞǼǣŸ¯`ŗÞĶʹˡ˟ˠˤ˚`ˠʰ˟˟˟ʺsOÌ - ˠʰ˟˟˟ʳ˟˟
Reliance Invesco Ultra Short Term Fund - Direct Plan
ŗÞĶʹˡ˟ˠˤ˚ˤˠʰˤ˧ˣʳ˥ˢʺȖŘÞǼǣŸ¯`ŗÞĶʹˡ˟ˠˤ˚`ˠʰ˟˟˟ʺsOÌ - ˠʰ˟˟˟ʳ˟˟
Tauras Short Term Income Fund
ŗÞĶʹˡ˟ˠˤ˚ˡ˟ʰˣ˟ˠʳˤ˥ʺȖŘÞǼǣŸ¯`ŗÞĶʹˡ˟ˠˤ˚`ˠʰ˟˟˟ʺsOÌ - ˤ˟˟ʳ˟˟
Tauras Ultra Short Term Bond Fund Super Institution
ˠ˥ʰˡ˨ˢʳˣ˧ˤʹˡ˟ˠˤ˚ˣˠʰˤ˨ˢʳˣˡʺȖŘÞǼǣŸ¯`ˠʰ˟˟˟ʹˡ˟ˠˤ˚`ˠʰ˟˟˟ʺsOÌ ˢ˟˟ʳ˟˟ ˦˟˟ʳ˟˟
Corporate Overview Performance Governance Financial Statements 161

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
` In Lacs

As at As at
March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ
ɮÞǣǻNjsǣȖNjɴ_ɚŘǼ¶s®ȖŘ_˚^ÞNjsOǼµNjŸɠǼÌ
ŗÞĶʹˡ˟ˠˤ˚ˠʰˣ˥ˤʳ˦ˠˣʺȖŘÞǼǣŸ¯`ŗÞĶʹˡ˟ˠˤ˚`ˠʰˣ˨˧ʳ˧˨ˠˣʺsOÌ - ˡˠʳ˨˦
NJsĶÞ¶NjsÝŘɚsǣOŸNNjs_ÞǼŷƼƼŸNjǼȖŘÞǼÞsǣ®ȖŘ_˚µNjŸɠǼÌʹNŷ˚ݵʺ
ŗÞĶʹˡ˟ˠˤ˚ˣ˥ʰ˥˦˧ʳˡˡˤʺȖŘÞǼǣŸ¯`ŗÞĶʹˡ˟ˠˤ˚`ˠʰˤ˥ˢʳˠ˨˦ˡʺsOÌ - ˦ˡ˨ʳ˥˦
TSTG Tata Short Term Bond Fund Plan A - Growth
ˠʰ˨ˤˢʰˣ˟˦ʳˢˡ˧ʹˡ˟ˠˤ˚ˠʰ˨ˤˢʰˣ˟˦ʳˢˡ˧ʺȖŘÞǼǣŸ¯`ˡˤʳˤ˨˥ˢʹˡ˟ˠˤ˚`ˡˤʳˤ˨˥ˢʺsOÌ ˤ˟˟ʳ˟˟ ˤ˟˟ʳ˟˟
Ë^®NËÞ¶ÌÝŘǼsNjsǣǼ®ȖŘ_˚^ɴŘŎÞOƻĶŘ˚µNjŸɠǼÌ
ˠʰ˟ˢ˦ʰˠˤ˟ʳ˦ˢ˨ʹˡ˟ˠˤ˚ˠʰ˟ˢ˦ʰˠˤ˟ʳ˦ˢ˨ʺȖŘÞǼǣŸ¯`ˣ˧ʳˡ˟˨˟ʹˡ˟ˠˤ˚`ˣ˧ʳˡ˟˨˟ʺsOÌ ˤ˟˟ʳ˟˟ ˤ˟˟ʳ˟˟
®NjŘĨĶÞŘÝŘ_ÞĵŸɠ^ȖNjǼÞŸŘ®ȖŘ_˚µNjŸɠǼÌ
ŗÞĶʹˡ˟ˠˤ˚˥ʰ˥ˣˤʰ˥ˡˡʳˠ˨˥ʺȖŘÞǼǣŸ¯`ŗÞĶʹˡ˟ˠˤ˚`ˠˤʳ˟ˣ˦ˤʺsOÌ - ˠʰ˟˟˟ʳ˟˟
ħŸǼĨĵŸɠ^ȖNjǼÞŸŘ®ȖŘ_
˨˨ʰ˧ˡˡʳ˟˥˦ʹˡ˟ˠˤ˚ŗÞĶʺȖŘÞǼǣŸ¯`ˠʰ˟˟˟ʹˡ˟ˠˤ˚`ŗÞĶʺsOÌ ˠʰ˦ˣˡʳˤˠ -
Tauras Dynamic Income Fund - Growth Option
˥˧ʰˢˡʰˣ˧˨ʳˠ˨˨ʹˡ˟ˠˤ˚ŗÞĶʺȖŘÞǼǣŸ¯`ˠ˟ʹˡ˟ˠˤ˚`ŗÞĶʺsOÌ ˠʰ˟˟ˠʳˣ˨ -
8,344.00 19,201.64
Aggregate amount of quoted investments ˧ʰˢˣˣʳ˟˟ ˠ˨ʰˡ˟ˠʳ˥ˣ
ōNjĨsǼɚĶȖsŸ¯LJȖŸǼs_ÞŘɚsǣǼŎsŘǼǣ ˧ʰˤ˧˨ʳˠˤ ˠ˨ʰˣ˨˦ʳˤ˦

As at As at
March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ
NOTE 17
ÝŗərŗǻŷNJÝrǢʹəĶȖs_ǼĶŸɠsNjŸ¯OŸǣǼŸNjŘsǼNjsĶÞǣEĶsɚĶȖsʺ
NJɠŘ_ƼOĨÞضŎǼsNjÞĶǣʹÞŘOĶȖ_Þض¶ŸŸ_ǣÞŘǼNjŘǣÞǼ`ˡʳˠ˨ʹˡ˟ˠˤ˚`ŗÞĶʺʺ ˤʰ˟ˢˣʳˠ˧ ˤʰˡˢ˧ʳ˨˨
ɟŸNjĨÞŘƼNjŸ¶Njsǣǣ ˠʰˤˣ˦ʳ˦ˡ ˠʰˢ˦ˠʳˡ˧
Finished goods manufactured ˧ʰ˟˧˨ʳˣˣ ˦ʰˢ˨ˤʳˠˡ
ǻNj_s_µŸŸ_ǣʹÞŘOĶȖ_Þض¶ŸŸ_ǣÞŘǼNjŘǣÞǼ`ˡˤˢʳ˥˥ʹˡ˟ˠˤ˚` ˢˡˡʳ˧˨ʺʺ ˢʰˠˤˣʳˢˠ ˣʰˠˠˢʳ˟˨
ǢǼŸNjsǣʰŷƼsNjǼÞضǣȖƼƼĶÞsǣŘ_ǣƼNjsƼNjǼǣ ˣˢ˨ʳ˧ˤ ˣ˟ˠʳ˧˧
18,265.50 18,520.36

As at As at
March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ

NOTE 18
TRADE RECEIVABLES
Unsecured
ʺ ŷȖǼǣǼŘ_Þض¯ŸNjƼsNjÞŸ_sɮOss_ÞضǣÞɮŎŸŘǼÌǣ¯NjŸŎǼÌs_ǼsǼÌsɴNjs_Ȗs¯ŸNjƼɴŎsŘǼ
Considered good ˧˦˥ʳˣ˟ ˧˦ˡʳˣ˨
Considered doubtful ˠʰˡ˟˟ʳˤˣ ˠʰˢ˨˦ʳˠˠ
 ĵsǣǣʲƻNjŸɚÞǣÞŸŘ¯ŸNj_ŸȖEǼ¯ȖĶNjsOsÞɚEĶsǣ ʹˠʰˡ˟˟ʳˤˣʺ ʹˠʰˢ˨˦ʳˠˠʺ
876.40 872.49
Eʺ ŷǼÌsNjNjsOsÞɚEĶsʰOŸŘǣÞ_sNjs_¶ŸŸ_ ˧ʰˤˢˣʳ˥ˢ ˣʰ˧˥˨ʳˣˠ
9,411.03 5,741.90
162 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
` In Lacs

NON CURRENT CURRENT


As at As at As at As at
March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ

NOTE 19
CASH AND BANK BALANCES
Cash in hand - - ˢ˦ʳ˧ˣ ˣˡʳ˥˨
DĶŘOsɠÞǼÌEŘĨǣ˚NȖNjNjsŘǼOOŸȖŘǼ - - ˠʰ˦˥ˣʳ˨˥ ˡʰˣ˦˦ʳ˨˦
˚ ^sƼŸǣÞǼ OOŸȖŘǼ ʹŷNjÞ¶ÞŘĶ ŎǼȖNjÞǼɴ Ÿ¯ Ķsǣǣ - - ˣˡˤʳˢˡ -
ǼÌŘǼÌNjssŎŸŘǼÌǣʺ
Unclaimed dividend accounts - - ˠˢ˨ʳˡ˧ ˤˢʳˢˣ
- - 2,367.40 2,574.00
Other bank balances
^sƼŸǣÞǼ OOŸȖŘǼ ʹŷNjÞ¶ÞŘĶ ŎǼȖNjÞǼɴ Ÿ¯ ŎŸNjs - - ˡ˦ˢʳ˥ˢ ˤ˦ˡʳ˟ˢ
ǼÌŘǼÌNjssŎŸŘǼÌǣʺ
Deposits with original maturity for more than ˨ˢʳ˧˦ ˡˤ˟ʳ˨ˢ ˢʰ˦ˣˤʳ˥˨ ˣʰˤˡˢʳ˦˟
12 months*
ŎŸȖŘǼ_ÞǣOĶŸǣs_ȖŘ_sNj˄ŸǼÌsNjǣǣsǼǣ˅ʹŗŸǼsˠˤʺ ʹ˨ˢʳ˧˦ʺ ʹˡˤ˟ʳ˨ˢʺ ʹˡ˥˥ʳ˧˧ʺ ʹˡ˟˦ʳ˟ˣʺ
- - 3,752.44 4,888.69
- - 6,119.84 7,462.69

ˎÝŘOĶȖ_sǣ_sƼŸǣÞǼǣƼNjŸɚÞ_s_ǣǣsOȖNjÞǼÞsǣ¶ÞŘǣǼEŘĨ¶ȖNjŘǼssǣʰ_sEsŘǼȖNjsNjs_sŎƼǼÞŸŘNjsǣsNjɚsǣʰƼsNj¯ŸNjŎŘOs¶ȖNjŘǼssʰŎNj¶ÞŘŎŸŘsɴŘ_
earnest money deposits in relation to tenders from railway authorities `ˢʰˡ˟˥ʳ˟ˣʹˡ˟ˠˤ˚`ˡʰ˧ˣ˦ʳˠ˦ʺ

2015-16 2014-15
NOTE 20
OTHER OPERATING INCOME
rɮƼŸNjǼÞŘOsŘǼÞɚsǣ ˡˡʳˠ˟ ˡˤʳ˨ˡ
Agricultural Income ˥ʳ˟ˤ ˣʳˡ˧
Sale of scrap ˢˤʳ˟ˣ ˠˢʳˢ˟
ĵÞEÞĶÞǼÞsǣŘŸĶŸŘ¶sNjNjsLJȖÞNjs_ɠNjÞǼǼsŘEOĨʹŘsǼʺ - ˢ˧˨ʳˠ˦
^Þ¯¯sNjsŘǼÞĶǻNjÞ¯¯ǼŸɠNj_ǣƼŸɠsNjŘ_¯ȖsĶsɮƼsŘǣsǣŸ¯sNjĶÞsNjɴsNjǣ - ˣ˟˟ʳˢˠ
Others ˠˡ˟ʳˡ˟ ˠˡˠʳ˟ˤ
183.39 954.03

2015-16 2014-15
NOTE 21
OTHER INCOME
Lease rent income ˧ʳˤˡ ˧ʳˡ˨
ƻNjŸʩǼŸŘǣĶsŸ¯OȖNjNjsŘǼÞŘɚsǣǼŎsŘǼǣ ˨ˢˣʳ˦ˠ ˤ˟˟ʳ˨ˢ
ƻNjŸʩǼŸŘǣĶsŸ¯ʩɮs_ǣǣsǼǣ ˣ˧ʳ˨˟ ˠ˥ʳˠ˦
®ŸNjsÞ¶ŘsɮOÌضsʪȖOǼȖǼÞŸŘ¶ÞŘʹŘsǼʺ ˠˣʳˣ˦ ˠˢʳˤˠ
Miscellaneous income ˠ˧ʳ˧ˤ ˡˢʳˤˤ
1,025.45 562.45
Corporate Overview Performance Governance Financial Statements ˠ˥ˢ

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
` In Lacs

2015-16 2014-15
NOTE 22
COST OF RAW MATERIALS AND COMPONENTS CONSUMED
ŷƼsŘÞضǣǼŸOĨ ˤʰˡˢ˧ʳ˨˨ ˣʰˣˢ˦ʳ˦˦
__ʲNŸǣǼŸ¯ƼȖNjOÌǣsǣ ˣ˨ʰˣˤ˧ʳˠ˟ ˣ˦ʰˤ˦˦ʳˤ˥
54,697.09 52,015.33
ĵsǣǣʲNĶŸǣÞضǣǼŸOĨ ˤʰ˟ˢˣʳˠ˧ ˤʰˡˢ˧ʳ˨˨
49,662.91 46,776.34

2015-16 2014-15
NOTE 23
(INCREASE)/ DECREASE IN INVENTORIES OF FINISHED GOODS,WORK IN PROGRESS AND
TRADED GOODS
Closing stock
Finished goods ˧ʰ˟˧˨ʳˣˣ ˦ʰˢ˨ˤʳˠˡ
Traded Goods ˢʰˠˤˣʳˢˠ ˣʰˠˠˢʳ˟˨
ɟŸNjĨÞŘƼNjŸ¶Njsǣǣ ˠʰˤˣ˦ʳ˦ˡ ˠʰˢ˦ˠʳˡ˧
12,791.47 12,879.49
Opening stock
Finished goods ˦ʰˢ˨ˤʳˠˡ ˥ʰˠˤ˧ʳ˦˥
Traded Goods ˣʰˠˠˢʳ˟˨ ˣʰ˧˧˨ʳˡ˟
ɟŸNjĨÞŘƼNjŸ¶Njsǣǣ ˠʰˢ˦ˠʳˡ˧ ˠʰˣ˟˦ʳˠ˨
12,879.49 12,455.15
Sub-total (A) 88.02 (424.34)
(Increase)/ decrease in excise duty
rɮOÞǣs_ȖǼɴŸŘOĶŸǣÞضǣǼŸOĨ ˠ˦ˤʳ˦˧ ˠˣ˧ʳˤ˟
rɮOÞǣs_ȖǼɴŸŘŸƼsŘÞضǣǼŸOĨ ˠˣ˧ʳˤ˟ ˡˣ˟ʳˠˠ
Sub-total (B) (27.28) 91.61
Total (A-B) 115.30 (515.95)

2015-16 2014-15
NOTE 24
EMPLOYEE BENEFITS EXPENSES
ǢĶNjÞsǣʰɠ¶sǣŘ_EŸŘȖǣ ˠˡʰ˥˟˦ʳˢ˧ ˠˠʰˣ˧˦ʳ˦ˣ
NŸŘǼNjÞEȖǼÞŸŘǼŸƼNjŸɚÞ_sŘǼŘ_ŸǼÌsNj¯ȖŘ_ǣʹŗŸǼsˡ˧ʺ ˧˦˥ʳˠˤ ˦˥ˤʳ˦˟
µNjǼȖÞǼɴʹŗŸǼsˡ˧ʺ ˣˣ˥ʳ˦ˠ ˣˢˣʳˣˡ
ǢǼ¯¯ɠsĶ¯NjssɮƼsŘǣsǣ ˦˟ˡʳˡˣ ˦ˢˠʳ˟ˢ
^ÞNjsOǼŸNjǣ˅NjsŎȖŘsNjǼÞŸŘ ˧˟˦ʳˡ˟ ˧˟ˠʳ˨ˣ
Commission to directors ˦˨˨ʳ˨˦ ˤ˨ˣʳˠ˟
Field staff incentives ˢ˦˟ʳˤ˦ ˡˠˠʳˡˠ
Sub-total (A) 16,610.22 15,026.14
rŎƼĶŸɴssǣǼŸOĨŸƼǼÞŸŘsɮƼsŘǣsǣʹŗŸǼsˢ˥ʺ ˠʰ˦ˤ˟ʳˡ˥ ˡʰ˧˦ˠʳˠˢ
Sub-total (B) 1,750.26 2,871.13
Total (A+B) 18,360.48 17,897.27
164 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
` In Lacs

2015-16 2014-15
NOTE 25
OTHER EXPENSES
Conversion charges ˧˥ˢʳ˦ˣ ˠ˥ˢʳ˦ˣ
ƻŸɠsNjŘ_¯ȖsĶsɮƼsŘǣsǣ ˡʰ˥ˤ˟ʳˢˡ ˡʰ˨ˡˡʳˣˤ
Rent ˡʰ˟ˢˣʳ˨˨ ˠʰ˧˧˥ʳ˦˦
Insurance ˠ˟ˡʳ˧˧ ˥˧ʳ˨˧
Repairs and maintenance
- Building ˠˡˣʳˡˢ ˠ˧˧ʳ˟˧
- Plant and machinery ˡ˨ˢʳˠ˟ ˢˡ˥ʳ˨˨
- Others ˡ˦ˣʳˣ˟ ˡˡ˧ʳ˧ˡ
Consumption of stores and spares ˦ˢˢʳˠˤ ˥ˡ˥ʳˢˠ
Research and development ˠˤ˟ʳˢˤ ˤˡʳˤ˟
rɮOÞǣs_ȖǼɴŸŘOƼǼÞɚsOŸŘǣȖŎƼǼÞŸŘ ˦ˠ˟ʳˣˤ ˥ˠ˦ʳˡ˨
Printing and stationery ˨˧ʳˢˢ ˦˦ʳ˦ˡ
Communication costs ˢˣ˨ʳ˨ˢ ˢˡˡʳˣ˟
Legal and professional fees ˠʰˡˢˠʳˣ˥ ˠʰˠˣˠʳˠ˥
NJǼsǣŘ_Ǽɮsǣ ˥ˢ˟ʳˡ˟ ˤˣˡʳ˨ˤ
^ÞNjsOǼŸNjǣ˅ǣÞǼǼÞض¯ssǣ ˦ʳ˦˟ ˤʳ˥˟
əsÌÞOĶsŎÞŘǼsŘŘOs ˢˣˣʳˠˡ ˢ˥˧ʳ˦˧
Donation ˥ʳ˥ˠ ˠˤʳˢ˨
ĵŸǣǣŸŘʩɮs_ǣǣsǼǣ_ÞǣONj_s_ ˠˠˤʳ˟˧ ˠˢˣʳˠˣ
Provision for doubtful debts ˡˢʳ˨ˠ ˠˡˢʳˡˤ
Bad debt written off - ˥ʳ˨˥
Provision for doubtful advances ˦˟ʳ˟˟ ˠˣʳˣˢ
_ɚsNjǼÞǣsŎsŘǼŘ_ǢĶsǣƻNjŸŎŸǼÞŸŘsɮƼsŘǣs ˡ˟ʰˠˤ˥ʳˡ˟ ˠ˧ʰ˟˨˥ʳˤ˧
®NjsÞ¶ÌǼʰÌŘ_ĶÞضŘ_¯ŸNjɠNj_ÞضOÌNj¶sǣ ˨ʰˤ˧˟ʳ˦˨ ˧ʰ˥˨ˢʳˡˤ
®ÞsĶ_ǣǼ¯¯sɮƼsŘǣsǣ ˠʰˣˠˠʳˣˠ ˠʰˡˡˤʳ˦ˠ
Travelling and conveyance ˣˠ˟ʳˢˠ ˢ˧˨ʳ˟˨
Royalty ˡ˧˧ʳˢˢ ˡˣˤʳˢˠ
NŸNjƼŸNjǼsǣŸOÞĶNjsǣƼŸŘǣÞEÞĶÞǼɴsɮƼsŘǣsǣʹŗŸǼsˢˠʺ ˡˢˣʳ˧ˣ ˠˡˠʳˢˢ
ōÞǣOsĶĶŘsŸȖǣsɮƼsŘǣsǣ ˠʰˣ˦˦ʳˠˡ ˨ˢˢʳˠˡ
44,373.95 39,539.10

2015-16 2014-15
NOTE 26
FINANCE COST
ÝŘǼsNjsǣǼŸŘǼsNjŎĶŸŘŘ_EŘĨŸɚsNj_Nj¯Ǽ ˠˡ˥ʳ˦ˤ ˠ˥ˣʳ˨ˠ
Interest on debentures ˣˣ˧ʳˠ˟ ˠʰˠˢ˨ʳ˦ˤ
Other borrowing cost ˡ˧ʳˣˤ ˦ˡʳˠ˟
603.30 1,376.76

2015-16 2014-15
NOTE 27
INTEREST INCOME
ÝŘǼsNjsǣǼŸŘʩɮs__sƼŸǣÞǼ ˣˡ˥ʳˢ˨ ˢ˧ˡʳˢ˧
Interest on inter-corporate deposit - ˣˡʳˣˤ
Interest on others ˧ʳˡ˧ ˣʳ˧ˢ
434.67 429.66
Corporate Overview Performance Governance Financial Statements 165

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
` In Lacs
NOTE 28 - EMPLOYEE BENEFIT
ʹÞʺ ^sʩŘs_DsŘsʩǼƻĶŘǣ˚
 ǻÌsµNjŸȖƼÌǣ_sʩŘs_EsŘsʩǼ¶NjǼȖÞǼɴƼĶŘʳrɚsNjɴsŎƼĶŸɴssɠÌŸÌǣOŸŎƼĶsǼs_ʩɚsɴsNjǣŸNjŎŸNjsŸ¯ǣsNjɚÞOs¶sǼǣ¶NjǼȖÞǼɴŸŘ_sƼNjǼȖNjs
Ǽˠˤ_ɴǣǣĶNjɴʹĶǣǼ_NjɠŘǣĶNjɴʺ¯ŸNjsOÌOŸŎƼĶsǼs_ɴsNjŸ¯ǣsNjɚÞOsʳǻÌsǣOÌsŎsÞǣ¯ȖŘ_s_ɠÞǼÌĵÞ¯sÝŘǣȖNjŘOsNŸNjƼŸNjǼÞŸŘŸ¯ÝŘ_Þʳ
 ǻÌs¯ŸĶĶŸɠÞضǼEĶsǣǣȖŎŎNjÞǣsǼÌsOŸŎƼŸŘsŘǼǣŸ¯ŘsǼEsŘsʩǼsɮƼsŘǣsNjsOŸ¶ŘÞǣs_ÞŘǼÌsǢǼǼsŎsŘǼƼNjŸʩǼŘ_ĶŸǣǣŘ_ǼÌs¯ȖŘ_s_ǣǼǼȖǣ
Ř_ŎŸȖŘǼǣNjsOŸ¶ŘÞǣs_ÞŘǼÌsEĶŘOsǣÌssǼ¯ŸNjǼÌsNjsǣƼsOǼÞɚsƼĶŘǣʳ
2015-16 2014-15
Gratuity Gratuity
Funded, except for certain subsidiaries
ɠÌsNjsÞǼÞǣŘŸŘ¯ȖŘ_s_
(A) Summary of the Actuarial Assumptions
Mortality Indian Assured Lives Indian Assured Lives
ōŸNjǼĶÞǼɴʹˡ˟˟˥˚˟˧ʺȕĶǼ ōŸNjǼĶÞǼɴʹˡ˟˟˥˚˟˧ʺȕĶǼ
Discount rate ˦ʳ˧˟̇ ˦ʳ˧˟̇
Rate of increase in compensation ˧ʳ˟˟̇ ˧ʳ˟˟̇
Withdrawal rates ˠ̇˚ˠ˟̇ ˠ̇˚ˠ˟̇
 NJǼsŸ¯NjsǼȖNjŘʹsɮƼsOǼs_ʺŸŘƼĶŘǣǣsǼǣ ˧ʳ˟˟̇˚˧ʳˤ˟̇ ˧ʳ˦ˤ̇˚˨ʳ˟˟̇
 ǻÌssǣǼÞŎǼsǣŸ¯¯ȖǼȖNjsǣĶNjɴÞŘONjsǣsǣʰOŸŘǣÞ_sNjs_ÞŘOǼȖNjÞĶɚĶȖǼÞŸŘǼĨsOOŸȖŘǼŸ¯
ÞŘʪǼÞŸŘʰǣsŘÞŸNjÞǼɴʰƼNjŸŎŸǼÞŸŘŘ_ŸǼÌsNjNjsĶsɚŘǼ¯OǼŸNjǣʰǣȖOÌǣǣȖƼƼĶɴŘ__sŎŘ_ÞŘǼÌs
sŎƼĶŸɴŎsŘǼŎNjĨsǼʳ
 ǻÌs ŸɚsNjĶĶ sɮƼsOǼs_ NjǼs Ÿ¯ NjsǼȖNjŘ ŸŘ ǣǣsǼǣ Þǣ _sǼsNjŎÞŘs_ Eǣs_ ŸŘ ǼÌs ŎNjĨsǼ ƼNjÞOs
ƼNjsɚÞĶÞضŸŘǼÌǼ_ǼsʰƼƼĶÞOEĶsǼŸǼÌsƼsNjÞŸ_ŸɚsNjɠÌÞOÌǼÌsŸEĶÞ¶ǼÞŸŘÞǣǼŸEsǣsǼǼĶs_ʳ
(B) Changes in present value of obligations (PVO)
 ƻəŷǼEs¶ÞŘŘÞضŸ¯ƼsNjÞŸ_ ˡʰ˟ˡˠʳ˧˥ ˠʰ˦˟ˠʳ˧ˡ
Interest cost ˠˤ˧ʳˤˠ ˠˤˣʳ˨ˣ
Current Service Cost ˡ˟ˡʳˡˣ ˡ˟˨ʳˡˣ
 DsŘsʩǼǣƻÞ_ ʹˢˢˣʳ˦ˠʺ ʹˠˡ˨ʳ˧ˠʺ
 OǼȖNjÞĶʹ¶ÞŘʺˀĶŸǣǣŸŘŸEĶÞ¶ǼÞŸŘ ˠˠˢʳˢˣ ˧ˤʳ˥˦
 ƻəŷǼsŘ_Ÿ¯ƼsNjÞŸ_ ˡʰˠ˥ˠʳˡˣ ˡʰ˟ˡˠʳ˧˥
(C) Changes in fair value of plan assets
Fair value of plan assets at the beginning of period ˥ˣ˟ʳ˨˨ ˥ˢ˧ʳ˥ˡ
 _ĠȖǣǼŎsŘǼǼŸŷƼsŘÞض®ÞNjəĶȖsŸ¯ƼĶŘǣǣsǼǣ - ʹˠ˧ʳ˦˧ʺ
 rɮƼsOǼs_NjsǼȖNjŘŸŘƼĶŘǣǣsǼǣ ˤ˥ʳˣˢ ˤˣʳˤˤ
Contributions ˦ʳ˨˨ ˠˠ˨ʳˢ˨
 DsŘsʩǼƼÞ_ ʹˢ˟˦ʳˣˡʺ ʹˠˠ˥ʳ˨˨ʺ
 OǼȖNjÞĶ¶ÞŘˀʹĶŸǣǣʺŸŘƼĶŘǣǣsǼǣ ʹˡ˥ʳ˧˦ʺ ʹˢˤʳ˧˟ʺ
Fair value of plan assets at end of period ˢ˦ˠʳˠˡ ˥ˣ˟ʳ˨˨
(D) Net Assets/(Liabilities) recognised in the balance sheet
 ƻəŷǼsŘ_Ÿ¯ƼsNjÞŸ_ ʹˡʰˠ˥ˠʳˡˣʺ ʹˡʰ˟ˡˠʳ˧˥ʺ
Fair value of plan assets at end of period ˢ˦ˠʳˠˡ ˥ˣ˟ʳ˨˨
 ®ȖŘ_s_ǣǼǼȖǣʹ_sʩOÞǼÞŘ¯ÞNjɚĶȖsŸ¯ƼĶŘǣǣsǼǣŸɚsNjƻəŷʺ ʹˠʰ˦˨˟ʳˠˡʺ ʹˠʰˢ˧˟ʳ˧˦ʺ
 ŗsǼǣǣsǼǣˀʹĵÞEÞĶÞǼɴʺNjsOŸ¶ŘÞǣs_ÞŘǼÌsEĶŘOsǣÌssǼ ʹˠʰ˦˨˟ʳˠˡʺ ʹˠʰˢ˧˟ʳ˧˦ʺ
ʹrʺ rɮƼsŘǣsǣNjsOŸ¶ŘÞǣs_ÞŘǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣ
Current service cost ˡ˟ˡʳˡˣ ˡ˟˨ʳˡˣ
Interest cost ˠˤ˧ʳˤˠ ˠˤˣʳ˨ˣ
 rɮƼsOǼs_NjsǼȖNjŘŸŘƼĶŘǣǣsǼǣ ʹˤ˥ʳˣˢʺ ʹˤˣʳˤˤʺ
 ŗsǼOǼȖNjÞĶʹµÞŘʺˀĵŸǣǣNjsOŸ¶ŘÞǣs_¯ŸNjǼÌsƼsNjÞŸ_ ˠˣ˟ʳˡˠ ˠˡˠʳˣ˦
Gratuity borne by the Company ˡʳˠ˧ ˢʳˢˡ
 rɮƼsŘǣsNjsOŸ¶ŘÞǣs_ÞŘǼÌsǣǼǼsŎsŘǼŸ¯ƼNjŸʩǼŘ_ĶŸǣǣ ˣˣ˥ʳ˦ˠ ˣˢˣʳˣˡ
(F) The major categories of plan assets as a percentage of the fair value of total plan
ǣǣsǼǣNjsǣ¯ŸĶĶŸɠǣʲ
Investment with insurer ˠ˟˟ʳ˟˟̇ ˠ˟˟ʳ˟˟̇
166 Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
` in Lacs
NOTE 28 - EMPLOYEE BENEFIT (contd.)

ʹµʺ ŎŸȖŘǼǣ¯ŸNjǼÌsOȖNjNjsŘǼŘ_ƼNjsɚÞŸȖǣ¯ŸȖNjƼsNjÞŸ_ǣNjsǣ¯ŸĶĶŸɠǣʲ

April to March 16 April to March 15 April to March 14 ƼNjÞĶǼŸōNjOÌˠˢ April to March 12

^sʩŘs_ EsŘsʩǼ ˡʰˠ˥ˠʳˡˣ ˡʰ˟ˡˠʳ˧˥ ˠʰ˦˟ˠʳ˧ˡ ˠʰ˥ˣˡʳ˨˦ ˠʰˤ˟˟ʳ˥˥


obligation

Plan assets ˢ˦ˠʳˠˡ ˥ˣ˟ʳ˨˨ ˥ˢ˧ʳ˥ˡ ˥ˢ˥ʳ˟ˡ ˥˦˦ʳˡˤ

ǢȖNjƼĶȖǣˀʹ^sʩOÞǼʺ ˠʰ˦˨˟ʳˠˡ ˠʰˢ˧˟ʳ˧˦ ˠʰ˟˥ˢʳˡ˟ ˠʰ˟˟˥ʳ˨ˤ ˧ˡˢʳˣˠ

rɮƼsNjÞsŘOs_ĠȖǣǼŎsŘǼǣ ˠˠˢʳˢˣ ˧ˤʳ˥˦ ˣˢʳˡˠ ˠˣʳˣˣ ˤ˧ʳ˨ˡ


on plan liabilities

rɮƼsNjÞsŘOs_ĠȖǣǼŎsŘǼǣ ʹˡ˥ʳ˧˦ʺ ʹˢˤʳ˧˟ʺ ˡʳˣˣ ˠʳˡ˧ ʹˢ˨ʳ˦˟ʺ


on plan assets

(H) ǻÌsµNjŸȖƼsɮƼsOǼǣǼŸOŸŘǼNjÞEȖǼs`ˢ˟˟ʳ˟˟ʹˡ˟ˠˤ˚`ŗÞĶʺǼŸ¶NjǼȖÞǼɴ¯ȖŘ_Ř_`ˢˤʳˤˢʹˡ˟ˠˤ˚`ˢˣʳ˥ˢʺǼŸǢȖƼsNjŘŘȖǼÞŸŘ¯ȖŘ_ÞŘǼÌsŘsɮǼɴsNjʳ

ʹÞÞʺ ^sʩŘs_NŸŘǼNjÞEȖǼÞŸŘƻĶŘǣ˚

Amount of `˨˦ˢʳˢˤʹˡ˟ˠˤ˚`˧˦˟ʳ˥ˣʺÞǣNjsOŸ¶ŘÞǣs_ǣŘsɮƼsŘǣsŘ_ÞŘOĶȖ_s_ÞŘŗŸǼsˡˣÞŘǼÌsǢǼǼsŎsŘǼŸ¯ƻNjŸʩǼŘ_ĵŸǣǣʳ

NOTE - 29 SEGMENT REPORTING

Business segments:

ǻÌsƼNjÞŎNjɴǣs¶ŎsŘǼŸ¯ǼÌsµNjŸȖƼÌǣEssŘ_sǼsNjŎÞŘs_ŸŘǼÌsEǣÞǣŸ¯EȖǣÞŘsǣǣǣs¶ŎsŘǼʳǻÌsµNjŸȖƼÞǣŸNj¶ŘÞʊs_ÞŘǼŸ¯ŸȖNjEȖǣÞŘsǣǣǣs¶ŎsŘǼǣ
˚ǢŸƼǣŘ_^sǼsNj¶sŘǼǣʰËŸŎsNNjsʰĵȖŘ_NjɴǣsNjɚÞOsǣŘ_ŷǼÌsNjǣʳǢs¶ŎsŘǼǣÌɚsEssŘÞ_sŘǼÞʩs_ǼĨÞضÞŘǼŸOOŸȖŘǼǼÌsŘǼȖNjsŸ¯ǼÌsƼNjŸ_ȖOǼǣ
Ř_ǣsNjɚÞOsǣʰǼÌs_Þ¯¯sNjÞضNjÞǣĨǣŘ_NjsǼȖNjŘǣʰǼÌsŸNj¶ŘÞʊǼÞŸŘǣǼNjȖOǼȖNjsŘ_ǼÌsÞŘǼsNjŘĶNjsƼŸNjǼÞضǣɴǣǼsŎʳ

ǢŸƼǣŘ_^sǼsNj¶sŘǼǣÞŘOĶȖ_sǣ¯ENjÞOɠÌÞǼsŘsNjǣʰ¯ENjÞO_sǼsNj¶sŘǼǣʰ_ÞǣÌɠǣÌENjŘ_ǣŸƼǣÞŘOĶȖ_ÞضɴȖNjɚs_ÞOǣŸƼǣʳËŸŎsNNjsƼNjŸ_ȖOǼǣÞŘOĶȖ_s
ÞŘOsŘǣsǣǼÞOĨǣʰ_ÌŸŸƼʰŎŸǣLJȖÞǼŸNjsƼsĶĶsŘǼǣŘ_ǣONjȖEEsNjʳĵȖŘ_NjɴǣsNjɚÞOsǣÞŘOĶȖ_s_Njɴ˚OĶsŘÞض˓ƼNjŸɚÞ_ÞضĶÞŘsŘŸŘNjsŘǼĶʳŷǼÌsNjǣÞŘOĶȖ_sǣDŸ_ɴ
ONjsʰǻsŘ_OŸ¯¯ssʳ

Secondary segment:

ǻÌsµNjŸȖƼŎÞŘĶɴOǼsNjǣǼŸǼÌsŘss_ǣŸ¯ǼÌs_ŸŎsǣǼÞOŎNjĨsǼʳǻÌssɮƼŸNjǼǼȖNjŘŸɚsNjÞǣŘŸǼǣÞ¶ŘÞʩOŘǼÞŘǼÌsOŸŘǼsɮǼŸ¯ǼŸǼĶǼȖNjŘŸɚsNjʳ

Segment revenue and result:

ǻÌsÞŘOŸŎsˀsɮƼsŘǣsǼÌǼNjsŘŸǼ_ÞNjsOǼĶɴǼǼNjÞEȖǼEĶsǼŸǼÌsEȖǣÞŘsǣǣǣs¶ŎsŘǼǣNjsǣÌŸɠŘǣȖŘĶĶŸOǼs_OŸNjƼŸNjǼsOŸǣǼǣʳ

Segment assets and liabilities:

Ǣs¶ŎsŘǼǣǣsǼǣÞŘOĶȖ_sĶĶŸƼsNjǼÞضǣǣsǼǣȖǣs_Eɴǣs¶ŎsŘǼŘ_OŸŘǣÞǣǼƼNjÞŘOÞƼĶĶɴŸ¯_sEǼŸNjǣʰÞŘɚsŘǼŸNjÞsǣʰ_ɚŘOsǣŘ_ʩɮs_ǣǣsǼǣʳǣǣsǼǣǼ
OŸNjƼŸNjǼsĶsɚsĶNjsŘŸǼĶĶŸOEĶsǼŸǣs¶ŎsŘǼǣŸŘNjsǣŸŘEĶsEǣÞǣŘ_ǼÌȖǣǼÌsǣŎsÌɚsŘŸǼEssŘĶĶŸOǼs_ʳ

Ǣs¶ŎsŘǼĶÞEÞĶÞǼÞsǣÞŘOĶȖ_sĶĶŸƼsNjǼÞضĶÞEÞĶÞǼÞsǣŘ_OŸŘǣÞǣǼƼNjÞŘOÞƼĶĶɴŸ¯ONjs_ÞǼŸNjǣŘ_OONjȖs_ĶÞEÞĶÞǼɴʳ
NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
` in Lacs
NOTE - 29 SEGMENT REPORTING (contd.)
Information about Business Segments
Soaps and Detergents Home care Laundry Services Others Eliminations Total
2015-16 2014-15 2015-16 2014-15 2015-16 2014-15 2015-16 2014-15 2015-16 2014-15 2015-16 2014-15
Revenue
rɮǼsNjŘĶNJsɚsŘȖs ˠˠ˨ʰ˨ˤˠʳ˧ˢ ˠˠˠʰ˦˨ˢʳ˧˦ ˢ˧ʰˤ˨˦ʳˤ˥ ˢˡʰ˦ˠˡʳ˟˟ ˣʰˢ˟ˤʳ˨ˣ ˣʰˡ˟ˤʳ˟ˡ ˠʰ˥ˠ˧ʳ˟˟ ˠʰ˧ˠ˧ʳˤ˧ - - ˠ˥ˣʰˣ˦ˢʳˢˢ ˠˤ˟ʰˤˡ˨ʳˣ˦
Inter Segment Revenue ˢˤʳˢ˨ - ˠˣˣʳˣˣ ˤˠ˦ʳ˥˨ - - - - ʹˠ˦˨ʳ˧ˢʺ ʹˤˠ˦ʳ˥˨ʺ - -
Net Revenue 119,987.22 111,793.87 38,742.00 33,229.69 4,305.94 4,205.02 1,618.00 1,818.58 (179.83) (517.69) 164,473.33 150,529.47
Segment results ˠ˨ʰˣˠ˟ʳ˧˨ ˠˣʰ˦˦ˠʳˢˣ ˡʰˠ˧˥ʳˡ˧ ˧ˡˡʳˣ˧ ʹˠʰˣˤˣʳˠˢʺ ʹˠʰˢ˟˦ʳ˟ˢʺ ˡˢˠʳˠ˟ ˡ˥ˣʳ˧˨ - - ˡ˟ʰˢ˦ˣʳˠˣ ˠˣʰˤˤˠʳ˥˧
ȕŘĶĶŸOǼs_sɮƼsŘ_ÞǼȖNjs ʹˠʰˤ˟ˣʳ˟˨ʺ ʹˠʰˤˢˠʳ˧ˠʺ
Unallocated income ˠʰˣˤ˨ʳˣ˨ ˠʰ˟ˠ˧ʳ˦ˤ
ÝŘǼsNjsǣǼ˓ʩŘŘOssɮƼsŘǣsǣ ʹ˥˟ˢʳˢ˟ʺ ʹˠʰˢ˦˥ʳ˦˥ʺ
ƻNjŸʩǼEs¯ŸNjssɮOsƼǼÞŸŘĶÞǼsŎǣʰƼNjÞŸNjƼsNjÞŸ_ÞǼsŎǣŘ_Ǽɮ 19,726.24 12,661.86
rɮOsƼǼÞŸŘĶÝǼsŎǣ - ˡ˟˨ʳˠ˧
ƻNjŸʩǼEs¯ŸNjsƼNjÞŸNjƼsNjÞŸ_ÞǼsŎǣŘ_Ǽɮ 19,726.24 12,452.68
Corporate Overview

ǻɮrɮƼsŘǣs ʹˢʰ˨ˢ˟ʳˣ˨ʺ ʹˢˤˣʳˡˤʺ


ƻNjŸʩǼ¯ǼsNjǼɮEs¯ŸNjsōÞŘŸNjÞǼɴÝŘǼsNjsǣǼ 15,795.75 12,098.43
ōÞŘŸNjÞǼɴÝŘǼsNjsǣǼʹǣÌNjsŸ¯ĶŸǣǣʺ ˟ʳˡ˨ ˠˢʳ˨˥
ƻNjŸʩǼ¯ǼsNjǼɮ¯ǼsNjōÞŘŸNjÞǼɴÝŘǼsNjsǣǼ 15,796.04 12,112.39
Other Information
Segment assets ˣ˟ʰ˟˧˦ʳˠˣ ˢ˧ʰˠˠ˨ʳˡˣ ˠˤʰ˧˨ˤʳˠ˟ ˠˢʰˤ˥ˡʳ˧˦ ˦ʰ˟˨˨ʳ˨ˠ ˦ʰ˥˦˨ʳˣ˦ ˥ˣˤʳ˦˟ ˤˢ˦ʳˣˠ - - ˥ˢʰ˦ˡ˦ʳ˧ˤ ˤ˨ʰ˧˨˧ʳ˨˨
Unallocated assets
Performance

ˠˠˡʰ˨˨˥ʳ˧ˤ ˠˡˠʰ˦˦ˢʳˤ˟
Total assets 176,724.70 181,672.49
Segment liabilities ˠˣʰ˨ˢˤʳ˧˧ ˠˢʰ˟˧ˤʳ˧˥ ˦ʰˢ˨˦ʳ˥˦ ˤʰ˟˧˧ʳˢˣ ˥˧˨ʳ˟ˤ ˦˨˦ʳ˧˧ ˠ˦ˣʳˢˢ ˨˦ʳ˥ˣ - - ˡˢʰˠ˨˥ʳ˨ˢ ˠ˨ʰ˟˥˨ʳ˦ˡ
Unallocated liabilities ˥˧ʰ˦ˣˣʳˢ˦ ˧ˣʰˣ˨ˢʳ˟˥
Total liabilities (excluding minority interest) 91,941.30 103,562.78
Ǣs¶ŎsŘǼNƼÞǼĶsɮƼsŘ_ÞǼȖNjsʹÞŘOĶȖ_ÞضOƼÞǼĶɠŸNjĨÞŘƼNjŸ¶Njsǣǣʺ ˠʰ˟ˤˣʳˠ˦ ˠʰ˟˥˟ʳˣˤ ˡ˨ˠʳˢ˥ ˣˡˤʳ˦˧ ˠ˟ˤʳ˥˦ ˠʰˠˤ˟ʳ˥ˣ ˠ˥˥ʳ˨˦ - - - ˠʰ˥ˠ˧ʳˠ˦ ˡʰ˥ˢ˥ʳ˧˦
ȕŘĶĶŸOǼs_OƼÞǼĶsɮƼsŘ_ÞǼȖNjsʹÞŘOĶȖ_ÞضOƼÞǼĶɠŸNjĨÞŘƼNjŸ¶Njsǣǣʺ ˢ˟ˤʳ˨ˠ ˢˤˠʳˤ˦
ǻŸǼĶ OƼÞǼĶ sɮƼsŘ_ÞǼȖNjs ʹÞŘOĶȖ_Þض OƼÞǼĶ ɠŸNjĨ ÞŘ ƼNjŸ¶Njsǣǣ
Governance

1,924.08 2,988.44
Ř_sɮOĶȖ_ÞضǼÌsµŸŸ_ɠÞĶĶŸŘOŸŘǣŸĶÞ_ǼÞŸŘʺ
Segment depreciation and amortisation ˠʰ˥ˤˣʳˣ˨ ˠʰ˦˦˧ʳ˨ˢ ˢ˥ˢʳˠˢ ˣˤ˨ʳˤˤ ˦˧ˢʳˢˤ ˥ˡˡʳ˨ˡ ˠʳ˥ˤ - - - ˡʰ˧˟ˡʳ˥ˡ ˡʰ˧˥ˠʳˣˠ
Unallocated depreciation and amortisation ˢˢ˦ʳˤˢ ˢ˨ˢʳˠˣ
Total depreciation and amortisation 3,140.15 3,254.55
Ǣs¶ŎsŘǼŘŸŘOǣÌsɮƼsŘǣsǣŸǼÌsNjǼÌŘ_sƼNjsOÞǼÞŸŘ ˧ˢʳ˨ˠ ˠˤˠʳˠ˥ ˠ˨ʳˤˡ ˡ˨ʳˡ˨ ˢ˨ʳˤˢ ˨˦ʳˠ˨ - ˟ʳˣ˦ - - ˠˣˡʳ˨˥ ˡ˦˧ʳˠˠ
ȕŘĶĶŸOǼs_ŘŸŘOǣÌsɮƼsŘǣsǣŸǼÌsNjǼÌŘ_sƼNjsOÞǼÞŸŘ ˦˟ʳ˦˟ ˟ʳ˥˦
Total non cash expenses other than depreciation 213.66 278.78
Financial Statements

Information about geographical segment : 2015-16 2014-15


India Outside India India Outside India
ˠʳ Ǣs¶ŎsŘǼNJsɚsŘȖs ˠ˥˟ʰˡ˧ˡʳ˨˥ ˣʰˠ˨˟ʳˢ˦ ˠˣ˥ʰ˧ˤˡʳˤˤ ˢʰ˥˦˥ʳ˨ˡ
ˠ˥˦

ˡʳ Ǣs¶ŎsŘǼǣǣsǼǣ ˠ˦˥ʰ˟ˠˢʳ˧ˣ ˦ˠ˟ʳ˧˥ ˠ˧˟ʰ˨˥˨ʳˢˠ ˦˟ˢʳˠ˧


ˢʳ NƼÞǼĶrɮƼsŘ_ÞǼȖNjs ˠʰ˨ˡˣʳ˟˧ - ˡʰ˨˧ˢʳ˧˦ ˣʳˤ˦
ˠ˥˧ Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
` In Lacs
NOTE 30 - RELATED PARTY DISCLOSURES

a) ƻNjǼÞsǣɠÌsNjsOŸŘǼNjŸĶsɮÞǣǼǣ
Individual having control
ōʳƻʳNJŎOÌŘ_NjŘ Chairman and Managing Director
ǣǼÌsōضÞض^ÞNjsOǼŸNjŸ¯ǼÌsNŸŎƼŘɴÞǣŘÞŘ_ÞɚÞ_ȖĶÌɚÞضOŸŘǼNjŸĶŘ_ÌsŘOsŘŸǼǣsƼNjǼsĶɴ_ÞǣOĶŸǣs_ǣĨsɴŎضsŎsŘǼƼsNjǣŸŘŘsĶ
b) NJsĶǼs_ƼNjǼɴNjsĶǼÞŸŘǣÌÞƼǣɠÌsNjsǼNjŘǣOǼÞŸŘǣÌɚsǼĨsŘƼĶOs_ȖNjÞضǼÌsɴsNj
®ÞNjŎˀËȕ®ÞŘɠÌÞOÌǼÌsNjsĶǼÞɚsǣŸ¯ÞŘ_ÞɚÞ_ȖĶÌɚÞضOŸŘǼNjŸĶNjsƼNjǼŘsNjǣˀŎsŎEsNjǣˀƼNjŸƼNjÞsǼŸNj
džȖÞĶŸŘǻNj_ÞضNŸʳ
ōʳƻʳ^ÞɚĨNjŘ˚Ëʳȕʳ®ʳ
ōʳƻʳǢÞ_ÌNjǼÌŘ˚Ëʳȕʳ®ʳ
Relative of individual having control
ōʳƻʳǢÞ_ÌNjǼÌŘ
ōʳNJʳğɴŸǼÌɴ
ōʳNJʳ^ssƼǼÌÞ
Ananth Rao T
Ravi Razdan
ōʳƻʳ^ÞɚĨNjŘ
rŘǼsNjƼNjÞǣsǣǣÞ¶ŘÞʩOŘǼĶɴÞŘʪȖsŘOs_EɴĨsɴŎضsŎsŘǼƼsNjǣŸŘŘsĶŸNjǼÌsÞNjNjsĶǼÞɚsǣ
ǢÌɴ_NjÞ¶sŘOÞsǣĵǼ_ʳ
Key management personnel
ħʳȕĶĶǣħŎǼÌ ğŸÞŘǼōضÞض^ÞNjsOǼŸNj˓N®ŷ
ǢʳNJ¶ÌȖŘŘ_Ř ɟÌŸĶsǻÞŎs^ÞNjsOǼŸNj˓Nrŷ
Additional related party as per Companies Act, 2013
ōʳĵʳDŘǣĶ Company Secretary

Oʺ ǻNjŘǣOǼÞŸŘǣɠÞǼÌNjsĶǼs_ƼNjǼÞsǣ_ȖNjÞضǼÌsɴsNj
2015-16 2014-15
Individual having control
Remuneration* ˟ʳ˟˟ ˟ʳ˟˟
Commission ˣˡˠʳ˟ˢ ˢˠˡʳ˥˨
Dividend ˤʰ˦˥˧ʳ˨˥ ˠʰˣˣˡʳˡˣ
Rent Paid - Quilon Trading Company ˠʳˡ˟ ˠʳˡ˟
^ÞɚÞ_sŘ_ʹōʳƻʳ^ÞɚĨNjŘ˚Ëʳȕʳ®ʳŘ_ōʳƻʳǢÞ_ÌNjǼÌŘ˚Ëʳȕʳ®ʳʺ ˡˤ˦ʳ˨ˡ ˥ˣʳˣ˧
^ÞɚÞ_sŘ_ʹǢÌɴ_NjÞ¶sŘOÞsǣĵǼ_ʳʺ ˠʰˡ˟˟ʳ˟˟ ˢ˟˟ʳ˟˟
ǣǣÞ¶ŘŎsŘǼŸ¯NJsOsÞɚEĶsǣʹǢÌɴ_NjÞ¶sŘOÞsǣĵǼ_ʳʺ - ˠʰˣ˦˧ʳ˟˟
Relatives of individuals having control
Remuneration*
 ōNJğɴŸǼÌɴʹ^ÞNjsOǼŸNjʺ ˠ˟ˡʳˣ˧ ˨˥ʳˢˡ
M P Sidharthan ˡˣʳ˟˟ ˡˣʳ˟˟
M R Deepthy ˢ˦ʳˤˠ ˡ˦ʳ˥˟
Ananth Rao T ˣˤʳ˟ˢ ˢˣʳ˦ˣ
Ravi Razdan ˢ˦ʳˤˠ ˡ˦ʳ˥˟
 ōʳƻʳ^ÞɚĨNjŘ ˡˣʳ˟˟ ˡˣʳ˟˟
Dividend ˡʰˢˡ˦ʳˤˡ ˤ˧ˠʳ˨˦
Contribution to Superannuation fund
M R Jyothy - ˟ʳ˨˟
M R Deepthi - ˡʳˣ˟
Ravi Razdan - ˡʳˣ˟
Key management personnel
Remuneration*# ˦ˡ˦ʳ˥˨ ˦ˡˠʳ˟˨
Commission ˢ˦˧ʳ˨ˢ ˡ˧ˠʳˣˡ
Dividend ˠˢˠʳ˦ˤ ˢˡʳ˨ˣ
Contribution to Superannuation fund ˡˠʳ˥˟ ˡ˧ʳˡ˟
ˎ ǣ ǼÌs ¯ȖǼȖNjs ĶÞEÞĶÞǼÞsǣ ¯ŸNj ¶NjǼȖÞǼɴ Þǣ ƼNjŸɚÞ_s_ ŸŘ Ř OǼȖNjÞĶ EǣÞǣ ¯ŸNj ǼÌs NŸŎƼŘɴ ǣ  ɠÌŸĶsʰ ǼÌs ŎŸȖŘǼ ƼsNjǼÞŘÞض ǼŸ ÞŘ_ÞɚÞ_ȖĶ Þǣ ŘŸǼ
ǣOsNjǼÞŘEĶsŘ_ǼÌsNjs¯ŸNjsŘŸǼÞŘOĶȖ_s_EŸɚsʳ

# The Company has accrued `ˠʰˤˣˣʳˤˢÞŘNjsǣƼsOǼŸ¯sŎƼĶŸɴssǣǼŸOĨŸƼǼÞŸŘǣ¶NjŘǼs_ǼŸɠÌŸĶsǼÞŎs_ÞNjsOǼŸNjŘ_NrŷʳǻÌsǣŎsÌǣŘŸǼEssŘ


OŸŘǣÞ_sNjs_ǣŎضsNjÞĶNjsŎȖŘsNjǼÞŸŘŸ¯ǼÌsOȖNjNjsŘǼɴsNjǣ_sʩŘs_ȖŘ_sNjǢsOǼÞŸŘˡʹ˦˧ʺŸ¯ǼÌsNŸŎƼŘÞsǣOǼʰˡ˟ˠˢǣǼÌsŸƼǼÞŸŘǣÌɚsŘŸǼ
EssŘsɮsNjOÞǣs_ʳ
Corporate Overview Performance Governance Financial Statements ˠ˥˨

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
` in Lacs
d) Related party balances
2015-16 2014-15
Amounts payable
Trade payables :
Individual having control ˣˡˠʳ˟ˢ ˢˠˡʳ˥˨
ħsɴŎضsŎsŘǼƼsNjǣŸŘŘsĶ ˢ˦˧ʳ˨ˢ ˡ˧ˠʳˣˡ

NOTE 31 - EXPENDITURE RELATED TO CORPORATE SOCIAL RESPONSIBILITY AS PER SECTION 135 OF THE COMPANIES ACT, 2013 READ
WITH SCHEDULE VII IS AS GIVEN BELOW:

Particulars 2015-16 2014-15


Promoting preventing health care and sanitation ˣˣʳˡ˧ ˨ˠʳˣˣ
Contribution to Prime Ministers National Relief Fund - ˠ˨ʳ˧˥
ƻNjŸŎŸǼÞŸŘŸ¯r_ȖOǼÞŸŘ ˤʳ˟˟ -
NJȖNjĶˀǣĶȖŎNjs_sɚsĶŸƼŎsŘǼ ˠ˧ˤʳˤ˥ ˠ˟ʳ˟ˢ
Total 234.84 121.33
Gross amount required to be spent during the year ˠ˨ˤʳˢ˟ ˠ˥˥ʳ˨ˡ

NOTE 32 -UNHEDGED FOREIGN CURRENCY EXPOSURE

Particulars Foreign Currency 2015-16 2014-15


` in Lacs Amount in ` in Lacs Amount in
Foreign Currency Foreign Currency
Trade Receivable USD ˠ˦˧ʳˡˣ ˡ˥˧ʰ˦˟˨ ˠ˟˟ʳˢ˨ ˠ˥˟ʰˢ˧ˤ
Trade Payable USD ˠˢˡʳˣˡ ˠ˨˨ʰ˥ˢ˥ ˤ˦ʳ˥˟ ˨ˡʰ˟ˡ˟
Trade Payables rȖNjŸ ˢ˨ʳ˧˧ ˤˢʰˠ˟˟ ˦ˠʳ˦˟ ˠ˟˥ʰˡ˟˟

NOTE 33 - OPERATING LEASES

In case of assets taken on lease


ǻÌsµNjŸȖƼÌǣsŘǼsNjs_ÞŘǼŸĵsǣs¶NjssŎsŘǼǣ¯ŸNjƼNjsŎÞǣsǣʰɠÌÞOÌsɮƼÞNjsǼɚNjÞŸȖǣ_ǼsǣŸɚsNjǼÌsŘsɮǼʩɚsɴsNjǣʳNsNjǼÞضNjssŎsŘǼǣƼNjŸɚÞ_s¯ŸNj
ÞŘONjsǣsÞŘNjsŘǼʳĶĶĶsǣs¶NjssŎsŘǼǣNjsOŘOsĶĶEĶssɮOsƼǼÞŘOǣsŸ¯¯sɠ¶NjssŎsŘǼǣɠÌsNjsÞŘǼÌsNjsÞǣĶŸOĨÞŘƼsNjÞŸ_ÞŘǼÌsNjضsŸ¯ˠˠŎŸŘǼÌǣ
ǼŸˢɴsNjǣʳĵsǣsNjsŘǼĶsɮƼsŘǣs¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥ɠǣ`ˡʰ˟ˢˣʳ˨˨ʹˡ˟ˠˤ˚`ˠʰ˧˧˥ʳ˦˦ʺʳǻÌsNjsNjsŘŸNjsǣǼNjÞOǼÞŸŘǣÞŎƼŸǣs_EɴĶsǣs
NjNjضsŎsŘǼǣʳǻÌsNjsNjsŘŸǣȖEĶsǣsǣʳ

2015-16 2014-15
®ȖǼȖNjsĶsǣsƼɴŎsŘǼȖŘ_sNjŘŸŘ˚OŘOsĶĶEĶsŸƼsNjǼÞضĶsǣsǣNjsǣ¯ŸĶĶŸɠǣʲ
Payable not later than one year ˢˡ˨ʳˤ˟ ˠ˥˦ʳ˨ˢ
ƻɴEĶsĶǼsNjǼÌŘŸŘsɴsNjŘ_ŘŸǼĶǼsNjǼÌŘʩɚsɴsNjǣ ˦ˠ˧ʳˠ˟ ˤ˦ʳˤˣ
ƻɴEĶsĶǼsNjǼÌŘʩɚsɴsNjǣ ˠ˟ˣʳˤˠ -
1,152.11 225.47
In case of assets given on lease
ǻÌsNŸŎƼŘɴÌǣĶsǣs_ŸȖǼ¯sɠŸ¯ÞǼǣƼNjsŎÞǣsǣŸŘŸƼsNjǼÞضĶsǣsʳǻÌs¶NjŸǣǣONjNjɴÞضŎŸȖŘǼŘ_OOȖŎȖĶǼs__sƼNjsOÞǼÞŸŘǣǼōNjOÌˢˠʰ
2016 is `ˤˣʳ˨ˤŘ_`˧ʳ˦˧ʹˡ˟ˠˤ˚`ˤˣʳ˨ˤŘ_`˦ʳ˧˥ʺNjsǣƼsOǼÞɚsĶɴʳĵsǣsNjsŘǼÞŘOŸŎs¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥ɠǣ`˧ʳˤˡʹˡ˟ˠˤ˛`˧ʳˡ˨ʺʳ
ǻÌsNjsÞǣŘŸsǣOĶǼÞŸŘOĶȖǣsÞŘǼÌsĶsǣs¶NjssŎsŘǼŘ_ǼÌsĶsǣsÞǣOŘOsĶĶEĶsÞŘŘǼȖNjsʳǻÌsNjsNjsŘŸNjsǣǼNjÞOǼÞŸŘǣÞŎƼŸǣs_EɴĶsǣsNjNjضsŎsŘǼǣʳ
ˠ˦˟ Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
` in Lacs
NOTE 34 - CONTINGENT LIABILITIES

2016 2015
Dǣs_ŸŘŎضsŎsŘǼ˅ǣsɚĶȖǼÞŸŘ¯ŸĶĶŸɠÞضOŸŘǼÞضsŘǼĶÞEÞĶÞǼÞsǣÞǣŘŸǼƼNjŸEEĶsŘ_ÌsŘOs
ŘŸǼƼNjŸɚÞ_s_EɴǼÌsµNjŸȖƼÞŘNjsǣƼsOǼŸ¯ʲ
ʹÞʺ ŎŸȖŘǼŸȖǼǣǼŘ_ÞضÞŘNjsǣƼsOǼŸ¯OŸNjƼŸNjǼsŘ_ŸǼÌsNjEŘĨ¶ȖNjŘǼssǣ - -
ʹÞÞʺ ǻɮŎǼǼsNjǣ
 ʹʺ ^ÞǣƼȖǼs_ǣĶsǣǼɮ_sŎŘ_ǣ˛ŎǼǼsNjǣȖŘ_sNjƼƼsĶ ˡʰˣˡ˨ʳ˦ˡ ˡʰˢˡ˨ʳˣˤ
 ʹEʺ ^ÞǣƼȖǼs_sɮOÞǣs_ȖǼɴŘ_ǣsNjɚÞOsǼɮ_sŎŘ_˚ŎǼǼsNjȖŘ_sNjƼƼsĶ ˣʰ˟ˤ˨ʳˤ˨ ˢʰˠ˟ˢʳˠˤ
 ʹOʺ ^ÞǣƼȖǼs_ÞŘOŸŎsǼɮ_sŎŘ_˚ŎǼǼsNjȖŘ_sNjƼƼsĶˎ ˥ʰ˦ˢˢʳˠˤ ˢʰ˦ˣˠʳ˥˟
ʹÞÞÞʺ ŷǼÌsNjǣǼǼȖǼŸNjɴ_Ȗsǣ ˣʳ˨ˣ ˧ʳ˧˧
ˎǻÌsŎŸȖŘǼǣÌŸɠŘEŸɚs_ŸsǣŘŸǼÞŘOĶȖ_sOŸŘǼÞضsŘǼĶÞEÞĶÞǼɴ¯ŸNjǣǣsǣǣŎsŘǼɴsNjǣɠÌÞOÌÌɚsEssŘNjsŸƼsŘs_ʹȖŘĶsǣǣ_sŎŘ_ŸNj_sNjÞǣNjÞǣs_ʺ
Ř_ǼÌŸǣsƼsŘ_ÞضǣǣsǣǣŎsŘǼǣʳ

NOTE - 35 - CAPITAL COMMITMENTS (NET OF ADVANCES)

2016 2015
rǣǼÞŎǼs_ŎŸȖŘǼŸ¯OŸŘǼNjOǼǣNjsŎÞŘÞضǼŸEssɮsOȖǼs_ŸŘOƼÞǼĶOOŸȖŘǼŘ_ŘŸǼƼNjŸɚÞ_s_¯ŸNj ˠʰ˟˥ˤʳ˥˦ ˤ˟˧ʳ˧˨
1,065.67 508.89

NOTE 36 - EMPLOYEE STOCK OPTION PLANS (‘ESOP’)

ŷŘȖ¶ȖǣǼˠ˥ʰˡ˟ˠˣǼÌsNJsŎȖŘsNjǼÞŸŘŘ_NŸŎƼsŘǣǼÞŸŘNŸŎŎÞǼǼssŸ¯ǼÌsDŸNj_Ÿ¯^ÞNjsOǼŸNjǣŸ¯ǼÌsNŸŎƼŘɴƼƼNjŸɚs_ǼÌsrŎƼĶŸɴssǢǼŸOĨ
ŷƼǼÞŸŘǢOÌsŎsˡ˟ˠˣʹˆrǢŷǢ˚ˡ˟ˠˣˇʺ¯ŸNjÞǣǣȖsŸ¯ǣǼŸOĨŸƼǼÞŸŘǣǼŸǼÌsĨsɴsŎƼĶŸɴssǣŘ_rŎƼĶŸɴssǢǼŸOĨŷƼǼÞŸŘǢOÌsŎsˡ˟ˠˣ˚ʹˆrǢŷǢ˚ˡ˟ˠˣ˚ˇʺ
¯ŸNjÞǣǣȖsŸ¯ǣǼŸOĨŸƼǼÞŸŘǣǼŸɟÌŸĶsǻÞŎs^ÞNjsOǼŸNj˓NrŷŸ¯ǼÌsNŸŎƼŘɴʳOOŸNj_ÞضǼŸǼÌsǣOÌsŎsʰɠÌŸĶsǼÞŎs^ÞNjsOǼŸNjŘ_NrŷŘ_sĶÞ¶ÞEĶs
sŎƼĶŸɴssǣǣsĶsOǼs_EɴǼÌsNJsŎȖŘsNjǼÞŸŘŘ_NŸŎƼsŘǣǼÞŸŘNŸŎŎÞǼǼssɠÞĶĶEssŘǼÞǼĶs_ǼŸŸƼǼÞŸŘǣ¯NjŸŎǼÞŎsǼŸǼÞŎsʰǣȖEĠsOǼǼŸǣǼÞǣ¯OǼÞŸŘŸ¯
ƼNjsǣONjÞEs_ɚsǣǼÞضOŸŘ_ÞǼÞŸŘǣʳǻÌsNjsĶsɚŘǼǼsNjŎǣŸ¯ǼÌs¶NjŘǼNjsǣEsĶŸɠʲ˚

Particulars (“ESOS -2014”) (“ESOS -2014”) (“ESOS -2014 - A”)


Grant – I Grant – II
Date of Grant Ȗ¶ȖǣǼˠ˥ʰˡ˟ˠˣ ğŘȖNjɴˡ˦ʰˡ˟ˠˤ Ȗ¶ȖǣǼˠ˥ʰˡ˟ˠˣ
Number of options granted ˤ˟ˢʰˣˣˤ ˢˣʰˤ˟˦ ˡʰ˦ˠˤʰˢˤˡ
əsǣǼÞضƼsNjÞŸ_ ˢˢ̇˚ɳsNjˠ ˢˢ̇˚ɳsNjˠ ˥˥ʳ˥˦̇˚ɳsNjˠ
ˢˢ̇˚ɳsNjˡ ˢˢ̇˚ɳsNjˡ ˠ˥ʳ˥˦̇˚ɳsNjˡ
ˢˣ̇˚ɳsNjˢ ˢˣ̇˚ɳsNjˢ ˠ˥ʳ˥˥̇˚ɳsNjˢ
rɮsNjOÞǣsƼsNjÞŸ_ 5 years from the respective dates of vesting
rɮsNjOÞǣsƻNjÞOs˚ƻsNjǣÌNjs `1 `1 `1
ōNjĨsǼƼNjÞOsǼ¶NjŘǼ_Ǽs˚ƻsNjǣÌNjs `ˠ˧˧ʳ˦˟ `ˡ˧˨ʳ˧˟ `ˠ˧˧ʳ˦˟

The details of the activity under the above schemes are summarised as below;

Particulars (“ESOS -2014”) (“ESOS -2014”) (“ESOS -2014 - A”)


Grant – I Grant – II
ŷȖǼǣǼŘ_ÞضǼƼNjÞĶˠʰˡ˟ˠˣ - - -
Granted during 2014-15 ˤ˟ˢʰˣˣˤ ˢˣʰˤ˟˦ ˡʰ˦ˠˤʰˢˤˡ
Cancelled during 2014-15 ˤˡʰ˨˨ˣ - -
rɮsNjOÞǣs__ȖNjÞضˡ˟ˠˣ˚ˠˤ - - -
ŷȖǼǣǼŘ_ÞضǼōNjOÌˢˠʰˡ˟ˠˤ ˣˤ˟ʰˣˤˠ ˢˣʰˤ˟˦ ˡʰ˦ˠˤʰˢˤˡ
rɮsNjOÞǣEĶsǼōNjOÌˢˠʰˡ˟ˠˤ ˣˤ˟ʰˣˤˠ ˢˣʰˤ˟˦ ˡʰ˦ˠˤʰˢˤˡ
ŷȖǼǣǼŘ_ÞضǼƼNjÞĶˠʰˡ˟ˠˤ ˣˤ˟ʰˣˤˠ ˢˣʰˤ˟˦ ˡʰ˦ˠˤʰˢˤˡ
Granted during 2015-16 - - -
Cancelled during 2015-16 ˧˦ʰ˨˦˟ ˢˣʰˤ˟˦ ˣˤˡʰˤˤ˨
rɮsNjOÞǣs__ȖNjÞضˡ˟ˠˤ˚ˠ˥ ˨˥ʰˠ˧ˣ - -
ŷȖǼǣǼŘ_ÞضǼōNjOÌˢˠʰˡ˟ˠ˥ ˡ˥˥ʰˡ˨˦ - ˡʰˡ˥ˡʰ˦˨ˢ
rɮsNjOÞǣEĶsǼōNjOÌˢˠʰˡ˟ˠ˥ ˡ˥˥ʰˡ˨˦ - ˡʰˡ˥ˡʰ˦˨ˢ

®ŸNjŸƼǼÞŸŘsɮsNjOÞǣs__ȖNjÞضǼÌsƼsNjÞŸ_ʰǻÌsɠsÞ¶ÌǼs_ɚsNj¶sǣÌNjsƼNjÞOsǼǼÌssɮsNjOÞǣs_Ǽsɠǣ`ˡ˨˦ʳˣˣƼsNjǣÌNjsʹˡ˟ˠˤ˚ŘŸǼƼƼĶÞOEĶsǣÞŘOs
ŘŸŸƼǼÞŸŘsɮsNjOÞǣsʺ
Corporate Overview Performance Governance Financial Statements ˠ˦ˠ

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
` in Lacs
ŗŸŘsɠǣǼŸOĨŸƼǼÞŸŘÌɚsEssضNjŘǼs_EɴǼÌsOŸŎƼŘɴÞŘǼÌsOȖNjNjsŘǼɴsNj

ǻÌsDĶOĨǢOÌŸĶsǣɚĶȖǼÞŸŘŎŸ_sĶÌǣEssŘȖǣs_¯ŸNjOŸŎƼȖǼÞضǼÌsɠsÞ¶ÌǼs_ɚsNj¶s¯ÞNjɚĶȖsŸ¯ǼÌsǣǼŸOĨ¶NjŘǼs_OŸŘǣÞ_sNjÞضǼÌs¯ŸĶĶŸɠÞض
ÞŘƼȖǼǣ¯ŸNjǼÌsɴsNjsŘ_s_ōNjOÌˢˠʰˡ˟ˠ˥Ř_ōNjOÌˢˠʰˡ˟ˠˤʲ˚

Variables (“ESOS -2014”)- Grant – I


Vest 1 Vest 2 Vest 3
August 16, 2015 August 16, 2016 August 16, 2017
əŸĶǼÞĶÞǼɴ ˢ˥ʳˠ˨̇ ˢ˦ʳˢˡ̇ ˣ˟ʳˢˢ̇
NJÞǣĨ¯NjssNJǼs ˧ʳ˦ˢ̇ ˧ʳ˦ˡ̇ ˧ʳ˦ˡ̇
rɮsNjOÞǣsƻNjÞOsʹ`ʺ ˠʳ˟˟ ˠʳ˟˟ ˠʳ˟˟
ǻÞŎsǻŸōǼȖNjÞǼɴʹÝŘɳsNjǣʺ ˢʳˤ˟ ˣʳˤ˟ ˤʳˤ˟
Dividend yield ˠʳˤ˨̇ ˠʳˤ˨̇ ˠʳˤ˨̇
Weighted average fair Value of per stock option granted (`) 174.98

Variables (“ESOS -2014 - A”)


Vest 1 Vest 2 Vest 3
August 16, 2015 August 16, 2016 August 16, 2017
əŸĶǼÞĶÞǼɴ ˢ˥ʳˠ˨̇ ˢ˦ʳˢˡ̇ ˣ˟ʳˢˢ̇
NJÞǣĨ¯NjssNJǼs ˧ʳ˦ˢ̇ ˧ʳ˦ˡ̇ ˧ʳ˦ˡ̇
rɮsNjOÞǣsƻNjÞOsʹ`ʺ ˠʳ˟˟ ˠʳ˟˟ ˠʳ˟˟
ǻÞŎsǻŸōǼȖNjÞǼɴʹÝŘɳsNjǣʺ ˢʳˤ˟ ˣʳˤ˟ ˤʳˤ˟
Dividend yield ˠʳˤ˨̇ ˠʳˤ˨̇ ˠʳˤ˨̇
Weighted average fair Value of per stock option granted (`) 176.38

ǻÌssɮƼsOǼs_ɚŸĶǼÞĶÞǼɴNjsʪsOǼǣǼÌsǣǣȖŎƼǼÞŸŘǼÌǼǼÌsÌÞǣǼŸNjÞOĶɚŸĶǼÞĶÞǼɴŸɚsNjƼsNjÞŸ_ǣÞŎÞĶNjǼŸǼÌsĶÞ¯sŸ¯ǼÌsŸƼǼÞŸŘǣÞǣÞŘ_ÞOǼÞɚsŸ¯¯ȖǼȖNjs
ǼNjsŘ_ǣʰɠÌÞOÌŎɴŘŸǼŘsOsǣǣNjÞĶɴEsǼÌsOǼȖĶŸȖǼOŸŎsʳ

ǻÌsNŸŎƼŘɴŎsǣȖNjsǣǼÌsOŸǣǼŸ¯rǢŷƻȖǣÞضǼÌsÞŘǼNjÞŘǣÞOɚĶȖsŎsǼÌŸ_ʳË_ǼÌsOŸŎƼŘɴȖǣs_ǼÌs¯ÞNjɚĶȖsŎŸ_sĶǼŸ_sǼsNjŎÞŘsOŸŎƼsŘǣǼÞŸŘʰ
ÞǼǣƼNjŸʩǼ¯ǼsNjǼɮŘ_sNjŘÞضǣƼsNjǣÌNjsǣNjsƼŸNjǼs_ɠŸȖĶ_ÌɚsOÌضs_ǼŸǼÌsŎŸȖŘǼǣǣÞŘ_ÞOǼs_EsĶŸɠʲ

As at As at
March 31, 2016 ōNjOÌˢˠʰˡ˟ˠˤ
ƻNjŸʩǼ¯ǼsNjǼɮǣNjsƼŸNjǼs_ ˠ˥ʰˡˢˤʳ˨˥ ˠˣʰˡ˦˧ʳ˨ˤ
__ʲrǢŷƻOŸǣǼȖǣÞضǼÌsÞŘǼNjÞŘǣÞOɚĶȖsŎsǼÌŸ_ ˠʰ˦ˤ˟ʳˡ˥ ˡʰ˧˦ˠʳˠˢ
ĵsǣǣʲrǢŷƻOŸǣǼȖǣÞضǼÌs¯ÞNjɚĶȖsŎsǼÌŸ_ ʹˠʰ˥ˢ˥ʳ˦˧ʺ ʹˡʰ˥˥ˠʳˠ˦ʺ
ƻNjŸ¯ŸNjŎƼNjŸʩǼ¯ǼsNjǼɮ ˠ˥ʰˢˣ˨ʳˣˣ ˠˣʰˣ˧˧ʳ˨ˠ
Earnings Per Share ` `
Basic
- As reported ˧ʳ˨˦ ˦ʳ˧˨
- Proforma ˨ʳ˟ˢ ˧ʳ˟˟
Diluted
- As reported ˧ʳ˧ˣ ˦ʳ˧ˢ
- Proforma ˧ʳ˨ˠ ˦ʳ˨ˤ
ˠ˦ˡ Jyothy Laboratories Limited
Annual Report 2015-16

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
` in Lacs

NOTE 37: INFORMATION REQUIRED FOR CONSOLIDATED FINANCIAL STATEMENTS PURSUANT TO SCHEDULE III OF COMPANIES ACT, 2013

ǻÌsEŸɚsÞŘ¯ŸNjŎǼÞŸŘÌǣEssŘ_sǼsNjŎÞŘs_ǼŸǼÌssɮǼsŘǼǣȖOÌƼNjǼÞsǣÌɚsEssŘÞ_sŘǼÞʩs_ŸŘǼÌsEǣÞǣŸ¯ÞŘ¯ŸNjŎǼÞŸŘɚÞĶEĶsɠÞǼÌǼÌsµNjŸȖƼʳ

Particulars 31-Mar-16 ˢˠ˚ōNj˚ˠˤ


Net Assets, i.e. Total ǢÌNjsÞŘƼNjŸʩǼŘ_ĶŸǣǣ ŗsǼǣǣsǼǣʰÞʳsʳǻŸǼĶ ǢÌNjsÞŘƼNjŸʩǼŘ_ĶŸǣǣ
Asset minus Total Asset minus Total
Liabilities Liabilities
As % of Amount As % of Amount ǣ̇Ÿ¯ Amount ǣ̇Ÿ¯ Amount
Consolidated Consolidated Consolidated Consolidated
net assets ƼNjŸʩǼŸNjĶŸǣǣ Net Assets ƼNjŸʩǼŸNjĶŸǣǣ
Parent
Jyothy Laboratories Limited ˠˣˡʳˣ˟̇ ˠʰˡ˟ʰˤ˟˟ʳ˟˟ ˠˢˠʳ˧ˠ̇ ˡ˟ʰ˧ˡ˟ʳˤ˥ ˠˢ˨ʳ˦˟̇ ˠʰ˟˧ʰ˨ˠ˨ʳ˟ˣ ˠˤˣʳˣ˟̇ ˠ˧ʰ˦˟ˠʳˡ˨
Subsidiaries
Indian
Jyothy Consumer Products ʹˤˣʳˠˤ̇ʺ ʹˣˤʰ˧ˠ˦ʳ˧˧ʺ ʹˡˡʳ˧ˤ̇ʺ ʹˢʰ˥˟˨ʳˠˠʺ ʹˤˣʳˠˣ̇ʺ ʹˣˡʰˡ˟˧ʳ˦˥ʺ ʹˢ˥ʳ˨ˣ̇ʺ ʹˣʰˣ˦ˢʳ˦˧ʺ
ōNjĨsǼÞضĵÞŎÞǼs_
Jyothy Fabricare Services Limited ˠ˟ʳ˥˧̇ ˨ʰ˟ˢˡʳ˥ˡ ʹ˧ʳ˦ˡ̇ʺ ʹˠʰˢ˦˧ʳˠ˦ʺ ˠˢʳˣ˟̇ ˠ˟ʰˣˣ˧ʳˢˢ ʹˠ˦ʳ˦ˢ̇ʺ ʹˡʰˠˣ˧ʳ˟˥ʺ
ǢŘŸɠɴǣĵȖŘ_NjsNjǣ˓^NjɴOĶsŘsNjǣ ˟ʳˡˢ̇ ˠ˨˟ʳˣˢ ˟ʳ˟˟̇ ʹ˟ʳˤˤʺ ˟ʳˡˣ̇ ˠ˨˟ʳ˨˧ ˟ʳ˟˟̇ ʹ˟ʳ˟ˠʺ
Private Limited
Four Seasons Drycleaning ʹ˟ʳˠˡ̇ʺ ʹ˨˨ʳ˧˨ʺ ʹ˟ʳˡˤ̇ʺ ʹˢ˧ʳ˦ˡʺ ʹ˟ʳ˟˧̇ʺ ʹ˥ˠʳˠ˦ʺ ʹ˟ʳˣˡ̇ʺ ʹˤˠʳˢˠʺ
Company Private Limited
ōˀǣğ®ǢĵğĵĵğəʹƻNjǼŘsNjǣÌÞƼ®ÞNjŎʺ ˟ʳˢ˧̇ ˢˡˠʳˢˤ ʹ˟ʳˢ˟̇ʺ ʹˣ˥ʳ˧ˤʺ ˟ʳˣˠ̇ ˢˠ˧ʳˡ˟ ˟ʳ˨˟̇ ˠ˟˧ʳ˥˦
Foreign
ğɴŸǼÌɴħĶĶŸĶDضĶ_sǣÌĵÞŎÞǼs_ ˟ʳ˦˧̇ ˥ˤ˥ʳ˦˦ ˟ʳˢˠ̇ ˣ˧ʳˤ˨ ˟ʳ˥ˤ̇ ˤ˟ˢʳ˟˨ ʹ˟ʳˢˢ̇ʺ ʹˢ˧ʳˢ˦ʺ
Minority interest ʹ˟ʳˡ˟̇ʺ ʹˠ˥˨ʳ˦ˣʺ ˟ʳ˟˟̇ ˟ʳˡ˨ ʹ˟ʳˠ˧̇ʺ ʹˠˣˢʳ˦ˣʺ ˟ʳˠˡ̇ ˠˢʳ˨˥
GRAND TOTAL 100.00% 84,613.66 100.00% 15,796.04 100.00% 77,965.97 100.00% 12,112.39

ŗsǼǣǣsǼǣŘ_ǣÌNjsŸ¯ƼNjŸʩǼǣŘ_ĶŸǣǣsǣNjsƼŸNjǼs_ÞŘǼÌsEŸɚsǼEĶsÌɚsEssŘOŸŘǣÞ_sNjs_¯NjŸŎǼÌsNjsǣƼsOǼÞɚsȖ_ÞǼs_ʩŘŘOÞĶǣǼǼsŎsŘǼǣ¯ǼsNj
ŎĨÞضŘsOsǣǣNjɴOÌضsǣ¯ŸNjOŸŘǣŸĶÞ_ǼÞŸŘ_ĠȖǣǼŎsŘǼǣÌɚÞضÞŎƼOǼŸŘǼÌsOŸŘǣŸĶÞ_Ǽs_ŘsǼǣǣsǼǣŘ_ŘsǼƼNjŸʩǼǣʳ

NOTE - 38
ǣƼsNjǼÌsŗŸǼÞʩOǼÞŸŘŘŸʳˢˡˀ˨˨˚Nr_Ǽs_ğȖĶɴ˧ʰˠ˨˨˨ʰǼÌsNŸŎƼŘɴɠǣsŘǼÞǼĶs_ǼŸNjs¯ȖŘ_Ÿ¯sɮOÞǣs_ȖǼɴÞصȖɠÌǼÞŘ_ğŎŎȖȖŘÞǼǣsLJȖÞɚĶsŘǼ
ǼŸˠ˟˟̇Ÿ¯ǼÌsŎŸȖŘǼŸ¯ǼÌs_ȖǼɴƼÞ_ǼÌNjŸȖ¶ÌƻsNjǣŸŘĶĵs_¶sNjOOŸȖŘǼʹ˄ƻĵ˅ʺʳ^ȖNjÞضŘsNjĶÞsNjɴsNjʰǼÌsµŸɚsNjŘŎsŘǼÞǣǣȖs_ŘŸǼÞʩOǼÞŸŘǣ
ŘŸʳˠ˦ˀˡ˟˟˧˚NrŘ_ˠ˨ˀˡ˟˟˧˚Nr_Ǽs_ōNjOÌˡ˦ʰˡ˟˟˧NjsǣǼNjÞOǼÞضǼÌsNjs¯ȖŘ_ŎŸȖŘǼǼŸŎɮÞŎȖŎƼsNjOsŘǼ¶sǣƼsOÞʩs_ÞŘǼÌsŘŸǼÞʩOǼÞŸŘʳǻÌs
NŸŎƼŘɴÌǣNjsOsÞɚs_¯ɚŸȖNjEĶsŸNj_sNj¯NjŸŎǼÌsËÞ¶ÌNŸȖNjǼŸ¯µȖɠÌǼÞ˓ğŎŎȖŘ_ħǣÌŎÞNjÞŘsNjĶÞsNjɴsNjǣʳOOŸNj_ÞضĶɴʰǼÌsNŸŎƼŘɴÌǣ
OONjȖs_Ř__ÞǼÞŸŘĶEsŘsʩǼŸ¯`˨ˣ˟ʳˣ˧ʹˡ˟ˠˤ˚`˨˟˦ʳ˟˥ʺÞŘǼÌsOȖNjNjsŘǼɴsNjʳ

NOTE - 39
ǻÌsNŸŎƼŘɴÌǣsŘǼsNjs_ÞŘǼŸŘŸƼǼÞŸŘ¶NjssŎsŘǼ_Ǽs_ōɴˤʰˡ˟ˠˠɠÞǼÌËsŘĨsĶµ˓NŸʳħµʹËsŘĨsĶµʺɠÌsNjsEɴǼÌsNŸŎƼŘɴÌǣ
¶NjŘǼs_ËsŘĨsĶµʩNjŎŘ_ÞNjNjsɚŸOEĶsŸƼǼÞŸŘʰǼÞǼǣǣŸĶs_ÞǣONjsǼÞŸŘǼŘɴǼÞŎs¯ǼsNjǼÌsEs¶ÞŘŘÞضŸ¯ǼÌsʩ¯ǼÌɴsNjŘ_sŘ_ÞضȖƼŸŘǼÌssɮƼÞNjɴ
Ÿ¯ǼÌsǣÞɮǼÌɴsNjŸ¯ǼÌsǣÞ_¶NjssŎsŘǼŸNjǣȖOÌŸǼÌsNjŎȖǼȖĶĶɴsɮǼsŘ_s_ƼsNjÞŸ_ʰǼŸOLJȖÞNjsŎɮÞŎȖŎŸ¯ˡ˥̇Ÿ¯ǼÌsÞǣǣȖs_sLJȖÞǼɴǣÌNjsOƼÞǼĶŸ¯
ǼÌsNŸŎƼŘɴǼƼNjÞOsɠÌÞOÌɠÞĶĶEsŎȖǼȖĶĶɴ_sǼsNjŎÞŘs_EɴǼÌsƼNjǼÞsǣǼĶǼsNj_Ǽsʳ

NOTE 40
ǼÞǼǣŎssǼÞضÌsĶ_ŸŘōɴˡˢʰˡ˟ˠ˥ǼÌsDŸNj_Ÿ¯^ÞNjsOǼŸNjǣÌɚsƼƼNjŸɚs_ǼÌsǣOÌsŎsŸ¯ŎĶ¶ŎǼÞŸŘŸ¯ğɴŸǼÌɴNŸŘǣȖŎsNjƻNjŸ_ȖOǼǣōNjĨsǼÞض
ĵÞŎÞǼs_ʹɠÌŸĶĶɴŸɠŘs_ǣȖEǣÞ_ÞNjɴʺɠÞǼÌǼÌsNŸŎƼŘɴŸŘōɴˡˢʰˡ˟ˠ˥ʳǻÌsƼƼŸÞŘǼs__ǼsȖŘ_sNjǼÌsǣOÌsŎsɠÞĶĶEsƼNjÞĶˠʰˡ˟ˠ˥ʳ
Corporate Overview Performance Governance Financial Statements ˠ˦ˢ

NOTES
to the Consolidated Financial Statements for the year ended March 31, 2016
` in Lacs
NOTE 41 - EARNINGS PER SHARE
2016 2015
ŗsǼƻNjŸʩǼ¯ŸNjOĶOȖĶǼÞŸŘŸ¯EǣÞOŘ__ÞĶȖǼs_rƻǢ ˠˤʰ˦˨˥ʳ˟ˣ ˠˡʰˠˠˡʳˢ˨
ɟsÞ¶ÌǼs_ɚsNj¶sŘȖŎEsNjŸ¯ǣÌNjsǣ¯ŸNjOĶOȖĶǼÞŸŘŸ¯EǣÞOrƻǢ ˠ˧ˠʰ˟˦˦ʰ˦˥ˣ ˠ˧ˠʰ˟ˡˢʰˣ˨˥
Effect of dilution :
ǢǼŸOĨŸƼǼÞŸŘ¶NjŘǼs_ȖŘ_sNjrǢŷƻ ˡʰˤ˟˥ʰ˧ˤ˟ ˠʰˡˡˣʰˤˣˤ
ɟsÞ¶ÌǼs_ɚsNj¶sŘȖŎEsNjŸ¯ǣÌNjsǣ¯ŸNjOĶOȖĶǼÞŸŘŸ¯_ÞĶȖǼs_rƻǢ ˠ˧ˢʰˤ˧ˣʰ˥ˠˣ ˠ˧ˡʰˡˣ˧ʰ˟ˣˠ
DǣÞOrƻǢʹ`ʺ ˧ʳ˦ˡ ˥ʳ˥˨
^ÞĶȖǼs_rƻǢʹ`ʺ ˧ʳ˥˟ ˥ʳ˥ˤ

NOTE 42 - EXCEPTIONAL ITEM


rɮOsƼǼÞŸŘĶÞǼsŎNjsĶǼsǣ__ÞǼÞŸŘĶƼɴŎsŘǼǼŸɠNj_ǣNjsǼNjsŘOÌŎsŘǼŸ¯sŎƼĶŸɴssǣ¯ŸNjǼÌsħŘ_ŘǣǣsNjɴȖŘÞǼÞŘƼNjsɚÞŸȖǣɴsNjʳ

NOTE 43 - MICRO, SMALL AND MEDIUM ENTERPRISES DEVELOPMENT ACT, 2006 (‘MSMED’)
ǻÌs_ÞǣOĶŸǣȖNjsƼȖNjǣȖŘǼǼŸǼÌsǣÞ_OǼÞǣǣȖŘ_sNjʲ
2016 2015
ƻNjÞŘOÞƼĶŎŸȖŘǼ_ȖsǼŸǣȖƼƼĶÞsNjǣȖŘ_sNjōǢōr^OǼ ˣʰ˦ˠ˧ʳˤˣ ˢʰ˦ˣˠʳ˦˧
ÝŘǼsNjsǣǼ OONjȖs_ Ř_ _Ȗs ǼŸ ǣȖƼƼĶÞsNjǣ ȖŘ_sNj ǢsOǼÞŸŘ ˠ˥ Ÿ¯ ōǢōr^ OǼʰ ˡ˟˟˥ ŸŘ ǼÌs EŸɚs ˣʳ˨˦ ˣʳˢˠ
ŎŸȖŘǼʰȖŘƼÞ_
ÝŘǼsNjsǣǼƼÞ_ǼŸǣȖƼƼĶÞsNjǣȖŘ_sNjǼÌsōǢōr^OǼ - -
ÝŘǼsNjsǣǼ_ȖsŘ_ƼɴEĶsǼŸɠNj_ǣǣȖƼƼĶÞsNjǣȖŘ_sNjōǢōr^OǼǼŸɠNj_ǣƼɴŎsŘǼĶNjs_ɴŎ_s - -
Interest accrued and remaining unpaid at the end of accounting year ˣʳ˨˦ ˣʳˢˠ

NOTE 44 - PREVIOUS YEAR FIGURES


ƻNjsɚÞŸȖǣɴsNjʩ¶ȖNjsǣÌɚsEssŘNjs¶NjŸȖƼs_ˀNjsOĶǣǣÞʩs_ʰɠÌsNjsŘsOsǣǣNjɴʰǼŸOŸŘ¯ŸNjŎǼŸǼÌÞǣɴsNjOĶǣǣÞʩOǼÞŸŘʳ

Signatures to Notes 1 to 44
As per our report of even date

For S R B C & CO LLP For and on behalf of the Board of Directors of


Chartered Accountants Jyothy Laboratories Limited
ÝNÝ®ÞNjŎNJs¶ÞǣǼNjǼÞŸŘŗŸʳˢˡˣ˨˧ˡrˀrˢ˟˟˟˟ˢ

per Vikram Mehta M.P. Ramachandran K.Ullas Kamath


Partner Chairman and Managing Director ğŸÞŘǼōضÞض^ÞNjsOǼŸNjŘ_NÌÞs¯®ÞŘŘOÞĶŷ¯ʩOsNj
ōsŎEsNjǣÌÞƼŗŸʳʲˠ˟ˤ˨ˢ˧ ^Ýŗʲ˟˟ˤˤˢˣ˟˥ ^Ýŗʲ˟˟ˤ˟˥˥˧ˠ
M.L. Bansal S.Raghunandan
Company Secretary ɟÌŸĶsǻÞŎs^ÞNjsOǼŸNjŘ_NÌÞs¯rɮsOȖǼÞɚsŷ¯ʩOsNj
ōsŎEsNjǣÌÞƼŗŸʳʲ®ˡˡ˨˦ ^Ýŗʲ˟ˡˡ˥ˢ˧ˣˤ
ƻĶOsʲōȖŎEÞ ƻĶOsʲōȖŎEÞ
^Ǽsʲōɴˡˢʰˡ˟ˠ˥ ^Ǽsʲōɴˡˢʰˡ˟ˠ˥
NOTES
NOTES
NOTES
‘Ujala House’, Ramkrishna Mandir Road,
Kondivita, Andheri (East),
Mumbai - 400 059.
Telephone: +91-22-6689 2800
Fax: +91-22-6689 2805
Website: www.jyothylaboratories.com

You might also like